"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,BR,A,BR 7502393 A,144-148-947-994-005,1976-03-09,1976,BR 7503047 A,1975-04-18,US 46239374 A,1974-04-19,AGENTE EXPANSOR APERFEICOADO,,DU PONT,BURT J,,https://lens.org/144-148-947-994-005,Patent Application,no,0,0,11,11,0,C08J9/143;;C08J2375/04,C08G18/00;;C08J9/02;;C08J9/14,8-11-4,0,0,,,,DISCONTINUED
2,US,A,US 3728268 A,175-017-340-966-82X,1973-04-17,1973,US 3728268D A,1970-12-11,US 9714170 A,1970-12-11,"MIXTURES OF 1,1,2-TRICHLORO-1,2,2-TRIFLUOROETHANE,ETHANOL AND ACETONE AND A TERNARY AZEOTROPE THEREOF",,DU PONT,BURT J,,https://lens.org/175-017-340-966-82X,Granted Patent,no,0,31,1,1,0,C09D9/00;;C09D9/00;;C09D9/005;;C09D9/005;;C11D7/5086;;C11D7/5086;;C23G5/02819;;C23G5/02819,C09D9/00;;C11D7/50;;C23G5/028,252-170,0,0,,,,EXPIRED
3,US,A,US 3794059 A,075-376-586-723-878,1974-02-26,1974,US 3794059D A,1970-05-27,US 4089070 A,1970-05-27,ELECTRONIC MONITORING CONTROL AND DISPLAY APPARATUS FOR BREATHING GAS SYSTEM,"There is disclosed an electronic monitoring, control and display system for breathing gas system, as for example, in a self-contained underwater breathing apparatus. The output voltage of one or more galvanic partial oxygen pressure sensors, after being compensated for temperature variation, is amplified, limited and averaged and (1) periodically compared with a first reference voltage level to determine whether make up oxygen is to be supplied to the breathing system and (2) compared with a plurality of stepped reference voltage levels, an intermediate level in the steps being the said first reference voltage level. Such plurality of stepped voltage levels are used in a plurality of comparator circuits along with logic circuitry and a bank of display lamps to digitize the conditioned signal voltage from the sensors, the logic circuitry permitting the energization of only one lamp to the exclusion of all others (except an alarm lamp) to eliminate any ambiguity or need for interpretation in the display to the user. In a preferred arrangement a plurality of lamps of the miniature type are housed in a straight row within a waterproof housing which is adapted for securement to the wrist of the diver.",BIOMARINE INDUSTRIES,BURT J,BIOMARINE INDUSTRIES INC (1980-09-05);;BIOMARINE INCORPORATED A DE CORP (1988-02-05);;REXNORD INC (1980-08-29),https://lens.org/075-376-586-723-878,Granted Patent,no,10,15,1,1,0,G05D16/2013;;G05D16/2013;;Y10T137/034;;Y10T137/034;;Y10T137/2509;;Y10T137/2509,G05D16/20,137-093,0,0,,,,EXPIRED
4,US,A,US 4861030 A,003-842-705-407-733,1989-08-29,1989,US 22816488 A,1988-08-04,US 22816488 A,1988-08-04,Two-handed racquet,"A racquet for use in tennis, racquetball, squash and badminton, having an oval or round head, two symmetrical shafts forming the racquet handle and two grips that are offset from the centerline of the handle. The grips may be angled or paralleled with the centerline. In the preferred embodiment, an adjustable torque stabilizer connects the two grips, providing torsional rigidity and permitting adjustment of the space between the grips. The racquet grips are configured so that the player holds the racquet by both grips, and can simply let go of one grip and swing the racquet with the other hand to play `forehand` shots, thus eliminating the critical time normally taken to switch grips.",BURT LIONEL J,BURT LIONEL J,,https://lens.org/003-842-705-407-733,Granted Patent,yes,5,12,7,7,0,A63B49/08;;A63B49/08;;A63B60/00;;A63B60/20;;A63B60/20;;A63B60/34;;A63B60/34;;A63B60/50;;A63B60/50,A63B49/08,273 73J;;273/75,0,0,,,,EXPIRED
5,US,A,US 6026974 A,021-876-700-465-780,2000-02-22,2000,US 14963798 A,1998-09-08,GB 9719020 A,1997-09-08,Fluid reservoir-fuel tank arrangement,"A fluid reservoir--fuel tank arrangement comprises a fluid reservoir module (1) and a fuel tank module (3) connected to the fluid reservoir module (1) via connecting elements (25, 27, and 29) provided for connecting the two modules (1 and 3) together in juxtaposed relationship.",TEXTRON AUTOMOTIVE CO LTD,BURT STEPHEN J,KAUTEX TEXTRON DVS LIMITED (2000-10-12),https://lens.org/021-876-700-465-780,Granted Patent,yes,12,38,5,5,0,B60K15/00;;B60K15/03;;B60K15/063;;B60K2015/03453;;B60K2015/0638;;B60S1/50;;B60S1/50;;B60K15/00;;B60K15/063;;B60K15/03;;B60K2015/03453;;B60K2015/0638,B60K15/00;;B60K15/03;;B60K15/063;;B60S1/50,220/564;;220/23.86;;220/23.4,0,0,,,,EXPIRED
6,WO,A2,WO 2007/092428 A2,063-403-119-336-057,2007-08-16,2007,US 2007/0003123 W,2007-02-06,US 76550006 P,2006-02-06,RACKET WITH VERSATILE HANDLE,"A racket (10). In an illustrative embodiment, the racket (10) includes plural handle portions (14, 16), including a first handle portion (14) and a second handle portion (16), which are equipped with a first gripping surface (18) and a second gripping surface (22), respectively. A first mechanism (46, 20, 24) couples the first handle portion (14) and the second handle portion (16) to a racket so that the first gripping surface (18) is angled relative to a first plane (32) coincident with a hitting surface (32) of the racket (10). In one embodiment, the first handle portion (14) and the second handle portion (16) are removably attached to the racket (10). Alternatively, the first handle portion (14) and the second handle portion (16) are integrated with the racket (10). The first and second handle portions (14, 16) form obtuse angles between the hitting surface (32) and the handle portions (14, 16).",BURT LIONEL J,BURT LIONEL J,,https://lens.org/063-403-119-336-057,Patent Application,yes,0,0,4,4,0,A63B49/08;;A63B60/32;;A63B60/28;;A63B60/20;;A63B60/00;;A63B49/08;;A63B60/28;;A63B60/32;;A63B60/20,,,0,0,,,,PENDING
7,US,B2,US 7976415 B2,005-345-989-049-071,2011-07-12,2011,US 70332107 A,2007-02-06,US 70332107 A;;US 76550006 P,2006-02-06,Racket with versatile handle,"A racket. In an illustrative embodiment, the racket includes plural handle portions, including a first handle portion and a second handle portion, which are equipped with a first gripping surface and a second gripping surface, respectively. A first mechanism couples the first handle portion and the second handle portion to the racket so that the first gripping surface is angled relative to a first plane coincident with a hitting surface of the racket. In a more specific embodiment, the first handle portion and the second handle portion are integrated with the racket. Alternatively, the first handle portion and the second handle portion are removably attached to the racket. The first and second handle portions form obtuse angles between the hitting surface and the handle portions.",BURT LIONEL J,BURT LIONEL J,NATURAL TENNIS INC (2013-12-13),https://lens.org/005-345-989-049-071,Granted Patent,yes,20,2,4,4,0,A63B49/08;;A63B60/32;;A63B60/28;;A63B60/20;;A63B60/00;;A63B49/08;;A63B60/28;;A63B60/32;;A63B60/20,A63B49/08,473/549,0,0,,,,INACTIVE
8,US,A,US 4823228 A,044-861-879-682-138,1989-04-18,1989,US 15294688 A,1988-02-08,US 15294688 A,1988-02-08,RF harmonic monitor for detecting potential lightning strikes by induced corona,"An apparatus for detecting the onset of a potential lightning discharge condition monitors the odd harmonics of an RF signal radiated from a conductive probe (antenna) for fluctuations that are representative of an electrostatic condition-induced corona. In response to the such fluctuations, an output signal representative of the onset of said condition is generated. This output signal may be employed to decouple communication equipment from its antenna until the lightning condition has subsided. In accordance with a further aspect of the present invention, there is provided a device for discharging static charge accumulation from a moving body (e.g. an aircraft) which is comprised of at least one discharging conductive wick arranged to be affixed to the trailing edge of a wing, so that charges may flow from the aircraft into the wick and be discharged therefrom. To enhance discharging of the aircraft, a tuned (LC) circuit, resonant at a frequency within an RF spectrum of frequencies of corona discharge currents that flow through the wick, is coupled between the wing and the wick. Once the level of static charge build-up on the aircraft is sufficient to initiate corona discharge, current flow through the resonant circuit begins to self-oscillate and continues to `ring` after the D.C. voltage level on the body has dropped below that level at which corona was initiated.",HARRIS CORP,BITTNER BURT J,HARRIS CORPORATION (1988-02-05),https://lens.org/044-861-879-682-138,Granted Patent,yes,8,24,1,1,0,B64D45/02;;G01R29/12;;G01W1/16;;G01W1/16;;G01R29/12;;B64D45/02,B64D45/02;;G01R29/12;;G01W1/16,361/218;;324/72;;324/457;;361/117;;361/231,0,0,,,,EXPIRED
9,US,A,US 1077750 A,071-481-480-949-86X,1913-11-04,1913,US 1908/0458234 A,1908-10-17,US 1908/0458234 A,1908-10-17,AEROPLANE.,,PRESSEY BURT J,PRESSEY BURT J,,https://lens.org/071-481-480-949-86X,Granted Patent,no,0,1,1,1,0,B64C17/00;;B64C17/00,,,0,0,,,,EXPIRED
10,US,A,US 734141 A,105-988-550-369-33X,1903-07-21,1903,US 1900/0014885 A,1900-04-30,US 1896/0600920 A;;US 1900/0014885 A,1896-07-29,APPARATUS FOR REPAIRING ASPHALT PAVEMENTS.,,BARBER ASPHALT PAVING CO,SINK BURT J,,https://lens.org/105-988-550-369-33X,Granted Patent,no,0,1,1,1,0,E01C23/14;;E01C23/14,,,0,0,,,,EXPIRED
11,US,A,US 2715469 A,133-574-538-938-662,1955-08-16,1955,US 42124354 A,1954-04-06,US 42124354 A,1954-04-06,Tiering station for bulk packing cans,,CONTINENTAL CAN CO,BURT HOWARD J,,https://lens.org/133-574-538-938-662,Granted Patent,no,0,5,1,1,0,B65B35/32;;B65B35/32,B65B35/32,,0,0,,,,EXPIRED
12,AU,B2,AU 559216 B2,141-414-578-511-732,1987-02-26,1987,AU 1983/012259 A,1983-01-18,US 34083982 A,1982-01-19,APPARATUS FOR IMPROVED CONTROL OF SKIS,,BURT L J,BURT L J,,https://lens.org/141-414-578-511-732,Granted Patent,no,0,0,9,10,0,A63C9/00;;A63C9/00;;A63C5/06;;A63C5/06;;A63C2203/50;;A63C2203/50,A63C5/06;;A63C9/00,,0,0,,,,EXPIRED
13,CA,A,CA 871902 A,160-118-461-743-014,1971-05-25,1971,CA 871902D A,,CA 871902T A,,CURRENT DISCONTINUITY DEVICE,,KAMAN SCIENCES CORP,BITTNER BURT J,,https://lens.org/160-118-461-743-014,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
14,US,A1,US 2007/0184924 A1,169-784-834-576-995,2007-08-09,2007,US 70332107 A,2007-02-06,US 70332107 A;;US 76550006 P,2006-02-06,Racket with versatile handle,"A racket. In an illustrative embodiment, the racket includes plural handle portions, including a first handle portion and a second handle portion, which are equipped with a first gripping surface and a second gripping surface, respectively. A first mechanism couples the first handle portion and the second handle portion to the racket so that the first gripping surface is angled relative to a first plane coincident with a hitting surface of the racket. In a more specific embodiment, the first handle portion and the second handle portion are integrated with the racket. Alternatively, the first handle portion and the second handle portion are removably attached to the racket. The first and second handle portions form obtuse angles between the hitting surface and the handle portions.",BURT LIONEL J,BURT LIONEL J,NATURAL TENNIS INC (2013-12-13),https://lens.org/169-784-834-576-995,Patent Application,yes,17,6,4,4,0,A63B49/08;;A63B60/32;;A63B60/28;;A63B60/20;;A63B60/00;;A63B49/08;;A63B60/28;;A63B60/32;;A63B60/20,A63B49/08,473/549,0,0,,,,INACTIVE
15,US,A1,US 2017/0115163 A1,197-735-788-690-133,2017-04-27,2017,US 201615335315 A,2016-10-26,US 201615335315 A;;US 201562246398 P,2015-10-26,FIELD LENS CORRECTED THREE MIRROR ANASTIGMAT SPECTROGRAPH,"A spectrograph that includes a first mirror having flat a mirror reflective surface and positioned to reflect light traversing a prism, a second mirror having a concave-shaped reflective mirror surface and positioned to reflect light received from the first mirror, a third mirror having a convex-shaped reflective mirror surface and positioned to receive light reflected by the second mirror, a fourth mirror having a spheroidal reflective mirror surface and positioned to receive light reflected by the third mirror, and a field lens comprising a concave mirror surface in combination with a convex mirror surface, wherein light received by said field lens from said fourth mirror enters said convex mirror surface, traverses said field lens, and exits from said concave mirror surface. The fifth mirror is positioned such that the second mirror, third mirror, fourth mirror, and fifth mirror share a common vertex axis.",BEARDSLEY BURT J,BEARDSLEY BURT J,,https://lens.org/197-735-788-690-133,Patent Application,yes,0,2,2,4,0,G01J3/0208;;G02B17/0844;;G02B17/0852;;G01J3/021;;G01J3/1809;;G01N21/718;;G01J2003/1208;;G01J3/021;;G01J3/1809;;G01N21/718;;G01J2003/1208;;G01J3/0208;;G02B17/0852;;G02B17/0844,G01J3/02;;G01J3/18;;G01J3/28;;G01N21/25;;G01N21/71;;G02B5/00;;G02B5/04;;G02B5/18;;G02B17/08;;G02B27/30,,0,0,,,,ACTIVE
16,EP,B1,EP 0098881 B1,014-926-293-451-451,1986-12-30,1986,EP 83900684 A,1983-01-18,US 34083982 A,1982-01-19,APPARATUS FOR IMPROVED CONTROL OF SKIS,,"BURT, LIONEL J.","BURT, LIONEL J.",,https://lens.org/014-926-293-451-451,Granted Patent,yes,0,0,9,10,0,A63C9/00;;A63C9/00;;A63C5/06;;A63C5/06;;A63C2203/50;;A63C2203/50,A63C5/06;;A63C9/00,,0,0,,,,EXPIRED
17,US,A,US 4989430 A,048-945-236-549-847,1991-02-05,1991,US 44313289 A,1989-11-29,GB 8725977 A,1987-11-05,Latch mechanism,"A latch mechanism for a door or the like includes first and second rotatable latch operating members which operate a latching bolt or the like. An axially movable square section spindle extends through complementary holes in both members. In an engaged position, the spindle operates both members when rotated. In a disengaged position, a circular section portion of the spindle registers with a hole in one of the members. In the disengaged position the bolt can be operated by the first member even though the second member may be prevented from rotating by means of pins. The spindle can be moved between engaged and disengaged positions by a push-rod extending out of the door. Thus, when the second member is locked it may be overriden by actuation of the rod and the first member.",TITON HARDWARE,BURT ARTHUR J,TITON HARDWARE LIMITED (1990-01-16),https://lens.org/048-945-236-549-847,Granted Patent,yes,13,1,6,6,0,E05B63/0069;;E05B63/0069;;E05B13/004;;E05B13/004;;Y10T70/7712;;Y10T70/7712;;Y10T292/59;;Y10T292/59,E05B13/00;;E05B63/00,70/380;;292/336.5,1,0,,,British Standard PS 5872 (1980).,EXPIRED
18,US,A,US 2749520 A,171-951-169-239-338,1956-06-05,1956,US 31870252 A,1952-11-04,US 31870252 A,1952-11-04,Directional coupling means for transmission lines,,BITTNER BURT J,BITTNER BURT J,,https://lens.org/171-951-169-239-338,Granted Patent,no,6,5,1,1,0,H01P5/183;;H01P5/183,H01P5/18,,0,0,,,,EXPIRED
19,US,B2,US 7325576 B2,010-313-297-874-905,2008-02-05,2008,US 50144406 A,2006-08-09,US 50144406 A;;US 70652805 P,2005-08-09,Inflatable suction hose,A flexible suction hose has supporting ribs that may be inflated to hold the hose open against suction for use and deflated to allow the suction hose to be folded or collapsed for storage and transportation.,PETERSON BURT J,PETERSON BURT J,,https://lens.org/010-313-297-874-905,Granted Patent,yes,13,7,2,3,0,A62C33/00;;A62C33/00;;F16L11/02;;F16L11/02;;F16L11/118;;F16L11/118,F16L11/00,138/115;;138/106;;138/109,0,0,,,,INACTIVE
20,US,A,US 2930070 A,026-368-858-297-36X,1960-03-29,1960,US 62686656 A,1956-12-07,US 62686656 A,1956-12-07,Door closer,,UEBELHOER BROTHERS INC,UEBELHOER BURT J,,https://lens.org/026-368-858-297-36X,Granted Patent,no,10,8,1,1,0,E05F3/06;;E05Y2900/132;;Y10T292/47;;Y10T292/47;;E05F3/06;;E05Y2900/132,E05F3/06,,0,0,,,,EXPIRED
21,US,S,US D0388867 S,024-241-177-530-575,1998-01-06,1998,US 5321596 F,1996-04-17,US 5321596 F,1996-04-17,Splashguard for bathtub,,BACA BURT J,BACA BURT J,,https://lens.org/024-241-177-530-575,Design Right,yes,5,4,1,1,0,,,D23/307;;2302,0,0,,,,EXPIRED
22,US,B2,US 9677932 B2,126-701-739-466-185,2017-06-13,2017,US 201615335315 A,2016-10-26,US 201615335315 A;;US 201562246398 P,2015-10-26,Field lens corrected three mirror anastigmat spectrograph,"A spectrograph that includes a first mirror having flat a mirror reflective surface and positioned to reflect light traversing a prism, a second mirror having a concave-shaped reflective mirror surface and positioned to reflect light received from the first mirror, a third mirror having a convex-shaped reflective mirror surface and positioned to receive light reflected by the second mirror, a fourth mirror having a spheroidal reflective mirror surface and positioned to receive light reflected by the third mirror, and a field lens comprising a concave mirror surface in combination with a convex mirror surface, wherein light received by said field lens from said fourth mirror enters said convex mirror surface, traverses said field lens, and exits from said concave mirror surface. The fifth mirror is positioned such that the second mirror, third mirror, fourth mirror, and fifth mirror share a common vertex axis.",BEARDSLEY BURT J,BEARDSLEY BURT J,,https://lens.org/126-701-739-466-185,Granted Patent,yes,1,2,2,4,0,G01J3/0208;;G02B17/0844;;G02B17/0852;;G01J3/021;;G01J3/1809;;G01N21/718;;G01J2003/1208;;G01J3/021;;G01J3/1809;;G01N21/718;;G01J2003/1208;;G01J3/0208;;G02B17/0852;;G02B17/0844,G01J3/28;;G01J3/02;;G01J3/12;;G01J3/18;;G01N21/25;;G01N21/71;;G02B5/00;;G02B5/04;;G02B5/18;;G02B17/08;;G02B27/30,,0,0,,,,ACTIVE
23,US,A,US 1081147 A,160-860-592-426-752,1913-12-09,1913,US 1908/0463460 A,1908-11-19,US 1908/0463460 A,1908-11-19,AEROPLANE.,,PRESSEY BURT J,PRESSEY BURT J,,https://lens.org/160-860-592-426-752,Granted Patent,no,0,1,1,1,0,B64C17/00;;B64C17/00,,,0,0,,,,EXPIRED
24,US,A,US 2262094 A,153-191-204-607-393,1941-11-11,1941,US 20957038 A,1938-05-23,US 20957038 A,1938-05-23,Blowing machine,,BURT HENRY J,BURT HENRY J,,https://lens.org/153-191-204-607-393,Granted Patent,no,0,33,1,1,0,B65G53/4616;;B65G53/4616,B65G53/46,,0,0,,,,EXPIRED
25,EP,A4,EP 0383867 A4,006-169-744-170-347,1991-01-02,1991,EP 89908004 A,1989-04-18,US 22816488 A,1988-08-04,TWO-HANDED RACQUET,,"BURT, LIONEL J.","BURT, LIONEL J.",,https://lens.org/006-169-744-170-347,Search Report,no,0,0,7,7,0,A63B49/08;;A63B49/08;;A63B60/00;;A63B60/20;;A63B60/20;;A63B60/34;;A63B60/34;;A63B60/50;;A63B60/50,A63B49/08,,2,0,,,No further relevant documents have been disclosed.;;See also references of WO 9001356A1,DISCONTINUED
26,US,A,US 4737839 A,014-038-801-163-582,1988-04-12,1988,US 83863686 A,1986-03-11,US 83863686 A;;US 59065284 A,1984-03-19,Semiconductor chip mounting system,"A semiconductor chip module with a flat mounting surface is disclosed. A wafer-scale silicon semiconductor chip is provided with electronic circuits formed therein. The chip has a metallized back face and contacts on the opposite, front face. A solder layer secures the metallized back face of the chip to the mounting surface substantially without voids.",TRILOGY COMPUTER DEV PARTNERS,BURT ROY J,ELXSI CORPORATION A DE CORP (1990-02-20);;INTEL CORPORATION A DE CORP (1990-02-20),https://lens.org/014-038-801-163-582,Granted Patent,yes,5,209,1,2,0,H01L21/76897;;H01L23/4827;;H01L2224/04026;;H01L2924/01322;;H01L2924/01327;;H01L2924/10253;;H01L21/76897;;H01L23/4827;;H01L2224/04026;;H01L2924/01322;;H01L2924/01327;;H01L2924/10253,H01L21/60;;H01L23/482,H1K KRM           RM,1,0,,,"Silicides for Interconnection Technology Solid State Technology Author Farrokh Mohammed Jan. 1981, pp. 65 72.",EXPIRED
27,US,A,US 4363425 A,090-486-178-064-261,1982-12-14,1982,US 12071680 A,1980-02-11,US 12071680 A,1980-02-11,Funnel for diesel oil cans,"An apparatus for opening a fluid-filled container and pouring the fluid therefrom being comprised of a circular member with an inner and outer surface with an elongated rim therearound, the circular member being placed over the fluid container; a plurality of container-piercing blades disposed on the inner surface of the member; an opening through the circular member cooperable with one of the container-piercing blade; and a flexible tubular funnel attached at one end thereof around the opening, the funnel being of sufficient rigidity to not bend under the weight of the apparatus and the fluid-filled container thereby supporting the apparatus and the container at any desired angle while fluid is being poured therefrom.",EHRENRICH BURT J,EHRENRICH BURT J,,https://lens.org/090-486-178-064-261,Granted Patent,yes,12,0,1,1,0,B67B7/28;;B67B7/28;;F02B3/06;;F02B3/06,B67B7/86;;F02B3/06,222/85,0,0,,,,EXPIRED
28,US,S,US D0284421 S,170-426-510-683-239,1986-07-01,1986,US 56208283 F,1983-12-16,US 56208283 F,1983-12-16,Container for storing personal effects while swimming or bathing,,SIRCO INT CORP,SIRIS BURT J,SIRCO INTERNATIONAL CORP. A CORP OF NY (1986-01-27),https://lens.org/170-426-510-683-239,Design Right,yes,6,9,1,1,0,,,D 3 301,0,0,,,,EXPIRED
29,US,A,US 1836442 A,166-698-699-746-487,1931-12-15,1931,US 33540329 A,1929-01-28,US 33540329 A,1929-01-28,Thermostat switch,,THERMOSTOVE CORP LTD,BURT ELMER J,,https://lens.org/166-698-699-746-487,Granted Patent,no,0,1,1,1,0,H01H73/30;;H01H73/30,H01H73/30,,0,0,,,,EXPIRED
30,US,A,US 4574470 A,029-817-623-010-037,1986-03-11,1986,US 59065284 A,1984-03-19,US 59065284 A,1984-03-19,Semiconductor chip mounting system,"A semiconductor chip module with a flat mounting surface is disclosed. A wafer-scale silicon semiconductor chip is provided with electronic circuits formed therein. The chip has a metallized back face and contacts on the opposite, front face. A solder layer secures the metallized back face of the chip to the mounting surface substantially without voids.",TRILOGY COMPUTER DEV PARTNERS,BURT ROY J,ELXSI CORPORATION A DE CORP (1990-02-20);;INTEL CORPORATION A DE CORP (1990-02-20);;TRILOGY COMPUTER DEVELOPMENT PARTNERS LTD (1984-03-15),https://lens.org/029-817-623-010-037,Granted Patent,yes,2,38,1,2,0,H01L23/4827;;H01L24/29;;H01L24/75;;H01L2224/04026;;H01L2224/274;;H01L2924/014;;H01L2924/10253;;H01L2924/01005;;H01L2924/01006;;H01L2924/01023;;H01L2924/01024;;H01L2924/01033;;H01L2924/01042;;H01L2924/01047;;H01L2924/01079;;H01L2924/01322;;H01L2924/01327;;H01L2924/01029;;Y10T428/12528;;Y10T428/12528;;H01L23/4827;;H01L2224/04026;;H01L24/75;;H01L24/29;;H01L2924/10253;;H01L2224/274;;H01L2924/014;;H01L2924/01005;;H01L2924/01033;;H01L2924/01042;;H01L2924/01006;;H01L2924/01023;;H01L2924/01047;;H01L2924/01322;;H01L2924/01024;;H01L2924/01079;;H01L2924/01327;;H01L2924/01029,H01L23/482,H1K KHAX          HAX;;H1K KPDB          PDB,0,0,,,,EXPIRED
31,US,A,US 1023320 A,042-295-828-171-024,1912-04-16,1912,US 1911/0623562 A,1911-04-27,US 1911/0623562 A,1911-04-27,CORN-PICKER.,,KAULL BURT J,KAULL BURT J,,https://lens.org/042-295-828-171-024,Granted Patent,no,0,6,1,1,0,A01D45/02;;A01D45/02,,,0,0,,,,EXPIRED
32,US,A,US 1988519 A,085-458-158-763-138,1935-01-22,1935,US 69776133 A,1933-11-13,US 69776133 A,1933-11-13,Cloth shrinking machine,,FASHION PARK MFG CORP,SHAW BURT J,,https://lens.org/085-458-158-763-138,Granted Patent,no,0,2,1,1,0,D06C7/02;;D06C7/02,D06C7/02,,0,0,,,,EXPIRED
33,US,A,US 4713999 A,100-554-530-690-951,1987-12-22,1987,US 87079886 A,1986-06-05,US 87079886 A,1986-06-05,Dual harmonica arrays and harmonica receptacles,"Dual harmonica arrays and dual harmonica receptacles are provided, facilitating the playing of dual diatonic, chord and bass harmonicas. The harmonicas are maintained in a lower forward position and an upper rear position which are readily reversible.",BURT RAYMOND J,BURT RAYMOND J,,https://lens.org/100-554-530-690-951,Granted Patent,yes,4,10,1,1,0,G10D7/14;;G10D7/14,G10D7/12,G5J JWAA          JWAA,0,0,,,,EXPIRED
34,US,A,US 1679810 A,156-690-916-046-542,1928-08-07,1928,US 25898028 A,1928-03-03,US 25898028 A,1928-03-03,Signaling device for automobiles,,BURT WILLIAM J,BURT WILLIAM J,,https://lens.org/156-690-916-046-542,Granted Patent,no,0,0,1,1,0,B60Q1/34;;B60Q1/34,B60Q1/34,,0,0,,,,EXPIRED
35,US,A1,US 2015/0312739 A1,173-867-345-389-214,2015-10-29,2015,US 201414261998 A,2014-04-25,US 201414261998 A,2014-04-25,"COMPUTER PROGRAM, METHOD, AND SYSTEM FOR OBTAINING AND PROVIDING EMERGENCY SERVICES","A computer program, method, and system for obtaining and providing emergency services, which includes an initial step of receiving user profile data from a plurality of emergency service users. A next step includes presenting a solicitation for a civilian user to select an emergency event type. A next step includes receiving information indicative of the emergency event type. Next, the emergency event type is compared with and the user profile data of the emergency service users, and a notification is sent to a first emergency service user of either a first type or a second type. A next step includes presenting a solicitation for the first emergency service user to communicate with the civilian user. Upon receiving information indicative of an assent to communicate with the civilian user, a communication link is opened between the first emergency service user and the civilian user.",BURT SHAUNCEY J,BURT SHAUNCEY J,,https://lens.org/173-867-345-389-214,Patent Application,yes,0,11,1,1,0,G16H10/60;;H04W4/90;;A61B7/00;;G16H10/60;;H04W4/90,H04W4/90;;A61B5/00;;A61B5/021;;A61B5/11;;A61B7/00,,0,0,,,,DISCONTINUED
36,JP,B1,JP S4417650 B1,005-161-498-853-376,1969-08-02,1969,JP 5792964 A,1964-10-12,US 31557363 A,1963-10-11,JP S4417650 B1,,KAMAN AIRCRAFT CORP,BITTNER BURT J,,https://lens.org/005-161-498-853-376,Patent Application,no,0,0,4,4,0,H01Q5/00;;H01Q5/00;;H01P5/08;;H01P5/08;;H01Q1/281;;H01Q1/281;;H01Q7/00;;H01Q7/00;;H01Q9/16;;H01Q9/16,H01P5/08;;H01Q1/28;;H01Q5/00;;H01Q5/15;;H01Q7/00;;H01Q9/16,,0,0,,,,DISCONTINUED
37,US,A,US 1163209 A,067-388-510-292-264,1915-12-07,1915,US 3909715 A,1915-07-10,US 3909715 A,1915-07-10,PAPER BOX.,,OKLAHOMA PAPER COMPANY,BURT WILLIAM J,,https://lens.org/067-388-510-292-264,Granted Patent,no,0,1,1,1,0,B65D5/3664;;B65D5/3664,,,0,0,,,,EXPIRED
38,US,A,US 2005352 A,092-554-722-208-850,1935-06-18,1935,US 73141834 A,1934-06-20,US 73141834 A,1934-06-20,Cloth shrinking machine,,FASHION PARK MFG CORP,SHAW BURT J,,https://lens.org/092-554-722-208-850,Granted Patent,no,0,4,1,1,0,D06C7/02;;D06C7/02,D06C7/02,,0,0,,,,EXPIRED
39,US,A,US 3010153 A,103-929-512-227-821,1961-11-28,1961,US 79901559 A,1959-03-12,US 79901559 A,1959-03-12,Construction of paraboloid surfaces,,GULTON IND INC,BITTNER BURT J,,https://lens.org/103-929-512-227-821,Granted Patent,no,4,31,1,1,0,B22D13/04;;B29C41/045;;B29L2011/0041;;B29L2031/76;;Y10S425/808;;B29C41/045;;B29L2011/0041;;B29L2031/76;;B22D13/04;;Y10S425/808,B22D13/04;;B29C41/04,,0,0,,,,EXPIRED
40,EP,A4,EP 0098881 A4,147-016-535-416-887,1984-06-29,1984,EP 83900684 A,1983-01-18,US 34083982 A,1982-01-19,APPARATUS FOR IMPROVED CONTROL OF SKIS.,,BURT LIONEL J,BURT LIONEL J,,https://lens.org/147-016-535-416-887,Search Report,no,4,0,9,10,0,A63C9/00;;A63C9/00;;A63C5/06;;A63C5/06;;A63C2203/50;;A63C2203/50,A63C5/06;;A63C9/00,,1,0,,,See also references of WO 8302397A1,EXPIRED
41,US,A,US 4760435 A,153-043-157-231-500,1988-07-26,1988,US 87819786 A,1986-06-25,GB 8517081 A,1985-07-05,Anti-blooming drain structure in charge coupled device image sensors,"A frame transfer buried channel CCD image sensor incorporating an anti-blooming drain structure (25, 27) wherein accumulation of charge of opposite polarity to that drained by the anti-blooming drain structure is prevented. This can conveniently be achieved by arranging for the buried channel diffusion (19) in each channel to stop short of the anti-blooming drain diffusion (25) on one side of each channel. As a result of the prevention of charge accumulation the anti-blooming drain structure remains effective with optical overloads much greater than the optical overload at which anti-blooming performance begins to deteriorate in conventional buried channel CCD image sensors.",GEN ELECTRIC CO PLC,BURT DAVID J,GENERAL ELECTRIC COMPANY P.L.C. THE 1 STANHOPE GATE LONDON W1A 1EH ENGLAND A BRITISH COMPANY (1986-08-20),https://lens.org/153-043-157-231-500,Granted Patent,yes,7,9,5,8,0,H01L27/14887;;H01L27/14887,H01L27/148,357/24;;357/30;;358/213.19,0,0,,,,EXPIRED
42,EP,A1,EP 0098881 A1,001-806-264-857-526,1984-01-25,1984,EP 83900684 A,1983-01-18,US 34083982 A,1982-01-19,APPARATUS FOR IMPROVED CONTROL OF SKIS.,"L'appareil de contrôle de ski comprend un assemblage de support de jambe (22) s'étendant vers le haut depuis le bord extérieur latéral du ski (24) pour s'attacher à l'aide d'une manche (42) autour de la jambe (14) du skieur en une position légèrement sous le genou (16). L'assemblage de support de jambe (22) est rigide latéralement pour transmettre les mouvements latéraux de la jambe (14) directement au bord extérieur du ski (24) et la manche (42) empêche une torsion vers l'intérieur du genou (16) lorsque l'on glisse sur les carres. Dans un mode de réalisation, l'appareil comprend un assemblage de liaison bidirectionnel (170, 172) incorporé dans l'assemblage de support de jambe (22) s'utilisant à la place d'une liaison de chaussure conventionnelle montée sur le ski (12). Dans un autre mode de réalisation, un câble réglable (182) est relié entre la manche et la pointe antérieure (186) du ski (12).",BURT LIONEL J,BURT LIONEL J,,https://lens.org/001-806-264-857-526,Patent Application,yes,0,0,9,10,0,A63C9/00;;A63C9/00;;A63C5/06;;A63C5/06;;A63C2203/50;;A63C2203/50,A63C5/06;;A63C9/00,,0,0,,,,EXPIRED
43,US,A,US 1727154 A,022-989-600-563-938,1929-09-03,1929,US 27132228 A,1928-04-19,US 27132228 A,1928-04-19,Attachment for plows,,ANDERSON BURT J,ANDERSON BURT J,,https://lens.org/022-989-600-563-938,Granted Patent,no,0,0,1,1,0,A01B17/002;;A01B17/002,A01B17/00,,0,0,,,,EXPIRED
44,US,A,US 2835890 A,109-349-427-665-357,1958-05-20,1958,US 25064551 A,1951-10-10,US 25064551 A,1951-10-10,Directional antenna,,BITTNER BURT J,BITTNER BURT J,,https://lens.org/109-349-427-665-357,Granted Patent,no,7,6,1,1,0,H01Q15/22;;H01Q15/22;;H01Q3/12;;H01Q3/12,H01Q3/12;;H01Q15/22,,0,0,,,,EXPIRED
45,US,S,US D0330281 S,128-241-431-357-538,1992-10-20,1992,US 27030188 F,1988-11-14,US 27030188 F,1988-11-14,Handbag,,SIRCO INT CORP,SIRIS BURT J,SIRCO INTERNATIONAL CORP. A CORP. OF NY (1988-11-03),https://lens.org/128-241-431-357-538,Design Right,yes,5,9,1,1,0,,,D 3 48,0,0,,,,EXPIRED
46,US,A,US 4473235 A,027-742-130-123-950,1984-09-25,1984,US 34083982 A,1982-01-19,US 34083982 A,1982-01-19,Apparatus for improved control of skis,"Apparatus is provided for improving control of snow skis while reducing likelihood of injury and permitting use of relatively flexible and comfortable ski boots. The apparatus comprises a leg support assembly extending upwardly from the laterally outside edge of the ski for connection by use of a wraparound cuff to the skier's leg at a position slightly below the knee. The leg support assembly is adjustable to permit a selected degree of unrestrained flexion of the leg, including the knee and the ankle, in a longitudinal direction with respect to the ski for enhanced ski control and reduced muscular fatigue. However, the leg support assembly is laterally rigid to transmit lateral movements of the leg directly to the outside edge of the ski for improved edging during turns, while the cuff helps to prevent inward twisting of the knee during edging to reduce likelihood of injury. In one embodiment, the apparatus further includes a bidirectional binding assembly incorporated into the leg support assembly for use in lieu of a conventional boot binding mounted on the ski. In another embodiment, an adjustable cable is connected between the cuff and the front tip of the ski for use in obtaining a reverse camber condition of the ski upon rearward flexion of the leg for lifting the front tip of the ski, particularly during turns in deep powder.",BURT LIONEL J,BURT LIONEL J,,https://lens.org/027-742-130-123-950,Granted Patent,yes,14,44,9,10,0,A63C9/00;;A63C9/00;;A63C5/06;;A63C5/06;;A63C2203/50;;A63C2203/50,A63C5/06;;A63C9/00,280/11.36;;36/121;;280/617,0,0,,,,EXPIRED
47,US,A,US 2099354 A,175-867-201-517-160,1937-11-16,1937,US 11209036 A,1936-11-21,US 11209036 A,1936-11-21,Envelope,,STEELE BURT J,STEELE BURT J,,https://lens.org/175-867-201-517-160,Granted Patent,no,0,2,1,1,0,B65D27/14;;B65D27/22;;B65D27/14;;B65D27/22,B65D27/14;;B65D27/22,,0,0,,,,EXPIRED
48,US,A,US 3365721 A,001-182-099-758-512,1968-01-23,1968,US 53958566 A,1966-04-01,US 53958566 A;;US 31557363 A,1963-10-11,Current discontinuity device,,KAMAN AIRCRAFT CORP,BITTNER BURT J,,https://lens.org/001-182-099-758-512,Granted Patent,no,6,16,4,4,0,H01Q5/00;;H01Q5/00;;H01P5/08;;H01P5/08;;H01Q1/281;;H01Q1/281;;H01Q7/00;;H01Q7/00;;H01Q9/16;;H01Q9/16,H01P5/08;;H01Q1/28;;H01Q5/00;;H01Q5/15;;H01Q7/00;;H01Q9/16,343/856,0,0,,,,EXPIRED
49,WO,A1,WO 1983/002397 A1,020-967-345-422-715,1983-07-21,1983,US 8300072 W,1983-01-18,US 34083982 A,1982-01-19,APPARATUS FOR IMPROVED CONTROL OF SKIS,"The ski control apparatus comprises a leg support assembly (22) extending upwardly from the lateral outside edge of the ski (24) for connection by use of a wrap-around cuff (42) to the skier's leg (14) at a position slightly below the knee (16). The leg support assembly (22) is laterally rigid to transmit lateral movements of the leg (14) directly to the outside edge of the ski (24) and the cuff (42) prevents inward twisting of the knee (16) during edging. In one embodiment, the apparatus includes a bi-directional binding assembly (170, 172) incorporated into the leg support assembly (22) for use in lieu of a conventional boot binding mounted on the ski (12). In another embodiment, an adjustable cable (182) is connected between the cuff and the front tip (186) of the ski (12).",BURT LIONEL J,BURT LIONEL J,,https://lens.org/020-967-345-422-715,Patent Application,yes,8,14,9,10,0,A63C9/00;;A63C9/00;;A63C5/06;;A63C5/06;;A63C2203/50;;A63C2203/50,A63C5/06;;A63C9/00,A6D DSB           DSB;;A6D D34           D31-35;;A6D D35C          D31-35,1,0,,,See also references of EP 0098881A4,PATENTED
50,US,A,US 5473364 A,031-618-211-361-172,1995-12-05,1995,US 25351294 A,1994-06-03,US 25351294 A,1994-06-03,Video technique for indicating moving objects from a movable platform,"An imaging technique, suitable for surveillance use by a moving robotic vehicle carrying two spatially displaced fixed cameras aligned with the direction of travel or, alternatively, a single camera movable to either of two positions on the vehicle corresponding to the positions occupied by the fixed cameras, is capable in a moving object indicator mode of deriving first image data of a viewed scene at a first time from a first position with respect to the vehicle and of deriving second image data of the viewed scene at a second time from a second position with respect to the vehicle that is spatially displaced a given distance from the first position such that the spatial position with respect to the viewed scene depicted by the second image data at least approximates the spatial position with respect to the viewed scene depicted by the first image data. As an aid to detecting driving hazards encountered by the moving vehicle, the imaging technique may also be operated in a stereo-vision mode, in which the first and second image data is derived at the same time from the same angle of gaze of the viewed scene.",SARNOFF DAVID RES CENTER,BURT PETER J,DAVID SARNOFF RESEARCH CENTER INC (1994-06-03);;SARNOFF CORPORATION (1997-04-04),https://lens.org/031-618-211-361-172,Granted Patent,yes,4,138,3,3,0,G08B13/19602;;G08B13/1963;;G08B13/19641;;G08B13/19647;;H04N7/181;;H04N7/185;;H04N2013/0081;;H04N2013/0085;;G06T2207/10012;;G06T2207/30252;;G06T2207/30261;;G06T7/254;;H04N13/194;;H04N13/221;;H04N13/189;;H04N13/296;;H04N13/239;;G08B13/19602;;G08B13/19647;;H04N7/185;;G08B13/19641;;H04N2013/0081;;H04N7/181;;H04N2013/0085;;G08B13/1963;;G06T2207/30252;;G06T2207/10012;;G06T2207/30261;;G06T7/254;;H04N13/239;;H04N13/221;;H04N13/189;;H04N13/194;;H04N13/296,G08B13/194;;H04N7/18;;H04N13/00,348/47;;348/144;;348/154;;348/155;;348/169,3,1,052-665-822-647-544,10.1109/wvm.1991.212812,"Anderson, et al Change Detection & Tracking Using Pyramid Transform Techniques SPIE Conference on Intelligent Robotics & Computer VisionBoston Mass., Sep. 1985 SPIE vol. 579.;;P. J. Burt, et al Object Tracking With A Moving Camera An Application Of Dynamic Motion Analysis Proceedings of the Workshop on Visual Motion, Irvine Calif., Mar. 20 22, 1989 pp. 1 12.;;K. J. Hanna, Direct Multi Resolution Estimation Of Ego Motion & Structure From Motion IEEE Workshop on Visual Motion , Princeton N.J. Sep. 1991.",EXPIRED
51,US,A,US 958649 A,058-342-397-704-73X,1910-05-17,1910,US 1909/0499436 A,1909-06-01,US 1909/0499436 A,1909-06-01,CORN-PICKER.,,INDIANA PICKER & HUSKER COMPANY,KAULL BURT J,,https://lens.org/058-342-397-704-73X,Granted Patent,no,0,0,1,1,0,A01D45/021;;A01D45/021,,,0,0,,,,EXPIRED
52,AU,A,AU 1983/012259 A,127-093-170-864-655,1983-07-28,1983,AU 1983/012259 A,1983-01-18,US 34083982 A,1982-01-19,APPARATUS FOR IMPROVED CONTROL OF SKIS,,BURT LIONEL J,BURT LIONEL J,,https://lens.org/127-093-170-864-655,Patent Application,no,0,0,9,10,0,A63C5/06;;A63C9/00;;A63C2203/50;;A63C9/00;;A63C5/06;;A63C2203/50,A63C5/06;;A63C9/00,,0,0,,,,EXPIRED
53,US,A,US 2087637 A,148-559-325-047-929,1937-07-20,1937,US 64535 A,1935-01-07,US 64535 A,1935-01-07,Ventilating system,,BURT HENRY J,BURT HENRY J,,https://lens.org/148-559-325-047-929,Granted Patent,no,0,19,1,1,0,F24F7/007;;F24F7/007;;F24F7/065;;F24F7/065,F24F7/007;;F24F7/06,,0,0,,,,EXPIRED
54,US,A,US 1246751 A,016-662-442-403-207,1917-11-13,1917,US 10877216 A,1916-07-12,US 10877216 A,1916-07-12,COLLAPSIBLE HOG-FEEDER.,,INDIANA WAGON COMPANY,KAULL BURT J,,https://lens.org/016-662-442-403-207,Granted Patent,no,0,2,1,1,0,A01K39/012;;A01K39/012,,,0,0,,,,EXPIRED
55,US,S,US D0386885 S,024-775-169-932-933,1997-12-02,1997,US 6195596 F,1996-11-04,US 6195596 F,1996-11-04,Edible cup,,BELL BURT J,BELL BURT J,,https://lens.org/024-775-169-932-933,Design Right,yes,5,3,1,1,0,,,D 1116;;0101,0,0,,,,EXPIRED
56,US,A,US 5063603 A,102-898-870-372-636,1991-11-05,1991,US 43201389 A,1989-11-06,US 43201389 A,1989-11-06,DYNAMIC METHOD FOR RECOGNIZING OBJECTS AND IMAGE PROCESSING SYSTEM THEREFOR,"A time series of successive relatively high-resolution frames of image data, any frame of which may or may not include a graphical representation of one or more predetermined specific members (e.g., particular known persons) of a given generic class (e.g. human beings), is examined in order to recognize the identity of a specific member if that member's image is included in the time series. The frames of image data may be examined in real time at various resolutions, starting with a relatively low resolution, to detect whether some earlier-occurring frame includes any of a group of image features possessed by an image of a member of the given class. The image location of a detected image feature is stored and then used in a later-occurring, higher resolution frame to direct the examination only to the image region of the stored location in order to (1) verify the detection of the aforesaid image feature, and (2) detect one or more other of the group of image features, if any is present in that image region of the frame being examined. By repeating this type of examination for later and later occurring frames, the accumulated detected features can first reliably recognize the detected image region to be an image of a generic object of the given class, and later can reliably recognize the detected image region to be an image of a certain specific member of the given class.",SARNOFF DAVID RES CENTER,BURT PETER J,DAVID SARNOFF RESEARCH CENTER INC. A CORP. OF DE (1989-11-03);;SARNOFF CORPORATION (1997-04-04),https://lens.org/102-898-870-372-636,Granted Patent,yes,8,516,10,10,0,G06V40/166;;G06V10/25;;G06V30/2504;;G06V40/166;;G06V10/25;;G06V30/2504,G06T7/00;;G06V10/25;;G06T7/20,382/37;;382/2;;382/39,0,0,,,,EXPIRED
57,US,A,US 2451531 A,193-695-455-428-269,1948-10-19,1948,US 66587346 A,1946-04-29,US 66587346 A,1946-04-29,Wire tightener,,BRADLEY BURT J,BRADLEY BURT J,,https://lens.org/193-695-455-428-269,Granted Patent,no,5,2,1,1,0,F16G11/12;;F16G11/12,F16G11/12,,0,0,,,,EXPIRED
58,US,A1,US 2007/0044859 A1,189-591-140-593-867,2007-03-01,2007,US 50144406 A,2006-08-09,US 50144406 A;;US 70652805 P,2005-08-09,Inflatable suction hose,A flexible suction hose has supporting ribs that may be inflated to hold the hose open against suction for use and deflated to allow the suction hose to be folded or collapsed for storage and transportation.,PETERSON BURT J,PETERSON BURT J,,https://lens.org/189-591-140-593-867,Patent Application,yes,13,6,2,3,0,A62C33/00;;A62C33/00;;F16L11/02;;F16L11/02;;F16L11/118;;F16L11/118,F16L11/00,138/119;;15/414;;138/118;;138/121;;138/122;;138/173,0,0,,,,INACTIVE
59,AT,T1,AT E24409 T1,110-042-669-323-893,1987-01-15,1987,AT 83900684 T,1983-01-18,EP 83900684 A;;US 34083982 A;;US 8300072 W,1982-01-19,VORRICHTUNG ZUR VERBESSERTEN KONTROLLE VON SKIERN.,,BURT LIONEL J,BURT LIONEL J,,https://lens.org/110-042-669-323-893,Granted Patent,no,0,1,1,10,0,,A43B5/04;;A63C5/06,,0,0,,,,DISCONTINUED
60,CA,A,CA 850815 A,154-831-955-936-816,1970-09-01,1970,CA 850815D A,,CA 850815T A,,CURRENT DISCONTINUITY DEVICE,,KAMAN SCIENCES CORP,BITTNER BURT J,,https://lens.org/154-831-955-936-816,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
61,US,A1,US 2010/0212461 A1,172-709-874-088-978,2010-08-26,2010,US 39159109 A,2009-02-24,US 39159109 A,2009-02-24,OPEN END RATCHET WRENCH,"An open ended ratchet wrench includes an elongated handle and generally C-shaped head that is pivotally connected to the elongated handle. A cavity is formed within the C-shaped head. A pair of dogs pivotally mounted within the cavity, each having ratchet teeth. An elongated spring is positioned within the cavity and heaving each of a first end thereof abuttingly engaging a predetermined portion of one of the pair of dogs and having an opposed second end thereof abuttingly engaging a predetermined portion of an opposed one of the pair of dogs. A generally C-shaped insert is centrally disposed within the head and having ratchet teeth on each dog. An actuating member is secured to the spring and is manually operable to selectively rotate the head with the insert or ratchet the head about the insert.",BURT WILLIAM J,BURT WILLIAM J,,https://lens.org/172-709-874-088-978,Patent Application,yes,15,9,1,1,0,B25B13/04;;B25B13/463;;B25B23/0028;;B25B13/04;;B25B23/0028;;B25B13/463,B25B13/08,81/58.2,0,0,,,,DISCONTINUED
62,US,A,US 3134341 A,183-640-352-371-967,1964-05-26,1964,US 25712263 A,1963-02-08,US 25712263 A,1963-02-08,Means for switching railroad cars for connection with a moving train,,GROESBECK BURT J,GROESBECK BURT J,,https://lens.org/183-640-352-371-967,Granted Patent,no,4,0,1,1,0,B61J3/00;;B61J3/00,B61J3/00,,0,0,,,,EXPIRED
63,EP,A1,EP 0383867 A1,188-429-281-602-50X,1990-08-29,1990,EP 89908004 A,1989-04-18,US 22816488 A,1988-08-04,TWO-HANDED RACQUET.,"Une raquette pour jouer au tennis, au squash et au badmington, comprend une tête (1) ovale ou ronde, deux axes symétriques (6, 7) formant le manche de la raquette, ainsi que deux poignées (8, 8) décalées de la ligne centrale du manche. Les poignées peuvent être à angle par rapport à la ligne centrale ou parallèles à celle-ci. Dans le mode de réalisation préféré, un stabilisateur (9) de torsion réglable relie les deux poignées, assurant une rigidité torsionelle et permettant le réglage de l'espace entre les poignées. Lesdites poignées de la raquette sont configurées de sorte que le joueur tienne ladite raquette par les deux poignées, et qu'il puisse simplement laisser aller une poignée et faire pivoter la raquette avec l'autre main pour jouer des coups droits, éliminant ainsi le temps critique normalement nécessaire pour changer la poignée de la raquette de main.",BURT LIONEL J,BURT LIONEL J,,https://lens.org/188-429-281-602-50X,Patent Application,yes,0,0,7,7,0,A63B49/08;;A63B49/08;;A63B60/00;;A63B60/20;;A63B60/20;;A63B60/34;;A63B60/34;;A63B60/50;;A63B60/50,A63B49/08,,0,0,,,,DISCONTINUED
64,CA,A,CA 747672 A,069-384-814-205-654,1966-12-06,1966,CA 747672D A,,CA 747672T A,,MEANS FOR SWITCHING RAILROAD CARS FOR CONNECTION WITH A MOVING TRAIN,,GROESBECK BURT J,GROESBECK BURT J,,https://lens.org/069-384-814-205-654,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
65,US,A,US 672750 A,122-644-314-180-479,1901-04-23,1901,US 1900/0033731 A,1900-10-20,US 1900/0033731 A,1900-10-20,COPY-HOLDER.,,BURT WILLIAM J,BURT WILLIAM J,,https://lens.org/122-644-314-180-479,Granted Patent,no,0,0,1,1,0,A47B23/042;;A47B23/042,,,0,0,,,,EXPIRED
66,DE,D1,DE 3368526 D1,167-460-478-544-909,1987-02-05,1987,DE 3368526 T,1983-01-18,US 34083982 A;;US 8300072 W,1982-01-19,APPARATUS FOR IMPROVED CONTROL OF SKIS,,BURT LIONEL J,BURT LIONEL J,,https://lens.org/167-460-478-544-909,Granted Patent,no,0,0,9,10,0,A63C9/00;;A63C9/00;;A63C5/06;;A63C5/06;;A63C2203/50;;A63C2203/50,A63C5/06;;A63C9/00,,0,0,,,,EXPIRED
67,US,A1,US 2008/0099074 A1,164-094-143-132-607,2008-05-01,2008,US 96850508 A,2008-01-02,US 96850508 A;;US 50144406 A;;US 70652805 P,2005-08-09,IRRIGATION SYSTEM WITH INFLATABLE SUCTION HOSE,A water pumping system for irrigation or the like uses a suction pump attached to a suction hose that has supporting ribs that may be inflated to hold the hose open against suction for use and deflated to allow the suction hose to be folded or collapsed for storage and transportation.,PETERSON BURT J,PETERSON BURT J,,https://lens.org/164-094-143-132-607,Patent Application,yes,20,8,1,3,0,A62C33/00;;A62C33/00;;F16L11/115;;F16L11/115;;F16L11/12;;F16L11/12;;F17D1/08;;Y10T137/402;;Y10T137/402,F16L11/00;;F17D1/08,137/236.1;;138/115,0,0,,,,DISCONTINUED
68,US,A,US 5159647 A,005-303-749-879-644,1992-10-27,1992,US 66351391 A,1991-03-04,US 66351391 A,1991-03-04,FAST AND EFFICIENT SEARCH METHOD FOR GRAPHICAL DATA,"By processing the highest-resolution graphical data (e.g., image data) pertaining to relevant-objects defined by the graphical data into abstracted multiple-attribute information that is stored in a group of nodes of the lowest level of a hierarchy of data arrays (e.g., the leaf nodes of a complete data tree file), the present invention processes the data of each of these hierarchy of data arrays backward toward a single node of the highest level of the hierarchy of data arrays (e.g., the root node of a complete data tree file), to derive an attribute vector of all the abstracted multiple-attribute information at this single node. The derived attribute vector is then used to guide a search down the hierarchy of data arrays from the single node of its highest level toward at least a selected one of the group of nodes of its lowest level (which, by way of example, may correspond to the location of a likely relevant object). In this manner, a search made over a relatively large spatial domain for a relatively small relevant object can be converted into a search for the relevant object as described in the attribute domain of the hierarchy of data arrays, where such means as direct indexing may be used.",SARNOFF DAVID RES CENTER,BURT PETER J,DAVID SARNOFF RESEARCH CENTER INC. A CORP. OF DE (1991-01-24);;SARNOFF CORPORATION (1997-04-04),https://lens.org/005-303-749-879-644,Granted Patent,yes,7,59,2,2,0,G06V30/2504;;G06V30/2504,G06K9/68,382/37;;382/36;;382/48;;395/51,0,0,,,,EXPIRED
69,US,A,US 4940510 A,156-111-245-544-989,1990-07-10,1990,US 5584487 A,1987-06-01,US 5584487 A,1987-06-01,Method of etching in the presence of positive photoresist,A wet chemical etchant for etching chromium films that have been patterned with positive photoresist comprising about 3 to about 9 grams potassium hydroxide per liter of water and about 15 to about 25 grams potassium permanganate per liter of water.,DIGITAL EQUIPMENT CORP,BURT ROY J,DIGITAL EQUIPMENT CORPORATION A CORP. OF MA (1987-08-06);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (1999-12-09),https://lens.org/156-111-245-544-989,Granted Patent,yes,19,6,1,1,0,C23F1/38;;C23F1/38;;H05K3/064;;H05K3/064;;H05K3/067;;H05K3/067,C23F1/38;;H05K3/06,156/656;;156/654;;156/659.1;;156/664;;252/74.5,1,0,,,"Vossen and Kern, Thin Film Processes, Academic Press, New York, N.Y., 1978, p. 408.",EXPIRED
70,US,A,US 2916071 A,173-450-209-745-591,1959-12-08,1959,US 68570857 A,1957-09-23,US 68570857 A,1957-09-23,Handbag assembly,,ITALI FASHIONS INC,MIRKEN BURT J,,https://lens.org/173-450-209-745-591,Granted Patent,no,7,5,1,1,0,A45C3/06;;A45C3/06,A45C3/06,,0,0,,,,EXPIRED
71,CA,A,CA 73299 A,190-514-554-636-35X,1901-10-08,1901,CA 73299D A,1901-09-16,CA 73299T A,1901-09-16,MACHINE FOR RE-SAWING,,BURT WILLIAM J,BURT WILLIAM J,,https://lens.org/190-514-554-636-35X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
72,US,A,US 3310306 A,006-874-276-494-300,1967-03-21,1967,US 33937864 A,1964-01-22,US 33937864 A,1964-01-22,Ball batting practice apparatus,,BURT HENRY J,BURT HENRY J,,https://lens.org/006-874-276-494-300,Granted Patent,no,5,16,1,1,0,A63B69/0084;;A63B69/0084;;A63B2208/12;;A63B2208/12,A63B69/00,,0,0,,,,EXPIRED
73,WO,A3,WO 2007/092428 A3,023-635-837-232-473,2008-05-29,2008,US 2007/0003123 W,2007-02-06,US 76550006 P,2006-02-06,RACKET WITH VERSATILE HANDLE,"A racket (10). In an illustrative embodiment, the racket (10) includes plural handle portions (14, 16), including a first handle portion (14) and a second handle portion (16), which are equipped with a first gripping surface (18) and a second gripping surface (22), respectively. A first mechanism (46, 20, 24) couples the first handle portion (14) and the second handle portion (16) to a racket so that the first gripping surface (18) is angled relative to a first plane (32) coincident with a hitting surface (32) of the racket (10). In one embodiment, the first handle portion (14) and the second handle portion (16) are removably attached to the racket (10). Alternatively, the first handle portion (14) and the second handle portion (16) are integrated with the racket (10). The first and second handle portions (14, 16) form obtuse angles between the hitting surface (32) and the handle portions (14, 16).",BURT LIONEL J,BURT LIONEL J,,https://lens.org/023-635-837-232-473,Search Report,yes,1,0,4,4,0,A63B49/08;;A63B60/32;;A63B60/28;;A63B60/20;;A63B60/00;;A63B49/08;;A63B60/28;;A63B60/32;;A63B60/20,A63B49/08,,0,0,,,,PENDING
74,US,A,US 1038435 A,019-327-460-918-379,1912-09-10,1912,US 1909/0524531 A,1909-10-25,US 1909/0524531 A,1909-10-25,AEROPLANE.,,PRESSEY BURT J,PRESSEY BURT J,,https://lens.org/019-327-460-918-379,Granted Patent,no,0,0,1,1,0,B64C17/00;;B64C17/00,,,0,0,,,,EXPIRED
75,US,A,US 1463000 A,057-599-534-379-257,1923-07-24,1923,US 48218021 A,1921-07-02,US 48218021 A,1921-07-02,Process of making paper pulp,,BELLINGER BURT J,BELLINGER BURT J,,https://lens.org/057-599-534-379-257,Granted Patent,no,0,0,1,1,0,D21D5/02;;D21D5/02,D21D5/02,,0,0,,,,EXPIRED
76,US,A,US 5916611 A,074-520-824-374-712,1999-06-29,1999,US 97135197 A,1997-11-17,US 97135197 A,1997-11-17,Edible food container and method for making edible product,"An edible food container has a hollow body having an interior wall and an exterior wall and having a generally flat bottom portion and an open top. The body has a concave curve side opposite to the convex side and has at least one elongated groove on the interior wall extending from adjacent the bottom portion to the body open top so that an edible container can be filled with a fluid material for later freezing and a plurality of containers can be nested together for dispensing from a vending machine. A method of making a frozen edible product includes selecting the edible container apparatus, filling the selected container with an edible fluid while allowing air to escape through the groove on the interior wall of the container, and freezing the edible fluid material in the edible container to provide an edible frozen product, such as ice cream and the like, which can be nested for dispensing from a vending machine or the like.",BELL; BURT J.,BELL BURT J,,https://lens.org/074-520-824-374-712,Granted Patent,yes,11,19,1,1,0,A23G9/221;;A23G9/506;;A23G9/506;;A23G9/221,A23G9/22;;A23G9/32;;A23G9/50,426/95;;426/138;;426/139;;426/282;;426/283;;426/391;;206/503;;206/505;;206/518;;220/669;;220/671;;D1/116,0,0,,,,EXPIRED
77,US,A,US 4797942 A,133-614-545-501-198,1989-01-10,1989,US 2081887 A,1987-03-02,US 2081887 A,1987-03-02,"Pyramid processor for building large-area, high-resolution image by parts","A technique, employing image-processing pyramids, which is capable of combining a plurality of small-area high-resolution sub-images, such as may be derived from an array of television cameras, into a single large-area high-resolution image, with substantially no introduction by such processing of image-artifacts in the combined single image.",GEN ELECTRIC,BURT PETER J,RCA CORPORATION A CORP OF (1987-02-26);;GENERAL ELECTRIC COMPANY (1988-01-29),https://lens.org/133-614-545-501-198,Granted Patent,yes,9,150,1,1,0,G06T3/40;;G06T3/40,G06T3/40,382/41;;382/1;;382/43;;358/87,1,1,132-084-424-081-455,10.1109/tcom.1983.1095851,"The Laplacian Pyramid as a Compact Image Code , by Peter J. Burt et al., IEEE Trans. on Communications , vol. COM 31, No. 4, Apr. 1983, pp. 532 540.",EXPIRED
78,US,A,US 3385399 A,192-451-501-145-570,1968-05-28,1968,US 56825266 A,1966-07-27,US 56825266 A,1966-07-27,"Ladder and hanger frame assembly, and reversibility and portability features therein",,J. DOUGLAS BURT,DOUGLAS BURT J,,https://lens.org/192-451-501-145-570,Granted Patent,no,1,22,1,1,0,E06C1/56;;E06C1/56,E06C1/56,182/70,0,0,,,,EXPIRED
79,US,A,US 690830 A,012-764-489-865-275,1902-01-07,1902,US 1901/0065636 A,1901-06-22,US 1901/0065636 A,1901-06-22,MOTOR-VEHICLE.,,WM H SMILEY;;BURT WILLIAM J,BURT WILLIAM J,,https://lens.org/012-764-489-865-275,Granted Patent,no,0,1,1,1,0,F16H3/145;;F16H3/145;;Y10T74/19493;;Y10T74/19493,,,0,0,,,,EXPIRED
80,US,S,US D0247069 S,038-567-923-846-714,1978-01-24,1978,US 65010676 F,1976-01-19,US 65010676 F,1976-01-19,Side pocket for a handbag or the like,,SIRIS BURT J,SIRIS BURT J,,https://lens.org/038-567-923-846-714,Design Right,yes,5,6,1,1,0,,,D87  3R;;D0301,0,0,,,,EXPIRED
81,WO,A1,WO 1992/015965 A1,079-019-508-273-234,1992-09-17,1992,US 9201410 W,1992-03-04,US 66351391 A,1991-03-04,FAST AND EFFICIENT SEARCH METHOD FOR GRAPHICAL DATA,"By processing the highest-resolution graphical data (102) (e.g., image data) pertaining to relevant-objects defined by the graphical data into abstracted multiple-attribute information that is stored in a group of nodes of the lowest level of a hierarchy of data arrays (e.g., the leaf nodes of a complete data tree file), the present invention processes the data of each of these hierarchy of data arrays backward toward a single node of the highest level of the hierarchy of data arrays (e.g., the root node of a complete data tree file), to derive an attribute vector of all the abstracted multiple-attributed information at this single node (106). The derived attribute vector is then used to guide a search down the hierarchy of data arrays (100) from the single node of its highest level toward at least a selected one of the group of nodes of its lowest level (which, by way of example, may correspond to the location of a likely relevant object).",SARNOFF DAVID RES CENTER,BURT PETER J,,https://lens.org/079-019-508-273-234,Patent Application,yes,3,10,2,2,0,G06V30/2504;;G06V30/2504,G06K9/68,,0,0,,,,PENDING
82,US,A,US 712508 A,098-623-703-049-094,1902-11-04,1902,US 1901/0081384 A,1901-11-07,US 1901/0081384 A,1901-11-07,AIR-COMPRESSOR FOR AIR-BRAKES.,,JOHN R B RANSOM,DENMAN BURT J,,https://lens.org/098-623-703-049-094,Granted Patent,no,0,0,1,1,0,B60C23/14;;B60C23/14,,,0,0,,,,EXPIRED
83,US,A,US 682909 A,098-203-404-115-716,1901-09-17,1901,US 1900/0034768 A,1900-10-29,US 1900/0034768 A,1900-10-29,RESAWING-MACHINE.,,BURT WILLIAM J,BURT WILLIAM J,,https://lens.org/098-203-404-115-716,Granted Patent,no,0,0,1,1,0,B26D7/018;;B26D7/018;;Y10T83/6579;;Y10T83/6579,,,0,0,,,,EXPIRED
84,AT,T1,AT E522081 T1,076-385-068-123-355,2011-09-15,2011,AT 01954933 T,2001-07-24,US 62557700 A;;US 77593401 A;;US 0123336 W,2000-07-25,AUTHENTIFIZIERUNGSWASSERZEICHEN FÜR VERPACKTE PRODUKTE,,DIGIMARC CORP,PERRY BURT;;CARR J,,https://lens.org/076-385-068-123-355,Granted Patent,no,0,0,7,1547,0,G06F21/10;;G06F21/6209;;G06F21/71;;G06F21/78;;G06F21/79;;G06F21/80;;G06F2221/2135;;G06Q10/00;;G06T1/0021;;G06T1/0042;;G06T1/0071;;G06T2201/0064;;H04N1/32144;;H04N1/32283;;H04N1/32288;;H04N1/32331;;H04N21/2347;;H04N21/2351;;H04N21/26613;;H04N21/4117;;H04N21/4223;;H04N21/4408;;H04N21/8352;;H04N21/8358;;H04N2201/3205;;H04N2201/3235;;H04N2201/3236;;H04N2201/3238;;H04N2201/3239;;H04N2201/3269;;H04N2201/327;;H04N2201/3271;;H04N2201/3281;;G07D7/0034;;G06F18/00;;H04N21/8358;;H04N21/2351;;H04N2201/3236;;G06F2221/2135;;H04N2201/3281;;H04N2201/3239;;H04N1/32331;;H04N2201/3238;;G06F21/71;;H04N1/32283;;H04N2201/3205;;G06T1/0042;;G06T2201/0064;;H04N21/8352;;G06F21/10;;G06T1/0021;;H04N2201/3235;;H04N21/26613;;G06T1/0071;;H04N1/32288;;G06F21/79;;H04N1/32144;;H04N21/2347;;G06F21/78;;H04N21/4223;;H04N2201/3269;;H04N2201/3271;;H04N21/4117;;H04N21/4408;;G06Q10/00;;G06F21/6209;;H04N2201/327;;G06F21/80;;G07D7/0034,B42D15/10;;B41J21/00;;G06T1/00;;G07D7/00;;G07D7/12;;G07D7/20;;H04N1/32;;H04N1/387;;H04N1/40,,0,0,,,,EXPIRED
85,US,A,US 1898759 A,064-714-615-672-847,1933-02-21,1933,US 31270628 A,1928-10-15,US 31270628 A,1928-10-15,Apparatus for handling comminuted material,,WALLFILL COMPANY,BURT JR HENRY J,,https://lens.org/064-714-615-672-847,Granted Patent,no,0,9,1,1,0,E04F21/12;;Y10S220/09;;Y10S55/26;;E04F21/12;;Y10S55/26;;Y10S220/09,E04F21/12,,0,0,,,,EXPIRED
86,US,A,US 1767168 A,179-007-342-165-176,1930-06-24,1930,US 34584929 A,1929-03-09,US 34584929 A,1929-03-09,Building material,,BURT JR HENRY J,BURT JR HENRY J,,https://lens.org/179-007-342-165-176,Granted Patent,no,0,11,1,1,0,E04B1/7654;;E04B1/7654,E04B1/76,,0,0,,,,EXPIRED
87,SE,B,SE 328455 B,122-163-908-314-692,1970-09-14,1970,SE 351367 A,1967-03-14,US 53442766 A,1966-03-15,SE 328455 B,,DU PONT,BURT J;;PHILLIPS H,,https://lens.org/122-163-908-314-692,Unknown,no,0,0,8,8,0,C11D1/345;;C11D3/43;;C23C22/03;;C23G5/02896;;F26B5/005;;C23C22/03;;C11D1/345;;C11D3/43;;F26B5/005;;C23G5/02896,C11D1/34;;C11D3/43;;C23C22/03;;C23G5/028;;F26B5/00,82A  1  08,0,0,,,,DISCONTINUED
88,KR,B1,KR 100268311 B1,150-645-591-134-067,2000-10-16,2000,KR 19950705473 A,1995-12-04,US 7181493 A;;US 9406032 W,1993-06-04,SYSTEM AND METHOD FOR ELECTRONIC IMAGE STABILIZATION,"본 발명은 비디오 카메라, IR 또는 X레이화상기, 레이더로부터의, 또는 컴퓨터 디스크메모리, 비디오테이프, 또는 컴퓨터 그래제너레이터등과 같은 저장매체로부터의 화상프레임 시퀀스일 수 있다. 본 발명은 또한 복수의 소오스로부터의 화상이 서로에 대해 안정화되어야 할 때 이들이 사용될 수 있다. 본 발명은 피드백 루프(104) 및 휨부(116)를 포함하여 변위 추정과정의 일부로 정밀 화상 일렬을 성취할 수 있다. 안정화 시스템의 출력은 화상이동의 원치 않는 성분이 감소되거나 제거되어 있는, 또는 원하는 형태의 새로운 이동이 유도되어 있는, 변형된 화상시퀀스이다. 출력은 또한 추정된 프레임 대 프레임 변위벡터 또는 이동 흐름 필드와 같은 입력시퀀스로부터 유도된 정보와, 노이즈가 감소되거나 변경이 하이라이트된 유도된 화상시퀀스를 포함한다.",SARNOFF CORPORATIO,BURT PETER J;;HANNA KEITH J,,https://lens.org/150-645-591-134-067,Granted Patent,no,0,0,16,16,0,G06T7/254;;H04N23/68;;H04N23/6811;;H04N23/683;;G06T7/254;;G06T7/254;;H04N23/68;;H04N23/683;;H04N23/6811,G06T3/00;;G06T7/20;;H04N5/232,,0,0,,,,EXPIRED
89,US,A,US 5566251 A,126-696-577-305-923,1996-10-15,1996,US 45602095 A,1995-05-31,US 45602095 A;;GB 9119964 A;;US 11581093 A;;US 94287792 A,1991-09-18,Video merging employing pattern-key insertion,"Disclosed is a technique for deriving a composite video image by merging foreground and background video image data supplied from a plurality of separate video signal sources employing pattern-key insertion, rather than prior-art color-key insertion, for this purpose. Pattern-key insertion involves replacing a first pattern in a video scene with a second pattern. This is accomplished by first detecting the first pattern in the video scene and estimating the pose of this detected first pattern with respect to a reference object in the video scene. The second pattern is then geometrically transformed using the pose estimate of the detected first pattern. Finally, the detected first pattern is replaced with the geometrically-transformed second pattern.",SARNOFF DAVID RES CENTER,HANNA KEITH J;;BURT PETER J,SARNOFF CORPORATION (1997-04-04),https://lens.org/126-696-577-305-923,Granted Patent,yes,21,221,17,17,0,H04N5/272;;H04N5/2723;;H04N5/275;;H04N5/2723;;H04N5/275;;H04N5/272,H04N5/272;;H04N5/275,382/284;;382/173;;382/103;;382/282;;382/295;;348/589;;348/590;;348/588,7,2,071-618-638-008-635;;189-381-508-464-292,10.5594/j01500;;10.1109/5.5971,"Patent Abstracts Of Japan vol. 15, No. 98 (E 1042)8 Mar. 1991 & JP A 02 306 782 (Asutoro Design K. K.) 20 Dec. 1990.;;Nakamura et al., High Quality Montage Pictures by a New Color Killer Soft Chromakey System , SMPTE Journal, vol. 90, Feb. 1981, p. 107.;;Burt Smart Sensing Within a Pyramid Vision Machine in the Proc. IEEE, vol. 76, No. 8, Aug. 1988, pp. 1006 1015.;;Bergen et al Hierarchical Model Based Motion Estimation in the Proc. European Conference on Computer Vision, 1992, pp. 237 252.;;Burt et al. Object Tracking With A Moving Camera: An Application Of Dynamic Motion Analysis in the Proc. IEEE Workshop On Visual Motion, Irvine, CA, Mar. 20 22, 1989.;;Burt et al. Dynamic Analysis Of Image Motion For Vehicle Guidance in the Proc IEEE Workshop On Intelligent Motion Control, Istanbul, Turkey, 20 22 Aug. 1990.;;Bergen et al. Computing Two Motions From Three Frames in the Proc. 3rd International Conference On Computer Vision, Osaka, Japan, Dec. 4 7, 1990.",EXPIRED
90,US,A,US 5629988 A,078-408-554-957-015,1997-05-13,1997,US 32878394 A,1994-10-28,US 32878394 A;;US 7181493 A,1993-06-04,System and method for electronic image stabilization,"The invention is a system and method for electronic stabilization of a image produced by an electronic imaging device. The input may be any sequence of image frames from an image source, such as a video camera, an IR or X-ray imager, radar, or from a storage medium such as computer disk memory, video tape or a computer graphics generator. The invention can also be used with images from multiple sources when these must be stabilized with respect to one another. The invention uses a feedback loop and second image warp stage to achieve precise image alignment as part of the displacement estimation process. The output of the stabilization system is a modified image sequence in which unwanted components of image motion have been reduced or removed, or in which new motion of a desired form has been introduced. The output may also include information derived from the input sequence, such as estimated frame-to-frame displacement vectors or motion flow fields, and derived image sequences with reduced noise or highlighted change.",SARNOFF DAVID RES CENTER,BURT PETER J;;HANNA KEITH J,SARNOFF CORPORATION (1997-04-04),https://lens.org/078-408-554-957-015,Granted Patent,yes,9,206,16,16,0,G06T7/254;;H04N23/68;;H04N23/6811;;H04N23/683;;G06T7/254;;G06T7/254;;H04N23/68;;H04N23/683;;H04N23/6811,G06T3/00;;G06T7/20;;H04N5/232,382/276;;382/107,6,1,017-294-321-670-317,10.1016/0923-5965(90)90047-l,"Paik et al., IEEE Transactions On Consumer Electronics, v. 38, No. 3, Aug. 1992, pp. 607 615.;;S. F. Wu et al, Signal processing: Image Communication 2, vol. 1, No. 2, May 1990, pp. 69 80,.;;G. S. van der Wal, P. J. Burt A VLSI Pyramid Chip For Multiresolution Image Analysis International Journal For Computer Vison Nov. 91 Special Issue.;;P. J. Burt, et al Object Tracking With A Moving Camera An Application Of Dynamic Motion Analysis Proceedings of the Workshop on Visual Motion , Irvine CA Mar. 20 22, 1989 pp. 1 12.;;G. S. van der Wal The Sarnoff Pyramid Chip Proceedings of Computer Architecture for Machine Perception (CAMP 91) Paris, Dec. 16, 1991.;;P. J. Burt, The Pyramid As A Structure For Efficient Computation Multiresolution Image Processing and Analaysis Springer Verlag 1984.",EXPIRED
91,CA,A1,CA 2119272 A1,089-648-069-465-756,1993-04-01,1993,CA 2119272 A,1992-09-10,GB 9119964 A;;US 9207498 W,1991-09-18,VIDEO MERGING EMPLOYING PATTERN-KEY INSERTION,"2119272 9306691 PCTABS00021 Disclosed is a technique for deriving a composite video image by merging foreground and background video image data supplied from a plurality of separate video signal sources employing pattern-key insertion, rather than prior-art color-key insertion, for this purpose. Pattern-key insertion involves replacing a first pattern (202) in a video scene (204A) with a second pattern (204B). This is accomplished by first detecting the first pattern (202) in the video scene and estimating the pose of this detected first pattern with respect to a reference object in the video scene. The second pattern is then geometrically transformed using the pose estimate of the detected first pattern. Finally, the detected first pattern is replaced with the geometrically-transformed second pattern.",SARNOFF DAVID RES CENTER,HANNA KEITH J;;BURT PETER J,,https://lens.org/089-648-069-465-756,Patent Application,no,0,0,17,17,0,H04N5/272;;H04N5/2723;;H04N5/275;;H04N5/2723;;H04N5/275;;H04N5/272,H04N5/272;;H04N5/275,,0,0,,,,EXPIRED
92,WO,A1,WO 1996/012001 A1,131-284-130-499-071,1996-04-25,1996,US 9512286 W,1995-09-25,US 32332394 A,1994-10-14,BIODEGRADABLE SURFACTANT AND BLENDS THEREOF AS A RINSE AID,"A surfactant composition comprising: (a) a carrier selected from the group consisting of water, organic solvents, and combinations thereof, the total amount of said carrier being between about 0.01 % and about 30 % by weight based upon the weight of the composition; and (b) an epoxy-capped poly(oxyalkylated) alcohol represented by the formula: R3O[CH2CH(CH3)O]x(CH2CHR4O)y[CH2CH(OH)R5]z wherein R3 is a linear, aliphatic hydrocarbon radical having an average of from about 4 to about 18 carbon atoms including mixtures thereof; R4 is hydrogen or a lower alkyl having between 1 and 6 carbon atoms; and R5 is a linear, aliphatic hydrocarbon radical having an average of from about 2 to about 14 carbon atoms including mixtures thereof; x is zero or an integer having a value from 1 to about 5; y in an integer having a value from 1 to about 30, and z is an integer having a value of from 1 to about 3.",OLIN CORP,GROOM THEODORE;;BURT DIANE J,,https://lens.org/131-284-130-499-071,Patent Application,yes,11,28,5,5,0,C11D1/721,C11D1/72,,1,0,,,See also references of EP 0785979A4,PENDING
93,US,B2,US 11595718 B2,193-976-800-305-659,2023-02-28,2023,US 202017093568 A,2020-11-09,US 202017093568 A;;US 201816020471 A,2018-06-27,Integrating real-time text with video services,"In one example, real-time text (RTT) communications are integrated with video services. For instance, one method for integrating RTT communications with video services includes receiving a real time text call intended for a recipient in a home network, forwarding the real time text call to a first device in the home network, receiving a signal to redirect the real time text call to a second device in the home network that is different from the first device, and forwarding the real time text call to the second device, in response to the signal.",AT & T IP I LP,BOSSI BURT J;;MYRICK MATTHEW,AT&T INTELLECTUAL PROPERTY I L.P (2018-06-26),https://lens.org/193-976-800-305-659,Granted Patent,yes,27,0,4,4,0,G06F40/58;;H04N21/4788;;H04N21/43615;;H04N21/440236;;H04N21/439;;G10L15/26;;H04N21/4316;;H04N21/4788;;H04N21/2187;;G06F40/40;;G10L15/26,H04N21/431;;G06F40/40;;G10L15/26;;H04N21/2187;;H04N21/4788,,3,2,107-320-430-821-072;;065-642-883-012-382,10.1177/1527476407301642;;10.1145/1182475.1182537,"Beyer, Yngvil, et al. “Small talk makes a big difference: recent developments in interactive, SMS-based television.” Television & New Media 8.3 (2007): 213-234. https://www.researchgate.net/profile/Gunn_Enli/publication/249829593_Small_Talk_Makes_a_Big_Difference_Recent_Developments_in_Interactive_SMSBased_Television/links/0deec527ce1a82c76d000000.pdf.;;Geerts, David. “Comparing voice chat and text chat in a communication tool for interactive television.” Proceedings of the 4th Nordic conference on Humancomputer interaction: changing roles. ACM, 2006. https://www.researchgate.net/profile/David_Geerts/publication/221248313_Comparing_voice_chat_and_text_chat_in_a_communication_tool_for_interactive_television/links/09e415110ea5615399000000.pdf.;;Welch, Chris, “Everything we know about T-Mobile's TV service coming in 2018,” The Verge, theverge.com, Dec. 15, 2017. https://www.theverge.com/2017/12/15/167815 40/tmobile-streaming-tvservice-features-rumors.pdf.",ACTIVE
94,TW,B,TW 387937 B,023-726-047-070-91X,2000-04-21,2000,TW 84108792 A,1995-08-23,US 32332394 A,1994-10-14,Biodegradable surfactant and blends thereof as a rinse aid,"A surfactant composition comrising: (a) a carrier selected from the group conisting of water, organic solvents, and combinations thereof, the total amount of said carrier being between about 0.01% and about 30% by weight based upon the weight of the composition; and (b) an epoxy-capped poly(oxyalkylated) alcohol represented by the formula: R<3>O[CH2CH(CH3)O]x(CH2CHR<4>O)y[CH2CH(OH)R<5>]z wherein R<3> is a linear, aliphatic hydrocarbon radical having an average of from about 4 to about 18 carbon atoms including mixtures thereof; R<4> is hydrogen or a lower alkyl having between 1 and 6 carbon atoms; and R<5> is a linear, aliphatic hydrocarbon radical haivng an average of from about 2 to about 14 carbon atoms including mixtures thereof; x is zero or an integer having a value from 1 to about 5; y is an integer having a value from 1 to about 30; and z is an integer having a value of from 1 to about 3.",OLIN CORP,GROOM THEODORE;;BURT DIANE J,,https://lens.org/023-726-047-070-91X,Granted Patent,no,0,0,5,5,0,C11D1/721,C11D1/72,,0,0,,,,EXPIRED
95,EP,A4,EP 0785979 A4,045-005-109-443-194,1999-06-16,1999,EP 95935125 A,1995-09-25,US 9512286 W;;US 32332394 A,1994-10-14,BIODEGRADABLE SURFACTANT AND BLENDS THEREOF AS A RINSE AID,,OLIN CORP,GROOM THEODORE;;BURT DIANE J,"ARCH CHEMICALS, INC. (1999-11-17)",https://lens.org/045-005-109-443-194,Search Report,no,2,0,5,5,0,C11D1/721,C11D1/72,,1,0,,,See also references of WO 9612001A1,DISCONTINUED
96,CA,A,CA 97585 A,006-857-359-176-354,1906-02-20,1906,CA 97585D A,1906-01-25,CA 97585T A,1906-01-25,WEED EXTERMINATOR,,THEONI HERMAN;;BURT ALBERT J,THEONI HERMAN;;BURT ALBERT J,,https://lens.org/006-857-359-176-354,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
97,CA,A1,CA 2089937 A1,008-670-957-493-416,1993-08-22,1993,CA 2089937 A,1993-02-19,GB 9203720 A,1992-02-21,VENTILATOR,"VENTILATOR A controllable slot ventilator comprises first and second parallel side walls (28,30) which define an air passage (32) between them. A closure member (34) is mounted adjacent the front edges of the side walls via parallel motion links, which allow the closure member to move generally away from and towards the side walls to open is and close the ventilator. At the rear of the side walls, i.e. the opposite end to the closure member, a mounting flange (38) is fitted, whereby the ventilator is mounted to a member. When the ventilator is installed in a slot, it is preassembled and then inserted into the slot from one end. (Figure 1A)",TITON HARDWARE,STONEY ARTHUR;;BURT ARTHUR J,,https://lens.org/008-670-957-493-416,Patent Application,no,0,0,11,11,0,F24F13/18;;F24F13/18,F24F13/18,,0,0,,,,EXPIRED
98,CA,A,CA 33973 A,045-244-767-111-341,1890-03-20,1890,CA 33973D A,,CA 33973T A,,TAKE-UP FOR STRING OR WRAPPING TWINE,,BURT ALBERT J;;LONG CHARLES,BURT ALBERT J;;LONG CHARLES,,https://lens.org/045-244-767-111-341,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
99,US,A1,US 2017/0268927 A1,084-786-444-368-08X,2017-09-21,2017,US 201715614307 A,2017-06-05,US 201715614307 A;;US 201615335315 A;;US 201562246398 P,2015-10-26,FIELD LENS CORRECTED THREE MIRROR ANASTIGMAT SPECTROGRAPH,"A spectrograph that includes camera focusing optics with a primary mirror having a concave-shaped reflective mirror surface, a secondary mirror having a convex-shaped reflective mirror surface and positioned to receive light reflected by the primary mirror, a tertiary mirror having a concave reflective mirror surface and positioned to receive light reflected by the secondary mirror, and a field correcting lens comprising a convex lens surface in combination with a concave lens surface, wherein light received by said field correcting lens from said tertiary mirror enters said convex lens surface, traverses said field correcting lens, and exits from said concave lens surface. The optional field correcting lens is positioned such that the primary mirror, secondary mirror, tertiary mirror, and the field correcting lens share the common parent vertex axis.",BEARDSLEY BURT J;;BEARDSLEY WENDY,BEARDSLEY BURT J;;BEARDSLEY WENDY,,https://lens.org/084-786-444-368-08X,Patent Application,yes,1,18,2,4,0,G01J3/0208;;G01J3/0208;;G01J3/021;;G01J3/021;;G01J3/0218;;G01J3/1809;;G01J3/1809;;G01J3/2823;;G01J2003/1208;;G01J2003/1208;;G01N21/718;;G02B5/005;;G02B5/04;;G02B5/1842;;G02B17/0832;;G02B17/0832;;G02B17/0848;;G02B27/30,G01J3/02;;G01J3/18;;G01J3/28;;G01N21/25;;G01N21/71;;G02B5/00;;G02B5/04;;G02B5/18;;G02B17/08;;G02B27/30,,0,0,,,,ACTIVE
100,US,B2,US 7897202 B2,041-949-631-463-895,2011-03-01,2011,US 75036207 A,2007-05-18,US 75036207 A,2007-05-18,Gelled solvent composition and method for restoring epoxy graphite composite materials,"A process using environmentally friendly materials for restoring a surface of an epoxy graphite composite material that has been degraded by exposure to ultraviolet radiation. An example process includes steps of providing a gelled solvent composition, applying the gelled solvent composition to a degraded surface of an epoxy graphite composite material, and thereafter removing the gelled solvent composition to produce a restored surface. The process uses a novel gelled solvent composition comprising one or more non-halogenated organic solvents, a thickening agent, an abrasive agent, and water; wherein the gelled solvent composition has an evaporative weight loss that is lower than the evaporative weight loss of the one or more non-halogenated solvents.",BOEING CO,WERNER GREGORY J;;SHAH BURT,THE BOEING COMPANY (2007-05-17),https://lens.org/041-949-631-463-895,Granted Patent,yes,47,2,2,2,0,B29C73/02;;C09D5/008;;C09D5/008;;B29C73/02,B32B43/00;;B05D3/00;;C09D11/00;;C09J101/00;;C09K17/40;;C09K23/00;;H01L21/316,427/140;;106/31.58;;106/163.01;;106/287.1;;106/287.17;;106/287.18;;106/287.19;;106/287.24;;106/287.26,1,0,,,"""FT-IR Spectroscopy Attenuated Total Reflectance (ATR) Technical Note,"" PerkinElmer, Inc. (Shelton, CT), 2005.",INACTIVE
101,US,A,US 4126168 A,106-545-905-019-704,1978-11-21,1978,US 84683977 A,1977-10-31,US 84683977 A,1977-10-31,Multi-purpose pocket-size carrying case,"A carrying case comprises three principal sections serially connected together such that the outer two can be folded inwardly over the center one to form a case of pocket size. One end section has a key compartment on the exterior side, and on the interior side is provided an inside compartment with a zipper closure for use as a change purse, and two inside pockets one disposed on either side of the inside compartment. The center section has an expandable compartment on the exterior side and a photograph compartment on the interior side. The other end section is provided with a series of credit card compartments on the exterior side and a photograph compartment on the interior side. A paper money compartment is formed between the interior and exterior sides for holding paper currency and the like. A closure strap is connected to one end section and is provided with a snap fastener for holding and maintaining the case in its folded condition.",SIRCO INTERNATIONAL CORP,GANZ JOSEPH;;SIRIS BURT J,,https://lens.org/106-545-905-019-704,Granted Patent,yes,8,28,1,1,0,A45C1/08;;A45C1/08,A45C1/08,150/35,0,0,,,,EXPIRED
102,JP,A,JP 2000311428 A,192-214-842-329-571,2000-11-07,2000,JP 37544799 A,1999-12-28,US 11493899 P;;US 22882899 A,1999-01-06,DEVICE FOR RECONSTRUCTING MOTOR IN A DISK DRIVE,"PROBLEM TO BE SOLVED: To reduce the number of drivers of a motor for driving a hard disk and to reduce the number of conductor wires which are to be extended out from the motor. SOLUTION: The number of conductor wires and drivers of the motor 14 are reduced by connecting three windings 414, 416, 418 of the motor in a delta shape. The three windings are energized by driver circuits 400, 402, 404. The driver circuit can selectively energize one of three windings.",TEXAS INSTRUMENTS INC,BURT J WHITE;;MICHAEL ARKIN,,https://lens.org/192-214-842-329-571,Patent Application,no,0,2,3,3,0,G11B19/2009;;G11B2220/20;;H01F7/02,G11B19/20;;G11B19/00;;H02K29/00,,0,0,,,,PENDING
103,US,A1,US 2020/0007923 A1,025-497-611-535-789,2020-01-02,2020,US 201816020471 A,2018-06-27,US 201816020471 A,2018-06-27,INTEGRATING REAL-TIME TEXT WITH VIDEO SERVICES,"In one example, real-time text (RTT) communications are integrated with video services. For instance, one method for integrating RTT communications with video services includes receiving a real time text call intended for a recipient in a home network, forwarding the real time text call to a first device in the home network, receiving a signal to redirect the real time text call to a second device in the home network that is different from the first device, and forwarding the real time text call to the second device, in response to the signal.",AT & T IP I LP,BOSSI BURT J;;MYRICK MATTHEW,AT&T INTELLECTUAL PROPERTY I L.P (2018-06-26),https://lens.org/025-497-611-535-789,Patent Application,yes,5,0,4,4,0,G06F40/58;;H04N21/4788;;H04N21/43615;;H04N21/440236;;H04N21/439;;G10L15/26;;H04N21/4316;;H04N21/4788;;H04N21/2187;;G06F40/40;;G10L15/26,H04N21/431;;G10L15/26;;H04N21/2187;;H04N21/4788,,0,0,,,,ACTIVE
104,AU,A,AU 1995/037262 A,150-041-768-526-027,1996-05-06,1996,AU 1995/037262 A,1995-09-25,US 32332394 A;;US 9512286 W,1994-10-14,Biodegradable surfactant and blends thereof as a rinse aid,,OLIN CORP,GROOM THEODORE;;BURT DIANE J,,https://lens.org/150-041-768-526-027,Patent Application,no,0,0,5,5,0,C11D1/721,C11D1/72,,0,0,,,,PENDING
105,EP,A1,EP 0785979 A1,176-791-970-403-545,1997-07-30,1997,EP 95935125 A,1995-09-25,US 9512286 W;;US 32332394 A,1994-10-14,BIODEGRADABLE SURFACTANT AND BLENDS THEREOF AS A RINSE AID,,OLIN CORP,GROOM THEODORE;;BURT DIANE J,"ARCH CHEMICALS, INC. (1999-11-17)",https://lens.org/176-791-970-403-545,Patent Application,yes,0,0,5,5,0,C11D1/721,C11D1/72,,0,0,,,,DISCONTINUED
106,CA,A,CA 85752 A,062-580-327-344-853,1904-03-01,1904,CA 85752D A,1904-01-19,CA 85752T A,1904-01-19,CALK FOR HORSESHOES,,SASS GEORGE J;;MCKENZIE BURT,SASS GEORGE J;;MCKENZIE BURT,,https://lens.org/062-580-327-344-853,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
107,US,B2,US 10834455 B2,052-777-746-507-932,2020-11-10,2020,US 201816020471 A,2018-06-27,US 201816020471 A,2018-06-27,Integrating real-time text with video services,"In one example, real-time text (RTT) communications are integrated with video services. For instance, one method for integrating RTT communications with video services includes receiving a real time text call intended for a recipient in a home network, forwarding the real time text call to a first device in the home network, receiving a signal to redirect the real time text call to a second device in the home network that is different from the first device, and forwarding the real time text call to the second device, in response to the signal.",AT & T IP I LP,BOSSI BURT J;;MYRICK MATTHEW,AT&T INTELLECTUAL PROPERTY I L.P (2018-06-26),https://lens.org/052-777-746-507-932,Granted Patent,yes,27,0,4,4,0,G06F40/58;;H04N21/4788;;H04N21/43615;;H04N21/440236;;H04N21/439;;G10L15/26;;H04N21/4316;;H04N21/4788;;H04N21/2187;;G06F40/40;;G10L15/26,H04N21/431;;G06F40/40;;G10L15/26;;H04N21/2187;;H04N21/4788,,3,2,107-320-430-821-072;;065-642-883-012-382,10.1177/1527476407301642;;10.1145/1182475.1182537,"Beyer, Yngvil, et al. “Small talk makes a big difference: recent developments in interactive, SMS-based television.” Television & New Media 8.3 (2007): 213-234. https://www.researchgate.net/profile/Gunn_Enli/publication/249829593_Small_Talk_Makes_a_Big_Difference_Recent_Developments_in_Interactive_SMSBased_Television/links/0deec527ce1a82c76d000000.pdf.;;Geerts, David. “Comparing voice chat and text chat in a communication tool for interactive television.”Proceedings of the 4th Nordic conference on Humancomputer interaction: changing roles. ACM, 2006. https://www.researchgate.net/profile/David_Geerts/publication/221248313_Comparing_voice_chat_and_text_chat_in_a_communication_tool_for_interactive_television/links/09e415110ea5615399000000.pdf.;;Welch, Chris, “Everything we know about T-Mobile's TV service coming in 2018,”The Verge, theverge.com, Dec. 15, 2017. https://www.theverge.com/2017/12/15/167815 40/tmobile-streaming-tvservice-features-rumors.pdf.",ACTIVE
108,CA,A,CA 224911 A,050-857-560-645-47X,1922-10-17,1922,CA 224911D A,,CA 224911T A,,ELECTRICAL TESTER,,HAIT CLARENCE J;;FURMAN BURT,HAIT CLARENCE J;;FURMAN BURT,,https://lens.org/050-857-560-645-47X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
109,US,A,US 5518452 A,132-929-705-561-836,1996-05-21,1996,US 40254995 A,1995-03-13,US 40254995 A;;GB 9203720 A;;US 2005993 A,1992-02-21,Ventilator,"A controllable slot ventilator comprises first and second parallel side walls which define an air passage between them. A closure member is mounted adjacent the front edges of the side walls via parallel motion links, which allow the closure member to move generally away from and towards the side walls to open and close the ventilator. At the rear of the side walls, i.e. the opposite end to the closure member, a mounting flange is fitted, whereby the ventilator is mounted to a member. When the ventilator is installed in a slot, it is preassembled and then inserted into the slot from one end.",TITON HARDWARE,STONEY ARTHUR;;BURT ARTHUR J,TITON HARDWARD LIMITED (1995-08-29),https://lens.org/132-929-705-561-836,Granted Patent,yes,13,1,11,11,0,F24F13/18;;F24F13/18,F24F13/18,454/213,0,0,,,,EXPIRED
110,US,B2,US 10024716 B2,006-633-787-151-417,2018-07-17,2018,US 201715614307 A,2017-06-05,US 201715614307 A;;US 201615335315 A;;US 201562246398 P,2015-10-26,Field lens corrected three mirror anastigmat spectrograph,"A spectrograph that includes camera focusing optics with a primary mirror having a concave-shaped reflective mirror surface, a secondary mirror having a convex-shaped reflective mirror surface and positioned to receive light reflected by the primary mirror, a tertiary mirror having a concave reflective mirror surface and positioned to receive light reflected by the secondary mirror, and a field correcting lens comprising a convex lens surface in combination with a concave lens surface, wherein light received by said field correcting lens from said tertiary mirror enters said convex lens surface, traverses said field correcting lens, and exits from said concave lens surface. The optional field correcting lens is positioned such that the primary mirror, secondary mirror, tertiary mirror, and the field correcting lens share the common parent vertex axis.",BEARDSLEY BURT J;;BEARDSLEY WENDY,BEARDSLEY BURT J;;BEARDSLEY WENDY,,https://lens.org/006-633-787-151-417,Granted Patent,yes,2,0,2,4,0,G01J3/0208;;G01J3/0208;;G01J3/021;;G01J3/021;;G01J3/0218;;G01J3/1809;;G01J3/1809;;G01J3/2823;;G01J2003/1208;;G01J2003/1208;;G01N21/718;;G02B5/005;;G02B5/04;;G02B5/1842;;G02B17/0832;;G02B17/0832;;G02B17/0848;;G02B27/30,G01J3/28;;G01J3/02;;G01J3/12;;G01J3/18;;G01N21/71;;G02B5/00;;G02B5/04;;G02B5/18;;G02B17/08;;G02B27/30,,0,0,,,,ACTIVE
111,US,A1,US 2008/0286451 A1,112-289-029-964-462,2008-11-20,2008,US 75036207 A,2007-05-18,US 75036207 A,2007-05-18,GELLED SOLVENT COMPOSITION AND METHOD FOR RESTORING EPOXY GRAPHITE COMPOSITE MATERIALS,"A process using environmentally friendly materials for restoring a surface of an epoxy graphite composite material that has been degraded by exposure to ultraviolet radiation. An example process includes steps of providing a gelled solvent composition, applying the gelled solvent composition to a degraded surface of an epoxy graphite composite material, and thereafter removing the gelled solvent composition to produce a restored surface. The process uses a novel gelled solvent composition comprising one or more non-halogenated organic solvents, a thickening agent, an abrasive agent, and water; wherein the gelled solvent composition has an evaporative weight loss that is lower than the evaporative weight loss of the one or more non-halogenated solvents.",BOEING CO,WERNER GREGORY J;;SHAH BURT,THE BOEING COMPANY (2007-05-17),https://lens.org/112-289-029-964-462,Patent Application,yes,46,3,2,2,0,B29C73/02;;C09D5/008;;C09D5/008;;B29C73/02,B05D3/00;;C09D5/00;;C09K23/00,427/140;;106/287.24;;106/287.26;;106/287.1;;106/287.34;;106/163.01;;106/287.17;;106/287.13;;106/287.19;;106/287.18,0,0,,,,INACTIVE
112,US,A1,US 2021/0058665 A1,142-338-125-350-205,2021-02-25,2021,US 202017093568 A,2020-11-09,US 202017093568 A;;US 201816020471 A,2018-06-27,INTEGRATING REAL-TIME TEXT WITH VIDEO SERVICES,"In one example, real-time text (RTT) communications are integrated with video services. For instance, one method for integrating RTT communications with video services includes receiving a real time text call intended for a recipient in a home network, forwarding the real time text call to a first device in the home network, receiving a signal to redirect the real time text call to a second device in the home network that is different from the first device, and forwarding the real time text call to the second device, in response to the signal.",AT & T IP I LP,BOSSI BURT J;;MYRICK MATTHEW,AT&T INTELLECTUAL PROPERTY I L.P (2018-06-26),https://lens.org/142-338-125-350-205,Patent Application,yes,0,0,4,4,0,G06F40/58;;H04N21/4788;;H04N21/43615;;H04N21/440236;;H04N21/439;;G10L15/26;;H04N21/4316;;H04N21/4788;;H04N21/2187;;G06F40/40;;G10L15/26,H04N21/431;;G06F40/40;;G10L15/26;;H04N21/2187;;H04N21/4788,,0,0,,,,ACTIVE
113,US,A,US 5992564 A,051-772-124-187-429,1999-11-30,1999,US 19892098 A,1998-11-24,US 19892098 A,1998-11-24,Ladder guide assembly for a scaffolding,"A ladder support device is secured to a scaffold by two base arms. At one end of the base arms the device forms a ""channel"" in which the ladder can move vertically but not horizontally. This secures the ladder so that it cannot fall away from the scaffold or to either side. In addition, it allows the scaffold to be raised or lowered without having to detach the ladder from the scaffold.",KIRKPATRICK; BRADLEY J.;;SCHWAB; BURT,KIRKPATRICK BRADLEY J;;SCHWAB BURT,,https://lens.org/051-772-124-187-429,Granted Patent,yes,17,15,1,1,0,E06C7/48;;E06C7/48;;E04G5/10;;E04G5/10,E04G5/10;;E06C7/48,182/117;;182/122,0,0,,,,EXPIRED
114,US,A,US 4698843 A,059-387-395-683-045,1987-10-06,1987,US 76693285 A,1985-08-19,US 76693285 A,1985-08-19,Method for compensating for void-defects in images,"A multistage pyramid analyzer, modified to include extrapolation of the input to each stage, together with a pyramid synthesizer, may be used for filling in one or more void defects in an image to provide a natural looking processed image.",RCA CORP,BURT PETER J;;ADELSON EDWARD H,RCA CORPORATION A CORP. OF DE (1985-08-16),https://lens.org/059-387-395-683-045,Granted Patent,yes,6,31,1,1,0,G06T2207/20016;;H04N19/63;;H04N19/895;;G06T5/77;;G06T2207/20016;;H04N19/895;;H04N19/63;;G06T5/77,G06T5/00;;H04N19/895,382/54;;358/166;;364/723;;364/724;;382/41;;382/49;;382/55,1,0,,,"Peter J. Burt et al., A Multiresolution Spline With Applications to Image Mosaics , Jun. 1983, Image Processing Laboratory, Electrical, Computer, and Systems Engineering Department, Rensselaer Polytechnic Institute, Troy, New York.",EXPIRED
115,CA,A,CA 392301 A,137-915-200-348-495,1940-11-05,1940,CA 392301D A,,CA 392301T A,,PHOTOGRAPHIC COLOUR CORRECTING METHOD,,CANADIAN KODAK CO,STAUD CYRIL J;;CARROLL BURT H,,https://lens.org/137-915-200-348-495,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
116,US,B2,US 10342295 B2,151-084-721-757-617,2019-07-09,2019,US 201715590185 A,2017-05-09,US 201715590185 A;;US 201314136075 A;;US 69533210 A;;US 14802209 P,2009-01-28,Replaceable traction cleat for footwear,Adjustable traction is provided in a traction cleat by selectively restricting or not the amount of flexure permitted for a dynamic traction element on the cleat. Restricting flexure is alternatively achieved by an adjustably positionable ring or by rotating the cleat to align the dynamic element with different shoe sole topographical features. A dual locking post is provided to reduce the surface area required on the cleat hub for locking structures. The cleat is formed in a two shot molding process that permits elongations of the dynamic traction elements without sacrificing the integrity of the cleat structure.,PRIDE MFG CO LLC,KRIKORIAN RAND J;;BURT JOHN ROBERT,,https://lens.org/151-084-721-757-617,Granted Patent,yes,29,0,9,9,0,A43C15/162;;A43C15/16;;A43C15/162;;A43C15/168;;A43B5/00;;A43C15/161,A43C15/00;;A43B5/00;;A43C15/16,,0,0,,,,ACTIVE
117,US,A,US 1340941 A,150-481-611-708-016,1920-05-25,1920,US 28176419 A,1919-03-10,US 28176419 A,1919-03-10,Roller-bearing,,DOHNER BURT E;;HUFF ALBERT J,DOHNER BURT E;;HUFF ALBERT J,,https://lens.org/150-481-611-708-016,Granted Patent,no,0,1,1,1,0,F16C33/543;;F16C33/543;;F16C19/26;;F16C19/26,F16C33/54,,0,0,,,,EXPIRED
118,DE,D1,DE 69910040 D1,040-197-031-995-761,2003-09-04,2003,DE 69910040 T,1999-05-11,US 11365098 A;;US 9910238 W,1998-07-10,ALKYLIERUNGSVERFAHREN,,ALBEMARLE CORP,KOEHL J;;BURT A;;WARD T,,https://lens.org/040-197-031-995-761,Granted Patent,no,0,0,7,7,0,B01J23/04;;C07C2/72;;C07C2531/12;;Y02P20/52;;B01J23/04;;C07C2/72;;C07C2531/12;;Y02P20/52,B01J23/04;;C07C2/72,,0,0,,,,EXPIRED
119,US,A,US 1011332 A,127-861-976-989-51X,1911-12-12,1911,US 1910/0588626 A,1910-10-24,US 1910/0588626 A,1910-10-24,VEHICLE-WHEEL.,,DOHNER BURT E;;HUFF ALBERT J,DOHNER BURT E;;HUFF ALBERT J,,https://lens.org/127-861-976-989-51X,Granted Patent,no,0,0,1,1,0,B60B9/20;;B60B9/20;;Y10T152/1063;;Y10T152/1063,,,0,0,,,,EXPIRED
120,US,A,US 1971408 A,181-445-658-396-685,1934-08-28,1934,US 56740431 A,1931-10-07,US 56740431 A,1931-10-07,Tent for gas-delivering apparatus,,HELDBRINK JAY A;;CLARK BURT J,HELDBRINK JAY A;;CLARK BURT J,,https://lens.org/181-445-658-396-685,Granted Patent,no,0,8,1,1,0,A61G10/04;;A61G10/04,A61G10/04,,0,0,,,,EXPIRED
121,CA,A1,CA 2416532 A1,194-154-235-560-182,2002-01-31,2002,CA 2416532 A,2001-07-24,US 62557700 A;;US 77593401 A;;US 0123336 W,2000-07-25,AUTHENTICATION WATERMARKS FOR PRINTED OBJECTS AND RELATED APPLICATIONS,"The disclosure describes systems for creating and authenticating printed objects (45, 46) using authentication and copy detection watermarks. For example, one verification system includes a watermark decoder (50) and a verification module (64, 66, 68, 70). The watermark decoder (50) detects a copy detection watermark in a printed object (45, 46) to determine whether t he printed object has been reproduced. The verification module (64, 66, 68, 70) processes a message decoded from an authentication watermark on the printed object to authenticate the printed object or bearer of the printed object. T he authentication and copy detection watermarks may be implemented as the same or different watermarks. For example, the authentication and copy detection watermarks may be separate watermarks embedded in an image that is printed o n the object. The authentication watermark, in some applications, includes an identifier that links the object to a database entry with related informatio n about the object.",DIGIMARC CORP,CARR J SCOTT;;PERRY BURT W,,https://lens.org/194-154-235-560-182,Patent Application,no,0,0,9,1547,0,G06F21/10;;G06F21/6209;;G06F21/71;;G06F21/78;;G06F21/79;;G06F21/80;;G06F2221/2135;;G06Q10/00;;G06T1/0042;;G06T1/0071;;H04N1/32144;;H04N1/32283;;H04N1/32288;;H04N1/32331;;H04N21/2347;;H04N21/2351;;H04N21/26613;;H04N21/4117;;H04N21/4223;;H04N21/4408;;H04N21/8352;;H04N21/8358;;H04N2201/3205;;H04N2201/3235;;H04N2201/3236;;H04N2201/3238;;H04N2201/3239;;H04N2201/3269;;H04N2201/327;;H04N2201/3271;;H04N2201/3281;;G07D7/0034;;G06F21/79;;H04N2201/327;;G06F21/71;;H04N2201/3236;;H04N21/4117;;H04N21/8352;;H04N21/4408;;H04N2201/3205;;G06F21/80;;H04N21/26613;;H04N2201/3269;;G06Q10/00;;H04N21/2351;;G06T1/0042;;H04N21/8358;;H04N1/32331;;H04N1/32144;;H04N2201/3281;;H04N2201/3239;;H04N2201/3238;;G06F21/10;;H04N1/32288;;G06T1/0071;;H04N21/2347;;H04N2201/3235;;G06F2221/2135;;H04N21/4223;;G06F21/78;;H04N1/32283;;G06F21/6209;;H04N2201/3271;;G07D7/0034,B42D15/10;;B41J21/00;;G06F21/00;;G06F21/22;;G06Q10/00;;G06T1/00;;G07D7/00;;G07D7/12;;G07D7/20;;H04N1/32;;H04N1/387;;H04N1/40,,0,0,,,,DISCONTINUED
122,US,E,US RE032997 E,074-465-207-931-422,1989-07-25,1989,US 82937586 A,1986-02-13,US 82937586 A;;US 36481582 A,1982-04-02,Electric control valve,An electrically operated control valve adapted to fit within a bore of a cooperating apparatus. The valve including an interchangeable stator and lower body member. The valve further includes a valve means having a swingable self-aligning valve closure element.,,Burt; David L.;;Krawczyk; Gregory J.,,https://lens.org/074-465-207-931-422,Amended Patent,yes,9,2,1,11,0,F02M59/466;;F02M59/466,F02M59/46,251 86;;25112919,0,0,,,,DISCONTINUED
123,WO,A1,WO 2009/108756 A1,065-977-586-100-102,2009-09-03,2009,US 2009/0035252 W,2009-02-26,US 3141208 P,2008-02-26,IMPROVED TRACTION CLEAT FOR FIELD SPORTS,"A cleat for use with an athletic shoe includes a hub, a stud of substantially non- flexible material and extending downwardly and away from a lower surface of the hub, a cleat connector extending upwardly and from an upper surface of the hub and configured to engage a shoe-mounted mating connector disposed on a sole of the shoe, the upper surface opposing the lower surface of the hub, and at least one dynamic traction element extending downwardly from the lower surface of the hub and adapted to flex upwardly when the cleat is connected to a shoe and the at least one dynamic traction element is forced downwardly to contact a ground surface due to a weight load applied to a shoe. The distal end of the stud extends further from the lower surface of the hub than the distal end of each unflexed dynamic traction element such that, when the shoe to which the cleat is connected is forced downward toward the ground surface, the stud contacts and/or begins to penetrate the ground surface to provide initial traction before each dynamic traction element makes contact with the ground surface.",SOFTSPIKES LLC;;KRIKORIAN RAND J;;BURT JOHN ROBERT,KRIKORIAN RAND J;;BURT JOHN ROBERT,,https://lens.org/065-977-586-100-102,Patent Application,yes,5,0,4,4,0,A43C15/16;;A43C15/16;;A43C15/161;;A43C15/161;;A43C15/165;;A43C15/165;;A43C15/167;;A43C15/167;;A43C15/168;;A43C15/168,A43B5/00,,1,0,,,See also references of EP 2247208A4,PENDING
124,US,A,US 1404940 A,087-637-356-604-206,1922-01-31,1922,US 31288419 A,1919-07-24,US 31288419 A,1919-07-24,Roller bearing,,DOHNER BURT E;;HUFF ALBERT J,DOHNER BURT E;;HUFF ALBERT J,,https://lens.org/087-637-356-604-206,Granted Patent,no,0,3,1,1,0,F16C33/543;;F16C33/547;;F16C19/364;;F16C19/364;;F16C33/547;;F16C33/543,F16C19/36;;F16C33/54,,0,0,,,,EXPIRED
125,US,A,US 1950782 A,080-460-347-091-124,1934-03-13,1934,US 65298033 A,1933-01-23,US 65298033 A,1933-01-23,Soap dispenser,,PROCTER & GAMBLE,BURT ROBERT V;;SHORT ROBERT J,,https://lens.org/080-460-347-091-124,Granted Patent,no,0,1,1,1,0,A47K5/1204;;A47K5/1204,A47K5/12,,0,0,,,,EXPIRED
126,CA,A,CA 204251 A,132-377-336-703-874,1920-09-28,1920,CA 204251D A,,CA 204251T A,,ANAESTHETIZING MACHINE,,CLARK BURT J;;HEIDBRINK JAY A,CLARK BURT J;;HEIDBRINK JAY A,,https://lens.org/132-377-336-703-874,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
127,US,A,US 1404939 A,135-895-598-483-380,1922-01-31,1922,US 19895217 A,1917-10-29,US 19895217 A,1917-10-29,Roller bearing,,DOHNER BURT E;;HUFF ALBERT J,DOHNER BURT E;;HUFF ALBERT J,,https://lens.org/135-895-598-483-380,Granted Patent,no,0,2,1,1,0,F16C33/543;;F16C19/26;;Y10T29/4968;;Y10T29/4968;;F16C33/543;;F16C19/26,F16C33/54,,0,0,,,,EXPIRED
128,CA,A,CA 404066 A,166-688-116-709-862,1942-04-14,1942,CA 404066D A,,CA 404066T A,,ULTRA VIOLET LIGHT FILTER,,CANADIAN KODAK CO,CARROLL BURT H;;STAUD CYRIL J,,https://lens.org/166-688-116-709-862,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
129,WO,A3,WO 2002/009019 A3,000-633-925-811-789,2002-06-27,2002,US 0123336 W,2001-07-24,US 62557700 A;;US 77593401 A,2000-07-25,AUTHENTICATION WATERMARKS FOR PRINTED OBJECTS AND RELATED APPLICATIONS,"The disclosure describes systems for creating and authenticating printed objects (45, 46) using authentication and copy detection watermarks. For example, one verification system includes a watermark decoder (50) and a verification module (64, 66, 68, 70). The watermark decoder (50) detects a copy detection watermark in a printed object (45, 46) to determine whether the printed object has been reproduced. The verification module (64, 66, 68, 70) processes a message decoded from an authentication watermark on the printed object to authenticate the printed object or bearer of the printed object. The authentication and copy detection watermarks may be implemented as the same or different watermarks. For example, the authentication and copy detection watermarks may be separate watermarks embedded in an image that is printed on the object. The authentication watermark, in some applications, includes an identifier that links the object to a database entry with related information about the object.",DIGIMARC CORP;;PERRY BURT W;;CARR J SCOTT,PERRY BURT W;;CARR J SCOTT,,https://lens.org/000-633-925-811-789,Search Report,yes,3,0,9,1547,0,G06F21/10;;G06F21/6209;;G06F21/71;;G06F21/78;;G06F21/79;;G06F21/80;;G06F2221/2135;;G06Q10/00;;G06T1/0042;;G06T1/0071;;H04N1/32144;;H04N1/32283;;H04N1/32288;;H04N1/32331;;H04N21/2347;;H04N21/2351;;H04N21/26613;;H04N21/4117;;H04N21/4223;;H04N21/4408;;H04N21/8352;;H04N21/8358;;H04N2201/3205;;H04N2201/3235;;H04N2201/3236;;H04N2201/3238;;H04N2201/3239;;H04N2201/3269;;H04N2201/327;;H04N2201/3271;;H04N2201/3281;;G07D7/0034;;G06F21/79;;H04N2201/327;;G06F21/71;;H04N2201/3236;;H04N21/4117;;H04N21/8352;;H04N21/4408;;H04N2201/3205;;G06F21/80;;H04N21/26613;;H04N2201/3269;;G06Q10/00;;H04N21/2351;;G06T1/0042;;H04N21/8358;;H04N1/32331;;H04N1/32144;;H04N2201/3281;;H04N2201/3239;;H04N2201/3238;;G06F21/10;;H04N1/32288;;G06T1/0071;;H04N21/2347;;H04N2201/3235;;G06F2221/2135;;H04N21/4223;;G06F21/78;;H04N1/32283;;G06F21/6209;;H04N2201/3271;;G07D7/0034,B42D15/10;;B41J21/00;;G06F21/00;;G06F21/22;;G06Q10/00;;G06T1/00;;G07D7/00;;G07D7/12;;G07D7/20;;H04N1/32;;H04N1/387;;H04N1/40,,2,0,,,"SZEPANSKI W.: ""A signal theoretic method for creating forgery-proof documents for automatic verification"", PROC. OF THE 1979 CARNAHAN CONFERENCE ON CRIME COUNTERMEASURES, 16 May 1979 (1979-05-16), pages 101 - 109, XP002917945;;PANKANTI S. ET AL.: ""Verification watermarks on fingerprint recognition and retrieval"", SPIE, vol. 3657, January 1999 (1999-01-01), pages 65 - 78, XP000949138",PENDING
130,US,A1,US 2003/0178978 A1,040-442-527-823-636,2003-09-25,2003,US 10727002 A,2002-03-25,US 10727002 A,2002-03-25,Output stage compensation circuit,"
   An output stage compensation circuit and method for a low drop-out regulator configured to facilitate stable operation while providing output voltage and current to downstream circuit devices is provided. An exemplary low drop-out regulator is configured with an output stage compensation circuit comprising one or more segmented sense devices configured to drive one or more fixed current sources. Each segmented sense device is configured to compensate a suitable range of output current and to multiply the effect of associated compensation capacitors. The one or more segmented sense devices are configured to provide pole-zero compensation based on output current. Further, the current range of each segment can be overlapped. As a result, the stability of the low drop-out regulator is not dependent upon the output current requirements or the capacitance requirements of the downstream circuit. 
",BIAGI HUBERT J.;;BURT RODNEY T.,BIAGI HUBERT J;;BURT RODNEY T,TEXAS INSTRUMENTS INCORPORATED (2002-03-25),https://lens.org/040-442-527-823-636,Patent Application,yes,8,32,2,10,0,G05F1/575;;G05F1/575,G05F1/575,323/282,0,0,,,,EXPIRED
131,US,A,US 2346065 A,040-943-491-546-58X,1944-04-04,1944,US 41197641 A,1941-09-23,US 41197641 A,1941-09-23,Production of neutral tones in photographic emulsions,,EASTMAN KODAK CO,CARROLL BURT H;;STAUD CYRIL J,,https://lens.org/040-943-491-546-58X,Granted Patent,no,0,3,2,2,0,G03C5/305;;G03C5/305;;G03C1/35;;G03C1/35,G03C1/35;;G03C5/305,,0,0,,,,EXPIRED
132,US,A1,US 2003/0182054 A1,053-169-795-860-991,2003-09-25,2003,US 10302302 A,2002-03-21,US 10302302 A,2002-03-21,Method and system for communicating vehicle location information,"
   The invention provides a method for communicating a vehicle location information by initiating communication between a mobile communication unit and a receiving center, requesting a location information wherein the request is initiated by an automated speech recognition unit, receiving the request for vehicle information at the receiving center, receiving a vehicle location signal at the receiving center from the mobile vehicle, retrieving geographic information from a database based on the vehicle location signal, and sending the geographic information to the mobile vehicle. 
",GEN MOTORS CORP,PETERSON MICHAEL J;;BURT WYLIE R,MOTORS LIQUIDATION COMPANY (2009-07-09);;GENERAL MOTORS LLC (2009-07-10),https://lens.org/053-169-795-860-991,Patent Application,yes,15,36,2,2,0,G01C21/26;;G01C21/26,G01C21/26,701/207;;340/988,0,0,,,,EXPIRED
133,US,B1,US 6788800 B1,126-026-715-248-961,2004-09-07,2004,US 62557700 A,2000-07-25,US 62557700 A,2000-07-25,Authenticating objects using embedded data,"
    This disclosure describes a method of making a secure product using data hidden in the product itself and a method of using the hidden data to authenticate the product. The method assigns a product identifier to the product, such as a unique serial number. It also steganographically embeds security data into the product. The security data includes the product identifier (e.g., a hashed version of it). The security data is embedded such that it is machine readable and enables automated authentication of the product by comparing the security data decoded from the product with the product identifier. 
",DIGIMARC CORP,CARR J SCOTT;;PERRY BURT W,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC LLC (2008-08-01);;DMRC CORPORATION (2008-08-01),https://lens.org/126-026-715-248-961,Granted Patent,yes,108,220,7,1547,0,G06F21/10;;G06F21/6209;;G06F21/71;;G06F21/78;;G06F21/79;;G06F21/80;;G06F2221/2135;;G06Q10/00;;G06T1/0021;;G06T1/0042;;G06T1/0071;;G06T2201/0064;;H04N1/32144;;H04N1/32283;;H04N1/32288;;H04N1/32331;;H04N21/2347;;H04N21/2351;;H04N21/26613;;H04N21/4117;;H04N21/4223;;H04N21/4408;;H04N21/8352;;H04N21/8358;;H04N2201/3205;;H04N2201/3235;;H04N2201/3236;;H04N2201/3238;;H04N2201/3239;;H04N2201/3269;;H04N2201/327;;H04N2201/3271;;H04N2201/3281;;G07D7/0034;;G06F18/00;;H04N21/8358;;H04N21/2351;;H04N2201/3236;;G06F2221/2135;;H04N2201/3281;;H04N2201/3239;;H04N1/32331;;H04N2201/3238;;G06F21/71;;H04N1/32283;;H04N2201/3205;;G06T1/0042;;G06T2201/0064;;H04N21/8352;;G06F21/10;;G06T1/0021;;H04N2201/3235;;H04N21/26613;;G06T1/0071;;H04N1/32288;;G06F21/79;;H04N1/32144;;H04N21/2347;;G06F21/78;;H04N21/4223;;H04N2201/3269;;H04N2201/3271;;H04N21/4117;;H04N21/4408;;G06Q10/00;;G06F21/6209;;H04N2201/327;;G06F21/80;;G07D7/0034,B42D15/10;;B41J21/00;;G06F21/10;;G06F21/12;;G06Q10/00;;G06T1/00;;G07D7/00;;G07D7/12;;G07D7/20;;H04N1/32;;H04N1/387;;H04N1/40,382/100;;235/375,100,21,094-340-567-700-843;;021-805-842-161-039;;090-278-413-005-637;;013-959-215-137-824;;052-069-041-781-619;;108-005-042-881-002;;054-431-441-479-71X;;155-569-330-453-350;;013-959-215-137-824;;084-121-868-105-586;;083-425-470-764-705;;145-082-256-860-62X;;056-012-264-606-429;;032-296-144-866-521;;017-465-278-834-438;;037-303-043-585-741;;031-124-561-510-481;;082-879-987-359-497;;090-079-829-022-607;;136-611-091-069-286;;007-289-924-251-577,10.1109/icdar.1999.791732;;10.1049/cp:19950674;;10.1109/ccst.1999.797927;;10.1045/december97-lotspiech;;10.1016/s0001-2998(05)80021-2;;7817202;;10.1109/infcom.1994.337544;;10.1007/bf01202298;;10.1109/csac.1992.228224;;10.1045/december97-lotspiech;;10.5594/j03939;;10.1109/21.44016;;10.1007/3-540-44750-4_36;;10.1109/mmcs.1996.535015;;10.1007/3-540-61028-6_28;;10.1109/tpami.1987.4767966;;21869430;;10.1109/southc.1996.535064;;10.1117/1.482616;;10.1109/30.267415;;10.1049/ji-3-2.1946.0074;;10.1109/tcom.1975.1092798;;10.1007/978-1-4612-3834-8,"Amano et al., ""A Feature Calibration Method for Watermarking of Document Images"", ICDAR 1999, pp. 91-94.*;;Szepanski, ""A Signal Theoretic Method for Creating Forgery-Proof Documents for Automatic Verification,"" Proceedings 1979 Carnahan Conference on Crime Countermeasures, May 16, 1979, pp. 101-109.;;Dautzenberg, ""Watermarking Images,"" Department of Microelectronics and Electrical Engineering, Trinity College Dublin, 47 pages, Oct. 1994.;;Szepanski, ""Additive Binary Data Transmission for Video Signals,"" Conference of the Communications Engineering Society, 1980, NTG Technical Reports, vol. 74, pp. 343-351. (German text and English translation enclosed).;;Audio Watermarking Architectures for Secure Digital Music Distribution, A Proposal to the SDMI Portable Devices Working Group by ARIS Technologies, Inc, Mar. 26, 1999, pp. 1-11.;;Audio Watermarking Architectures for Persistent Protection, Presentation to SDMI PDWG, Mar. 29, 1999, J. Winograd, Aris Technologies, pp. 1-16.;;Audio Watermarking System to Screen Digital Audio Content for LCM Acceptance, A Proposal Submitted in Response to PDWG990050504-Transition CfP by ARIS Technologies, Inc., May 23, 1999, Document Version 1.0, 15 pages.;;Boland et al., ""Watermarking Digital Images for Copyright Protection"", Fifth Int'l Conference on Image Processing and it's Application, Jul. 1995, pp. 326-330.;;Levy, ""AIPL's Proposal for SDMI: An Underlying Security System"" (slide presentation), Mar. 29, 1999, 23 slides.;;Microsoft Response to CfP for Technology Solutions to Screen Digital Audio Content for LCM Acceptance, SDMI, PDWG Tokyo, May 23, 1999, 9 pages.;;Response to CfP for Technology Solutions to Screen Digital Audio Content for LCM Acceptance, NTT Waveless Radio Consotium, May 23, 1999, 9 pages.;;Sandford II et al., ""The Data Embedding Method"", Processing of the SPIE vol. 2615, pp. 226-259, 1996.;;Thomas, Keith, Screening Technology for Content from Compact Discs, May 24, 1999, 11 pages.;;Tirkel et al., ""Electronic Water Mark,"" Dicta-93, Marquarie University, Sydney, Australia, Dec., 1993, pp. 666-672.;;Vidal et al., ""Non-Noticeable Information Embedding in Color Images: Marking and Detection"", IEEE 1999, pp. 293-297.;;Wolfgang et al., ""A Watermark for Digital Images,"" Computer Vision and Image Processing Laboratory, Purdue University, Sep. 1996, pp. 219-222.;;U.S. patent application Ser. No. 60/071,983, Levy, filed Jan. 20, 1998.;;U.S. patent application Ser. No. 09/404,291, Levy, filed Sep. 23, 1999.;;U.S. patent application Ser. No. 60/114,725, Levy, filed Dec. 31, 1998.;;U.S. patent application Ser. No. 09/234,780, Rhoads et al., filed Jan. 20, 1999.;;U.S. patent application Ser. No. 60/116,641, Cookson, filed Jan. 21, 1999.;;U.S. patent application Ser. No. 09/478,713, Cookson, filed Jan. 6, 2000.;;Cookson, Chris, General Principles of Music Uses on Portable Devices, presented to SDMI, Mar. 5, 1999.;;Winograd, J.M., ""Audio Watermarking Architecture for Secure Digital Music Distribution,"" a Proposal to the SDMI Portable Devices Working Group, by Aris Technologies, Inc., Mar. 26, 1999.;;Mintzer et al., ""Safeguarding Digital Library Contents and Users: Digital Watermarking,"" D-Lib Magazine, Dec. 1997, 12 pages.;;Tirkel et al., ""Electronic Water Mark,"" DICTA-93, Macquarie University, Sydney, Australia, Dec., 1993, pp. 666-673.;;Weber et al., ""Correlative Image Registration,"" Seminars in Nuclear Medicine, vol XXIV, No. 4, Oct., 1994, pp. 311-323.;;Brassil et al., Electronic Marking and Identification Techniques to Discourage Document Copying, Proceedings of the INFOCOM '94 Conference on Computer, IEEE Commun. Soc Conference, Jun. 12-16, 1994, 1278-1287.;;Bruckstein, A.M.; Richardson, T.J., A holographic transform domain image watermarking method, Circuits, Systems, and Signal Processing vol. 17, No. 3, p. 361-89, 1998. This paper includes an appendix containing an internal memo of Bell Labs, which according to the authors of the paper, was dated Sep. 1994.;;""High Water FBI Limited Presentation Image Copyright Protection Software,"" FBI Ltd brochure, Jul., 1995, 17 pages.;;Koch et al., ""Copyright Protection for Multimedia Data,"" Fraunhofer Institute for Computer Graphics, Dec. 16, 1994, 15 pages.;;Koch et al., ""Towards Robust and Hidden Image Copyright Labeling,"" Proc. of 1995 IEEE Workshop on Nonlinear Signal and Image Processing, Jun. 20-22, 1995, 4 pages.;;Kurak et al., ""A Cautionary Note On Image Downgrading,"" 1992 IEEE, pp. 153-159.;;Mintzer et al., ""Safeguarding Digital library Contents and Users"" Digital Watermarking, D-Lib Magazine, Dec. 1997: ISSN 1082-9873.;;Rindfrey, ""Towards an Equitable System for Access Control and Copyright Protection in Broadcast Image Services: The Equicrypt Approach,"" Intellectual Property Rights and New Technologies, Proc. of the Conference, R. Oldenbourg Verlag Wien Munchen 1995, 12 pages.;;Schreiber et al., ""A Compatible High-Definition Television System Using the Noise-Margin Method of Hiding Enhancement Information,"" SMPTE Journal, Dec. 1989, pp. 873-879.;;SDMI Example Use Scenarios (Non-Exhaustive), Version 1.2, Jun. 16, 1999.;;Szepanski, ""A Signal Theoretic Method for Creating Forgery-Proof Documents for Automatic Verification,"" Proceedings 1979 Carnahan Conference on Crime Countermeasures, May 16, 1979, pp. 101-109.;;Szepanski, ""Additive Binary Data Transmission for Video Signals,"" Papers Presented at Conf. Of Comm. Engineering Soc. Sep. 30-Oct. 3, 1980, Technical Reports vol. 74, pp. 342-352.;;Tanaka et al., ""A Visual Retrieval System with Private Information for Image Database,"" Proceeding International Conference on DSP Applications and Technology, Oct. 1991, pp. 415-421.;;Tanaka et al., ""New Integrated Coding Schemes for Computer-Aided Facsimile,"" Proc. IEEE Int'l Conf. on Sys. Integration, Apr. 1990, pp. 275-281.;;U.S. patent application Ser. No. 60/000,442, Hudetz, filed Jun. 6, 1995.;;U.S. patent application Ser. No. 60/082,228, Rhoads, filed Apr. 16, 1998.;;U.S. patent application Ser. No. 60/141,763, Davis, filed Jun. 30, 1999.;;U.S. patent application Ser. No. 60/158,015, Davis et al., filed Oct. 6, 1999.;;U.S. patent application Ser. No. 09/314,648, Rodriguez et al., filed May 19, 1999.;;U.S. patent application Ser. No. 60/198,138, Alattar, filed Apr. 17, 2000.;;U.S. patent application Ser. No. 60/198,849, Carr et al., filed Apr. 21, 2000.;;U.S. patent application Ser. No. 09/198,022, Rhoads, filed Nov. 23, 1998.;;U.S. patent application Ser. No. 09/498,223, Rhoads et al., filed Feb. 3, 2000.;;U.S. patent application Ser. No. 09/525,865, Davis et al., filed Mar. 15, 2000.;;U.S. patent application Ser. No. 09/571,422, Rhoads et al., filed May 15, 2000.;;U.S. patent application Ser. No. 09/585,678, Ellingson, filed Jun. 1, 2000.;;""Access Control and COpyright Protection for Images, WorkPackage 8: Watermarking,"" Jun. 30, 1995, 46 pages.;;""Access Control and COpyright Protection for Images, WorkPackage 3: Evaluation of Existing Systems,"" Apr. 19, 1995, 68 pages.;;""Access Control and COpyright Protection for Images, WorkPackage 1: Access Control and Copyright Protection for Images Need Evaluation,"" Jun., 1995, 21 pages.;;""Access Control and COpyright Protection for Images, Conditional Access and Copyright Protection Based on the Use of Trusted Third Parties,"" 1995, 43 pages.;;Arachelian, ""White Noise Storm,"" Apr. 11, 1994, Internet reference, 13 pages.;;Arazi, et al., ""Intuition, Perception, and Secure Communication,"" IEEE Transactionson Systems, Man, and Cybernetics, vol. 19, No. 5, Sep./Oct. 1989, pp. 1016-1020.;;Arthur, ""Digital Fingerprints Protect Artwork,"" New Scientist, Nov. 12, 1994, p. 24.;;Aura, ""Invisible Communication,"" Helsinki University of Technology, Digital Systems Laboratory, Nov. 5, 1995, 13 pages.;;Bender et al, ""Techniques for Data Hiding,"" Draft Preprint, Private Correspondence, dated Oct. 30, 1995.;;Bender et al., ""Techniques for Data Hiding,"" Massachusetts Institute of Technology, Media Laboratory, Jan. 1995, 10 pages.;;Boneh, ""Collusion-Secure Fingerprinting for Digital Data,"" Department of Computer Science, Princeton University, 1995, 31 pages.;;Boney et al., ""Digital Watermarks for Audio Signals,"" Proceedings of Multimedia '96, 1996 IEEE, pp. 473-480.;;Boucqueau et al., Equitable Conditional Access and Copyright Protection for Image Based on Trusted Third Parties, Teleservices & Multimedia Communications, 2nd Int. Cost 237 Workshop, Second International Cost 237 Workshop, Nov., 1995; published 1996, pp. 229-243.;;Brassil et al., ""Hiding Information in Document Images,"" Nov., 1995, 7 pages.;;Brown, ""S-Tools for Windows, Version 1.00, .COPYRGT. 1994 Andy Brown, What is Steganography,"" Internet reference, Mar. 6, 1994, 6 pages.;;Bruyndonckx et al., Neural Network Post-Processing of Coded Images Using Perceptual Masking, 1994, 3 pages.;;Bruyndonckx et al., ""Spatial Method for Copyright Labeling of Digital Images,"" 1994, 6 pages.;;Burgett et al., ""A Novel Method for Copyright Labeling Digitized Image Data,"" requested by e-mail from author (unavailable/password protected on IGD WWW site); received Sep. 18, 1995, 12 pages.;;Caronni, ""Assuring Ownership Rights for Digital Images,"" Published in the Proceedings of Reliable IT Systems, VIS '95, HH. Bruggemann and W. Gerhardt-Hackl (Ed.), Vieweg Publishing Company, Germany, 1995, Jun. 14, 1994, 10 pages.;;Caruso, ""Digital Commerce, 2 plans for watermarks, which can bind proof of authorship to electronic works."" New York Times, Aug. 7, 1995, one page.;;Castro et al., ""Registration of Translated and Rotated Images Using Finite Fourier Transforms,"" IEEE Transactions on Pattern Analysis and Machine Intelligence, vol. PAMI-9, No. 5, Sep. 1987, pp. 700-703.;;Choudhury, et al., ""Copyright Protection for Electronic Publishing over Computer Networks,"" IEEE Network Magazine, Jun. 1994, 18 pages.;;Clarke, ""Invisible Code Tags Electronic Images,"" Electronic Engineering Times, Jun. 12, 1995, n. 852, p. 42.;;""Copyright Protection for Digital Images, Digital Fingerprinting from FBI,"" Highwater FBI brochure, 1995, 4 pages.;;""The Copyright Can of Worms Opened Up By The New Electronic Media,"" Computergram Internations, pCGN07170006, Jul. 17, 1995 and ""The Copyright Can of Worms Opened Up By the New Electronic Media-2,"" Computergram Internations, pCGN07210008, Jul. 21, 1995, 3 pages total.;;Cox et al., ""Secure Spread Spectrum Watermarking for Multimedia,"" NEC Research Institute Technical Report, Dec. 5, 1995, 33 pages.;;Cox et al., ""A Secure, Imperceptable Yet Perceptually Salient, Spread Spectrum Watermark for Multimedia,"" IEEE, Southcon/96, Conference Record, pp. 192-197, 1996.;;""Cyphertech Systems: Introduces Digital Encoding Device to Prevent TV Piracy,"" Hollywood Reporter, Oct. 20, 1993, p. 23.;;Delaigle et al., ""Digital Watermarking,"" Proc. SPIE-Int. Soc. Opt. Eng., vol. 2659, pp. 99-110, 1996.;;Delaigle et al., ""A Psychovisual Approach for Digital Picture Watermarking,"" 1995, 20 pages.;;DICE Digital Watermark System, Q&A, Dec., 1995, 12 pages.;;Digimarc presentation at RSA Conference, approximately Jan. 17, 1996, 4 pages.;;Fimmerstad, ""The Virtual Art Museum,"" Ericsson Connexion, Dec., 1995, pp. 29-31.;;Fitzgerald, ""Invisible Digital Copyright ID,"" Editor & Publisher, Jun. 25, 1994, p. 62.;;""Foiling Card Forgers With Magnetic Noise,"" Wall Street Journal, Feb. 8, 1994.;;Frequently Asked Questions About Digimarc Signature Technology, Aug. 1, 1995, HTTP:WWW.DIGIMARC.COM, 9 pages.;;Friedman, ""The Trustworthy Digital Camera: Restoring Credibility to the Photographic Image,"" IEEE Transactions on Consumer Electronics, vol. 39, No. 4, Nov., 1993, pp. 905-910.;;Gabor, et al., ""Theory of Communication,"" J. Inst. Elect. Eng. 93, 1946, pp. 429-441.;;Hartung et al., Digital Watermarking of Raw and Compressed Video, Proc. SPIE 2952, Digital Compression Technologies and Systems for Video Communications, Oct., 1996, pp 205-213.;;Hecht, ""Embedded Data Glyph Technology for Hardcopy Digital Documents,"" SPIE vol. 2171, Feb. 1994, pp. 341-352.;;""Holographic signatures for digital images,"" The Seybold Report on Desktop Publishing, Aug. 1995, one page.;;Humphrey, ""Stamping Out Crime,"" Hollywood Reporter, Jan. 26, 1994, p. S48.;;Jain, ""Image Coding Via a Nearest Neighbors Image Model,"" IEEE Transactions on Communications, vol. COM-23, No. 3, Mar. 1975, pp. 318-331.;;Johhnson, ""Steganography,"" Dec. 10, 1995, 32 pages.;;JPEG Group's JPEG Software (release 4), FTP.CSUA.BEREKELEY.EDU/PUB/CYPHERPUNKS/APPLICATIONS/JSTEG/JPEG.ANNOUNCEMENT.GZ.;;Kassam, Signal Detection in Non-Gaussian Noise, Dowden & Culver, 1988, pp. 1-96.;;Koch et al., ""Digital Copyright Labeling: Providing Evidence of Misuse and Tracking Unauthorized Distribution of Copyrighted Materials,"" Oasis Magazine, Dec. 1995, 3 pages.",EXPIRED
134,US,A,US 4460015 A,160-144-892-628-041,1984-07-17,1984,US 36481482 A,1982-04-02,US 36481482 A,1982-04-02,Three-way control valve,An electrically operating three-way control valve adapted to fit with a bore of a cooperating apparatus. The three-way control valve including a low pressure seat and a high pressure seat. The three-way control valve further including movable valve means having a self aligning closure element for seating upon the high pressure valve seat.,BENDIX CORP,BURT DAVID L;;KRAWCZYK GREGORY J,BENDIX CORPORATION THE (1982-03-31),https://lens.org/160-144-892-628-041,Granted Patent,yes,7,11,7,7,0,F16K11/048;;F16K11/048;;F02M59/466;;F02M59/466;;Y10T137/86895;;Y10T137/86895;;Y10T137/87772;;Y10T137/87772,F16K31/06;;F02M59/46;;F16K11/048,137/625.5;;137/870,0,0,,,,EXPIRED
135,CA,A,CA 547161 A,031-796-929-765-450,1957-10-08,1957,CA 547161D A,,CA 547161T A,,ULTRAVIOLET LIGHT FILTER,,CANADIAN KODAK CO LTD,CHECHAK JONAS J;;CARROLL BURT H,,https://lens.org/031-796-929-765-450,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
136,US,A,US 902118 A,054-004-395-155-354,1908-10-27,1908,US 1908/0419361 A,1908-03-05,US 1908/0419361 A,1908-03-05,SIGNAL SYSTEM.,,SLATER BURT A;;MCDERMOTT MICHAEL J,SLATER BURT A;;MCDERMOTT MICHAEL J,,https://lens.org/054-004-395-155-354,Granted Patent,no,0,1,1,1,0,B61L1/187;;B61L1/187,,,0,0,,,,EXPIRED
137,EP,A2,EP 2252173 A2,091-055-373-494-111,2010-11-24,2010,EP 09717434 A,2009-03-06,US 2009/0036282 W;;US 3420408 P,2008-03-06,IMPROVED ATHLETIC SHOE CLEAT WITH DYNAMIC TRACTION,,SOFTSPIKES LLC,KRIKORIAN RAND J;;BURT JOHN ROBERT,"SOFTSPIKES, LLC (2015-07-29)",https://lens.org/091-055-373-494-111,Patent Application,yes,0,0,7,7,0,A43C15/161;;A43C15/00;;A43C15/06;;A43C15/161;;A43C15/06;;A43C15/00,A43C13/04;;A43C15/00;;A43C15/06;;A43C15/16,,0,0,,,,ACTIVE
138,US,A,US 5443475 A,128-996-973-818-226,1995-08-22,1995,US 92522592 A,1992-08-03,US 92522592 A;;US 61210690 A,1990-11-09,Surgical instrument,"A surgical instrument has an elongate support shaft, a tip assembly permanently attached to the shaft, a cutting jaw which opens in a backward facing direction and which is laterally offset from the longitudinal axis of the support shaft, and a rod extending coaxially with the elongate support shaft for applying closing and opening forces to the cutting jaw. The tip assembly comprises a stationary portion and a movable portion having respective tissue cutting edges which define the cutting jaw. The stationary portion of the tip assembly is permanently attached to the distal end of the support shaft, and the movable portion of the tip assembly is pivotally attached to a distal end of the stationary portion. The stationary portion of the tip assembly has a plurality of cutting edges which define an opening which extends axially adjacent the longitudinal axis of the support shaft. The movable portion has corresponding cutting edges which cooperate with the cutting edges of the stationary portion to define the cutting jaw. The cutting jaw has a fully open position in which the movable element extends outwardly from the longitudinal axis and toward a proximal end of the elongate shaft at an angle of approximately 60.degree.. The cutting jaw has a fully closed position in which the cutting element is disposed within the opening in the stationary portion of the tip assembly. The tip assembly has an overall height dimension, when the cutting element is in the fully closed position, which is substantially equal to a corresponding cross-sectional dimension of the elongate support shaft.",ARTHROTEK INC,AUERBACH BURT J;;SHUTT GEORGE V,BIOMET INC (2017-11-03);;BIOMET SPORTS MEDICINE LLC (2008-02-27);;ZB MANUFACTURING LLC (2017-11-03);;BIOMET MANUFACTURING LLC (2017-11-03);;BIOMET U.S. RECONSTRUCTION LLC (2017-11-03),https://lens.org/128-996-973-818-226,Granted Patent,yes,33,111,3,3,0,A61B17/1608;;A61B17/1675;;A61B17/1684;;A61B17/29;;A61B17/29;;A61B17/1684;;A61B17/1608;;A61B17/1675,A61B17/28;;A61B17/32,606/170;;606/83;;606/174;;128/751,3,0,,,"Zimmer Brochure, The Master Series, 1990.;;Zimmer News Release, No. 606 83, Oct. 11, 1966.;;Karl Storz, Catalog Pages, Endoscopic Diagnosis, Surgery and Treatment of Paranasal Sinus Mycoses, Endoscopes and Instruments as used by Prof. W. Messerklinger and H. Stammberger. Mar., 1985.",EXPIRED
139,US,A,US 1964594 A,067-816-483-554-684,1934-06-26,1934,US 65365033 A,1933-01-26,US 65365033 A,1933-01-26,Method of cleaning mercury boilers,,GEN ELECTRIC,NERAD ANTHONY J;;NEWKIRK BURT L,,https://lens.org/067-816-483-554-684,Granted Patent,no,0,0,1,1,0,F22B3/02;;F22B3/02,F22B3/02,,0,0,,,,EXPIRED
140,CA,A,CA 1253683 A,175-982-604-356-297,1989-05-09,1989,CA 509332 A,1986-05-16,US 73993885 A,1985-05-31,NUTATING ORIFICE DISPERSION APPARATUS,"52,569 ABSTRACT OF THE DISCLOSURE A nutating orifice dispersion apparatus applies a material to a work surface by producing a ribbon of the material as the apparatus is moved along the work surface The apparatus is omnidirectional and it does not have to be oriented with respect to the travel direction. More importantly, the flow rate through the dispersion apparatus can be modulated at will without affecting the ribbon pattern width. This feature is key to the robotic applica-tion of sealant in that the speed of the arm is not con-stant throughout the dispensing cycle and the material flow rate needs to be varied correspondingly in order to main-tain ribbon uniformity.",UNIMATION INC,CASLER RICHARD J;;SHULMAN BURT H,,https://lens.org/175-982-604-356-297,Granted Patent,no,0,1,2,7,0,,B05C5/00;;B05B13/04;;B05B15/10;;B25J11/00,32-3,0,0,,,,EXPIRED
141,AU,A,AU 2001/077147 A,035-995-114-687-620,2002-02-05,2002,AU 2001/077147 A,2001-07-24,US 62557700 A;;US 77593401 A;;US 0123336 W,2000-07-25,Authentication watermarks for printed objects and related applications,,DIGIMARC CORP,PERRY BURT W;;CARR J SCOTT,,https://lens.org/035-995-114-687-620,Patent Application,no,0,0,9,1547,0,G06F21/10;;G06F21/6209;;G06F21/71;;G06F21/78;;G06F21/79;;G06F21/80;;G06F2221/2135;;G06Q10/00;;G06T1/0042;;G06T1/0071;;H04N1/32144;;H04N1/32283;;H04N1/32288;;H04N1/32331;;H04N21/2347;;H04N21/2351;;H04N21/26613;;H04N21/4117;;H04N21/4223;;H04N21/4408;;H04N21/8352;;H04N21/8358;;H04N2201/3205;;H04N2201/3235;;H04N2201/3236;;H04N2201/3238;;H04N2201/3239;;H04N2201/3269;;H04N2201/327;;H04N2201/3271;;H04N2201/3281;;G07D7/0034;;G06F21/79;;H04N2201/327;;G06F21/71;;H04N2201/3236;;H04N21/4117;;H04N21/8352;;H04N21/4408;;H04N2201/3205;;G06F21/80;;H04N21/26613;;H04N2201/3269;;G06Q10/00;;H04N21/2351;;G06T1/0042;;H04N21/8358;;H04N1/32331;;H04N1/32144;;H04N2201/3281;;H04N2201/3239;;H04N2201/3238;;G06F21/10;;H04N1/32288;;G06T1/0071;;H04N21/2347;;H04N2201/3235;;G06F2221/2135;;H04N21/4223;;G06F21/78;;H04N1/32283;;G06F21/6209;;H04N2201/3271;;G07D7/0034,B42D15/10;;B41J21/00;;G06F21/00;;G06F21/22;;G06Q10/00;;G06T1/00;;G07D7/00;;G07D7/12;;G07D7/20;;H04N1/32;;H04N1/387;;H04N1/40,,0,0,,,,PENDING
142,US,B2,US 6853907 B2,048-246-937-071-679,2005-02-08,2005,US 10302302 A,2002-03-21,US 10302302 A,2002-03-21,Method and system for communicating vehicle location information,"The invention provides a method for communicating a vehicle location information by initiating communication between a mobile communication unit and a receiving center, requesting a location information wherein the request is initiated by an automated speech recognition unit, receiving the request for vehicle information at the receiving center, receiving a vehicle location signal at the receiving center from the mobile vehicle, retrieving geographic information from a database based on the vehicle location signal, and sending the geographic information to the mobile vehicle.",GEN MOTORS CORP,PETERSON MICHAEL J;;BURT WYLIE R,MOTORS LIQUIDATION COMPANY (2009-07-09);;GENERAL MOTORS LLC (2009-07-10),https://lens.org/048-246-937-071-679,Granted Patent,yes,15,38,2,2,0,G01C21/26;;G01C21/26,G01C21/26,701/207;;701/208;;701/214;;340/995.12;;340/995.25;;455/456.1,0,0,,,,EXPIRED
143,US,A1,US 2017/0245597 A1,071-119-978-497-475,2017-08-31,2017,US 201715590185 A,2017-05-09,US 201715590185 A;;US 201314136075 A;;US 69533210 A;;US 14802209 P,2009-01-28,Replaceable Traction Cleat for Footwear,Adjustable traction is provided in a traction cleat by selectively restricting or not the amount of flexure permitted for a dynamic traction element on the cleat. Restricting flexure is alternatively achieved by an adjustably positionable ring or by rotating the cleat to align the dynamic element with different shoe sole topographical features. A dual locking post is provided to reduce the surface area required on the cleat hub for locking structures. The cleat is formed in a two shot molding process that permits elongations of the dynamic traction elements without sacrificing the integrity of the cleat structure.,PRIDE MFG CO LLC,KRIKORIAN RAND J;;BURT JOHN ROBERT,,https://lens.org/071-119-978-497-475,Patent Application,yes,0,0,9,9,0,A43C15/162;;A43C15/16;;A43C15/162;;A43C15/168;;A43B5/00;;A43C15/161,A43C15/16;;A43B5/00,,0,0,,,,ACTIVE
144,CA,C,CA 1327848 C,080-347-784-284-35X,1994-03-15,1994,CA 592329 A,1989-02-28,US 16990188 A,1988-03-18,POWER TRANSFER CIRCUIT INCLUDING A SYMPATHETIC RESONATOR,"Abstract A power transfer circuit includes first and second windings sharing a common magnetic core. Each winding has associated with it a parallel capacitor to thus form a pair of ""tank"" circuits. The first winding is connected at one end to a voltage supply and, at the other end, to ground through an FET switch. The switch is turned on and off at a predetermined frequency and at a 50% duty cycle. The second winding and associated capacitor achieves parallel resonance at the predetermined frequency. Similarly the combined first and second windings and associated capacitors achieve parallel resonance at said predetermined frequency. The second winding need not be electrically connected to the first winding which transfers energy to it through the magnetic core. The transfer circuit efficiently couples power across a dielectric interface to a pickup coil. One particularly good application of the power transfer circuit is in connection with a contactless Smart Card.",AMERICAN TELEPHONE & TELEGRAPH,BOSSI BURT J;;EBERHART MARK A,,https://lens.org/080-347-784-284-35X,Granted Patent,no,0,0,15,15,0,G06K7/0008;;G06K7/10178;;G06K19/0701;;G06K19/0715;;H01F2038/143;;H02M7/537;;H01F3/00;;H02J3/00;;H02M7/537;;G06K7/10178;;H01F2038/143;;G06K7/0008;;G06K19/0701;;G06K19/0715,B42D15/10;;G06K7/00;;G06K17/00;;H01F38/14;;H02J17/00;;H02M7/5383;;H02M7/53846,D13520053    M;;3230030    S,0,0,,,,EXPIRED
145,WO,A2,WO 2002/009019 A2,127-408-068-765-013,2002-01-31,2002,US 0123336 W,2001-07-24,US 62557700 A;;US 77593401 A,2000-07-25,AUTHENTICATION WATERMARKS FOR PRINTED OBJECTS AND RELATED APPLICATIONS,"The disclosure describes systems for creating and authenticating printed objects (45, 46) using authentication and copy detection watermarks. For example, one verification system includes a watermark decoder (50) and a verification module (64, 66, 68, 70). The watermark decoder (50) detects a copy detection watermark in a printed object (45, 46) to determine whether the printed object has been reproduced. The verification module (64, 66, 68, 70) processes a message decoded from an authentication watermark on the printed object to authenticate the printed object or bearer of the printed object. The authentication and copy detection watermarks may be implemented as the same or different watermarks. For example, the authentication and copy detection watermarks may be separate watermarks embedded in an image that is printed on the object. The authentication watermark, in some applications, includes an identifier that links the object to a database entry with related information about the object.",DIGIMARC CORP;;PERRY BURT W;;CARR J SCOTT,PERRY BURT W;;CARR J SCOTT,,https://lens.org/127-408-068-765-013,Patent Application,yes,0,14,9,1547,0,G06F21/10;;G06F21/6209;;G06F21/71;;G06F21/78;;G06F21/79;;G06F21/80;;G06F2221/2135;;G06Q10/00;;G06T1/0042;;G06T1/0071;;H04N1/32144;;H04N1/32283;;H04N1/32288;;H04N1/32331;;H04N21/2347;;H04N21/2351;;H04N21/26613;;H04N21/4117;;H04N21/4223;;H04N21/4408;;H04N21/8352;;H04N21/8358;;H04N2201/3205;;H04N2201/3235;;H04N2201/3236;;H04N2201/3238;;H04N2201/3239;;H04N2201/3269;;H04N2201/327;;H04N2201/3271;;H04N2201/3281;;G07D7/0034;;G06F21/79;;H04N2201/327;;G06F21/71;;H04N2201/3236;;H04N21/4117;;H04N21/8352;;H04N21/4408;;H04N2201/3205;;G06F21/80;;H04N21/26613;;H04N2201/3269;;G06Q10/00;;H04N21/2351;;G06T1/0042;;H04N21/8358;;H04N1/32331;;H04N1/32144;;H04N2201/3281;;H04N2201/3239;;H04N2201/3238;;G06F21/10;;H04N1/32288;;G06T1/0071;;H04N21/2347;;H04N2201/3235;;G06F2221/2135;;H04N21/4223;;G06F21/78;;H04N1/32283;;G06F21/6209;;H04N2201/3271;;G07D7/0034,B42D15/10;;B41J21/00;;G06F21/00;;G06F21/22;;G06Q10/00;;G06T1/00;;G07D7/00;;G07D7/12;;G07D7/20;;H04N1/32;;H04N1/387;;H04N1/40,,0,0,,,,PENDING
146,US,A,US 4458715 A,125-670-140-248-530,1984-07-10,1984,US 36481782 A,1982-04-02,US 36481782 A,1982-04-02,Solenoid actuated control valve,A solenoid control valve comprising a valve body enclosing an armature and reversible valve means including a valve seat adapted to be received within the valve body including at least one flow passage and a movable valve closure element such that when said valve seat is received in one orientation the solenoid control valve is of the normally open variety and when inserted in an opposite orientation said solenoid control valve is of normally closed variety.,BENDIX CORP,BURT DAVID L;;KRAWCZYK GREGORY J,BENDIX CORPORATION THE (1982-03-31),https://lens.org/125-670-140-248-530,Granted Patent,yes,2,3,1,1,0,F16K31/0655;;F16K31/0655;;Y10T137/5196;;Y10T137/5196,F16K31/06,137/270;;251/129,0,0,,,,EXPIRED
147,US,B2,US 8245422 B2,140-595-525-299-028,2012-08-21,2012,US 39918309 A,2009-03-06,US 39918309 A;;US 3420408 P,2008-03-06,Athletic shoe cleat with dynamic traction and method of making and using same,A single component traction cleat of co-molded hub and dynamic traction portions includes dynamic traction elements flexible about proximal ends secured inboard of and below a hub periphery having cut-outs through which the elements move when flexed. The hub has a cross-like configuration with spoke-like legs from which static traction elements depend. Locking posts located on the hub spoke legs include a recess between two symmetrical interference sections for receiving a locking tooth on a mating receptacle.,KRIKORIAN RAND J;;BURT JOHN ROBERT;;SOFTSPIKES LLC,KRIKORIAN RAND J;;BURT JOHN ROBERT,SOFTSPIKES LLC (2009-04-10),https://lens.org/140-595-525-299-028,Granted Patent,yes,21,8,7,7,0,A43C15/161;;A43C15/00;;A43C15/06;;A43C15/161;;A43C15/06;;A43C15/00,A43C15/16;;A43B5/00,36/134;;X 36 67 D;;36/127,1,0,,,"International Search Report and Written Opinion dated Oct. 7, 2010 received in PCT/US09/36282.",ACTIVE
148,US,A,US 5649947 A,091-079-158-956-375,1997-07-22,1997,US 51750195 A,1995-08-21,US 51750195 A;;US 92522592 A;;US 61210690 A,1990-11-09,Surgical instrument,"A surgical instrument has an elongate support shaft, a tip assembly permanently attached to the shaft, a cutting jaw which opens in a backward facing direction and which is laterally offset from the longitudinal axis of the support shaft, and a rod extending coaxially with the elongate support shaft for applying closing and opening forces to the cutting jaw. The tip assembly comprises a stationary portion and a movable portion having respective tissue cutting edges which define the cutting jaw. The stationary portion of the tip assembly is permanently attached to the distal end of the support shaft, and the movable portion of the tip assembly is pivotally attached to a distal end of the stationary portion. The stationary portion of the tip assembly has a plurality of cutting edges which define an opening which extends axially adjacent the longitudinal axis of the support shaft. The movable portion has corresponding cutting edges which cooperate with the cutting edges of the stationary portion to define the cutting jaw. The cutting jaw has a fully open position in which the movable element extends outwardly from the longitudinal axis and toward a proximal end of the elongate shaft at an angle of approximately 60.degree.. The cutting jaw has a fully closed position in which the cutting element is disposed within the opening in the stationary portion of the tip assembly. The tip assembly has an overall height dimension, when the cutting element is in the fully closed position, which is substantially equal to a corresponding cross-sectional dimension of the elongate support shaft.",ARTHROTEK INC,AUERBACH BURT J;;SHUTT GEORGE V,BIOMET INC (2017-11-03);;BIOMET SPORTS MEDICINE LLC (2008-02-27);;ZB MANUFACTURING LLC (2017-11-03);;BIOMET MANUFACTURING LLC (2017-11-03);;BIOMET U.S. RECONSTRUCTION LLC (2017-11-03),https://lens.org/091-079-158-956-375,Granted Patent,yes,34,163,3,3,0,A61B17/1608;;A61B17/1675;;A61B17/1684;;A61B17/29;;A61B17/29;;A61B17/1684;;A61B17/1608;;A61B17/1675,A61B17/28;;A61B17/32,606/170;;606/83;;606/174;;128/751,3,0,,,"Zimmer Brochure, The Master Series 1990.;;Zimmer News Release, No. 606 83, Oct. 11, 1966.;;Karl Storz, Catalog Pages, Endoscopic Diagnosis, Surgery and Treatment of Paranasal Sinus Mycoses, Endoscopes and Instruments as used by Professor W. Messerklinger and H. Stammberger. Mar. 1985.",EXPIRED
149,EP,A1,EP 2247208 A1,096-153-414-403-791,2010-11-10,2010,EP 09715301 A,2009-02-26,US 2009/0035252 W;;US 3141208 P,2008-02-26,IMPROVED TRACTION CLEAT FOR FIELD SPORTS,,SOFTSPIKES LLC,KRIKORIAN RAND J;;BURT JOHN ROBERT,,https://lens.org/096-153-414-403-791,Patent Application,yes,0,0,4,4,0,A43C15/16;;A43C15/16;;A43C15/161;;A43C15/161;;A43C15/165;;A43C15/165;;A43C15/167;;A43C15/167;;A43C15/168;;A43C15/168,A43B5/00;;A43C15/16,,0,0,,,,DISCONTINUED
150,US,A,US 1227592 A,144-827-191-783-834,1917-05-29,1917,US 7841516 A,1916-02-15,US 7841516 A,1916-02-15,FEED-TUBE.,,DOHNER BURT E;;HUFF ALBERT J,DOHNER BURT E;;HUFF ALBERT J,,https://lens.org/144-827-191-783-834,Granted Patent,no,0,0,1,1,0,B23B13/125;;B23B13/125;;Y10T279/17119;;Y10T279/17119,,,0,0,,,,EXPIRED
151,EP,A4,EP 2252173 A4,171-024-020-656-662,2014-01-01,2014,EP 09717434 A,2009-03-06,US 2009/0036282 W;;US 3420408 P,2008-03-06,IMPROVED ATHLETIC SHOE CLEAT WITH DYNAMIC TRACTION AND METHOD OF MAKING AND USING SAME,,SOFTSPIKES LLC,KRIKORIAN RAND J;;BURT JOHN ROBERT,"SOFTSPIKES, LLC (2015-07-29)",https://lens.org/171-024-020-656-662,Search Report,no,3,0,7,7,0,A43C15/161;;A43C15/00;;A43C15/06;;A43C15/161;;A43C15/06;;A43C15/00,A43C13/04;;A43C15/00;;A43C15/06;;A43C15/16,,1,0,,,See also references of WO 2009111683A2,ACTIVE
152,US,A1,US 2009/0211118 A1,042-036-475-178-602,2009-08-27,2009,US 39345109 A,2009-02-26,US 39345109 A;;US 3141208 P,2008-02-26,Traction Cleat for Field Sports,"A cleat for use with an athletic shoe includes a hub, a stud of substantially non-flexible material and extending downwardly and away from a lower surface of the hub, a cleat connector extending upwardly and from an upper surface of the hub and configured to engage a shoe-mounted mating connector disposed on a sole of the shoe, the upper surface opposing the lower surface of the hub, and at least one dynamic traction element extending downwardly from the lower surface of the hub and adapted to flex upwardly when the cleat is connected to a shoe and the at least one dynamic traction element is forced downwardly to contact a ground surface due to a weight load applied to a shoe. The distal end of the stud extends further from the lower surface of the hub than the distal end of each unflexed dynamic traction element such that, when the shoe to which the cleat is connected is forced downward toward the ground surface, the stud contacts and/or begins to penetrate the ground surface to provide initial traction before each dynamic traction element makes contact with the ground surface.",SOFTSPIKES LLC,KRIKORIAN RAND J;;BURT JOHN ROBERT,SOFTSPIKES LLC (2009-04-10),https://lens.org/042-036-475-178-602,Patent Application,yes,24,41,4,4,0,A43C15/16;;A43C15/16;;A43C15/161;;A43C15/161;;A43C15/165;;A43C15/165;;A43C15/167;;A43C15/167;;A43C15/168;;A43C15/168,A43B5/00;;A43C15/00,36/134;;X 36 67  A,0,0,,,,DISCONTINUED
153,CA,A,CA 1199252 A,053-989-563-498-915,1986-01-14,1986,CA 423744 A,1983-03-16,US 36481482 A,1982-04-02,THREE-WAY CONTROL VALVE,: THREE-WAY CONTROL VALVE An electrically operating three-way control valve adopted to fit with a bore of a cooperating apparatus. The three-way control valve including a low pressure seat and a high pressure seat. The three-way control valve further including movable valve means having a self lining closure element for seating upon the high pressure valve seat.,ALLIED CORP,BURT DAVID L;;KRAWCZYK GREGORY J,,https://lens.org/053-989-563-498-915,Granted Patent,no,0,0,7,7,0,F16K11/048;;F16K11/048;;F02M59/466;;F02M59/466;;Y10T137/86895;;Y10T137/86895;;Y10T137/87772;;Y10T137/87772,F16K31/06;;F02M59/46;;F16K11/048,137-127,0,0,,,,EXPIRED
154,US,A,US 2655633 A,077-524-708-643-943,1953-10-13,1953,US 22498451 A,1951-05-07,US 22498451 A,1951-05-07,Apparatus for measuring pipe in or out of holes,,REGAN FORGE & ENG CO,MINOR BURT S;;LOPKER FRANK J,,https://lens.org/077-524-708-643-943,Granted Patent,no,5,14,1,1,0,E21B47/04;;E21B47/04,E21B47/04,,0,0,,,,EXPIRED
155,EP,B1,EP 2252173 B1,122-516-729-627-838,2015-10-14,2015,EP 09717434 A,2009-03-06,US 2009/0036282 W;;US 3420408 P,2008-03-06,IMPROVED ATHLETIC SHOE CLEAT WITH DYNAMIC TRACTION,,SOFTSPIKES LLC,KRIKORIAN RAND J;;BURT JOHN ROBERT,"SOFTSPIKES, LLC (2015-07-29)",https://lens.org/122-516-729-627-838,Granted Patent,yes,9,0,7,7,0,A43C15/161;;A43C15/00;;A43C15/06;;A43C15/161;;A43C15/06;;A43C15/00,A43C13/04;;A43C15/00;;A43C15/06;;A43C15/16,,0,0,,,,ACTIVE
156,KR,B1,KR 920007372 B1,138-262-304-632-643,1992-08-31,1992,KR 890003154 A,1989-03-15,US 16990188 A,1988-03-18,POWER TRANSFER CIRCUIT INCULDING A SYMPATHETIC RESONATOR,"A power transfer circuit includes first and second windings (L1,L2) sharing a common magnetic core (101). Each winding (L1,L2) has associated with it a parallel capacitor (C1,C2) to thus form a pair of ""tank"" circuits. The first winding (L1) is connected at one end to a voltage supply and, at the other end, to ground through an FET switch (100,200). The switch (100,200) is turned on and off at a predetermined frequency and at a 50% duty cycle. The second winding (L2) and associated capacitor (C2) achieves parallel resonance at the predetermined frequency. Similarly the combined first and second windings (L1,L2) and associated capacitors (C1,C2) achieve parallel resonance at said predetermined frequency. The second winding (L2) need not be electrically connected to the first winding (L1) which transfers energy to it through the magnetic core (101). The transfer circuit efficiently couples power across a dielectric interface to a pickup coil (L3). One particularly good application of the power taansfer circuit is in connection with a contactless Smart Card.",AMERICAN TELEPHONE & TELEGRAPH,BOSSI BURT J;;EBERHART MARK A,,https://lens.org/138-262-304-632-643,Granted Patent,no,0,0,15,15,0,G06K7/0008;;G06K7/10178;;G06K19/0701;;G06K19/0715;;H01F2038/143;;H02M7/537;;H01F3/00;;H02J3/00;;H02M7/537;;G06K7/10178;;H01F2038/143;;G06K7/0008;;G06K19/0701;;G06K19/0715,G06K7/00;;B42D15/10;;G06K17/00;;H01F38/14;;H02J17/00;;H02M7/5383;;H02M7/53846,,0,0,,,,EXPIRED
157,US,B2,US 6700360 B2,141-627-693-056-13X,2004-03-02,2004,US 10727002 A,2002-03-25,US 10727002 A,2002-03-25,Output stage compensation circuit,"
    An output stage compensation circuit and method for a low drop-out regulator configured to facilitate stable operation while providing output voltage and current to downstream circuit devices is provided. An exemplary low drop-out regulator is configured with an output stage compensation circuit including one or more segmented sense devices configured to drive one or more fixed current sources. Each segmented sense device is configured to compensate a suitable range of output current and to multiply the effect of associated compensation capacitors. The one or more segmented sense devices are configured to provide pole-zero compensation based on output current. Further, the current range of each segment can be overlapped. As a result, the stability of the low drop-out regulator is not dependent upon the output current requirements or the capacitance requirements of the downstream circuit. 
",TEXAS INSTRUMENTS INC,BIAGI HUBERT J;;BURT RODNEY T,TEXAS INSTRUMENTS INCORPORATED (2002-03-25),https://lens.org/141-627-693-056-13X,Granted Patent,yes,8,35,2,10,0,G05F1/575;;G05F1/575,G05F1/575,323/280;;323/281;;323/275;;327/553;;327/555,0,0,,,,EXPIRED
158,DE,T2,DE 69910040 T2,129-959-005-415-888,2004-04-15,2004,DE 69910040 T,1999-05-11,US 11365098 A;;US 9910238 W,1998-07-10,ALKYLIERUNGSVERFAHREN,,ALBEMARLE CORP,KOEHL J;;BURT A;;WARD T,,https://lens.org/129-959-005-415-888,Granted Patent,no,0,0,7,7,0,B01J23/04;;C07C2/72;;C07C2531/12;;Y02P20/52;;B01J23/04;;C07C2/72;;C07C2531/12;;Y02P20/52,B01J23/04;;C07C2/72,,0,0,,,,EXPIRED
159,US,A,US 2893594 A,159-608-684-975-02X,1959-07-07,1959,US 56402956 A,1956-02-07,US 56402956 A,1956-02-07,Bulk storage of cans for delivery to an operating unit,,CONTINENTAL CAN CO,BURT HOWARD J;;JANESEK LOUIS F,,https://lens.org/159-608-684-975-02X,Granted Patent,no,10,6,1,1,0,B65D88/60;;B65D88/60,B65D88/60,,0,0,,,,EXPIRED
160,WO,A1,WO 1992/008415 A1,197-869-941-292-275,1992-05-29,1992,US 9108346 W,1991-11-08,US 61210690 A,1990-11-09,SURGICAL CUTTING INSTRUMENT,"A surgical instrument (10) has an elongate support shaft (14), a tip assembly (16) permanently attached (72) to the shaft (14), a cutting jaw which opens in a backward facing direction and which is laterally offset from the longitudinal axis (26) of the support shaft (14) and a rod (74) extending coaxially with the elongate support shaft (14) for applying closing and opening forces to the cutting jaw. The tip assembly (16) comprises a stationary portion (22) and a movable portion (20) having respective tissue cutting edges (54, 56, 58) and (36, 38, 40) which define the cutting jaw. The stationary portion (22) of the tip assembly (16) is permanently attached (72) to the distal end (70) of the support shaft (14) and the movable portion (20) of the tip assembly (16) is pivotally attached (32, 50, 82) to a distal end of the stationary portion (22). The stationary portion (22) of the tip assembly (16) has a plurality of cutting edges (54, 56, 58) which define an opening (24) which extends axially adjacent the longitudinal axis (26) of the support shaft (14). The cutting jaw has a fully open position in which the movable element (20) extends outwardly from the longitudinal axis (26) and toward a proximal end of the elongate shaft (14) at an angle (A) of approximately 60°. The cutting jaw has a fully closed position in which the cutting element (20) is disposed within the opening (24) in the stationary portion (22) of the tip assembly (16). The tip assembly (16) has an overall height dimension (H), when the cutting element (20) is in the fully closed position, which is substantially equal to a corresponding cross-sectional dimension of the elongate support shaft (14).",ARTHROTEK INC,AUERBACH BURT J;;SHUTT GEORGE V,,https://lens.org/197-869-941-292-275,Patent Application,yes,5,9,3,3,0,A61B17/1608;;A61B17/1675;;A61B17/1684;;A61B17/29;;A61B17/29;;A61B17/1684;;A61B17/1608;;A61B17/1675,A61B17/28;;A61B17/32,,0,0,,,,PENDING
161,EP,A4,EP 1312030 A4,020-647-043-497-962,2007-07-11,2007,EP 01954933 A,2001-07-24,US 0123336 W;;US 62557700 A;;US 77593401 A,2000-07-25,AUTHENTICATION WATERMARKS FOR PRINTED OBJECTS AND RELATED APPLICATIONS,,DIGIMARC CORP,PERRY BURT W;;CARR J SCOTT,DIGIMARC CORPORATION (2005-05-11),https://lens.org/020-647-043-497-962,Search Report,no,11,0,9,1547,0,G06F21/10;;G06F21/6209;;G06F21/71;;G06F21/78;;G06F21/79;;G06F21/80;;G06F2221/2135;;G06Q10/00;;G06T1/0042;;G06T1/0071;;H04N1/32144;;H04N1/32283;;H04N1/32288;;H04N1/32331;;H04N21/2347;;H04N21/2351;;H04N21/26613;;H04N21/4117;;H04N21/4223;;H04N21/4408;;H04N21/8352;;H04N21/8358;;H04N2201/3205;;H04N2201/3235;;H04N2201/3236;;H04N2201/3238;;H04N2201/3239;;H04N2201/3269;;H04N2201/327;;H04N2201/3271;;H04N2201/3281;;G07D7/0034;;G06F21/79;;H04N2201/327;;G06F21/71;;H04N2201/3236;;H04N21/4117;;H04N21/8352;;H04N21/4408;;H04N2201/3205;;G06F21/80;;H04N21/26613;;H04N2201/3269;;G06Q10/00;;H04N21/2351;;G06T1/0042;;H04N21/8358;;H04N1/32331;;H04N1/32144;;H04N2201/3281;;H04N2201/3239;;H04N2201/3238;;G06F21/10;;H04N1/32288;;G06T1/0071;;H04N21/2347;;H04N2201/3235;;G06F2221/2135;;H04N21/4223;;G06F21/78;;H04N1/32283;;G06F21/6209;;H04N2201/3271;;G07D7/0034,B42D15/10;;G06K1/00;;B41J21/00;;G06F21/00;;G06F21/22;;G06Q10/00;;G06T1/00;;G07D7/00;;G07D7/12;;G07D7/20;;H04N1/32;;H04N1/387;;H04N1/40,,1,0,,,"MINTZER F ET AL: ""Effective and ineffective digital watermarks"", IMAGE PROCESSING, 1997. PROCEEDINGS., INTERNATIONAL CONFERENCE ON SANTA BARBARA, CA, USA 26-29 OCT. 1997, LOS ALAMITOS, CA, USA,IEEE COMPUT. SOC, US, vol. 3, 26 October 1997 (1997-10-26), pages 9 - 12, XP010253686, ISBN: 0-8186-8183-7",EXPIRED
162,AU,B2,AU 2001/277147 B2,071-123-946-823-477,2006-05-18,2006,AU 2001/277147 A,2001-07-24,US 77593401 A;;US 62557700 A;;US 0123336 W,2000-07-25,Authentication watermarks for printed objects and related applications,,DIGIMARC CORP,PERRY BURT W;;CARR J SCOTT,DIGIMARC CORPORATION (2010-12-09),https://lens.org/071-123-946-823-477,Granted Patent,no,9,0,9,1547,0,G06F21/10;;G06F21/6209;;G06F21/71;;G06F21/78;;G06F21/79;;G06F21/80;;G06F2221/2135;;G06Q10/00;;G06T1/0042;;G06T1/0071;;H04N1/32144;;H04N1/32283;;H04N1/32288;;H04N1/32331;;H04N21/2347;;H04N21/2351;;H04N21/26613;;H04N21/4117;;H04N21/4223;;H04N21/4408;;H04N21/8352;;H04N21/8358;;H04N2201/3205;;H04N2201/3235;;H04N2201/3236;;H04N2201/3238;;H04N2201/3239;;H04N2201/3269;;H04N2201/327;;H04N2201/3271;;H04N2201/3281;;G07D7/0034;;G06F21/79;;H04N2201/327;;G06F21/71;;H04N2201/3236;;H04N21/4117;;H04N21/8352;;H04N21/4408;;H04N2201/3205;;G06F21/80;;H04N21/26613;;H04N2201/3269;;G06Q10/00;;H04N21/2351;;G06T1/0042;;H04N21/8358;;H04N1/32331;;H04N1/32144;;H04N2201/3281;;H04N2201/3239;;H04N2201/3238;;G06F21/10;;H04N1/32288;;G06T1/0071;;H04N21/2347;;H04N2201/3235;;G06F2221/2135;;H04N21/4223;;G06F21/78;;H04N1/32283;;G06F21/6209;;H04N2201/3271;;G07D7/0034,B42D15/10;;H04N1/32;;B41J21/00;;G06F21/00;;G06F21/22;;G06Q10/00;;G06T1/00;;G07D7/00;;G07D7/12;;G07D7/20;;H04N1/387;;H04N1/40,,2,0,,,"PANKANTI, S. ET AL VERIFICATION WATERMARKS ON FINGERPRINT RECOGNITION AND RETRIEVAL. SPIE, VOL. 3657, JAN 1999. page 65, lines 1-18 and page 66, lines 1-25;;SZEPANSKI, W. A SIGNAL THEORETIC METHOD FOR CREATING FORGERY-PROOF DOCUMENTS FOR AUTOMATIC VERIFICATION. PROCEEDINGS OF THE 1979 CARNAHAN CONFERENCE ON CRIME COUNTERMEASURES MAY 16 1979 page 101 col 1 lines 1-25",EXPIRED
163,US,A,US 2241239 A,096-900-048-048-078,1941-05-06,1941,US 31466740 A,1940-01-19,GB 2241239X A,1939-01-23,Ultraviolet light filter,,EASTMAN KODAK CO,CARROLL BURT H;;STAUD CYRIL J,,https://lens.org/096-900-048-048-078,Granted Patent,no,0,13,1,1,0,G03C1/8155;;G03C1/8155,G03C1/815,,0,0,,,,EXPIRED
164,US,A,US 3668308 A,166-082-673-541-779,1972-06-06,1972,US 3668308D A,1970-07-20,US 5656370 A,1970-07-20,A TELEVISION SYSTEM FOR TERRAIN SURVEILLANCE,"A system for terrain surveillance from an aircraft utilizing a scanning optical system, a TV monitor, and a modified video recorder. A rotating mirror scans a section of the terrain below the aircraft extending transversely to the aircraft flight path and directs the reflected light onto a photocell. The photocell signal forms the input to the video recorder and TV monitor. The TV display is unconventional in that each frame presented has one new scan added and the lower-most old scan is removed and thus the pilot sees on his monitor a terrain picture which advances as the aircraft moves along its flight path.",US NAVY,BURT WARREN T;;HOFFMAN HERMAN J,,https://lens.org/166-082-673-541-779,Granted Patent,no,4,10,1,1,0,H04N5/765;;H04N7/005;;H04N5/765;;H04N7/005,H04N5/765;;H04N7/00,178  66  A;;1791002  T;;178DIG20,0,0,,,,EXPIRED
165,US,A,US 2940624 A,184-574-635-580-893,1960-06-14,1960,US 57902556 A,1956-04-18,US 57902556 A,1956-04-18,Can unbagging and transferring apparatus and method,,CONTINENTAL CAN CO,BURT HOWARD J;;JANESEK LOUIS F,,https://lens.org/184-574-635-580-893,Granted Patent,no,13,2,1,1,0,B65B69/00;;B65B69/00,B65B69/00,,0,0,,,,EXPIRED
166,US,A1,US 2009/0223088 A1,000-642-207-817-582,2009-09-10,2009,US 39918309 A,2009-03-06,US 39918309 A;;US 3420408 P,2008-03-06,Athletic Shoe Cleat With Dynamic Traction and Method of Making and Using Same,A single component traction cleat of co-molded hub and dynamic traction portions includes dynamic traction elements flexible about proximal ends secured inboard of and below a hub periphery having cut-outs through which the elements move when flexed. The hub has a cross-like configuration with spoke-like legs from which static traction elements depend. Locking posts located on the hub spoke legs include a recess between two symmetrical interference sections for receiving a locking tooth on a mating receptacle.,SOFTSPIKES LLC,KRIKORIAN RAND J;;BURT JOHN ROBERT,SOFTSPIKES LLC (2009-04-10),https://lens.org/000-642-207-817-582,Patent Application,yes,21,39,7,7,0,A43C15/161;;A43C15/00;;A43C15/06;;A43C15/161;;A43C15/06;;A43C15/00,A43B5/00;;A43C15/02,36/127;;36/134;;36/62,0,0,,,,ACTIVE
167,US,A,US 2943275 A,074-905-837-206-31X,1960-06-28,1960,US 68299257 A,1957-09-09,US 68299257 A,1957-09-09,Transformer for joining unbalanced to balanced transmission means,,BITTNER BURT J;;OPPERMAN RAYMOND H,BITTNER BURT J;;OPPERMAN RAYMOND H,,https://lens.org/074-905-837-206-31X,Granted Patent,no,8,10,1,1,0,H01P5/10;;H01P5/10,H01P5/10,,0,0,,,,EXPIRED
168,EP,A4,EP 2247208 A4,113-249-094-010-892,2013-10-02,2013,EP 09715301 A,2009-02-26,US 2009/0035252 W;;US 3141208 P,2008-02-26,IMPROVED TRACTION CLEAT FOR FIELD SPORTS,,SOFTSPIKES LLC,KRIKORIAN RAND J;;BURT JOHN ROBERT,,https://lens.org/113-249-094-010-892,Search Report,no,4,0,4,4,0,A43C15/16;;A43C15/16;;A43C15/161;;A43C15/161;;A43C15/165;;A43C15/165;;A43C15/167;;A43C15/167;;A43C15/168;;A43C15/168,A43B5/00;;A43C15/16,,1,0,,,See also references of WO 2009108756A1,DISCONTINUED
169,US,A,US 5923209 A,181-885-220-400-247,1999-07-13,1999,US 70738096 A,1996-09-04,US 70738096 A,1996-09-04,Two trim current source and method for a digital-to-analog converter,"A trimmable current cell and method for providing an output current at a desired level which may be used to provide a particular current level for a digital-to-analog converter. The cell includes a first circuit with two fixed resistors connected in series which initially establish the output current, and a second circuit for trimming the output current from the first circuit to the desired level. The second circuit has a series-connected pair of trimmable resistors whose common node is connected to the first circuit at a common node between the fixed resistors. Trimming one of the trimmable resistors increases the output current to the desired level and trimming the other of the trimmable resistors decreases the output current to the desired level.",HARRIS CORP,PRICE BURT L;;TESCH BRUCE J,INTERSIL COMMUNICATIONS INC (2001-05-23);;INTERSIL AMERICAS LLC (2001-12-21);;HARRIS CORPORATION (1996-09-03),https://lens.org/181-885-220-400-247,Granted Patent,yes,6,4,1,1,0,G05F3/222;;G05F3/222,G05F3/22,327/538;;327/545;;323/312,0,0,,,,EXPIRED
170,EP,A2,EP 1312030 A2,169-629-726-966-849,2003-05-21,2003,EP 01954933 A,2001-07-24,US 0123336 W;;US 62557700 A;;US 77593401 A,2000-07-25,AUTHENTICATION WATERMARKS FOR PACKAGED PRODUCTS,,DIGIMARC CORP,PERRY BURT W;;CARR J SCOTT,DIGIMARC CORPORATION (2005-05-11),https://lens.org/169-629-726-966-849,Patent Application,yes,0,4,9,1547,0,G06F21/10;;G06F21/6209;;G06F21/71;;G06F21/78;;G06F21/79;;G06F21/80;;G06F2221/2135;;G06Q10/00;;G06T1/0042;;G06T1/0071;;H04N1/32144;;H04N1/32283;;H04N1/32288;;H04N1/32331;;H04N21/2347;;H04N21/2351;;H04N21/26613;;H04N21/4117;;H04N21/4223;;H04N21/4408;;H04N21/8352;;H04N21/8358;;H04N2201/3205;;H04N2201/3235;;H04N2201/3236;;H04N2201/3238;;H04N2201/3239;;H04N2201/3269;;H04N2201/327;;H04N2201/3271;;H04N2201/3281;;G07D7/0034;;G06F21/79;;H04N2201/327;;G06F21/71;;H04N2201/3236;;H04N21/4117;;H04N21/8352;;H04N21/4408;;H04N2201/3205;;G06F21/80;;H04N21/26613;;H04N2201/3269;;G06Q10/00;;H04N21/2351;;G06T1/0042;;H04N21/8358;;H04N1/32331;;H04N1/32144;;H04N2201/3281;;H04N2201/3239;;H04N2201/3238;;G06F21/10;;H04N1/32288;;G06T1/0071;;H04N21/2347;;H04N2201/3235;;G06F2221/2135;;H04N21/4223;;G06F21/78;;H04N1/32283;;G06F21/6209;;H04N2201/3271;;G07D7/0034,B42D15/10;;H04N1/32;;B41J21/00;;G06F21/00;;G06F21/22;;G06K1/00;;G06Q10/00;;G06T1/00;;G07D7/00;;G07D7/12;;G07D7/20;;H04N1/387;;H04N1/40,,0,0,,,,EXPIRED
171,US,A,US 4431160 A,030-098-898-134-124,1984-02-14,1984,US 36481582 A,1982-04-02,US 36481582 A,1982-04-02,Electric control valve,An electrically operated control valve adapted to fit within a bore of a cooperating apparatus. The valve including an interchangeable stator and lower body member. The valve further includes a valve means having a swivable self-aligning valve closure element.,BENDIX CORP,BURT DAVID L;;KRAWCZYK GREGORY J,BENDIX CORPORATION THE (1982-03-31),https://lens.org/030-098-898-134-124,Granted Patent,yes,4,4,10,11,0,F16K1/34;;F16K1/34;;F02M61/12;;F02M61/12,F16K31/06;;F02M61/12;;F16K1/34,251/86;;251/129,0,0,,,,EXPIRED
172,US,A,US 2448858 A,081-254-214-507-13X,1948-09-07,1948,US 63054445 A,1945-11-23,US 63054445 A,1945-11-23,Optically supersensitized photographic silver halide emulsion,,EASTMAN KODAK CO,CARROLL BURT H;;STAUD CYRIL J,,https://lens.org/081-254-214-507-13X,Granted Patent,no,1,4,4,4,0,C09B23/083;;C09B23/083;;G03C1/29;;G03C1/29,C09B23/08;;G03C1/29,,0,0,,,,EXPIRED
173,US,A,US 1108722 A,124-319-651-593-50X,1914-08-25,1914,US 1913/0748828 A,1913-02-17,US 1913/0748828 A,1913-02-17,ROLLER-BEARING.,,DOHNER BURT E;;HUFF ALBERT J,DOHNER BURT E;;HUFF ALBERT J,,https://lens.org/124-319-651-593-50X,Granted Patent,no,0,7,1,1,0,F16C33/4605;;F16C33/4605;;F16C19/26;;F16C19/26;;F16C33/543;;F16C33/543;;Y10T29/4968;;Y10T29/4968,,,0,0,,,,EXPIRED
174,DE,C,DE 721249 C,157-007-732-481-053,1942-05-30,1942,DE K0150194 D,1938-03-31,US 13411837 A,1937-03-31,Verfahren zum Herstellen korrigierter photographischer Teilfarbenauszuege,,KODAK AG,CARROLL BURT H;;STAUD CYRIL J,,https://lens.org/157-007-732-481-053,Granted Patent,no,0,2,4,4,0,G03C7/18;;G03C7/18,G03C7/18,,0,0,,,,EXPIRED
175,US,A1,US 2013/0039760 A1,170-980-944-882-014,2013-02-14,2013,US 201213553115 A,2012-07-19,GB 201113893 A,2011-08-12,OIL MIST SEPARATION IN GAS TURBINE ENGINES,"A rotor stage is provided which comprises a shank passage for separating liquid from secondary air system (SAS) air. The shank passage is formed between a radially outer surface of a disc post, a radially inner surface of one or more blade platforms, and the shanks of two neighbouring blades. In use, SAS air is supplied to the shank passage. Any liquid, such as oil, is separated from the SAS air due to the centripetal acceleration of the rotation of the rotor disc. The separated oil can then flow, or seep, past the blade platform and into the working fluid. The remainder of the SAS air passes through a hole in a sealing plate at the downstream end of the rotor stage, thereby providing SAS air with a lower liquid content for use downstream of the rotor stage.",ROLLS ROYCE PLC;;BURT ALEXANDER J;;SADLER KEITH C,BURT ALEXANDER J;;SADLER KEITH C,ROLLS-ROYCE PLC (2012-06-19),https://lens.org/170-980-944-882-014,Patent Application,yes,14,8,4,4,0,F01D11/001;;F01D11/001;;F01D5/081;;F01D5/081;;F01D5/3015;;F01D5/3015;;Y02T50/60;;Y02T50/60,F01D25/18;;F01D5/18;;F01D5/30,416/1;;X416204  A;;X416 97  R,0,0,,,,DISCONTINUED
176,WO,A1,WO 2023/219660 A1,171-623-880-738-793,2023-11-16,2023,US 2023/0011126 W,2023-01-19,US 202263339541 P,2022-05-09,WIRELESS ARCHITECTURES FOR SURGICAL ROBOTIC SYSTEMS,"A surgical robotic system includes a control tower and a robotic system component. The control tower includes a tower Li-Fi transceiver configured to communicate on a first communication data channel. The robotic system component includes a robotic system component Li-Fi transceiver configured to communicate first data, and a self-aligning mechanism. The selfaligning mechanism includes an imaging device configured to capture images configured to allow detection of a detected a geospatial location of the tower Li-Fi transceiver, and an actuatable base configured for aligning the imaging device with the detected geospatial location of the tower Li-Fi transceiver. The robotic system component Li-Fi transceiver is mounted to the actuatable base.",COVIDIEN LP,PEINE WILLIAM J;;OCHS BURT D,,https://lens.org/171-623-880-738-793,Patent Application,yes,2,0,1,1,0,H04B10/116;;A61B34/37;;G16H40/63;;G06T7/70;;A61B2017/00221;;A61B2560/0437;;A61B2034/2059;;A61B2017/00119,G16H40/63;;A61B34/00;;A61B34/37;;G06T7/285;;G06T7/70;;G06T7/77;;H04B10/116,,2,2,080-219-684-092-389;;104-587-667-881-261,10.1109/tmc.2016.2602834;;10.1109/mce.2020.2990383,"KHAN MAHMUDUR ET AL: ""GPS-Free Maintenance of A Free-Space-Optical Link Between Two Autonomous Mobiles"", IEEE TRANSACTIONS ON MOBILE COMPUTING, IEEE SERVICE CENTER, LOS ALAMITOS, CA, US, vol. 16, no. 6, 30 June 2017 (2017-06-30), pages 1644 - 1657, XP011648712, ISSN: 1536-1233, [retrieved on 20170504], DOI: 10.1109/TMC.2016.2602834;;CHOWDHURY MOSTAFA ZAMAN ET AL: ""A New 5G eHealth Architecture Based on Optical Camera Communication: An Overview, Prospects, and Applications"", IEEE CONSUMER ELECTRONICS MAGAZINE, IEEE, PISCATAWAY, NJ, USA, vol. 9, no. 6, 8 May 2020 (2020-05-08), pages 23 - 33, XP011812697, ISSN: 2162-2248, [retrieved on 20201005], DOI: 10.1109/MCE.2020.2990383",PENDING
177,US,A,US 2218229 A,082-887-235-537-537,1940-10-15,1940,US 13411837 A,1937-03-31,US 13411837 A,1937-03-31,Process and material for masking in color correction,,EASTMAN KODAK CO,CARROLL BURT H;;STAUD CYRIL J,,https://lens.org/082-887-235-537-537,Granted Patent,no,0,7,4,4,0,G03C7/18;;G03C7/18,G03C7/18,,0,0,,,,EXPIRED
178,US,A,US 6150190 A,099-929-916-448-310,2000-11-21,2000,US 32086699 A,1999-05-27,US 32086699 A,1999-05-27,Method of formation of buried mirror semiconductive device,"A method for forming a buried optical mirror in an integrated circuit (IC) begins by forming an opening (18) within a substrate (12). The opening (18) is then filled with a plurality of dielectric layers (20-26) that have different indexes of refraction whereby a Bragg reflector can be formed. A chemical mechanical polishing (CMP) process is then used to planarize the layers (20-26) such that these layers (20-26) only reside within the opening (18) whereby a mirror is formed. Lateral selective epitaxial growth, polysilicon deposition and recrystallization, or wafer bonding is then used to form a single crystalline or near single crystalline semiconductive material (32b) over a top of the substrate (12) and the reflecting mirror. Photodevice(s) are then formed over the mirror in the region (28) of material (32b) whereby reflecting mirror (20-26) will improve the quantum efficiency and speed of the photodevice(s).",MOTOROLA INC,STANKUS JOHN J;;FOWLER BURT WAYNE,VLSI TECHNOLOGY LLC (2017-12-04);;NXP USA INC (2016-11-07);;MOTOROLA INC (1999-05-20),https://lens.org/099-929-916-448-310,Granted Patent,yes,1,39,1,1,0,H01L31/1804;;H01L33/10;;H01L31/02327;;Y02P70/50;;H01L33/10;;H01L31/1804;;Y02E10/547;;H01L31/02327;;Y02P70/50,H01L31/0232;;H01L31/18;;H01L33/10,438/72,8,7,081-999-116-122-734;;042-686-282-876-919;;013-199-340-961-442;;027-062-869-274-889;;165-846-795-438-164;;118-994-880-284-374;;081-999-116-122-734,10.1109/68.651135;;10.1109/55.55243;;10.1016/s0924-4247(96)01319-2;;10.1109/16.285047;;10.1016/s0167-9317(97)00087-7;;10.1007/bf02676844;;10.1109/68.651135,"G. Neudeck et al., Selective Epitaxial Growth Si Resonant Cavity Photodetector , IEEE Photonics Technology Letters, vol. 10, No. 1, pp. 129 131, Jan. 1998.;;Peter J. Schubert et al., Confined Lateral Selective Epitaxial Growth of Silicon for Device Fabrication , May 1990 IEEE Electron Device Letters, vol. 11, No. 5, pp. 181 183.;;M. Edward Motamedi et al., Micro Optics/Micromechanics and Laser Scanning and Shaping , SPIE (The Society of Photo Optical Instrumentation Engineers), vol. 2383, pp. 146 153.;;James J. Pak et al., A bridge type piezoresistive accelerometer using merged epitaxial lateral overgrowth for thin silicon beam formation , Elsevier Science S.A., Sensors and Actuators A 56 (1996), pp. 267 271.;;J.W. Siekkinen et al., A Novel High Speed Silicon Bipolar Transistor Utilizing SEG and CLSEG , May 1994 IEEE Transactions on Electron Devices, vol. 41, No. 5, pp. 862 864.;;Gerold W. Neudeck et al., Stacking Fault Reduction in Silicon on Insulator (SOI) Islands Produced by Selective Epataxial Growth (SEG) of Silicon Using a Thermally Nitrided SiO2 Field Insulator , Elsevier Science B.V. Microelectronic Engineering 36 (1997, pp. 391 394.;;Srikanth B. Samavedam et al., Defect Structures in Silicon Merged Epataxial Lateral Overgrowth , Journal of Electronic Materials, vol. 24, No. 11, 1995, pp. 1747 1751.;;Gerold W. Neudeck et al., Selective Epataxial Growth Si Resonant Cavity Photodetector , 1998 IEEE Photonics Technology Letters, vol. 10, No. 1, Jan. 1998, pp. 129 131.",EXPIRED
179,US,A,US 1188632 A,110-680-312-420-697,1916-06-27,1916,US 6832215 A,1915-12-23,US 6832215 A,1915-12-23,ROLLER-BEARING.,,DOHNER BURT E;;HUFF ALBERT J,DOHNER BURT E;;HUFF ALBERT J,,https://lens.org/110-680-312-420-697,Granted Patent,no,0,2,1,1,0,F16C33/46;;F16C33/46,,,0,0,,,,EXPIRED
180,CA,A,CA 484290 A,113-116-511-393-902,1952-06-24,1952,CA 484290D A,,CA 484290T A,,SENSITIZED PHOTOGRAPHIC EMULSION,,CANADIAN KODAK CO,CARROLL BURT H;;STAUD CYRIL J,,https://lens.org/113-116-511-393-902,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
181,WO,A3,WO 2009/111683 A3,016-938-840-739-86X,2010-12-02,2010,US 2009/0036282 W,2009-03-06,US 3420408 P,2008-03-06,IMPROVED ATHLETIC SHOE CLEAT WITH DYNAMIC TRACTION AND METHOD OF MAKING AND USING SAME,A single component traction cleat of co-molded hub and dynamic traction portions includes dynamic traction elements flexible about proximal ends secured inboard of and below a hub periphery having cut-outs through which the elements move when flexed. The hub has a cross-like configuration with spoke- like legs from which static traction elements depend. Locking posts located on the hub spoke legs include a recess between two symmetrical interference sections for receiving a locking tooth on a mating receptacle.,SOFTSPIKES LLC;;KRIKORIAN RAND J;;BURT JOHN ROBERT,KRIKORIAN RAND J;;BURT JOHN ROBERT,,https://lens.org/016-938-840-739-86X,Search Report,yes,6,0,7,7,0,A43C15/161;;A43C15/00;;A43C15/06;;A43C15/161;;A43C15/06;;A43C15/00,A43C13/04,,0,0,,,,PENDING
182,US,A,US 1683339 A,090-987-179-714-129,1928-09-04,1928,US 73767924 A,1924-09-15,US 73767924 A,1924-09-15,Machine for reboring or refinishing cylinders,,FARR BURT J;;WESTBROOK MOSES H,FARR BURT J;;WESTBROOK MOSES H,,https://lens.org/090-987-179-714-129,Granted Patent,no,0,0,1,1,0,B23B41/12;;B23B41/12;;Y10T408/375;;Y10T408/375,B23B41/12,,0,0,,,,EXPIRED
183,WO,A2,WO 2009/111683 A2,115-283-514-407-047,2009-09-11,2009,US 2009/0036282 W,2009-03-06,US 3420408 P,2008-03-06,IMPROVED ATHLETIC SHOE CLEAT WITH DYNAMIC TRACTION AND METHOD OF MAKING AND USING SAME,A single component traction cleat of co-molded hub and dynamic traction portions includes dynamic traction elements flexible about proximal ends secured inboard of and below a hub periphery having cut-outs through which the elements move when flexed. The hub has a cross-like configuration with spoke- like legs from which static traction elements depend. Locking posts located on the hub spoke legs include a recess between two symmetrical interference sections for receiving a locking tooth on a mating receptacle.,SOFTSPIKES LLC;;KRIKORIAN RAND J;;BURT JOHN ROBERT,KRIKORIAN RAND J;;BURT JOHN ROBERT,,https://lens.org/115-283-514-407-047,Patent Application,yes,1,0,7,7,0,A43C15/161;;A43C15/00;;A43C15/06;;A43C15/161;;A43C15/06;;A43C15/00,A43B5/00;;A43C15/02,,0,0,,,,PENDING
184,US,A,US 4811106 A,116-887-931-023-056,1989-03-07,1989,US 4771987 A,1987-05-05,GB 8611962 A,1986-05-16,Frame transfer image sensor having two vertical clock standards,"A charge coupled device (CCD) image sensor for producing a video output for a given TV line standard wherein the image section (9) has a number of CCD elements appropriate to the given line standard and the store section (11) has a number of CCD elements appropriate to a second, higher line standard. The electronic package required to drive the sensor is then not very different from an electronic package required to drive a sensor for the higher line standard, thus making it practicable to use in the sensor an electronic package capable of use in sensors for either standard.",GEN ELECTRIC CO PLC,BURT DAVID J;;BELL RAYMOND T,GENERAL ELECTRIC COMPANY THE P.L.C. A BRITISH COMPANY (1987-08-07),https://lens.org/116-887-931-023-056,Granted Patent,yes,3,28,5,8,0,H01L27/14831;;H04N25/443;;H04N25/72;;H04N3/1562;;H01L27/14831,H01L27/148;;H04N5/345;;H04N5/3725,H1K KECC          ECC,0,0,,,,EXPIRED
185,CA,A,CA 1181054 A,157-469-556-282-608,1985-01-15,1985,CA 423751 A,1983-03-16,US 36481582 A,1982-04-02,ELECTRIC CONTROL VALVE,: ELECTRIC CONTROL VALVE An electrically operated control valve adapted to fit within a bore of a cooperating apparatus. The valve including an interchangeable stator and lower body member. The valve further includes a valve means having a swivable self-aligning valve closure element.,BENDIX CORP,BURT DAVID L;;KRAWCZYK GREGORY J,,https://lens.org/157-469-556-282-608,Granted Patent,no,0,0,10,11,0,F16K1/34;;F16K1/34;;F02M61/12;;F02M61/12,F16K31/06;;F02M61/12;;F16K1/34,251-14,0,0,,,,EXPIRED
186,US,A,US 4802080 A,003-352-033-555-191,1989-01-31,1989,US 16990188 A,1988-03-18,US 16990188 A,1988-03-18,Power transfer circuit including a sympathetic resonator,"A power transfer circuit includes first and second windings (L1, L2) sharing a common magnetic core (101). Each winding has associated with it a parallel capacitor to thus form a pair of ""tank"" circuits. The first winding (L1) is connected at one end to a voltage supply and, at the other end, to ground through an FET switch (100,200). The switch (100,200) is turned on and off at a predetermined frequency and at a 50% duty cycle. The second winding (L2) and associated capacitor (C2) achieves parallel resonance at the predetermined frequency. Similarly the combined first and second windings (L1,L2) and associated capacitors (C1,C2) achieve parallel resonance at said predetermined frequency. The second winding (L2) need not be electrically connected to the first winding (L1) which transfers energy to it through the magnetic core (101). The transfer circuit efficiently couples power across a dielectric interface to a pickup coil (L3). One particularly good application of the power transfer circuit is in connection with a contactless Smart Card.",AMERICAN TELEPHONE & TELEGRAPH,BOSSI BURT J;;EBERHART MARK A,AMERICAN TELEPHONE AND TELEGRAPH COMPANY A CORP. OF NY (1988-03-15);;AT&T INFORMATION SYSTEMS INC. A CORP. OF DE (1988-03-15),https://lens.org/003-352-033-555-191,Granted Patent,yes,9,98,15,15,0,G06K7/0008;;G06K7/10178;;G06K19/0701;;G06K19/0715;;H01F2038/143;;H02M7/537;;H01F3/00;;H02J3/00;;H02M7/537;;G06K7/10178;;H01F2038/143;;G06K7/0008;;G06K19/0701;;G06K19/0715,G06K7/00;;B42D15/10;;G06K17/00;;H01F38/14;;H02J17/00;;H02M7/5383;;H02M7/53846,363/75;;363/20;;363/90,2,0,,,"Application Ser. 851,849 Files 4 14 86, Power Regulator for a Contactless Credit Card System , R. L. Billings.;;Does Your Coupling Coefficient Matter , Electronics & Wireless World, Tom Ivall, 6/87, pp. 577 579.",EXPIRED
187,US,A,US 1733509 A,013-620-511-181-106,1929-10-29,1929,US 26996728 A,1928-04-14,US 26996728 A,1928-04-14,Hook for handling oil-well casings and the like,,REGAN FORGE & ENG CO,STANLEY MINOR BURT;;REGAN JAMES J,,https://lens.org/013-620-511-181-106,Granted Patent,no,0,2,1,1,0,Y10T24/45288;;Y10T24/45325;;E21B19/04;;E21B19/04;;F16B45/00,E21B19/04,,0,0,,,,EXPIRED
188,US,A,US 1412866 A,159-556-083-631-641,1922-04-18,1922,US 18465217 A,1917-08-06,US 18465217 A,1917-08-06,Anesthetizing machine,,HEIDBRINK JAY A;;CLARK BURT J,HEIDBRINK JAY A;;CLARK BURT J,,https://lens.org/159-556-083-631-641,Granted Patent,no,0,0,1,1,0,A61M16/104;;A61M16/104,A61M16/10,,0,0,,,,EXPIRED
189,EP,B1,EP 1312030 B1,196-286-536-024-364,2011-08-24,2011,EP 01954933 A,2001-07-24,US 0123336 W;;US 62557700 A;;US 77593401 A,2000-07-25,AUTHENTICATION WATERMARKS FOR PACKAGED PRODUCTS,,DIGIMARC CORP,PERRY BURT W;;CARR J SCOTT,DIGIMARC CORPORATION (2005-05-11),https://lens.org/196-286-536-024-364,Granted Patent,yes,1,0,9,1547,0,G06F21/10;;G06F21/6209;;G06F21/71;;G06F21/78;;G06F21/79;;G06F21/80;;G06F2221/2135;;G06Q10/00;;G06T1/0042;;G06T1/0071;;H04N1/32144;;H04N1/32283;;H04N1/32288;;H04N1/32331;;H04N21/2347;;H04N21/2351;;H04N21/26613;;H04N21/4117;;H04N21/4223;;H04N21/4408;;H04N21/8352;;H04N21/8358;;H04N2201/3205;;H04N2201/3235;;H04N2201/3236;;H04N2201/3238;;H04N2201/3239;;H04N2201/3269;;H04N2201/327;;H04N2201/3271;;H04N2201/3281;;G07D7/0034;;G06F21/79;;H04N2201/327;;G06F21/71;;H04N2201/3236;;H04N21/4117;;H04N21/8352;;H04N21/4408;;H04N2201/3205;;G06F21/80;;H04N21/26613;;H04N2201/3269;;G06Q10/00;;H04N21/2351;;G06T1/0042;;H04N21/8358;;H04N1/32331;;H04N1/32144;;H04N2201/3281;;H04N2201/3239;;H04N2201/3238;;G06F21/10;;H04N1/32288;;G06T1/0071;;H04N21/2347;;H04N2201/3235;;G06F2221/2135;;H04N21/4223;;G06F21/78;;H04N1/32283;;G06F21/6209;;H04N2201/3271;;G07D7/0034,B42D15/10;;H04N1/32;;B41J21/00;;G06F21/00;;G06F21/22;;G06K1/00;;G06Q10/00;;G06T1/00;;G07D7/00;;G07D7/12;;G07D7/20;;H04N1/387;;H04N1/40,,0,0,,,,EXPIRED
190,AU,B2,AU 2016/243160 B2,015-110-673-282-56X,2022-02-24,2022,AU 2016/243160 A,2016-03-30,US 201562140277 P;;US 201562214293 P;;US 201562140289 P;;US 2016/0024921 W,2015-03-30,Plasma kallikrein inhibitors and uses thereof for preventing hereditary angioedema attack,Provided herein are plasma kallikrein antibodies binding to active plasma kallikrein and methods of using such antibodies in preventing hereditary angioedema attack or reducing the rate of hereditary angioedema attack.,TAKEDA PHARMACEUTICALS CO,CHYUNG YUNG;;ADELMAN BURT;;SEXTON DANIEL J,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/015-110-673-282-56X,Granted Patent,no,1,0,27,27,0,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,C07K16/40,,0,0,,,,ACTIVE
191,US,A1,US 2012/0228949 A1,015-827-681-365-312,2012-09-13,2012,US 201213370954 A,2012-02-10,GB 201103798 A,2011-03-07,DC ELECTRICAL POWER SYSTEM,"A DC electrical power system has a power generator converter system, a positive supply rail extending from the converter system, a negative supply rail extending from the converter system, and a midpoint earthing arrangement operatively connecting to the supply rails. The earthing arrangement is connected to earth by a solid earth connection. The network further has a first protective device on one of the supply rails which in case of a fault is operable to interrupt current flowing on that rail, and a second protective device on the earthing arrangement which in case of a fault is operable to interrupt current flowing to earth through the solid earth connection.",NORMAN PATRICK J;;GALLOWAY STUART J;;BURT GRAEME M;;ROLLS ROYCE PLC,NORMAN PATRICK J;;GALLOWAY STUART J;;BURT GRAEME M,ROLLS-ROYCE PLC (2012-01-17),https://lens.org/015-827-681-365-312,Patent Application,yes,2,1,5,5,0,H02H3/16;;H02H3/16;;H02H3/087;;H02H3/087;;H02H7/268;;H02H7/268,H02J3/00;;H02H7/125,307/84;;363/53,0,0,,,,ACTIVE
192,KR,A,KR 20160089368 A,019-134-658-840-799,2016-07-27,2016,KR 20167013312 A,2014-10-17,US 201361893542 P;;US 2014/0061242 W,2013-10-21,DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES,"자가면역 질환, 예컨대 류마티스성 관절염, 크론병 및 궤양성 대장염을 진단하고 치료하기 위한 방법, 키트 및 조성물.",DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,,https://lens.org/019-134-658-840-799,Patent Application,no,5,2,44,44,14,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,,,4,2,051-663-279-687-169;;088-052-241-032-685,2451949;;10.1182/blood.v71.5.1334.bloodjournal7151334;;10.1182/blood.v71.5.1334.1334;;10.1161/01.atv.0000240290.70852.c0;;pmc2637648;;16902163,"Irma Isordia-Salas et al, Archives of Medical Research (2005), vol 36, pp 119-130.;;Nielsen E W et al, Journal of Internal Medicine (1996), vol 239, pp 87-95.;;Reddigari S et al, Blood (1988), vol 71, no 5, pp 1334-1340.;;Khan M M et al, Thrombosis and Vascular Biology (20060, vol 26, pp 2260-2266.",ACTIVE
193,BR,A2,BR 112016008975 A2,027-445-932-008-857,2017-09-19,2017,BR 112016008975 A,2014-10-17,US 2014/0061242 W;;US 201361893542 P,2013-10-21,"MÉTODOS PARA DETECTAR, MONITORAR O DESENVOLVIMENTO E AVALIAR A EFICÁCIA DE UM TRATAMENTO DE UMA DOENÇA AUTOIMUNE","MÉTODO PARA DIAGNOSTICAR UMA DOENÇA AUTOIMUNE, MONITORAR SEU DESENVOLVIMENTO E AVALIAR A EFICÁCIA DE UM TRATAMENTO PARA TAL DOENÇA. Métodos, kits e composições para diagnosticar e tratar doenças autoimunes, tais como artrite reumatoide, doença de Crohn e colite ulcerativa.",TAKEDA PHARMACEUTICALS CO;;DYAX CORP,DANIEL J SEXTON;;BURT ADELMAN;;ANDREW NIXON,TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) (2021-10-05);;DYAX CORP. (US) (2018-08-28),https://lens.org/027-445-932-008-857,Patent Application,no,0,0,44,44,0,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/00;;A61K39/00,,0,0,,,,ACTIVE
194,EP,B1,EP 3060908 B1,071-458-215-524-443,2021-02-24,2021,EP 14855002 A,2014-10-17,US 201361893542 P;;US 2014/0061242 W,2013-10-21,DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES,,DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,"TAKEDA PHARMACEUTICAL COMPANY LIMITED, OSAKA-S, JP (2021-07-28);;TAKEDA PHARMACEUTICAL COMPANY LIMITED, JP (2021-09-13);;TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-09-08);;DYAX CORP. (2018-06-20);;TAKEDA PHARMACEUTICAL COMPANY LIMITED; JP (2021-11-05)",https://lens.org/071-458-215-524-443,Granted Patent,yes,2,0,44,44,0,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/00;;A61K39/00;;G01N33/564,,0,0,,,,ACTIVE
195,US,A1,US 2020/0371120 A1,075-464-195-846-942,2020-11-26,2020,US 202016849492 A,2020-04-15,US 202016849492 A;;US 201816131781 A;;US 201615030790 A;;US 2014/0061242 W;;US 201361893542 P,2013-10-21,DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES,"Methods, kits and compositions for diagnosing and treating autoimmue diseases such as rheumatiodi arthritis, Crohn's disease, and ulcerative colitis.",DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2016-08-16),https://lens.org/075-464-195-846-942,Patent Application,yes,2,2,44,44,7,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/86;;G01N33/564,,1,0,,,"Strongin, Laboratory Diagnosis of Viral INfections, Sensitivity, Specificity, and Predictive Value of Diagnostic Tests: Definitions and Clinical Applications, Lennette, ed. Marcel Dekker, Inc. New York, pp. 211-219, 1992. (Year: 1992)",PENDING
196,WO,A1,WO 2016/160926 A1,110-154-073-944-740,2016-10-06,2016,US 2016/0024921 W,2016-03-30,US 201562214293 P;;US 201562140289 P;;US 201562140277 P,2015-03-30,PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR PREVENTING HEREDITARY ANGIOEDEMA ATTACK,Provided herein are plasma kallikrein antibodies binding to active plasma kallikrein and methods of using such antibodies in preventing hereditary angioedema attack or reducing the rate of hereditary angioedema attack.,DYAX CORP,CHYUNG YUNG;;ADELMAN BURT;;SEXTON DANIEL J,,https://lens.org/110-154-073-944-740,Patent Application,yes,2,18,27,27,10,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,C07K16/40,,3,1,008-499-354-702-218,24980392;;10.1016/j.anai.2014.05.028,"FAIR DISCLOSURE WIRE: ""Dyax Corp. announces positive results from phase 1a clinical trial . of DX2930"", 25 February 2014 (2014-02-25), XP055317760, Retrieved from the Internet <URL:http://dialog.proquest.com/professional/docview/1506520567?accountid=157282> [retrieved on 20160520];;CHYUNG ET AL.: ""A phase 1 study investigating DX-2930 in healthy subjects''."", ANN ALLERGY ASTHMA IMMUNOL., vol. 113, no. 4., October 2014 (2014-10-01), pages 460 - 466, XP029068455;;See also references of EP 3286226A4",PENDING
197,HK,A1,HK 1250995 A1,176-324-871-386-281,2019-01-18,2019,HK 18110329 A,2018-08-13,US 201562140277 P;;US 201562140289 P;;US 201562214293 P;;US 2016/0024921 W,2015-03-30,PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR PREVENTING HEREDITARY ANGIOEDEMA ATTACK,,DYAX CORP,CHYUNG YUNG;;ADELMAN BURT;;SEXTON DANIEL J,,https://lens.org/176-324-871-386-281,Patent Application,no,0,0,27,27,0,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,C07K/,,0,0,,,,PENDING
198,AU,A1,AU 2022/203180 A1,033-459-738-728-468,2022-06-02,2022,AU 2022/203180 A,2022-05-12,AU 2022/203180 A;;AU 2016/243160 A;;US 201562140277 P;;US 201562214293 P;;US 201562140289 P;;US 2016/0024921 W,2015-03-30,Plasma kallikrein inhibitors and uses thereof for preventing hereditary angioedema attack,PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR PREVENTING HEREDITARY ANGIOEDEMA ATTACK Provided herein are plasma kallikrein antibodies binding to active plasma kallikrein and methods of using such anti-bodies in preventing hereditary angioedema attack or reducing the rate of hereditary angioedema attack.,TAKEDA PHARMACEUTICALS CO,CHYUNG YUNG;;ADELMAN BURT;;SEXTON DANIEL J,,https://lens.org/033-459-738-728-468,Patent Application,no,0,0,27,27,0,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,C07K16/40,,0,0,,,,PENDING
199,AU,A1,AU 2003/293008 A1,029-241-789-430-34X,2004-06-18,2004,AU 2003/293008 A,2003-11-21,US 42858802 P;;US 71878103 A;;US 0337579 W,2002-11-22,PROACTIVE SUPPORT OF A HEALTHCARE INFORMATION SYSTEM,,IDX SYSTEMS CORP,BURT CHRISTOPHER J;;LAWTON KYLE;;KEEN RONALD,,https://lens.org/029-241-789-430-34X,Patent Application,no,0,0,5,5,0,G06Q10/10;;G06Q10/10,G06Q10/10,,0,0,,,,DISCONTINUED
200,CA,C,CA 2927695 C,029-549-076-985-91X,2022-03-01,2022,CA 2927695 A,2014-10-17,US 201361893542 P;;US 2014/0061242 W,2013-10-21,DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES,"Methods, kits and compositions for diagnosing and treating autoimmune diseases such rheumatiodi arthritis (RA), Crohn's disease (CD), and ulcerative colitis (UC). For example, disclosed herein are methods for diagnosing an autoimmune disease such as RA, CD or UC, monitoring progress of the autoimmune disease, or assessing efficacy of a treatment for the autoimmune disease in a subject based on the level of cleaved high molecular weight kininogen (HMWK) in one or more biological samples from the subject.",DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,,https://lens.org/029-549-076-985-91X,Granted Patent,no,0,0,44,44,7,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/48;;G01N33/564,,0,0,,,,PENDING
201,KR,A,KR 20170135885 A,108-439-368-567-011,2017-12-08,2017,KR 20177031279 A,2016-03-30,US 201562140277 P;;US 201562140289 P;;US 201562214293 P;;US 2016/0024921 W,2015-03-30,혈장 칼리크레인 저해제 및 유전성 혈관부종 발작을 예방하기 위한 이의 용도,"유전성 혈관부종 발작을 예방하거나 유전성 혈관부종 발작률을 감소시키는 데 있어서, 활성 혈장 칼리크레인에 결합하는 혈장 칼리크레인 항체 및 이러한 항체를 사용하는 방법이 본 명세서에 제공된다.",DYAX CORP,CHYUNG YUNG;;ADELMAN BURT;;SEXTON DANIEL J,,https://lens.org/108-439-368-567-011,Patent Application,no,1,0,27,27,20,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,A61K39/395;;A61K39/00;;C07K16/40,,0,0,,,,ACTIVE
202,CA,A1,CA 2927695 A1,126-347-739-924-423,2015-04-30,2015,CA 2927695 A,2014-10-17,US 201361893542 P;;US 2014/0061242 W,2013-10-21,DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES,"Methods, kits and compositions for diagnosing and treating autoimmue diseases such rheumatiodi arthritis, Crohn's disease, and ulcerative colitis.",DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,,https://lens.org/126-347-739-924-423,Patent Application,no,0,0,44,44,7,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/48;;G01N33/564,,0,0,,,,PENDING
203,CA,A,CA 1083881 A,072-465-787-857-827,1980-08-19,1980,CA 285489 A,1977-08-25,CA 285489 A,1977-08-25,SEPARATION AND RECOVERY OF COFFEE AROMA CONSTITUENTS FROM ROASTED COFFEE,"ABSTRACT This invention relates to an improved process for the separation and recovery of coffee aroma constituents from roasted coffee. A higher recovery of volatile aroma components from ex-pressed roasted coffee may be obtained than previously possible by the process which comprises adding a lipophilic or oleaginous substance in liquid form to roasted coffee, subdividing the roast-ed coffee and then separating the aromatized lipophilic or oleaginous substance from the subdivided roasted coffee.",GEN FOODS LMITED,FAIRBAIRN NORMAN J;;PERRY WILLIAM J;;BURT RALPH W,,https://lens.org/072-465-787-857-827,Granted Patent,no,0,0,13,13,0,A23F5/48,A23L27/10;;A23F5/48;;B01D11/02,99-81,0,0,,,,EXPIRED
204,AU,B2,AU 2020/200423 B2,069-693-866-635-102,2022-03-31,2022,AU 2020/200423 A,2020-01-21,AU 2020/200423 A;;AU 2014/340449 A;;US 201361893542 P;;US 2014/0061242 W,2013-10-21,Diagnosis and treatment of autoimmune diseases,"DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES Methods, kits and compositions for diagnosing and treating autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis.",TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/069-693-866-635-102,Granted Patent,no,2,0,44,44,0,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,A61K39/395;;A61K39/00;;A61P19/02;;A61P29/00;;A61P37/00;;G01N33/00,,0,0,,,,ACTIVE
205,KR,A,KR 20230010003 A,147-695-579-841-014,2023-01-17,2023,KR 20237000230 A,2014-10-17,US 201361893542 P;;KR 20217026950 A;;US 2014/0061242 W,2013-10-21,DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES,"자가면역 질환, 예컨대 류마티스성 관절염, 크론병 및 궤양성 대장염을 진단하고 치료하기 위한 방법, 키트 및 조성물.",TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,,https://lens.org/147-695-579-841-014,Patent Application,no,0,0,44,44,14,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/569,,0,0,,,,DISCONTINUED
206,US,A1,US 2019/0120862 A1,192-847-614-264-788,2019-04-25,2019,US 201816131781 A,2018-09-14,US 201816131781 A;;US 201615030790 A;;US 2014/0061242 W;;US 201361893542 P,2013-10-21,DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES,"Methods, kits and compositions for diagnosing and treating autoimmue diseases such as rheumatiodi arthritis, Crohn's disease, and ulcerative colitis.",DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2016-08-16),https://lens.org/192-847-614-264-788,Patent Application,yes,0,4,44,44,7,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/86;;G01N33/564,,0,0,,,,ACTIVE
207,AU,A1,AU 2016/243160 A1,078-956-623-928-275,2017-10-05,2017,AU 2016/243160 A,2016-03-30,US 201562140277 P;;US 201562214293 P;;US 201562140289 P;;US 2016/0024921 W,2015-03-30,Plasma kallikrein inhibitors and uses thereof for preventing hereditary angioedema attack,Provided herein are plasma kallikrein antibodies binding to active plasma kallikrein and methods of using such antibodies in preventing hereditary angioedema attack or reducing the rate of hereditary angioedema attack.,TAKEDA PHARMACEUTICALS CO,CHYUNG YUNG;;ADELMAN BURT;;SEXTON DANIEL J,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/078-956-623-928-275,Patent Application,no,0,0,27,27,0,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,C07K16/40,,0,0,,,,ACTIVE
208,AU,B2,AU 2014/340449 B2,131-836-087-446-988,2019-10-31,2019,AU 2014/340449 A,2014-10-17,US 201361893542 P;;US 2014/0061242 W,2013-10-21,Diagnosis and treatment of autoimmune diseases,"Methods, kits and compositions for diagnosing and treating autoimmue diseases such rheumatiodi arthritis, Crohn's disease, and ulcerative colitis.",TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/131-836-087-446-988,Granted Patent,no,1,0,44,44,0,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/00;;A61K39/00,,2,2,074-177-607-507-835;;088-052-241-032-685,10.1016/j.arcmed.2005.02.001;;15900628;;10.1161/01.atv.0000240290.70852.c0;;pmc2637648;;16902163,"ISORDIA-SALAS I ET AL, ""The Role of Plasma High Molecular Weight Kininogen in Experimental Intestinal and Systemic Inflammation"", ARCHIVES OF MEDICAL RESEARCH, vol. 36, no. 1, ISSN 0188-4409, (2005-01-01), pages 87 - 95, (2005-01-01);;M. M. KHAN ET AL, ""High-Molecular-Weight Kininogen Fragments Stimulate the Secretion of Cytokines and Chemokines Through uPAR, Mac-1, and gC1qR in Monocytes"", ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 2006, vol. 26(10), pg 2260",ACTIVE
209,US,B2,US 8837095 B2,045-844-570-403-243,2014-09-16,2014,US 201213370954 A,2012-02-10,GB 201103798 A,2011-03-07,DC electrical power system,"A DC electrical power system has a power generator converter system, a positive supply rail extending from the converter system, a negative supply rail extending from the converter system, and a midpoint earthing arrangement operatively connecting to the supply rails. The earthing arrangement is connected to earth by a solid earth connection. The network further has a first protective device on one of the supply rails which in case of a fault is operable to interrupt current flowing on that rail, and a second protective device on the earthing arrangement which in case of a fault is operable to interrupt current flowing to earth through the solid earth connection.",NORMAN PATRICK J;;GALLOWAY STUART J;;BURT GRAEME M;;ROLLS ROYCE PLC,NORMAN PATRICK J;;GALLOWAY STUART J;;BURT GRAEME M,ROLLS-ROYCE PLC (2012-01-17),https://lens.org/045-844-570-403-243,Granted Patent,yes,2,0,5,5,0,H02H3/16;;H02H3/16;;H02H3/087;;H02H3/087;;H02H7/268;;H02H7/268,H02H7/00;;H02H3/087;;H02H3/16;;H02H7/26,361/18,3,1,023-127-479-628-628,10.1109/61.634167,"Xu et al., ""Study on Bipole Protection of ± 800KV UHVDC System,"" 2010 International Conference on Electrical and Control Engineering, Jun. 25, 2010, pp. 4279-4282.;;Chrysanthou et al., ""Analysis of Coordination Between Primary and Secondary Protectors,"" IEEE Transactions on Power Delivery, Oct. 1997, pp. 1501-1507, vol. 12, No. 4.;;European Search Report issued in European Application No. 12 15 4844 dated Jul. 23, 2012.",ACTIVE
210,CO,A2,CO 2017009404 A2,135-048-665-810-103,2018-03-09,2018,CO 2017009404 A,2017-09-15,US 2016/0024921 W;;US 201562214293 P;;US 201562140289 P;;US 201562140277 P,2015-03-30,Inhibidores de calicreina plasmática y uso de los mismos para prevenir el ataque del angioedema hereditario,En este documento se proporcionan anticuerpos calicreína de union a la calicreina plasmática activa y métodos de uso de tales anticuerpos en la prevención del ataque de angioedema hereditario o la reducción de la tasa del ataque del angioedema hereditario.,DYAX CORP,SEXTON J DANIEL;;ADELMAN BURT;;CHYUNG YUNG,,https://lens.org/135-048-665-810-103,Patent Application,no,0,0,27,27,0,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,C07K16/40,,0,0,,,,PENDING
211,MX,A,MX 2017012423 A,130-828-254-930-472,2018-01-26,2018,MX 2017012423 A,2016-03-30,US 201562140277 P;;US 201562140289 P;;US 201562214293 P;;US 2016/0024921 W,2015-03-30,PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR PREVENTING HEREDITARY ANGIOEDEMA ATTACK.,Provided herein are plasma kallikrein antibodies binding to active plasma kallikrein and methods of using such antibodies in preventing hereditary angioedema attack or reducing the rate of hereditary angioedema attack.,DYAX CORP,YUNG CHYUNG;;BURT ADELMAN;;DANIEL J SEXTON,,https://lens.org/130-828-254-930-472,Patent Application,no,0,0,27,27,0,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,C07K16/40,,0,0,,,,PENDING
212,US,A,US 4645271 A,157-872-367-656-586,1987-02-24,1987,US 74895985 A,1985-06-26,US 74895985 A,1985-06-26,Parking brake control system,A parking brake control device has a differential area shuttle valve which has an outlet connected to a brake actuator and a larger area of a poppet directed to an inlet connected to a control valve for applying a parking brake pressure and a smaller area of the poppet facing a second inlet connected to a service brake pressure such that in the event of simultaneous application of parking brake and service brake pressures the shuttle valve will be moved to close off the inlet to the service brake pressure while introducing park brake pressure to the brake cylinder.,KNORR BREMSE AG,BREAREY NICHOLAS J;;BURT HARRY G P,KNORR-BREMSE GMBH (1985-06-12);;KNORR-BREMSE AKTIENGESELLSCHAFT (1985-10-18),https://lens.org/157-872-367-656-586,Granted Patent,yes,11,11,1,1,0,B60T13/12;;B60T13/66;;B60T15/14;;B60T17/18;;Y10T137/2567;;Y10T137/2567;;B60T13/12;;B60T15/14;;B60T13/66;;B60T17/18,B60T13/12;;B60T13/66;;B60T15/14;;B60T17/18,303/14;;137/112;;303/15;;303/28;;303/68;;X303 84R,0,0,,,,EXPIRED
213,JP,A,JP 2023130442 A,170-066-353-036-372,2023-09-20,2023,JP 2023110592 A,2023-07-05,JP 2021204200 A;;US 201562214293 P;;US 201562140289 P;;US 201562140277 P;;JP 2017549388 A;;US 2016/0024921 W,2015-03-30,PLASMA KALLIKREIN INHIBITOR AND USE THEREOF FOR PREVENTING HEREDITARY ANGIOEDEMA ATTACKS,"To provide a plasma kallikrein antibody that binds to active plasma kallikrein and a method of using the antibody in preventing or reducing the rate of hereditary angioedema attacks.SOLUTION: A pharmaceutical composition comprises 150 mg of antibody that binds to active plasma kallikrein and a pharmaceutically acceptable carrier. The antibody comprises heavy chain complementarity determining region (CDR) 1, heavy chain CDR2, and heavy chain CDR3 having specific sequences, as well as light chain CDR1, light chain CDR2, and light chain CDR3 having specific sequences.SELECTED DRAWING: Figure 7",TAKEDA PHARMACEUTICAL,CHYUNG YUNG;;BURT ADELMAN;;DANIEL J SEXTON,,https://lens.org/170-066-353-036-372,Patent Application,no,0,0,27,27,0,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,A61K39/395;;A61K9/08;;A61K47/02;;A61K47/10;;A61K47/12;;A61K47/22;;A61P7/10,,0,0,,,,PENDING
214,AU,A1,AU 2014/340449 A1,192-808-765-035-251,2016-06-02,2016,AU 2014/340449 A,2014-10-17,US 201361893542 P;;US 2014/0061242 W,2013-10-21,Diagnosis and treatment of autoimmune diseases,"Methods, kits and compositions for diagnosing and treating autoimmue diseases such rheumatiodi arthritis, Crohn's disease, and ulcerative colitis.",DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/192-808-765-035-251,Patent Application,no,0,0,44,44,0,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/00;;A61K39/00,,0,0,,,,ACTIVE
215,EP,A1,EP 3913364 A1,045-444-193-620-775,2021-11-24,2021,EP 21158440 A,2014-10-17,US 201361893542 P;;EP 14855002 A;;US 2014/0061242 W,2013-10-21,DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES,"Methods, kits and compositions for diagnosing and treating autoimmue diseases such as rheumatiodi arthritis, Crohn's disease, and ulcerative colitis.",DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2022-06-01),https://lens.org/045-444-193-620-775,Patent Application,yes,37,0,44,44,7,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/00;;A61K39/00;;G01N33/564,,55,48,074-177-607-507-835;;088-052-241-032-685;;028-584-999-150-491;;000-875-274-929-40X;;004-782-005-460-503;;049-592-572-924-891;;016-180-871-182-084;;109-500-732-467-583;;049-134-753-209-354;;035-188-943-391-21X;;017-150-654-990-340;;002-264-966-090-625;;048-188-266-680-461;;037-104-736-197-766;;005-248-320-665-556;;012-206-824-167-831;;092-845-354-377-772;;064-409-159-039-974;;014-581-174-616-945;;085-610-907-501-527;;103-477-074-900-777;;071-498-620-602-771;;045-864-048-030-411;;084-421-189-184-547;;018-144-967-742-095;;122-080-830-470-164;;050-507-714-041-493;;150-526-239-777-942;;069-863-076-076-464;;096-809-977-928-291;;038-056-207-283-274;;093-122-402-165-609;;038-535-940-466-805;;002-237-818-610-496;;053-209-061-746-894;;028-862-168-091-90X;;030-451-543-728-673;;052-397-009-533-722;;026-944-353-804-488;;032-728-154-591-070;;023-676-781-371-861;;092-023-577-402-127;;039-508-259-975-855;;002-664-741-683-318;;021-641-900-032-887;;051-940-176-386-905;;029-667-686-534-996;;007-551-089-881-647,10.1016/j.arcmed.2005.02.001;;15900628;;10.1161/01.atv.0000240290.70852.c0;;pmc2637648;;16902163;;12842992;;10.1182/blood-2003-02-0661;;9354649;;10.1182/blood.v90.10.3819;;10.1517/13543784.17.5.697;;18447596;;21859431;;10.1111/j.1398-9995.2011.02686.x;;10.2174/138161206777698710;;16842160;;8605931;;10.1002/eji.1830260319;;10.1016/0022-2836(87)90412-8;;3681981;;10.1038/338518a0;;2927510;;3140379;;10.1126/science.3140379;;10.1073/pnas.85.16.5879;;3045807;;pmc281868;;2315699;;10.1126/science.2315699;;2553722;;10.1016/s0021-9258(18)51542-8;;10.1111/j.1365-2141.1984.tb03955.x;;6691922;;10.1182/blood.v74.2.695.695;;10.1182/blood.v74.2.695.bloodjournal742695;;2752143;;3501619;;10.1016/0049-3848(87)90434-8;;15306150;;10.1016/j.thromres.2004.05.005;;7654936;;10.1097/00001721-199505000-00005;;10.1002/elps.201200095;;22965727;;10.1016/s0022-1759(00)00290-8;;11292488;;10.1201/9781420046663;;10.2210/pdb7pti/pdb;;10.1093/protein/3.7.591;;1699222;;2125487;;10.1021/bi00495a002;;3263966;;10.1016/s0021-9258(19)81329-7;;pmc43575;;10.1073/pnas.91.8.3353;;8159751;;10.1002/(sici)1097-0134(199707)28:3<405::aid-prot10>3.0.co;2-l;;9223186;;10.1016/0076-6879(90)83011-w;;2314273;;pmc305087;;10.1073/pnas.84.13.4355;;3474607;;8107089;;10.1006/jmbi.1994.1104;;pmc2142382;;10.1002/pro.5560020302;;8453370;;9600884;;pmc34487;;10.1073/pnas.95.11.5857;;0009600884;;pmc102444;;10592234;;10.1093/nar/28.1.231;;9700502;;10.1111/j.1600-065x.1998.tb01188.x;;9847197;;10.1093/nar/27.1.263;;pmc148152;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;10.1016/s0097-8485(99)00011-x;;10404623;;10.1093/nar/30.1.235;;pmc99105;;11752303;;10.1021/ja00897a025;;10.1016/0022-2836(70)90057-4;;5420325;;10.1126/science.3929380;;3929380;;1404388;;10.1016/0022-2836(92)90223-7;;7779254;;10.1016/0167-5699(95)80166-9;;10.1016/0022-2836(92)90224-8;;1404389;;pmc394555;;7556106;;10.1002/j.1460-2075.1995.tb00142.x;;10.1073/pnas.77.7.4216;;pmc349802;;6933469;;6292436;;10.1016/0022-2836(82)90103-6;;10.1016/s0065-2776(08)60486-1;;1502974,"ISORDIA-SALAS I ET AL: ""The Role of Plasma High Molecular Weight Kininogen in Experimental Intestinal and Systemic Inflammation"", ARCHIVES OF MEDICAL RESEARCH, INSTITUTO MEXICANO DEL SEGURO SOCIAL, MEXICO, MX, vol. 36, no. 1, 1 January 2005 (2005-01-01), pages 87 - 95, XP027775638, ISSN: 0188-4409, [retrieved on 20050101];;M. M. KHAN ET AL: ""High-Molecular-Weight Kininogen Fragments Stimulate the Secretion of Cytokines and Chemokines Through uPAR, Mac-1, and gC1qR in Monocytes"", ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY., vol. 26, no. 10, 1 October 2006 (2006-10-01), US, pages 2260 - 2266, XP055343572, ISSN: 1079-5642, DOI: 10.1161/01.ATV.0000240290.70852.c0;;I. ISORDIA-SALAS: ""The mutation Ser511Asn leads to N-glycosylation and increases the cleavage of high molecular weight kininogen in rats genetically susceptible to inflammation"", BLOOD, vol. 102, no. 8, 15 October 2003 (2003-10-15), US, pages 2835 - 2842, XP055336291, ISSN: 0006-4971, DOI: 10.1182/blood-2003-02-0661;;COLMAN, R. W.SCHMAIER, A. H.: ""Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes"", BLOOD, vol. 90, 1997, pages 3819 - 3843, XP002928335;;ZURAW, B. L.CHRISTIANSEN, S. C., EXPERT OPIN INVESTIG DRUGS, vol. 17, 2008, pages 697 - 706;;MAURER, M. ET AL., ALLERGY, vol. 66, 2011, pages 1397 - 1406;;COLMAN, R. W., CURR PHARM DES, vol. 12, 2006, pages 2599 - 2607;;DE WILDT ET AL., EUR J IMMUNOL., vol. 26, no. 3, 1996, pages 629 - 39;;KABAT, E.A. ET AL.: ""Sequences of Proteins of Immunological Interest"", 1991, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, NIH;;CHOTHIA, C. ET AL., J. MOL. BIOL., vol. 196, 1987, pages 901 - 917;;GIRARD, T. ET AL., NATURE, vol. 338, 1989, pages 518 - 520;;BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426;;HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 5879 - 5883;;BOWIE ET AL., SCIENCE, vol. 247, 1990, pages 1306 - 1310;;NOVOTNY ET AL., J. BIOL. CHEM., vol. 264, no. 31, 1989, pages 18832 - 18837;;KERBIRIOU-NABIAS, D.M., BR J HAEMATOL, vol. 56, no. 2, 1984, pages 2734 - 86;;REDDIGARI, S.R.KAPLAN, A.P., BLOOD, vol. 74, 1999, pages 695 - 702;;SCOTT, C.F. ET AL., THROMB RES, vol. 48, no. 6, 1987, pages 685 - 700;;GALLIMORE, M.J. ET AL., THROMB RES, vol. 114, no. 2, 2004, pages 91 - 96;;BUHLER R. ET AL., BLOOD COAGUL FIBRINOLYSIS, vol. 6, no. 3, 1995, pages 223 - 232;;RUSTANDI ET AL.: ""Qualitative and quantitative evaluation of SimonTM, a new CE-based automated Western blot system as applied to vaccine development"", ELECTROPHORESIS, vol. 33, no. 17, September 2012 (2012-09-01), pages 2790 - 7, XP055688276, DOI: 10.1002/elps.201200095;;POWERS ET AL., J. IMMUNOL. METHODS, vol. 251, 2001, pages 123 - 35;;R. MATSON: ""Microarray Methods and Protocols"", 2009, CRC PRESS;;EIGENBROT ET AL., PROTEIN ENGINEERING, vol. 3, no. 7, 1990, pages 591 - 598;;""GeneBank"", Database accession no. NP_036857.2;;HYNES ET AL., BIOCHEMISTRY, vol. 29, 1990, pages 10018 - 10022;;KIDO ET AL., J. BIOL. CHEM., vol. 263, no. 34, 1988, pages 18104 - 18107;;SPRECHER ET AL., PNAS USA, vol. 91, 1994, pages 3353 - 3357;;SONHAMMER ET AL., PROTEINS, vol. 28, no. 3, 1997, pages 405 - 420;;GRIBSKOV ET AL., METH. ENZYMOL., vol. 183, 1990, pages 146 - 159;;GRIBSKOV ET AL., PROC. NATL. ACAD. SCI. USA, vol. 84, 1987, pages 4355 - 4358;;KROGH ET AL., J. MOL. BIOL., vol. 235, 1994, pages 1501 - 1531;;STULTZ ET AL., PROTEIN SCI., vol. 2, 1993, pages 305 - 314;;SCHULTZ ET AL., PROC. NATL. ACAD. SCI. USA, vol. 95, 1998, pages 5857;;SCHULTZ ET AL., NUCL. ACIDS RES, vol. 28, 2000, pages 231;;JEFFERIS ET AL., IMMUNOL. REV., vol. 163, 1998, pages 59 - 76;;CORPET ET AL., NUCL. ACIDS RES., vol. 27, 1999, pages 263 - 267;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402;;GOUZY ET AL., COMPUTERS AND CHEMISTRY, vol. 23, 1999, pages 333 - 340;;FALQUET ET AL., NUCLEIC ACIDS RES., vol. 30, 2002, pages 235 - 238;;STEWART, J.YOUNG, J.: ""Solid-Phase Peptide Synthesis"", 1989, W. H. FREEMAN CO.;;MERRIFIELD, J., AM. CHEM. SOC., vol. 85, 1963, pages 2149 - 2154;;BODANSZKY, M.BODANSZKY, A.: ""The Practice of Peptide Synthesis"", 1984, SPRINGER-VERLAG;;NEEDLEMANWUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 444 - 453;;MORRISON, S. L., SCIENCE, vol. 229, 1985, pages 1202 - 1207;;OI ET AL., BIOTECHNIQUES, vol. 4, 1986, pages 214;;TOMLINSON, I.A. ET AL., J. MOL. BIOL., vol. 227, 1992, pages 776 - 798;;COOK, G. P. ET AL., IMMUNOL. TODAY, vol. 16, no. 5, 1995, pages 237 - 242;;CHOTHIA, D. ET AL., J. MOL. BIO., vol. 227, 1992, pages 799 - 817;;TOMLINSON ET AL., EMBO J., vol. 14, no. 18, 1995, pages 4628 - 38;;URLAUBCHASIN, PROC. NATL. ACAD. SCI. USA, vol. 77, 1980, pages 4216 - 4220;;KAUFMANSHARP, MOL. BIOL., vol. 159, 1982, pages 601 621;;J. IMMUNOL. METHODS, vol. 289, no. 1-2, 2004, pages 65 - 80;;BURTONWOOF, ADV. IMMUNOL., vol. 51, 1992, pages 1 - 84;;SILVERBERG ET AL.: ""Blood: Principles and Practice of Hematology"", 1995, J B LIPPINCOTT CO., article ""The Contact System and Its Disorders""",PENDING
216,US,B2,US 10101344 B2,044-595-383-253-189,2018-10-16,2018,US 201415030790 A,2014-10-17,US 201415030790 A;;US 201361893542 P;;US 2014/0061242 W,2013-10-21,Diagnosis and treatment of autoimmune diseases,"Methods, kits and compositions for diagnosing and treating autoimmune diseases such as rheumatiodi arthritis, Crohn's disease, and ulcerative colitis.",DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2016-08-16),https://lens.org/044-595-383-253-189,Granted Patent,yes,31,5,44,44,7,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/53;;G01N33/564;;G01N33/86,,38,34,048-397-262-376-455;;078-352-985-001-170;;051-002-109-848-312;;149-344-504-021-407;;004-479-946-889-393;;014-581-174-616-945;;046-466-057-379-095;;009-164-382-634-699;;064-409-159-039-974;;028-584-999-150-491;;074-177-607-507-835;;082-795-239-301-865;;005-248-320-665-556;;088-052-241-032-685;;030-422-305-823-971;;008-684-349-046-919;;024-019-418-021-281;;042-513-826-438-891;;117-939-959-946-344;;012-206-824-167-831;;109-028-520-036-638;;092-309-561-609-370;;092-845-354-377-772;;026-394-309-301-759;;014-581-174-616-945;;008-499-354-702-218;;006-789-023-934-519;;088-462-073-629-715;;080-844-532-992-816;;046-363-627-958-215;;001-680-842-915-740;;133-940-816-817-578;;125-182-572-021-927;;051-663-279-687-169,10.1097/xce.0000000000000009;;10.1155/2014/683598;;pmc4020216;;24872599;;8182230;;10.1016/0091-6749(94)90380-8;;19691495;;10.1111/j.1742-4658.2009.07218.x;;11150653;;10.1016/s0196-9781(00)00348-x;;7654936;;10.1097/00001721-199505000-00005;;10.1172/jci105959;;4974623;;pmc322187;;pmc3100311;;21625439;;10.1371/journal.pone.0020036;;15306150;;10.1016/j.thromres.2004.05.005;;12842992;;10.1182/blood-2003-02-0661;;10.1016/j.arcmed.2005.02.001;;15900628;;10.1111/j.1476-5381.1989.tb12688.x;;pmc1854808;;2692754;;10.1111/j.1365-2141.1984.tb03955.x;;6691922;;10.1161/01.atv.0000240290.70852.c0;;pmc2637648;;16902163;;10.1016/j.jaci.2006.12.591;;10.1038/nmeth.f.353;;7947259;;10.1111/j.1365-2141.1994.tb04874.x;;19124682;;10.1161/hypertensionaha.108.117663;;pmc4978181;;10.1016/0022-1759(94)00320-v;;7714339;;10.1182/blood.v74.2.695.695;;10.1182/blood.v74.2.695.bloodjournal742695;;2752143;;2651524;;10.1016/0022-1759(89)90376-1;;2433279;;10.1016/s0021-9258(19)75800-1;;3501619;;10.1016/0049-3848(87)90434-8;;3730610;;10.1182/blood.v68.2.455.bloodjournal682455;;10.1182/blood.v68.2.455.455;;7654936;;10.1097/00001721-199505000-00005;;24980392;;10.1016/j.anai.2014.05.028;;9129025;;10.1182/blood.v89.9.3213;;pmc3734293;;23940538;;10.1371/journal.pone.0070140;;10.1016/s1081-1206(10)60493-0;;18814451;;10.1016/s0021-9150(01)00666-9;;11888508;;14572818;;10.1016/s1473-0502(03)00170-8;;11099478;;10.1096/fj.99-1025com;;10.1046/j.1365-2796.1996.418764000.x;;8568479;;2451949;;10.1182/blood.v71.5.1334.bloodjournal7151334;;10.1182/blood.v71.5.1334.1334,"Van Der Vekiens et al., Human and equine cardiovascular endocrinology: beware to compare, Cardiovascular Endocrinology 2013, vol. 2, No. 4, pp. 67-76.;;Torzewski et al., Animal Models of C-Reactive Protein, Hindawl Publishing Corporation, Mediators of Inflammation, vol. 2014, Article ID 683598, 2014, pp. 1-7.;;Cugno et al., Activfation of the contact system and fibrinolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamic acid, J. Allergy Clin Immunol, vol. 93, No. 5, pp. 870-876.;;Schousboe et al., High molecular weight kininogen binds to laminin—characterization and kinetic analysis, FEBS Journal, 276, 2009, pp. 5228-5238.;;Image Studio Compatible, 2012, Image Studio Software Compatible with Mac Systems Now Available from LI-COR, Bio Blog, May 8, 2012, pp. 1-3.;;Blais et al., The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins. Peptides. Dec. 2000;21(12):1903-40. Review.;;Buhler et al., Improved detection of proteolytically cleaved high molecular weight kininogen by immunoblotting using an antiserum against its reduced 47 kDa light chain. Blood Coagul Fibrinolysis. May 1995;6(3):223-32.;;Colman et al., Studies on the prekallikrein (kallikreinogen)—kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins. J Clin Invest. Jan. 1969;48(1):11-22.;;Dobo et al., Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1. PLoS One. 2011;6(5):e20036. doi: 10.1371/journal.pone.0020036. Epub May 23, 2011.;;Gallimore et al., Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis. Thromb Res. 2004;114(2):91-6.;;Isordia-Salas et al., The mutation Ser511Asn leads to N-glycosylation and increases the cleavage of high molecular weight kininogen in rats genetically susceptible to inflammation. Blood. Oct. 15, 2003;102(8):2835-42.;;Isordia-Salas et al., The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation. Arch Med Res. Jan.-Feb. 2005;36(1):87-95.;;Katori et al., Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in anaesthetized rats. Br J Pharmacol. Dec. 1989;98(4):1383-91.;;Kerbiriou-Nabias et al., Radioimmunoassays of human high and low molecular weight kininogens in plasmas and platelets. Br J Haematol. Feb. 1984;56(2):273-86.;;Khan et al., High-molecular-weight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac-1, and gC1qR in monocytes. Arterioscler Thromb Vasc Biol. Oct. 2006;26(10):2260-6. Epub Aug. 10, 2006. Erratum in: Arterioscler Thromb Vasc Biol. Nov. 2006;26(11):e146.;;Ladner et al., Discovery of Ecallantide: A Potent and Selective Inhibitor of Plasma Kallikrein. J Allergy and Clinical Immuno. Jan. 1, 2007;119(1):S312.;;Nguyen et al., The Simple Western™: a gel-free, blot-free, hands-free Western blotting reinvention. Nature Methods. Oct. 28, 2011;8:5-6.;;Page et al., An autoantibody to human plasma prekallikrein blocks activation of the contact system. Br J Haematol. May 1994;87(1):81-6.;;Phipps et al., Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability. Hypertension. Feb. 2009;53(2):175-81. doi: 10.1161/HYPERTENSIONAHA.108.117663.;;Raymond et al., Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation. J Immunol Methods. Mar. 27, 1995;180(2):247-57.;;Reddigari et al., Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity. Blood. Aug. 1, 1989;74(2):695-702.;;Reddigari et al., Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody. J Immunol Methods. Apr. 21, 1989;119(1):19-25.;;Schmaier et al., Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains. J Biol Chem. Jan. 25, 1987;262(3):1405-11.;;Scott et al., A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate. Thromb Res. Dec. 15, 1987;48(6):685-700.;;U.S. Appl. No. 14/761,690, filed Jul. 17, 2015, Published, 2015-0362493, Name: Sexton et al Pub date: Dec. 17, 2015.;;U.S. Appl. No. 15/030,811, filed Apr. 20, 2016, Published, 2016-0252527, Name Sexton et al Pub date: Sep. 1, 2016.;;Berrettini et al., Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies. Blood. Aug. 1986;68(2):455-62.;;Bühler et al., Improved detection of proteolytically cleaved high molecular weight kininogen by immunoblotting using an antiserum against its reduced 47 kDa light chain. Blood Coagul Fibrinolysis. May 1995;6(3):223-32.;;Chyung et al., A phase 1 study investigating DX-2930 in healthy subjects. Ann Allergy Asthma Immunol. Oct. 2014;113(4):460-6.e2. doi: 10.1016/j.anai.2014.05.028. Epub Jun. 26, 2014.;;Cugno et al., Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood. May 1, 1997;89(9):3213-8.;;Defendi et al., Enzymatic assays for the diagnosis of bradykinin-dependent angioedema. PLoS One. Aug. 5, 2013;8(8):e70140. doi:10.1371/journal.pone.0070140. Print 2013. Erratum in: PLoS One. 2014;9(6):e100345.;;Faucette et al., A Biomarker Assay for the Detection of Contact System Activation. Blood. 2013;122:2347. Avaible online at http://www.bloodjournal.org/conten/122/21/2347. Last accessed on Mar. 30, 2018.;;Joseph et al., Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma. Ann Allergy Asthma Immunol. Sep. 2008;101(3):279-86. doi: 10.1016/S1081-1206(10)60493-0.;;Merlo et al., Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease. Atherosclerosis. Apr. 2002;161(2):261-7.;;Williams et al., DX-88 and HAE: a developmental perspective. Transfus Apher Sci. Dec. 2003;29(3):255-8.;;Zhang et al., Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5. FASEB J. Dec. 2000;14(15):2589-600.;;Nielsen et al., Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses. J Intern Med. Feb. 1996;239(2):119-30.;;Reddigari et al., Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma. Blood. May 1988;71(5):1334-40.",ACTIVE
217,US,A1,US 2022/0169749 A1,082-131-547-365-981,2022-06-02,2022,US 202117500214 A,2021-10-13,US 202117500214 A;;US 201715562671 A;;US 2016/0024921 W;;US 201562214293 P;;US 201562140277 P;;US 201562140289 P,2015-03-30,PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR PREVENTING HEREDITARY ANGIOEDEMA ATTACK,Provided herein are plasma kallikrein antibodies binding to active plasma kallikrein and methods of using such antibodies in preventing hereditary angioedema attack or reducing the rate of hereditary angioedema attack.,TAKEDA PHARMACEUTICALS CO,CHYUNG YUNG;;ADELMAN BURT;;SEXTON DANIEL J,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2020-06-19),https://lens.org/082-131-547-365-981,Patent Application,yes,0,0,27,27,10,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,C07K16/40;;A61P7/10,,0,0,,,,PENDING
218,CN,A,CN 107614532 A,096-190-248-172-301,2018-01-19,2018,CN 201680018200 A,2016-03-30,US 201562140289 P;;US 201562140277 P;;US 201562214293 P;;US 2016/0024921 W,2015-03-30,Plasma kallikrein inhibitors and uses thereof for preventing hereditary angioedema attack,Provided herein are plasma kallikrein antibodies binding to active plasma kallikrein and methods of using such antibodies in preventing hereditary angioedema attack or reducing the rate of hereditaryangioedema attack.,DYAX CORP,CHYUNG YUNG;;ADELMAN BURT;;SEXTON DANIEL J,,https://lens.org/096-190-248-172-301,Patent Application,no,3,1,27,27,0,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,C07K16/40,,1,1,008-499-354-702-218,24980392;;10.1016/j.anai.2014.05.028,"YUNG CHYUNG ET AL: ""A phase 1 study investigating DX-2930 in healthy subjects"", 《ANN ALLERGY ASTHMA IMMUNOL》",PENDING
219,BR,B1,BR 112016008975 B1,001-354-243-732-973,2023-02-28,2023,BR 112016008975 A,2014-10-17,US 2014/0061242 W;;US 201361893542 P,2013-10-21,"MÉTODOS PARA DETECTAR, MONITORAR O DESENVOLVIMENTO E AVALIAR A EFICÁCIA DE UM TRATAMENTO DE UMA DOENÇA AUTOIMUNE","MÉTODO PARA DIAGNOSTICAR UMA DOENÇA AUTOIMUNE, MONITORAR SEU DESENVOLVIMENTO E AVALIAR A EFICÁCIA DE UM TRATAMENTO PARA TAL DOENÇA. Métodos, kits e composições para diagnosticar e tratar doenças autoimunes, tais como artrite reumatoide, doença de Crohn e colite ulcerativa.",TAKEDA PHARMACEUTICALS CO;;DYAX CORP,DANIEL J SEXTON;;BURT ADELMAN;;ANDREW NIXON,TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) (2021-10-05);;DYAX CORP. (US) (2018-08-28),https://lens.org/001-354-243-732-973,Granted Patent,no,0,0,44,44,0,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/00;;A61K39/00,,0,0,,,,ACTIVE
220,EP,A1,EP 1576515 A1,062-991-724-359-895,2005-09-21,2005,EP 03789998 A,2003-11-21,US 0337579 W;;US 42858802 P;;US 71878103 A,2002-11-22,PROACTIVE SUPPORT OF A HEALTHCARE INFORMATION SYSTEM,,IDX SYSTEMS CORP,BURT CHRISTOPHER J;;LAWTON KYLE;;KEEN RONALD,,https://lens.org/062-991-724-359-895,Patent Application,yes,0,0,5,5,0,G06Q10/10;;G06Q10/10,G06Q10/10,,0,0,,,,DISCONTINUED
221,CN,A,CN 110658337 A,065-619-908-302-015,2020-01-07,2020,CN 201910994046 A,2014-10-17,CN 201910994046 A;;CN 201480069823 A;;US 201361893542 P;;US 2014/0061242 W,2013-10-21,Diagnosis and treatment of autoimmune diseases,"Diagnosis and treatment of autoimmune diseases. Methods, kits and compositions for diagnosing and treating autoimmue diseases such rheumatiodi arthritis, Crohn's disease, and ulcerative colitis are provided.",DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,,https://lens.org/065-619-908-302-015,Patent Application,no,3,0,44,44,0,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/564,,2,2,068-291-091-858-619;;028-584-999-150-491,10873024;;10.1053/jpsu.2000.6861;;12842992;;10.1182/blood-2003-02-0661,"KARIM ALAVI ET AL: ""Treatment of Inflammatory Bowel Disease in a Rodent Model With the Intestinal Growth Factor Glucagon-Like Peptide-2"", 《JOURNAL OF PEDIATRIC SURGERY》;;IRMA ISORDIA-SALAS ET AL: ""The mutation Ser511Asn leads to N-glycosylation and increases the cleavage of high molecular weight kininogen in rats genetically susceptible to inflammation"", 《BLOOD》",ACTIVE
222,US,A1,US 2018/0298110 A1,080-257-260-494-71X,2018-10-18,2018,US 201615562671 A,2016-03-30,US 201615562671 A;;US 201562140289 P;;US 201562140277 P;;US 201562214293 P;;US 2016/0024921 W,2015-03-30,PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR PREVENTING HEREDITARY ANGIOEDEMA ATTACK,Provided herein are plasma kallikrein antibodies binding to active plasma kallikrein and methods of using such antibodies in preventing hereditary angioedema attack or reducing the rate of hereditary angioedema attack.,DYAX CORP;;SYNVINA C V,CHYUNG YUNG;;ADELMAN BURT;;SEXTON DANIEL J,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2020-06-19),https://lens.org/080-257-260-494-71X,Patent Application,yes,1,10,27,27,10,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,A61P7/10;;C07K16/40,,0,0,,,,DISCONTINUED
223,AU,A1,AU 2022/204649 A1,128-727-331-161-781,2022-07-21,2022,AU 2022/204649 A,2022-06-29,AU 2022/204649 A;;AU 2020/200423 A;;AU 2014/340449 A;;US 201361893542 P;;US 2014/0061242 W,2013-10-21,Diagnosis and treatment of autoimmune diseases,"DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES Methods, kits and compositions for diagnosing and treating autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis.",TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,,https://lens.org/128-727-331-161-781,Patent Application,no,0,0,44,44,0,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/00;;A61K39/00,,0,0,,,,PENDING
224,EP,A1,EP 3916020 A1,168-947-846-728-121,2021-12-01,2021,EP 21167802 A,2016-03-30,US 201562140289 P;;US 201562140277 P;;US 201562214293 P;;EP 16774069 A;;US 2016/0024921 W,2015-03-30,PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR PREVENTING HEREDITARY ANGIOEDEMA ATTACK,Provided herein are plasma kallikrein antibodies binding to active plasma kallikrein and methods of using such antibodies in preventing hereditary angioedema attack or reducing the rate of hereditary angioedema attack.,DYAX CORP,CHYUNG YUNG;;ADELMAN BURT;;SEXTON DANIEL J,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2022-07-06),https://lens.org/168-947-846-728-121,Patent Application,yes,21,0,27,27,10,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,C07K16/40,,50,44,008-499-354-702-218;;006-137-353-823-826;;164-277-261-420-791;;016-326-550-218-68X;;109-500-732-467-583;;028-423-517-648-100;;049-134-753-209-354;;074-817-300-512-106;;017-150-654-990-340;;002-264-966-090-625;;048-188-266-680-461;;013-181-635-285-001;;019-779-601-634-917;;056-201-471-905-934;;028-862-168-091-90X;;022-133-574-143-973;;030-630-100-818-462;;030-607-398-087-475;;030-607-398-087-475;;030-323-674-660-051;;029-295-665-407-969;;103-477-074-900-777;;101-039-255-543-294;;126-013-549-735-904;;042-026-882-861-725;;046-750-736-499-556;;051-971-787-908-276;;012-214-936-917-65X;;085-434-580-555-434;;005-941-618-976-731;;097-318-320-850-899;;074-203-723-868-757;;016-534-677-137-074;;104-243-866-474-715;;001-166-444-961-82X;;069-917-507-345-672;;051-940-176-386-905;;029-667-686-534-996;;011-389-300-335-273;;007-551-089-881-647;;002-237-818-610-496;;007-364-858-655-289;;056-942-841-068-650;;127-185-373-141-041,24980392;;10.1016/j.anai.2014.05.028;;24970892;;10.1074/jbc.m114.569061;;pmc4156074;;10.1160/th07-04-0250;;10.1056/nejmcp0803977;;18768946;;8605931;;10.1002/eji.1830260319;;1367574;;10.1016/0168-1656(91)90350-5;;10.1016/0022-2836(87)90412-8;;3681981;;10.1038/341544a0;;2677748;;3140379;;10.1126/science.3140379;;10.1073/pnas.85.16.5879;;3045807;;pmc281868;;2315699;;10.1126/science.2315699;;10.1073/pnas.87.6.2264;;2315319;;pmc53667;;pmc46825;;8390686;;10.1073/pnas.90.12.5873;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;10.1146/annurev.iy.12.040194.002245;;10.1146/annurev.immunol.12.1.433;;8011287;;10.1038/348552a0;;2247164;;pmc392030;;10.1073/pnas.81.21.6851;;6436822;;pmc392030;;10.1073/pnas.81.21.6851;;6436822;;pmc298637;;2513570;;10.1073/pnas.86.24.10029;;10.1016/j.pep.2006.10.011;;17141527;;10.1016/s0022-1759(00)00290-8;;11292488;;pmc2736937;;19671134;;10.1186/1472-6750-9-70;;11499924;;10.1007/s002530000572;;11129586;;10.1271/bbb.64.2138;;10.1186/1752-0509-4-141;;20969759;;pmc2987880;;20346137;;pmc2867824;;10.1186/1471-2164-11-207;;19216534;;10.1021/pr8007623;;15943904;;10.5483/bmbrep.2005.38.3.294;;15612595;;10.1023/b:mbil.0000049871.17260.46;;10.1073/pnas.85.22.8678;;pmc282523;;3054890;;2050687;;10.1016/s0021-9258(18)99043-5;;16570317;;10.1002/bit.20851;;9231415;;10.1016/s0378-1097(97)00203-6;;10.1111/j.1574-6968.1997.tb10433.x;;10.1007/bf02788058;;8756614;;10.1021/bc010003g;;11562193;;10.1073/pnas.77.7.4216;;pmc349802;;6933469;;6292436;;10.1016/0022-2836(82)90103-6;;10.1186/1479-5876-4-39;;17010186;;pmc1592514;;10.1016/s0065-2776(08)60486-1;;1502974;;9700502;;10.1111/j.1600-065x.1998.tb01188.x;;10.1002/jps.2600660104;;833720;;2674208;;10.1002/j.1552-4604.1989.tb03403.x;;10.1016/j.jaci.2010.08.012;;20889195,"CHYUNG YUNG ET AL: ""A phase 1 study investigating DX-2930 in healthy subjects"", ANNALS OF ALLERGY, ASTHMA & IMMUNOLOGY, ARLINGTON HEIGHTS, IL, US, vol. 113, no. 4, 26 June 2014 (2014-06-26), pages 460, XP029068455, ISSN: 1081-1206, DOI: 10.1016/J.ANAI.2014.05.028;;DYAX: ""Dyax Announces Positive Results from Phase 1a Clinical Trial of DX-2930"", DYAX, 25 February 2014 (2014-02-25), pages 1 - 3, XP055317760, Retrieved from the Internet <URL:http://files.shareholder.com/downloads/DYAX/0x0x728704/080fce37-bdbe-4c1b-beaf-59632ab0ae15/DYAX_News_2014_2_25_Earnings.pdf> [retrieved on 20161109];;J. A. KENNISTON ET AL: ""Inhibition of Plasma Kallikrein by a Highly Specific Active Site Blocking Antibody"", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 289, no. 34, 26 June 2014 (2014-06-26), pages 23596 - 23608, XP055215056, ISSN: 0021-9258, DOI: 10.1074/jbc.M114.569061;;SAINZ I.M. ET AL., THROMB HAEMOST, vol. 98, 2007, pages 77 - 83;;ZURAW B.L. ET AL., N ENGL J MED, vol. 359, 2008, pages 1027 - 1036;;DE WILDT ET AL., EUR J IMMUNOL., vol. 26, no. 3, 1996, pages 629 - 39;;EDQVIST, J. ET AL., J BIOTECHNOL, vol. 20, no. 3, 1991, pages 291 - 300;;CHOTHIA, C. ET AL., J. MOL. BIOL., vol. 196, 1987, pages 901 - 917;;WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546;;BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426;;HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 5879 - 5883;;BOWIE ET AL., SCIENCE, vol. 247, 1990, pages 1306 - 1310;;KARLINALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 2264 - 68;;KARLINALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 5873 - 77;;ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 10;;ALTSCHUL ET AL., NUCLEIC ACIDS RES, vol. 25, no. 17, 1997, pages 3389 - 3402;;GREENFIELD: ""Antibodies: A Laboratory Manual"", 2013, COLD SPRING HARBOR LABORATORY PRESS;;WINTER ET AL., ANNU. REV. IMMUNOL., vol. 12, 1994, pages 433 - 455;;MCCAFFERTY ET AL., NATURE, vol. 348, 1990, pages 552 - 553;;MORRISON ET AL., PROC. NAT. ACAD. SCI., vol. 81, 1984, pages 6851;;MORRISON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 81, 1984, pages 6851;;NEUBERGER ET AL., NATURE, vol. 314, 1984, pages 452;;QUEEN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 10029 - 10033;;NADKARNI, A. ET AL., PROTEIN EXPR PURIF, vol. 52, no. l, 2007, pages 219 - 29;;POWERS ET AL., J. IMMUNOL. METHODS., vol. 251, 2001, pages 123 - 35;;SCHOONOOGHE S. ET AL., BMC BIOTECHNOL, vol. 9, 2009, pages 70;;ABDEL-SALAM, HA. ET AL., APPL MICROBIOL BIOTECHNOL, vol. 56, no. 1-2, 2001, pages 157 - 64;;TAKAHASHI K. ET AL., BIOSCI BIOTECHNOL BIOCHEM, vol. 64, no. 10, 2000, pages 2138 - 44;;BAUMANN K. ET AL., BMC SYST. BIOL., vol. 4, 2010, pages 141;;DRAGOSITS, M. ET AL.: ""11"", BMC GENOMICS, 2010, pages 207;;DRAGOSITS, M. ET AL., J PROTEOME RES, vol. 8, no. 3, 2009, pages 1380 - 92;;NING, D. ET AL., J. BIOCHEM. AND MOL. BIOL., vol. 38, no. 3, 2005, pages 294 - 299;;KOZYR, AV ET AL., MOL BIOL (MOSK, vol. 38, no. 6, 2004, pages 1067 - 75;;HORWITZ, AH. ET AL., PROC NATL ACAD SCI U S A, vol. 85, no. 22, 1988, pages 8678 - 82;;BOWDISH, K. ET AL., J BIOL CHEM, vol. 266, no. 18, 1991, pages 11901 - 8;;GASSER, B. ET AL., BIOTECHOL. BIOENG., vol. 94, no. 2, 2006, pages 353 - 61;;KOBAYASHI H. ET AL., FEMS MICROBIOL LETT, vol. 152, no. 2, 1997, pages 235 - 42;;KO JH. ET AL., 2996 APPL BIOCHEM BIOTECHNOL, vol. 60, no. 1, pages 41 - 8;;SMITH, BJ. ET AL., BIOCONJUG CHEM, vol. 12, no. 5, 2001, pages 750 - 756;;URLAUBCHASIN, PROC. NATL. ACAD. SCI. USA, vol. 77, 1980, pages 4216 - 4220;;KAUFMANSHARP, MOL. BIOL., vol. 159, 1982, pages 601 - 621;;J. IMMUNOL. METHODS, vol. 289, no. 1-2, 2004, pages 65 - 80;;GALEFFI, P. ET AL., J TRANSL MED, vol. 4, 2006, pages 39;;BURTONWOOF, ADV. IMMUNOL., vol. 51, 1992, pages 1 - 84;;JEFFERIS ET AL., IMMUNOL. REV., vol. 163, 1998, pages 59 - 76;;BERGE, S.M. ET AL., J. PHARM. SCI., vol. 66, 1977, pages 1 - 19;;""Sustained and Controlled Release Drug Delivery Systems"", 1978, MARCEL DEKKER, INC.;;V.V. RANADE, J. CLIN. PHARMACOL., vol. 29, 1989, pages 685;;KAPLAN, A.P., J ALLERGY CLIN IMMUNOL, vol. 126, no. 5, 2010, pages 918 - 925;;MCMILLAN, C.V. ET AL., PATIENT, vol. 5, no. 2, 2012, pages 113 - 26",PENDING
225,PL,T3,PL 3060908 T3,174-785-560-571-913,2021-10-25,2021,PL 14855002 T,2014-10-17,US 201361893542 P;;EP 14855002 A;;US 2014/0061242 W,2013-10-21,DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES,,TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,,https://lens.org/174-785-560-571-913,Patent Application,no,0,0,44,44,0,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/00;;A61K39/00;;G01N33/564,,0,0,,,,PENDING
226,US,B2,US 10648990 B2,179-660-863-774-972,2020-05-12,2020,US 201816131781 A,2018-09-14,US 201816131781 A;;US 201615030790 A;;US 2014/0061242 W;;US 201361893542 P,2013-10-21,Diagnosis and treatment of autoimmune diseases,"Methods, kits and compositions for diagnosing and treating autoimmue diseases such as rheumatiodi arthritis, Crohn's disease, and ulcerative colitis.",DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2016-08-16),https://lens.org/179-660-863-774-972,Granted Patent,yes,37,3,44,44,7,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/53;;G01N33/564;;G01N33/86,,61,41,026-394-309-301-759;;004-479-946-889-393;;014-581-174-616-945;;008-499-354-702-218;;046-466-057-379-095;;006-789-023-934-519;;051-002-109-848-312;;088-462-073-629-715;;009-164-382-634-699;;064-409-159-039-974;;028-584-999-150-491;;074-177-607-507-835;;080-844-532-992-816;;082-795-239-301-865;;005-248-320-665-556;;088-052-241-032-685;;030-422-305-823-971;;046-363-627-958-215;;008-684-349-046-919;;125-182-572-021-927;;024-019-418-021-281;;042-513-826-438-891;;117-939-959-946-344;;051-663-279-687-169;;012-206-824-167-831;;109-028-520-036-638;;092-309-561-609-370;;149-344-504-021-407;;092-845-354-377-772;;078-352-985-001-170;;048-397-262-376-455;;001-680-842-915-740;;133-940-816-817-578;;028-104-991-485-38X;;006-769-540-567-683;;005-127-586-276-928;;144-602-947-164-877;;126-568-744-168-22X;;019-467-602-686-96X;;006-297-863-625-283;;116-078-088-684-888,3730610;;10.1182/blood.v68.2.455.bloodjournal682455;;10.1182/blood.v68.2.455.455;;11150653;;10.1016/s0196-9781(00)00348-x;;7654936;;10.1097/00001721-199505000-00005;;24980392;;10.1016/j.anai.2014.05.028;;10.1172/jci105959;;4974623;;pmc322187;;9129025;;10.1182/blood.v89.9.3213;;8182230;;10.1016/0091-6749(94)90380-8;;pmc3734293;;23940538;;10.1371/journal.pone.0070140;;pmc3100311;;21625439;;10.1371/journal.pone.0020036;;15306150;;10.1016/j.thromres.2004.05.005;;12842992;;10.1182/blood-2003-02-0661;;10.1016/j.arcmed.2005.02.001;;15900628;;10.1016/s1081-1206(10)60493-0;;18814451;;10.1111/j.1476-5381.1989.tb12688.x;;pmc1854808;;2692754;;10.1111/j.1365-2141.1984.tb03955.x;;6691922;;10.1161/01.atv.0000240290.70852.c0;;pmc2637648;;16902163;;10.1016/j.jaci.2006.12.591;;10.1016/s0021-9150(01)00666-9;;11888508;;10.1038/nmeth.f.353;;10.1046/j.1365-2796.1996.418764000.x;;8568479;;7947259;;10.1111/j.1365-2141.1994.tb04874.x;;19124682;;10.1161/hypertensionaha.108.117663;;pmc4978181;;10.1016/0022-1759(94)00320-v;;7714339;;2451949;;10.1182/blood.v71.5.1334.bloodjournal7151334;;10.1182/blood.v71.5.1334.1334;;10.1182/blood.v74.2.695.695;;10.1182/blood.v74.2.695.bloodjournal742695;;2752143;;2651524;;10.1016/0022-1759(89)90376-1;;2433279;;10.1016/s0021-9258(19)75800-1;;19691495;;10.1111/j.1742-4658.2009.07218.x;;3501619;;10.1016/0049-3848(87)90434-8;;10.1155/2014/683598;;pmc4020216;;24872599;;10.1097/xce.0000000000000009;;14572818;;10.1016/s1473-0502(03)00170-8;;11099478;;10.1096/fj.99-1025com;;8856187;;10.1016/0162-3109(96)00086-0;;12190172;;10.1111/j.1572-0241.2002.05919.x;;10.1016/s0002-9270(02)04276-4;;10.1021/bi00396a025;;2447941;;1727910;;10.1016/j.jaci.2012.12.795;;10.1016/0014-5793(81)80174-3;;6912817;;483270;;10.1016/0049-3848(79)90058-6;;10.1182/blood.v70.4.1053.bloodjournal7041053;;2443201,"[No Author Listed], Image Studio Software Compatible with Mac® Systems Now Available from LI-COR!. BioB Blog. May 2012 8:1-3.;;Berrettini et al., Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies. Blood. Aug. 1986;68(2):455-62.;;Blais et al., The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins. Peptides. Dec. 2000;21(12):1903-40. Review.;;Bühler et al., Improved detection of proteolytically cleaved high molecular weight kininogen by immunoblotting using an antiserum against its reduced 47 kDa light chain. Blood Coagul Fibrinolysis. May 1995;6(3):223-32.;;Chyung et al., A phase 1 study investigating DX-2930 in healthy subjects. Ann Allergy Asthma Immunol. Oct. 2014;113(4):460-6.e2. doi: 10.1016/j.anai.2014.05.028. Epub Jun. 26, 2014.;;Colman et al., Studies on the prekallikrein (kallikreinogen)—kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins. J Clin Invest. Jan. 1969;48(1):11-22.;;Cugno et al., Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood. May 1, 1997;89(9):3213-8.;;Cugno et al., Activation of the contact system and fibronolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamic acid. J Allergy Clin Immunol. 1994;93(5):870-876.;;Defendi et al., Enzymatic assays for the diagnosis of bradykinin-dependent angioedema. PLoS One. Aug. 5, 2013;8(8):e70140. doi:10.1371/journal.pone.0070140. Print 2013. Erratum in: PLoS One. 2014;9(6):e100345.;;Dobo et al., Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1. PLoS One. 2011;6(5):e20036. doi: 10.1371/journal.pone.0020036. Epub May 23, 2011.;;Faucette et al., A Biomarker Assay for the Detection of Contact System Activation. Blood. 2013;122:2347. Avaible online at http://www.bloodjournal.org/conten/122/21/2347. Last accessed on Mar. 30, 2018.;;Gallimore et al., Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis. Thromb Res. 2004;114(2):91-6.;;Isordia-Salas et al., The mutation Ser511Asn leads to N-glycosylation and increases the cleavage of high molecular weight kininogen in rats genetically susceptible to inflammation. Blood. Oct. 15, 2003;102(8):2835-42.;;Isordia-Salas et al., The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation. Arch Med Res. Jan.-Feb. 2005;36(1):87-95.;;Joseph et al., Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma. Ann Allergy Asthma Immunol. Sep. 2008;101(3):279-86. doi: 10.1016/S1081-1206(10)60493-0.;;Katori et al., Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in anaesthetized rats. Br J Pharmacol. Dec. 1989;98(4):1383-91.;;Kerbiriou-Nabias et al., Radioimmunoassays of human high and low molecular weight kininogens in plasmas and platelets. Br J Haematol. Feb. 1984;56(2):273-86.;;Khan et al., High-molecular-weight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac-1, and gC1qR in monocytes. Arterioscler Thromb Vasc Biol. Oct. 2006;26(10):2260-6. Epub Aug. 10, 2006. Erratum in: Arterioscler Thromb Vasc Biol. Nov. 2006;26(11):e146.;;Ladner et al., Discovery of Ecallantide: A Potent and Selective Inhibitor of Plasma Kallikrein. J Allergy and Clinical Immuno. Jan. 1, 2007;119(1):S312.;;Merlo et al., Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease. Atherosclerosis. Apr. 2002;161(2):261-7.;;Nguyen et al., The Simple Western™: a gel-free, blot-free, hands-free Western blotting reinvention. Nature Methods. Oct. 28, 2011;8:5-6.;;Nielsen et al., Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses. J Intern Med. Feb. 1996;239(2):119-30.;;Page et al., An autoantibody to human plasma prekallikrein blocks activation of the contact system. Br J Haematol. May 1994;87(1):81-6.;;Phipps et al., Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability. Hypertension. Feb. 2009;53(2):175-81. doi: 10.1161/HYPERTENSIONAHA.108.117663.;;Raymond et al., Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation. J Immunol Methods. Mar. 27, 1995;180(2):247-57.;;Reddigari et al., Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma. Blood. May 1988;71(5):1334-40.;;Reddigari et al., Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity. Blood. Aug. 1, 1989;74(2):695-702.;;Reddigari et al., Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody. J Immunol Methods. Apr. 21, 1989;119(1):19-25.;;Schmaier et al., Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains. J Biol Chem. Jan. 25, 1987;262(3):1405-11.;;Schousboe et al., High molecular weight kininogen binds to laminin—characterization and kinetic analysis.FEBS J. Sep. 2009;276(18):5228-38. doi: 10.1111/j.1742-4658.2009.07218.x. Epub Aug. 19, 2009.;;Scott et al., A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate. Thromb Res. Dec. 15, 1987;48(6):685-700.;;Torzewski et al., Animal Models of c-Reactive Protein. Hindawi Publishing Corpl, Mediators of Inflammation. 2014:1-7.;;Van Der Vekens et al., Human and equine cardiovascular endrocrinology: beware to compare. Cardivosacular Endicronology. 2013;2(4):67-76.;;Williams et al., DX-88 and HAE: a developmental perspective. Transfus Apher Sci. Dec. 2003;29(3):255-8.;;Zhang et al., Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5. FASEB J. Dec. 2000;14(15):2589-600.;;U.S. Appl. No. 15/769,237, filed Apr. 18, 2018, Sexton et al.;;PCT/US2016/057640, Jan. 26, 2017, International Search Report and Written Opinion.;;PCT/US2016/057640, May 3, 2018, International Preliminary Report on Patentability.;;EP 18186356.4, Jan. 18, 2019, Extended European Search Report.;;[No Author Listed], Mouse High Molecular Weight Kininogen (HMWK) ELISA Kit (Cat. No. BMS089195). MyBiosource Datasheet. Jan. 2, 1984. Retrieved from <https://www.mybiosource.com/prods/ELIS-A-Kit/Mouse/High-Molecular-Weight-Kinogen/HMWK/datasheet.php?products_id=89195> on Dec. 13, 2018. 4 pages.;;Cugno et al., Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies. Immunopharmacology. Jun. 1996;33(1-3):361-4.;;Devani et al., Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers. Am J Gastroenterol. Aug. 2002;97(8):2026-32.;;Ishiguro et al., Mapping of functional domains of human high molecular weight and low molecular weight kininogens using murine monoclonal antibodies. Biochemistry. Nov. 3, 1987;26(22):7021-9.;;Scott et al., Sensitive antigenic determinations of high molecular weight kininogen performed by covalent coupling of capture antibody. J Lab Clin Med. Jan. 1992;119(1):77-86. Abstract only.;;Sexton et al., Discovery and Characterization of a Fully Human Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Treatment of Plamsa Kallikrein-Mediated Edema. J. Allergy Clin. Immunol. Feb. 2013;131(2):AB32.;;Syvänen et al., A radioimmunoassay for the detection of molecular forms of human plasma kininogen. FEBS Lett. Jul. 6, 1981;129(2):241-5.;;Uchida et al., Differential assay method for high molecular weight and low molecular weight kininogens. Thromb Res. 1979;15(1-2):127-34.;;Veloso et al., A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface. Blood. Oct. 1987;70(4):1053-62.;;U.S. Appl. No. 15/030,790, dated Apr. 20, 2016, Granted, U.S. Pat. No. 10,101,344.;;U.S. Appl. No. 14/761,690, dated Jul. 17, 2015, Published, 2015-0362493.;;U.S. Appl. No. 15/030,811, dated Apr. 20, 2016, Published, 2016-0252527.;;EP 14855002.3, dated Feb. 20, 2017, Extended European Search Report.;;PCT/US2014/061242, dated Feb. 3, 2015, International Search Report and Written Opinion.;;PCT/US2014/061242, dated May 6, 2016, International Preliminary Report on Patentability.;;EP 147404440.6, dated Jun. 17, 2016, Extended European Search Report.;;PCT/US2014/012107, dated Apr. 14, 2014, International Search Report and Written Opinion.;;PCT/US2014/012107, dated Jun. 30, 2015, International Preliminary Report on Patentability.;;EP 14856778.7, dated Feb. 28, 2017, Partial Supplmentary European Search Report.;;EP14856778.7, dated Jun. 16, 2017, Supplementary European Search Report.;;PCT/US2014/061247, dated Feb. 4, 2015, International Search Report and Written Opinion.;;PCT/US2014/061247, dated May 6, 2016, International Preliminary Report on Patentability.",ACTIVE
227,JP,A,JP 2020091296 A,082-321-233-721-741,2020-06-11,2020,JP 2020018129 A,2020-02-05,US 201361893542 P,2013-10-21,DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES,"To provide methods, kits and compositions for diagnosing and treating autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis.SOLUTION: A method of diagnosing an autoimmune disease in a subject is provided, the method comprising: providing a biological sample of a subject suspected of having the autoimmune disease; measuring a level of cleaved high molecular weight kininogen (HMWK) in the biological sample; and identifying the subject as having or being at risk of developing the autoimmune disease if the level of cleaved HMWK in the biological sample is elevated as compared to that in a control sample.SELECTED DRAWING: Figure 1",DYAX CORP,DANIEL J SEXTON;;BURT ADELMAN;;NIXON ANDREW,,https://lens.org/082-321-233-721-741,Patent Application,no,4,0,44,44,0,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/53;;A61K45/00;;A61P37/02;;A61P43/00;;G01N33/543,,5,5,125-182-572-021-927;;074-177-607-507-835;;051-663-279-687-169;;088-052-241-032-685;;006-769-540-567-683,10.1046/j.1365-2796.1996.418764000.x;;8568479;;10.1016/j.arcmed.2005.02.001;;15900628;;2451949;;10.1182/blood.v71.5.1334.bloodjournal7151334;;10.1182/blood.v71.5.1334.1334;;10.1161/01.atv.0000240290.70852.c0;;pmc2637648;;16902163;;12190172;;10.1111/j.1572-0241.2002.05919.x;;10.1016/s0002-9270(02)04276-4,"NIELSEN, E.W. ET AL.: ""Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikre"", JOURNAL OF INTERNAL MEDICINE, vol. 239, JPN6018028564, 1996, pages 119 - 130, ISSN: 0004459531;;ISORDIA-SALAS, I. ET AL.: ""The Role of Plasma High Molecular Weight Kininogen in Experimental Intestinal and Systemic Inflammat"", ARCHIVES OF MEDICAL RESEARCH, vol. 36, JPN6018028560, 2005, pages 87 - 95, XP025288234, ISSN: 0004459532, DOI: 10.1016/j.arcmed.2005.02.001;;REDDIGARI, S. ET AL.: ""Cleavage of Human High-Molecular Weight Kininogen by Purified Kallikreins and Upon Contact Activatio"", BLOOD, vol. 71, no. 5, JPN6018028562, 1988, pages 1334 - 1340, ISSN: 0004459533;;KHAN, M.M. ET AL: ""High-molecular-weight kininogen fragments stimulate the secretion of cytokines and chemokines throug"", ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, vol. 26, JPN6018028563, 2006, pages 2260 - 2266, XP055343572, ISSN: 0004459534, DOI: 10.1161/01.ATV.0000240290.70852.c0;;DEVANI, M. ET AL.: ""Kallikrein-Kinin System Activavtion in Crohn's Disease: Differences in Intestinal and Systemic Marke"", THE AMERICAN JOURNAL OF GASTROENTEROLOGY, vol. 97, no. 8, JPN6019020496, August 2002 (2002-08-01), pages 2026 - 2032, ISSN: 0004459535",ACTIVE
228,BR,A2,BR 112017020864 A2,177-823-481-234-592,2018-07-10,2018,BR 112017020864 A,2016-03-30,US 2016/0024921 W;;US 201562140289 P;;US 201562140277 P;;US 201562214293 P,2015-03-30,inibidores de calicreína plasmática e usos dos mesmos para a prevenção de ataque de angioedema hereditário,são providos neste documento os anticorpos de calicreína plasmática para ligação a calicreína plasmática ativa e métodos de uso de tais anticorpos na prevenção de ataque de angioedema hereditário ou redução da taxa de ataque de angioedema hereditário.,DYAX CORP,BURT ADELMAN;;DANIEL J SEXTON;;YUNG CHYUNG,TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) (2021-09-21);;DYAX CORP. (US) (2018-08-28),https://lens.org/177-823-481-234-592,Patent Application,no,0,3,27,27,0,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,C07K16/40,,0,0,,,,PENDING
229,SE,B,SE 444255 B,022-288-393-441-599,1986-04-07,1986,SE 7808531 A,1978-08-09,CA 285489 A,1977-08-25,FORFARANDE FOR SEPARATION OCH ATERVINNING AV AROMBESTANDSDELAR FRAN ROSTAT KAFFE,,GEN FOODS LTD,FAIRBAIRN N J;;PERRY W J;;BURT R W,,https://lens.org/022-288-393-441-599,Unknown,no,0,0,13,13,0,A23F5/48,A23F5/48;;A23L27/10;;B01D11/02,,0,0,,,,DISCONTINUED
230,CN,A,CN 105874332 A,009-577-001-020-067,2016-08-17,2016,CN 201480069823 A,2014-10-17,US 201361893542 P;;US 2014/0061242 W,2013-10-21,Diagnosis and treatment of autoimmune diseases,"Methods, kits and compositions for diagnosing and treating autoimmue diseases such rheumatiodi arthritis, Crohn's disease, and ulcerative colitis.",DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,,https://lens.org/009-577-001-020-067,Patent Application,no,3,2,44,44,0,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/00;;A61K39/00,,4,4,028-584-999-150-491;;074-177-607-507-835;;149-344-504-021-407;;051-002-109-848-312,12842992;;10.1182/blood-2003-02-0661;;10.1016/j.arcmed.2005.02.001;;15900628;;19691495;;10.1111/j.1742-4658.2009.07218.x;;8182230;;10.1016/0091-6749(94)90380-8,"IRMA ISORDIA-SALAS ET AL.: ""he mutation Ser511Asn leads to N-glycosylation and increases the cleavage of high molecular weight kininogen in rats genetically susceptible to inflammation"", 《BLOOD》;;ISORDIA-SALAS ET AL.: ""The Role of Plasma High Molecular Weight Kininogen in Experimental Intestinal and Systemic Inflammation"", 《ARCHIVES OF MEDICAL RESEARCH》;;SCHOUSBOE I. ET AL.: ""High molecular weight kininogen binds to laminin--characterization and kinetic analysis"", 《FEBS JOURNAL》;;CUGNO M.ET AL.: ""Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid"", 《JOURNAL OF ALLERGY & CLINICAL IMMUNOLOGY》",ACTIVE
231,WO,A1,WO 2004/049233 A1,069-033-509-269-42X,2004-06-10,2004,US 0337579 W,2003-11-21,US 42858802 P;;US 71878103 A,2002-11-22,PROACTIVE SUPPORT OF A HEALTHCARE INFORMATION SYSTEM,"Systems and methods are provided for proactively monitoring a healthcare information system. The proactive monitor system has a plurality of counters (310) and one or more notification agents (148). Counters monitor performance parameters by recording the values of the parameters at a predetermined interval. Multiple counter instances may be implemented. Agents notify designated representatives when the value of a counter exceeds a threshold. Notifications may be escalated as needed. The proactive monitor system may further include an operator capable of performing fixes to bring the value of the counter back within the threshold. Two user interfaces may be included, connecting to a customer support system (110) and a user (140) of the healthcare information system, respectively. The proactive detection, notification, and repair of business or system failures may be performed manually or automatically, onsite or over a network.",IDX SYSTEMS CORP,BURT CHRISTOPHER J;;LAWTON KYLE;;KEEN RONALD,,https://lens.org/069-033-509-269-42X,Patent Application,yes,3,0,5,5,0,G06Q10/10;;G06Q10/10,G06Q10/10,,1,0,,,See also references of EP 1576515A4,PENDING
232,US,A1,US 2012/0247597 A1,114-658-095-412-192,2012-10-04,2012,US 201213437995 A,2012-04-03,FR 1152868 A,2011-04-04,DEVICE FOR CONNECTING AN AIR LEAK DETECTION SYSTEM TO A SLEEVE THAT ENVELOPS A PRESSURIZED AIR HOSE OF AN AIRCRAFT,"An aircraft includes a hose that makes it possible to channel the pressurized air that is used in a sleeve ( 52 ) that delimits an annular chamber with the hose, with the sleeve ( 52 ) including at least one opening ( 54 ) that is delimited by an edge ( 58 ) that makes it possible to link the annular chamber and the outside of the sleeve ( 52 ), and a leak detection system that includes at least one loop (A) in the form of a threadlike element ( 56 ), characterized in that it includes a connecting device that includes a ring ( 60 ) that is connected at at least one connecting point ( 64 ) with a loop (A), and a flexible wall that delimits a hose ( 68 ) for channeling the air that extends from the edge ( 58 ) of the opening ( 54 ) up to the ring ( 60 ).",MILLET GERARD;;BURT TERENCE J;;BERNARD XAVIER;;AIRBUS OPERATIONS LTD;;AIRBUS OPERATIONS SAS,MILLET GERARD;;BURT TERENCE J;;BERNARD XAVIER,AIRBUS OPERATIONS LTD (2011-04-21);;AIRBUS OPERATIONS (SAS) (2011-04-21),https://lens.org/114-658-095-412-192,Patent Application,yes,8,4,4,4,0,B64D13/00;;B64D13/00;;G01M3/165;;G01M3/165;;G01M3/002;;G01M3/002,F16L55/00,138/103,0,0,,,,INACTIVE
233,US,A,US 5057823 A,148-797-362-261-936,1991-10-15,1991,US 49187990 A,1990-03-12,US 49187990 A,1990-03-12,Probe for sensing the presence of liquid in a container,"The present invention is a liquid sensing device used for in determining the presence or absence of liquid in a container by the presence or absence of electrical current flow between two conductive probes. Moreover, the present invention prevents the false indication of liquid as can result from the presence of foam, or from bridging of the probes at the proximal ends thereof. A main body portion is formed of an electrically conductive material and has a probe channel extending therethrough. A non-conductive plug is inserted into the proximal end of the probe channel and provides for the retaining of a conductive probe that extends along the central axis of the probe channel. An end cap is secured to the distal end of the main body and covers the distal end of the probe channel for preventing foam access into the probe channel. An inlet port is formed through the main body into the probe channel at the distal end thereof for allowing restricted access of the liquid into the probe channel when the present invention is inserted into the container. The proximal end plug includes an air tight cavity that physically isolated the proximal ends of the probe and the conductive main body from the liquid.",IMI CORNELIUS INC,DYER JOHN J;;SHACKLE JR BURT N,IMI CORNELIUS INC. A CORP. OF MN (1991-06-14),https://lens.org/148-797-362-261-936,Granted Patent,yes,10,7,1,1,0,G01F23/242;;G01F23/242,G01F23/24,340/620;;X 73304R;;73/864.24;;324/663,0,0,,,,EXPIRED
234,EP,A1,EP 3286226 A1,064-324-150-497-407,2018-02-28,2018,EP 16774069 A,2016-03-30,US 201562140289 P;;US 201562140277 P;;US 201562214293 P;;US 2016/0024921 W,2015-03-30,PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR PREVENTING HEREDITARY ANGIOEDEMA ATTACK,,DYAX CORP,CHYUNG YUNG;;ADELMAN BURT;;SEXTON DANIEL J,DYAX CORP. (2018-06-20),https://lens.org/064-324-150-497-407,Patent Application,yes,0,0,27,27,10,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,C07K16/40,,0,0,,,,DISCONTINUED
235,KR,A,KR 20210107182 A,066-075-082-911-044,2021-08-31,2021,KR 20217026950 A,2014-10-17,US 201361893542 P;;KR 20167013312 A;;US 2014/0061242 W,2013-10-21,DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES,"자가면역 질환, 예컨대 류마티스성 관절염, 크론병 및 궤양성 대장염을 진단하고 치료하기 위한 방법, 키트 및 조성물.",DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,,https://lens.org/066-075-082-911-044,Patent Application,no,4,0,44,44,14,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/564,,4,4,051-663-279-687-169;;088-052-241-032-685;;125-182-572-021-927;;074-177-607-507-835,2451949;;10.1182/blood.v71.5.1334.bloodjournal7151334;;10.1182/blood.v71.5.1334.1334;;10.1161/01.atv.0000240290.70852.c0;;pmc2637648;;16902163;;10.1046/j.1365-2796.1996.418764000.x;;8568479;;10.1016/j.arcmed.2005.02.001;;15900628,"Reddigari S et al, Blood (1988), vol 71, no 5, pp 1334-1340.;;Khan M M et al, Thrombosis and Vascular Biology (20060, vol 26, pp 2260-2266.;;Nielsen E W et al, Journal of Internal Medicine (1996), vol 239, pp 119-130.;;Irma Isordia-Salas et al, Archives of Medical Research (2005), vol 36, pp 87-95.",ACTIVE
236,US,A,US 5242598 A,127-616-919-335-852,1993-09-07,1993,US 93679592 A,1992-08-28,US 93679592 A;;US 74490291 A,1991-08-14,Solid phase extraction,Hydrophobic contaminants are removed from a particulate matter by contacting the particulate matter with a solid organic phase. The hydrophobic contaminants have greater affinity for the solid organic phase than for the particulate matter and repartition to the solid organic phase. The solid organic phase is then separated from the particulate matter. A typical embodiment utilizes polystyrene particles to remove polychlorinated biphenyls from soil.,ENVIROGEN INC,SHANNON MICHAEL J R;;ENSLEY BURT D,ENVIROGEN INC (1992-10-05),https://lens.org/127-616-919-335-852,Granted Patent,yes,28,16,1,1,0,B09C1/02;;B09C1/02;;B01D11/0288;;B01D11/0288;;Y10S210/908;;Y10S210/908;;Y10S210/909;;Y10S210/909;;Y10S210/924;;Y10S210/924,B01D11/02;;B09C1/02,210/690;;210/692;;210/747;;210/908;;210/909;;210/924;;134/7;;134/25.1;;134/42;;405/128;;196/14.52;;209/5;;209/173,6,3,133-141-465-733-071;;042-565-322-042-505;;116-574-055-849-714,10.1021/ac50009a009;;830366;;10.2166/wst.1990.0134;;10.1039/j19700001082,"Evaluation of 14 Charcoal Polyurethane Foam Mixtures for the Separation of Mirex and Photomirex from Aroclor 1254, by Ludwig J. Babjak and Alfred S. Y. Chau, Babjak & Chau: J. Assoc. Off. Anal. Chem (vol. 62, No. 5, 1979), pp. 1174 1176.;;Column Chromatographic Determination of Mirex, Photomirex, and Polychlorinated Biphenyls in Lake Sediments, by Alfred S. Y. Chau and Ludwig J. Babjak, Chau & Babjak: J. Assoc. Off. Anal. Chem. (vol. 62, No. 1, 1979) pp. 107 113.;;Field Air Sampling of Pesticide Vapors with Polyurethane Foam, by Benjamin C. Turner and Dwight E. Glotfelty, Analytical Chemistry, vol. 49, No. 1, Jan. 1977, pp. 7 10.;;Brochure Reusable Scumball under U.S. Pat. No. 4,894,166 3 pages.;;Modified Polyurethane Carriers for Biochemical Waste Water Treatment, by Imre Pascik, Wat. Sci. Tech. vol. 22, No. 1/2, pp. 33 42, 1990.;;Absorption by Polyurethane Foams; New Method of Separation, by H. J. M. Bowen, J. Chem. Soc. (A), 1970 pp. 1082 1085.",EXPIRED
237,US,A,US 5238449 A,155-472-973-816-302,1993-08-24,1993,US 78134491 A,1991-10-25,GB 9023310 A,1990-10-25,VENTILATORS,"A canopy for use with a ventilator slot extending through a window frame has pressure differential responsive flow control means arranged to progressively close the flow passage through the canopy as the pressure differential increases, thus preventing draughts. The canopy has a body with an inlet and an outlet and a bowed wall therebetween. A normally straight baffle strip is attached to the center of the wall and there are non-aligned apertures in the wall and the baffle respectively. When the pressure differential between the inlet and outlet is low, the baffle is well-spaced from the wall but as the pressure differential increases the baffle is bowed progressively towards the wall against the inherent bias of the strip to progressively close the flow path through the apertures.",TITON HARDWARE,STONEY ARTHUR;;BURT ARTHUR J;;WATERS RICHARD,TITON HARDWARE LIMITED (1991-11-13),https://lens.org/155-472-973-816-302,Granted Patent,yes,9,0,9,9,0,F24F13/18;;F24F13/18,F24F13/18,454/213,0,0,,,,EXPIRED
238,CA,A1,CA 2979713 A1,190-240-427-492-108,2016-10-06,2016,CA 2979713 A,2016-03-30,US 201562140289 P;;US 201562140277 P;;US 201562214293 P;;US 2016/0024921 W,2015-03-30,PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR PREVENTING HEREDITARY ANGIOEDEMA ATTACK,Provided herein are plasma kallikrein antibodies binding to active plasma kallikrein and methods of using such antibodies in preventing hereditary angioedema attack or reducing the rate of hereditary angioedema attack.,DYAX CORP,CHYUNG YUNG;;ADELMAN BURT;;SEXTON DANIEL J,,https://lens.org/190-240-427-492-108,Patent Application,no,0,0,27,27,10,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,C07K16/40,,0,0,,,,PENDING
239,SE,L,SE 7808531 L,049-237-404-907-674,1979-02-26,1979,SE 7808531 A,1978-08-09,CA 285489 A,1977-08-25,FORFARANDE FOR SEPARATION AV KAFFEAROM,,GEN FOODS LTD,FAIRBAIRN N J;;PERRY W J;;BURT R W,,https://lens.org/049-237-404-907-674,Abstract,no,0,0,13,13,0,A23F5/48,A23F5/48;;A23L27/10;;B01D11/02,,0,0,,,,DISCONTINUED
240,AU,B2,AU 519730 B2,107-993-810-142-289,1981-12-17,1981,AU 1978/038603 A,1978-08-03,CA 285489 A,1977-08-25,SEPARATION AND RECOVERY OF COFFEE AROMA CONSTITUENTS FROM ROASTED COFFEE,,GEN FOODS LTD,FAIRBAIRN N J;;PERRY W J;;BURT R W,,https://lens.org/107-993-810-142-289,Granted Patent,no,0,0,13,13,0,A23F5/48,A23L27/10;;A23F5/48;;B01D11/02,,0,0,,,,EXPIRED
241,EP,A4,EP 1576515 A4,137-092-278-043-38X,2006-01-25,2006,EP 03789998 A,2003-11-21,US 0337579 W;;US 42858802 P;;US 71878103 A,2002-11-22,PROACTIVE SUPPORT OF A HEALTHCARE INFORMATION SYSTEM,,IDX SYSTEMS CORP,BURT CHRISTOPHER J;;LAWTON KYLE;;KEEN RONALD,,https://lens.org/137-092-278-043-38X,Search Report,no,5,0,5,5,0,G06Q10/10;;G06Q10/10,G06Q10/10,,1,0,,,See also references of WO 2004049233A1,DISCONTINUED
242,KR,A,KR 20230164767 A,007-515-422-751-101,2023-12-04,2023,KR 20237040648 A,2016-03-30,US 201562140277 P;;US 201562140289 P;;US 201562214293 P;;KR 20177031279 A;;US 2016/0024921 W,2015-03-30,PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR PREVENTING HEREDITARY ANGIOEDEMA ATTACK,"유전성 혈관부종 발작을 예방하거나 유전성 혈관부종 발작률을 감소시키는 데 있어서, 활성 혈장 칼리크레인에 결합하는 혈장 칼리크레인 항체 및 이러한 항체를 사용하는 방법이 본 명세서에 제공된다.",TAKEDA PHARMACEUTICALS CO,CHYUNG YUNG;;ADELMAN BURT;;SEXTON DANIEL J,,https://lens.org/007-515-422-751-101,Patent Application,no,0,0,27,27,0,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,C07K16/40;;A61K9/00;;A61K39/00;;A61K47/02;;A61K47/12;;A61K47/22;;A61P7/10,,0,0,,,,PENDING
243,WO,A1,WO 2015/061182 A1,049-676-046-172-157,2015-04-30,2015,US 2014/0061242 W,2014-10-17,US 201361893542 P,2013-10-21,DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES,"Methods, kits and compositions for diagnosing and treating autoimmue diseases such rheumatiodi arthritis, Crohn's disease, and ulcerative colitis.",DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,,https://lens.org/049-676-046-172-157,Patent Application,yes,37,8,44,44,7,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/00;;A61K39/00,,56,49,028-584-999-150-491;;000-875-274-929-40X;;004-782-005-460-503;;049-592-572-924-891;;016-180-871-182-084;;074-177-607-507-835;;088-052-241-032-685;;028-584-999-150-491;;109-500-732-467-583;;049-134-753-209-354;;035-188-943-391-21X;;017-150-654-990-340;;002-264-966-090-625;;048-188-266-680-461;;037-104-736-197-766;;005-248-320-665-556;;012-206-824-167-831;;092-845-354-377-772;;064-409-159-039-974;;014-581-174-616-945;;085-610-907-501-527;;103-477-074-900-777;;071-498-620-602-771;;045-864-048-030-411;;084-421-189-184-547;;018-144-967-742-095;;122-080-830-470-164;;050-507-714-041-493;;150-526-239-777-942;;069-863-076-076-464;;096-809-977-928-291;;038-056-207-283-274;;093-122-402-165-609;;038-535-940-466-805;;002-237-818-610-496;;053-209-061-746-894;;028-862-168-091-90X;;030-451-543-728-673;;052-397-009-533-722;;026-944-353-804-488;;032-728-154-591-070;;023-676-781-371-861;;092-023-577-402-127;;039-508-259-975-855;;002-664-741-683-318;;021-641-900-032-887;;051-940-176-386-905;;029-667-686-534-996;;007-551-089-881-647,12842992;;10.1182/blood-2003-02-0661;;9354649;;10.1182/blood.v90.10.3819;;10.1517/13543784.17.5.697;;18447596;;21859431;;10.1111/j.1398-9995.2011.02686.x;;10.2174/138161206777698710;;16842160;;10.1016/j.arcmed.2005.02.001;;15900628;;10.1161/01.atv.0000240290.70852.c0;;pmc2637648;;16902163;;12842992;;10.1182/blood-2003-02-0661;;8605931;;10.1002/eji.1830260319;;10.1016/0022-2836(87)90412-8;;3681981;;10.1038/338518a0;;2927510;;3140379;;10.1126/science.3140379;;10.1073/pnas.85.16.5879;;3045807;;pmc281868;;2315699;;10.1126/science.2315699;;2553722;;10.1016/s0021-9258(18)51542-8;;10.1111/j.1365-2141.1984.tb03955.x;;6691922;;10.1182/blood.v74.2.695.695;;10.1182/blood.v74.2.695.bloodjournal742695;;2752143;;3501619;;10.1016/0049-3848(87)90434-8;;15306150;;10.1016/j.thromres.2004.05.005;;7654936;;10.1097/00001721-199505000-00005;;10.1002/elps.201200095;;22965727;;10.1016/s0022-1759(00)00290-8;;11292488;;10.1201/9781420046663;;10.2210/pdb7pti/pdb;;10.1093/protein/3.7.591;;1699222;;2125487;;10.1021/bi00495a002;;3263966;;10.1016/s0021-9258(19)81329-7;;pmc43575;;10.1073/pnas.91.8.3353;;8159751;;10.1002/(sici)1097-0134(199707)28:3<405::aid-prot10>3.0.co;2-l;;9223186;;10.1016/0076-6879(90)83011-w;;2314273;;pmc305087;;10.1073/pnas.84.13.4355;;3474607;;8107089;;10.1006/jmbi.1994.1104;;pmc2142382;;10.1002/pro.5560020302;;8453370;;9600884;;pmc34487;;10.1073/pnas.95.11.5857;;0009600884;;pmc102444;;10592234;;10.1093/nar/28.1.231;;9700502;;10.1111/j.1600-065x.1998.tb01188.x;;9847197;;10.1093/nar/27.1.263;;pmc148152;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;10.1016/s0097-8485(99)00011-x;;10404623;;10.1093/nar/30.1.235;;pmc99105;;11752303;;10.1021/ja00897a025;;10.1016/0022-2836(70)90057-4;;5420325;;10.1126/science.3929380;;3929380;;1404388;;10.1016/0022-2836(92)90223-7;;7779254;;10.1016/0167-5699(95)80166-9;;10.1016/0022-2836(92)90224-8;;1404389;;pmc394555;;7556106;;10.1002/j.1460-2075.1995.tb00142.x;;10.1073/pnas.77.7.4216;;pmc349802;;6933469;;6292436;;10.1016/0022-2836(82)90103-6;;10.1016/s0065-2776(08)60486-1;;1502974,"ISORDIA-SALAS ET AL.: ""The mutation Ser511Asn leads to N-glycosylation and increases the cleavage of high molecular weight kininogen in rats genetically susceptible to inflammation"", BLOOD, vol. 102, no. 8, 15 October 2003 (2003-10-15), pages 2835 - 2842, XP055336291;;COLMAN, R. W.SCHMAIER, A. H.: ""Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes"", BLOOD, vol. 90, 1997, pages 3819 - 3843, XP002928335;;ZURAW, B. L.CHRISTIANSEN, S. C., EXPERT OPIN INVESTIG DRUGS, vol. 17, 2008, pages 697 - 706;;MAURER, M. ET AL., ALLERGY, vol. 66, 2011, pages 1397 - 1406;;COLMAN, R. W., CURR PHARM DES, vol. 12, 2006, pages 2599 - 2607;;ISORDIA-SALAS ET AL., ARCH MED RES., vol. 36, no. 1, January 2005 (2005-01-01), pages 87 - 95;;KHAN ET AL., ARTERIOSCLER THROMB VASE BIOL., vol. 26, no. 10, October 2006 (2006-10-01), pages 2260 - 6;;ISORDIA-SALAS ET AL., BLOOD, vol. 102, no. 8, 15 October 2003 (2003-10-15), pages 2835 - 42;;DE WILDT ET AL., EUR J IMMUNOL., vol. 26, no. 3, 1996, pages 629 - 39;;KABAT, E.A. ET AL.: ""Sequences of Proteins of Immunological Interest"", 1991, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, NIH;;CHOTHIA, C. ET AL., J. MOL. BIOL., vol. 196, 1987, pages 901 - 917;;GIRARD, T. ET AL., NATURE, vol. 338, 1989, pages 518 - 520;;BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426;;HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 5879 - 5883;;BOWIE ET AL., SCIENCE, vol. 247, 1990, pages 1306 - 1310;;NOVOTNY ET AL., J. BIOL. CHEM., vol. 264, no. 31, 1989, pages 18832 - 18837;;KERBIRIOU-NABIAS, D.M., BR J HAEMATOL, vol. 56, no. 2, 1984, pages 2734 - 86;;REDDIGARI, S.R.KAPLAN, A.P., BLOOD, vol. 74, 1999, pages 695 - 702;;SCOTT, C.F. ET AL., THROMB RES, vol. 48, no. 6, 1987, pages 685 - 700;;GALLIMORE, M.J. ET AL., THROMB RES, vol. 114, no. 2, 2004, pages 91 - 96;;BUHLER R. ET AL., BLOOD COAGUL FIBRINOLYSIS, vol. 6, no. 3, 1995, pages 223 - 232;;RUSTANDI ET AL.: ""Qualitative and quantitative evaluation of Simon™, a new CE-based automated Western blot system as applied to vaccine development"", ELECTROPHORESIS, vol. 33, no. 17, September 2012 (2012-09-01), pages 2790 - 7;;POWERS ET AL., J. IMMUNOL. METHODS, vol. 251, 2001, pages 123 - 35;;R. MATSON: ""Microarray Methods and Protocols"", 2009, CRC PRESS;;EIGENBROT ET AL., PROTEIN ENGINEERING, vol. 3, no. 7, 1990, pages 591 - 598;;""GeneBank"", Database accession no. NP_036857.2;;HYNES ET AL., BIOCHEMISTRY, vol. 29, 1990, pages 10018 - 10022;;KIDO ET AL., J. BIOL. CHEM., vol. 263, no. 34, 1988, pages 18104 - 18107;;SPRECHER ET AL., PNAS USA, vol. 91, 1994, pages 3353 - 3357;;SONHAMMER ET AL., PROTEINS, vol. 28, no. 3, 1997, pages 405 - 420;;GRIBSKOV ET AL., METH. ENZYMOL., vol. 183, 1990, pages 146 - 159;;GRIBSKOV ET AL., PROC. NATL. ACAD. SCI. USA, vol. 84, 1987, pages 4355 - 4358;;KROGH ET AL., J. MOL. BIOL., vol. 235, 1994, pages 1501 - 1531;;STULTZ ET AL., PROTEIN SCI., vol. 2, 1993, pages 305 - 314;;SCHULTZ ET AL., PROC. NATL. ACAD. SCI. USA, vol. 95, 1998, pages 5857;;SCHULTZ ET AL., NUCL. ACIDS RES, vol. 28, 2000, pages 231;;JEFFERIS ET AL., IMMUNOL. REV., vol. 163, 1998, pages 59 - 76;;CORPET ET AL., NUCL. ACIDS RES., vol. 27, 1999, pages 263 - 267;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402;;GOUZY ET AL., COMPUTERS AND CHEMISTRY, vol. 23, 1999, pages 333 - 340;;FALQUET ET AL., NUCLEIC ACIDS RES., vol. 30, 2002, pages 235 - 238;;STEWART, J.YOUNG, J.: ""Solid-Phase Peptide Synthesis"", 1989, W. H. FREEMAN CO.;;MERRIFIELD, J., AM. CHEM. SOC., vol. 85, 1963, pages 2149 - 2154;;BODANSZKY, M.BODANSZKY, A.: ""The Practice of Peptide Synthesis"", 1984, SPRINGER-VERLAG;;NEEDLEMANWUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 444 - 453;;MORRISON, S. L., SCIENCE, vol. 229, 1985, pages 1202 - 1207;;OI ET AL., BIOTECHNIQUES, vol. 4, 1986, pages 214;;TOMLINSON, I.A. ET AL., J. MOL. BIOL., vol. 227, 1992, pages 776 - 798;;COOK, G. P. ET AL., IMMUNOL. TODAY, vol. 16, no. 5, 1995, pages 237 - 242;;CHOTHIA, D. ET AL., J. MOL. BIO., vol. 227, 1992, pages 799 - 817;;TOMLINSON ET AL., EMBO J., vol. 14, no. 18, 1995, pages 4628 - 38;;URLAUBCHASIN, PROC. NATL. ACAD. SCI. USA, vol. 77, 1980, pages 4216 - 4220;;KAUFMANSHARP, MOL. BIOL., vol. 159, 1982, pages 601 621;;J. IMMUNOL. METHODS, vol. 289, no. 1-2, 2004, pages 65 - 80;;BURTONWOOF, ADV. IMMUNOL., vol. 51, 1992, pages 1 - 84;;SILVERBERG ET AL.: ""Blood: Principles and Practice of Hematology"", 1995, J B LIPPINCOTT CO., article ""The Contact System and Its Disorders""",PENDING
244,US,A1,US 2006/0079427 A1,081-138-020-617-084,2006-04-13,2006,US 52598205 A,2005-03-23,GB 0220295 A;;GB 0303579 W,2002-08-31,Water soluble sachet containing hard surface cleaner,"The invention relates to a water-soluble container which contains a composition useful for hard surface cleaning. The composition comprises at least one surfactant selected from non-ionic surfactant, anionic surfactant, and mixtures thereof, at least 70% wt. of at least one organic solvent having a solubility in water of at least 4% wt., optionally at least one alkanolamine; and optionally, conventional additives. The water soluble containers can be made by thermoforming or injection molding.",RECKITT BENCKISER INC,BURT DIANE J;;GENCARELLI RALPH;;STRZEPEK SOPHIE,RECKITT BENCKISER INC (2005-02-23);;RECKITT BENCKISER LLC (2011-01-01),https://lens.org/081-138-020-617-084,Patent Application,yes,17,9,19,19,0,C11D3/30;;C11D3/43;;C11D17/0004;;C11D17/043;;C11D17/043;;C11D17/0004;;C11D3/30;;C11D3/43,C11D17/00;;C11D3/30;;C11D3/43;;C11D17/04,510/295,0,0,,,,EXPIRED
245,US,B2,US 8826942 B2,174-492-213-830-088,2014-09-09,2014,US 201213437995 A,2012-04-03,FR 1152868 A,2011-04-04,Device for connecting an air leak detection system to a sleeve that envelops a pressurized air hose of an aircraft,"An aircraft includes a hose that makes it possible to channel the pressurized air that is used in a sleeve ( 52 ) that delimits an annular chamber with the hose, with the sleeve ( 52 ) including at least one opening ( 54 ) that is delimited by an edge ( 58 ) that makes it possible to link the annular chamber and the outside of the sleeve ( 52 ), and a leak detection system that includes at least one loop (A) in the form of a threadlike element ( 56 ), characterized in that it includes a connecting device that includes a ring ( 60 ) that is connected at at least one connecting point ( 64 ) with a loop (A), and a flexible wall that delimits a hose ( 68 ) for channeling the air that extends from the edge ( 58 ) of the opening ( 54 ) up to the ring ( 60 ).",MILLET GÉRARD;;BURT TERENCE J;;BERNARD XAVIER;;AIRBUS OPERATIONS SAS;;AIRBUS OPERATIONS LTD,MILLET GÉRARD;;BURT TERENCE J;;BERNARD XAVIER,AIRBUS OPERATIONS LTD (2011-04-21);;AIRBUS OPERATIONS (SAS) (2011-04-21),https://lens.org/174-492-213-830-088,Granted Patent,yes,12,5,4,4,0,B64D13/00;;B64D13/00;;G01M3/165;;G01M3/165;;G01M3/002;;G01M3/002,F16L55/00;;B64D13/00;;G01M3/00;;G01M3/02;;G01M3/16;;G01M3/28,138/104;;X 73 405 R,1,0,,,"French Search Report dated Nov. 4, 2011 in corresponding French Appln. 11 52868.",INACTIVE
246,US,A,US 5344366 A,188-653-586-324-615,1994-09-06,1994,US 9472693 A,1993-07-21,US 9472693 A;;GB 9023310 A;;US 78134491 A,1990-10-25,Ventilators,"A canopy for use with a ventilator slot extending through a window frame has pressure differential responsive flow control means arranged to progressively close the flow passage through the canopy as the pressure differential increases, thus preventing draughts. The canopy has a body with an inlet and an outlet and a bowed wall therebetween. A normally straight baffle strip is attached to the center of the wall and there are non-aligned apertures in the wall and the baffle respectively. When the pressure differential between the inlet and outlet is low, the baffle is well-spaced from the wall but as the pressure differential increases the baffle is bowed progressively towards the wall against the inherent bias of the strip to progressively close the flow path through the apertures.",TITON HARDWARE,STONEY ARTHUR;;BURT ARTHUR J;;WATERS RICHARD,,https://lens.org/188-653-586-324-615,Granted Patent,yes,9,2,9,9,0,F24F13/18;;F24F13/18,F24F13/18,454/213;;454/271,0,0,,,,EXPIRED
247,EP,A4,EP 3060908 A4,035-665-928-365-450,2017-03-22,2017,EP 14855002 A,2014-10-17,US 201361893542 P;;US 2014/0061242 W,2013-10-21,DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES,,DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,"TAKEDA PHARMACEUTICAL COMPANY LIMITED, OSAKA-S, JP (2021-07-28);;TAKEDA PHARMACEUTICAL COMPANY LIMITED, JP (2021-09-13);;TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-09-08);;DYAX CORP. (2018-06-20);;TAKEDA PHARMACEUTICAL COMPANY LIMITED; JP (2021-11-05)",https://lens.org/035-665-928-365-450,Search Report,no,1,0,44,44,0,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/00;;A61K39/00;;G01N33/564,,2,2,074-177-607-507-835;;088-052-241-032-685,10.1016/j.arcmed.2005.02.001;;15900628;;10.1161/01.atv.0000240290.70852.c0;;pmc2637648;;16902163,"ISORDIA-SALAS I ET AL: ""The Role of Plasma High Molecular Weight Kininogen in Experimental Intestinal and Systemic Inflammation"", ARCHIVES OF MEDICAL RESEARCH, INSTITUTO MEXICANO DEL SEGURO SOCIAL, MEXICO, MX, vol. 36, no. 1, 1 January 2005 (2005-01-01), pages 87 - 95, XP027775638, ISSN: 0188-4409, [retrieved on 20050101];;M. M. KHAN ET AL: ""High-Molecular-Weight Kininogen Fragments Stimulate the Secretion of Cytokines and Chemokines Through uPAR, Mac-1, and gC1qR in Monocytes"", ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY., vol. 26, no. 10, 1 October 2006 (2006-10-01), US, pages 2260 - 2266, XP055343572, ISSN: 1079-5642, DOI: 10.1161/01.ATV.0000240290.70852.c0",ACTIVE
248,DK,T3,DK 3060908 T3,073-585-638-817-322,2021-05-25,2021,DK 14855002 T,2014-10-17,US 201361893542 P;;US 2014/0061242 W,2013-10-21,DIAGNOSTICERING OG BEHANDLING AF AUTOIMMUNE SYGDOMME,,DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,,https://lens.org/073-585-638-817-322,Granted Patent,no,0,0,44,44,0,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/00;;A61K39/00;;G01N33/564,,0,0,,,,ACTIVE
249,FR,A1,FR 2973341 A1,156-383-018-438-229,2012-10-05,2012,FR 1152868 A,2011-04-04,FR 1152868 A,2011-04-04,DISPOSITIF DE RACCORDEMENT D'UN SYSTEME DE DETECTION D'UNE FUITE D'AIR A UN MANCHON ENVELOPPANT UN CONDUIT D'AIR SOUS PRESSION D'UN AERONEF,"L'objet de l'invention est un aéronef comprenant d'une part un conduit permettant de canaliser de l'air sous pression disposé dans un manchon (52) délimitant avec ledit conduit une chambre annulaire, ledit manchon (52) comprenant au moins un orifice (54) délimité par un bord (58) permettant de faire communiquer ladite chambre annulaire et l'extérieur du manchon (52), et d'autre part, un système de détection d'une fuite comprenant au moins une boucle (A, B) sous forme d'un élément filiforme (56), caractérisé en ce qu'il comprend un dispositif de raccordement entre le bord (58) de l'orifice (54) et une boucle (A, B).",AIRBUS OPERATIONS SAS;;AIRBUS OPERATIONS LTD,MILLET GERARD;;BURT TERENCE J;;BERNARD XAVIER,,https://lens.org/156-383-018-438-229,Patent Application,no,3,1,4,4,0,B64D13/00;;B64D13/00;;G01M3/165;;G01M3/165;;G01M3/002;;G01M3/002,B64D45/00;;F16L55/00;;G01M3/40,,0,0,,,,INACTIVE
250,US,A1,US 2016/0252533 A1,192-628-572-598-834,2016-09-01,2016,US 201415030790 A,2014-10-17,US 201415030790 A;;US 201361893542 P;;US 2014/0061242 W,2013-10-21,DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES,"Methods, kits and compositions for diagnosing and treating autoimmune diseases such as rheumatiodi arthritis, Crohn's disease, and ulcerative colitis.",DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2016-08-16),https://lens.org/192-628-572-598-834,Patent Application,yes,2,4,44,44,7,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/86,,5,4,048-397-262-376-455;;078-352-985-001-170;;051-002-109-848-312;;149-344-504-021-407,10.1097/xce.0000000000000009;;10.1155/2014/683598;;pmc4020216;;24872599;;8182230;;10.1016/0091-6749(94)90380-8;;19691495;;10.1111/j.1742-4658.2009.07218.x,"Van Der Vekiens et al., Human and equine cardiovascular endocrinology: beware to compare, Cardiovascular Endocrinology 2013, Vol 2, No. 4, pages 67-76.;;Torzewski et al., Animal Models of C-Reactive Protein, Hindawl Publishing Corporation, Mediators of Inflammation, Vol. 2014, Article ID 683598, 2014, pages 1-7.;;Cugno et al., Activfation of the contact system and fibrinolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamic acid, J. Allergy Clin Immunol, Vol 93, No. 5, pages 870-876.;;Schousboe et al., High molecular weight kininogen binds to laminin - characterization and kinetic analysis, FEBS Journal, 276, 2009, pages 5228-5238.;;Image Studio Compatible, Image Studio Software Compatible with Mac Systems Now Available from LI-COR, Bio Blog, May 8, 2012, pages 1-3.",ACTIVE
251,FR,B1,FR 2973341 B1,046-472-470-351-484,2013-12-06,2013,FR 1152868 A,2011-04-04,FR 1152868 A,2011-04-04,DISPOSITIF DE RACCORDEMENT D'UN SYSTEME DE DETECTION D'UNE FUITE D'AIR A UN MANCHON ENVELOPPANT UN CONDUIT D'AIR SOUS PRESSION D'UN AERONEF,,AIRBUS OPERATIONS SAS;;AIRBUS OPERATIONS LTD,MILLET GERARD;;BURT TERENCE J;;BERNARD XAVIER,,https://lens.org/046-472-470-351-484,Granted Patent,no,0,0,4,4,0,B64D13/00;;B64D13/00;;G01M3/165;;G01M3/165;;G01M3/002;;G01M3/002,B64D45/00;;F16L55/00;;G01M3/40,,0,0,,,,INACTIVE
252,AU,A1,AU 2020/200423 A1,047-344-522-262-986,2020-02-13,2020,AU 2020/200423 A,2020-01-21,AU 2020/200423 A;;AU 2014/340449 A;;US 201361893542 P;;US 2014/0061242 W,2013-10-21,Diagnosis and treatment of autoimmune diseases,"DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES Methods, kits and compositions for diagnosing and treating autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis.",TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/047-344-522-262-986,Patent Application,no,0,0,44,44,0,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/00;;A61K39/00,,0,0,,,,ACTIVE
253,EP,A4,EP 3286226 A4,088-846-896-295-333,2018-12-05,2018,EP 16774069 A,2016-03-30,US 201562140289 P;;US 201562140277 P;;US 201562214293 P;;US 2016/0024921 W,2015-03-30,PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR PREVENTING HEREDITARY ANGIOEDEMA ATTACK,,DYAX CORP,CHYUNG YUNG;;ADELMAN BURT;;SEXTON DANIEL J,DYAX CORP. (2018-06-20),https://lens.org/088-846-896-295-333,Search Report,no,1,0,27,27,0,A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;C07K16/40;;C07K2317/94;;C07K2317/565;;C07K2317/21;;A61K2039/54;;A61P7/10;;A61K2039/545;;C07K2317/76;;A61K2039/505;;C07K16/40;;A61K2039/505;;C07K2317/94;;A61K47/02;;A61K47/12;;A61K47/22;;A61K9/0019;;A61P7/10;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76;;A61K2039/505;;C07K2317/94;;C07K16/40;;A61P7/10;;A61K2039/54;;A61K2039/545;;C07K2317/21;;C07K2317/565;;C07K2317/76,C07K16/40,,4,2,008-499-354-702-218;;006-137-353-823-826,24980392;;10.1016/j.anai.2014.05.028;;24970892;;10.1074/jbc.m114.569061;;pmc4156074,"CHYUNG YUNG ET AL: ""A phase 1 study investigating DX-2930 in healthy subjects"", ANNALS OF ALLERGY, ASTHMA & IMMUNOLOGY, ARLINGTON HEIGHTS, IL, US, vol. 113, no. 4, 26 June 2014 (2014-06-26), pages 460, XP029068455, ISSN: 1081-1206, DOI: 10.1016/J.ANAI.2014.05.028;;DYAX: ""Dyax Announces Positive Results from Phase 1a Clinical Trial of DX-2930"", DYAX, 25 February 2014 (2014-02-25), pages 1 - 3, XP055317760, Retrieved from the Internet <URL:http://files.shareholder.com/downloads/DYAX/0x0x728704/080fce37-bdbe-4c1b-beaf-59632ab0ae15/DYAX_News_2014_2_25_Earnings.pdf> [retrieved on 20161109];;J. A. KENNISTON ET AL: ""Inhibition of Plasma Kallikrein by a Highly Specific Active Site Blocking Antibody"", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 289, no. 34, 26 June 2014 (2014-06-26), pages 23596 - 23608, XP055215056, ISSN: 0021-9258, DOI: 10.1074/jbc.M114.569061;;See also references of WO 2016160926A1",DISCONTINUED
254,EP,A1,EP 3060908 A1,194-301-639-672-049,2016-08-31,2016,EP 14855002 A,2014-10-17,US 201361893542 P;;US 2014/0061242 W,2013-10-21,DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES,,DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;NIXON ANDREW,"TAKEDA PHARMACEUTICAL COMPANY LIMITED, OSAKA-S, JP (2021-07-28);;TAKEDA PHARMACEUTICAL COMPANY LIMITED, JP (2021-09-13);;TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-09-08);;DYAX CORP. (2018-06-20);;TAKEDA PHARMACEUTICAL COMPANY LIMITED; JP (2021-11-05)",https://lens.org/194-301-639-672-049,Patent Application,yes,0,1,44,44,7,G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;A61P1/00;;A61P1/04;;A61P19/02;;A61P29/00;;A61P37/06;;A61P43/00;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/56;;G01N33/564;;G01N33/86;;A61P43/00;;A61P19/02;;A61P1/04;;A61P37/06;;G01N2333/745;;A61P29/00;;A61P1/00;;G01N2800/102;;G01N2800/065;;G01N2333/8139;;G01N33/569;;G01N33/564;;G01N2333/8139;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N33/86;;G01N2333/745;;G01N2800/56,G01N33/00;;A61K39/00;;G01N33/564,,0,0,,,,ACTIVE
255,US,A,US 4663660 A,148-769-739-954-399,1987-05-05,1987,US 87699486 A,1986-06-20,US 87699486 A,1986-06-20,Compressed quantized image-data transmission technique suitable for use in teleconferencing,A technique for transmitting compressed quantized image-data from a transmitter to a receiver over a limited bandwidth communication channel employs temporal differential pulse code modulation incorporating pyramid image processing spectrum analyzers and synthesizers. This technique permits the selective elimination by data-compression of only those portions of the original image information which contribute least to the perception of image quality by a viewer of a synthesized display image at the receiver.,RCA CORP,FEDELE NICOLA J;;ACAMPORA ALFONSE;;BURT PETER J;;HINGORANI RAJESH,RCA CORPORATION A CORP. OF DE (1986-06-18),https://lens.org/148-769-739-954-399,Granted Patent,yes,3,120,1,1,0,H04N19/503;;H04N19/63;;H04N19/115;;H04N19/61;;H04N19/593;;H04N19/186;;H04N19/146;;H04N19/10;;H04N19/619;;H04N19/186;;H04N19/63;;H04N19/503;;H04N19/619;;H04N19/593;;H04N19/146;;H04N19/10;;H04N19/115;;H04N19/61,G06T9/00;;H04N7/26;;H04N7/36;;H04N19/593,358/136;;358/13;;358/133,3,0,,,"Co pending patent application Ser. No. 596,817, Carlson et al., filed Apr. 4, 1984, assigned to RCA Corporation, Princeton, NJ.;;Co pending currently allowed patent application Ser. No. 685,239, Arbeiter et al., filed Dec. 21, 1984, assigned to RCA Corporation, Princeton, NJ.;;Co pending patent application Ser. No. 774,984, Anderson, filed Sep. 11, 1985, assigned to RCA Corporation, Princeton, NJ.",EXPIRED
256,GB,A,GB 2233637 A,035-344-735-306-027,1991-01-16,1991,GB 9010937 A,1990-05-16,US 35388189 A,1989-05-18,LID DISPENSER/APPLICATOR FOR DRINKS MACHINE.,,PEPSICO INC,BROGNA SALVATORE J;;RIEHM GEORGE E;;SHULMAN BURT,,https://lens.org/035-344-735-306-027,Patent Application,no,0,1,9,9,0,B65B7/2807;;B65B7/2807;;B67D2210/00076;;B67D2210/00076;;G07F13/10;;G07F13/10,B67B1/10;;B65B7/28;;B67D1/00;;G07F13/10,B8U UAD           UAD;;U1S S1811;;U1S S1877,0,0,,,,EXPIRED
257,US,B2,US 6549638 B2,110-680-191-417-335,2003-04-15,2003,US 18538098 A,1998-11-03,US 18538098 A,1998-11-03,Methods for evidencing illicit use of a computer system or device,"
    A computer is provided with software that looks for certain activities that may be illicit (e.g. processing of a graphic file corresponding to a banknote). If such an activity is detected, tracer data detailing the activity is generated and secretly stored. in the computer. If the computer is later searched or seized, the tracer data can be recovered and employed as evidence of the computer's use, e.g. in counterfeiting. 
",DIGIMARC CORP,DAVIS BRUCE L;;PERRY BURT;;CARR J SCOTT,DIGIMARC CORPORATION (A DELAWARE CORPORATION) (1999-11-24);;DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC LLC (2008-08-01);;DMRC CORPORATION (2008-08-01),https://lens.org/110-680-191-417-335,Granted Patent,yes,33,65,10,1547,0,G06F21/10;;G06F2221/2101;;G07D7/20;;H04N1/00843;;H04N1/00877;;G07D7/0034;;G06V10/40;;G06F12/16;;H04N1/00843;;G06F2221/2101;;G07D7/20;;H04N1/00877;;G06F21/10;;G07D7/0034;;G06V10/40,G06F3/12;;G06F1/00;;G06F21/00;;G06V10/40;;G07D7/12;;G07D7/20;;H04N1/00;;H04N1/387;;H04N1/40,382/100;;711/161;;713/189,6,3,122-399-272-117-650;;023-126-971-417-668;;123-478-746-608-833,10.1007/3-540-61996-8_31;;10.1007/3-540-49380-8_6;;10.1007/3-540-49380-8_1,"Pfitzmann, ""Trials of Traced Traitors,"" Proc. 1st Int. Workshop on Information Hiding, May/Jun. 1996, pp. 49-64.*;;Wayner, Digital Copyright Protection, Academic Press, 1997, pp. 184-185.*;;Anderson, et al., ""The Steganographic File System,"" Proc. 2nd Int. Workshop on Information Hiding, Apr. 1998, pp. 73-82.*;;Gruhl et al., ""Information Hiding to Foil the Casual Counterfeiter,"" Proc. 2nd Int. Workshop on Information Hiding, Apr. 1998, pp. 1-15.*;;Tirkel et al, ""Electronic Water Mark,"" DICTA-93, Macquarie University, Sydney, Australia, Dec. 1993, pp. 666-672.;;Szepanski, ""A Signal Theoretic Method for Creating Forgery-Proof Documents for Automatic Verification,"" Proceedings 1979 Carnahan Conference on Crime Countermeasures, May 16, 1979, pp. 101-109.",EXPIRED
258,DE,D1,DE 60314758 D1,169-894-626-181-494,2007-08-16,2007,DE 60314758 T,2003-06-09,GB 0215269 A;;GB 0302460 W,2002-07-03,LASERSCHWEISSVERFAHREN ZUR PLASMAVERHINDERUNG,,ROLLS ROYCE PLC,BURT PAUL;;GRIFFITH ANTHONY J;;GREEN ANDREW P,,https://lens.org/169-894-626-181-494,Granted Patent,no,0,0,11,11,0,B23K26/147;;B23K26/18;;B23K26/702;;B23K26/1437;;B23K26/1438;;B23K26/147;;B23K26/18;;B23K26/702;;B23K26/1437;;B23K26/1438,B23K26/14;;B23K26/16;;B23K26/18;;B23K26/42,,0,0,,,,EXPIRED
259,CA,A,CA 139719 A,023-816-406-201-758,1912-04-16,1912,CA 139719D A,1912-02-27,CA 139719T A,1912-02-27,FOLDING FEED BOX,,BURT KINSBOROUGH;;YOUNG BENJAMIN J;;PRUIT RICHARD F,BURT KINSBOROUGH;;YOUNG BENJAMIN J;;PRUIT RICHARD F,,https://lens.org/023-816-406-201-758,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
260,WO,A1,WO 2005/027964 A1,032-760-567-930-376,2005-03-31,2005,US 2004/0030361 W,2004-09-15,US 50311403 P,2003-09-15,MEASLES SUBUNIT VACCINE,"Compositions and methods for making and using therapeutic formulations of measles virus antigens with a Proteosome-based adjuvant are provided. The measles virus antigens may be derived from a variety of sources, such as from recombinant production or from a split antigen preparation. The measles vaccine formulations may be used, for example, in methods for treating or preventing a measles virus infection and eliciting a protective immune response.",ID BIOMEDICAL CORP QUEBEC;;UNIV MCGILL;;ID BIOMEDICAL CORP OF WASHINGT;;BURT DAVID S;;WARD BRIAN J;;CHABOT SOPHIE,BURT DAVID S;;WARD BRIAN J;;CHABOT SOPHIE,,https://lens.org/032-760-567-930-376,Patent Application,yes,4,7,6,6,0,A61K39/165;;A61K39/39;;A61K2039/53;;A61K2039/54;;A61K2039/541;;A61K2039/543;;A61K2039/55511;;A61K2039/55516;;A61K2039/55572;;C07K16/1027;;C12N2760/18434;;A61K39/12;;A61P31/12;;A61P31/14;;A61P37/04;;C07K16/1027;;A61K39/165;;A61K2039/55516;;A61K2039/54;;A61K2039/53;;A61K2039/55572;;A61K2039/541;;A61K2039/55511;;A61K2039/543;;A61K39/39;;C12N2760/18434;;A61K39/12,A61K39/165;;A61K39/295;;A61K39/39;;A61P31/14;;C07K16/10,,1,1,019-811-649-173-627,11567770;;10.1016/s0264-410x(01)00266-3,"GREEN T D ET AL: ""C3d enhancement of neutralizing antibodies to measles hemagglutinin"", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 20, no. 1-2, 12 October 2001 (2001-10-12), pages 242 - 248, XP004305138, ISSN: 0264-410X",PENDING
261,US,A1,US 2013/0028735 A1,113-157-012-703-284,2013-01-31,2013,US 201213546678 A,2012-07-11,GB 201112880 A,2011-07-27,BLADE COOLING AND SEALING SYSTEM,"A cooled component for a gas turbine engine, for example a turbine rotor blade, is provided. The component has an internal cooling flow passage. Cooling air is passed through the internal cooling flow passage to remove heat from the component and thereby reduce its temperature. The cooling air is bled from the internal cooling passage after it has passed through a portion of the passage into an internal bleed flow passage. This bled air is then used in a seal. Thus, some of the cooling air that enters the internal cooling flow passage is used both to cool the component and to form a seal, for example with another component.",ROLLS ROYCE PLC;;BURT ALEXANDER J;;SADLER KEITH C;;GORTON KEVIN,BURT ALEXANDER J;;SADLER KEITH C;;GORTON KEVIN,ROLLS-ROYCE PLC (2012-05-09),https://lens.org/113-157-012-703-284,Patent Application,yes,9,11,3,3,0,F01D5/187;;F01D11/04;;F05D2250/75;;F05D2260/60;;F01D5/225;;F01D5/187;;F01D11/04;;F05D2250/75;;F05D2260/60;;F01D5/225,F01D5/08,416/1;;416/95,0,0,,,,DISCONTINUED
262,CA,A1,CA 2319080 A1,006-140-789-685-505,1999-12-16,1999,CA 2319080 A,1999-06-07,US 8844898 P;;US 9307298 P;;US 31719899 A;;US 9912776 W,1998-06-08,NOVEL ANTIBACTERIAL AGENTS,"This invention relates to novel multibinding compounds (agents) that are antibacterial agents. The multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands in their monovalent (i.e., unlinked) state have the ability to bind to an enzyme involved in cell wall biosynthesis and metabolism. A precursor used in the synthesis of the bacterial cell wall and/or the bacterial cell surface thereby interfere with the synthesis and/or metabolism of the cell wall. In particular the multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands has a ligand domain capable of binding to penicillin binding proteins, a transpeptidase enzyme, a substrate of a transpeptidase enzyme, a beta-lactamase enzyme, penicillinase enzyme, cephalosporinase enzyme, a transglycosylase enzyme, or a transglycosylase enzyme substrate. Preferably, the ligands are selected from the beta-lactam or glycopeptide class of antibacterial agents.",ADVANCED MEDICINE INC,GRIFFIN JOHN H;;MORAN EDMUND J;;CHRISTENSEN BURT,,https://lens.org/006-140-789-685-505,Patent Application,no,0,0,86,429,0,A61K31/00;;C07C233/36;;C07C233/78;;C07C237/24;;C07C271/20;;C07C321/04;;C07C323/12;;C07C335/08;;C07C335/32;;C07D207/333;;C07D211/58;;C07D215/56;;C07D233/90;;C07D235/30;;C07D401/06;;C07D401/12;;C07D401/14;;C07D405/04;;C07D413/14;;C07D471/04;;C07D471/14;;C07D473/00;;C07D473/34;;C07D475/04;;C07D475/08;;C07D487/04;;C07D487/06;;C07D493/04;;C07D493/06;;C07H19/20;;C12Q1/26;;C12Q1/44;;C12Q1/48;;C12Q1/533;;C40B30/04;;C40B40/04;;G01N33/573;;G01N33/6842;;G01N33/6845;;G01N33/92;;G01N2500/00;;G01N2500/04;;G01N2800/044;;Y10S530/807;;C07C2603/18;;A61K47/60;;A61K47/54;;A61K47/55;;A61K47/552;;A61P31/04;;A61P31/18;;A61P37/02;;A61P43/00;;A61P5/14;;A61P3/10;;Y02A50/30;;C40B30/04;;G01N33/573;;C07D405/04;;C07D207/333;;C07C321/04;;G01N33/92;;C07C323/12;;C07D211/58;;C07D235/30;;C12Q1/48;;C12Q1/26;;C07C335/08;;C07D473/34;;C07D475/08;;C07C271/20;;C07D401/12;;C07D487/04;;C12Q1/44;;C07C233/78;;C07D471/04;;G01N2800/044;;C07C237/24;;C40B40/04;;C07D473/00;;C07D487/06;;C07D493/06;;C07D413/14;;C07D401/14;;A61K31/00;;C07D493/04;;C07D471/14;;C12Q1/533;;G01N33/6842;;G01N33/6845;;C07D401/06;;C07H19/20;;C07D215/56;;C07D475/04;;G01N2500/04;;C07C233/36;;G01N2500/00;;C07C335/32;;C07D233/90;;Y10S530/807;;A61K47/552;;A61K47/54;;C07C2603/18;;A61K47/60;;A61K47/55;;Y02A50/30,C07D499/44;;A01N57/34;;A61K31/00;;A61K31/357;;A61K31/397;;A61K31/407;;A61K31/421;;A61K31/424;;A61K31/431;;A61K31/439;;A61K31/444;;A61K31/4545;;A61K31/496;;A61K31/522;;A61K31/536;;A61K31/5377;;A61K31/546;;A61K31/551;;A61K31/65;;A61K31/7028;;A61K31/7034;;A61K31/7036;;A61K31/7042;;A61K31/7048;;A61K31/7052;;A61K31/7056;;A61K31/7064;;A61K31/7068;;A61K31/7072;;A61K38/00;;A61K39/00;;A61K39/395;;A61K39/44;;A61K47/48;;A61K51/00;;A61P31/04;;A61P31/18;;A61P43/00;;C07B61/00;;C07C233/36;;C07C233/78;;C07C237/24;;C07C237/26;;C07C271/20;;C07C275/42;;C07C321/04;;C07C323/12;;C07C335/08;;C07C335/32;;C07D207/32;;C07D207/333;;C07D211/58;;C07D215/56;;C07D233/90;;C07D235/30;;C07D263/28;;C07D265/18;;C07D401/06;;C07D401/12;;C07D401/14;;C07D405/04;;C07D413/14;;C07D453/02;;C07D471/04;;C07D471/14;;C07D473/00;;C07D473/34;;C07D475/04;;C07D475/08;;C07D477/00;;C07D487/04;;C07D487/06;;C07D493/04;;C07D493/06;;C07D495/04;;C07D498/04;;C07D498/18;;C07D501/20;;C07D519/00;;C07H15/236;;C07H15/238;;C07H15/26;;C07H17/08;;C07H19/06;;C07H19/20;;C07K2/00;;C07K4/00;;C12N9/99;;C12P19/38;;C12Q1/26;;C12Q1/44;;C12Q1/48;;C12Q1/533;;C40B30/04;;C40B40/04;;G01N33/15;;G01N33/50;;G01N33/53;;G01N33/543;;G01N33/566;;G01N33/573;;G01N33/68;;G01N33/92;;G01N37/00,,0,0,,,,EXPIRED
263,US,B2,US 8931601 B2,053-466-863-198-938,2015-01-13,2015,US 94074410 A,2010-11-05,US 94074410 A,2010-11-05,Dampening device,"An assembly for dampening vibration movement between a cylinder and a concentric duct, where the cylinder is positioned radially inside the duct, includes a damper attached to the duct. The damper includes a housing attached to the duct, a contact member positioned at least partially inside the housing and having a contact surface adjacent an outer surface of the cylinder, and a cap threadedly engaged with the housing for applying a load on the contact member in a direction toward the cylinder.",BURT JONATHAN P;;JONES JAMES;;BAUER STEVEN J;;UNITED TECHNOLOGIES CORP,BURT JONATHAN P;;JONES JAMES;;BAUER STEVEN J,RTX CORPORATION (2010-10-13),https://lens.org/053-466-863-198-938,Granted Patent,yes,16,1,5,5,0,F16F15/021;;F16F15/021;;F01D25/164;;F01D25/164;;F16F9/34;;F16F9/34,F16D63/00;;F16F7/10;;F16F9/34;;F16F15/02,188/80;;188/378,0,0,,,,ACTIVE
264,AU,A,AU 1990/055197 A,136-041-652-421-218,1990-11-22,1990,AU 1990/055197 A,1990-05-18,US 35388189 A,1989-05-18,LID DISPENSER FOR AN AUTOMATED DRINKMAKER SYSTEM,,PEPSICO INC,BROGNA SALVATORE J;;RIEHM GEORGE E;;SHULMAN BURT,,https://lens.org/136-041-652-421-218,Patent Application,no,0,0,9,9,0,B65B7/2807;;B65B7/2807;;B67D2210/00076;;B67D2210/00076;;G07F13/10;;G07F13/10,B67B1/10;;B65B7/28;;B67D1/00;;G07F13/10,,0,0,,,,EXPIRED
265,US,A1,US 2002/0136426 A1,048-791-179-425-530,2002-09-26,2002,US 18538098 A,1998-11-03,US 18538098 A,1998-11-03,Methods for evidencing illicit use of a computer system or device,"
   A computer is provided with software that looks for certain activities that may be illicit (e.g. processing of a graphic file corresponding to a banknote). If such an activity is detected, tracer data detailing the activity is generated and secretly stored in the computer. If the computer is later searched or seized, the tracer data can be recovered and employed as evidence of the computer's use, e.g. in counterfeiting. 
",DAVIS BRUCE L.;;PERRY BURT;;CARR J. SCOTT,DAVIS BRUCE L;;PERRY BURT;;CARR J SCOTT,DIGIMARC CORPORATION (A DELAWARE CORPORATION) (1999-11-24);;DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC LLC (2008-08-01);;DMRC CORPORATION (2008-08-01),https://lens.org/048-791-179-425-530,Patent Application,yes,0,14,10,1547,0,G06F21/10;;G06F2221/2101;;G07D7/20;;H04N1/00843;;H04N1/00877;;G07D7/0034;;G06V10/40;;G06F12/16;;H04N1/00843;;G06F2221/2101;;G07D7/20;;H04N1/00877;;G06F21/10;;G07D7/0034;;G06V10/40,G06F3/12;;G06F1/00;;G06F21/00;;G06V10/40;;G07D7/12;;G07D7/20;;H04N1/00;;H04N1/387;;H04N1/40,3821,0,0,,,,EXPIRED
266,DK,B,DK 123038 B,132-752-102-618-986,1972-05-08,1972,DK 302165 A,1965-06-16,GB 2532664 A,1964-06-18,Hydraulisk system.,,CASTROL LTD,CLARKE J;;BURT P;;KER R;;CARSWELL R,,https://lens.org/132-752-102-618-986,Patent Application,no,0,0,8,9,0,C10M105/36;;C10M105/36;;C10M2201/08;;C10M2201/08;;C10M2201/081;;C10M2201/081;;C10M2201/082;;C10M2201/082;;C10M2201/083;;C10M2201/083;;C10M2201/084;;C10M2201/084;;C10M2207/024;;C10M2207/024;;C10M2207/026;;C10M2207/026;;C10M2207/123;;C10M2207/123;;C10M2207/125;;C10M2207/125;;C10M2207/129;;C10M2207/129;;C10M2207/22;;C10M2207/22;;C10M2207/282;;C10M2207/282;;C10M2207/287;;C10M2207/287;;C10M2207/288;;C10M2207/288;;C10M2207/34;;C10M2207/34;;C10M2207/40;;C10M2207/40;;C10M2207/402;;C10M2207/402;;C10M2207/404;;C10M2207/404;;C10M2209/103;;C10M2209/103;;C10M2209/104;;C10M2209/104;;C10M2209/105;;C10M2209/105;;C10M2209/106;;C10M2209/106;;C10M2209/107;;C10M2209/107;;C10M2209/108;;C10M2209/108;;C10M2209/109;;C10M2209/109;;C10M2215/04;;C10M2215/04;;C10M2215/042;;C10M2215/042;;C10M2215/044;;C10M2215/044;;C10M2215/06;;C10M2215/06;;C10M2215/064;;C10M2215/064;;C10M2215/065;;C10M2215/065;;C10M2215/22;;C10M2215/22;;C10M2215/221;;C10M2215/221;;C10M2215/225;;C10M2215/225;;C10M2215/226;;C10M2215/226;;C10M2215/26;;C10M2215/26;;C10M2215/30;;C10M2215/30;;C10M2219/082;;C10M2219/082;;C10M2219/10;;C10M2219/10;;C10M2219/102;;C10M2219/102;;C10M2219/104;;C10M2219/104;;C10M2219/106;;C10M2219/106;;C10M2219/108;;C10M2219/108;;C10M2223/04;;C10M2223/04;;C10M2223/041;;C10M2223/041;;C10M2223/042;;C10M2223/042;;C10M2227/061;;C10M2227/061;;C10N2010/02;;C10N2010/02;;C10N2020/01;;C10N2020/01;;C10N2040/08;;C10N2040/08,C10M105/36,23C5,0,0,,,,DISCONTINUED
267,AU,B2,AU 627026 B2,032-578-910-900-430,1992-08-13,1992,AU 1990/055197 A,1990-05-18,US 35388189 A,1989-05-18,LID DISPENSER FOR AN AUTOMATED DRINKMAKER SYSTEM,,PEPSICO INC,BROGNA SALVATORE J;;RIEHM GEORGE E;;SHULMAN BURT,,https://lens.org/032-578-910-900-430,Granted Patent,no,0,0,9,9,0,B65B7/2807;;B65B7/2807;;B67D2210/00076;;B67D2210/00076;;G07F13/10;;G07F13/10,B67B1/10;;B65B7/28;;B67D1/00;;G07F13/10,,0,0,,,,EXPIRED
268,US,A1,US 2007/0050278 A1,041-859-248-667-757,2007-03-01,2007,US 21105805 A,2005-08-24,US 21105805 A,2005-08-24,Trading rights facility,"The trading rights facility of the present invention comprises guaranteeing an access for the quantity and price of a potential imbalanced or complex order, which price is acceptable to both the buyer, the seller, and the market as a whole; and agreeing to fully deliver the quantities at the discovered price within a pre-set delayed time frame. In effect, the trading rights facility of the present invention creates a secondary “liquidity base” that augments the ordinary access liquidity base, and allows for that initial liquidity base to remain untouched by the complex order itself, which is in sharp contrast to current experience where it would take all and ask for more. The initial liquidity base would be there to cushion the access community. The complex access would be at a premium to current market price and would be competitively bid in relation to the whole of the initial liquidity base environment. The trading rights facility of the present invention ensures the transparency of all operations. The trading rights facility of the present invention further allows for the creation for a variable access index product that also provides a supply zero sum diffusion base. In a further embodiment, the trading rights facility of the present invention allows a contract on a settlement price to be traded before the settlement price has been derived.",STEIDLMAYER J P;;BRONSTEIN KEITH D;;GUTTERMAN BURT,STEIDLMAYER J P;;BRONSTEIN KEITH D;;GUTTERMAN BURT,,https://lens.org/041-859-248-667-757,Patent Application,yes,19,8,1,2,0,G06Q40/04;;G06Q40/04,G06Q40/00,705/37,0,0,,,,DISCONTINUED
269,EP,A2,EP 2450592 A2,161-869-267-908-878,2012-05-09,2012,EP 11007173 A,2011-09-05,US 94074410 A,2010-11-05,Dampening device,"An assembly for dampening vibration movement between a cylinder 12 and a concentric duct 14, where the cylinder is positioned radially inside the duct, includes a damper 14 attached to the duct. The damper includes a housing 18 attached to the duct, a contact member 20 positioned at least partially inside the housing and having a contact surface adjacent an outer surface of the cylinder, and a cap 24 threadedly engaged with the housing for applying a load on the contact member in a direction toward the cylinder.
",UNITED TECHNOLOGIES CORP,BURT JONATHAN P;;BAUER STEVEN J;;JONES JAMES,"RAYTHEON TECHNOLOGIES CORPORATION (N.D.GES.D.S, US (2022-09-23);;UNITED TECHNOLOGIES CORPORATION (2016-10-26)",https://lens.org/161-869-267-908-878,Patent Application,yes,0,1,5,5,0,F16F15/021;;F16F15/021;;F01D25/164;;F01D25/164;;F16F9/34;;F16F9/34,F16F9/34;;F01D25/16;;F16F15/02,,0,0,,,,ACTIVE
270,CA,A1,CA 2016804 A1,070-123-652-402-718,1990-11-18,1990,CA 2016804 A,1990-05-15,US 35388189 A,1989-05-18,LID DISPENSER FOR AN AUTOMATED DRINKMAKER SYSTEM,"-34-ABSTRACT OF THE DISCLOSURE An automatic lid dispensing and applicator arrangement for an automated drinkmaker machine. The lidding arrangement automatically separates lids from a stack of lids and applies the separated lids onto cups. A large supply of lids is maintained in a rotatable lid supply carousel which periodically resupplies lids to a lid dispenser which supports a stack of lids to be dispensed. A lid shuttle is positioned adjacent the bottom of the lid dispenser, and is supported for linear translating and reciprocating movement between retracted and extended positions. The lid shuttle supports a lid engaging member designed to engage a first bottommost lid of the stack of lids and to retain the first bottommost lid in a first intermediate position in the lid shuttle while the lid shuttle is moved in translation to its extended position. The lid shuttle is then moved in translation to its retracted position, during which the first lid is moved within the lid shuttle to a second loaded position therein beneath a lid applicator supported by the lid shuttle. The lid shuttle is then moved to its extended position, during which the first lid remains in the second loaded position while the lid engaging member simultaneously engages a second bottommost lid of the lid stack and retains the second lid in the first intermediate position in the lid shuttle. The lid shuttle is then moved in translation to its retracted position, during which the lid applicator presses and applies the first lid onto a cup positioned therebeneath, and the second lid is moved within the lid shuttle to the second loaded position. The cycle is then repeated for subsequent lids during linear translating and reciprocating movements of the lid shuttle.",PEPSICO INC,BROGNA SALVATORE J;;RIEHM GEORGE E;;SHULMAN BURT,,https://lens.org/070-123-652-402-718,Patent Application,no,0,0,9,9,0,B65B7/2807;;B67D2210/00076;;G07F13/10;;G07F13/10;;B67D2210/00076;;B65B7/2807,B67B1/10;;B65B7/28;;B67D1/00;;G07F13/10,D122200078   M;;2210134    S,0,0,,,,DISCONTINUED
271,US,A,US 2060025 A,174-183-217-574-326,1936-11-10,1936,US 458435 A,1935-02-01,US 458435 A,1935-02-01,Vibrator power supply system,,RCA CORP,BURT ALEXANDER D;;ROHNER ARNOLD J;;FREDERIC SHOUP,,https://lens.org/174-183-217-574-326,Granted Patent,no,0,4,1,1,0,H02M3/42;;H02M3/42,H02M3/42,,0,0,,,,EXPIRED
272,US,A,US 4949526 A,172-576-321-681-556,1990-08-21,1990,US 35388189 A,1989-05-18,US 35388189 A,1989-05-18,Lid dispenser for an automated drinkmaker system,"An automatic lid dispensing and applicator arrangement for an automated drinkmaker machine. The lidding arrangement automatically separates lids from a stack of lids and applies the separated lids onto cups. A large supply of lids is maintained in a rotatable lid supply carousel. A lid shuttle is positioned adjacent the bottom of a lid dispenser, and is supported for linear translating and reciprocating movement between retracted and extended positions. The lid shuttle supports a lid engaging member designed to engage a first bottommost lid of the stack of lids and to retain the first bottommost lid in a first intermediate position in the lid shuttle while the lid shuttle is moved in translation to its extended position. The lid shuttle is then moved in translation to its retracted position, during which the first lid is moved within the lid shuttle to a second loaded position therein beneath a lid applicator supported by the lid shuttle. The lid shuttle is then moved to its extended position, during which the first lid remains in the second loaded position while the lid engaging member simultaneously engages a second bottommost lid of the lid stack and retains the second lid in the first intermediate position in the lid shuttle. The lid shuttle is then moved in translation to its retracted position, during which the lid applicator presses and applies the first lid onto a cup positioned therebeneath, and the second lid is moved within the lid shuttle to the second loaded position.",PEPSICO INC,BROGNA SALVATORE J;;RIEHM GEORGE E;;SHULMAN BURT,CONNECTICUT INNOVATIONS INCORPORATED (1995-02-17);;PEPSICO INC. A CORP. OF NC (1989-05-16),https://lens.org/172-576-321-681-556,Granted Patent,yes,16,69,9,9,0,B65B7/2807;;B65B7/2807;;B67D2210/00076;;B67D2210/00076;;G07F13/10;;G07F13/10,B67B1/10;;B65B7/28;;B67D1/00;;G07F13/10,53/306;;53/314;;53/315;;53/310;;221/11;;221/22;;221/104;;221/240;;221/268,0,0,,,,EXPIRED
273,DE,A1,DE 4016093 A1,113-621-067-448-301,1990-11-22,1990,DE 4016093 A,1990-05-18,US 35388189 A,1989-05-18,DECKELAUSGEBER FUER EIN AUTOMATISIERTES GETRAENKEHERSTELLSYSTEM,,PEPSICO INC,BROGNA SALVATORE J;;RIEHM GEORGE E;;SHULMAN BURT,,https://lens.org/113-621-067-448-301,Patent Application,no,0,2,9,9,0,B65B7/2807;;B65B7/2807;;B67D2210/00076;;B67D2210/00076;;G07F13/10;;G07F13/10,B67B1/10;;B65B7/28;;B67D1/00;;G07F13/10,,0,0,,,,DISCONTINUED
274,US,A1,US 2007/0055608 A1,145-318-145-345-455,2007-03-08,2007,US 37690906 A,2006-03-16,US 37690906 A;;US 21105805 A,2005-08-24,Trading rights facility,"The trading rights facility of the present invention comprises guaranteeing an access for the quantity and price of a potential imbalanced or complex order, which price is acceptable to both the buyer and the seller, and to the market as a whole; and agreeing to fully deliver the quantities at the discovered price within a pre-set delayed time frame. In effect, the trading rights facility of the present invention creates a secondary “liquidity base” that augments the ordinary access liquidity base, and allows for that initial liquidity base to remain untouched by the complex order itself, which is in sharp contrast to current experience where it would take all and ask for more. The initial liquidity base would be there to cushion the access community. The complex access would be at a premium to current market price and would be competitively bid in relation to the whole of the initial liquidity base environment. The trading rights facility of the present invention ensures the transparency of all operations. The trading rights facility of the present invention further allows for the creation for a variable access index product that also provides a supply zero sum diffusion base. In a further embodiment, the trading rights facility of the present invention allows a contract on a settlement price to be traded before the settlement price has been derived. Where a premium based transaction introduces a new third party to the trading mix whose role is limited to that of just the differential and not to the remaining structural balance, the trading rights facility of the present invention retains the right to eliminate the time cost necessity of such third parties to remain in the initial structure by cashing out such third party differentials without impairing transactional integrity.",STEIDLMAYER J P;;BRONSTEIN KEITH D;;GUTTERMAN BURT,STEIDLMAYER J P;;BRONSTEIN KEITH D;;GUTTERMAN BURT,,https://lens.org/145-318-145-345-455,Patent Application,yes,23,10,1,2,0,G06Q40/04;;G06Q40/04,G06Q40/00,705/37,0,0,,,,DISCONTINUED
275,DE,T2,DE 60314758 T2,184-449-254-752-994,2008-04-10,2008,DE 60314758 T,2003-06-09,GB 0215269 A;;GB 0302460 W,2002-07-03,LASERSCHWEISSVERFAHREN ZUR PLASMAVERHINDERUNG,,ROLLS ROYCE PLC,BURT PAUL;;GRIFFITH ANTHONY J;;GREEN ANDREW P,,https://lens.org/184-449-254-752-994,Granted Patent,no,0,0,11,11,0,B23K26/147;;B23K26/18;;B23K26/702;;B23K26/1437;;B23K26/1438;;B23K26/147;;B23K26/18;;B23K26/702;;B23K26/1437;;B23K26/1438,B23K26/14;;B23K26/16;;B23K26/18;;B23K26/42,,0,0,,,,EXPIRED
276,CA,A,CA 1018169 A,035-150-142-089-615,1977-09-27,1977,CA 182301 A,1973-10-01,US 29386372 A,1972-10-02,2-(2-PYRIDYL) -X-UPHENYLALKYLAMINES,,ROBINS CO INC A H,WELSTEAD WILLIAM J JR;;MERRIMAN BURT T JR,,https://lens.org/035-150-142-089-615,Granted Patent,no,0,0,28,34,0,C07D213/16;;C07D213/26;;C07D213/38;;C07D213/57;;A61P1/00;;C07D213/16;;C07D213/26;;C07D213/38;;C07D213/57,A61K31/44;;A61K31/4402;;A61K31/4418;;A61P1/00;;C07D213/16;;C07D213/26;;C07D213/38;;C07D213/57,260-278.2,0,0,,,,EXPIRED
277,US,A1,US 2012/0112394 A1,047-816-393-482-925,2012-05-10,2012,US 94074410 A,2010-11-05,US 94074410 A,2010-11-05,DAMPENING DEVICE,"An assembly for dampening vibration movement between a cylinder and a concentric duct, where the cylinder is positioned radially inside the duct, includes a damper attached to the duct. The damper includes a housing attached to the duct, a contact member positioned at least partially inside the housing and having a contact surface adjacent an outer surface of the cylinder, and a cap threadedly engaged with the housing for applying a load on the contact member in a direction toward the cylinder.",BURT JONATHAN P;;JONES JAMES;;BAUER STEVEN J;;UNITED TECHNOLOGIES CORP,BURT JONATHAN P;;JONES JAMES;;BAUER STEVEN J,RTX CORPORATION (2010-10-13),https://lens.org/047-816-393-482-925,Patent Application,yes,7,2,5,5,0,F16F15/021;;F16F15/021;;F01D25/164;;F01D25/164;;F16F9/34;;F16F9/34,F16F7/00,267/136,0,0,,,,ACTIVE
278,US,A,US 3818712 A,014-125-383-435-404,1974-06-25,1974,US 27031572 A,1972-07-10,US 27031572 A,1972-07-10,FROZEN EMBANKMENTS,"Improved particulate embankment structures for use in cold environments and on frozen terrain are described together with methods of construction; generally involving the introduction of up to a prescribed amount of moisture homogeneously dispersed throughout the particulate embankment such as to maximize the ice content thereof yet without appreciably moving the particles relative to one another or risking any such moving subsequently such as frost heaves, subsidence or the like. Also described are methods and arrangements for coating terrestrial and similar substrates with urethane foam and like materials. Various aspects of the preferred methods are illustratively described such as the application of foams in a laminate form; the application of a petroleum base pre-coating or similar moisture barrier; the application of petroleum based super-coatings or similar sealant; subjection of the foam and related coatings to certain heating during application; and the ""staggering"" of successive foam layers.",ATLANTIC RICHFIELD CO,BURT G;;CONDO A;;ELIASON K;;MCCORMACK J,,https://lens.org/014-125-383-435-404,Granted Patent,no,6,8,2,3,0,E02D17/18;;E02D27/32;;E02D27/32;;E02D17/18,E02D17/18;;E02D27/32,061-050,0,0,,,,EXPIRED
279,US,B2,US 7241965 B2,045-843-305-734-514,2007-07-10,2007,US 51935904 A,2004-12-28,GB 0215269 A;;GB 0302460 W,2002-07-03,Method and apparatus for laser welding with plasma suppression,"Laser welding apparatus, in which a laser beam is impinged upon a component to be welded at a laser beam impingement point, wherein a plasma suppressor is arranged to impinge a jet of gas on the component at an angle to its surface, flowing towards the laser beam impingement point.",ROLLS ROYCE PLC,BURT PAUL;;GRIFFITH ANTHONY J;;GREEN ANDREW P,ROLLS-ROYCE PLC (2003-03-17),https://lens.org/045-843-305-734-514,Granted Patent,yes,13,12,11,11,0,B23K26/147;;B23K26/18;;B23K26/702;;B23K26/1437;;B23K26/1438;;B23K26/147;;B23K26/18;;B23K26/702;;B23K26/1437;;B23K26/1438,B23K26/24;;B23K26/14;;B23K26/16;;B23K26/18;;B23K26/42,219/121.63;;219/121.64;;219/121.84,0,0,,,,EXPIRED
280,US,A1,US 2005/0152919 A1,083-875-163-376-524,2005-07-14,2005,US 94163404 A,2004-09-15,US 94163404 A;;US 50311403 P,2003-09-15,Measles subunit vaccine,"Compositions and methods for making and using therapeutic formulations of measles virus antigens with a Proteosome-based adjuvant are provided. The measles virus antigens may be derived from a variety of sources, such as from recombinant production or from a split antigen preparation. The measles vaccine formulations may be used, for example, in methods for treating or preventing a measles virus infection and eliciting a protective immune response.",UNIV MCGILL,WARD BRIAN J;;BURT DAVID S;;CHABOT SOPHIE,MCGILL UNIVERSITY (2005-01-07);;ID BIOMEDICAL CORPORATION OF QUEBEC (2005-01-13),https://lens.org/083-875-163-376-524,Patent Application,yes,13,29,6,6,0,A61K39/165;;A61K39/39;;A61K2039/53;;A61K2039/54;;A61K2039/541;;A61K2039/543;;A61K2039/55511;;A61K2039/55516;;A61K2039/55572;;C07K16/1027;;C12N2760/18434;;A61K39/12;;A61P31/12;;A61P31/14;;A61P37/04;;C07K16/1027;;A61K39/165;;A61K2039/55516;;A61K2039/54;;A61K2039/53;;A61K2039/55572;;A61K2039/541;;A61K2039/55511;;A61K2039/543;;A61K39/39;;C12N2760/18434;;A61K39/12,A61K39/165;;A61K39/295;;A61K39/39;;A61P31/14;;C07K16/10,424/212.1;;514/54;;424/201.1,0,0,,,,DISCONTINUED
281,CA,A1,CA 2538887 A1,125-172-610-546-769,2005-03-31,2005,CA 2538887 A,2004-09-15,US 50311403 P;;US 2004/0030361 W,2003-09-15,MEASLES SUBUNIT VACCINE,"Compositions and methods for making and using therapeutic formulations of measles virus antigens with a Proteosome-based adjuvant are provided. The measles virus antigens may be derived from a variety of sources, such as fro m recombinant production or from a split antigen preparation. The measles vaccine formulations may be used, for example, in methods for treating or preventing a measles virus infection and eliciting a protective immune response.",ID BIOMEDICAL CORP QUEBEC;;UNIV MCGILL,BURT DAVID S;;CHABOT SOPHIE;;WARD BRIAN J,,https://lens.org/125-172-610-546-769,Patent Application,no,0,0,6,6,0,A61K39/165;;A61K39/39;;A61K2039/53;;A61K2039/54;;A61K2039/541;;A61K2039/543;;A61K2039/55511;;A61K2039/55516;;A61K2039/55572;;C07K16/1027;;C12N2760/18434;;A61K39/12;;A61P31/12;;A61P31/14;;A61P37/04;;C07K16/1027;;A61K39/165;;A61K2039/55516;;A61K2039/54;;A61K2039/53;;A61K2039/55572;;A61K2039/541;;A61K2039/55511;;A61K2039/543;;A61K39/39;;C12N2760/18434;;A61K39/12,A61K39/165;;A61K39/295;;A61K39/39;;A61P31/14;;C07K16/10,,0,0,,,,DISCONTINUED
282,EP,A1,EP 1539419 A1,024-408-107-258-424,2005-06-15,2005,EP 03740705 A,2003-06-09,GB 0302460 W;;GB 0215269 A,2002-07-03,LASER WELDING METHOD FOR SUPPRESSING PLASMA,,ROLLS ROYCE PLC,BURT PAUL;;GRIFFITH ANTHONY J;;GREEN ANDREW P,,https://lens.org/024-408-107-258-424,Patent Application,yes,0,0,11,11,0,B23K26/147;;B23K26/18;;B23K26/702;;B23K26/1437;;B23K26/1438;;B23K26/147;;B23K26/18;;B23K26/702;;B23K26/1437;;B23K26/1438,B23K26/14;;B23K26/16;;B23K26/18;;B23K26/42,,0,0,,,,EXPIRED
283,WO,A1,WO 2004/004965 A1,160-907-300-230-754,2004-01-15,2004,GB 0302460 W,2003-06-09,GB 0215269 A,2002-07-03,LASER WELDING METHOD AND APPARATUS FOR SUPPRESSING PLASMA,"Laser welding apparatus (12), in which a laser beam (14) is impinged upon a component (2) to be welded at a laser beam impingement point (18), wherein plasma suppression means (30) is arranged to impinge a jet of gas on the component (2) at an angle to its surface, flowing towards the laser beam impingement point (18).",ROLLS ROYCE PLC A BRITISH COMP;;BURT PAUL;;GRIFFITH ANTHONY J;;GREEN ANDREW P,BURT PAUL;;GRIFFITH ANTHONY J;;GREEN ANDREW P,,https://lens.org/160-907-300-230-754,Patent Application,yes,6,0,11,11,0,B23K26/147;;B23K26/18;;B23K26/702;;B23K26/1437;;B23K26/1438;;B23K26/147;;B23K26/18;;B23K26/702;;B23K26/1437;;B23K26/1438,B23K26/14;;B23K26/16;;B23K26/18;;B23K26/42,,4,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1997, no. 01 31 January 1997 (1997-01-31);;PATENT ABSTRACTS OF JAPAN vol. 009, no. 098 (M - 375) 27 April 1985 (1985-04-27);;PATENT ABSTRACTS OF JAPAN vol. 009, no. 179 (M - 399) 24 July 1985 (1985-07-24);;PATENT ABSTRACTS OF JAPAN vol. 2000, no. 12 3 January 2001 (2001-01-03)",PATENTED
284,EP,A3,EP 2450592 A3,175-337-867-495-836,2015-06-17,2015,EP 11007173 A,2011-09-05,US 94074410 A,2010-11-05,Dampening device,"An assembly for dampening vibration movement between a cylinder 12 and a concentric duct 14, where the cylinder is positioned radially inside the duct, includes a damper 14 attached to the duct. The damper includes a housing 18 attached to the duct, a contact member 20 positioned at least partially inside the housing and having a contact surface adjacent an outer surface of the cylinder, and a cap 24 threadedly engaged with the housing for applying a load on the contact member in a direction toward the cylinder.
",UNITED TECHNOLOGIES CORP,BURT JONATHAN P;;BAUER STEVEN J;;JONES JAMES,"RAYTHEON TECHNOLOGIES CORPORATION (N.D.GES.D.S, US (2022-09-23);;UNITED TECHNOLOGIES CORPORATION (2016-10-26)",https://lens.org/175-337-867-495-836,Search Report,yes,3,0,5,5,0,F16F15/021;;F16F15/021;;F01D25/164;;F01D25/164;;F16F9/34;;F16F9/34,F16F9/34;;F01D25/16;;F16F15/02,,0,0,,,,ACTIVE
285,US,A1,US 2009/0175903 A1,087-863-896-059-953,2009-07-09,2009,US 18204708 A,2008-07-29,US 18204708 A;;US 94163404 A;;US 50311403 P,2003-09-15,MEASLES SUBUNIT VACCINE,"Compositions and methods for making and using therapeutic formulations of measles virus antigens with a Proteosome-based adjuvant are provided. The measles virus antigens may be derived from a variety of sources, such as from recombinant production or from a split antigen preparation. The measles vaccine formulations may be used, for example, in methods for treating or preventing a measles virus infection and eliciting a protective immune response.",ID BIOMEDICAL CORP QUEBEC;;UNIV MCGILL,WARD BRIAN J;;BURT DAVID S;;CHABOT SOPHIE,MCGILL UNIVERSITY (2009-04-04),https://lens.org/087-863-896-059-953,Patent Application,yes,0,4,6,6,0,A61K39/165;;A61K39/39;;A61K2039/53;;A61K2039/54;;A61K2039/541;;A61K2039/543;;A61K2039/55511;;A61K2039/55516;;A61K2039/55572;;C07K16/1027;;C12N2760/18434;;A61K39/12;;A61P31/12;;A61P31/14;;A61P37/04;;C07K16/1027;;A61K39/165;;A61K2039/55516;;A61K2039/54;;A61K2039/53;;A61K2039/55572;;A61K2039/541;;A61K2039/55511;;A61K2039/543;;A61K39/39;;C12N2760/18434;;A61K39/12,A61K39/295;;A61K39/165;;A61K39/39;;A61P31/14;;A61P37/04;;C07K16/10,424/201.1;;424/212.1;;424/202.1,0,0,,,,DISCONTINUED
286,AU,A1,AU 2003/281350 A1,163-602-820-679-944,2004-01-23,2004,AU 2003/281350 A,2003-06-09,GB 0215269 A;;GB 0302460 W,2002-07-03,LASER WELDING METHOD AND APPARATUS FOR SUPPRESSING PLASMA,,ROLLS ROYCE PLC A BRITISH COMP,BURT PAUL;;GRIFFITH ANTHONY J;;GREEN ANDREW P,,https://lens.org/163-602-820-679-944,Patent Application,no,0,1,11,11,0,B23K26/147;;B23K26/18;;B23K26/702;;B23K26/1437;;B23K26/1438;;B23K26/147;;B23K26/18;;B23K26/702;;B23K26/1437;;B23K26/1438,B23K26/14;;B23K26/16;;B23K26/18;;B23K26/42,,0,0,,,,DISCONTINUED
287,GB,B,GB 2233637 B,087-021-566-589-838,1993-05-12,1993,GB 9010937 A,1990-05-16,US 35388189 A,1989-05-18,LID DISPENSER FOR AN AUTOMATED DRINKMAKER SYSTEM,,PEPSICO INC,BROGNA SALVATORE J;;RIEHM GEORGE E;;SHULMAN BURT,,https://lens.org/087-021-566-589-838,Granted Patent,no,0,0,9,9,0,B65B7/2807;;B65B7/2807;;B67D2210/00076;;B67D2210/00076;;G07F13/10;;G07F13/10,B67B1/10;;B65B7/28;;B67D1/00;;G07F13/10,B8U UAD           UAD;;U1S S1811;;U1S S1877,0,0,,,,EXPIRED
288,CA,A,CA 369659 A,187-336-161-947-23X,1937-11-02,1937,CA 369659D A,,CA 369659T A,,VIBRATION POWER SUPPLY SYSTEM,,RCA CORP,ROHNER ARNOLD J;;SHOUP FREDERIC;;BURT ALEXANDER D,,https://lens.org/187-336-161-947-23X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
289,EP,B1,EP 2450592 B1,010-082-376-804-416,2019-08-21,2019,EP 11007173 A,2011-09-05,US 94074410 A,2010-11-05,Dampening device,,UNITED TECHNOLOGIES CORP,BURT JONATHAN P;;BAUER STEVEN J;;JONES JAMES,"RAYTHEON TECHNOLOGIES CORPORATION (N.D.GES.D.S, US (2022-09-23);;UNITED TECHNOLOGIES CORPORATION (2016-10-26)",https://lens.org/010-082-376-804-416,Granted Patent,yes,3,0,5,5,0,F16F9/34;;F01D25/164;;F16F15/021;;F16F9/34;;F01D25/164;;F16F15/021,F16F9/34;;F01D25/16;;F16F15/02,,0,0,,,,ACTIVE
290,US,A1,US 2005/0005202 A1,031-842-340-266-40X,2005-01-06,2005,US 71878103 A,2003-11-20,US 71878103 A;;US 42858802 P,2002-11-22,Proactive support of a healthcare information system,"Systems and methods are provided for proactively monitoring a healthcare information system. The monitor system has a plurality of counters and one or more notification agents. Counters monitor performance parameters by recording the values of the parameters at a predetermined interval. Multiple counter instances may be implemented. Agents notify designated representatives when the value of a counter exceeds a threshold. Notifications may be escalated as needed. The proactive monitor system may further include an operator capable of performing fixes to bring the value of the counter back within the threshold. Two user interfaces may be included, connecting to a customer support system and a user of the healthcare information system, respectively. The proactive detection, notification, and repair of business or system failures may be performed manually or automatically, onsite or over a network.",BURT CHRISTOPHER J.;;LAWTON KYLE W.;;KEEN RONALD,BURT CHRISTOPHER J;;LAWTON KYLE W;;KEEN RONALD,IDX SYSTEMS CORPORATION (2004-03-31),https://lens.org/031-842-340-266-40X,Patent Application,yes,5,13,5,5,0,G06Q10/10;;G06Q10/10,G06Q10/10,714/47,0,0,,,,DISCONTINUED
291,EP,A1,EP 1667713 A1,091-690-842-681-925,2006-06-14,2006,EP 04784276 A,2004-09-15,US 2004/0030361 W;;US 50311403 P,2003-09-15,MEASLES SUBUNIT VACCINE,,ID BIOMEDICAL CORP QUEBEC;;UNIV MCGILL,BURT DAVID S;;WARD BRIAN J;;CHABOT SOPHIE,,https://lens.org/091-690-842-681-925,Patent Application,yes,0,0,6,6,0,A61K39/165;;A61K39/39;;A61K2039/53;;A61K2039/54;;A61K2039/541;;A61K2039/543;;A61K2039/55511;;A61K2039/55516;;A61K2039/55572;;C07K16/1027;;C12N2760/18434;;A61K39/12;;A61P31/12;;A61P31/14;;A61P37/04;;C07K16/1027;;A61K39/165;;A61K2039/55516;;A61K2039/54;;A61K2039/53;;A61K2039/55572;;A61K2039/541;;A61K2039/55511;;A61K2039/543;;A61K39/39;;C12N2760/18434;;A61K39/12,A61K39/165;;A61K39/295;;A61K39/39;;A61P31/14;;C07K16/10,,0,0,,,,DISCONTINUED
292,EP,B1,EP 1539419 B1,098-146-536-411-930,2007-07-04,2007,EP 03740705 A,2003-06-09,GB 0302460 W;;GB 0215269 A,2002-07-03,LASER WELDING METHOD FOR SUPPRESSING PLASMA,,ROLLS ROYCE PLC,BURT PAUL;;GRIFFITH ANTHONY J;;GREEN ANDREW P,,https://lens.org/098-146-536-411-930,Granted Patent,yes,6,0,11,11,0,B23K26/147;;B23K26/18;;B23K26/702;;B23K26/1437;;B23K26/1438;;B23K26/147;;B23K26/18;;B23K26/702;;B23K26/1437;;B23K26/1438,B23K26/14;;B23K26/16;;B23K26/18;;B23K26/42,,4,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1997, no. 01, 31 January 1997 (1997-01-31) & JP 08 238587 A (NISSHIN STEEL CO LTD), 17 September 1996 (1996-09-17);;PATENT ABSTRACTS OF JAPAN vol. 009, no. 098 (M-375), 27 April 1985 (1985-04-27) & JP 59 223191 A (RYOMEI ENG CORP LTD), 14 December 1984 (1984-12-14);;PATENT ABSTRACTS OF JAPAN vol. 009, no. 179 (M-399), 24 July 1985 (1985-07-24) & JP 60 049887 A (MITSUBISHI MOTORS CORP), 19 March 1985 (1985-03-19);;PATENT ABSTRACTS OF JAPAN vol. 2000, no. 12, 3 January 2001 (2001-01-03) & JP 2000 263276 A (SEKISUI CHEM CO LTD), 26 September 2000 (2000-09-26)",EXPIRED
293,US,A1,US 2014/0101970 A1,110-762-591-926-998,2014-04-17,2014,US 201314136075 A,2013-12-20,US 201314136075 A;;US 69533210 A;;US 14802209 P,2009-01-28,Replaceable Traction Cleat for Footwear,Adjustable traction is provided in a traction cleat by selectively restricting or not the amount of flexure permitted for a dynamic traction element on the cleat. Restricting flexure is alternatively achieved by an adjustably positionable ring or by rotating the cleat to align the dynamic element with different shoe sole topographical features. A dual locking post is provided to reduce the surface area required on the cleat hub for locking structures. The cleat is formed in a two shot molding process that permits elongations of the dynamic traction elements without sacrificing the integrity of the cleat structure.,PRIDE MFG CO LLC,KRIKORIAN RAND J;;BURT JOHN ROBERT;;MCMULLIN FARIS W,,https://lens.org/110-762-591-926-998,Patent Application,yes,16,2,9,9,0,A43C15/162;;A43C15/16;;A43C15/162;;A43C15/168;;A43B5/00;;A43C15/161,A43C15/16,36/61,0,0,,,,DISCONTINUED
294,US,A1,US 2010/0186262 A1,126-396-379-724-76X,2010-07-29,2010,US 69533210 A,2010-01-28,US 69533210 A;;US 14802209 P,2009-01-28,Replaceable Traction Cleat for Footwear,Adjustable traction is provided in a traction cleat by selectively restricting or not the amount of flexure permitted for a dynamic traction element on the cleat. Restricting flexure is alternatively achieved by an adjustably positionable ring or by rotating the cleat to align the dynamic element with different shoe sole topographical features. A dual locking post is provided to reduce the surface area required on the cleat hub for locking structures. The cleat is formed in a two shot molding process that permits elongations of the dynamic traction elements without sacrificing the integrity of the cleat structure.,SOFTSPIKES LLC,KRIKORIAN RAND J;;BURT JOHN ROBERT;;MCMULLIN FARIS W,PRIDE MANUFACTURING COMPANY LLC (2010-04-13),https://lens.org/126-396-379-724-76X,Patent Application,yes,21,8,9,9,0,A43C15/162;;A43C15/16;;A43C15/162;;A43C15/168;;A43B5/00;;A43C15/161,A43C15/00;;A43B5/00;;A43D11/00,36/134;;X 12146  R;;X 36 67  D,0,0,,,,ACTIVE
295,US,B1,US 8990463 B1,131-932-302-505-355,2015-03-24,2015,US 201314139931 A,2013-12-24,US 201314139931 A;;US 92570910 A,2010-10-28,Transfer of data storage device features,"Transferring storage device functionality includes providing a device coupled to the storage device, where the device is separate from the storage device, having the device handle I/O requests between an application and the storage device, and, in response to the application issuing an I/O request, having the device determine if the request corresponds to functionality being transferred and, if so, having the device provide the functionality. The device may be a host computer. The application may run on the host computer. A driver on the host computer may provide the functionality. The functionality may include read only functionality, data compression, data encryption, mirroring, and/or status reporting.",EMC CORP,LECRONE DOUGLAS E;;LINSTEAD PAUL A;;BURT DENIS J,EMC CORPORATION (2010-10-28);;EMC IP HOLDING COMPANY LLC (2016-09-06),https://lens.org/131-932-302-505-355,Granted Patent,yes,2,0,2,2,0,G06F3/0664;;G06F3/0605;;G06F3/0653;;G06F3/0661;;G06F3/0689;;G06F11/3485;;G06F11/2056;;G06F11/3433;;G06F3/0661;;G06F3/0605;;G06F3/0653;;G06F3/0664;;G06F3/0689;;G06F11/2056;;G06F11/3485;;G06F11/3433;;G06F30/20,G06F3/00;;G06F13/00;;G06F13/38;;G06F17/50,710/74;;710/33;;710/15,0,0,,,,ACTIVE
296,CA,A,CA 571509 A,123-787-387-606-252,1959-03-03,1959,CA 571509D A,,CA 571509T A,,CROSS-LINKED COPOLYMERS OF ETHYLENE WITH AN ALKYL ACRYLATE AND AN ALKYL MONOESTER,,DU PONT,PRATT BURT C;;PINKNEY PAUL S;;WAYNE WINSTON J,,https://lens.org/123-787-387-606-252,Granted Patent,no,0,2,1,1,0,,,,0,0,,,,EXPIRED
297,EP,A4,EP 1735429 A4,134-824-261-326-57X,2008-06-11,2008,EP 05732221 A,2005-03-31,US 2005/0010610 W;;US 55801804 P,2004-03-31,METHODS AND COMPOSITIONS FOR OBTAINING HEMATOPOIETIC STEM CELLS DERIVED FROM EMBRYONIC STEM CELLS AND USES THEREOF,,NEWLINK GENETICS CORP,BURT RICHARD K;;VERDA LARISSA;;LINK CHARLES J JR,,https://lens.org/134-824-261-326-57X,Search Report,no,2,0,5,5,0,A61K2035/122;;A61K2035/124;;C12N5/0647;;C12N2501/125;;C12N2501/23;;C12N2506/02;;C12N2533/70;;C12N5/0647;;C12N2506/02;;A61K2035/124;;C12N2533/70;;A61K2035/122;;C12N2501/125;;C12N2501/23,C12N5/00;;A61K35/12;;C12N5/02;;C12N5/0789;;C12N5/10,,1,1,000-144-975-304-518,15051761;;10.1084/jem.20031916;;pmc2211878,"BURT RICHARD K ET AL: ""Embryonic stem cells as an alternate marrow donor source: engraftment without graft-versus-host disease."", THE JOURNAL OF EXPERIMENTAL MEDICINE 5 APR 2004, vol. 199, no. 7, 29 March 2004 (2004-03-29) - 5 April 2004 (2004-04-05), pages 895 - 904, XP002477811, ISSN: 0022-1007",DISCONTINUED
298,US,B2,US 6750276 B2,054-516-859-855-455,2004-06-15,2004,US 9903602 A,2002-03-15,US 9903602 A;;US 69213896 A,1996-08-05,Waterborne soft-feeling coating composition with high gloss,"
    A waterborne, soft feeling coating composition and a substrate coated with the composition. The coating composition comprises an aqueous solvent, a resin, and an alcohol alkoxylate surfactant. The invention is also directed to a process of making the waterborne coating composition of the invention, and a process of coating a substrate with the waterborne coating composition. 
",ARCH CHEM INC,RUGGIERO MURRAY A;;CHUBB HAROLD W;;BURT DIANE J,MONUMENT CHEMICAL KENTUCKY LLC (2012-12-27),https://lens.org/054-516-859-855-455,Granted Patent,yes,20,12,4,4,0,C08G18/6254;;C08K5/06;;C08L71/00;;C09D175/04;;C08K5/06;;C08L71/00;;C09D175/04;;C08G18/6254,C08G18/62;;C08K5/06;;C08L71/00;;C09D175/04,524/104;;524/376;;524/377;;524/762,3,1,080-755-362-976-80X,10.4271/960697,"Charles R. Hegedus et al., ""Film Formation Mechanism of Two-Component Waterborne Polyurethane Coatings"", J. Coat. Tech. vol. 68, pp. 51-61 (Jan. 1996).;;Cynthia Ahmed, ""The Advantages of Two-Component Waterborne Soft Feel"", Abstract from Adv. Coating Tech. Conference Exhibition, Nov. 7-9, 1995, pp. 3-11.;;Cynthia Ahmed, ""A Study in the Application of a Two-Component Waterborne Soft Feeling Coating"", SAE Spec. Pub. SP-1135, pp. 59-64 (1996).",EXPIRED
299,WO,A1,WO 2014/130214 A1,101-428-081-118-923,2014-08-28,2014,US 2014/0013276 W,2014-01-28,US 201361767870 P,2013-02-22,STATOR VANE ASSEMBLY AND METHOD THEREFORE,"A stator vane assembly includes a plurality of distinct vane segments that each respectively include a first platform, a second platform and at least one vane airfoil connected at opposed ends thereof to the first platform and the second platform. The first platforms meet at distinct first joints with each other, and the second platforms meet at distinct second joints with each other such that the plurality of vane segments forms an annular structure.",UNITED TECHNOLOGIES CORP,FARAH JORGE I;;BURT JONATHAN P;;PRAISNER THOMAS J,,https://lens.org/101-428-081-118-923,Patent Application,yes,5,1,3,3,0,F01D25/162;;F02C7/20;;F05D2230/23;;F01D25/162;;F02C7/20;;F05D2230/23;;F01D9/047;;F05D2240/12;;F05D2240/80,F01D9/02;;F02C7/00,,0,0,,,,PENDING
300,US,A,US 2797164 A,110-073-746-346-469,1957-06-25,1957,US 56566156 A,1956-02-15,US 56566156 A,1956-02-15,Process for margarine manufacture,,CANADA PACKERS LTD,MCGOWAN RAYMOND J;;BURT ROBERT A;;TEASDALE BARTON F,,https://lens.org/110-073-746-346-469,Granted Patent,no,0,14,1,1,0,A23D7/05;;A23D7/05,A23D7/05,,0,0,,,,EXPIRED
301,CN,A,CN 113582065 A,119-209-442-362-299,2021-11-02,2021,CN 202110654048 A,2014-05-19,CN 202110654048 A;;CN 201480026975 A;;SE 2014050611 W,2014-05-19,Lifting column and method for controlling height thereof,"The invention discloses a lifting column for an X-ray device. The X-ray device is movable, where the column is preferably rotationally fixed relative to a base of the X-ray device, and the column is provided with a plurality of sections and a first height adjustment unit; the plurality of sections include a first section and a second section, the first section has a first end part and an opposite second end part, and the first end part is arranged on the base; the second section has a first end part and an opposite second end part, and the second section is arranged at the first end part with an overlap of the second end part of the first section and is movable relative to the first section; and the first height adjustment unit comprises at least one first threaded slender member fixed at one of the first section and the second section, and a first threaded receiving element arranged at the other one of the first section and the second section and engaged with the threaded slender member in a pairing manner to adjust the height of the column.",SOLUTIONS FOR TOMORROW AB,M GOODSTRAND;;M G K IAN WIESSON;;J BURT,,https://lens.org/119-209-442-362-299,Patent Application,no,0,0,4,4,0,,B66F3/08;;A61B6/00;;B66F3/44,,0,0,,,,PENDING
302,US,A,US 2692899 A,148-123-886-380-468,1954-10-26,1954,US 26371451 A,1951-12-27,US 26371451 A,1951-12-27,Pentachlorophenol,,ETHYL CORP,KOLKA ALFRED J;;BURT WILLIAM E;;HOFTIEZER HENRY W,,https://lens.org/148-123-886-380-468,Granted Patent,no,3,3,1,1,0,C07C37/64;;C07C37/64;;C07C37/02;;C07C37/02;;C07C37/055;;C07C37/055,C07C37/02;;C07C37/055;;C07C37/64,,0,0,,,,EXPIRED
303,US,B2,US 7639837 B2,154-587-347-709-239,2009-12-29,2009,US 62615007 A,2007-01-23,US 62615007 A;;US 28615405 A;;US 1112901 A;;US 44278099 A;;US 7403498 A;;US 19802298 A;;US 76384796 A;;US 51299395 A;;US 10925998 P,1995-08-09,Identification documents and authentication of such documents,"The present invention relates generally to identification documents. In one implementation, a provided method includes: obtaining optical scan data associated with text characters provided on an identification document to obtain first data; using at least a portion of the first data to facilitate decryption of information—not the text characters—carried on or in the identification document. The information corresponds to the identification document or to an authorized bearer of the identification document. In another implementation, a method is providing including: obtaining optical scan data associated with an identification document to obtain first data; obtaining second data from the identification document, the second data comprising encrypted data; communicating the encrypted data and the first data to a remote device, the remote device decrypting the encrypted data with at least reference to the first data; and receiving decrypted data from the remote device. Other implementations and embodiments are provided as well.",DIGIMARC CORP,CARR J SCOTT;;PERRY BURT W;;RHOADS GEOFFREY B,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC CORPORATION (2008-08-01);;DMRC LLC (2008-08-01),https://lens.org/154-587-347-709-239,Granted Patent,yes,94,11,22,1547,0,B29C45/1418;;G06K1/121;;G06K7/1417;;G06K7/1447;;G06K19/06037;;G06K19/06046;;G06K19/14;;G06K2019/06253;;G06Q20/341;;G06Q20/40145;;G06T1/0071;;G06T2201/0051;;G07C2209/41;;G07D7/004;;G07F7/086;;G07F7/1008;;G10L19/018;;G11B20/00891;;H04N1/00846;;H04N1/32144;;H04N1/32203;;H04N1/32208;;H04N1/32219;;H04N1/32261;;H04N1/32304;;H04N2201/3205;;H04N2201/3207;;H04N2201/3226;;H04N2201/3233;;H04N2201/3235;;H04N2201/3239;;H04N2201/327;;H04N2201/3271;;B42D25/333;;G07D7/0034;;G06F16/955;;G07C9/257;;B42D25/24;;B42D25/21;;B42D25/23;;B42D25/313;;G06K7/1417;;G06T1/0071;;B42D25/333;;H04N1/00846;;H04N1/32208;;G06K1/121;;H04N2201/3235;;G07F7/086;;H04N2201/3233;;H04N1/32219;;H04N2201/3207;;H04N1/32261;;G07D7/004;;G07F7/1008;;G06Q20/341;;H04N2201/3226;;H04N1/32304;;G06Q20/40145;;G06K2019/06253;;G06K7/1447;;G06K19/06037;;G06K19/14;;G07C2209/41;;H04N2201/3205;;G06K19/06046;;H04N1/32203;;H04N2201/3239;;G10L19/018;;H04N1/32144;;H04N2201/327;;G11B20/00891;;H04N2201/3271;;G06T2201/0051;;B29C45/1418;;B42D25/00;;G07D7/0034;;G06F16/955;;G07C9/257,H04K1/00;;B29C45/14;;B42D15/00;;G06F17/30;;G06K1/12;;G06K17/00;;G06K19/06;;G06K19/14;;G06T1/00;;G07D7/00;;G07D7/12;;G07F7/08;;G10L19/00;;H04N1/00;;H04N1/32,382/100;;340/5.86,20,4,047-765-062-522-147;;113-553-769-478-730;;123-478-746-608-833;;112-571-607-869-774,10.1007/3-540-49380-8_8;;10.1109/ccst.1993.386835;;10.1007/3-540-49380-8_1;;10.1145/357744.357902,"U.S. Appl. No. 60/109,259, filed Nov. 19, 1998, Carr et al.;;U.S. Appl. No. 08/512,993, filed Aug. 9, 1995, Rhoads.;;Office Action (Oct. 4, 2004) and Amendment (Jun. 14, 2004) from U.S. Appl. No. 10/164,899.;;Anand, D. and Niranjan V.C. ""Watermarking Medical Images with Patient Information"" IEEE, Oct. 29, 1998.;;Bleumer, ""Biometric yet Privacy Protecting Person Authentication,"" Proc. 2.sup.nd Information Hiding Workshop, LNCS vol. 1525, Apr. 1998, pp. 99-110.;;Chow et al. ""Forgery and Tamper-Proof Identification Document"" IEEE Proc. 1993 Int. Carnahan Conf. on Security Technology Oct. 13-15, 1993, pp. 11-14.;;Gruhl et al., ""Information Hiding to Foil the Casual Counterfeiter,"" Proc. 2.sup.nd Information Hiding Workshop, LNCS vol. 1525, Apr. 1998, pp. 1-15.;;Kawaguchi et al. ""Principle and Applications of BPCS-Steganography"" Proc. SPIE vol. 3528: Multimedia Systems and Applications Nov. 2-4 1998 pp. 464-473.;;Komatsu et al. ""A Proposal on Digital Watermarking in Document Image Communication and Its Application to Realizing a Signature"" Electronics and Communications in Japan Part I vol. 73 No. 5 1990 pp. 22-23.;;Komatsu et al. ""Authentication System Using Concealed Image in Telematics"" Memoirs of the School of Science & Engineering Waseda Univ. No. 52 1988 pp. 45-60.;;Pankanti, S. et al. ""Verification Watermarks on Finger print Recognition and Retrieval"" IS&T/SPIE Conference on Security and Watermarking on MuItimmedia: Oct. 2000, pp. 66-78.;;Perry, B.et al :Digital Watermarks as a Security Feature for Identity Documents Proceedings of SPIE, vol. 3973, Apr. 2000 pp. 80-87.;;Ratha, N. et al. ""Secure Data hiding in Wavelet Compressed Fingerprint Images"" ACM Multimedia 2000 Workshop Oct. 30, 2000 pp. 127-130.;;Seybold Report on desktop Publishing ""Holographic Signatures for Digital Images"" Aug. 1995 1 page.;;Szepanski, ""A Signal Theoretic Method For Creating Forgery-Proof Documents For Automatic Verification"", 1979 Carnahan Conference on Crime Countermeasures, University of Kentucky, Lexington, Kentucky, May 16-18, 1979.;;Jul. 28. 2008 Notice of Appeal; and Apr. 14, 2008 Notice of Abandonment; all-from assignee's U.S. Appl. No. 10/686,495 (published as US 2004-0181671 A1).;;Feb. 28, 2008 final Office Action (including Examiner Interview Summary); Feb. 8, 2008 Supplemental Response; all from assignee's U.S. Appl. No. 10/686,495 (published as US 2004-0181671 A1).;;Nov. 19, 2007 Amendment: and May 18, 2007 non-final Office Action; all from assignee's U.S. Appl. No. 10/686,495 (published as US 2004-0181671 A1).;;Mar. 1, 2007 Pre-Brief Appeal Conference decision: Feb. 9, 2007 final Office Action; Jan. 10, 2007 Amendment: and Jan. 8, 2007 Office Action; all from assignees U.S. Appl. No. 10/686,495 (published as US 2004-0181671 A1).;;Eric Kleefeld, ""Passports to contain RFID chips next year: Government says it's ""more secure""; ACLU raises privacy concerns,"" Wisconsin Technology Network, published at http://wistechnology.com/article.php?id=2444 (published on Nov. 2, 2005; submitted sheets printed from the internet on Mar. 23, 2006), 3 pages.",EXPIRED
304,AU,A,AU 1999/045518 A,023-052-507-340-346,1999-12-30,1999,AU 1999/045518 A,1999-06-07,US 8844898 P;;US 9307298 P;;US 31719899 A;;US 9912776 W,1998-06-08,Novel antibacterial agents,,THERAVANCE BIOPHARMA ANTIBIOTICS IP LLC,GRIFFIN JOHN H;;MORAN EDMUND J;;CHRISTENSEN BURT G,"THERAVANCE, INC. (2002-06-06)",https://lens.org/023-052-507-340-346,Patent Application,no,0,0,86,429,0,A61K31/00;;C07C233/36;;C07C233/78;;C07C237/24;;C07C271/20;;C07C321/04;;C07C323/12;;C07C335/08;;C07C335/32;;C07D207/333;;C07D211/58;;C07D215/56;;C07D233/90;;C07D235/30;;C07D401/06;;C07D401/12;;C07D401/14;;C07D405/04;;C07D413/14;;C07D471/04;;C07D471/14;;C07D473/00;;C07D473/34;;C07D475/04;;C07D475/08;;C07D487/04;;C07D487/06;;C07D493/04;;C07D493/06;;C07H19/20;;C12Q1/26;;C12Q1/44;;C12Q1/48;;C12Q1/533;;C40B30/04;;C40B40/04;;G01N33/573;;G01N33/6842;;G01N33/6845;;G01N33/92;;G01N2500/00;;G01N2500/04;;G01N2800/044;;Y10S530/807;;C07C2603/18;;A61K47/60;;A61K47/54;;A61K47/55;;A61K47/552;;A61P31/04;;A61P31/18;;A61P37/02;;A61P43/00;;A61P5/14;;A61P3/10;;Y02A50/30;;C40B30/04;;G01N33/573;;C07D405/04;;C07D207/333;;C07C321/04;;G01N33/92;;C07C323/12;;C07D211/58;;C07D235/30;;C12Q1/48;;C12Q1/26;;C07C335/08;;C07D473/34;;C07D475/08;;C07C271/20;;C07D401/12;;C07D487/04;;C12Q1/44;;C07C233/78;;C07D471/04;;G01N2800/044;;C07C237/24;;C40B40/04;;C07D473/00;;C07D487/06;;C07D493/06;;C07D413/14;;C07D401/14;;A61K31/00;;C07D493/04;;C07D471/14;;C12Q1/533;;G01N33/6842;;G01N33/6845;;C07D401/06;;C07H19/20;;C07D215/56;;C07D475/04;;G01N2500/04;;C07C233/36;;G01N2500/00;;C07C335/32;;C07D233/90;;Y10S530/807;;A61K47/552;;A61K47/54;;C07C2603/18;;A61K47/60;;A61K47/55;;Y02A50/30,C07D499/44;;A01N57/34;;A61K31/00;;A61K31/357;;A61K31/397;;A61K31/407;;A61K31/421;;A61K31/424;;A61K31/431;;A61K31/439;;A61K31/444;;A61K31/4545;;A61K31/496;;A61K31/522;;A61K31/536;;A61K31/5377;;A61K31/546;;A61K31/551;;A61K31/65;;A61K31/7028;;A61K31/7034;;A61K31/7036;;A61K31/7042;;A61K31/7048;;A61K31/7052;;A61K31/7056;;A61K31/7064;;A61K31/7068;;A61K31/7072;;A61K38/00;;A61K39/00;;A61K39/395;;A61K39/44;;A61K47/48;;A61K51/00;;A61P31/04;;A61P31/18;;A61P43/00;;C07B61/00;;C07C233/36;;C07C233/78;;C07C237/24;;C07C237/26;;C07C271/20;;C07C275/42;;C07C321/04;;C07C323/12;;C07C335/08;;C07C335/32;;C07D207/32;;C07D207/333;;C07D211/58;;C07D215/56;;C07D233/90;;C07D235/30;;C07D263/28;;C07D265/18;;C07D401/06;;C07D401/12;;C07D401/14;;C07D405/04;;C07D413/14;;C07D453/02;;C07D471/04;;C07D471/14;;C07D473/00;;C07D473/34;;C07D475/04;;C07D475/08;;C07D477/00;;C07D487/04;;C07D487/06;;C07D493/04;;C07D493/06;;C07D495/04;;C07D498/04;;C07D498/18;;C07D501/20;;C07D519/00;;C07H15/236;;C07H15/238;;C07H15/26;;C07H17/08;;C07H19/06;;C07H19/20;;C07K2/00;;C07K4/00;;C12N9/99;;C12P19/38;;C12Q1/26;;C12Q1/44;;C12Q1/48;;C12Q1/533;;C40B30/04;;C40B40/04;;G01N33/15;;G01N33/50;;G01N33/53;;G01N33/543;;G01N33/566;;G01N33/573;;G01N33/68;;G01N33/92;;G01N37/00,,0,0,,,,EXPIRED
305,NZ,A,NZ 222733 A,010-034-895-123-237,1990-02-26,1990,NZ 22273387 A,1987-11-27,GB 8628472 A,1986-11-28,METERED DOSE VALVE FOR AEROSOL CANS WITH DEEP-DRAWN METAL PARTS,,GLAXO GROUP LTD,THOMAS J H;;HUTCHINSON A;;BURT P C W,,https://lens.org/010-034-895-123-237,Patent Application,no,0,0,26,26,0,B65D83/54,B65D83/14;;B05B9/04,,0,0,,,,DISCONTINUED
306,WO,A1,WO 2010/118329 A1,056-731-867-262-478,2010-10-14,2010,US 2010/0030551 W,2010-04-09,US 16824509 P,2009-04-10,METHOD AND APPARATUS FOR INTERCONNECTING TRACTION CLEATS AND RECEPTACLES,A thinner shoe mounted receptacle results from a thin cleat attachment flange received in a shallow receptacle cavity. An angled interface between the cleat and receptacle provide a friction fit engagement to minimize inadvertent disengagement of the cleat and receptacle. Rotational locking occurring inside or outside the cavity further prevents inadvertent cleat rotation. Multiple positionally synchronized angular stops positively define the final angular orientation of the cleat in the receptacle.,PRIDE MFG CO LLC;;BURT JOHN ROBERT;;SHUTTLEWORTH LEE PAUL;;KRIKORIAN RAND J,BURT JOHN ROBERT;;SHUTTLEWORTH LEE PAUL;;KRIKORIAN RAND J,,https://lens.org/056-731-867-262-478,Patent Application,yes,18,4,15,15,0,A43C15/161;;A43C15/161;;A43C15/02,A43C15/02,,1,0,,,See also references of EP 2375930A4,PENDING
307,US,B2,US 8170756 B2,057-667-044-819-282,2012-05-01,2012,US 89619507 A,2007-08-30,US 89619507 A,2007-08-30,Excavating system utilizing machine-to-machine communication,"A method for enhancing productivity for an excavating operation is disclosed. The method includes establishing a machine-to-machine communication system for a fleet of machines, including at least two machines. The method also includes removing material during the excavating operation with at least a first machine of the fleet of machines. The method additionally includes operating a second machine of the fleet of machines in a mode involving contact between at least the first machine and the second machine. The method further includes employing the machine-to-machine communication system to effect controlled contact between at least the first machine and the second machine.",MOREY STEPHEN J;;VIK TIMOTHY A;;BURT QUENTIN D;;CATERPILLAR INC,MOREY STEPHEN J;;VIK TIMOTHY A;;BURT QUENTIN D,CATERPILLAR INC (2007-08-27),https://lens.org/057-667-044-819-282,Granted Patent,yes,45,27,3,3,0,E02F3/651;;E02F3/651;;E02F3/6436;;E02F3/6436;;E02F3/6481;;E02F3/6481;;E02F9/2045;;E02F9/2045,G06F7/70;;G06F19/00;;G06G7/00;;G06G7/76,701/50;;701/1;;701/24;;701/400;;701/468;;318/580;;318/587;;340/435;;340/436;;340/988;;340/989;;280/481;;172/786;;172/788,1,0,,,"Morey et al., U.S. Appl. No. 11/889,169, filed Aug. 9, 2007.",ACTIVE
308,DE,C2,DE 3535070 C2,117-856-085-125-145,1994-06-09,1994,DE 3535070 A,1985-09-28,US 67884784 A,1984-12-06,Verfahren zur Herstellung eines Verbundkörpers,,AVCO CORP,GRANT WILLIAM F;;BURT GARY W;;KUMNICK ALBERT J,,https://lens.org/117-856-085-125-145,Granted Patent,no,0,0,13,13,0,B22F2998/00;;C22C47/064;;C22C47/20;;B29L2031/06;;B29C70/545;;B29C2793/0045;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;B29C70/347;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;C22C47/064;;C22C47/20;;B22F2998/00;;B29C70/545;;B29L2031/06;;B29C2793/0045,B29B15/08;;B21C37/02;;B32B15/01;;C22C47/06;;C22C47/20,,0,0,,,,EXPIRED
309,JP,A,JP 2013090963 A,119-964-159-581-794,2013-05-16,2013,JP 2013028631 A,2013-02-18,US 14802209 P,2009-01-28,IMPROVED REPLACEABLE TRACTION CLEAT FOR FOOTWEAR,PROBLEM TO BE SOLVED: To provide an improved replaceable traction cleat for footwear.SOLUTION: Adjustable traction is provided in a traction cleat by selectively restricting or not the amount of flexure permitted for a dynamic traction element on the cleat. Restricting flexure is alternatively achieved by an adjustably positionable ring or by rotating the cleat to align the dynamic element with different shoe sole topographical features. A dual locking post is provided to reduce the surface area required on the cleat hub for locking structures. The cleat is formed in a two shot molding process that permits elongations of the dynamic traction elements without sacrificing the integrity of the cleat structure.,PRIDE MFG CO LLC,KRIKORIAN RAND J;;BURT JOHN ROBERT;;MCMULLIN FARIS W,,https://lens.org/119-964-159-581-794,Patent Application,no,0,0,9,9,0,A43C15/162;;A43C15/16;;A43C15/162;;A43C15/168;;A43B5/00;;A43C15/161,A43C15/02,,0,0,,,,DISCONTINUED
310,US,B2,US 7269275 B2,166-137-214-443-593,2007-09-11,2007,US 28615405 A,2005-11-23,US 28615405 A;;US 1112901 A;;US 44278099 A;;US 19802298 A;;US 76384796 A;;US 51299395 A;;US 7403498 A;;US 10925998 P,1995-08-09,Physical objects and validation of physical objects,"The present invention relates generally to validating and providing physical objects. In one implementation, a physical object includes a first digital watermark carried thereon. The first digital watermark includes a first plural-bit message representing at least a reduced-bit representation of a biometric corresponding to an authorized bearer of the physical object. The physical object further includes semantic information carried thereon. At least a portion of the semantic information corresponds to the authorized bearer of the physical object. In another implementation, an apparatus is provided to validate physical objects. In some cases the objects include identification documents.",DIGIMARC CORP,CARR J SCOTT;;PERRY BURT W;;RHOADS GEOFFREY B,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC LLC (2008-08-01);;DMRC CORPORATION (2008-08-01),https://lens.org/166-137-214-443-593,Granted Patent,yes,91,19,22,1547,0,B29C45/1418;;G06K1/121;;G06K7/1417;;G06K7/1447;;G06K19/06037;;G06K19/06046;;G06K19/14;;G06K2019/06253;;G06Q20/341;;G06Q20/40145;;G06T1/0071;;G06T2201/0051;;G07C2209/41;;G07D7/004;;G07F7/086;;G07F7/1008;;G10L19/018;;G11B20/00891;;H04N1/00846;;H04N1/32144;;H04N1/32203;;H04N1/32208;;H04N1/32219;;H04N1/32261;;H04N1/32304;;H04N2201/3205;;H04N2201/3207;;H04N2201/3226;;H04N2201/3233;;H04N2201/3235;;H04N2201/3239;;H04N2201/327;;H04N2201/3271;;B42D25/333;;G07D7/0034;;G06F16/955;;G07C9/257;;B42D25/24;;B42D25/21;;B42D25/23;;B42D25/313;;G06K7/1417;;G06T1/0071;;B42D25/333;;H04N1/00846;;H04N1/32208;;G06K1/121;;H04N2201/3235;;G07F7/086;;H04N2201/3233;;H04N1/32219;;H04N2201/3207;;H04N1/32261;;G07D7/004;;G07F7/1008;;G06Q20/341;;H04N2201/3226;;H04N1/32304;;G06Q20/40145;;G06K2019/06253;;G06K7/1447;;G06K19/06037;;G06K19/14;;G07C2209/41;;H04N2201/3205;;G06K19/06046;;H04N1/32203;;H04N2201/3239;;G10L19/018;;H04N1/32144;;H04N2201/327;;G11B20/00891;;H04N2201/3271;;G06T2201/0051;;B29C45/1418;;B42D25/00;;G07D7/0034;;G06F16/955;;G07C9/257,H04K1/00;;B29C45/14;;B42D15/00;;G06F17/30;;G06K1/12;;G06K17/00;;G06K19/06;;G06K19/14;;G06T1/00;;G07D7/00;;G07D7/12;;G07F7/08;;G10L19/00;;H04N1/00;;H04N1/32,382/100;;382/115;;340/5.82;;283/75,17,5,047-765-062-522-147;;047-765-062-522-147;;113-553-769-478-730;;123-478-746-608-833;;112-571-607-869-774,10.1007/3-540-49380-8_8;;10.1007/3-540-49380-8_8;;10.1109/ccst.1993.386835;;10.1007/3-540-49380-8_1;;10.1145/357744.357902,"Bleumer, ""Biometric yet Privacy Protecting Person Authentication,"" Proc. 2nd Int. Information Hiding Workshop, LNCS vol. 1525, Apr. 1998, pp. 99-110.;;Szepanski, ""A Signal Theoretic Method for Creating Forgery-Proof Documents for Automatic Verification,"" Proc. Carnahan Conf. on Crime Countermeasures, May 1979, pp. 101-109.;;U.S. Appl. No. 60/109,259, filed Nov. 19, 1998, Carr et al.;;U.S. Appl. No. 08/512,993, filed Aug. 9, 1995, Rhoads.;;Office Action (Oct. 4, 2004) and Amendment (Jun. 14, 2004) from U.S. Appl. No. 10/164,899.;;Anand, D. amd Niranjan V.C. ""Watermarking Medical Images with Patient Information"" IEEE, Oct. 29, 1998.;;Bleumer, ""Biometric yet Privacy Protecting Person Authentication,"" IEEE Proc. 2.sup.nd Information Hiding Workshop, LNCS vol. 1525, Apr. 1998, pp. 99-110.;;Chow et al. ""Forgery and Tamper-Proof Identification Document"" IEEE Proc. 1993 Int. Carnahan Conf. on Security Technology Oct. 13-15, 1993, pp. 11-14.;;Gruhl et al., ""Information Hiding to Foil the Casual Counterfeiter,"" Proc. 2.sup.nd Information Hiding Worskshop, LNCS vol. 1525, Apr. 1998, pp. 1-15.;;Kawaguchi et al. ""Principle and Applications of BPCS-Steganography"" Proc. SPIE vol. 3528: Multimedia Systems and Applications Nov. 2-4, 1998 pp. 464-473.;;Komatsu et al. ""A Proposal on Digital Watermarking in Document Image Communication and Its Application to Realizing a Signature"" Electronics and Communications in Japan Part I vol. 73 No. 5 1990 pp. 22-23.;;Komatsu et al. ""Authentication System Using Concealed Image in Telematics"" Memoirs of the School of Science & Engineering Waseda Univ. No. 52, 1988 pp. 45-60.;;Pankanti, S. et al. ""Verifictaion Watermarks on Finger print Recognition and Retrieval"" IS&T/SPIE Conference on Security and Watermarking on Multimmedia: Oct. 2000, pp. 66-78.;;Perry, B. et al : Digital Watermarks as a Security Feature for Identity Documents Proceedings of SPIE, vol. 3973, Apr. 2000 pp. 80-87.;;Ratha, N. et al. ""Secure Data hiding in Wavelet Compressed Fingerprint Images"" ACM Multimedia 2000 Workshop Oct. 30, 2000 pp. 127-130.;;Seybold Report on Desktop Publishing ""Holographic Signatures for Digital Images"" Aug. 1995 1 page.;;Szepanski, ""A Signal Theoretic Method for Creating Forgery-Proof Documents For Automatic Verification,"", 1979 Carnahan Conference on Crime Countermeasures, University of Kentucky, Lexington, Kentucky, May 16-18, 1979.",EXPIRED
311,US,B2,US 7770013 B2,187-029-195-857-160,2010-08-03,2010,US 65693003 A,2003-09-04,US 65693003 A;;US 9606618 W;;US 16489902 A;;US 19802298 A;;US 76384796 A;;US 51299395 A;;US 77593401 A;;US 62557700 A;;US 83756401 A;;US 50388100 A;;US 18696298 A;;US 64941996 A;;US 63753196 A;;US 57142200 A;;US 34310499 A;;US 34268899 A;;US 34310199 A;;US 31464899 A;;US 1112901 A;;US 44278099 A;;US 7403498 A;;US 76384701 A;;US 46541899 A;;US 14722802 A;;US 67011500 A;;US 56366400 A;;US 47668699 A;;US 74661396 A;;US 50808395 A;;US 19813800 P;;US 19884900 P;;US 10925998 P;;US 11295598 P;;US 17802800 P;;US 13478299 P,1995-07-27,Digital authentication with digital and analog documents,"The present invention relates generally to systems for creating and authenticating printed objects using authentication information. One implementation recites: An apparatus for determining authenticity of a digital representation of an object. The digital representation includes embedded first authentication information. The apparatus includes: a storage system in which stored second authentication information is associated with stored reference codes; and a processor which receives the digital representation and a reference code associated therewith. The processor includes: an authentication information reader, and the processor: i) employs the reference code to retrieve the second authentication information associated therewith from the storage system, ii) employs the authentication information reader to recover the embedded first authentication information, and iii) employs recovered first authentication information and the second authentication information to determine authenticity of the digital representation. Other implementations are provided and claimed as well.",DIGIMARC CORP,RHOADS GEOFFREY B;;CARR J SCOTT;;PERRY BURT W,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC LLC (2008-08-01);;DMRC CORPORATION (2008-08-01),https://lens.org/187-029-195-857-160,Granted Patent,yes,58,64,2,1547,0,B29C45/1418;;G06F21/00;;G06K1/121;;G06K7/1417;;G06K7/1447;;G06K19/06037;;G06K19/06046;;G06K19/14;;G06K19/18;;G06K2019/06253;;G06Q20/341;;G06Q20/40145;;G06Q30/02;;G06T1/0028;;G06T1/0071;;G06T2201/0051;;G06T2201/0052;;G07D7/004;;G07F7/086;;G07F7/1008;;G07F17/16;;G07F17/26;;G11B20/00007;;G11B20/00086;;G11B20/00884;;G11B20/00891;;G11B20/00898;;H04H20/31;;H04N1/00005;;H04N1/00037;;H04N1/00079;;H04N1/00973;;H04N1/32122;;H04N1/32144;;H04N1/32154;;H04N1/3216;;H04N1/32203;;H04N1/32208;;H04N1/32219;;H04N1/32229;;H04N1/32251;;H04N1/32261;;H04N1/32288;;H04N1/32304;;H04N1/32352;;H04N21/23892;;H04N21/8358;;H04N2201/3205;;H04N2201/3207;;H04N2201/3225;;H04N2201/3226;;H04N2201/3233;;H04N2201/3235;;H04N2201/3239;;H04N2201/327;;H04N2201/3271;;H04N2201/3274;;H04N2201/328;;H04N2201/3284;;B42D25/29;;B42D25/00;;H04N19/467;;G10L15/26;;G07D7/0034;;G06F16/955;;G07C9/253;;G06F40/169;;G06V30/40;;B42D25/333;;G06Q20/40145;;G11B20/00884;;B42D25/29;;H04N1/32154;;G07F7/086;;G06K19/14;;H04N1/00079;;H04N21/23892;;H04N2201/3225;;H04N1/32288;;H04N1/32122;;H04N2201/3233;;H04N2201/3235;;G06F21/00;;G06K19/18;;G11B20/00898;;G11B20/00007;;H04N1/32229;;G06K2019/06253;;G11B20/00891;;G07F17/26;;H04N1/32144;;H04N2201/3239;;H04N2201/327;;H04N2201/3284;;G06K1/121;;H04N1/32251;;H04N1/32352;;G07F7/1008;;H04N1/32304;;B29C45/1418;;G06K19/06037;;H04N1/00037;;H04N1/3216;;H04N2201/3207;;H04N2201/3271;;G06T2201/0051;;G07F17/16;;H04N1/32261;;G06T2201/0052;;H04N1/00973;;G06K7/1447;;G07D7/004;;H04N1/32203;;H04N2201/328;;H04N21/8358;;G06Q30/02;;H04N1/00005;;H04H20/31;;G11B20/00086;;H04N2201/3274;;G06T1/0071;;H04N1/32219;;H04N2201/3205;;G06K19/06046;;H04N2201/3226;;G06T1/0028;;G06K7/1417;;G06Q20/341;;H04N1/32208;;B42D25/00;;H04N19/467;;G10L15/26;;G07D7/0034;;G06F16/955;;G07C9/253;;G06F40/169;;G06V30/40,B29C45/14;;H04L9/00;;B42D15/00;;B42D15/10;;G06F1/00;;G06F17/24;;G06F17/30;;G06F21/00;;G06K1/12;;G06K17/00;;G06K19/06;;G06K19/14;;G06K19/18;;G06Q20/34;;G06Q20/40;;G06Q30/02;;G06T1/00;;G06V30/40;;G07C9/00;;G07D7/00;;G07D7/12;;G07F7/08;;G07F7/10;;G07F17/16;;G07F17/26;;G10L15/26;;G11B20/00;;H04H20/31;;H04N1/00;;H04N1/32;;H04N7/26;;H04Q7/38,713/176;;713/178,18,4,113-553-769-478-730;;049-334-467-914-083;;153-768-531-984-130;;019-112-432-289-992,10.1109/ccst.1993.386835;;10.1109/5.771070;;10.1109/icassp.1998.678149;;10.1002/(sici)1520-684x(199701)28:1<87::aid-scj9>3.0.co;2-o,"Chow et al., ""Forgery and Tamper-Proof Identification Document,"" IEEE Proc. 1993 Int. Carnahan Conf. on Security Technology, Oct. 13-15, 1993, pp. 11-14.;;Kawaguchi et al., ""Principle and Applications of BPCS-Steganography,"" Proc. SPIE vol. 3528: Multimedia Systems and Applications, Nov. 2-4, 1998, pp. 464-473.;;Komatsu et al., ""A Proposal on Digital Watermarking in Document Image Communication and Its Application to Realizing a Signature,"" Electronics and Communications in Japan, Part I, vol. 73, No. 5, 1990, pp. 22-23.;;Kundur et al., ""Digital Watermarking for Telltale Tamper Proofing and Authentication"", IEEE, vol. 87, No. 7, pp. 1167-1180.;;Kundur et al., ""Digital Watermarking Using Multiresolution Wavelet Decomposition,"" Proc. of 1998 IEEE Int. Conf. on Acoustics, Speech and Signal Processing, ICASSP '98, pp. 2969-2972, vol. 5.;;Matsui et al., ""Embedding a Signature to Pictures Under Wavelet Transformation,"" Transactions of the Institute of Electronics Information and Communication Engineers D-II, vol. J79D-II, No. 6, Jun. 1996, pp. 1017-1024.;;Matsui et al., ""Use of the Wavelet Transformation to Embed Signatures in Images,"" Systems and Computers in Japan, Jan. 1997, vol. 28, No. 1, pp. 87-94.;;Szepanski, ""A Signal Theoretic Method for Creating Forgery-Proof Documents for Automatic Verification"", 1979 Carnahan Conference on Crime Countermeasures, University of Kentucky, Lexington, Kentucky, May 16-18, 1979.;;Aug. 22, 2003, 37 CFR 1.607 Amendment and 37 CFR 1.607 Request for an Interference with a Patent from U.S. Appl. No. 10/164,899.;;Dec. 12, 2003 Office Action from U.S. Appl. No. 10/164,899.;;Jun. 11, 2004 Declaration of Garth Zambory and Aug. 30, 2004 Supplemental Declaration of Garth Zambory, each from U.S. Appl. No. 10/164,899.;;Jun. 11, 2004 Declaration of Bert Shaw, PhD. (with attachments) from U.S. Appl. No. 10/164,899.;;Jun. 14, 2004 Amendment from U.S. Appl. No. 10/164,899.;;Oct. 4, 2004 Office Action from U.S. Appl. No. 10/164,899.;;Mar. 2, 2005 Amendment from U.S. Appl. No. 10/164,899.;;Jun. 28, 2005 Office Action from U.S. Appl. No. 10/164,899.;;Nov. 21, 2005 Amendment Accompanying Request for Continued Examination from U.S. Appl. No. 10/164,899.;;Dec. 9, 2005, Notice of Allowance and Fees Due from U.S. Appl. No. 10/164,899.",EXPIRED
312,US,A1,US 2004/0209983 A1,016-834-561-527-630,2004-10-21,2004,US 84091704 A,2004-05-07,US 84091704 A;;US 9903602 A;;US 69213896 A,1996-08-05,Waterborne soft-feeling coating composition with high gloss,"
   A waterborne, soft feeling coating composition and a substrate coated with the composition. The coating composition comprises an aqueous solvent, a resin, and an alcohol alkoxylate surfactant. The invention is also directed to a process of making the waterborne coating composition of the invention, and a process of coating a substrate with the waterborne coating composition. 
",RUGGIERO MURRAY A.;;CHUBB HAROLD W.;;BURT DIANE J.,RUGGIERO MURRAY A;;CHUBB HAROLD W;;BURT DIANE J,MONUMENT CHEMICAL KENTUCKY LLC (2012-12-27),https://lens.org/016-834-561-527-630,Patent Application,yes,25,9,4,4,0,C08G18/6254;;C08K5/06;;C08L71/00;;C09D175/04;;C08K5/06;;C08L71/00;;C09D175/04;;C08G18/6254,C08G18/62;;C08K5/06;;C08L71/00;;C09D175/04,524/127;;524/379;;524/493;;524/322;;524/445;;524/386,0,0,,,,EXPIRED
313,CA,A,CA 1259018 A,120-752-216-230-829,1989-09-05,1989,CA 496873 A,1985-12-04,US 67884784 A,1984-12-06,FILAMENTARY STRUCTURAL MODULE FOR COMPOSITES,This invention includes a continuous in-plane spiral of monofilament/metallic ribbon which forms a preform for metal matrix composite fabrication. The purpose is to provide continuous spiral filament reinforcement around a hole or central core. This spiral monolayer is fabricated by co-winding the filament and a ribbon or wire made from the intended composite material around a mandrel. Monolayers so constructed could then be stacked to form cylindrical or torus-shaped components and consolidated in a direction parallel to the axis of the shape.,AVCO CORP,GRANT WILLIAM F;;BURT GARY W;;KUMNICK ALBERT J,,https://lens.org/120-752-216-230-829,Granted Patent,no,0,0,13,13,0,B22F2998/00;;C22C47/064;;C22C47/20;;B29L2031/06;;B29C70/545;;B29C2793/0045;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;B29C70/347;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;C22C47/064;;C22C47/20;;B22F2998/00;;B29C70/545;;B29L2031/06;;B29C2793/0045,B29B15/08;;B21C37/02;;B32B15/01;;C22C47/06;;C22C47/20,154-70,0,0,,,,EXPIRED
314,US,B2,US 8280101 B2,153-754-253-098-632,2012-10-02,2012,US 64453409 A,2009-12-22,US 64453409 A;;US 62615007 A;;US 28615405 A;;US 1112901 A;;US 44278099 A;;US 7403498 A;;US 19802298 A;;US 76384796 A;;US 51299395 A;;US 10925998 P,1995-08-09,Identification documents and authentication of such documents,"The present invention relates generally to identification documents. One claim recites an apparatus to authentic an identification document. The identification document comprising first machine-readable information including a first plural-bit message, and semantic information carried on or in the identification document. The apparatus includes: a first reader to read the first machine-readable information to obtain the first plural-bit message; a second reader to obtain information from the semantic information carried on or in the identification document; an electronic processor programmed as a decryption unit to decrypt the first plural-bit message or the information obtained from the semantic information; and an electronic processor programmed as a decision unit to determine whether the identification document is authentic based at least in part on the first plural-bit message and the semantic information. Other claims and combinations are provided as well.",CARR J SCOTT;;PERRY BURT W;;RHOADS GEOFFREY B;;DIGIMARC CORP,CARR J SCOTT;;PERRY BURT W;;RHOADS GEOFFREY B,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC CORPORATION (2008-08-01);;DMRC LLC (2008-08-01),https://lens.org/153-754-253-098-632,Granted Patent,yes,105,0,22,1547,0,B29C45/1418;;G06K1/121;;G06K7/1417;;G06K7/1447;;G06K19/06037;;G06K19/06046;;G06K19/14;;G06K2019/06253;;G06Q20/341;;G06Q20/40145;;G06T1/0071;;G06T2201/0051;;G07C2209/41;;G07D7/004;;G07F7/086;;G07F7/1008;;G10L19/018;;G11B20/00891;;H04N1/00846;;H04N1/32144;;H04N1/32203;;H04N1/32208;;H04N1/32219;;H04N1/32261;;H04N1/32304;;H04N2201/3205;;H04N2201/3207;;H04N2201/3226;;H04N2201/3233;;H04N2201/3235;;H04N2201/3239;;H04N2201/327;;H04N2201/3271;;B42D25/333;;G07D7/0034;;G06F16/955;;G07C9/257;;B42D25/24;;B42D25/21;;B42D25/23;;B42D25/313;;G06K7/1417;;G06T1/0071;;B42D25/333;;H04N1/00846;;H04N1/32208;;G06K1/121;;H04N2201/3235;;G07F7/086;;H04N2201/3233;;H04N1/32219;;H04N2201/3207;;H04N1/32261;;G07D7/004;;G07F7/1008;;G06Q20/341;;H04N2201/3226;;H04N1/32304;;G06Q20/40145;;G06K2019/06253;;G06K7/1447;;G06K19/06037;;G06K19/14;;G07C2209/41;;H04N2201/3205;;G06K19/06046;;H04N1/32203;;H04N2201/3239;;G10L19/018;;H04N1/32144;;H04N2201/327;;G11B20/00891;;H04N2201/3271;;G06T2201/0051;;B29C45/1418;;B42D25/00;;G07D7/0034;;G06F16/955;;G07C9/257,H04K1/00;;B29C45/14;;B42D15/00;;G06F7/04;;G06F17/30;;G06K1/12;;G06K17/00;;G06K19/06;;G06K19/14;;G06T1/00;;G07D7/00;;G07D7/12;;G07F7/08;;G10L19/00;;H04N1/00;;H04N1/32,382/100;;713/176;;340/5.86,28,4,047-765-062-522-147;;113-553-769-478-730;;123-478-746-608-833;;112-571-607-869-774,10.1007/3-540-49380-8_8;;10.1109/ccst.1993.386835;;10.1007/3-540-49380-8_1;;10.1145/357744.357902,"Szepanski, ""A Signal Theoretic Method for Creating Forgery-Proof Documents for Automatic Verification,"" Proc. IEEE Carnahan Conference on Crime Countermeasures, May 1979, pp. 101-109.;;U.S. Appl. No. 08/154,866, filed Nov. 18, 1993, Geoffrey B. Rhoads.;;U.S. Appl. No. 08/215,289, filed Mar. 17, 1994, Geoffrey B. Rhoads.;;U.S. Appl. No. 09/150,147, filed Sep. 9, 1998, Geoffrey B. Rhoads.;;U.S. Appl. No. 09/151,492, filed Sep. 11, 1998, Bruce L. Davis et al.;;U.S. Appl. No. 09/496,380, filed Feb. 2, 2000, Geoffrey B. Rhoads.;;U.S. Appl. No. 12/881,911, filed Sep. 14, 2010, Geoffrey B. Rhoads et al.;;U.S. Appl. No. 12/692,470, filed Jan. 22, 2010, Jun Tian et al.;;U.S. Appl. No. 60/109,259, filed Nov. 19, 1998, Carr et al.;;U.S. Appl. No. 08/512,993, filed Aug. 9, 1995, Rhoads.;;Notice of Allowance (Dec. 9, 2005), Amendment with RCE (Nov. 21, 2005), final Office Action (Jun. 28, 2005), Amendment (Mar. 7, 2005), Office Action (Oct. 4, 2004) and Amendment (Jun. 14, 2004); all from U.S. Appl. No. 10/164,899; Jun. 11, 2004 Declaration of Garth Zambory and Aug. 30, 2004 Supplemental Declaration of Garth Zambory, each from U.S. Appl. No. 10/164,899; Jun. 11, 2004 Declaration of Bert Shaw, PhD. (with attachments) from U.S. Appl. No. 10/164,899; Jun. 11, 2004.;;Anand, D. and Niranjan V.C. ""Watermarking Medical Images with Patient Information"" IEEE, Oct. 29, 1998.;;Bleumer, ""Biometric yet Privacy Protecting Person Authentication,"" Proc. 2.sup.nd Information Hiding Workshop, LNCS vol. 1525, Apr. 1998, pp. 99-110.;;Chow et al. ""Forgery and Tamper-Proof Identification Document"" IEEE Proc. 1993 Int. Carnahan Conf. on Security Technology Oct. 13-15, 1993, pp. 11-14.;;Gruhl et al., ""Information Hiding to Foil the Casual Counterfeiter,"" Proc. 2.sup.nd Information Hiding Workshop, LNCS vol. 1525, Apr. 1998, pp. 1-15.;;Kawaguchi et al. ""Principle and Applications of BPCS-Steganography"" Proc. SPIE vol. 3528: Multimedia Systems and Applications Nov. 2-4, 1998 pp. 464-473.;;Komatsu et al. ""A Proposal on Digital Watermarking in Document Image Communication and Its Application to Realizing a Signature"" Electronics and Communications in Japan Part I vol. 73 No. 5 1990 pp. 22-23.;;Komatsu et al. ""Authentication System Using Concealed Image in Telematics"" Memoirs of the School of Science & Engineering Waseda Univ. No. 52 1988 pp. 45-60.;;Pankanti, S. et al. ""Verification Watermarks on Finger print Recognition and Retrieval"" IS&T/SPIE Conference on Security and Watermarking on Multimmedia: Oct. 2000, pp. 66-78.;;Perry, B.et al : Digital Watermarks as a Security Feature for Identity Documents Proceedings of SPIE, vol. 3973, Apr. 2000 pp. 80-87.;;Ratha, N. et al. ""Secure Data hiding in Wavelet Compressed Fingerprint Images"" ACM Multimedia 2000 Workshop Oct. 30, 2000 pp. 127-130.;;Seybold Report on desktop Publishing ""Holographic Signatures for Digital Images"" Aug. 1995 1 page.;;Szepanski, ""A Signal Theoretic Method for Creating Forgery-Proof Documents for Automatic Verification"", 1979 Carnahan Conference on Crime Countermeasures, University of Kentucky, Lexington, Kentucky, May 16-18, 1979.;;Apr. 14, 2009 Notice of Abandonment; Jul. 28, 2008 Notice of Appeal; and Apr. 14, 2008 Notice of Abandonment; all from assignee's U.S. Appl. No. 10/686,495 (published as US 2004-0181671 A1).;;Feb. 28, 2008 final Office Action (including Examiner Interview Summary); Feb. 8, 2008 Supplemental Response; all from assignee's U.S. Appl. No. 10/686,495 (published as US 2004-0181671 A1).;;Nov. 19, 2007 Amendment; and May 18, 2007 non-final Office Action; all from assignee's U.S. Appl. No. 10/686,495 (published as US 2004-0181671 A1).;;Mar. 1, 2007 Pre-Brief Appeal Conference decision; Feb. 9, 2007 final Office Action; Jan. 10, 2007 Amendment; and Jan. 8, 2007 Office Action; all from assignee's U.S. Appl. No. 10/686,495 (published as US 2004-0181671 A1).;;Eric Kleefeld, ""Passports to contain RFID chips next year: Government says it's ""more secure""; ACLU raises privacy concerns,"" Wisconsin Technology Network, published at http://wistechnology.com/article.php?id=2444 (published on Nov. 2, 2005; submitted sheets printed from the internet on Mar. 23, 2006), 3 pages.",EXPIRED
315,GB,B,GB 2168032 B,168-167-519-969-545,1988-04-07,1988,GB 8524253 A,1985-10-02,US 67884784 A,1984-12-06,A FILAMENTARY STRUCTURAL MODULE FOR COMPOSITES,,AVCO CORP,GRANT WILLIAM F;;BURT GARY W;;KUMNICK ALBERT J,,https://lens.org/168-167-519-969-545,Granted Patent,no,0,0,13,13,0,B22F2998/00;;C22C47/064;;C22C47/20;;B29L2031/06;;B29C70/545;;B29C2793/0045;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;B29C70/347;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;C22C47/064;;C22C47/20;;B22F2998/00;;B29C70/545;;B29L2031/06;;B29C2793/0045,B21C37/02;;B29B15/08;;B32B15/01;;C22C47/06;;C22C47/20,B8G4;;B8MHA,0,0,,,,EXPIRED
316,CA,A,CA 755470 A,025-147-037-426-237,1967-03-28,1967,CA 755470D A,,CA 755470T A,,DUST PROOF CARTON,,PROCTER & GAMBLE,BURT ROBERT V;;GEX VIRGIL E;;FRANZ NORMAN J,,https://lens.org/025-147-037-426-237,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
317,US,B2,US 10364690 B2,072-447-723-273-727,2019-07-30,2019,US 201414766178 A,2014-01-28,US 201414766178 A;;US 201361767870 P;;US 2014/0013276 W,2013-02-22,Stator vane assembly and method therefor,"A stator vane assembly includes a plurality of distinct vane segments that each respectively include a first platform, a second platform and at least one vane airfoil connected at opposed ends thereof to the first platform and the second platform. The first platforms meet at distinct first joints with each other, and the second platforms meet at distinct second joints with each other such that the plurality of vane segments forms an annular structure.",UNITED TECHNOLOGIES CORP,FARAH JORGE I;;BURT JONATHAN P;;PRAISNER THOMAS J,RTX CORPORATION (2023-07-14),https://lens.org/072-447-723-273-727,Granted Patent,yes,12,1,3,3,0,F01D25/162;;F02C7/20;;F05D2230/23;;F01D25/162;;F02C7/20;;F05D2230/23;;F01D9/047;;F05D2240/12;;F05D2240/80,F01D9/04;;F01D25/16;;F02C7/20,,3,0,,,"International Preliminary Report on Patentability for PCT Application No. PCT/US2014/013276 dated Sep. 3, 2015.;;Reid, K. 2006. Reducing the Performance Penalty Due to Turbine Inter-Platform Gaps. Proceedings of GT2006 ASME Turbo Expo 2006: Power for Land, Sea and Air. May 8-11, 2006. GT2006-90839. ASME, Barcelona, Spain.;;The International Search Report and Written Opinion for PCT Application No. PCT/US2014/013276, dated May 20, 2014.",ACTIVE
318,US,A,US 6100437 A,094-897-816-129-667,2000-08-08,2000,US 11365098 A,1998-07-10,US 11365098 A,1998-07-10,Alkylation process of alkyl-benzene with olefin using a sodium-and-potassium catalyst,"An alkylbenzene is alkylated with an alkene, in the presence of a sodium/potassium alloy catalyst, on a saturated carbon atom which is alpha to the ring at temperatures which are lower than the temperatures used in a current commercial process. In a pre-alkylation reaction, the catalyst is reacted with a compound which has a saturated carbon atom alpha to a double bond in order to form a catalytic species. Higher amounts of catalyst are used in the pre-alkylation reaction than in the analogous reaction of the current commercial process. Following alkylation, the phase which contains the alkylation product is separated from the phase which contains the catalytic species. The process produces less isomeric and other soluble byproducts, and enables the efficacious production of longer chain alkylbenzenes without the formation of insoluble tars characteristic of the current commercial process.",ALBEMARLE CORP,KOEHL DAVID J;;BURT EDWARD A;;WARD PATRICK T,ALBEMARLE CORPORATION (1998-08-03),https://lens.org/094-897-816-129-667,Granted Patent,yes,14,7,7,7,0,B01J23/04;;C07C2/72;;C07C2531/12;;Y02P20/52;;B01J23/04;;C07C2/72;;C07C2531/12;;Y02P20/52,B01J23/04;;C07C2/72,585/452;;585/457,2,2,029-474-525-825-61X;;091-018-429-357-624,10.1021/ja01503a041;;10.1016/b978-0-12-557150-0.50010-1,"Schramm et al., The Alkali Metal Catalyzed Alkylation of Toluene with Propylene , Journal of Am. Chem. Soc., 1960, vol. 82, pp. 4912 4918.;;Herman Pines and Wayne Stalick, Academic Press, Base Catalyzed Reactions of Hydrocarbons and Related Compounds, 1977, pp. 240 308.",EXPIRED
319,SE,L,SE 8704753 L,163-042-167-430-990,1988-05-29,1988,SE 8704753 A,1987-11-27,GB 8628472 A,1986-11-28,VENTILAGGREGAT,,GLAXO GROUP LTD,THOMAS J H;;HUTCHINSON A;;BURT P C W,,https://lens.org/163-042-167-430-990,Abstract,no,0,0,26,26,0,B65D83/54,B65D83/14;;B05B9/04,,0,0,,,,PENDING
320,US,B2,US 8631591 B2,168-424-797-811-785,2014-01-21,2014,US 69533210 A,2010-01-28,US 69533210 A;;US 14802209 P,2009-01-28,Replaceable traction cleat for footwear,Adjustable traction is provided in a traction cleat by selectively restricting or not the amount of flexure permitted for a dynamic traction element on the cleat. Restricting flexure is alternatively achieved by an adjustably positionable ring or by rotating the cleat to align the dynamic element with different shoe sole topographical features. A dual locking post is provided to reduce the surface area required on the cleat hub for locking structures. The cleat is formed in a two shot molding process that permits elongations of the dynamic traction elements without sacrificing the integrity of the cleat structure.,KRIKORIAN RAND J;;BURT JOHN ROBERT;;MCMULLIN FARIS W;;PRIDE MFG CO LLC,KRIKORIAN RAND J;;BURT JOHN ROBERT;;MCMULLIN FARIS W,PRIDE MANUFACTURING COMPANY LLC (2010-04-13),https://lens.org/168-424-797-811-785,Granted Patent,yes,21,6,9,9,0,A43C15/162;;A43C15/16;;A43C15/162;;A43C15/168;;A43B5/00;;A43C15/161,A43B5/00;;A43C15/00;;A43B23/28,36/134;;X 36 67 A;;X 36 67 D;;36/127,0,0,,,,ACTIVE
321,US,A1,US 2013/0326909 A1,055-520-333-375-594,2013-12-12,2013,US 201313963533 A,2013-08-09,US 201313963533 A;;US 75760110 A;;US 16824509 P,2009-04-10,Attachment and Locking System for Replaceable Traction Cleats,A thinner shoe mounted receptacle results from a thin cleat attachment flange received in a shallow receptacle cavity. An angled interface between the cleat and receptacle provide a friction fit engagement to minimize inadvertent disengagement of the cleat and receptacle. Rotational locking occurring inside or outside the cavity further prevents inadvertent cleat rotation. Multiple positionally synchronized angular stops positively define the final angular orientation of the cleat in the receptacle.,SOFTSPIKES LLC,BURT JOHN ROBERT;;SHUTTLEWORTH LEE PAUL;;KRIKORIAN RAND J,,https://lens.org/055-520-333-375-594,Patent Application,yes,0,0,15,15,0,A43C15/161;;A43C15/161;;A43C15/02,A43C15/02,36/62,0,0,,,,ACTIVE
322,US,A1,US 2005/0283564 A1,104-539-710-399-221,2005-12-22,2005,US 87207404 A,2004-06-18,US 87207404 A,2004-06-18,Method and apparatus for data set migration,"A method and apparatus for migrating one or more data sets each having one or more extents from one or more source logical devices to one or more target logical devices concurrently with interaction between the application and the data being migrated. A background operation copies each extent from the source logical device to the target logical device in a copy state. When a certain level of data has been copied, the extent is locked to assure synchronization of the data in the target logical device to the corresponding data in the source logical device. The status is changed to a mirrored state. When the extents for a data set in a source logical device or in a group of data sets have been mirrored, all the extents are changed to a diverted state. I/O requests to the diverted extents thereafter are intercepted and processed according to whether they access an extent that is in the copy, mirrored, or diverted state.",LECRONE DOUGLAS E;;LINSTEAD PAUL A;;BURT DENIS J,LECRONE DOUGLAS E;;LINSTEAD PAUL A;;BURT DENIS J,EMC CORPORATION (2004-06-17);;EMC IP HOLDING COMPANY LLC (2016-09-06),https://lens.org/104-539-710-399-221,Patent Application,yes,38,41,2,3,0,G06F3/0646;;G06F3/0646;;G06F3/0617;;G06F3/0617;;G06F3/0689;;G06F3/0689,G06F17/30,711/100,0,0,,,,ACTIVE
323,US,B2,US 7707186 B2,128-690-191-282-509,2010-04-27,2010,US 87207404 A,2004-06-18,US 87207404 A,2004-06-18,Method and apparatus for data set migration,"A method and apparatus for migrating one or more data sets each having one or more extents from one or more source logical devices to one or more target logical devices concurrently with interaction between the application and the data being migrated. A background operation copies each extent from the source logical device to the target logical device in a copy state. When a certain level of data has been copied, the extent is locked to assure synchronization of the data in the target logical device to the corresponding data in the source logical device. The status is changed to a mirrored state. When the extents for a data set in a source logical device or in a group of data sets have been mirrored, all the extents are changed to a diverted state. I/O requests to the diverted extents thereafter are intercepted and processed according to whether they access an extent that is in the copy, mirrored, or diverted state.",EMC CORP,LECRONE DOUGLAS E;;LINSTEAD PAUL A;;BURT DENIS J,EMC CORPORATION (2004-06-17);;EMC IP HOLDING COMPANY LLC (2016-09-06),https://lens.org/128-690-191-282-509,Granted Patent,yes,38,30,2,3,0,G06F3/0646;;G06F3/0646;;G06F3/0617;;G06F3/0617;;G06F3/0689;;G06F3/0689,G06F7/00;;G06F17/30,707/656;;707/659,0,0,,,,ACTIVE
324,FR,B1,FR 2574342 B1,131-741-436-092-902,1989-04-07,1989,FR 8513602 A,1985-09-13,US 67884784 A,1984-12-06,STRUCTURE FILAMENTAIRE MODULAIRE POUR COMPOSITES,,AVCO CORP,GRANT WILLIAM F;;BURT GARY W;;KUMNICK ALBERT J,,https://lens.org/131-741-436-092-902,Granted Patent,no,0,0,13,13,0,B22F2998/00;;C22C47/064;;C22C47/20;;B29L2031/06;;B29C70/545;;B29C2793/0045;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;B29C70/347;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;C22C47/064;;C22C47/20;;B22F2998/00;;B29C70/545;;B29L2031/06;;B29C2793/0045,B21C37/02;;B32B15/01;;C22C47/06;;C22C47/20;;B29B15/08,,0,0,,,,EXPIRED
325,US,B2,US 8667714 B2,176-072-480-812-345,2014-03-11,2014,US 201313963533 A,2013-08-09,US 201313963533 A;;US 75760110 A;;US 16824509 P,2009-04-10,Attachment and locking system for replaceable traction cleats,A thinner shoe mounted receptacle results from a thin cleat attachment flange received in a shallow receptacle cavity. An angled interface between the cleat and receptacle provide a friction fit engagement to minimize inadvertent disengagement of the cleat and receptacle. Rotational locking occurring inside or outside the cavity further prevents inadvertent cleat rotation. Multiple positionally synchronized angular stops positively define the final angular orientation of the cleat in the receptacle.,SOFTSPIKES LLC;;PRIDE MFG CO LLC,BURT JOHN ROBERT;;SHUTTLEWORTH LEE PAUL;;KRIKORIAN RAND J,,https://lens.org/176-072-480-812-345,Granted Patent,yes,29,2,15,15,0,A43C15/161;;A43C15/161;;A43C15/02,A43C15/02,36/134;;X 36 67 D;;36/127,3,0,,,"JP Office Action dated May 31, 2013 cited in corresponding JP 2011-508727.;;European Search Report received in counterpart application PCT/US2010030551, dated Feb. 5, 2013.;;International Search Report and Written Opinion received in PCT/US10/30551 dated Sep. 1, 2010, pp. 1-14.",ACTIVE
326,WO,A1,WO 2009/029178 A1,189-821-770-575-365,2009-03-05,2009,US 2008/0009822 W,2008-08-15,US 89619507 A,2007-08-30,EXCAVATING SYSTEM UTILIZING MACHINE-TO-MACHINE COMMUNICATION,"A method for enhancing productivity for an excavating operation is disclosed. The method includes establishing a machine-to-machine communication system (48) for a fleet of machines, including at least two machines (10, 11, 13). The method also includes removing material during the excavating operation with at least a first machine (10) of the fleet of machines. The method additionally includes operating a second machine (11) of the fleet of machines in a mode involving contact between at least the first machine and the second machine. The method further includes employing the machine-to-machine communication system to effect controlled contact between at least the first machine and the second machine.",CATERPILLAR INC;;MOREY STEPHEN J;;VIK TIMOTHY A;;BURT QUENTIN D,MOREY STEPHEN J;;VIK TIMOTHY A;;BURT QUENTIN D,,https://lens.org/189-821-770-575-365,Patent Application,yes,5,2,3,3,0,E02F3/651;;E02F3/651;;E02F3/6436;;E02F3/6436;;E02F3/6481;;E02F3/6481;;E02F9/2045;;E02F9/2045,E02F3/65;;E02F9/20,,0,0,,,,PENDING
327,US,A,US 3875270 A,023-214-292-923-542,1975-04-01,1975,US 48439874 A,1974-07-01,US 48439874 A;;US 37317873 A,1973-06-25,PROCESS OF PREPARING BATTERY SEPARATORS,An inert filler is mixed with a thermoplastic resin emulsion prior to spray drying the emulsion. The resultant resin powder is sintered to form high strength microporous diaphragms.,ETHYL CORP,HAEFNER ALBERT J;;GLASS JOSEPH B;;BURT WILLIAM E,GEORGIA-PACIFIC CORPORATION A GA CORP (1983-11-28);;NCNB NATIONAL BANK OF NORTH CAROLINA (1986-10-28);;GEORGIA-PACIFIC CHEMICALS INC. (1984-08-27),https://lens.org/023-214-292-923-542,Granted Patent,no,5,18,1,1,0,B29C67/205;;C08K3/36;;H01M2300/0005;;Y10S524/904;;Y10S521/919;;Y10T428/249921;;Y10T428/249979;;Y02E60/10;;H01M50/491;;H01M50/414;;Y10T428/249921;;Y10T428/249979;;H01M2300/0005;;C08K3/36;;B29C67/205;;Y10S524/904;;Y10S521/919;;H01M50/414;;H01M50/491,B29C67/20;;C08K3/36;;H01M50/414;;H01M50/491,264/6,0,0,,,,EXPIRED
328,CA,A,CA 608326 A,010-894-948-616-87X,1960-11-08,1960,CA 608326D A,,CA 608326T A,,SENSITIZATION OF PHOTOGRAPHIC EMULSIONS WITH IONIC POLYALKYLENE OXIDE SALTS,,CANADIAN KODAK CO LTD,BEAVERS DOROTHY J;;CARROLL BURT H;;SAGAL JOHN JR,,https://lens.org/010-894-948-616-87X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
329,US,A,US 4697324 A,035-909-672-169-656,1987-10-06,1987,US 67884784 A,1984-12-06,US 67884784 A,1984-12-06,Filamentary structural module for composites,This invention includes a continuous in-plane spiral of monofilament/metallic ribbon which forms a preform for metal matrix composite fabrication. The purpose is to provide continuous spiral filament reinforcement around a hole or central core. This spiral monolayer is fabricated by co-winding the filament and a ribbon or wire made from the intended composite material around a mandrel. Monolayers so constructed could then be stacked to form cylindrical or torus-shaped components and consolidated in a direction parallel to the axis of the shape.,AVCO CORP,GRANT WILLIAM F;;BURT GARY W;;KUMNICK ALBERT J,AVCO CORPORATION (1984-11-29);;TEXTRON SYSTEMS CORPORATION (1996-12-20);;SPECIALTY MATERIALS INCORPORATED (2002-03-28),https://lens.org/035-909-672-169-656,Granted Patent,yes,8,39,13,13,0,B22F2998/00;;C22C47/064;;C22C47/20;;B29L2031/06;;B29C70/545;;B29C2793/0045;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;B29C70/347;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;C22C47/064;;C22C47/20;;B22F2998/00;;B29C70/545;;B29L2031/06;;B29C2793/0045,B21C37/02;;B32B15/01;;C22C47/06;;B29B15/08;;C22C47/20,29419R;;228/190;;428/37;;428/65;;428/608,0,0,,,,EXPIRED
330,US,B1,US 6273810 B1,070-409-825-183-714,2001-08-14,2001,US 39360699 A,1999-09-10,US 39360699 A,1999-09-10,Inflatable air cell having combined pneumatically adjusted occupant support and thermal conditioning,An air cell support system for vehicle seat and mattress applications includes an air cell constructed from facing sheets of flexible material that are sealed along their marginal edges. One of the sheets is impermeable and the other of the sheets is perforated to direct air from the air cell for ventilating an occupant support surface while providing a source of pressure for inflating the air cell.,MCCORD WINN TEXTRON INC,RHODES JR RICHARD D;;MORAN SCOTT J;;BURT STEPHEN,KONGSBERG AUTOMOTIVE SP.Z O.O (2011-12-08);;MCCORD WINN TEXTRON INC (2000-09-28);;KONGSBERG AUTOMOTIVE LIMITED (2004-04-06),https://lens.org/070-409-825-183-714,Granted Patent,yes,12,224,4,4,0,A47C4/54;;A47C7/467;;A47C7/744;;A47C21/044;;A47C21/048;;A47C27/082;;A47C27/083;;A47C27/10;;A47C27/18;;B60N2/5657;;B60N2/914;;B60N2/5628;;A47C27/10;;A47C7/744;;A47C4/54;;A47C27/082;;A47C7/467;;A47C27/083;;A47C21/048;;A47C21/044;;A47C27/18;;B60N2/5657;;B60N2/914,A47C7/46;;A47C7/74;;A47C27/10,454/120;;6/652.2;;6/654;;6/655.3;;297/180.13;;297/452.47,0,0,,,,EXPIRED
331,US,B2,US 8229631 B2,086-680-817-980-480,2012-07-24,2012,US 88916907 A,2007-08-09,US 88916907 A,2007-08-09,Wheel tractor scraper production optimization,A method for enhancing productivity for an excavating machine is disclosed. The method includes determining at least one cycle characteristic for an operating cycle of the excavating machine. The method also includes measuring payload accumulated by the machine during a loading phase of an operating cycle of the excavating machine. The method further includes controlling payload accumulated by the machine based on at least one of the at least one determined cycle characteristics.,MOREY STEPHEN J;;VIK TIMOTHY A;;BURT QUENTIN D;;CATERPILLAR INC,MOREY STEPHEN J;;VIK TIMOTHY A;;BURT QUENTIN D,CATERPILLAR INC (2007-07-30),https://lens.org/086-680-817-980-480,Granted Patent,yes,47,25,2,2,0,E02F3/6436;;E02F3/6481;;E02F3/651;;E02F9/26;;E02F3/651;;E02F3/6481;;E02F3/6436;;E02F9/26,G06F7/00,701/50;;37/414,1,0,,,"""Optimum Scraper Load Time,"" Caterpillar publication, 1994, 16 pages.",INACTIVE
332,US,A1,US 2005/0190990 A1,156-811-329-374-304,2005-09-01,2005,US 4415505 A,2005-01-27,US 4415505 A;;US 54010004 P,2004-01-27,Method and apparatus for combining a plurality of images,"A method and apparatus for combining a plurality of images is disclosed. In one embodiment, at least one signal component is determined from a plurality of source images using feature selective fusion. At least one color component is determined from the plurality of source images using color fusion. An output image is formed from the at least one signal component and the at least one color component. In another embodiment, at least one image component is determined from a plurality of source images using feature selective fusion. An output image is formed from the at least one image component using color fusion.",BURT PETER J.;;DER WAL GOOITZEN V.;;ZHANG CHAO,BURT PETER J;;DER WAL GOOITZEN V;;ZHANG CHAO,SARNOFF CORPORATION (2005-05-06),https://lens.org/156-811-329-374-304,Patent Application,yes,16,75,3,3,0,G06T5/50;;G06T5/50,G03G9/00;;G06K9/32;;G06K9/36,382/294;;382/284,0,0,,,,DISCONTINUED
333,US,B1,US 8732364 B1,163-919-561-104-569,2014-05-20,2014,US 92570910 A,2010-10-28,US 92570910 A,2010-10-28,Transfer of data storage device features,"Transferring storage device functionality includes providing a device coupled to the storage device, where the device is separate from the storage device, having the device handle I/O requests between an application and the storage device, and, in response to the application issuing an I/O request, having the device determine if the request corresponds to functionality being transferred and, if so, having the device provide the functionality. The device may be a host computer. The application may run on the host computer. A driver on the host computer may provide the functionality. The functionality may include read only functionality, data compression, data encryption, mirroring, and/or status reporting.",LECRONE DOUGLAS E;;LINSTEAD PAUL A;;BURT DENIS J;;EMC CORP,LECRONE DOUGLAS E;;LINSTEAD PAUL A;;BURT DENIS J,EMC CORPORATION (2010-10-28);;EMC IP HOLDING COMPANY LLC (2016-09-06),https://lens.org/163-919-561-104-569,Granted Patent,yes,9,4,2,2,0,G06F3/0664;;G06F3/0605;;G06F3/0653;;G06F3/0661;;G06F3/0689;;G06F11/3485;;G06F11/2056;;G06F11/3433;;G06F3/0661;;G06F3/0605;;G06F3/0653;;G06F3/0664;;G06F3/0689;;G06F11/2056;;G06F11/3485;;G06F11/3433;;G06F30/20,G06F3/00;;G06F13/00;;G06F13/38,710/74;;710/33;;710/15,0,0,,,,ACTIVE
334,WO,A1,WO 2000/002835 A1,198-835-638-405-151,2000-01-20,2000,US 9910238 W,1999-05-11,US 11365098 A,1998-07-10,ALKYLATION PROCESS,"An alkylbenzene is alkylated with an alkene, in the presence of a sodium/potassium alloy catalyst, on a saturated carbon atom which is alpha to the ring at temperatures which are lower than the temperatures used in a current commercial process. In a pre-alkylation reaction, the catalyst is reacted with a compound which has a saturated carbon atom alpha to a double bond in order to form a catalytic species. Higher amounts of catalyst are used in said pre-alkylation reaction than in the analogous reaction of said current commercial process. Following alkylation, the phase which contains the alkylation product is separated from the phase which contains the catalytic species. The process produces less isomeric and other soluble byproducts, and enables the efficacious production of longer chain alkylbenzenes without the formation of insoluble tars characteristic of said current commercial process.",ALBEMARLE CORP,KOEHL DAVID J;;BURT EDWARD A;;WARD PATRICK T,,https://lens.org/198-835-638-405-151,Patent Application,yes,1,3,7,7,0,B01J23/04;;C07C2/72;;C07C2531/12;;Y02P20/52;;B01J23/04;;C07C2/72;;C07C2531/12;;Y02P20/52,B01J23/04;;C07C2/72,,1,1,029-474-525-825-61X,10.1021/ja01503a041,"R. M. SCHRAMM ET AL: ""The Alkali Metal Catalyzed Alkyklation of Toluene with Propylene"", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY., vol. 82, 20 September 1960 (1960-09-20), WASHINGTON, DC., US, pages 4912 - 4917, XP002110842, ISSN: 0002-7863",PATENTED
335,US,A,US 4561305 A,116-892-672-717-569,1985-12-31,1985,US 50293783 A,1983-06-10,US 50293783 A,1983-06-10,Liquid sight gage cover,"A liquid level sight gage has an elongated chamber block with a liquid chamber, a lens covering the liquid chamber, and a cover with an elongated viewing slot secured to the block with the lens interposed therebetween. Side beams of the cover, through which bolts securing the cover to the chamber block extend, have ovate configurations, providing greater mass at their centers, thereby providing greater support towards the centers of the chamber block sidewalls where the tendency to bulge is greatest. The bolts extend through longitudinally spaced holes in the side beams in contact with the chamber sidewalls and are transversely supported by the side beams.",HOUDAILLE INDUSTRIES INC,TREMAIN DAVID L;;BEACH BURT L;;RIMINGTON DAVID J,PENBERTHY INC. A CORP. OF DE (1989-04-03);;STANWICH INDUSTRIES INC. 781 NORTH STREET GREENWICH CONNECTICUT 06830 A DE. CORP (1986-05-18);;PENBERTHY-HOUDAILLE INC (1985-01-31);;HOUDAILLE INDUSTRIES INC (1983-06-02);;STANWICH INDUSTRIES INC. A CORP. OF DE (1986-04-17),https://lens.org/116-892-672-717-569,Granted Patent,yes,10,5,1,1,0,B65D90/48;;B65D90/48,B65D90/48,73/323;;73/325,0,0,,,,EXPIRED
336,US,A,US 2599123 A,130-722-727-133-727,1952-06-03,1952,US 18030250 A,1950-08-18,US 18030250 A,1950-08-18,"Copolymers of ethylene with an alkyl acrylate and an alkyl monoester of a butene-1,4-dioic acid",,DU PONT,PINKNEY PAUL S;;PRATT BURT C;;WAYNE WINSTON J,,https://lens.org/130-722-727-133-727,Granted Patent,no,1,27,3,3,0,C08F220/12;;C08F220/12;;Y10T436/10;;Y10T436/10;;Y10T436/106664;;Y10T436/106664;;Y10T436/108331;;Y10T436/108331,C08F220/12;;C08F222/16,,0,0,,,,EXPIRED
337,US,A1,US 2013/0318821 A1,157-225-162-616-475,2013-12-05,2013,US 201313963495 A,2013-08-09,US 201313963495 A;;US 75760110 A;;US 16824509 P,2009-04-10,Traction Cleat for Footwear,A thinner shoe mounted receptacle results from a thin cleat attachment flange received in a shallow receptacle cavity. An angled interface between the cleat and receptacle provide a friction fit engagement to minimize inadvertent disengagement of the cleat and receptacle. Rotational locking occurring inside or outside the cavity further prevents inadvertent cleat rotation. Multiple positionally synchronized angular stops positively define the final angular orientation of the cleat in the receptacle.,SOFTSPIKES LLC,BURT JOHN ROBERT;;SHUTTLEWORTH LEE PAUL;;KRIKORIAN RAND J,,https://lens.org/157-225-162-616-475,Patent Application,yes,0,0,15,15,0,A43C15/161;;A43C15/161;;A43C15/02,A43C15/02,36/62,0,0,,,,ACTIVE
338,EP,A1,EP 2375930 A1,019-671-590-017-969,2011-10-19,2011,EP 10762500 A,2010-04-09,US 2010/0030551 W;;US 16824509 P,2009-04-10,RECEPTACLE FOR REPLACEABLY MOUNTING A TRACTION CLEAT,,PRIDE MFG CO LLC,BURT JOHN ROBERT;;SHUTTLEWORTH LEE PAUL;;KRIKORIAN RAND J,,https://lens.org/019-671-590-017-969,Patent Application,yes,0,0,15,15,0,A43C15/161;;A43C15/161;;A43C15/02,A43C15/16,,0,0,,,,ACTIVE
339,WO,A3,WO 2005/097979 A3,030-706-921-815-654,2006-01-26,2006,US 2005/0010610 W,2005-03-31,US 55801804 P,2004-03-31,METHODS AND COMPOSITIONS FOR OBTAINING HEMATOPOIETIC STEM CELLS DERIVED FROM EMBRYONIC STEM CELLS AND USES THEREOF,"The present invention provides an isolated population of adult hematopoietic stem cells (HSC) derived from embryonic stem cells (ESC) induced to differentiate in vitro by culturing ESCs in a medium with stem cell factor, interleukin (IL)-3, and IL-6. HSC of immunophenotype c-kit+ or c-kit+/CD45+from this population are isolated and injected either intra bone marrow or intravenously into myeloablated recipient individuals. This method allows for the establishment of banks of allogeneic ESC-derived adult stem cells for treatments of autoimmune diseases, immune deficiencies and induction of immunotolerance during organ transplantation. These allogeneic ESC-derived adult hematopoietic stem cells (HSC) may be used in reconstituting bone marrow, without the development of teratomas or graft versus host disease, despite crossing histocompatibility barriers. Additionally, allogeneic ESC-derived HSC can be used to prevent the development of autoimmune diseases or organ rejection during transplantation.",NEWLINK GENETICS CORP;;BURT RICHARD K;;VERDA LARISSA;;LINK CHARLES J JR,BURT RICHARD K;;VERDA LARISSA;;LINK CHARLES J JR,,https://lens.org/030-706-921-815-654,Search Report,yes,0,0,5,5,0,A61K2035/122;;A61K2035/124;;C12N5/0647;;C12N2501/125;;C12N2501/23;;C12N2506/02;;C12N2533/70;;C12N5/0647;;C12N2506/02;;A61K2035/124;;C12N2533/70;;A61K2035/122;;C12N2501/125;;C12N2501/23,A61K35/12;;C12N5/0789,,7,4,028-260-133-624-384;;085-129-927-991-120;;101-858-993-446-057;;000-347-047-547-066,12482507;;10.1016/s0301-472x(02)00961-x;;10.1016/s0301-472x(00)00653-6;;11166456;;9718862;;10.1016/s0301-472x(99)00020-x;;10340408,"MIYAGI T. ET AL: ""Flk1+ Cells Derived From Mouse Embryonic Stem Cells Reconstitute Hematopoiesis In Vivo in SCID Mice"", EXP. HEMATOLOGY, vol. 30, no. 12, December 2002 (2002-12-01), pages 1444 - 1453, XP002992703;;YAMAGUCHI M. ET AL: ""Serum-Free Coculture System for Ex Vivo Expansion of Human Cord Blood Primitive Progenitors and SCID mouse-Reconstituting Cells using Human Bone Marrow Primary Stromal Cells"", EXP. HEMATOLOGY, vol. 29, no. 2, February 2001 (2001-02-01), pages 174 - 182, XP002992704;;D'ARENA G. ET AL: ""Thy-1 (CDw90) and C-kit Receptor (CD117) Expression on CD34+ Hematopoietic Progenitor Cells: A Five Dimensional Flow Cytometric Study"", HAEMATOLOGICA, vol. 83, no. 2, July 1998 (1998-07-01), pages 587 - 592, XP008055550;;XIAO M. ET AL: ""Expression of Flt3 and c-kit During Growth and Maturation of human CD37+ CD38-cells"", EXP. HEMATOLOGY, vol. 27, no. 5, May 1999 (1999-05-01), pages 916 - 927, XP002992705;;ZAMBIDIS E.T. ET AL: ""Efficient Stromal-Free Generation of Primitive Human Hematopoietic Progenitors from Human Embryonic Stem Cells"", BLOOD, vol. 102, no. 11, 16 November 2003 (2003-11-16), pages 168A, XP008055621;;BURT R.K. ET AL: ""Embryonic Stem Cells as an Alternative Donor Marrow Source"", BLOOD, vol. 102, no. 11, 16 November 2003 (2003-11-16), pages 76A, XP008055620;;NARAYAN A.D. ET AL: ""In-Vitro and In-Vivo Hematopoietic Potential of Human Embryonic Stem Cells"", BLOOD, vol. 100, no. 11, 16 November 2002 (2002-11-16), XP008055619",PENDING
340,JP,A,JP 2013121529 A,051-861-503-058-576,2013-06-20,2013,JP 2013022231 A,2013-02-07,US 16824509 P,2009-04-10,METHOD AND APPARATUS FOR INTERCONNECTING TRACTION CLEAT AND RECEPTACLE,PROBLEM TO BE SOLVED: To provide an improved method and apparatus for interconnecting traction cleats and cleat receptacles for athletic shoes.SOLUTION: A thinner shoe mounted receptacle 150 results from a thin cleat 110 attachment flange received in a shallow receptacle cavity. An angled interface between the cleat 110 and receptacle 150 provide a friction fit engagement to minimize inadvertent disengagement of the cleat 110 and receptacle 150. Rotational engagement occurring inside or outside the cavity further prevents inadvertent cleat 110 rotation. Multiple positionally synchronized angular stops positively define the final angular orientation of the cleat 110 in the receptacle 150.,PRIDE MFG CO LLC,BURT JOHN ROBERT;;SHUTTLEWORTH LEE PAUL;;KRIKORIAN RAND J,,https://lens.org/051-861-503-058-576,Patent Application,no,3,0,15,15,0,A43C15/161;;A43C15/161;;A43C15/02,A43C13/04;;A43B5/00,,0,0,,,,DISCONTINUED
341,ES,T3,ES 2205817 T3,077-450-576-784-234,2004-05-01,2004,ES 99921848 T,1999-05-11,US 11365098 A,1998-07-10,PROCEDIMIENTO DE ALQUILACION.,"Un procedimiento de alquilación que comprende: A) formar una mezcla de reacción a partir de componentes que comprenden (i) un alqueno de más de dos átomos de carbono, (ii) un alquilbenceno que tiene al menos un átomo de hidrógeno en el átomo de carbono alfa del grupo alquilo y (iii) una composición de catalizador de alquilación de organometal alcalino que comprende átomos de sodio, átomos de potasio y un alquilbenceno, estando la relación de potasio a alquilbenceno en el intervalo de 0, 03 a 0, 10 moles de potasio por mol de alquilbenceno, y estando la relación de sodio a potasio en el intervalo de 0, 1 a 10, 0 átomos de sodio por átomo de potasio y B) mantener la temperatura de dicha mezcla de reacción en el intervalo de 130ºC a 160ºC durante de 1 hora a 10 horas, a las que el alquilbenceno de la misma se alquila sobre dicho átomo de carbono alfa para producir una masa de reacción que comprende (iv) un alquilbenceno de cadena más larga y (v) residuo de catalizador que comprende átomos de sodio y potasio, y retirar de dicha masa de reacción al menos una porción de dicho alquilbenceno de cadena más larga.",ALBEMARLE CORP,KOEHL DAVID J;;BURT EDWARD A;;WARD PATRICK T,,https://lens.org/077-450-576-784-234,Granted Patent,no,0,0,7,7,0,B01J23/04;;C07C2/72;;C07C2531/12;;Y02P20/52;;B01J23/04;;C07C2/72;;C07C2531/12;;Y02P20/52,B01J23/04;;C07C2/72,,0,0,,,,EXPIRED
342,US,A1,US 2005/0221482 A1,114-937-918-135-213,2005-10-06,2005,US 9497705 A,2005-03-31,US 9497705 A;;US 55801804 P,2004-03-31,Methods and compositions for obtaining hematopoietic stem cells derived from embryonic stem cells and uses thereof,"The present invention provides an isolated population of adult hematopoietic stem cells (HSC) derived from embryonic stem cells (ESC) induced to differentiate in vitro by culturing ESCs in a medium with stem cell factor, interleukin (IL)-3, and IL-6. HSC of immunophenotype c-kit + or c-kit+/CD45 + from this population are isolated and injected either intra bone marrow or intravenously into myeloablated recipient individuals. This method allows for the establishment of banks of allogeneic ESC-derived adult stem cells for treatments of autoimmune diseases, immune deficiencies and induction of immunotolerance during organ transplantation. These allogeneic ESC-derived adult hematopoietic stem cells (HSC) may be used in reconstituting bone marrow, without the development of teratomas or graft versus host disease, despite crossing histocompatibility barriers. Additionally, allogeneic ESC-derived HSC can be used to prevent the development of autoimmune diseases or organ rejection during transplantation.",BURT RICHARD K;;VERDA LARISSA;;LINK CHARLES J JR,BURT RICHARD K;;VERDA LARISSA;;LINK CHARLES J JR,NEWLINK GENETICS (2005-04-11);;NORTHWESTERN UNIVERSITY (2005-04-27),https://lens.org/114-937-918-135-213,Patent Application,yes,5,19,5,5,0,A61K2035/122;;A61K2035/124;;C12N5/0647;;C12N2501/125;;C12N2501/23;;C12N2506/02;;C12N2533/70;;C12N5/0647;;C12N2506/02;;A61K2035/124;;C12N2533/70;;A61K2035/122;;C12N2501/125;;C12N2501/23,A61K35/12;;C12N5/0789,435/372;;435/354,0,0,,,,DISCONTINUED
343,CN,A,CN 1239880 A,157-689-727-692-105,1999-12-29,1999,CN 97180337 A,1997-10-08,US 73815696 A,1996-10-25,Styling shampoo compositions with improved styling polymer deposition,,PROCTER & GAMBLE,SNYDER MICHAEL A;;HILL BURT L;;INMAN EVERETT J,,https://lens.org/157-689-727-692-105,Patent Application,no,0,1,23,23,0,A61K8/31;;A61K8/416;;A61K8/44;;A61K8/73;;A61K8/731;;A61K8/737;;A61K8/8152;;A61K8/8182;;A61K8/891;;A61K8/895;;A61K2800/5426;;A61K2800/594;;A61Q5/02;;A61Q5/06;;A61K8/72;;A61Q5/00;;A61K8/895;;A61K8/891;;A61K8/8182;;A61K2800/5426;;A61K8/31;;A61Q5/02;;A61K8/731;;A61K2800/594;;A61K8/73;;A61K8/416;;A61K8/8152;;A61Q5/06;;A61K8/737;;A61K8/44,A61K8/00;;A61K8/31;;A61K8/37;;A61K8/40;;A61K8/41;;A61K8/44;;A61K8/46;;A61K8/72;;A61K8/73;;A61K8/81;;A61K8/89;;A61K8/891;;A61K8/895;;A61K8/896;;A61Q5/00;;A61Q5/02;;A61Q5/06;;C08L83/04;;C11D3/20,,0,0,,,,EXPIRED
344,EP,B1,EP 2375930 B1,185-550-620-333-515,2018-10-31,2018,EP 10762500 A,2010-04-09,US 2010/0030551 W;;US 16824509 P,2009-04-10,RECEPTACLE FOR REPLACEABLY MOUNTING A TRACTION CLEAT,,PRIDE MFG CO LLC,BURT JOHN ROBERT;;SHUTTLEWORTH LEE PAUL;;KRIKORIAN RAND J,,https://lens.org/185-550-620-333-515,Granted Patent,yes,10,0,15,15,0,A43C15/161;;A43C15/161;;A43C15/02,A43C15/16,,0,0,,,,ACTIVE
345,US,A1,US 2015/0377048 A1,022-632-466-526-80X,2015-12-31,2015,US 201414766178 A,2014-01-28,US 201414766178 A;;US 201361767870 P;;US 2014/0013276 W,2013-02-22,STATOR VANE ASSEMBLY AND METHOD THEREFORE,"A stator vane assembly includes a plurality of distinct vane segments that each respectively include a first platform, a second platform and at least one vane airfoil connected at opposed ends thereof to the first platform and the second platform. The first platforms meet at distinct first joints with each other, and the second platforms meet at distinct second joints with each other such that the plurality of vane segments forms an annular structure.",UNITED TECHNOLOGIES CORP,FARAH JORGE I;;BURT JONATHAN P;;PRAISNER THOMAS J,RTX CORPORATION (2023-07-14),https://lens.org/022-632-466-526-80X,Patent Application,yes,7,2,3,3,0,F01D25/162;;F02C7/20;;F05D2230/23;;F01D25/162;;F02C7/20;;F05D2230/23;;F01D9/047;;F05D2240/12;;F05D2240/80,F01D9/04;;F02C7/20,,0,0,,,,ACTIVE
346,US,A1,US 2002/0137828 A1,027-782-200-419-228,2002-09-26,2002,US 9903602 A,2002-03-15,US 9903602 A;;US 69213896 A,1996-08-05,Waterborne soft-feeling coating composition with high gloss,"
   A waterborne, soft feeling coating composition and a substrate coated with the composition. The coating composition comprises an aqueous solvent, a resin, and an alcohol alkoxylate surfactant. The invention is also directed to a process of making the waterborne coating composition of the invention, and a process of coating a substrate with the waterborne coating composition. 
",RUGGIERO MURRAY A.;;CHUBB HAROLD W.;;BURT DIANE J.,RUGGIERO MURRAY A;;CHUBB HAROLD W;;BURT DIANE J,MONUMENT CHEMICAL KENTUCKY LLC (2012-12-27),https://lens.org/027-782-200-419-228,Patent Application,yes,0,14,4,4,0,C08G18/6254;;C08K5/06;;C08L71/00;;C09D175/04;;C08K5/06;;C08L71/00;;C09D175/04;;C08G18/6254,C08G18/62;;C08K5/06;;C08L71/00;;C09D175/04,524/376;;524/431;;524/432;;524/445;;524/451,0,0,,,,EXPIRED
347,CA,A,CA 561281 A,056-856-746-798-70X,1958-08-05,1958,CA 561281D A,,CA 561281T A,,PROCESS FOR MARGARINE MANUFACTURE,,CANADA PACKERS LTD,TEASDALE BARTON F;;BURT ROBERT A;;MCGOWAN RAYMOND J,,https://lens.org/056-856-746-798-70X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
348,EP,A2,EP 1735429 A2,149-034-227-460-01X,2006-12-27,2006,EP 05732221 A,2005-03-31,US 2005/0010610 W;;US 55801804 P,2004-03-31,METHODS AND COMPOSITIONS FOR OBTAINING HEMATOPOIETIC STEM CELLS DERIVED FROM EMBRYONIC STEM CELLS AND USES THEREOF,,NEWLINK GENETICS CORP,BURT RICHARD K;;VERDA LARISSA;;LINK CHARLES J JR,,https://lens.org/149-034-227-460-01X,Patent Application,yes,0,0,5,5,0,A61K2035/122;;A61K2035/124;;C12N5/0647;;C12N2501/125;;C12N2501/23;;C12N2506/02;;C12N2533/70;;C12N5/0647;;C12N2506/02;;A61K2035/124;;C12N2533/70;;A61K2035/122;;C12N2501/125;;C12N2501/23,C12N5/00;;A61K35/12;;C12N5/02;;C12N5/0789;;C12N5/10,,0,0,,,,DISCONTINUED
349,US,B1,US 7685129 B1,144-326-950-351-050,2010-03-23,2010,US 95648404 A,2004-10-01,US 95648404 A;;US 87207404 A,2004-06-18,Dynamic data set migration,"Determining when to migrate a data set includes providing performance criteria for the data set, measuring performance of the data set to provide a measured performance of the data set, and, if the measured performance indicates that the data set is not performing according to the performance criteria, choosing a new location for migrating the data set and migrating the data set to the new location. Migrating the data set may include moving the data set to a new location irrespective of whether other applications are accessing the data set. Choosing a new location may include analyzing each of a plurality of locations to determine if a projected performance thereof is according to the performance criteria. Determining when to migrate a data set may include adjusting the performance criteria after the data set has been made operational.",EMC CORP,LECRONE DOUGLAS E;;LINSTEAD PAUL A;;BURT DENIS J,EMC CORPORATION (2004-10-29);;EMC IP HOLDING COMPANY LLC (2016-09-06),https://lens.org/144-326-950-351-050,Granted Patent,yes,9,30,1,3,0,G06F3/0647;;G06F3/0647;;G06F3/0617;;G06F3/0617;;G06F3/0689;;G06F3/0689;;G06F11/1662;;G06F11/1662;;G06F11/2076;;G06F11/2076;;G06F11/3419;;G06F11/3419;;G06F11/3485;;G06F11/3485,G06F17/30;;G06F12/00,707/10;;707/2;;707/200;;707/204,1,0,,,"U.S. Appl. No. 10/283,976, filed Oct. 30, 2002, Lecrone, et al.",ACTIVE
350,US,A,US 5172781 A,144-856-680-318-178,1992-12-22,1992,US 81685592 A,1992-01-02,US 81685592 A;;US 42822689 A;;US 69117691 A,1989-10-27,Scale for fluidized bed and method for using same,"A fluidized bead bed having a scale integrated into the frame of the bed for providing a continuous readout of the weight of a patient supported on the upper surface of the bed. The bed includes a fluidized bead bed support mounted atop a frame such that a torque, corresponding to the supported, load is transmitted to the beam arms cantilevered from each end of the frame and extending to the longitudinal median of the bed along one side thereof. Springs oppose the torque and LVDT's are provided at the distal ends of the arms to produce an electrical signal with pulses of an amplitude related to the weight of the patient on the bed. The distal ends of both beam arms are protected and confined in their movements by a lower guard in the form of a single U-shaped channel, and the springs are mounted to the frame by means of upstanding supports on the top surface thereof. A control panel incorporates a signal processor for providing an accurate but readable output based on the LVDT signals. The processor includes a synchronous detector, an analog low-pass filter, an A/D converter, and a digital filter. The digital filter effectuates a highly weighted average characterized by a filter coefficient which is ordinarilly 128 but may be automatically or selectively decreased in order to quicken an accurate readout following a rapid weight change.",KINETIC CONCEPTS INC,HLAVINKA DENNIS J;;HARRIS DOUGLAS S;;SWERSEY BURT L,KCI LICENSING INC (2001-09-19),https://lens.org/144-856-680-318-178,Granted Patent,yes,15,22,1,5,0,G01G19/445;;G01G19/445,G01G19/44,177/144;;5/449;;5/453,0,0,,,,EXPIRED
351,US,A1,US 2010/0257751 A1,177-759-830-693-989,2010-10-14,2010,US 75760110 A,2010-04-09,US 75760110 A;;US 16824509 P,2009-04-10,Method and Apparatus for Interconnecting Traction Cleats and Receptacles,A thinner shoe mounted receptacle results from a thin cleat attachment flange received in a shallow receptacle cavity. An angled interface between the cleat and receptacle provide a friction fit engagement to minimize inadvertent disengagement of the cleat and receptacle. Rotational locking occurring inside or outside the cavity further prevents inadvertent cleat rotation. Multiple positionally synchronized angular stops positively define the final angular orientation of the cleat in the receptacle.,SOFTSPIKES LLC,BURT JOHN ROBERT;;SHUTTLEWORTH LEE PAUL;;KRIKORIAN RAND J,PRIDE MANUFACTURING COMPANY LLC (2010-04-19),https://lens.org/177-759-830-693-989,Patent Application,yes,19,24,15,15,0,A43C15/161;;A43C15/161;;A43C15/02,A43C15/00;;A43B5/00,36/66;;X 12142  P,0,0,,,,ACTIVE
352,US,B2,US 7304268 B2,193-560-580-878-666,2007-12-04,2007,US 35555206 A,2006-02-16,US 35555206 A,2006-02-16,Method for rating stick electrodes for pipe welding,"Stick welding electrode rating and ranking procedures are provided for determining stackability performance of stick electrodes for pipe welding operations. The rating technique involves performance of a standardized vertical down weld procedure using a stick electrode to form a weld bead in a test workpiece groove, in which the electrode is maintained during welding at a substantially constant angle relative to the workpiece groove. The electrode is advanced toward the groove at a slow speed to deposit molten metal in the groove while keeping the molten metal above the stick electrode end or the arc thereof without dripping. The resulting bead distance is measured along with the welding time and the stick electrode is rated according to a ratio of the weld time and the bead distance.",LINCOLN GLOBAL INC,BURT RANDALL M;;DALLAM CRAIG B;;WEAVER ROBERT J,LINCOLN GLOBAL INC (2006-02-10),https://lens.org/193-560-580-878-666,Granted Patent,yes,6,3,2,2,0,B23K9/0286;;B23K31/12;;B23K2101/10;;B23K9/0286;;B23K31/12;;B23K2101/10,B23K9/095,219/130.01;;X219137 R;;228/103,0,0,,,,INACTIVE
353,US,A,US 977175 A,021-265-189-489-757,1910-11-29,1910,US 1909/0525345 A,1909-10-29,US 1909/0525345 A,1909-10-29,MACHINE FOR AFFIXING STAMPS AND LABELS.,,SIMPLEX MFG COMPANY,FANCHER CHARLES J;;BURT JAMES H;;WINKLE EDWARD VAN,,https://lens.org/021-265-189-489-757,Granted Patent,no,0,0,1,1,0,B65C11/046;;B65C11/046;;Y10T156/1339;;Y10T156/1339,,,0,0,,,,EXPIRED
354,DE,A1,DE 3535070 A1,036-752-393-021-492,1986-06-12,1986,DE 3535070 A,1985-09-28,US 67884784 A,1984-12-06,FADENFOERMIGES BAUELEMENT FUER VERBUNDKOERPER,,AVCO CORP,GRANT WILLIAM F;;BURT GARY W;;KUMNICK ALBERT J,,https://lens.org/036-752-393-021-492,Patent Application,no,3,0,13,13,0,B22F2998/00;;C22C47/064;;C22C47/20;;B29L2031/06;;B29C70/545;;B29C2793/0045;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;B29C70/347;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;C22C47/064;;C22C47/20;;B22F2998/00;;B29C70/545;;B29L2031/06;;B29C2793/0045,B29B15/08;;B21C37/02;;B32B15/01;;C22C47/06;;C22C47/20,,0,0,,,,EXPIRED
355,US,A1,US 2009/0062993 A1,094-451-028-213-765,2009-03-05,2009,US 89619507 A,2007-08-30,US 89619507 A,2007-08-30,Excavating system utilizing machine-to-machine communication,"A method for enhancing productivity for an excavating operation is disclosed. The method includes establishing a machine-to-machine communication system for a fleet of machines, including at least two machines. The method also includes removing material during the excavating operation with at least a first machine of the fleet of machines. The method additionally includes operating a second machine of the fleet of machines in a mode involving contact between at least the first machine and the second machine. The method further includes employing the machine-to-machine communication system to effect controlled contact between at least the first machine and the second machine.",CATERPILLAR INC,MOREY STEPHEN J;;VIK TIMOTHY A;;BURT QUENTIN D,CATERPILLAR INC (2007-08-27),https://lens.org/094-451-028-213-765,Patent Application,yes,45,18,3,3,0,E02F3/651;;E02F3/651;;E02F3/6436;;E02F3/6436;;E02F3/6481;;E02F3/6481;;E02F9/2045;;E02F9/2045,G06F19/00,701/50,0,0,,,,ACTIVE
356,WO,A1,WO 2010/088330 A1,116-062-003-836-242,2010-08-05,2010,US 2010/0022322 W,2010-01-28,US 14802209 P,2009-01-28,IMPROVED REPLACEABLE TRACTION CLEAT FOR FOOTWEAR,Adjustable traction is provided in a traction cleat by selectively restricting or not the amount of flexure permitted for a dynamic traction element on the cleat. Restricting flexure is alternatively achieved by an adjustably positionable ring or by rotating the cleat to align the dynamic element with different shoe sole topographical features. A dual locking post is provided to reduce the surface area required on the cleat hub for locking structures. The cleat is formed in a two shot molding process that permits elongations of the dynamic traction elements without sacrificing the integrity of the cleat structure.,PRIDE MFG CO LLC;;KRIKORIAN RAND J;;BURT JOHN ROBERT;;MCMULLIN FARIS W,KRIKORIAN RAND J;;BURT JOHN ROBERT;;MCMULLIN FARIS W,,https://lens.org/116-062-003-836-242,Patent Application,yes,5,1,9,9,0,A43C15/162;;A43C15/16;;A43C15/162;;A43C15/168;;A43B5/00;;A43C15/161,A43C15/00;;A43C15/02;;A43C15/04,,0,0,,,,PENDING
357,US,A1,US 2009/0043460 A1,120-931-991-532-434,2009-02-12,2009,US 88916907 A,2007-08-09,US 88916907 A,2007-08-09,Wheel tractor scraper production optimization,A method for enhancing productivity for an excavating machine is disclosed. The method includes determining at least one cycle characteristic for an operating cycle of the excavating machine. The method also includes measuring payload accumulated by the machine during a loading phase of an operating cycle of the excavating machine. The method further includes controlling payload accumulated by the machine based on at least one of the at least one determined cycle characteristics.,CATERPILLAR INC,MOREY STEPHEN J;;VIK TIMOTHY A;;BURT QUENTIN D,CATERPILLAR INC (2007-07-30),https://lens.org/120-931-991-532-434,Patent Application,yes,46,11,2,2,0,E02F3/6436;;E02F3/6481;;E02F3/651;;E02F9/26;;E02F3/651;;E02F3/6481;;E02F3/6436;;E02F9/26,G06G7/76,701/50,0,0,,,,INACTIVE
358,WO,A2,WO 2005/097979 A2,128-258-069-721-560,2005-10-20,2005,US 2005/0010610 W,2005-03-31,US 55801804 P,2004-03-31,METHODS AND COMPOSITIONS FOR OBTAINING HEMATOPOIETIC STEM CELLS DERIVED FROM EMBRYONIC STEM CELLS AND USES THEREOF,"The present invention provides an isolated population of adult hematopoietic stem cells (HSC) derived from embryonic stem cells (ESC) induced to differentiate in vitro by culturing ESCs in a medium with stem cell factor, interleukin (IL)-3, and IL-6. HSC of immunophenotype c-kit+ or c-kit+/CD45+from this population are isolated and injected either intra bone marrow or intravenously into myeloablated recipient individuals. This method allows for the establishment of banks of allogeneic ESC-derived adult stem cells for treatments of autoimmune diseases, immune deficiencies and induction of immunotolerance during organ transplantation. These allogeneic ESC-derived adult hematopoietic stem cells (HSC) may be used in reconstituting bone marrow, without the development of teratomas or graft versus host disease, despite crossing histocompatibility barriers. Additionally, allogeneic ESC-derived HSC can be used to prevent the development of autoimmune diseases or organ rejection during transplantation.",NEWLINK GENETICS CORP;;BURT RICHARD K;;VERDA LARISSA;;LINK CHARLES J JR,BURT RICHARD K;;VERDA LARISSA;;LINK CHARLES J JR,,https://lens.org/128-258-069-721-560,Patent Application,yes,0,7,5,5,0,A61K2035/122;;A61K2035/124;;C12N5/0647;;C12N2501/125;;C12N2501/23;;C12N2506/02;;C12N2533/70;;C12N5/0647;;C12N2506/02;;A61K2035/124;;C12N2533/70;;A61K2035/122;;C12N2501/125;;C12N2501/23,A61K35/12;;C12N5/0789,,0,0,,,,PENDING
359,WO,A1,WO 1999/064049 A1,148-011-325-950-25X,1999-12-16,1999,US 9912776 W,1999-06-07,US 8844898 P;;US 9307298 P,1998-06-08,NOVEL ANTIBACTERIAL AGENTS,"This invention relates to novel multibinding compounds (agents) that are antibacterial agents. The multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands in their monovalent (i.e., unlinked) state have the ability to bind to an enzyme involved in cell wall biosynthesis and metabolism. A precursor used in the synthesis of the bacterial cell wall and/or the bacterial cell surface thereby interfere with the synthesis and/or metabolism of the cell wall. In particular the multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands has a ligand domain capable of binding to penicillin binding proteins, a transpeptidase enzyme, a substrate of a transpeptidase enzyme, a beta-lactamase enzyme, penicillinase enzyme, cephalosporinase enzyme, a transglycosylase enzyme, or a transglycosylase enzyme substrate. Preferably, the ligands are selected from the beta-lactam or glycopeptide class of antibacterial agents.",ADVANCED MEDICINE INC;;GRIFFIN JOHN H;;MORAN EDMUND J;;CHRISTENSEN BURT G,GRIFFIN JOHN H;;MORAN EDMUND J;;CHRISTENSEN BURT G,,https://lens.org/148-011-325-950-25X,Patent Application,yes,1,41,86,429,0,A61K31/00;;C07C233/36;;C07C233/78;;C07C237/24;;C07C271/20;;C07C321/04;;C07C323/12;;C07C335/08;;C07C335/32;;C07D207/333;;C07D211/58;;C07D215/56;;C07D233/90;;C07D235/30;;C07D401/06;;C07D401/12;;C07D401/14;;C07D405/04;;C07D413/14;;C07D471/04;;C07D471/14;;C07D473/00;;C07D473/34;;C07D475/04;;C07D475/08;;C07D487/04;;C07D487/06;;C07D493/04;;C07D493/06;;C07H19/20;;C12Q1/26;;C12Q1/44;;C12Q1/48;;C12Q1/533;;C40B30/04;;C40B40/04;;G01N33/573;;G01N33/6842;;G01N33/6845;;G01N33/92;;G01N2500/00;;G01N2500/04;;G01N2800/044;;Y10S530/807;;C07C2603/18;;A61K47/60;;A61K47/54;;A61K47/55;;A61K47/552;;A61P31/04;;A61P31/18;;A61P37/02;;A61P43/00;;A61P5/14;;A61P3/10;;Y02A50/30;;C40B30/04;;G01N33/573;;C07D405/04;;C07D207/333;;C07C321/04;;G01N33/92;;C07C323/12;;C07D211/58;;C07D235/30;;C12Q1/48;;C12Q1/26;;C07C335/08;;C07D473/34;;C07D475/08;;C07C271/20;;C07D401/12;;C07D487/04;;C12Q1/44;;C07C233/78;;C07D471/04;;G01N2800/044;;C07C237/24;;C40B40/04;;C07D473/00;;C07D487/06;;C07D493/06;;C07D413/14;;C07D401/14;;A61K31/00;;C07D493/04;;C07D471/14;;C12Q1/533;;G01N33/6842;;G01N33/6845;;C07D401/06;;C07H19/20;;C07D215/56;;C07D475/04;;G01N2500/04;;C07C233/36;;G01N2500/00;;C07C335/32;;C07D233/90;;Y10S530/807;;A61K47/552;;A61K47/54;;C07C2603/18;;A61K47/60;;A61K47/55;;Y02A50/30,A01N57/34;;A61K31/00;;A61K31/357;;A61K31/397;;A61K31/407;;A61K31/421;;A61K31/424;;A61K31/431;;A61K31/439;;A61K31/444;;C07D499/44;;A61K31/4545;;A61K31/496;;A61K31/522;;A61K31/536;;A61K31/5377;;A61K31/546;;A61K31/551;;A61K31/65;;A61K31/7028;;A61K31/7034;;A61K31/7036;;A61K31/7042;;A61K31/7048;;A61K31/7052;;A61K31/7056;;A61K31/7064;;A61K31/7068;;A61K31/7072;;A61K38/00;;A61K39/00;;A61K39/395;;A61K39/44;;A61K47/48;;A61K51/00;;A61P31/04;;A61P31/18;;A61P43/00;;C07B61/00;;C07C233/36;;C07C233/78;;C07C237/24;;C07C237/26;;C07C271/20;;C07C275/42;;C07C321/04;;C07C323/12;;C07C335/08;;C07C335/32;;C07D207/32;;C07D207/333;;C07D211/58;;C07D215/56;;C07D233/90;;C07D235/30;;C07D263/28;;C07D265/18;;C07D401/06;;C07D401/12;;C07D401/14;;C07D405/04;;C07D413/14;;C07D453/02;;C07D471/04;;C07D471/14;;C07D473/00;;C07D473/34;;C07D475/04;;C07D475/08;;C07D477/00;;C07D487/04;;C07D487/06;;C07D493/04;;C07D493/06;;C07D495/04;;C07D498/04;;C07D498/18;;C07D501/20;;C07D519/00;;C07H15/236;;C07H15/238;;C07H15/26;;C07H17/08;;C07H19/06;;C07H19/20;;C07K2/00;;C07K4/00;;C12N9/99;;C12P19/38;;C12Q1/26;;C12Q1/44;;C12Q1/48;;C12Q1/533;;C40B30/04;;C40B40/04;;G01N33/15;;G01N33/50;;G01N33/53;;G01N33/543;;G01N33/566;;G01N33/573;;G01N33/68;;G01N33/92;;G01N37/00,,4,4,065-909-122-678-470;;111-874-896-251-824;;059-030-315-792-304;;033-758-058-737-918,10.1021/ja953322p;;10.1016/s0960-894x(97)10170-6;;9060179;;10.1016/s0008-6215(96)00261-3;;8929414;;10.1126/science.274.5292.1531,"RUHLAND B., ET AL.: ""SOLID-SUPPORTED COMBINATORIAL SYNTHESIS OF STRUCTURALLY DIVERSE BETA-LACTAMS."", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, US, vol. 118., 10 January 1996 (1996-01-10), US, pages 253/254., XP002919650, ISSN: 0002-7863, DOI: 10.1021/ja953322p;;PITLIK J, TOWNSEND C A: ""SOLUTION-PHASE SYNTHESIS OF A COMBINATORIAL MONOCYCLIC BETA-LACTAM LIBRARY: POTENTIAL PROTEASE INHIBITORS"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 07, no. 24, 16 December 1997 (1997-12-16), AMSTERDAM, NL, pages 3129 - 3134, XP002919651, ISSN: 0960-894X, DOI: 10.1016/S0960-894X(97)10170-6;;MURATA J, ET AL.: ""EFFECT OF DIMERIZATION OF THE D-GLUCOSE ANALOGUE OF MURAMYL DIPEPTIDE ON STIMULATION OF MACROPHAGE-LIKE CELLS"", CARBOHYDRATE RESEARCH, PERGAMON, GB, vol. 297, 2 January 1997 (1997-01-02), GB, pages 127 - 133, XP002919652, ISSN: 0008-6215, DOI: 10.1016/S0008-6215(96)00261-3;;S.B.SHUKER ET AL.: ""Discovering High-Affinity Ligands for Proteins: SAR by NMR"", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, no. 274, 1 January 1996 (1996-01-01), US, pages 1531 - 1534, XP002074440, ISSN: 0036-8075, DOI: 10.1126/science.274.5292.1531",PATENTED
360,US,A1,US 2018/0090988 A1,009-869-500-009-908,2018-03-29,2018,US 201715716108 A,2017-09-26,US 201715716108 A;;US 201662399700 P,2016-09-26,Time-Locked Data Alignment in Distributed Embedded Systems,"An embedded system may distribute, e.g. at the point of coupling to a main power grid, information corresponding to one or more operational parameters (e.g. phase angle, frequency, amplitude, etc.) of a power delivery device to other power delivery devices, using a deterministic communication link. Updates of some or all of the information may be transmitted at future or past points in time, for example at defined time intervals. Time synchronization methods, e.g. a locked instantaneous interpolation mechanism may be used to create a coordinated time, shared among all power delivery devices. Various operating parameter mismatches, e.g. a phase mismatch between power delivery devices delivering power to the power grid, may thereby be reduced to less than a specified, negligible value. This creates tight time synchronization between the power delivery devices and allows them to interoperate in a manner that stabilizes rather than destabilizes the power grid.",NAT INSTRUMENTS CORP,MACCLEERY BRIAN C;;WALTER TODD J;;SNOVER BURT D,NATIONAL INSTRUMENTS CORPORATION (2017-09-26),https://lens.org/009-869-500-009-908,Patent Application,yes,0,9,2,2,0,Y04S10/123;;H02J3/24;;H02J3/40;;G05B2219/25474;;G05B2219/25232;;H02J2300/28;;H02J2300/24;;H02J3/381;;H02J13/00017;;Y02E10/56;;Y02E10/76;;Y02E40/70;;Y04S40/124;;Y02E60/00;;G05B19/0423;;G05B2219/25474;;G05B2219/25232;;Y04S10/123;;H02J3/24;;H02J3/40;;Y02E10/56;;Y02E10/76;;Y02E40/70;;H02J13/00017;;H02J2300/24;;H02J2300/28;;H02J3/381,H02J13/00;;G05B19/042,,0,0,,,,ACTIVE
361,US,B2,US 8769751 B2,015-898-564-697-084,2014-07-08,2014,US 201313963561 A,2013-08-09,US 201313963561 A;;US 75760110 A;;US 16824509 P,2009-04-10,Method of attaching a traction cleat to a shoe mounted receptacle,A thinner shoe mounted receptacle results from a thin cleat attachment flange received in a shallow receptacle cavity. An angled interface between the cleat and receptacle provide a friction fit engagement to minimize inadvertent disengagement of the cleat and receptacle. Rotational locking occurring inside or outside the cavity further prevents inadvertent cleat rotation. Multiple positionally synchronized angular stops positively define the final angular orientation of the cleat in the receptacle.,SOFTSPIKES LLC;;PRIDE MFG CO LLC,BURT JOHN ROBERT;;SHUTTLEWORTH LEE PAUL;;KRIKORIAN RAND J,,https://lens.org/015-898-564-697-084,Granted Patent,yes,29,1,15,15,0,A43C15/161;;A43C15/161;;A43C15/02,A43C15/02,12142P;;36/134;;X 36 67 D,3,0,,,"JP Office Action dated May 31, 2013 cited in corresponding JP 2011-508727.;;European Search Report received in counterpart application PCT/US2010030551, dated Feb. 5, 2013.;;International Search Report and Written Opinion received in PCT/US10/30551 dated Sep. 1, 2010, pp. 1-14.",ACTIVE
362,US,A1,US 2013/0326828 A1,010-570-349-404-292,2013-12-12,2013,US 201313963561 A,2013-08-09,US 201313963561 A;;US 75760110 A;;US 16824509 P,2009-04-10,METHOD OF ATTACHING A TRACTION CLEAT TO A SHOE MOUNTED RECEPTACLE,A thinner shoe mounted receptacle results from a thin cleat attachment flange received in a shallow receptacle cavity. An angled interface between the cleat and receptacle provide a friction fit engagement to minimize inadvertent disengagement of the cleat and receptacle. Rotational locking occurring inside or outside the cavity further prevents inadvertent cleat rotation. Multiple positionally synchronized angular stops positively define the final angular orientation of the cleat in the receptacle.,SOFTPIKES LLC,BURT JOHN ROBERT;;SHUTTLEWORTH LEE PAUL;;KRIKORIAN RAND J,,https://lens.org/010-570-349-404-292,Patent Application,yes,0,0,15,15,0,A43C15/161;;A43C15/161;;A43C15/02,A43C15/16,12142 P,0,0,,,,ACTIVE
363,SE,D0,SE 8704753 D0,020-839-503-249-107,1987-11-27,1987,SE 8704753 A,1987-11-27,GB 8628472 A,1986-11-28,VENTILAGGREGAT,,GLAXO GROUP LTD,THOMAS J H;;HUTCHINSON A;;BURT P C W,,https://lens.org/020-839-503-249-107,Patent Application,no,0,0,26,26,0,B65D83/54,B65D83/14;;B05B9/04,,0,0,,,,PENDING
364,US,A,US 2962598 A,030-550-765-133-53X,1960-11-29,1960,US 58756156 A,1956-05-28,US 58756156 A,1956-05-28,Electric power control system,,GEN ELECTRIC,LAREW JOHN J;;BURT WESLEY S;;SHEPARD BILLY R,,https://lens.org/030-550-765-133-53X,Granted Patent,no,18,6,2,2,0,H02J3/06;;H02J3/06,H02J3/06,,0,0,,,,EXPIRED
365,US,A,US 2841593 A,017-051-737-350-492,1958-07-01,1958,US 50221455 A,1955-04-18,US 50221455 A,1955-04-18,"Reaction of substituted benzene, chlorine, and substituted maleic anhydride and products thereof",,ETHYL CORP,ECKE GEORGE G;;KOLKA ALFRED J;;BURT WILLIAM E,,https://lens.org/017-051-737-350-492,Granted Patent,no,9,2,1,1,0,C07C51/567;;C07C51/567;;C07C51/087;;C07C51/087;;C07C51/16;;C07C51/16,C07C51/087;;C07C51/16;;C07C51/567,,0,0,,,,EXPIRED
366,EP,A1,EP 1097118 A1,016-925-766-492-092,2001-05-09,2001,EP 99921848 A,1999-05-11,US 9910238 W;;US 11365098 A,1998-07-10,ALKYLATION PROCESS,,ALBEMARLE CORP,KOEHL DAVID J;;BURT EDWARD A;;WARD PATRICK T,,https://lens.org/016-925-766-492-092,Patent Application,yes,0,0,7,7,0,B01J23/04;;C07C2/72;;C07C2531/12;;Y02P20/52;;B01J23/04;;C07C2/72;;C07C2531/12;;Y02P20/52,B01J23/04;;C07C2/72,,0,0,,,,EXPIRED
367,IT,B,IT 1200823 B,028-111-571-561-433,1989-01-27,1989,IT 2274385 A,1985-11-07,US 67884784 A,1984-12-06,MODULO STRUTTURALE FILAMENTARE PER ELEMENTI COMPOSITI,,AVCO CORP,GRANT WILLIAM W;;BURT GARY W;;KUMNICK ALBERT J,,https://lens.org/028-111-571-561-433,Granted Patent,no,0,0,13,13,0,B22F2998/00;;C22C47/064;;C22C47/20;;B29L2031/06;;B29C70/545;;B29C2793/0045;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;B29C70/347;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;C22C47/064;;C22C47/20;;B22F2998/00;;B29C70/545;;B29L2031/06;;B29C2793/0045,B21C37/02;;B29B15/08;;B32B15/01;;C22C47/06;;C22C47/20,,0,0,,,,EXPIRED
368,EP,A1,EP 1005356 A1,052-145-529-559-597,2000-06-07,2000,EP 99928455 A,1999-06-07,US 9912776 W;;US 8844898 P;;US 9307298 P,1998-06-08,NOVEL ANTIBACTERIAL AGENTS,,ADVANCED MEDICINE INC,GRIFFIN JOHN H;;MORAN EDMUND J;;CHRISTENSEN BURT G,"THERAVANCE BIOPHARMA ANTIBIOTICS IP; US (2015-08-20);;THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC (2015-10-16);;THERAVANCE BIOPHARMA ANTIBIOTICS  IP, LLC, US (2016-08-05);;ADVANCED MEDICINE, INC. (2000-07-12);;THERAVANCE BIOPHARMA R&D IP, LLC, US (2014-10-28);;THERAVANCE, INC. (2008-06-25);;THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC; US (2015-11-19);;THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC, SOUT, US (2014-11-25)",https://lens.org/052-145-529-559-597,Patent Application,yes,0,1,86,429,0,A61K31/00;;C07C233/36;;C07C233/78;;C07C237/24;;C07C271/20;;C07C321/04;;C07C323/12;;C07C335/08;;C07C335/32;;C07D207/333;;C07D211/58;;C07D215/56;;C07D233/90;;C07D235/30;;C07D401/06;;C07D401/12;;C07D401/14;;C07D405/04;;C07D413/14;;C07D471/04;;C07D471/14;;C07D473/00;;C07D473/34;;C07D475/04;;C07D475/08;;C07D487/04;;C07D487/06;;C07D493/04;;C07D493/06;;C07H19/20;;C12Q1/26;;C12Q1/44;;C12Q1/48;;C12Q1/533;;C40B30/04;;C40B40/04;;G01N33/573;;G01N33/6842;;G01N33/6845;;G01N33/92;;G01N2500/00;;G01N2500/04;;G01N2800/044;;Y10S530/807;;C07C2603/18;;A61K47/60;;A61K47/54;;A61K47/55;;A61K47/552;;A61P31/04;;A61P31/18;;A61P37/02;;A61P43/00;;A61P5/14;;A61P3/10;;Y02A50/30;;C40B30/04;;G01N33/573;;C07D405/04;;C07D207/333;;C07C321/04;;G01N33/92;;C07C323/12;;C07D211/58;;C07D235/30;;C12Q1/48;;C12Q1/26;;C07C335/08;;C07D473/34;;C07D475/08;;C07C271/20;;C07D401/12;;C07D487/04;;C12Q1/44;;C07C233/78;;C07D471/04;;G01N2800/044;;C07C237/24;;C40B40/04;;C07D473/00;;C07D487/06;;C07D493/06;;C07D413/14;;C07D401/14;;A61K31/00;;C07D493/04;;C07D471/14;;C12Q1/533;;G01N33/6842;;G01N33/6845;;C07D401/06;;C07H19/20;;C07D215/56;;C07D475/04;;G01N2500/04;;C07C233/36;;G01N2500/00;;C07C335/32;;C07D233/90;;Y10S530/807;;A61K47/552;;A61K47/54;;C07C2603/18;;A61K47/60;;A61K47/55;;Y02A50/30,C07D499/44;;A01N57/34;;A61K31/00;;A61K31/357;;A61K31/397;;A61K31/407;;A61K31/421;;A61K31/424;;A61K31/431;;A61K31/439;;A61K31/444;;A61K31/4545;;A61K31/496;;A61K31/522;;A61K31/536;;A61K31/5377;;A61K31/546;;A61K31/551;;A61K31/65;;A61K31/7028;;A61K31/7034;;A61K31/7036;;A61K31/7042;;A61K31/7048;;A61K31/7052;;A61K31/7056;;A61K31/7064;;A61K31/7068;;A61K31/7072;;A61K38/00;;A61K39/00;;A61K39/395;;A61K39/44;;A61K47/48;;A61K51/00;;A61P31/04;;A61P31/18;;A61P43/00;;C07B61/00;;C07C233/36;;C07C233/78;;C07C237/24;;C07C237/26;;C07C271/20;;C07C275/42;;C07C321/04;;C07C323/12;;C07C335/08;;C07C335/32;;C07D207/32;;C07D207/333;;C07D211/58;;C07D215/56;;C07D233/90;;C07D235/30;;C07D263/28;;C07D265/18;;C07D401/06;;C07D401/12;;C07D401/14;;C07D405/04;;C07D413/14;;C07D453/02;;C07D471/04;;C07D471/14;;C07D473/00;;C07D473/34;;C07D475/04;;C07D475/08;;C07D477/00;;C07D487/04;;C07D487/06;;C07D493/04;;C07D493/06;;C07D495/04;;C07D498/04;;C07D498/18;;C07D501/20;;C07D519/00;;C07H15/236;;C07H15/238;;C07H15/26;;C07H17/08;;C07H19/06;;C07H19/20;;C07K2/00;;C07K4/00;;C12N9/99;;C12P19/38;;C12Q1/26;;C12Q1/44;;C12Q1/48;;C12Q1/533;;C40B30/04;;C40B40/04;;G01N33/15;;G01N33/50;;G01N33/53;;G01N33/543;;G01N33/566;;G01N33/573;;G01N33/68;;G01N33/92;;G01N37/00,,0,0,,,,EXPIRED
369,IT,A0,IT 8522743 A0,049-109-067-264-332,1985-11-07,1985,IT 2274385 A,1985-11-07,US 67884784 A,1984-12-06,MODULO STRUTTURALE FILAMENTARE PER ELEMENTI COMPOSITI.,,AVCO CORP,GRANT WILLIAM F;;BURT GARY W;;KUMNICK ALBERT J,,https://lens.org/049-109-067-264-332,Patent Application,no,0,0,13,13,0,B22F2998/00;;C22C47/064;;C22C47/20;;B29L2031/06;;B29C70/545;;B29C2793/0045;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;B29C70/347;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;C22C47/064;;C22C47/20;;B22F2998/00;;B29C70/545;;B29L2031/06;;B29C2793/0045,B21C37/02;;B29B15/08;;B32B15/01;;C22C47/06;;C22C47/20,,0,0,,,,EXPIRED
370,US,B2,US 8707588 B2,098-067-879-491-287,2014-04-29,2014,US 201313963495 A,2013-08-09,US 201313963495 A;;US 75760110 A;;US 16824509 P,2009-04-10,Traction cleat for footwear,A thinner shoe mounted receptacle results from a thin cleat attachment flange received in a shallow receptacle cavity. An angled interface between the cleat and receptacle provide a friction fit engagement to minimize inadvertent disengagement of the cleat and receptacle. Rotational locking occurring inside or outside the cavity further prevents inadvertent cleat rotation. Multiple positionally synchronized angular stops positively define the final angular orientation of the cleat in the receptacle.,SOFTSPIKES LLC;;PRIDE MFG CO LLC,BURT JOHN ROBERT;;SHUTTLEWORTH LEE PAUL;;KRIKORIAN RAND J,,https://lens.org/098-067-879-491-287,Granted Patent,yes,28,1,15,15,0,A43C15/161;;A43C15/161;;A43C15/02,A43C15/02,36/134;;X 36 67 D,3,0,,,"JP Office Action dated May 31, 2013 cited in corresponding JP 2011-508727.;;European Search Report received in counterpart application PCT/US2010030551, dated Feb. 5, 2013.;;International Search Report and Written Opinion received in PCT/US10/30551 dated Sep. 1, 2010, pp. 1-14.",ACTIVE
371,US,A,US 2135325 A,184-294-019-968-679,1938-11-01,1938,US 1410435 A,1935-04-01,US 1410435 A,1935-04-01,Apparatus for finishing soap,,PROCTER & GAMBLE,BURT ROBERT V;;DUNCAN ROBERT A;;SHORT ROBERT J,,https://lens.org/184-294-019-968-679,Granted Patent,no,0,13,1,1,0,C11D13/18;;C11D13/18,C11D13/18,,0,0,,,,EXPIRED
372,US,A,US 3097783 A,191-746-595-080-529,1963-07-16,1963,US 9349061 A,1961-03-06,US 9349061 A,1961-03-06,Dust-proof carton,,PROCTER & GAMBLE,BURT ROBERT V;;GEX VIRGIL E;;FRANZ NORMAN J,,https://lens.org/191-746-595-080-529,Granted Patent,no,6,15,4,5,0,B65D5/0227;;B65D5/0227,B65D5/02,,0,0,,,,EXPIRED
373,US,A1,US 2007/0187375 A1,187-590-903-257-603,2007-08-16,2007,US 35555206 A,2006-02-16,US 35555206 A,2006-02-16,Method for rating stick electrodes for pipe welding,"Stick welding electrode rating and ranking procedures are provided for determining stackability performance of stick electrodes for pipe welding operations. The rating technique involves performance of a standardized vertical down weld procedure using a stick electrode to form a weld bead in a test workpiece groove, in which the electrode is maintained during welding at a substantially constant angle relative to the workpiece groove. The electrode is advanced toward the groove at a slow speed to deposit molten metal in the groove while keeping the molten metal above the stick electrode end or the arc thereof without dripping. The resulting bead distance is measured along with the welding time and the stick electrode is rated according to a ratio of the weld time and the bead distance.",LINCOLN GLOBAL INC,BURT RANDALL M;;DALLAM CRAIG B;;WEAVER ROBERT J,LINCOLN GLOBAL INC (2006-02-10),https://lens.org/187-590-903-257-603,Patent Application,yes,6,6,2,2,0,B23K9/0286;;B23K31/12;;B23K2101/10;;B23K9/0286;;B23K31/12;;B23K2101/10,B23K9/095,219/130.01,0,0,,,,INACTIVE
374,US,B2,US 8507591 B2,034-803-884-802-044,2013-08-13,2013,US 84091704 A,2004-05-07,US 84091704 A;;US 9903602 A;;US 69213896 A,1996-08-05,Waterborne soft-feeling coating composition with high gloss,"A waterborne, soft feeling coating composition and a substrate coated with the composition. The coating composition comprises an aqueous solvent, a resin, and an alcohol alkoxylate surfactant. The invention is also directed to a process of making the waterborne coating composition of the invention, and a process of coating a substrate with the waterborne coating composition.",RUGGIERO MURRAY A;;CHUBB HAROLD W;;BURT DIANE J;;MONUMENT CHEMICAL KENTUCKY LLC,RUGGIERO MURRAY A;;CHUBB HAROLD W;;BURT DIANE J,MONUMENT CHEMICAL KENTUCKY LLC (2012-12-27),https://lens.org/034-803-884-802-044,Granted Patent,yes,25,0,4,4,0,C08G18/6254;;C08K5/06;;C08L71/00;;C09D175/04;;C08K5/06;;C08L71/00;;C09D175/04;;C08G18/6254,C08G18/62;;C08L1/00;;C08K5/06;;C08L71/00;;C09D175/04,524/104;;524/379,2,0,,,"Charles R. Hegedus et al., ""Film Formation Mechanism of Two-Component Waterborne Polyurethane Coatings"", J. Coat. Tech. vol. 68, pp. 51-61 (Jan. 1996).;;Cynthia Ahmed, ""The Advantages of Two-Component Waterborne Soft Feel"", Abstract from Adv. Coating Tech. Conference Exhibition, Nov. 7-9, 1995, pp. 3-11.",EXPIRED
375,US,A,US 2944902 A,112-014-506-824-815,1960-07-12,1960,US 62713556 A,1956-12-10,US 62713556 A;;US 60067956 A;;US 12989761 A,1956-07-30,Sensitization of photographic emulsions with ionic polyalkylene oxide salts,,EASTMAN KODAK CO,CARROLL BURT H;;SAGAL JOHN JR;;BEAVERS DOROTHY J,,https://lens.org/112-014-506-824-815,Granted Patent,no,7,22,3,10,0,G03C1/043;;G03C1/34;;G03C1/38;;G03C1/38;;G03C1/34;;G03C1/043,G03C1/043;;G03C1/34;;G03C1/38,,0,0,,,,EXPIRED
376,EP,A4,EP 2375930 A4,128-982-688-503-287,2013-03-13,2013,EP 10762500 A,2010-04-09,US 2010/0030551 W;;US 16824509 P,2009-04-10,METHOD AND APPARATUS FOR INTERCONNECTING TRACTION CLEATS AND RECEPTACLES,,PRIDE MFG CO LLC,BURT JOHN ROBERT;;SHUTTLEWORTH LEE PAUL;;KRIKORIAN RAND J,,https://lens.org/128-982-688-503-287,Search Report,no,6,0,15,15,0,A43C15/161;;A43C15/161;;A43C15/02,A43C15/16,,1,0,,,See also references of WO 2010118329A1,ACTIVE
377,US,A1,US 2004/0153649 A1,139-163-279-522-479,2004-08-05,2004,US 65693003 A,2003-09-04,US 65693003 A;;US 9606618 W;;US 16489902 A;;US 19802298 A;;US 76384796 A;;US 51299395 A;;US 77593401 A;;US 62557700 A;;US 83756401 A;;US 50388100 A;;US 18696298 A;;US 64941996 A;;US 63753196 A;;US 57142200 A;;US 34310499 A;;US 34268899 A;;US 34310199 A;;US 31464899 A;;US 1112901 A;;US 44278099 A;;US 7403498 A;;US 76384701 A;;US 46541899 A;;US 14722802 A;;US 67011500 A;;US 56366400 A;;US 47668699 A;;US 74661396 A;;US 50808395 A;;US 19813800 P;;US 19884900 P;;US 10925998 P;;US 11295598 P;;US 17802800 P;;US 13478299 P,1995-07-27,Digital authentication with digital and analog documents,"
   The disclosure describes systems for creating and authenticating printed objects using authentication information. Techniques for incorporating authentication information into digital representations of objects and using the authentication information to authenticate the objects are also provided. 
",RHOADS GEOFFREY B.;;CARR J. SCOTT;;PERRY BURT W.,RHOADS GEOFFREY B;;CARR J SCOTT;;PERRY BURT W,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC LLC (2008-08-01);;DMRC CORPORATION (2008-08-01),https://lens.org/139-163-279-522-479,Patent Application,yes,53,424,2,1547,0,B29C45/1418;;G06F21/00;;G06K1/121;;G06K7/1417;;G06K7/1447;;G06K19/06037;;G06K19/06046;;G06K19/14;;G06K19/18;;G06K2019/06253;;G06Q20/341;;G06Q20/40145;;G06Q30/02;;G06T1/0028;;G06T1/0071;;G06T2201/0051;;G06T2201/0052;;G07D7/004;;G07F7/086;;G07F7/1008;;G07F17/16;;G07F17/26;;G11B20/00007;;G11B20/00086;;G11B20/00884;;G11B20/00891;;G11B20/00898;;H04H20/31;;H04N1/00005;;H04N1/00037;;H04N1/00079;;H04N1/00973;;H04N1/32122;;H04N1/32144;;H04N1/32154;;H04N1/3216;;H04N1/32203;;H04N1/32208;;H04N1/32219;;H04N1/32229;;H04N1/32251;;H04N1/32261;;H04N1/32288;;H04N1/32304;;H04N1/32352;;H04N21/23892;;H04N21/8358;;H04N2201/3205;;H04N2201/3207;;H04N2201/3225;;H04N2201/3226;;H04N2201/3233;;H04N2201/3235;;H04N2201/3239;;H04N2201/327;;H04N2201/3271;;H04N2201/3274;;H04N2201/328;;H04N2201/3284;;B42D25/29;;B42D25/00;;H04N19/467;;G10L15/26;;G07D7/0034;;G06F16/955;;G07C9/253;;G06F40/169;;G06V30/40;;B42D25/333;;G06Q20/40145;;G11B20/00884;;B42D25/29;;H04N1/32154;;G07F7/086;;G06K19/14;;H04N1/00079;;H04N21/23892;;H04N2201/3225;;H04N1/32288;;H04N1/32122;;H04N2201/3233;;H04N2201/3235;;G06F21/00;;G06K19/18;;G11B20/00898;;G11B20/00007;;H04N1/32229;;G06K2019/06253;;G11B20/00891;;G07F17/26;;H04N1/32144;;H04N2201/3239;;H04N2201/327;;H04N2201/3284;;G06K1/121;;H04N1/32251;;H04N1/32352;;G07F7/1008;;H04N1/32304;;B29C45/1418;;G06K19/06037;;H04N1/00037;;H04N1/3216;;H04N2201/3207;;H04N2201/3271;;G06T2201/0051;;G07F17/16;;H04N1/32261;;G06T2201/0052;;H04N1/00973;;G06K7/1447;;G07D7/004;;H04N1/32203;;H04N2201/328;;H04N21/8358;;G06Q30/02;;H04N1/00005;;H04H20/31;;G11B20/00086;;H04N2201/3274;;G06T1/0071;;H04N1/32219;;H04N2201/3205;;G06K19/06046;;H04N2201/3226;;G06T1/0028;;G06K7/1417;;G06Q20/341;;H04N1/32208;;B42D25/00;;H04N19/467;;G10L15/26;;G07D7/0034;;G06F16/955;;G07C9/253;;G06F40/169;;G06V30/40,B29C45/14;;B42D15/00;;B42D15/10;;G06F1/00;;G06F17/24;;G06F17/30;;G06F21/00;;G06K1/12;;G06K17/00;;G06K19/06;;G06K19/14;;G06K19/18;;G06Q20/34;;G06Q20/40;;G06Q30/02;;G06T1/00;;G06V30/40;;G07C9/00;;G07D7/00;;G07D7/12;;G07F7/08;;G07F7/10;;G07F17/16;;G07F17/26;;G10L15/26;;G11B20/00;;H04H20/31;;H04N1/00;;H04N1/32;;H04N7/26;;H04Q7/38,713/176,0,0,,,,EXPIRED
378,FR,A1,FR 2574342 A1,007-265-428-493-888,1986-06-13,1986,FR 8513602 A,1985-09-13,US 67884784 A,1984-12-06,STRUCTURE FILAMENTAIRE MODULAIRE POUR COMPOSITES,"<P>STRUCTURE MODULAIRE OU PREFORME POUR LA FABRICATION D'UN COMPOSITE A MATRICE METALLIQUE, CONSTITUEE PAR L'ENROULEMENT EN SPIRALE PLANE CONTINUE D'UN MONOFILAMENT ET D'UN RUBAN METALLIQUE. LE BUT EST DE FORMER UN RENFORT FILAMENTAIRE EN SPIRALE CONTINUE AUTOUR D'UN ORIFICE OU D'UN NOYAU CENTRAL. CETTE MONOCOUCHE EN SPIRALE EST FABRIQUEE PAR ENROULEMENT CONJOINT D'UN FILAMENT24 ET D'UN FIL OU RUBAN26 EN MATIERE DE MATRICE DESIREE, AUTOUR D'UN MANDRIN. ON PEUT ENSUITE SUPERPOSER LES MONOCOUCHES15 AINSI OBTENUES POUR FORMER DES ELEMENTS CYLINDRIQUES OU TORIQUES ET LES CONSOLIDER DANS UNE DIRECTION PARALLELE A L'AXE DE L'ELEMENT.</P>",AVCO CORP,GRANT WILLIAM F;;BURT GARY W;;KUMNICK ALBERT J,,https://lens.org/007-265-428-493-888,Patent Application,no,3,2,13,13,0,B22F2998/00;;C22C47/064;;C22C47/20;;B29L2031/06;;B29C70/545;;B29C2793/0045;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;B29C70/347;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;C22C47/064;;C22C47/20;;B22F2998/00;;B29C70/545;;B29L2031/06;;B29C2793/0045,B21C37/02;;B32B15/01;;C22C47/06;;C22C47/20;;B29B15/08,,0,0,,,,EXPIRED
379,GB,A,GB 2168032 A,048-673-460-811-348,1986-06-11,1986,GB 8524253 A,1985-10-02,US 67884784 A,1984-12-06,A FILAMENTARY STRUCTURAL MODULE FOR COMPOSITES,,AVCO CORP,GRANT WILLIAM F;;BURT GARY W;;KUMNICK ALBERT J,,https://lens.org/048-673-460-811-348,Patent Application,no,0,12,13,13,0,B22F2998/00;;C22C47/064;;C22C47/20;;B29L2031/06;;B29C70/545;;B29C2793/0045;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;B29C70/347;;Y10T428/218;;Y10T29/49801;;Y10T428/12444;;C22C47/064;;C22C47/20;;B22F2998/00;;B29C70/545;;B29L2031/06;;B29C2793/0045,B21C37/02;;B29B15/08;;B32B15/01;;C22C47/06;;C22C47/20,B8G G4            G;;B8M MHA           MHA,0,0,,,,EXPIRED
380,EP,B1,EP 1097118 B1,054-358-467-043-385,2003-07-30,2003,EP 99921848 A,1999-05-11,US 9910238 W;;US 11365098 A,1998-07-10,ALKYLATION PROCESS,,ALBEMARLE CORP,KOEHL DAVID J;;BURT EDWARD A;;WARD PATRICK T,,https://lens.org/054-358-467-043-385,Granted Patent,yes,1,0,7,7,0,B01J23/04;;C07C2/72;;C07C2531/12;;Y02P20/52;;B01J23/04;;C07C2/72;;C07C2531/12;;Y02P20/52,B01J23/04;;C07C2/72,,1,0,,,"R. M. SCHRAMM ET AL: ""The Alkali Metal Catalyzed Alkyklation of Toluene with Propylene"" JOURNAL OF THE AMERICAN CHEMICAL SOCIETY., vol. 82, 20 September 1960 (1960-09-20), pages 4912-4917, XP002110842 WASHINGTON, DC., US ISSN: 0002-7863 cited in the application",EXPIRED
381,US,B2,US 8544195 B2,086-666-838-210-791,2013-10-01,2013,US 75760110 A,2010-04-09,US 75760110 A;;US 16824509 P,2009-04-10,Method and apparatus for interconnecting traction cleats and receptacles,A thinner shoe mounted receptacle results from a thin cleat attachment flange received in a shallow receptacle cavity. An angled interface between the cleat and receptacle provide a friction fit engagement to minimize inadvertent disengagement of the cleat and receptacle. Rotational locking occurring inside or outside the cavity further prevents inadvertent cleat rotation. Multiple positionally synchronized angular stops positively define the final angular orientation of the cleat in the receptacle.,BURT JOHN ROBERT;;SHUTTLEWORTH LEE PAUL;;KRIKORIAN RAND J;;PRIDE MFG CO LLC,BURT JOHN ROBERT;;SHUTTLEWORTH LEE PAUL;;KRIKORIAN RAND J,PRIDE MANUFACTURING COMPANY LLC (2010-04-19),https://lens.org/086-666-838-210-791,Granted Patent,yes,25,5,15,15,0,A43C15/161;;A43C15/161;;A43C15/02,A43B5/00;;A43C15/02,36/134;;X 36 67 D,3,0,,,"International Search Report and Written Opinion received in PCT/US10/30551 dated Sep. 1, 2010, pp. 1-14.;;European Search Report received in counterpart application PCT/US2010030551, dated Feb. 5, 2013.;;JP Office Action dated May 31, 2013 cited in corresponding JP 2011-508727.",ACTIVE
382,BE,A,BE 614727 A,086-125-109-882-57X,1962-07-02,1962,BE 614727 A,1962-03-06,US 9349061 A,1961-03-06,Boîte en carton étanche aux poursières,,PROCTER & GAMBLE,BURT ROBERT V;;GEX VIRGIL E;;FRANZ NORMAN J,,https://lens.org/086-125-109-882-57X,Granted Patent,no,0,0,4,5,0,B65D5/0227;;B65D5/0227,B65D5/02,,0,0,,,,EXPIRED
383,US,B2,US 10374456 B2,151-055-802-020-104,2019-08-06,2019,US 201715716108 A,2017-09-26,US 201715716108 A;;US 201662399700 P,2016-09-26,Time-locked data alignment in distributed embedded systems,"An embedded system may distribute, e.g. at the point of coupling to a main power grid, information corresponding to one or more operational parameters (e.g. phase angle, frequency, amplitude, etc.) of a power delivery device to other power delivery devices, using a deterministic communication link. Updates of some or all of the information may be transmitted at future or past points in time, for example at defined time intervals. Time synchronization methods, e.g. a locked instantaneous interpolation mechanism may be used to create a coordinated time, shared among all power delivery devices. Various operating parameter mismatches, e.g. a phase mismatch between power delivery devices delivering power to the power grid, may thereby be reduced to less than a specified, negligible value. This creates tight time synchronization between the power delivery devices and allows them to interoperate in a manner that stabilizes rather than destabilizes the power grid.",NAT INSTRUMENTS CORP,MACCLEERY BRIAN C;;WALTER TODD J;;SNOVER BURT D,NATIONAL INSTRUMENTS CORPORATION (2017-09-26),https://lens.org/151-055-802-020-104,Granted Patent,yes,14,2,2,2,0,Y04S10/123;;H02J3/24;;H02J3/40;;G05B2219/25474;;G05B2219/25232;;H02J2300/28;;H02J2300/24;;H02J3/381;;H02J13/00017;;Y02E10/56;;Y02E10/76;;Y02E40/70;;Y04S40/124;;Y02E60/00;;G05B19/0423;;G05B2219/25474;;G05B2219/25232;;Y04S10/123;;H02J3/24;;H02J3/40;;Y02E10/56;;Y02E10/76;;Y02E40/70;;H02J13/00017;;H02J2300/24;;H02J2300/28;;H02J3/381,H02J3/24;;G05B19/042;;H02J3/38;;H02J3/40;;H02J13/00,,0,0,,,,ACTIVE
384,WO,A1,WO 2001/017402 A1,116-609-647-893-871,2001-03-15,2001,US 0024526 W,2000-09-07,US 39360699 A,1999-09-10,INFLATABLE AIR CELL HAVING COMBINED PNEUMATICALLY ADJUSTED OCCUPANT SUPPORT AND THERMAL CONDITIONING,"An air cell support system (15) for vehicle seat (10) and mattress applications includes an air cell (18, 20) constructed from facing sheets (22, 24) of flexible material that are sealed along their marginal edges. One of the sheets is impermeable and the other of the sheets is perforated to direct air from the air cell for ventilating an occupant support surface while providing a source of pressure for inflating the air cell.",MCCORD WINN TEXTRON INC;;RHODES RICHARD D;;MORAN SCOTT J;;BURT STEPHEN J;;WEEKS RYAN K,RHODES RICHARD D;;MORAN SCOTT J;;BURT STEPHEN J;;WEEKS RYAN K,,https://lens.org/116-609-647-893-871,Patent Application,yes,2,8,4,4,0,A47C4/54;;A47C7/467;;A47C7/744;;A47C21/044;;A47C21/048;;A47C27/082;;A47C27/083;;A47C27/10;;A47C27/18;;B60N2/5657;;B60N2/914;;B60N2/5628;;A47C27/10;;A47C7/744;;A47C4/54;;A47C27/082;;A47C7/467;;A47C27/083;;A47C21/048;;A47C21/044;;A47C27/18;;B60N2/5657;;B60N2/914,A47C7/46;;A47C7/74;;A47C27/10,,0,0,,,,PENDING
385,EP,A1,EP 1221877 A1,185-913-460-435-108,2002-07-17,2002,EP 00959974 A,2000-09-07,US 0024526 W;;US 39360699 A,1999-09-10,INFLATABLE AIR CELL HAVING COMBINED PNEUMATICALLY ADJUSTED OCCUPANT SUPPORT AND THERMAL CONDITIONING,,MCCORD WINN TEXTRON INC;;RHODES RICHARD D;;MORAN SCOTT J;;BURT STEPHEN J;;WEEKS RYAN K,RHODES RICHARD D;;MORAN SCOTT J;;BURT STEPHEN J;;WEEKS RYAN K,"MORAN, SCOTT J. (2003-04-23);;BURT, STEPHEN J. (2003-04-23);;WEEKS, RYAN K. (2003-04-23);;MCCORD WINN TEXTRON INC. (2004-01-21);;CTEX SEAT COMFORT LIMITED (2004-03-03);;RHODES, RICHARD D. (2003-04-23)",https://lens.org/185-913-460-435-108,Patent Application,yes,0,0,4,4,0,A47C4/54;;A47C7/467;;A47C7/744;;A47C21/044;;A47C21/048;;A47C27/082;;A47C27/083;;A47C27/10;;A47C27/18;;B60N2/5657;;B60N2/914;;B60N2/5628;;A47C27/10;;A47C7/744;;A47C4/54;;A47C27/082;;A47C7/467;;A47C27/083;;A47C21/048;;A47C21/044;;A47C27/18;;B60N2/5657;;B60N2/914,A47C7/46;;A47C7/74;;A47C27/10,,0,0,,,,DISCONTINUED
386,EP,A4,EP 1221877 A4,118-856-387-078-387,2004-09-08,2004,EP 00959974 A,2000-09-07,US 0024526 W;;US 39360699 A,1999-09-10,INFLATABLE AIR CELL HAVING COMBINED PNEUMATICALLY ADJUSTED OCCUPANT SUPPORT AND THERMAL CONDITIONING,,CTEX SEAT COMFORT LTD,RHODES RICHARD D;;MORAN SCOTT J;;BURT STEPHEN J;;WEEKS RYAN K,"BURT, STEPHEN J. (2003-04-23);;MORAN, SCOTT J. (2003-04-23);;WEEKS, RYAN K. (2003-04-23);;MCCORD WINN TEXTRON INC. (2004-01-21);;CTEX SEAT COMFORT LIMITED (2004-03-03);;RHODES, RICHARD D. (2003-04-23)",https://lens.org/118-856-387-078-387,Search Report,no,6,0,4,4,0,A47C4/54;;A47C7/467;;A47C7/744;;A47C21/044;;A47C21/048;;A47C27/082;;A47C27/083;;A47C27/10;;A47C27/18;;B60N2/5657;;B60N2/914;;B60N2/5628;;A47C27/10;;A47C7/744;;A47C4/54;;A47C27/082;;A47C7/467;;A47C27/083;;A47C21/048;;A47C21/044;;A47C27/18;;B60N2/5657;;B60N2/914,A47C7/46;;A47C7/74;;A47C27/10,,0,0,,,,DISCONTINUED
387,WO,A1,WO 2022/132470 A1,009-824-181-133-338,2022-06-23,2022,US 2021/0061932 W,2021-12-06,US 202063127647 P,2020-12-18,METHOD OF PRODUCING A POLYMER USING A PIGMENT DISPERSION,"A method of producing a polymer using a pigment dispersion that is stable at elevated temperatures is provided, wherein the dispersion contains a pigment, solvent, and dispersant that is a salt of a polyether functionalized polyacid.",LUBRIZOL ADVANCED MAT INC,BURT JONATHAN;;COULBECK ELLIOT;;ZHANG LE-YANG;;SHOOTER ANDREW J,,https://lens.org/009-824-181-133-338,Patent Application,yes,6,0,6,6,0,C08L67/02;;C08J3/20;;C08F8/44;;C08J2367/02;;C08J2453/00,C08F8/44;;C08G63/00;;C08L67/02,,1,0,,,"TAKEO SAEGUSA ET AL., MACROMOLECULES, vol. 5, 1972, pages 4470",PENDING
388,US,A1,US 2007/0167341 A1,115-051-441-143-112,2007-07-19,2007,US 59871105 A,2005-03-17,GB 0406720 A;;GB 2005001043 W,2004-03-25,Chemical composition and uses,"A product comprising separate compartments, contains first and second components of a composition and a catalyst for a reaction between the two components. In use, the two components are combined together to form the composition, preferably a cleaning composition, whose temperature is elevated when compared to the temperature of the components prior combination, providing improved performance. Method of manufacture, method of cleaning a surface, a kit, and an applicator means are disclosed.",RECKITT BENCKISER UK LTD,BURT DIANE J;;COKE MARK;;MATHUR DILIP S;;THOMSON ANDREW,RECKITT BENCKISER (UK) LIMITED (2006-09-14),https://lens.org/115-051-441-143-112,Patent Application,yes,10,11,13,13,0,C11D3/0052;;C11D3/3947;;C11D17/041;;C11D3/0052;;C11D17/041;;C11D3/3947,C11D17/04;;C11D3/00;;C11D3/39,510/277,0,0,,,,DISCONTINUED
389,DE,T2,DE 68918542 T2,002-305-262-419-881,1995-01-26,1995,DE 68918542 T,1989-08-30,US 23940988 A,1988-09-01,Verfahren zur Transhalogenierung einer Halogenphosphor-Verbindung mit Fluorwasserstoff.,,ALBEMARLE CORP,BURT EDWARD ANGUS;;BURTON LESTER PERCY J;;STAHLY BARBARA CLACK,,https://lens.org/002-305-262-419-881,Granted Patent,no,0,0,8,10,0,C07F9/65744;;C07F9/146,C07F9/146;;C07F9/52;;C07F9/6574,,0,0,,,,EXPIRED
390,WO,A1,WO 1999/045793 A1,034-379-206-436-532,1999-09-16,1999,US 9905433 W,1999-03-12,US 4135598 A,1998-03-12,NUTRITIONAL SUPPLEMENTS,"A method of producing metal-rich plants for the production of nutritional supplements. Edible plants are placed in a growth environment containing metal, and are cultivated in a fashion which enhances the uptake of metal into edible portions of the plants. The plants are then harvested, and may be eaten directly or processed into capsule or tablet form, in order to obtain the metallic nutrients so incorporated.",PHYTOTECH INC,ENSLEY BURT D;;ELLESS MARK;;BLAYLOCK MICHAEL J;;HUANG JIANWEI,,https://lens.org/034-379-206-436-532,Patent Application,yes,0,3,3,9,0,A01G7/06;;A23V2002/00;;Y10S426/809;;A23L33/10;;A23L33/16;;A01G7/06;;A23V2002/00;;Y10S426/809;;A23L33/16;;A23L33/10,A01G7/06;;A23L1/30;;A23L1/304,,4,4,057-883-674-197-98X;;006-343-854-424-230;;033-623-027-870-291;;003-754-505-188-054,10.1080/01635589209514197;;1437646;;10.1093/carcin/15.4.573;;8149465;;8233978;;10.1080/01635589309514279;;10.1016/0304-3835(89)90034-7;;2496915,"IP C., LISK D. J., STOEWSAND G. S.: ""MAMMARY CANCER PREVENTION BY REGULAR GARLIC AND SELENIUM-ENRICHED GARLIC."", NUTRITION AND CANCER, ROUTLEDGE, US, vol. 17., no. 03., 1 January 1992 (1992-01-01), US, pages 279 - 286., XP002920430, ISSN: 0163-5581;;IP C., LISK D. J.: ""CHARACTERIZATION OF TISSUE SELENIUM PROFILES AND ANTICARCINOGENIC RESPONSES IN RATS FED NATURAL SOURCES OF SELENIUM-RICH PRODUCTS."", CARCINOGENESIS., XX, XX, vol. 15., no. 04., 1 January 1994 (1994-01-01), XX, pages 573 - 576., XP002920431;;IP C., LISK D. J.: ""BIOAVAILABILITY OF SELENIUM FROM SELENIUM-ENRICHED GARLIC."", NUTRITION AND CANCER, ROUTLEDGE, US, vol. 20., no. 02., 1 January 1993 (1993-01-01), US, pages 129 - 137., XP002920432, ISSN: 0163-5581;;STOEWSAND G. S., ET AL.: ""EFFECT OF DIETARY BRUSSELS SPROUTS WITH INCREASED SELENIUM CONTENT ON MAMMARY CARCINOGENESIS IN THE RAT."", CANCER LETTERS, NEW YORK, NY, US, vol. 45., 1 January 1989 (1989-01-01), US, pages 43 - 48., XP002920433, ISSN: 0304-3835, DOI: 10.1016/0304-3835(89)90034-7",PENDING
391,WO,A1,WO 2022/132491 A1,154-868-587-352-970,2022-06-23,2022,US 2021/0062128 W,2021-12-07,US 202063127617 P,2020-12-18,STABLE PIGMENT DISPERSION COMPOSITION,"A method for forming a pigment dispersion that is stable at elevated temperatures is provided, wherein the dispersion contains a pigment, solvent, and dispersant that is a salt of a polyether functionalized polyacid.",LUBRIZOL ADVANCED MAT INC,COULBECK ELLIOT;;BURT JONATHAN;;ZHANG LE-YANG;;SHOOTER ANDREW J,,https://lens.org/154-868-587-352-970,Patent Application,yes,44,0,7,7,0,C09K23/42;;C09C1/44;;C09C1/56;;C09B67/009;;C09K23/52,C09K23/42,,1,0,,,"TAKEO SAEGUSA ET AL., MACROMOLECULES, vol. 5, 1972, pages 4470",PENDING
392,DE,T2,DE 69529622 T2,165-640-767-076-959,2003-11-27,2003,DE 69529622 T,1995-11-14,US 33949194 A;;US 9514130 W,1994-11-14,AUF MOSAIKEN BASIERTES BILDVERARBEITUNGSSYSTEM UND VERFAHREN ZUM VERARBEITEN VON BILDERN,,SARNOFF CORP,BURT J;;IRANI MICHAL;;HSU C;;ANANDAN PADMANABHAN;;HANSEN W,,https://lens.org/165-640-767-076-959,Granted Patent,no,0,0,16,18,0,G06T3/4038;;G06T11/00;;H04N5/781;;H04N5/85;;H04N9/8047;;H04N19/503;;H04N19/30;;H04N19/63;;H04N19/61;;H04N19/20;;H04N19/23;;G06V10/16;;G06V10/24;;G06V10/20;;H04N9/8047;;G06T11/00;;H04N5/781;;H04N5/85;;G06T3/4038;;H04N19/63;;H04N19/30;;H04N19/503;;H04N19/20;;H04N19/61;;H04N19/23;;G06V10/24;;G06V10/16,G06T3/00;;G06T9/00;;H04N5/262;;G06T11/00;;G06V10/24;;H03M7/36;;H04N1/387;;H04N5/781;;H04N5/85;;H04N5/91;;H04N7/167;;H04N7/18;;H04N7/26;;H04N7/30;;H04N7/36;;H04N7/50;;H04N9/804;;H04N21/4402;;H04N21/854,,0,0,,,,EXPIRED
393,TW,A,TW 202235454 A,008-782-662-620-664,2022-09-16,2022,TW 110147462 A,2021-12-17,US 202063127647 P,2020-12-18,Method of producing a polymer using a pigment dispersion,"A method of producing a polymer using a pigment dispersion that is stable at elevated temperatures is provided, wherein the dispersion contains a pigment, solvent, and dispersant that is a salt of a polyether functionalized polyacid.",LUBRIZOL ADVANCED MATERIALS INC,BURT JONATHAN;;COULBECK ELLIOT;;ZHANG LE-YANG;;SHOOTER ANDREW J,,https://lens.org/008-782-662-620-664,Patent of Addition,no,0,0,6,6,0,C08L67/02;;C08J3/20;;C08F8/44;;C08J2367/02;;C08J2453/00,C08F212/08;;C08F222/06;;C08F222/40;;C08G63/183;;C08G63/78;;C09D7/45;;C09D17/00,,0,0,,,,PENDING
394,EP,A1,EP 1124438 A1,102-755-285-522-658,2001-08-22,2001,EP 99960247 A,1999-11-08,US 9926401 W;;US 18760898 A,1998-11-06,NUTRITIONAL SUPPLEMENTS,,NUCYCLE THERAPY INC,ENSLEY BURT D;;ELLESS MARK;;BLAYLOCK MICHAEL J;;HUANG JIANWEI,"INB:BIOTECHNOLOGIES, INC. (2005-05-18);;IBIO, INC. (2011-07-13)",https://lens.org/102-755-285-522-658,Patent Application,yes,0,0,10,10,0,A23K20/30;;A23L33/105;;A23L33/16;;A23K20/30;;A23L33/105;;A23L33/16,A23K1/175;;A23L1/30;;A23L1/304,,0,0,,,,DISCONTINUED
395,US,A,US 5067014 A,038-638-503-706-323,1991-11-19,1991,US 62434390 A,1990-12-13,US 62434390 A;;GB 9001468 A,1990-01-23,THREE-FRAME TECHNIQUE FOR ANALYZING TWO MOTIONS IN SUCCESSIVE IMAGE FRAMES DYNAMICALLY,"An iterative process, implemented by a feedback loop, responds to all the image data in the respective analysis regions of three consecutive frames of a motion picture, to provide, after a plurality of cycles of operation thereof, an accurate estimation of the motion of either one or both of two differently moving patterns defined by the image data of these respective analysis regions. The analysis region of each frame is preferably large, and may occupy the entire frame area of a frame. The type of differently moving patterns include (1) separation by a motion bounty, (2) overlapping transparent surface in motion, (3) ""picket fence"" motion (4) masking of a small and/or low-contrast pattern by a dominant pattern, and (5) two-component aperture effects. Also, the operation of this iterative process inherently accurately estimates the motion of image data defining a single moving pattern.",SARNOFF DAVID RES CENTER,BERGEN JAMES R;;BURT PETER J;;HINGORANI RAJESH;;PELEG SHMUEL,DAVID SARNOFF RESEARCH CENTER INC. A CORP. OF DE (1990-12-16);;SARNOFF CORPORATION (1997-04-04),https://lens.org/038-638-503-706-323,Granted Patent,yes,4,113,10,10,0,G06T7/254;;G06T7/254;;H04N5/145;;H04N5/145;;H04N19/527;;H04N19/527;;H04N19/54;;H04N19/54,G06T1/00;;G06K9/36;;G06T7/20;;H04N5/14;;H04N7/26,358/105;;358/125;;382/54;;364/516,2,0,,,"Burt et al Object Tracking with a Moving Camera an Application of Dynamic Motion Analysis Proceedings of the Workshop on Visual Motion, Irvine, CA Mar. 20 22, 1989, IEEE Computer Society.;;Burt et al A Practical, Real Time Motion Analysis System for Navigation and Target Tracking , Pattern Recognition for Advanced Missile Systems Conference, Huntsville, AL Nov. 14 15, 1988.",EXPIRED
396,WO,A3,WO 2022/132469 A3,042-309-318-949-777,2022-08-25,2022,US 2021/0061931 W,2021-12-06,US 202063127617 P,2020-12-18,STABLE PIGMENT DISPERSION COMPOSITION,"A method for forming a pigment dispersion that is stable at elevated temperatures is provided, wherein the dispersion contains a pigment, solvent, and dispersant that is a salt of a polyether functionalized polyacid.",LUBRIZOL ADVANCED MAT INC,COULBECK ELLIOT;;BURT JONATHAN;;ZHANG LE-YANG;;SHOOTER ANDREW J,,https://lens.org/042-309-318-949-777,Search Report,yes,4,0,7,7,0,C09K23/42;;C09C1/44;;C09C1/56;;C09B67/009;;C09K23/52,C09K23/42,,0,0,,,,PENDING
397,AU,A,AU 1999/030834 A,101-895-841-698-83X,1999-09-27,1999,AU 1999/030834 A,1999-03-12,US 4135598 A;;US 9905433 W,1998-03-12,Nutritional supplements,,PHYTOTECH INC,ENSLEY BURT D;;ELLESS MARK;;BLAYLOCK MICHAEL J;;HUANG JIANWEI,,https://lens.org/101-895-841-698-83X,Patent Application,no,0,0,3,9,0,A01G7/06;;A23V2002/00;;Y10S426/809;;A23L33/10;;A23L33/16;;A01G7/06;;A23V2002/00;;Y10S426/809;;A23L33/16;;A23L33/10,A01G7/06;;A23L1/30;;A23L1/304,,0,0,,,,PENDING
398,DE,D1,DE 69529622 D1,106-522-989-748-186,2003-03-20,2003,DE 69529622 T,1995-11-14,US 33949194 A;;US 9514130 W,1994-11-14,AUF MOSAIKEN BASIERTES BILDVERARBEITUNGSSYSTEM UND VERFAHREN ZUM VERARBEITEN VON BILDERN,,SARNOFF CORP,BURT J;;IRANI MICHAL;;HSU C;;ANANDAN PADMANABHAN;;HANSEN W,,https://lens.org/106-522-989-748-186,Granted Patent,no,0,0,16,18,0,G06T3/4038;;G06T11/00;;H04N5/781;;H04N5/85;;H04N9/8047;;H04N19/503;;H04N19/30;;H04N19/63;;H04N19/61;;H04N19/20;;H04N19/23;;G06V10/16;;G06V10/24;;G06V10/20;;H04N9/8047;;G06T11/00;;H04N5/781;;H04N5/85;;G06T3/4038;;H04N19/63;;H04N19/30;;H04N19/503;;H04N19/20;;H04N19/61;;H04N19/23;;G06V10/24;;G06V10/16,G06T3/00;;G06T9/00;;H04N5/262;;G06T11/00;;G06V10/24;;H03M7/36;;H04N1/387;;H04N5/781;;H04N5/85;;H04N5/91;;H04N7/167;;H04N7/18;;H04N7/26;;H04N7/30;;H04N7/36;;H04N7/50;;H04N9/804;;H04N21/4402;;H04N21/854,,0,0,,,,EXPIRED
399,DE,D1,DE 68918542 D1,147-351-066-743-321,1994-11-03,1994,DE 68918542 T,1989-08-30,US 23940988 A,1988-09-01,Verfahren zur Transhalogenierung einer Halogenphosphor-Verbindung mit Fluorwasserstoff.,,ALBEMARLE CORP,BURT EDWARD ANGUS;;BURTON LESTER PERCY J;;STAHLY BARBARA CLACK,,https://lens.org/147-351-066-743-321,Granted Patent,no,0,0,8,10,0,C07F9/65744;;C07F9/146,C07F9/146;;C07F9/52;;C07F9/6574,,0,0,,,,EXPIRED
400,WO,A1,WO 2000/027221 A1,179-978-558-450-656,2000-05-18,2000,US 9926401 W,1999-11-08,US 18760898 A,1998-11-06,NUTRITIONAL SUPPLEMENTS,The invention provides methods for producing edible plant tissue biomasses suitable for use as nutritional supplements. The seedlings are exposed to at least one metal and normal seedling growth is interrupted prior to the eleventh day following germination to thereby produce a metal-enriched plant seedling tissue biomass. The metal-containing edible plant tissue biomasses are also provided.,NUCYCLE THERAPY INC;;ENSLEY BURT D;;ELLESS MARK;;BLAYLOCK MICHAEL J;;HUANG JIANWEI,ENSLEY BURT D;;ELLESS MARK;;BLAYLOCK MICHAEL J;;HUANG JIANWEI,,https://lens.org/179-978-558-450-656,Patent Application,yes,1,5,10,10,0,A23K20/30;;A23L33/105;;A23L33/16;;A23K20/30;;A23L33/105;;A23L33/16,A23K1/175;;A23L1/30;;A23L1/304,,0,0,,,,PATENTED
401,EP,A4,EP 1124438 A4,162-755-512-411-250,2005-02-02,2005,EP 99960247 A,1999-11-08,US 9926401 W;;US 18760898 A,1998-11-06,NUTRITIONAL SUPPLEMENTS,,NUCYCLE THERAPY INC,ENSLEY BURT D;;ELLESS MARK;;BLAYLOCK MICHAEL J;;HUANG JIANWEI,"INB:BIOTECHNOLOGIES, INC. (2005-05-18);;IBIO, INC. (2011-07-13)",https://lens.org/162-755-512-411-250,Search Report,no,4,0,10,10,0,A23K20/30;;A23L33/105;;A23L33/16;;A23K20/30;;A23L33/105;;A23L33/16,A23K1/175;;A23L1/30;;A23L1/304,,5,3,014-079-553-610-515;;003-754-505-188-054;;033-623-027-870-291,10.1021/es960802n;;10.1016/0304-3835(89)90034-7;;2496915;;8233978;;10.1080/01635589309514279,"SALT D E ET AL: ""METAL ACCUMULATION BY AQUACULTURED SEEDLINGS OF INDIAN MUSTARD"", ENVIRONMENTAL SCIENCE AND TECHNOLOGY, AMERICAN CHEMICAL SOCIETY. EASTON, PA, US, vol. 31, no. 6, June 1997 (1997-06-01), pages 1636 - 1644, XP000692780, ISSN: 0013-936X;;DATABASE WPI Section Ch Week 199221, Derwent World Patents Index; Class C04, AN 1992-171621, XP002308687;;STOEWSAND G S ET AL: ""EFFECT OF DIETARY BRUSSELS SPROUTS WITH INCREASED SELENIUM CONTENT ON MAMMARY CARCINOGENESIS IN THE RAT"", CANCER LETTERS, NEW YORK, NY, US, vol. 45, 1989, pages 43 - 48, XP002920433, ISSN: 0304-3835;;IP C ET AL: ""BIOAVAILABILITY OF SELENIUM FROM SELENIUM-ENRICHED GARLIC"", NUTRITION AND CANCER, LONDON, GB, vol. 20, no. 2, 1993, pages 129 - 137, XP002920432, ISSN: 0163-5581;;See also references of WO 0027221A1",DISCONTINUED
402,WO,A2,WO 2022/132469 A2,011-634-960-737-784,2022-06-23,2022,US 2021/0061931 W,2021-12-06,US 202063127617 P,2020-12-18,STABLE PIGMENT DISPERSION COMPOSITION,"A method for forming a pigment dispersion that is stable at elevated temperatures is provided, wherein the dispersion contains a pigment, solvent, and dispersant that is a salt of a polyether functionalized polyacid.",LUBRIZOL ADVANCED MAT INC,COULBECK ELLIOT;;BURT JONATHAN;;ZHANG LE-YANG;;SHOOTER ANDREW J,,https://lens.org/011-634-960-737-784,Patent Application,yes,1,0,7,7,0,C09K23/42;;C09C1/44;;C09C1/56;;C09B67/009;;C09K23/52,,,1,0,,,"TAKEO SAEGUSA ET AL., MACROMOLECULES, vol. 5, 1972, pages 4470",PENDING
403,AU,A,AU 2000/017161 A,017-881-781-902-39X,2000-05-29,2000,AU 2000/017161 A,1999-11-08,US 18760898 A;;US 9926401 W,1998-11-06,Nutritional supplements,,INB BIOTECHNOLOGIES INC,ENSLEY BURT D;;ELLESS MARK;;BLAYLOCK MICHAEL J;;HUANG JIANWEI,,https://lens.org/017-881-781-902-39X,Patent Application,no,0,0,10,10,0,A23K20/30;;A23L33/105;;A23L33/16;;A23K20/30;;A23L33/105;;A23L33/16,A23K1/175;;A23L1/30;;A23L1/304,,0,0,,,,EXPIRED
404,US,A,US 2634405 A,117-629-043-611-655,1953-04-07,1953,US 8419649 A,1949-03-29,US 8419649 A,1949-03-29,Traveling block indicator for oil well derricks,,STONE CLIFFORD E VAN;;LOPKER FRANK J;;STANLEY MINOR BURT,STONE CLIFFORD E VAN;;LOPKER FRANK J;;STANLEY MINOR BURT,,https://lens.org/117-629-043-611-655,Granted Patent,no,6,14,1,1,0,E21B19/02;;E21B19/02,E21B19/02,,0,0,,,,EXPIRED
405,EP,A3,EP 0357048 A3,114-020-349-627-802,1990-06-20,1990,EP 89116023 A,1989-08-30,US 23940988 A,1988-09-01,PROCESS FOR TRANSHALOGENATING A HALOPHOSPHORUS COMPOUND WITH HYDROGEN FLUORIDE,"Phosphorus compounds having at least one chlorine, bromine or iodine bonded directly to phosphorus are trans­halogenated with fluorine by reaction with anhydrous hydrogen fluoride in an inert solvent in a manner such that said anhydrous hydrogen fluoride is added to said phosphorus compound at a rate such that said anhydrous hydrogen fluoride reacts with said phosphorus compound without the accumulation of an amount of unreacted anhy­drous hydrogen fluoride which is sufficient to cause substantial decomposition of the desired fluorophosphorus product.  ",ETHYL CORPORATION,"BURT, EDWARD ANGUS;;BURTON, LESTER PERCY J.;;STAHLY, BARBARA CLACK",ALBEMARLE CORPORATION (1994-12-14),https://lens.org/114-020-349-627-802,Search Report,yes,2,0,8,10,0,C07F9/65744;;C07F9/146,C07F9/146;;C07F9/52;;C07F9/6574,,1,0,,,"HOUBEN-WEYL, Methoden der organischen Chemie, vol. XII/1, 1963, page 247, herausgegeben von Eugen Müller et al., Georg Thieme Verlag, Stuttgart, DE; K. SASSE: ""Organische Phosphor-Verbindungen""",EXPIRED
406,CA,C,CA 2349626 C,062-027-973-006-273,2012-05-01,2012,CA 2349626 A,1999-11-08,US 18760898 A;;US 9926401 W,1998-11-06,NUTRITIONAL SUPPLEMENTS,The invention provides methods for producing edible plant tissue biomasses suitable for use as nutritional supplements. The seedlings are exposed to at least one metal and normal seedling growth is interrupted prior to the eleventh day following germination to thereby produce a metal-enriched plant seedling tissue biomass. The metal-containing edible plant tissue biomasses are also provided.,NUCYCLE THERAPY INC,ENSLEY BURT D;;ELLESS MARK;;BLAYLOCK MICHAEL J;;HUANG JIANWEI,,https://lens.org/062-027-973-006-273,Granted Patent,no,0,0,10,10,0,A23K20/30;;A23L33/105;;A23L33/16;;A23K20/30;;A23L33/105;;A23L33/16,A23L1/304;;A01G7/00;;A23K1/175;;A23L1/30;;A61K33/00;;A61K36/31,,0,0,,,,EXPIRED
407,US,A1,US 2009/0234767 A1,165-425-061-525-124,2009-09-17,2009,US 7554808 A,2008-03-12,US 7554808 A,2008-03-12,Cost-based financial product,"In accordance with the principles of the present invention, a cost-based financial product is provided. The cost-based financial product is created at a front end that differentiates at the access level, thereby providing two distinct products—one evolving from direct arbitrage; the other an indigenous copy—that are essentially the same that can flow separately into different service entities. A fixed yield or amount of supply of a first component is divided into a variable yield of a second component that represents the cost basis relationship sought, thereby creating a partial supply devisor quotient scale—a new scale of cost unit change that becomes the new price array on the front end. A front-end application ladder can be created by substituting a price per divisor supply (whether shares of stock, bushels of grain, etc.) quotient scale for the matrix price array of the cost component to accept the expanding or contracting value of the gross changes of the cost product value. Each trade price increment allowing buying or selling of those differentials as they occur in the mimicked cost product ladder or the indigenous one. The cost-based financial product of the present invention enables an indigenous marketplace where traders can make a directly offsetting trade at any of the trade prices, thereby bypassing the arbitrage base by choosing to use the indigenous one.",STEIDLMAYER J PETER;;BRONSTEIN KEITH D;;GUTTERMAN BURT;;ROSENTHAL LESLIE,STEIDLMAYER J PETER;;BRONSTEIN KEITH D;;GUTTERMAN BURT;;ROSENTHAL LESLIE,,https://lens.org/165-425-061-525-124,Patent Application,yes,6,3,1,1,0,G06Q40/04;;G06Q40/04;;G06Q40/00;;G06Q40/00,G06Q30/00;;G06Q40/00,705/37;;705/35,0,0,,,,DISCONTINUED
408,CA,A1,CA 2349626 A1,182-838-182-576-528,2000-05-18,2000,CA 2349626 A,1999-11-08,US 18760898 A;;US 9926401 W,1998-11-06,NUTRITIONAL SUPPLEMENTS,The invention provides methods for producing edible plant tissue biomasses suitable for use as nutritional supplements. The seedlings are exposed to at least one metal and normal seedling growth is interrupted prior to the eleventh day following germination to thereby produce a metal-enriched plant seedling tissue biomass. The metal-containing edible plant tissue biomasses are also provided.,NUCYCLE THERAPY INC,HUANG JIANWEI;;ENSLEY BURT D;;BLAYLOCK MICHAEL J;;ELLESS MARK,,https://lens.org/182-838-182-576-528,Patent Application,no,0,0,10,10,0,A23K20/30;;A23L33/105;;A23L33/16;;A23K20/30;;A23L33/105;;A23L33/16,A23K1/175;;A23L1/30;;A23L1/304,,0,0,,,,EXPIRED
409,EP,A2,EP 0357048 A2,057-099-487-514-418,1990-03-07,1990,EP 89116023 A,1989-08-30,US 23940988 A,1988-09-01,Process for transhalogenating a halophosphorus compound with hydrogen fluoride.,"Phosphorus compounds having at least one chlorine, bromine or iodine bonded directly to phosphorus are trans­halogenated with fluorine by reaction with anhydrous hydrogen fluoride in an inert solvent in a manner such that said anhydrous hydrogen fluoride is added to said phosphorus compound at a rate such that said anhydrous hydrogen fluoride reacts with said phosphorus compound without the accumulation of an amount of unreacted anhy­drous hydrogen fluoride which is sufficient to cause substantial decomposition of the desired fluorophosphorus product.  ",ETHYL CORP,BURT EDWARD ANGUS;;BURTON LESTER PERCY J;;STAHLY BARBARA CLACK,ALBEMARLE CORPORATION (1994-12-14),https://lens.org/057-099-487-514-418,Patent Application,yes,0,0,8,10,0,C07F9/65744;;C07F9/146,C07F9/146;;C07F9/52;;C07F9/6574,,0,0,,,,EXPIRED
410,US,A,US 4863073 A,102-899-987-826-114,1989-09-05,1989,US 10872987 A,1987-10-14,GB 8624670 A,1986-10-15,Valve for aerosol container,"A valve is provided for dispensing metered doses from an aerosol container, which contains a substance to be dispensed suspended in a liquid propellant. The valve comprises a valve body (2, 3), first and second valve seals (6,7) at opposite ends of the valve body (2,3), and a valve stem (5) having an outlet (18) and a transfer port (19) extending from the exterior of the valve stem (5) to the outlet (18). A metering chamber (4) is defined by the internal wall of the valve body (2,3), the first and second valve seals (6,7) and the portion of the valve stem (5) within the cavity. The valve stem (5) is biased to a position in which, when the container is orientated with the valve at the bottom, liquid can enter the metering chamber through at least one orifice (12) which communicates with the interior of the container at a location which, when the container is orientated with the valve at the bottom, is an appreciable distance above the nearest surface which is horizontal or has an appreciable horizontal component. The orifice (12) is directed transversely with respect to the direction of movement of the valve stem (5).",GLAXO GROUP LTD,BURT PETER C W;;SMITH IAN J;;WYATT DAVID A,GLAXO GROUP LIMITED (1987-10-06),https://lens.org/102-899-987-826-114,Granted Patent,yes,11,51,13,13,0,B65D83/54;;G01F11/36;;B65D83/54;;G01F11/36,B65D83/14;;F17C7/00;;B65D83/44;;G01F11/36,222/402.2;;222/453,1,0,,,Bespak BK 300 Pressure Filling Valve.,EXPIRED
411,TW,A,TW 202239782 A,119-618-083-340-270,2022-10-16,2022,TW 110147460 A,2021-12-17,US 202063127647 P,2020-12-18,Method of producing a polymer using a pigment dispersion,"A method of producing a polymer using a pigment dispersion that is stable at elevated temperatures is provided, wherein the dispersion contains a pigment, solvent, and dispersant that is a salt of a polyether functionalized polyacid.",LUBRIZOL ADVANCED MATERIALS INC,BURT JONATHAN;;COULBECK ELLIOT;;ZHANG LE-YANG;;SHOOTER ANDREW J,,https://lens.org/119-618-083-340-270,Patent of Addition,no,0,0,6,6,0,C08L67/02;;C08J3/20;;C08F8/44;;C08J2367/02;;C08J2453/00,C08F8/44;;C08F8/30;;C08F293/00;;C08J3/20;;C08K3/04;;C08L53/00;;C08L67/02;;C08L79/02,,0,0,,,,PENDING
412,TW,A,TW 202235542 A,144-471-365-659-637,2022-09-16,2022,TW 110147459 A,2021-12-17,US 202063127617 P,2020-12-18,Stable pigment dispersion composition,"A method for forming a pigment dispersion that is stable at elevated temperatures is provided, wherein the dispersion contains a pigment, solvent, and dispersant that is a salt of a polyether functionalized polyacid.",LUBRIZOL ADVANCED MATERIALS INC,COULBECK ELLIOT;;BURT JONATHAN;;ZHANG LE-YANG;;SHOOTER ANDREW J,,https://lens.org/144-471-365-659-637,Patent of Addition,no,0,0,7,7,0,C09K23/42;;C09C1/44;;C09C1/56;;C09B67/009;;C09K23/52,C09C1/48;;C09C3/10;;C09D17/00,,0,0,,,,PENDING
413,EP,B1,EP 0357048 B1,187-725-670-860-895,1994-09-28,1994,EP 89116023 A,1989-08-30,US 23940988 A,1988-09-01,Process for transhalogenating a halophosphorus compound with hydrogen fluoride.,,ALBEMARLE CORP,BURT EDWARD ANGUS;;BURTON LESTER PERCY J;;STAHLY BARBARA CLACK,ALBEMARLE CORPORATION (1994-12-14),https://lens.org/187-725-670-860-895,Granted Patent,yes,2,0,8,10,0,C07F9/65744;;C07F9/146,C07F9/146;;C07F9/52;;C07F9/6574,,1,0,,,"HOUBEN-WEYL, Methoden der organischen Chemie, vol. XII/1, 1963, page 247,herausgegeben von Eugen Müller et al., Georg Thieme Verlag, Stuttgart, DE; K.SASSE: ""Organische Phosphor-Verbindungen""",EXPIRED
414,US,A1,US 2006/0130496 A1,091-004-190-468-72X,2006-06-22,2006,US 90652605 A,2005-02-23,US 90652605 A;;US 63717004 P,2004-12-17,"ENHANCED DIAGNOSTICS FOR A HEATING, VENTILATION AND AIR CONDITIONING CONTROL SYSTEM AND AN ASSOCIATED METHOD OF USE","A heating, ventilation and air conditioning diagnostic system and associated method of use is disclosed. The system includes a controller for operating a heating, ventilation and air conditioning system, a plurality of sensors for monitoring various parameters associated with the operation of the heating, ventilation and air conditioning system that are in electronic communication with the controller, at least one input device that is in electronic communication with the controller, wherein the at least one input device is able to modify variables utilized by the controller to improve performance of the heating, ventilation and air conditioning system; and at least one output device that is in electronic communication with the controller. The variables can include non-safety timing values and text-based information. The system may include counters that can be read-only, reset to zero and overwritten through the plurality of input devices. Historical data can be recorded, reviewed and selectively analyzed.",RANCO INC,CHAPMAN JOHN;;BURT ROBERT;;KAPLAN YELENA N;;VENDT STEPHEN J,RANCO INCORPORATED OF DELAWARE (2005-02-21),https://lens.org/091-004-190-468-72X,Patent Application,yes,20,26,8,9,0,F24F11/30;;F24F11/52;;F24F11/38;;G05B23/02;;F24F11/38;;F24F11/52;;F24F11/30;;F24F11/52;;F24F11/38,F24F7/00;;F25B49/00;;G05D23/32,62/126;;62/158;;X23600100C,0,0,,,,DISCONTINUED
415,WO,A1,WO 2022/132492 A1,119-012-540-245-513,2022-06-23,2022,US 2021/0062133 W,2021-12-07,US 202063127647 P,2020-12-18,METHOD OF PRODUCING A POLYMER USING A PIGMENT DISPERSION,"A method of producing a polymer using a pigment dispersion that is stable at elevated temperatures is provided, wherein the dispersion contains a pigment, solvent, and dispersant that is a salt of a polyether functionalized polyacid.",LUBRIZOL ADVANCED MAT INC,BURT JONATHAN;;COULBECK ELLIOT;;ZHANG LE-YANG;;SHOOTER ANDREW J,,https://lens.org/119-012-540-245-513,Patent Application,yes,43,0,6,6,0,C08L67/02;;C08J3/20;;C08F8/44;;C08J2367/02;;C08J2453/00,C08G63/00;;C08J3/20;;C08L67/02;;C09K23/00,,2,1,010-179-080-086-786,10.3138/9781442653399-017,"TAKEO SAEGUSA ET AL., MACROMOLECULES, vol. 5, 1972, pages 4470;;""Third Edition of the Colour Index"", 1971",PENDING
416,CA,C,CA 1317969 C,133-567-894-546-74X,1993-05-18,1993,CA 608907 A,1989-08-21,US 23940988 A,1988-09-01,PROCESS FOR TRANSHALOGENATING A HALOPHOSPHORUS COMPOUND WITH FLUORIDE,"PROCESS FOR TRANSHALOGENATING A HALOPHOSPHORUS COMPOUND WITH FLUORIDE Phosphorus compounds having at least one chlorine, bromine or iodine bonded directly to phosphorus are transhalogenated with fluorine by reaction with anhydrous hydrogen fluoride in an inert solvent in a manner such that said anhydrous hydrogen fluoride is added to said phosphorus compound at a rate such that said anhydrous hydrogen fluoride reacts with said phosphorus compound without the accumulation of an amount of unreacted anhydrous hydrogen fluoride which is sufficient to cause substantial decomposition of the desired fluorophosphorus product.",ETHYL CORP,BURT EDWARD A;;BURTON LESTER P J;;STAHLY BARBARA C,,https://lens.org/133-567-894-546-74X,Granted Patent,no,0,0,8,10,0,C07F9/65744;;C07F9/146,C07F9/146;;C07F9/52;;C07F9/6574,D12600457    M,0,0,,,,EXPIRED
417,US,B2,US 7735327 B2,135-366-255-578-237,2010-06-15,2010,US 77978007 A,2007-07-18,US 77978007 A;;US 45865706 A,2006-07-19,Active thermal insulation system utilizing phase change material and a cool air source,"An active thermal insulation system is disclosed. The system utilizes a cool air source or ambient air below a threshold temperature in conjunction with a phase change material and/or conventional insulation. In a controlled manner, the cooled air or ambient air facilitates the transition of the phase change material from a substantially liquid state to a substantially solid state allowing the solid phase change material to absorb heat. Cooled air or ambient air may be directed to the phase change material via a gap or plenum capable of introducing the cooled air or ambient air adjacent to the phase change material. A fan, blower or air intake device may be used to direct ambient air to the gap or plenum.",NEAL ENERGY MAN LLC,BROWER KEITH R;;DOLE BURT;;NEAL THOMAS;;SHRAMO DANIEL J,NEAL ENERGY MANAGEMENT LLC (2007-10-16),https://lens.org/135-366-255-578-237,Granted Patent,yes,29,9,8,10,0,F24F5/0017;;F24F5/0021;;F28D20/02;;F28D2020/0008;;Y02E60/14;;F28D20/02;;F24F5/0021;;F28D2020/0008;;F24F5/0017;;Y02E60/14,F25D17/02,62/98;;62/457.2;;62/530,0,0,,,,ACTIVE
418,TW,A,TW 202233770 A,184-898-073-734-416,2022-09-01,2022,TW 110147463 A,2021-12-17,US 202063127617 P,2020-12-18,Stable pigment dispersion composition,"A method for forming a pigment dispersion that is stable at elevated temperatures is provided, wherein the dispersion contains a pigment, solvent, and dispersant that is a salt of a polyether functionalized polyacid.",LUBRIZOL ADVANCED MATERIALS INC,COULBECK ELLIOT;;BURT JONATHAN;;ZHANG LE-YANG;;SHOOTER ANDREW J,,https://lens.org/184-898-073-734-416,Patent of Addition,no,0,0,7,7,0,C09K23/42;;C09C1/44;;C09C1/56;;C09B67/009;;C09K23/52,C09D17/00,,0,0,,,,PENDING
419,US,B1,US 6270809 B1,108-223-157-032-84X,2001-08-07,2001,US 18760898 A,1998-11-06,US 18760898 A,1998-11-06,Nutritional supplements,The invention provides methods for producing edible plant tissue biomasses suitable for use as nutritional supplements. The seedlings are exposed to at least one metal and normal seedling growth is interrupted prior to the eleventh day following germination to thereby produce a metal-enriched plant seedling tissue biomass. The metal-containing edible plant tissue biomasses are also provided.,PHYTOTECH INC,ENSLEY BURT D;;ELLESS MARK;;BLAYLOCK MICHAEL J;;HUANG JIANWEI,INB:BIOTECHNOLOGIES INC (2004-11-23);;PHYTOTECH INC. A NEW JERSEY CORPORATION (1998-12-16);;IBIO INC (2008-07-17),https://lens.org/108-223-157-032-84X,Granted Patent,yes,5,13,10,10,0,A23K20/30;;A23L33/105;;A23L33/16;;A23K20/30;;A23L33/105;;A23L33/16,A23K1/175;;A23L1/30;;A23L1/304,424/617;;424/600;;424/630;;424/639;;424/646;;424/641;;424/650;;424/655;;424/657;;424/682;;424/702;;424/195.1;;426/74;;514/492;;514/494;;514/499;;514/501;;514/502;;514/505,36,25,032-538-665-956-708;;043-417-177-490-740;;010-406-579-252-154;;067-493-162-396-490;;040-577-376-077-290;;080-248-966-537-027;;112-725-112-974-993;;153-537-728-396-713;;124-781-015-463-974;;091-244-176-740-056;;005-532-195-252-530;;060-304-177-359-764;;025-873-143-969-987;;011-583-110-425-947;;002-519-047-881-209;;046-789-268-069-923;;032-202-897-285-393;;118-470-805-263-306;;004-374-322-586-553;;014-079-553-610-515;;074-576-821-261-07X;;003-754-505-188-054;;114-898-343-352-970;;165-367-977-989-065;;145-350-837-041-938,10.1080/01904169509364991;;10.1080/01904169409364818;;10.2134/jeq1993.00472425002200040021x;;10.1080/01904168909364034;;9440291;;10.1016/s0021-9673(97)00657-2;;10.2134/jeq1994.00472425002300060004x;;10.1001/jama.1996.03530380029025;;8601925;;pmc157769;;12226213;;10.1104/pp.110.3.715;;10.1203/00006450-199412000-00024;;7898991;;2132752;;9294217;;10.1073/pnas.94.19.10367;;pmc23369;;10.2134/agronj1994.00021962008600050029x;;8137319;;10.2136/sssabookser3.3ed.c15;;10.1093/jxb/45.6.733;;10.1080/01904169109364191;;10.2134/jeq1994.00472425002300020004x;;10.1001/archpedi.1991.02160080029016;;1858720;;10.1136/bmj.290.6466.417;;3918611;;pmc1417771;;10.1021/es960802n;;9634787;;10.1038/nbt0595-468;;10.1016/0304-3835(89)90034-7;;2496915;;10.2136/sssaj1995.03615995005900010035x;;10.1021/ac50043a017;;10.1111/j.1365-3040.1996.tb00210.x,"The Merck Index (10th Ed.), p. 126 (1989).;;Halperin et al., ""Germanium accumulation and toxicity in barley', Journal of Plant Nutrition (1995), vol. 18, No. 7, pp. 1417-1426.*;;Berti et al., ""Sequential chemical extraction of trace elements: Development and use in remediating contaminated soils,"" Proc. Third Int'l. Conf. Biogeochem. of Trace Elements (1995).;;USEPA, ""Test Methods for Evaluating Solid Waste, Physical/Chemical Methods"", SW-846, (U.S. Environmental Protection Agency, Washington DC) (Dec. 1996).;;Ashraf, M., et al., ""Does Pattern Of Ion Accumulation Vary In Alfalfa At Different Growth Stages?,"" Journal of Plant Nutrition, 17(8):1443-1461 (1994).;;Baker, A. J. M., et al., ""Terrestrial Higher Plants which Hyper-accumulate Metallic Elements-A Review of their Distribution, Ecology and Phytochemistry,"" pp. 81-126 (A B Academic Publishers, West Yorkshire, England 1989).;;Baker, D.A., et al., ""Uptake of Cations and their Transport within the Plant,"" in Metals and Micronutrients: Uptake and Utilization by Plants (Robb, D.A., et al., eds.) (AP Academic Press, New York, N.Y. 1983).;;Banuelos, G.S., et al., ""Boron and Selenium Removal in Boron-Laden Soils by Four Sprinkler Irrigated Plant Species,"" J. Environ. Qual. 22:786-792 (1993).;;Banuelos, G.S., et al., ""Evaluation of Different Plant Species Used for Phytoremediation of High Soil Selenium,"" J. Environ. Qual. 26:639-646 (1997).;;Banuelos, G.S., et al., ""Selenium Accumulation in Selected Vegetables,"" Journal of Plant Nutrition, 12(10):1255-1272 (1989).;;Bird, S.M., et al., ""High-performance liquid chromatography of selenoamino acids and organo selenium compounds: Speciation by inductively coupled plasma mass spectrometry,"" Journal of Chromatography A 789:349-359 (1997).;;Brown, S.L., et al., ""Phytoremediation Potential of Thlaspi Caerulescens and Bladder Campion for Zinc- and Cadmium-Contaminated Soil,"" J. Environ. Qual. 23:1151-1157 (1994).;;Clark, R.F., et al., ""Selenium Poisoning From a Nutritional Supplement,"" JAMA 275(14):1087:1088 (1996).;;Cunningham, S.D., et al., ""Promises and Prospects of Phytoremediation,"" Plant Physiol. 110:715-719 (1996).;;Davidsson, L., et al., ""Iron Bioavailability Studied in Infants: The Influence of Phytic Acid and Ascorbic Acid in Infant Formulas Based on Soy Isolate,"" Pediatric Research 36(6):816-822 (1994).;;Durlach, J., ""Magnesium depletion and pathogenesis of Alzheimer's disease,"" Magnesium Research 3(3):217-218 (1990).;;Fahey, J.W., et al., ""Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens,"" Proc. Natl. Acad. Sci. (USA) 94:10367-10372 (1997).;;Fenn, L.B., et al., ""Calcium Stimulation of Ammonium Absorption and Growth by Beet,"" Agron. J. 86:916-920 (1994).;;Ip, C., et al., ""Potential of Food Modification in Cancer Prevention,"" Cancer Research (Suppl.) 54:1957s-1959s (1994).;;James, L.F., et al., ""Selenium Poisoning in Livestock: A Review and Progress,"" Selenium in Agriculture and the Environment 23:123-127 (1989).;;Jones, J. B., et al., ""Sampling, Handling, and Analyzing Plant Tissue Samples,"" in Soil Testing and Plant Analysis, 3d Ed., Chap.15, pp. 389-427 (Soil Science Society of America, Inc. 1990).;;Kabata-Pendias, A., et al., in ""Trace Elements in Soils and Plants,"" pp. 102, 108-109, 230-231, and 238-239 (CRC Press, Inc., Boca Raton, FL 1989).;;Peuke, A.D., et al., ""The uptake and flow of C, N and ions between roots and shoots in Ricinus communis L. II. Grown with low or high nitrate supply,"" J. Exp. Botany 45(275):733-740 (1994).;;Pugnaire, F. I., et al., ""Nutritional Adaptations of Caper Shrub (Capparis-ovata Desf.) To Environmental Stress,"" J. Plant Nutrition 14(2):151-161 (1991).;;Rodecap, K.D., et al., ""Iron Nutrition Influence on Cadmium Accumulation by Arabidopsis thaliana (L.) Heynh.,"" J. Environ. Qual. 23:239-246 (1994).;;Sandstead, H.H., ""Zinc Deficiency: A Public Health Problem?,"" AJDC 145:853-859 (1991).;;Salonen, J.T., et al., ""Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data,"" British Medical Journal 290:417-420 (1985).;;Salt, D.E., et al., ""Metal Accumulation by Aquacultured Seedlings of Indian Mustard,"" Environmental Science & Technology 31(6):1636-1644 (1997).;;Salt, D.E., et al., ""Phytoremediation: A Novel Strategy for the Removal of Toxic Materials from the Environment Using Plants,"" Bio/Technology 13:468-473 (1995).;;Spackman, L.K., et al., ""Standard Operating Procedures For The Sampling And Analysis of Selenium in Soil And Overburden/Spoil Material,"" Agriculture Experiment Station pp. 1-13 (University of Wyoming 1994).;;Stoewsand, G.S., et al., ""Effect of dietary brussels sprouts with increased selenium content on mammary carcinogenesis in the rat,"" Cancer Letters 45:43-48 (1989).;;Taiz, L., et al., ""Mineral Nutrition,"" in Plant Physiology, Chap. 5, pp. 100-119 (Benjamin/Cummings Publishing Co., Inc. New York, N.Y. 1991).;;Teng, Y., et al., ""Rhizosphere Phosphorus Depletion Induced by Heavy Nitrogen Fertilization in Forest Nursery Soils,"" Soil Sci. Soc. Am. J. 59:227-233 (1995).;;Tessier, A., et al., ""Sequential Extraction Procedure for the Speciation of Particulate Trace Metals,"" Analytical Chemistry 51(7):844-851 (1979).;;Wang, M. Y., et al., ""Interactions between K+ and NH4+: effects on ion uptake by rice roots,"" Plant, Cell and Environment 19:1037-1046 (1996).;;Wilson, S., ""A build up of salt in the topsoil has some San Joaquin Valley growers considering certain plant species to help overcome the problem,"" California Farmer, pp. 25-27 (Jan. 1998).",EXPIRED
420,AU,B2,AU 778184 B2,015-440-033-761-695,2004-11-18,2004,AU 2000/017161 A,1999-11-08,US 18760898 A;;US 9926401 W,1998-11-06,Nutritional supplements,,NUCYCLE THERAPY INC,ENSLEY BURT D;;ELLESS MARK;;BLAYLOCK MICHAEL J;;HUANG JIANWEI,,https://lens.org/015-440-033-761-695,Granted Patent,no,2,0,10,10,0,A23K20/30;;A23L33/105;;A23L33/16;;A23K20/30;;A23L33/105;;A23L33/16,A23K1/175;;A23L1/30;;A23L1/304,,0,0,,,,EXPIRED
421,US,A1,US 2008/0034774 A1,095-169-497-212-674,2008-02-14,2008,US 77978007 A,2007-07-18,US 77978007 A;;US 45865706 A,2006-07-19,ACTIVE THERMAL INSULATION SYSTEM UTILIZING PHASE CHANGE MATERIAL AND A COOL AIR SOURCE,"An active thermal insulation system is disclosed. The system utilizes a cool air source or ambient air below a threshold temperature in conjunction with a phase change material and/or conventional insulation. In a controlled manner, the cooled air or ambient air facilitates the transition of the phase change material from a substantially liquid state to a substantially solid state allowing the solid phase change material to absorb heat. Cooled air or ambient air may be directed to the phase change material via a gap or plenum capable of introducing the cooled air or ambient air adjacent to the phase change material. A fan, blower or air intake device may be used to direct ambient air to the gap or plenum.",BROWER KEITH R;;DOLE BURT;;NEAL THOMAS;;SHRAMO DANIEL J,BROWER KEITH R;;DOLE BURT;;NEAL THOMAS;;SHRAMO DANIEL J,NEAL ENERGY MANAGEMENT LLC (2007-10-16),https://lens.org/095-169-497-212-674,Patent Application,yes,15,1,8,10,0,F24F5/0017;;F24F5/0021;;F28D20/02;;F28D2020/0008;;Y02E60/14;;F28D20/02;;F24F5/0021;;F28D2020/0008;;F24F5/0017;;Y02E60/14,F25D23/06,62/259.1,0,0,,,,ACTIVE
422,US,A,US 5488674 A,067-678-279-366-229,1996-01-30,1996,US 5961093 A,1993-05-12,US 5961093 A;;US 88409892 A,1992-05-15,Method for fusing images and apparatus therefor,A method for fusing two or more source images to form a composite image with extended information content which may be color augmented and apparatus for forming the composite image from the source images is disclosed. Each source image is decomposed into a number of source images of varying resolution. The decomposed source images are analyzed using directionally sensitive operators to generate a set of oriented basis functions characteristic of the information content of the original images. The oriented basis functions for the composite image are then selected from those of the different source images and the inverse of the decomposition performed to construct the composite image. Color augmentation provides information as to the relative weighting of the contribution of each source to the composite image.,SARNOFF DAVID RES CENTER,BURT PETER J;;VAN DER WAL GOOITZEN S;;KOLCZYNSKI RAYMOND J;;HINGORANI RAJESH,DAVID SARNOFF RESEARCH CENTER INC (1993-06-30);;SARNOFF CORPORATION (1997-04-04),https://lens.org/067-678-279-366-229,Granted Patent,yes,8,397,10,10,0,G06T5/50;;G06T2207/20016;;G06T2207/20221;;H04N7/181;;H04N19/23;;G06T5/50;;G06T2207/20221;;G06T2207/20016;;H04N7/181;;H04N19/23,G06T3/00;;G06T5/50;;H04N1/409;;H04N1/46;;H04N7/18;;H04N7/26,382/284;;382/162;;348/584;;348/598,11,8,071-200-818-046-69X;;070-625-968-995-265;;042-689-645-533-661;;143-502-655-624-03X;;050-628-907-804-240;;064-409-780-330-153;;019-713-887-004-440;;122-199-226-478-846,21869279;;10.1109/tpami.1985.4767680;;10.1016/0146-664x(81)90092-7;;10.1145/245.247;;10.1117/12.966501;;10.2514/6.1991-3730;;10.1007/bf01211447;;10.1109/79.91217;;10.1109/34.192463,"Recognizing Partially Occluded Parts IEEE Transactions on Pattern Analysis and Machine Intelligence, vol. PAMI 7, No. 4 Jul. 1985 Jerry L. Turney et al.;;P. Burt, Fast Filter Transforms For Image Processing in Multiresolution Image processing And Analysis, vol. 16 pp. 20 51, 1981.;;P. Burt, The Pyramid As A Structure For Efficient Computation in Computer Graphics And Image Orcessing, A. Rosenfelf, Ed., SpringerVerlag, NY., 1984.;;P. Burt & E. H. Adelson, A Multiresoulution Spline With Application To Image Mosaics ACM Trans. on Graphics, vol. 2, pp. 217 236, 1983.;;P. J. Burt and E. H. Adelson, Merging Images Through Pattern Decomposition Proceeding of SPIE , vol. 575, pp. 173 181, 1985.;;M. Pavel, J. Larimer, and A. Ahumade, Sensor Fusion For Synthetic Vision , Proceedings AIAA Conference on Computing in Aerospace 8, Baltimore Oct. 1991.;;A. Toet, Hierarchical Image Fusion , Machine Vision And Applications, vol. 3 pages Jan. 11, 1991.;;O. Rioul and M. Veterli, Wavelets and Signal Processing IEEE SP Magazine, Oct. 1991.;;S. Mallat, A Theory For Multiresolution Signal Decomposition: The Wavelet Representation , IEE Trans. Pattern Analysis and Machine Intell. vol. 11 pp. 674 693, 1989.;;P. J. Burt and W. A. Lee, A Family of Pyramid Structures For Multiresolution Image Processing , David Sarnoff Research Center, Internal Communication, 1988.;;van der Wal The Sarnoff Pyramid Chip CAMP 91 Paris, Dec. 16, 1991.",EXPIRED
423,US,A,US 5325449 A,118-105-764-299-867,1994-06-28,1994,US 88409892 A,1992-05-15,US 88409892 A,1992-05-15,Method for fusing images and apparatus therefor,A method for fusing two or more source images to form a composite image with extended information content and apparatus for forming the composite image from the source images is disclosed. Each source image is decomposed into a number of source images of varying resolution. The decomposed source images are analyzed using directionally sensitive operators to generate a set of oriented basis functions characteristic of the information content of the original images. The oriented basis functions for the composite image are then selected from those of the different source images and the inverse of the decomposition performed to construct the composite image. Apparatus for fusing two or more source images to form a composite image is also disclosed.,SARNOFF DAVID RES CENTER,BURT PETER J;;VAN DER WAL GOOITZEN S;;KOLCZYNSKI RAYMOND J;;HINGORANI RAJESH,DAVID SARNOFF RESEARCH CENTER INC. A DE CORP (1992-07-13);;SARNOFF CORPORATION (1997-04-04),https://lens.org/118-105-764-299-867,Granted Patent,yes,4,333,10,10,0,G06T5/50;;G06T2207/20016;;G06T2207/20221;;H04N7/181;;H04N19/23;;G06T5/50;;G06T2207/20221;;G06T2207/20016;;H04N7/181;;H04N19/23,G06T3/00;;G06T5/50;;H04N1/409;;H04N1/46;;H04N7/18;;H04N7/26,382/56;;382/22;;382/41,10,7,143-502-655-624-03X;;050-628-907-804-240;;064-409-780-330-153;;019-713-887-004-440;;122-199-226-478-846;;070-625-968-995-265;;042-689-645-533-661,10.1117/12.966501;;10.2514/6.1991-3730;;10.1007/bf01211447;;10.1109/79.91217;;10.1109/34.192463;;10.1016/0146-664x(81)90092-7;;10.1145/245.247,"Richard Tinkler, Multi Spectral Image Fusion , Defence Helicopter, Autumn Supplement, pp. 8 10, 1992.;;P. J. Burt and E. H. Adelson, Merging Images Through Pattern Decomposition Proceeding of SPIE , vol. 575, pp. 173 181, 1985.;;M. Pavel, J. Larimer, and A. Ahumade, Sensor Fusion for Synthetic Vision , Proceedings AIAA Conference on Computing in Aerospace 8, Baltimore Oct. 1991.;;A. Toet, Hierarchical Image Fusion , Machine Vision and Applications, vol. 3 pp. Jan. 11, 1991.;;O. Rioul and M. Veterli, Wavelets and Signal Processing IEEE SP Magazine, Oct. 1991.;;S. Mallat, A Theory For Multiresolution Signal Decomposition: The Wavelet Representation , IEE Trans. Pattern Analysis and Machine Intell. vol. 11 pp. 674 693, 1989.;;P. J. Burt and W. A. Lee, A Family of Pyramid Structure For Multiresolution Image Processing , David Sarnoff Research Center, Internal Communication, 1988.;;P. Burt, Fast Filter Transforms For Image Processing in Multiresolution Image processing And Analysis, vol. 16 pp. 20 51, 1981.;;P. Burt, The Pyramid As A Structure For Efficient Computation in Computer Graphics And Image Orcessing, A. Resenfelf, Ed., Springer/Verlag, N.Y., 1984.;;P. Burt & E. H. Adelson, A Multiresolution Spline With Application To Image Mosaics ACM Trans. on Graphics, vol. 2, pp. 217 236, 1983.",EXPIRED
424,AU,B2,AU 630955 B2,147-730-895-971-030,1992-11-12,1992,AU 1990/055128 A,1990-05-17,US 35388089 A,1989-05-18,AUTOMATED DRINKMAKER SYSTEM,,PEPSICO INC.,SALVATORE J. BROGNA;;RICHARD J. CASLER;;JOHN W. MEADOWS;;JOSEPH F LYNDERS;;BURT SHULMAN,,https://lens.org/147-730-895-971-030,Granted Patent,no,3,0,9,9,0,B67D1/00;;B67D1/06;;B67D2210/00065;;B67D2210/00076;;G07F13/10;;B67D1/00;;B67D1/06;;G07F13/10;;B67D2210/00076;;B67D2210/00065,A47J31/00;;A47J31/40;;B67D1/00;;B67D1/06;;B67D1/07;;G07F13/10,,0,0,,,,EXPIRED
425,US,S,US D0625378 S,161-569-837-068-950,2010-10-12,2010,US 33137909 F,2009-01-23,US 33137909 F,2009-01-23,Rail cover,,MAGPUL IND CORP,FITZPATRICK RICHARD;;MAYBERRY MICHAEL T;;BURT ERIC CHRISTOPHER;;BARANELLO MIKE J,MAGPUL INDUSTRIES CORPORATION (2009-04-16),https://lens.org/161-569-837-068-950,Design Right,no,0,6,1,1,0,,,2201;;D22/108,0,0,,,,ACTIVE
426,CA,A1,CA 2344731 A1,058-587-419-971-800,2001-10-25,2001,CA 2344731 A,2001-04-19,US 19942400 P;;US 68125301 A,2000-04-25,"STATOR, DYNAMOELECTRIC MACHINE, AND METHODS FOR FABRICATING SAME","A dynamoelectric machine includes a stator having teeth fabricated from a non-magnetic material and containing at least one embedded conductor. The teeth are unitary with a back portion that is mounted to a stator back iron. Permeance variations induced by a stator winding mounted on the non-magnetic stator teeth are low which facilitates a reduction of motor noise. Specifically, since the no n- magnetic teeth reduce production of permeance variations, changes in air gap forces between the rotor and the stator are decreased.",GEN ELECTRIC CANADA,ONG RAYMOND K J;;SALASOO LEMBIT;;YOUNG JOHN;;KLIMAN GERALD BURT,,https://lens.org/058-587-419-971-800,Patent Application,no,0,2,4,4,0,H02K1/16;;H02K3/47;;H02K55/04;;Y10T29/49009;;Y02E40/60;;Y10T29/49009;;H02K55/04;;H02K1/16;;H02K3/47;;Y02E40/60,H02K1/16;;H02K3/47;;H02K55/04,,0,0,,,,EXPIRED
427,SG,A1,SG 172061 A1,127-452-926-305-493,2011-07-28,2011,SG 2011042199 A,2009-12-09,US 12114108 P;;US 2009/0067395 W,2008-12-09,TWO-WHEELED ROBOT WITH ENHANCED CLIMBING FEATURES,A robot has an electronic surveillance system embedded within a chassis disposed between two wheels. The wheels include a main body and a plurality of treads. The treads are generally disposed radially around the main body and extend distally from outer portion of the main body. The main body generally defines a plurality of compression cells and may present a substantially frustoconical outer surface.,RECONROBOTICS INC,KOSSETT ALEX J;;BURT IAN T;;CARLSON CASEY R;;DRENNER ANDREW,,https://lens.org/127-452-926-305-493,Patent Application,no,0,0,18,18,0,B62D57/02;;B62D61/00;;Y10S901/01;;B25J5/00;;B25J19/00;;B62D57/02;;B62D61/00;;B60B9/10;;B25J5/007;;B25J19/023;;Y10S901/01,,,0,0,,,,PENDING
428,US,B2,US 11312031 B2,159-290-767-595-113,2022-04-26,2022,US 202016909406 A,2020-06-23,US 202016909406 A;;US 201715717443 A;;US 201514747780 A;;US 201314012910 A;;US 63461009 A;;US 12114108 P,2008-12-09,Two wheeled robot with enhanced climbing features,A robot has an electronic surveillance system embedded within a chassis disposed between two wheels. The wheels include a main body and a plurality of treads. The treads are generally disposed radially around the main body and extend distally from outer portion of the main body. The main body generally defines a plurality of compression cells and may present a substantially frustoconical outer surface.,RECONROBOTICS INC,CARLSON CASEY R;;DRENNER ANDREW;;KOSSETT ALEX J;;BURT IAN T,RECONROBOTICS INC (2009-12-22),https://lens.org/159-290-767-595-113,Granted Patent,yes,29,0,18,18,0,B62D57/02;;B62D61/00;;Y10S901/01;;B25J5/00;;B25J19/00;;B62D57/02;;B62D61/00;;B60B9/10;;B25J5/007;;B25J19/023;;Y10S901/01,B60K1/00;;B25J5/00;;B25J19/02;;B60B9/10;;B62D57/02;;B62D61/00,,5,0,,,"File history for U.S. Appl. No. 29/351,692, filed Dec. 9, 2009. Inventors: Casey R. Carlson et al. (96 pages).;;Dunbar, Thomas W., “Demonstration of Waypoint Navigation for a Semi-Autonomous Prototype Surf-Zone Robot,” (Master of Science Thesis, Naval Postgraduate School, Jun. 2006), 63 pages.;;Hearing Notice for Application No. 5272/DELNP/2011, dated Dec. 10, 2019 (3 pages).;;File history for U.S. Appl. No. 12/634,610, filed Dec. 9, 2009, Inventors: Casey R. Carlson et al. (321 pages).;;Admitted Prior Art, (Dec. 1, 2008), 1 page.",ACTIVE
429,US,A,US 5000345 A,129-274-489-317-229,1991-03-19,1991,US 35388089 A,1989-05-18,US 35388089 A,1989-05-18,Automated drinkmaker system,"An automated drinkmaker system which is designed to accept an input drink order, as from a cash register, and deliver the drink order, for different sizes and different flavors, with or without ice, completely finished in lidded containers to an output station. The automated drinkmaker system is designed for labor free processing of drink orders in high volume quick service or fast food establishments. The machine is designed around a carousel type of drink transporter which intermittently carries each drink to and from four circularly spaced stations, cup dispensing, ice dispensing, soda dispensing, lid application and marking. The carousel design allows a cup to be dispensed at one station while another cup is being filled with ice at a second station, and yet another is being filled with soda at a third station, etc. The use of carousels is extended to both cup and lid dispensing. The system is designed to interface with any commercially-available, portioning ice dispenser, and also to interface directly with a cash register system to enable the cashier to input a customer's order. At an output station, the cup is transferred from the carousel to a linear transporter elevator which carries the cup up and down through a lidding and marking procedure, after which the completed drink is transferred to an output conveyor.",PEPSICO INC,BROGNA SALVATORE J;;CASLER RICHARD J;;MEADOWS JOHN W;;LYNDERS JOSEPH F;;SHULMAN BURT,CONNECTICUT INNOVATIONS INCORPORATED (1995-02-17);;PEPSICO INC. A CORP. OF NC (1989-05-11),https://lens.org/129-274-489-317-229,Granted Patent,yes,20,113,9,9,0,B67D1/00;;B67D1/06;;B67D2210/00065;;B67D2210/00076;;G07F13/10;;B67D1/00;;B67D1/06;;G07F13/10;;B67D2210/00076;;B67D2210/00065,A47J31/40;;A47J31/00;;B67D1/00;;B67D1/06;;B67D1/07;;G07F13/10,221/5;;53/281;;53/282;;141/103;;141/141;;141/170;;141/174;;221/8;;221/13;;221/21;;221/96;;221/221,0,0,,,,EXPIRED
430,DE,A1,DE 4016095 A1,068-507-659-170-80X,1990-11-22,1990,DE 4016095 A,1990-05-18,US 35388089 A,1989-05-18,AUTOMATISIERTES GETRAENKEHERSTELLSYSTEM,,PEPSICO INC,BROGNA SALVATORE J;;CASLER RICHARD J;;LYNDERS JOSEPH F;;SHULMAN BURT;;MEADOWS JOHN W,,https://lens.org/068-507-659-170-80X,Patent Application,no,0,12,9,9,0,B67D1/00;;B67D1/06;;B67D2210/00065;;B67D2210/00076;;G07F13/10;;B67D1/00;;B67D1/06;;G07F13/10;;B67D2210/00076;;B67D2210/00065,A47J31/00;;A47J31/40;;B67D1/00;;B67D1/06;;B67D1/07;;G07F13/10,,0,0,,,,DISCONTINUED
431,GB,A,GB 2233313 A,142-272-896-053-090,1991-01-09,1991,GB 9010938 A,1990-05-16,US 35388089 A,1989-05-18,AUTOMATED DRINKS MACHINE,,PEPSICO INC,BROGNA SALVATORE J;;CASLER RICHARD J;;MEADOWS JOHN W;;LYNDERS JOSEPH F;;SHULMAN BURT,,https://lens.org/142-272-896-053-090,Patent Application,no,0,1,9,9,0,B67D1/00;;B67D1/06;;B67D2210/00065;;B67D2210/00076;;G07F13/10;;B67D1/00;;B67D1/06;;G07F13/10;;B67D2210/00076;;B67D2210/00065,A47J31/00;;A47J31/40;;B67D1/00;;B67D1/06;;B67D1/07;;G07F13/10,B8N NAA           NAA;;B8N N24A6         NAA;;B8N N24D16        NAA,0,0,,,,EXPIRED
432,WO,A3,WO 2010/068704 A3,009-269-346-757-289,2011-09-29,2011,US 2009/0067395 W,2009-12-09,US 12114108 P,2008-12-09,TWO-WHEELED ROBOT WITH ENHANCED CLIMBING FEATURES,A robot has an electronic surveillance system embedded within a chassis disposed between two wheels. The wheels include a main body and a plurality of treads. The treads are generally disposed radially around the main body and extend distally from outer portion of the main body. The main body generally defines a plurality of compression cells and may present a substantially frustoconical outer surface.,RECONROBOTICS INC;;KOSSETT ALEX J;;BURT IAN T;;CARLSON CASEY R;;DRENNER ANDREW,KOSSETT ALEX J;;BURT IAN T;;CARLSON CASEY R;;DRENNER ANDREW,,https://lens.org/009-269-346-757-289,Search Report,yes,3,0,18,18,0,B62D57/02;;B62D61/00;;Y10S901/01;;B25J5/00;;B25J19/00;;B62D57/02;;B62D61/00;;B60B9/10;;B25J5/007;;B25J19/023;;Y10S901/01,B25J19/00;;B25J5/00,,0,0,,,,PENDING
433,EP,A4,EP 2384264 A4,012-724-837-649-565,2014-03-19,2014,EP 09832501 A,2009-12-09,US 2009/0067395 W;;US 12114108 P,2008-12-09,TWO-WHEELED ROBOT WITH ENHANCED CLIMBING FEATURES,,RECONROBOTICS INC,KOSSETT ALEX J;;BURT IAN T;;CARLSON CASEY R;;DRENNER ANDREW,,https://lens.org/012-724-837-649-565,Search Report,no,4,0,18,18,0,B62D57/02;;B62D61/00;;Y10S901/01;;B25J5/00;;B25J19/00;;B62D57/02;;B62D61/00;;B60B9/10;;B25J5/007;;B25J19/023;;Y10S901/01,B25J19/00;;B25J5/00;;B62D57/02;;B62D61/00,,1,0,,,See also references of WO 2010068704A2,DISCONTINUED
434,US,B2,US 10688671 B2,021-572-605-157-744,2020-06-23,2020,US 201715717443 A,2017-09-27,US 201715717443 A;;US 201514747780 A;;US 201314012910 A;;US 63461009 A;;US 12114108 P,2008-12-09,Two wheeled robot with enhanced climbing features,A robot has an electronic surveillance system embedded within a chassis disposed between two wheels. The wheels include a main body and a plurality of treads. The treads are generally disposed radially around the main body and extend distally from outer portion of the main body. The main body generally defines a plurality of compression cells and may present a substantially frustoconical outer surface.,RECONROBOTICS INC,CARLSON CASEY R;;DRENNER ANDREW;;KOSSETT ALEX J;;BURT IAN T,RECONROBOTICS INC (2009-12-22),https://lens.org/021-572-605-157-744,Granted Patent,yes,26,0,18,18,0,B62D57/02;;B62D61/00;;Y10S901/01;;B25J5/00;;B25J19/00;;B62D57/02;;B62D61/00;;B60B9/10;;B25J5/007;;B25J19/023;;Y10S901/01,B60K1/00;;B25J5/00;;B25J19/02;;B60B9/10;;B62D57/02;;B62D61/00,,5,0,,,"File history for U.S. Appl. No. 29/351,692, filed Dec. 9, 2009. Inventors: Casey R. Carlson et al.;;Dunbar, Thomas W., “Demonstration of Waypoint Navigation for a Semi-Autonomous Prototype Surf-Zone Robot,” (Master of Science Thesis, Naval Postgraduate School, Jun. 2006), 63 pages.;;File history for U.S. Appl. No. 12/634,610, filed Dec. 9, 2009, Inventors: Casey R. Carlson et al.;;Admitted Prior Art reference, Dec. 1, 2008.;;Hearing Notice for Application No. 5272/DELNP/2011, dated Dec. 10, 2019 (3 pages).",ACTIVE
435,CA,C,CA 2344731 C,076-624-659-522-011,2009-11-17,2009,CA 2344731 A,2001-04-19,US 19942400 P;;US 68125301 A,2000-04-25,"STATOR, DYNAMOELECTRIC MACHINE, AND METHODS FOR FABRICATING SAME","A dynamoelectric machine includes a stator having teeth fabricated from a non-magnetic material and containing at least one embedded conductor. The teeth are unitary with a back portion that is mounted to a stator back iron. Permeance variations induced by a stator winding mounted on the non-magnetic stator teeth are low which facilitates a reduction of motor noise. Specifically, since the no n- magnetic teeth reduce production of permeance variations, changes in air gap forces between the rotor and the stator are decreased.",GEN ELECTRIC CANADA,YOUNG JOHN;;SALASOO LEMBIT;;KLIMAN GERALD BURT;;ONG RAYMOND K J,,https://lens.org/076-624-659-522-011,Granted Patent,no,0,0,4,4,0,H02K1/16;;H02K3/47;;H02K55/04;;Y10T29/49009;;Y02E40/60;;Y10T29/49009;;H02K55/04;;H02K1/16;;H02K3/47;;Y02E40/60,H02K15/00;;H02K1/16;;H02K3/47;;H02K15/02;;H02K55/04,,0,0,,,,EXPIRED
436,US,A1,US 2010/0152922 A1,125-469-962-987-75X,2010-06-17,2010,US 63461009 A,2009-12-09,US 63461009 A;;US 12114108 P,2008-12-09,TWO WHEELED ROBOT WITH ENHANCED CLIMBING FEATURES,A robot has an electronic surveillance system embedded within a chassis disposed between two wheels. The wheels include a main body and a plurality of treads. The treads are generally disposed radially around the main body and extend distally from outer portion of the main body. The main body generally defines a plurality of compression cells and may present a substantially frustoconical outer surface.,RECONROBOTICS INC,CARLSON CASEY R;;DRENNER ANDREW;;KOSSETT ALEX J;;BURT IAN T,RECONROBOTICS INC (2009-12-22),https://lens.org/125-469-962-987-75X,Patent Application,yes,20,32,18,18,0,B62D57/02;;B62D61/00;;Y10S901/01;;B25J5/00;;B25J19/00;;B62D57/02;;B62D61/00;;B60B9/10;;B25J5/007;;B25J19/023;;Y10S901/01,G06F17/00;;B62D61/00,701/2;;180/218,0,0,,,,DISCONTINUED
437,EP,A2,EP 2384264 A2,142-218-785-771-025,2011-11-09,2011,EP 09832501 A,2009-12-09,US 2009/0067395 W;;US 12114108 P,2008-12-09,TWO-WHEELED ROBOT WITH ENHANCED CLIMBING FEATURES,,RECONROBOTICS INC,KOSSETT ALEX J;;BURT IAN T;;CARLSON CASEY R;;DRENNER ANDREW,,https://lens.org/142-218-785-771-025,Patent Application,yes,0,0,18,18,0,B62D57/02;;B62D61/00;;Y10S901/01;;B25J5/00;;B25J19/00;;B62D57/02;;B62D61/00;;B60B9/10;;B25J5/007;;B25J19/023;;Y10S901/01,B25J19/00;;B25J5/00;;B62D57/02;;B62D61/00,,0,0,,,,DISCONTINUED
438,US,A,US 2998190 A,087-716-161-238-723,1961-08-29,1961,US 73422058 A,1958-05-09,US 73422058 A,1958-05-09,Accumulator,,GEN DYNAMICS CORP,JACK ROSENBERG;;MCCOY ROBERT E;;SCUITTO THOMAS J;;BURT ROGER A,,https://lens.org/087-716-161-238-723,Granted Patent,no,5,5,1,1,0,G05B19/4103;;G05B19/4103,G05B19/4103,,0,0,,,,EXPIRED
439,WO,A2,WO 2010/068704 A2,110-598-977-255-136,2010-06-17,2010,US 2009/0067395 W,2009-12-09,US 12114108 P,2008-12-09,TWO-WHEELED ROBOT WITH ENHANCED CLIMBING FEATURES,A robot has an electronic surveillance system embedded within a chassis disposed between two wheels. The wheels include a main body and a plurality of treads. The treads are generally disposed radially around the main body and extend distally from outer portion of the main body. The main body generally defines a plurality of compression cells and may present a substantially frustoconical outer surface.,RECONROBOTICS INC;;KOSSETT ALEX J;;BURT IAN T;;CARLSON CASEY R;;DRENNER ANDREW,KOSSETT ALEX J;;BURT IAN T;;CARLSON CASEY R;;DRENNER ANDREW,,https://lens.org/110-598-977-255-136,Patent Application,yes,4,1,18,18,0,B62D57/02;;B62D61/00;;Y10S901/01;;B25J5/00;;B25J19/00;;B62D57/02;;B62D61/00;;B60B9/10;;B25J5/007;;B25J19/023;;Y10S901/01,,,1,0,,,See also references of EP 2384264A4,PENDING
440,US,A1,US 2022/0362951 A1,132-989-742-326-151,2022-11-17,2022,US 202217729239 A,2022-04-26,US 202217729239 A;;US 202016909406 A;;US 201715717443 A;;US 201514747780 A;;US 201314012910 A;;US 63461009 A;;US 12114108 P,2008-12-09,TWO WHEELED ROBOT WITH ENHANCED CLIMBING FEATURES,A robot has an electronic surveillance system embedded within a chassis disposed between two wheels. The wheels include a main body and a plurality of treads. The treads are generally disposed radially around the main body and extend distally from outer portion of the main body. The main body generally defines a plurality of compression cells and may present a substantially frustoconical outer surface.,RECONROBOTICS INC,CARLSON CASEY R;;DRENNER ANDREW;;KOSSETT ALEX J;;BURT IAN T,RECONROBOTICS INC (2009-12-22),https://lens.org/132-989-742-326-151,Patent Application,yes,8,0,18,18,0,B62D57/02;;B62D61/00;;Y10S901/01;;B25J5/00;;B25J19/00;;B62D57/02;;B62D61/00;;B60B9/10;;B25J5/007;;B25J19/023;;Y10S901/01,B25J19/02;;B25J5/00;;B60B9/10;;B62D57/02;;B62D61/00,,0,0,,,,ACTIVE
441,GB,B,GB 2233313 B,156-013-021-568-341,1993-04-14,1993,GB 9010938 A,1990-05-16,US 35388089 A,1989-05-18,AUTOMATED DRINKMAKER SYSTEM,,PEPSICO INC,BROGNA SALVATORE J;;CASLER RICHARD J;;MEADOWS JOHN W;;LYNDERS JOSEPH F;;SHULMAN BURT,,https://lens.org/156-013-021-568-341,Granted Patent,no,0,0,9,9,0,B67D1/00;;B67D1/06;;B67D2210/00065;;B67D2210/00076;;G07F13/10;;B67D1/00;;B67D1/06;;G07F13/10;;B67D2210/00076;;B67D2210/00065,A47J31/00;;A47J31/40;;B67D1/00;;B67D1/06;;B67D1/07;;G07F13/10,B8N NAA           NAA;;B8N N24A6         NAA;;B8N N24D16        NAA,0,0,,,,EXPIRED
442,US,A1,US 2016/0144517 A1,035-179-861-042-564,2016-05-26,2016,US 201514747780 A,2015-06-23,US 201514747780 A;;US 201314012910 A;;US 63461009 A;;US 12114108 P,2008-12-09,TWO WHEELED ROBOT WITH ENHANCED CLIMBING FEATURES,A robot has an electronic surveillance system embedded within a chassis disposed between two wheels. The wheels include a main body and a plurality of treads. The treads are generally disposed radially around the main body and extend distally from outer portion of the main body. The main body generally defines a plurality of compression cells and may present a substantially frustoconical outer surface.,RECONROBOTICS INC,CARLSON CASEY R;;DRENNER ANDREW;;KOSSETT ALEX J;;BURT IAN T,,https://lens.org/035-179-861-042-564,Patent Application,yes,5,3,18,18,0,B62D57/02;;B62D61/00;;Y10S901/01;;B25J5/00;;B25J19/00;;B62D57/02;;B62D61/00;;B60B9/10;;B25J5/007;;B25J19/023;;Y10S901/01,B25J19/02;;B25J5/00;;B60B9/10;;B62D57/02,,0,0,,,,DISCONTINUED
443,US,B2,US 7856749 B2,181-232-378-825-706,2010-12-28,2010,US 35909609 A,2009-01-23,US 35909609 A;;US 2354108 P,2008-01-25,Rail cover panel for a firearm,"A panel system for covering a lengthwise segment of an elongate firearm mounting rail. The panel system comprises at least one pair of identically shaped panel halves. Each panel half comprises a body having a top, a bottom, an abutting proximal edge and a distal edge. At least one axial tongue extends from the abutting proximal edge and a corresponding axial groove having a groove mouth is defined in the body. A cantilevered clip extends from the abutting proximal edge. A clip receptacle is defined by the body. A proximally extending lip extends from the body bottom near the distal edge. Each panel half is configured so that with the abutting proximal edges brought into abutment, each axial tongue of each panel is received in a corresponding axial groove of the other and each cantilevered clip engages the clip receptacle of the other.",MAGPUL IND CORP,FITZPATRICK RICHARD;;MAYBERRY MICHAEL T;;BURT ERIC CHRISTOPHER;;BARANELLO MIKE J,MAGPUL INDUSTRIES CORPORATION (2009-03-16),https://lens.org/181-232-378-825-706,Granted Patent,yes,18,13,4,4,0,F41C23/16;;F41G11/003;;F41A35/02;;F41C23/16;;F41G11/003;;F41A35/02,F41A35/04,42/96;;42/85;;42/90,0,0,,,,ACTIVE
444,US,A1,US 2011/0099879 A1,052-925-510-534-020,2011-05-05,2011,US 97815310 A,2010-12-23,US 97815310 A;;US 35909609 A;;US 2354108 P,2008-01-25,Rail Cover Panel for a Firearm,"A panel system for covering a lengthwise segment of an elongate firearm mounting rail. The panel system comprises at least one pair of identically shaped panel halves. Each panel half comprises a body having a top, a bottom, an abutting proximal edge and a distal edge. At least one axial tongue extends from the abutting proximal edge and a corresponding axial groove having a groove mouth is defined in the body. A cantilevered clip extends from the abutting proximal edge. A clip receptacle is defined by the body. A proximally extending lip extends from the body bottom near the distal edge. Each panel half is configured so that with the abutting proximal edges brought into abutment, each axial tongue of each panel is received in a corresponding axial groove of the other and each cantilevered clip engages the clip receptacle of the other.",MAGPUL IND CORP,FITZPATRICK RICHARD;;MAYBERRY MICHAEL T;;BURT ERIC CHRISTOPHER;;BARANELLO MIKE J,MAGPUL INDUSTRIES CORPORATION (2009-03-16),https://lens.org/052-925-510-534-020,Patent Application,yes,18,4,4,4,0,F41C23/16;;F41G11/003;;F41A35/02;;F41C23/16;;F41G11/003;;F41A35/02,F41C27/00,42/90,0,0,,,,ACTIVE
445,US,A1,US 2001/0035692 A1,084-846-036-228-549,2001-11-01,2001,US 68125301 A,2001-03-08,US 68125301 A;;US 19942400 P,2000-04-25,"Stator, dynamoelectric machine, and methods for fabricating same","
   A dynamoelectric machine includes a stator having teeth fabricated from a non-magnetic material and containing at least one embedded conductor. The teeth are unitary with a back portion that is mounted to a stator back iron. Permeance variations induced by a stator winding mounted on the non-magnetic stator teeth are low which facilitates a reduction of motor noise. Specifically, since the non-magnetic teeth reduce production of permeance variations, changes in air gap forces between the rotor and the stator are decreased. 
",ONG RAYMOND K.J.;;YOUNG JOHN;;KLIMAN GERALD BURT;;SALASOO LEMBIT,ONG RAYMOND K J;;YOUNG JOHN;;KLIMAN GERALD BURT;;SALASOO LEMBIT,GENERAL ELECTRIC CANADA INC (2001-02-16),https://lens.org/084-846-036-228-549,Patent Application,yes,2,17,4,4,0,H02K1/16;;H02K3/47;;H02K55/04;;Y10T29/49009;;Y02E40/60;;Y10T29/49009;;H02K55/04;;H02K1/16;;H02K3/47;;Y02E40/60,H02K1/16;;H02K3/47;;H02K55/04,310/254,0,0,,,,EXPIRED
446,KR,A,KR 20110120867 A,191-134-426-891-796,2011-11-04,2011,KR 20117015986 A,2009-12-09,US 12114108 P,2008-12-09,TWO-WHEELED ROBOT WITH ENHANCED CLIMBING FEATURES,,RECONROBOTICS INC,KOSSETT ALEX J;;BURT IAN T;;CARLSON CASEY R;;DRENNER ANDREW,,https://lens.org/191-134-426-891-796,Patent Application,no,0,1,18,18,0,B62D57/02;;B62D61/00;;Y10S901/01;;B25J5/00;;B25J19/00;;B62D57/02;;B62D61/00;;B60B9/10;;B25J5/007;;B25J19/023;;Y10S901/01,B25J5/00;;B25J19/00,,0,0,,,,DISCONTINUED
447,US,S,US D0626577 S,002-018-825-988-542,2010-11-02,2010,US 35169209 F,2009-12-09,US 35169209 F,2009-12-09,Two wheeled robot with enhanced climbing features,,RECONROBOTICS INC,CARLSON CASEY R;;DRENNER ANDREW;;KOSSETT ALEX J;;BURT IAN T,RECONROBOTICS INC (2010-02-22),https://lens.org/002-018-825-988-542,Design Right,no,0,9,2,2,0,,,1599;;D15/199,0,0,,,,ACTIVE
448,US,B2,US 7971383 B2,089-043-611-594-864,2011-07-05,2011,US 97815310 A,2010-12-23,US 97815310 A;;US 35909609 A;;US 2354108 P,2008-01-25,Rail cover panel for a firearm,"A panel system for covering a lengthwise segment of an elongate firearm mounting rail. The panel system comprises at least one pair of identically shaped panel halves. Each panel half comprises a body having a top, a bottom, an abutting proximal edge and a distal edge. At least one axial tongue extends from the abutting proximal edge and a corresponding axial groove having a groove mouth is defined in the body. A cantilevered clip extends from the abutting proximal edge. A clip receptacle is defined by the body. A proximally extending lip extends from the body bottom near the distal edge. Each panel half is configured so that with the abutting proximal edges brought into abutment, each axial tongue of each panel is received in a corresponding axial groove of the other and each cantilevered clip engages the clip receptacle of the other.",MAGPUL IND CORP,FITZPATRICK RICHARD;;MAYBERRY MICHAEL T;;BURT ERIC CHRISTOPHER;;BARANELLO MIKE J,MAGPUL INDUSTRIES CORPORATION (2009-03-16),https://lens.org/089-043-611-594-864,Granted Patent,yes,18,11,4,4,0,F41C23/16;;F41G11/003;;F41A35/02;;F41C23/16;;F41G11/003;;F41A35/02,F41A35/04,42/96;;42/85;;42/90,0,0,,,,ACTIVE
449,US,B2,US 6768244 B2,125-768-990-931-42X,2004-07-27,2004,US 68125301 A,2001-03-08,US 68125301 A;;US 19942400 P,2000-04-25,"Stator, dynamoelectric machine, and methods for fabricating same","
    A dynamoelectric machine includes a stator having teeth fabricated from a non-magnetic material and containing at least one embedded conductor. The teeth are unitary with a back portion that is mounted to a stator back iron. Permeance variations induced by a stator winding mounted on the non-magnetic stator teeth are low which facilitates a reduction of motor noise. Specifically, since the non-magnetic teeth reduce production of permeance variations, changes in air gap forces between the rotor and the stator are decreased. 
",GEN ELECTRIC CANADA,ONG RAYMOND K J;;YOUNG JOHN;;KLIMAN GERALD BURT;;SALASOO LEMBIT,GENERAL ELECTRIC CANADA INC (2001-02-16),https://lens.org/125-768-990-931-42X,Granted Patent,yes,27,8,4,4,0,H02K1/16;;H02K3/47;;H02K55/04;;Y10T29/49009;;Y02E40/60;;Y10T29/49009;;H02K55/04;;H02K1/16;;H02K3/47;;Y02E40/60,H02K1/16;;H02K3/47;;H02K55/04,310/254;;29/596,1,0,,,"Advances In Cryogenic Engineering, vol. 27, New York, Cryogenic Engineering Conference; distributed by Plenum Press, 1960.",EXPIRED
450,CN,A,CN 116964225 A,022-950-527-090-098,2023-10-27,2023,CN 202280015535 A,2022-02-18,US 202163274342 P;;US 2022/0016961 W,2021-11-01,Gene markers for selecting immunotherapy,"The present disclosure relates to methods of diagnosis and prognosis, compositions for immunotherapy, methods of improving the compositions, and immunotherapies (e.g., T cells, non-T cells, TCR-based therapies, CAR-based therapies, bispecific T cell cement (BiTE), and/or immune checkpoint blocking) using these compositions.",KITE PHARMA INC,BURT ALAN;;CHOU SHIH-TING;;PRAX VALERIE;;PODDAR SUSHMITA;;J ROSI,,https://lens.org/022-950-527-090-098,Patent Application,no,0,0,1,10,0,,C12Q1/6886,,0,0,,,,PENDING
451,US,B2,US 9061544 B2,083-180-761-768-949,2015-06-23,2015,US 201314012910 A,2013-08-28,US 201314012910 A;;US 63461009 A;;US 12114108 P,2008-12-09,Two-wheeled robot with enhanced climbing features,A robot has an electronic surveillance system embedded within a chassis disposed between two wheels. The wheels include a main body and a plurality of treads. The treads are generally disposed radially around the main body and extend distally from outer portion of the main body. The main body generally defines a plurality of compression cells and may present a substantially frustoconical outer surface.,RECONROBOTICS INC,CARLSON CASEY R;;DRENNER ANDREW;;KOSSETT ALEX J;;BURT IAN T,RECONROBOTICS INC (2009-12-22),https://lens.org/083-180-761-768-949,Granted Patent,yes,3,8,18,18,0,B62D57/02;;B62D61/00;;Y10S901/01;;B25J5/00;;B25J19/00;;B62D57/02;;B62D61/00;;B60B9/10;;B25J5/007;;B25J19/023;;Y10S901/01,B60K1/00;;B60B9/10;;B62D57/02;;B62D61/00,,0,0,,,,ACTIVE
452,US,A1,US 2009/0241397 A1,091-500-879-981-585,2009-10-01,2009,US 35909609 A,2009-01-23,US 35909609 A;;US 2354108 P,2008-01-25,Rail Cover Panel for a Firearm,"A panel system for covering a lengthwise segment of an elongate firearm mounting rail. The firearm mounting rail is a T-rail comprising a T-shaped cross-section with the top of the T corresponding to the top of the T-rail. The firearm T-rail further includes a number of transverse slots in the top spanning the length of the T-shaped cross-section. The panel system comprises at least one pair of identically shaped panel halves. Each panel half comprises a body having a top, a bottom, an abutting proximal edge and a distal edge. At least one axial tongue extends from the abutting proximal edge and a corresponding axial groove is defined in the body, with each axial groove having a groove mouth associated with the abutting proximal edge. A cantilevered clip extends from the abutting proximal edge. A clip receptacle is defined by the body. A proximally extending lip extends from the body bottom near the distal edge. Each panel half is configured so that with the abutting proximal edges brought into abutment, each axial tongue of each panel is received in a corresponding axial groove of the other and the proximally extending lip of the cantilevered clip engages the clip shoulder of the other.",MAGPUL IND CORP,FITZPATRICK RICHARD;;MAYBERRY MICHAEL T;;BURT ERIC CHRISTOPHER;;BARANELLO MIKE J,MAGPUL INDUSTRIES CORPORATION (2009-03-16),https://lens.org/091-500-879-981-585,Patent Application,yes,17,47,4,4,0,F41C23/16;;F41G11/003;;F41A35/02;;F41C23/16;;F41G11/003;;F41A35/02,F41C27/00,42/90,0,0,,,,ACTIVE
453,CA,A,CA 1086556 A,147-826-836-028-807,1980-09-30,1980,CA 267753 A,1976-12-13,CA 267753 A,1976-12-13,PROCESS OF OBTAINING COFFEE OIL FROM ROASTED COFFEE,"ABSTRACT A process of obtaining coffee oil having aroma prin-ciples useful in the aromatization of foodstuffs is described. The process involves expressing coffee oil from roasted coffee by subjecting roasted coffee to a pressure of from 5,000 to 20,000 psi (350 to 1400 kg/cm2) while passing an inert gas through, and maintaining an environment of said inert gas over, the roaster coffee and the oil expressed therefrom. By controlling the flow rate of the inert gas within critical limits, the aroma principles may be balanced and the aroma quality and intensity may be improved.",GEN FOODS LTD,CSAKANY PETER;;RICHARD JEAN-CLAUDE;;BURT RALPH W;;PERRY WILLIAM J,,https://lens.org/147-826-836-028-807,Granted Patent,no,0,1,1,1,0,A23F5/48,A23F5/48,99-81,0,0,,,,EXPIRED
454,US,A1,US 2018/0290312 A1,181-016-695-491-15X,2018-10-11,2018,US 201715717443 A,2017-09-27,US 201715717443 A;;US 201514747780 A;;US 201314012910 A;;US 63461009 A;;US 12114108 P,2008-12-09,TWO WHEELED ROBOT WITH ENHANCED CLIMBING FEATURES,A robot has an electronic surveillance system embedded within a chassis disposed between two wheels. The wheels include a main body and a plurality of treads. The treads are generally disposed radially around the main body and extend distally from outer portion of the main body. The main body generally defines a plurality of compression cells and may present a substantially frustoconical outer surface.,RECONROBOTICS INC,CARLSON CASEY R;;DRENNER ANDREW;;KOSSETT ALEX J;;BURT IAN T,RECONROBOTICS INC (2009-12-22),https://lens.org/181-016-695-491-15X,Patent Application,yes,3,7,18,18,0,B62D57/02;;B62D61/00;;Y10S901/01;;B25J5/00;;B25J19/00;;B62D57/02;;B62D61/00;;B60B9/10;;B25J5/007;;B25J19/023;;Y10S901/01,B25J19/02;;B25J5/00;;B60B9/10;;B62D57/02;;B62D61/00,,0,0,,,,ACTIVE
455,ZA,B,ZA 200404466 B,191-694-119-713-151,2006-05-31,2006,ZA 200404466 A,2004-06-07,GB 0130419 A,2001-12-20,Water soluble container conatining dry actives,,RECKITT BENCKISER INC,BURT DIAN J;;FENG JAMES C;;GENCARELLI RALPH;;LESICA JEANNE M,,https://lens.org/191-694-119-713-151,Granted Patent,no,0,0,24,24,0,C11D1/62;;C11D1/72;;C11D1/835;;C11D3/046;;C11D3/10;;C11D3/2082;;C11D3/2086;;C11D3/48;;C11D17/041;;C11D17/044;;C11D3/046;;C11D1/835;;C11D3/48;;C11D3/2086;;C11D1/62;;C11D3/2082;;C11D3/10;;C11D1/72;;C11D17/041;;C11D17/044,C11D/;;C11D1/62;;C11D1/72;;C11D1/835;;C11D3/02;;C11D3/10;;C11D3/20;;C11D3/48;;C11D17/04,,0,0,,,,ACTIVE
456,US,A1,US 2021/0078188 A1,070-506-994-791-635,2021-03-18,2021,US 202016909406 A,2020-06-23,US 202016909406 A;;US 201715717443 A;;US 201514747780 A;;US 201314012910 A;;US 63461009 A;;US 12114108 P,2008-12-09,TWO WHEELED ROBOT WITH ENHANCED CLIMBING FEATURES,A robot has an electronic surveillance system embedded within a chassis disposed between two wheels. The wheels include a main body and a plurality of treads. The treads are generally disposed radially around the main body and extend distally from outer portion of the main body. The main body generally defines a plurality of compression cells and may present a substantially frustoconical outer surface.,RECONROBOTICS INC,CARLSON CASEY R;;DRENNER ANDREW;;KOSSETT ALEX J;;BURT IAN T,RECONROBOTICS INC (2009-12-22),https://lens.org/070-506-994-791-635,Patent Application,yes,0,0,18,18,0,B62D57/02;;B62D61/00;;Y10S901/01;;B25J5/00;;B25J19/00;;B62D57/02;;B62D61/00;;B60B9/10;;B25J5/007;;B25J19/023;;Y10S901/01,B25J19/02;;B25J5/00;;B60B9/10;;B62D57/02;;B62D61/00,,0,0,,,,ACTIVE
457,US,A1,US 2006/0234899 A1,154-532-601-943-592,2006-10-19,2006,US 54740804 A,2004-03-01,US 54740804 A;;GB 0317198 A;;GB 0321869 A;;US 45215003 P;;GB 2004000843 W,2003-03-05,Hydrophilic polyurethane foam articles comprising an antimicrobial compound,"Foamed polyurethane articles, such as a sponges, sheets, tapes or ribbons, blocks or other molded, extruded or cast article which foamed polyurethane articles comprising one or more quaternary ammonium compounds having germicidal properties and are particularly useful in the formation of cleaning articles. Processes for the manufacture of such cleaning articles based on hydrophilic polyurethane foams exhibit an antimicrobial benefit and their use are also described.",HH BROWN SHOE TECH INC,NEKMARD FARID A;;BURT DIANE J;;FENG JAMES C;;HERMANN PAUL,,https://lens.org/154-532-601-943-592,Patent Application,yes,24,97,3,12,0,A47L13/16;;A47L13/16;;C11D1/62;;C11D1/62;;C11D3/48;;C11D3/48;;C11D17/041;;C11D17/041;;C11D17/049;;C11D17/049,C11D17/00,510/439,0,0,,,,DISCONTINUED
458,CA,A1,CA 2016803 A1,100-472-068-511-87X,1990-11-18,1990,CA 2016803 A,1990-05-15,US 35388089 A,1989-05-18,AUTOMATED DRINKMAKER SYSTEM,"ABSTRACT OF THE DISCLOSURE An automated drinkmaker system which is designed to accept an input drink order, as from a cash register, and deliver the drink order, for different sizes and different flavors, with or without ice, completely finished in lidded containers to an output station. The automated drinkmaker system is designed for labor free processing of drink orders in high volume quick service or fast food establishments. The machine is designed around a carousel type of drink transporter which intermittently carries each drink to and from four circularly spaced stations, cup dispensing, ice dispensing, soda dispensing, lid application and marking. The carousel design allows a cup to be dispensed at one station while another cup is being filled with ice at a second station, and yet another is being filled with soda at a third station, etc. The use of carousels is extended to both cup and lid dispensing. The system is designed to interface with any commercially-available, portioning ice dispenser, and also to interface directly with a cash register system to enable the cashier to input a customer's order. At an output station, the cup is transferred from the carousel to a linear transporter elevator which carries the cup up and down through a lidding and marking procedure, after which the completed drink is transferred to an output conveyor.",PEPSICO INC,BROGNA SALVATORE J;;CASLER RICHARD J;;MEADOWS JOHN W;;LYNDERS JOSEPH F;;SHULMAN BURT,,https://lens.org/100-472-068-511-87X,Patent Application,no,0,0,9,9,0,B67D1/00;;B67D1/06;;B67D2210/00065;;B67D2210/00076;;G07F13/10;;B67D1/00;;B67D1/06;;G07F13/10;;B67D2210/00076;;B67D2210/00065,A47J31/00;;A47J31/40;;B67D1/00;;B67D1/06;;B67D1/07;;G07F13/10,D122200077   M,0,0,,,,DISCONTINUED
459,AU,A,AU 1990/055128 A,103-279-592-500-522,1991-11-21,1991,AU 1990/055128 A,1990-05-17,US 35388089 A,1989-05-18,AUTOMATED DRINKMAKER SYSTEM,,PEPSICO INC,BROGNA SALVATORE J;;CASLER RICHARD J;;MEADOWS JOHN W;;LYNDERS JOSEPH F;;SHULMAN BURT,,https://lens.org/103-279-592-500-522,Patent Application,no,0,0,9,9,0,B67D1/00;;B67D1/06;;B67D2210/00065;;B67D2210/00076;;G07F13/10;;B67D1/00;;B67D1/06;;G07F13/10;;B67D2210/00076;;B67D2210/00065,A47J31/00;;A47J31/40;;B67D1/00;;B67D1/06;;B67D1/07;;G07F13/10,,0,0,,,,EXPIRED
460,CA,A,CA 29366 A,183-292-791-194-677,1888-06-19,1888,CA 29366D A,,CA 29366T A,,CIGAR AND CIGARETTE CASE,,NEEDHAM ARTHUR J;;BURT FREDERIC J;;HAMMOND ROBERT;;NEEDHAM WALTER C;;NEEDHAM HORACE C,NEEDHAM ARTHUR J;;BURT FREDERIC J;;HAMMOND ROBERT;;NEEDHAM WALTER C;;NEEDHAM HORACE C,,https://lens.org/183-292-791-194-677,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
461,US,A1,US 2005/0119153 A1,115-956-239-181-840,2005-06-02,2005,US 49940505 A,2005-01-26,GB 0130419 A;;GB 0204614 W,2001-12-20,Water soluble container containing dry actives,"The invention relates to a water soluble container which contains a composition useful for hard surface cleaning. The composition comprises a cationic surfactant having germicidal properties, a non-ionic surfactant, an alkali salt, an organic acid; and optionally, conventional additives, where the composition is in powder form. The water soluble containers can be made by thermoforming or injection molding.",BURT DIANE J.;;FENG JAMES C.;;LESICA JEANNE M.;;GENCARELLI RALPH,BURT DIANE J;;FENG JAMES C;;LESICA JEANNE M;;GENCARELLI RALPH,RECKITT BENCKISER INC (2004-06-15);;RECKITT BENCKISER LLC (2011-01-01),https://lens.org/115-956-239-181-840,Patent Application,yes,12,16,24,24,0,C11D1/62;;C11D1/72;;C11D1/835;;C11D3/046;;C11D3/10;;C11D3/2082;;C11D3/2086;;C11D3/48;;C11D17/041;;C11D17/044;;C11D3/046;;C11D1/835;;C11D3/48;;C11D3/2086;;C11D1/62;;C11D3/2082;;C11D3/10;;C11D1/72;;C11D17/041;;C11D17/044,C11D1/62;;C11D1/72;;C11D1/835;;C11D3/02;;C11D3/10;;C11D3/20;;C11D3/48;;C11D17/04,510/504,0,0,,,,EXPIRED
462,CN,A,CN 102355985 A,132-707-500-201-358,2012-02-15,2012,CN 200980154201 A,2009-12-09,US 2009/0067395 W;;US 12114108 P,2008-12-09,Two-wheeled robot with enhanced climbing features,A robot has an electronic surveillance system embedded within a chassis disposed between two wheels. The wheels include a main body and a plurality of treads. The treads are generally disposed radially around the main body and extend distally from outer portion of the main body. The main body generally defines a plurality of compression cells and may present a substantially frustoconical outer surface.,RECONROBOTICS INC,KOSSETT ALEX J;;BURT IAN T;;CARLSON CASEY R;;ANDREW DRENNER,,https://lens.org/132-707-500-201-358,Patent Application,no,0,5,18,18,0,B62D57/02;;B62D61/00;;Y10S901/01;;B25J5/00;;B25J19/00;;B62D57/02;;B62D61/00;;B60B9/10;;B25J5/007;;B25J19/023;;Y10S901/01,B25J19/00;;B25J5/00,,0,0,,,,DISCONTINUED
463,US,B2,US 11691302 B2,073-556-264-352-029,2023-07-04,2023,US 202217729239 A,2022-04-26,US 202217729239 A;;US 202016909406 A;;US 201715717443 A;;US 201514747780 A;;US 201314012910 A;;US 63461009 A;;US 12114108 P,2008-12-09,Two wheeled robot with enhanced climbing features,A robot has an electronic surveillance system embedded within a chassis disposed between two wheels. The wheels include a main body and a plurality of treads. The treads are generally disposed radially around the main body and extend distally from outer portion of the main body. The main body generally defines a plurality of compression cells and may present a substantially frustoconical outer surface.,RECONROBOTICS INC,CARLSON CASEY R;;DRENNER ANDREW;;KOSSETT ALEX J;;BURT IAN T,RECONROBOTICS INC (2009-12-22),https://lens.org/073-556-264-352-029,Granted Patent,yes,8,0,18,18,0,B62D57/02;;B62D61/00;;Y10S901/01;;B25J5/00;;B25J19/00;;B62D57/02;;B62D61/00;;B60B9/10;;B25J5/007;;B25J19/023;;Y10S901/01,B60K1/00;;B25J5/00;;B25J19/02;;B60B9/10;;B62D57/02;;B62D61/00,,0,0,,,,ACTIVE
464,US,S,US D0637217 S,128-551-213-647-805,2011-05-03,2011,US 37831710 F,2010-11-02,US 37831710 F;;US 35169209 F,2009-12-09,Two wheeled robot with enhanced climbing features,,RECONROBOTICS INC,CARLSON CASEY R;;DRENNER ANDREW;;KOSSETT ALEX J;;BURT IAN T,RECONROBOTICS INC (2010-02-22),https://lens.org/128-551-213-647-805,Design Right,no,0,10,2,2,0,,,1599;;D15/199,0,0,,,,ACTIVE
465,US,A1,US 2014/0224560 A1,122-577-066-124-306,2014-08-14,2014,US 201314012910 A,2013-08-28,US 201314012910 A;;US 63461009 A;;US 12114108 P,2008-12-09,TWO-WHEELED ROBOT WITH ENHANCED CLIMBING FEATURES,A robot has an electronic surveillance system embedded within a chassis disposed between two wheels. The wheels include a main body and a plurality of treads. The treads are generally disposed radially around the main body and extend distally from outer portion of the main body. The main body generally defines a plurality of compression cells and may present a substantially frustoconical outer surface.,RECONROBOTICS INC,CARLSON CASEY R;;DRENNER ANDREW;;KOSSETT ALEX J;;BURT IAN T,RECONROBOTICS INC (2009-12-22),https://lens.org/122-577-066-124-306,Patent Application,yes,3,3,18,18,0,B62D57/02;;B62D61/00;;Y10S901/01;;B25J5/00;;B25J19/00;;B62D57/02;;B62D61/00;;B60B9/10;;B25J5/007;;B25J19/023;;Y10S901/01,B62D61/00;;B60B9/10,180/218;;152/41,0,0,,,,ACTIVE
466,US,B2,US 10006308 B2,070-025-126-416-133,2018-06-26,2018,US 201314438562 A,2013-09-11,US 201314438562 A;;US 201261707425 P;;US 2013/0059195 W,2012-09-28,Mid-turbine frame with fairing attachment,"A mid-turbine frame (MTF) system for a gas turbine engine is disclosed. The MTF includes an inner case, an outer case and a fairing sandwiched between the inner and outer cases. The fairing includes an inner ring spaced apart from and coupled to an outer ring by a plurality of hollow struts. The hollow struts accommodate support rods that connect the inner case to the outer case. Further, the hollow struts act as turning vanes for turning the flow of gases passing from a high pressure turbine (HPT) to a low pressure turbine (LPT) for purposes of providing the correct incidence angle to the first vane of the LPT. The outer ring of the fairing includes a plurality of bosses which receive attachment pins that pass through the outer case for correctly locating the fairing with respect to the outer case and for permitting radial expansion in contraction of the fairing.",UNITED TECHNOLOGIES CORP,FARAH JORGE I;;BURT JONATHAN P;;SANCHEZ PAUL K;;PAREKH KALPENDU J;;JAKIEL JONATHAN J,RTX CORPORATION (2015-06-30),https://lens.org/070-025-126-416-133,Granted Patent,yes,8,0,6,6,0,F01D25/24;;F02C7/20;;F01D25/162;;F01D25/26;;F01D25/26;;F01D25/24;;F02C7/20;;F01D25/162;;F01D25/28;;F05D2240/91,F01D1/00;;F01D25/16;;F01D25/24;;F01D25/26;;F01D25/28;;F02C7/20,,2,0,,,"International Search Report for related International Application No. PCT/US13/59195; report dated Feb. 10, 2014.;;Extended European Search Report for Application No./Patent No. 13842236.5-1610/2900973, dated Oct. 21, 2016 (6 pp).",ACTIVE
467,EP,A4,EP 2900973 A4,014-252-342-742-645,2016-11-23,2016,EP 13842236 A,2013-09-11,US 201261707425 P;;US 2013/0059195 W,2012-09-28,MID-TURBINE FRAME WITH FAIRING ATTACHMENT,,UNITED TECHNOLOGIES CORP,FARAH JORGE I;;BURT JONATHAN P;;SANCHEZ PAUL K;;PAREKH KALPENDU J;;JAKIEL JONATHAN J,"RAYTHEON TECHNOLOGIES CORPORATION (N.D.GES.D.S, US (2022-09-23);;UNITED TECHNOLOGIES CORPORATION (2016-10-26)",https://lens.org/014-252-342-742-645,Search Report,no,3,0,6,6,0,F01D25/24;;F02C7/20;;F01D25/162;;F01D25/26;;F01D25/26;;F01D25/24;;F02C7/20;;F01D25/162;;F01D25/28;;F05D2240/91,F02C7/20;;F01D25/24;;F01D25/26;;F02C3/073;;F02C3/13,,1,0,,,See also references of WO 2014052007A1,ACTIVE
468,US,A1,US 2015/0260057 A1,015-066-335-813-860,2015-09-17,2015,US 201314438562 A,2013-09-11,US 201314438562 A;;US 201261707425 P;;US 2013/0059195 W,2012-09-28,Mid-Turbine Frame with Fairing Attachment,"A mid-turbine frame (MTF) system for a gas turbine engine is disclosed. The MTF includes an inner case, an outer case and a fairing sandwiched between the inner and outer cases. The fairing includes an inner ring spaced apart from and coupled to an outer ring by a plurality of hollow struts. The hollow struts accommodate support rods that connect the inner case to the outer case. Further, the hollow struts act as turning vanes for turning the flow of gases passing from a high pressure turbine (HPT) to a low pressure turbine (LPT) for purposes of providing the correct incidence angle to the first vane of the LPT. The outer ring of the fairing includes a plurality of bosses which receive attachment pins that pass through the outer case for correctly locating the fairing with respect to the outer case and for permitting radial expansion in contraction of the fairing.",UNITED TECHNOLOGIES CORP,FARAH JORGE I;;BURT JONATHAN P;;SANCHEZ PAUL K;;PAREKH KALPENDU J;;JAKIEL JONATHAN J,RTX CORPORATION (2015-06-30),https://lens.org/015-066-335-813-860,Patent Application,yes,4,29,6,6,0,F01D25/24;;F02C7/20;;F01D25/162;;F01D25/26;;F01D25/26;;F01D25/24;;F02C7/20;;F01D25/162;;F01D25/28;;F05D2240/91,F01D25/28,,0,0,,,,ACTIVE
469,EP,B1,EP 2900973 B1,136-500-690-553-836,2018-12-12,2018,EP 13842236 A,2013-09-11,US 201261707425 P;;US 2013/0059195 W,2012-09-28,MID-TURBINE FRAME WITH FAIRING ATTACHMENT,,UNITED TECHNOLOGIES CORP,FARAH JORGE I;;BURT JONATHAN P;;SANCHEZ PAUL K;;PAREKH KALPENDU J;;JAKIEL JONATHAN J,"RAYTHEON TECHNOLOGIES CORPORATION (N.D.GES.D.S, US (2022-09-23);;UNITED TECHNOLOGIES CORPORATION (2016-10-26)",https://lens.org/136-500-690-553-836,Granted Patent,yes,6,0,6,6,0,F01D25/24;;F02C7/20;;F01D25/162;;F01D25/26;;F01D25/26;;F01D25/24;;F02C7/20;;F01D25/162;;F01D25/28;;F05D2240/91,F02C7/20;;F01D25/24;;F01D25/26;;F02C3/073;;F02C3/13,,0,0,,,,ACTIVE
470,WO,A1,WO 2014/052007 A1,014-624-915-062-933,2014-04-03,2014,US 2013/0059195 W,2013-09-11,US 201261707425 P,2012-09-28,MID-TURBINE FRAME WITH FAIRING ATTACHMENT,"A mid-turbine frame (MTF) system for a gas turbine engine is disclosed. The MTF includes an inner case, an outer case and a fairing sandwiched between the inner and outer cases. The fairing includes an inner ring spaced apart from and coupled to an outer ring by a plurality of hollow struts. The hollow struts accommodate support rods that connect the inner case to the outer case. Further, the hollow struts act as turning vanes for turning the flow of gases passing from a high pressure turbine (HPT) to a low pressure turbine (LPT) for purposes of providing the correct incidence angle to the first vane of the LPT. The outer ring of the fairing includes a plurality of bosses which receive attachment pins that pass through the outer case for correctly locating the fairing with respect to the outer case and for permitting radial expansion in contraction of the fairing.",UNITED TECHNOLOGIES CORP,FARAH JORGE I;;BURT JONATHAN P;;SANCHEZ PAUL K;;PAREKH KALPENDU J;;JAKIEL JONATHAN J,,https://lens.org/014-624-915-062-933,Patent Application,yes,4,28,6,6,0,F01D25/24;;F02C7/20;;F01D25/162;;F01D25/26;;F01D25/26;;F01D25/24;;F02C7/20;;F01D25/162;;F01D25/28;;F05D2240/91,F01D25/24;;F02C7/20;;F02C3/073;;F02C3/13,,0,0,,,,PENDING
471,EP,A1,EP 2900973 A1,006-842-074-540-093,2015-08-05,2015,EP 13842236 A,2013-09-11,US 201261707425 P;;US 2013/0059195 W,2012-09-28,MID-TURBINE FRAME WITH FAIRING ATTACHMENT,,UNITED TECHNOLOGIES CORP,FARAH JORGE I;;BURT JONATHAN P;;SANCHEZ PAUL K;;PAREKH KALPENDU J;;JAKIEL JONATHAN J,"RAYTHEON TECHNOLOGIES CORPORATION (N.D.GES.D.S, US (2022-09-23);;UNITED TECHNOLOGIES CORPORATION (2016-10-26)",https://lens.org/006-842-074-540-093,Patent Application,yes,0,0,6,6,0,F01D25/24;;F02C7/20;;F01D25/162;;F01D25/26;;F01D25/26;;F01D25/24;;F02C7/20;;F01D25/162;;F01D25/28;;F05D2240/91,F02C7/20;;F01D25/24;;F01D25/26;;F02C3/073;;F02C3/13,,0,0,,,,ACTIVE
472,US,B2,US 9095919 B2,038-577-691-607-966,2015-08-04,2015,US 35786206 A,2006-02-21,US 35786206 A,2006-02-21,Stick electrode,"A stick electrode for depositing an high strength weld metal bead on a workpiece where the yield strength of the weld metal is between 85 ksi and 125 ksi irrespective of the cooling rate. The electrode deposits weld metal having 0.80-1.85% by weight manganese, 0.25-0.50% by weight molybdenum, 1.25-2.50% by weight nickel, and less than 0.07% by weight carbon, wherein the ratios of the carbon, manganese and molybdenum are adjusted to provide a carbon equivalent in deposited weld metal in the range of 0.17 to 0.30 and preferably less than 0.22.",BURT RANDALL M;;CHIAPPONE JON P;;DALLAM CRAIG B;;WEAVER ROBERT J;;LINCOLN GLOBAL INC,BURT RANDALL M;;CHIAPPONE JON P;;DALLAM CRAIG B;;WEAVER ROBERT J,LINCOLN GLOBAL INC (2006-02-14),https://lens.org/038-577-691-607-966,Granted Patent,yes,29,2,13,13,0,B23K9/02;;B23K9/02;;B23K35/3053;;B23K35/368,B23K35/22;;B23K9/02;;B23K35/30;;B23K35/34;;B23K35/368,,9,1,052-845-177-003-516,10.1007/bf02898278,"Y. Ito, M. Nakanishi, Y. Komizo, Cold cracking susceptibility of girth welding for arctic grade line pipe, Sep. 1982, vol. 4, No. 2, p. 110.;;Stick Electrode Product Catalog-Lincoln Electric Jun. 2004.;;""ATOM ARC T Tech Data Sheet"", www.esab.com, 3 pages.;;""HOBALLOY 11018M"" Hobart Brothers catalog, 2 pages.;;All-Weld-Metal Design for AWS E10018M, E11018M and E12018M Type Electrodes [online], accessed via the Internet [retrieved on Feb. 1, 2011], URL: , 12 pages.;;Examination Report issued in related Australian Patent Application No. 2007200924, Aug. 25, 2009, 2 pages (corresponds to U.S. Appl. No. 11/466,917).;;Partial European Search Report dated Sep. 14, 2010 in European Patent Application No. EP 07 10 3527, 8 pages (corresponds to U.S. Appl. No. 11/466,917).;;Lincoln Electric, ""Stick Electrode Product Calalog"" dated Jun. 2004.;;Examiner report from corresponding Brazilian Application No. PI0602507-2, dated Dec. 12, 2014.",ACTIVE
473,AU,A1,AU 2006/202602 A1,044-721-142-454-742,2007-09-06,2007,AU 2006/202602 A,2006-06-19,US 35786106 A,2006-02-21,Improved cellulose coated stick electrode,,LINCOLN GLOBAL INC,WEAVER ROBERT J;;BURT RANDALL M;;DALLAM CRAIG B;;CHIAPPONE JON P,,https://lens.org/044-721-142-454-742,Patent Application,no,0,0,11,11,0,B23K35/3602;;B23K35/3602;;B23K35/0261;;B23K35/0261;;B23K35/0266;;B23K35/0266;;B23K35/3053;;B23K35/3053;;B23K35/3608;;B23K35/3608;;B23K35/3613;;B23K35/3613;;B23K35/365;;B23K35/365,B23K35/365,,0,0,,,,INACTIVE
474,US,B2,US 6917724 B2,056-461-897-793-272,2005-07-12,2005,US 11865302 A,2002-04-08,US 11865302 A;;US 62940100 A;;US 34310499 A;;US 57142200 A,1999-06-29,Methods for opening file on computer via optical sensing,"By printing documents and other objects with machine readable indicia, such as steganographic digital watermarks or barcodes, a great variety of document management functions can be enabled. The indicia can be added as part of the printing process (after document data has been output by an originating application program), such as by printer driver software, by a Postscript engine in a printer, etc. The indicia can encode data about the document, or can encode an identifier that references a database record containing such data. By showing the printed document to a computer device with a suitable optical input device (e.g., a webcam), an electronic version of the document can be recalled for editing, or other responsive action can be taken.",DIGIMARC CORP,SEDER PHILLIP ANDREW;;CARR J SCOTT;;PERRY BURT W;;RHOADS GEOFFREY B,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC LLC (2008-08-01);;DMRC CORPORATION (2008-08-01),https://lens.org/056-461-897-793-272,Granted Patent,yes,99,132,9,1547,0,G06Q10/10;;G06Q30/02;;G07F17/26;;G06Q30/02;;G06Q10/10;;G07F17/26,G06Q10/00;;G06Q30/00;;G07F17/26,382/321;;358/403;;382/140;;709/310;;713/176,99,13,013-959-215-137-824;;054-431-441-479-71X;;155-569-330-453-350;;108-005-042-881-002;;054-431-441-479-71X;;155-569-330-453-350;;084-121-868-105-586;;052-069-041-781-619;;013-959-215-137-824;;021-805-842-161-039;;090-278-413-005-637;;083-425-470-764-705;;145-082-256-860-62X,10.1045/december97-lotspiech;;10.1007/bf01202298;;10.1109/csac.1992.228224;;10.1109/infcom.1994.337544;;10.1007/bf01202298;;10.1109/csac.1992.228224;;10.5594/j03939;;10.1016/s0001-2998(05)80021-2;;7817202;;10.1045/december97-lotspiech;;10.1049/cp:19950674;;10.1109/ccst.1999.797927;;10.1109/21.44016;;10.1007/3-540-44750-4_36,"U.S. Appl. No. 09/074,034, filed May 6, 1998, Rhoads.;;U.S. Appl. No. 09/127,502, filed Jul. 31, 1998, Rhoads.;;U.S. Appl. No. 09/185,380, filed Nov. 3, 1998, Davis et al.;;U.S. Appl. No. 09/314,648, filed May 19, 1999, Rodriguez et al.;;U.S. Appl. No. 09/342,688, filed Jun. 29, 1999, Rodriguez et al.;;U.S. Appl. No. 09/343,104, filed Jun. 29, 1999, Rodriguez et al.;;U.S. Appl. No. 09/452,021, filed Nov. 30, 1999, Davis et al.;;U.S. Appl. No. 09/503,881, filed Feb. 14, 2000, Rhoads et al.;;U.S. Appl. No. 09/571,422, filed May 15, 2000, Rhoads et al.;;U.S. Appl. No. 09/790,322, filed Feb. 21, 2001, Lofgren et al.;;U.S. Appl. No. 60/000,442, filed Jun. 20, 1995, Hudetz.;;Mintzer et al., ""Safeguarding Digital library Contents and Users Digital Watermarking,"" D-Lib Magazine, Dec. 1997: ISSN 1082-9873.;;""Copyright Protection for Digital Images, Digital Fingerprinting from FBI,"" Highwater FBI brochure, 1995, 4 pages.;;""High Water FBI Limited Presentation Image Copyright Protection Software,"" FBI Ltd brochure, Jul., 1995, 17 pages.;;Dautzenberg, ""Watermarking Images,"" Department of Microelectronics and Electrical Engineering, Trinity College Dublin, 47 pages, Oct. 1994.;;Bruckstein, A.M.; Richardson, T.J., A holographic transform domain image watermarking method, Circuits, Systems, and Signal Processing vol.l 17, No. 3 pp. 361-389, 1998. This paper includes an appendix containing an internal memo of Bell Labs, which according to the authors of the paper, was dated Sep. 1994.;;Szepanski, ""A Signal Theoretic Method for Creating Forgery-Proof Documents for Automatic Verification,"" Proceedings 1979 Carnahan Conference on Crime Countermeasures, May 16, 1979, pp. 101-109.;;Szepanski, ""Additive Binary Data Transmission for Video Signals,"" Papers Presented at Conf. Of Comm. Engineering Soc. Sep. 30-Oct. 3, 1980, Technical Reports vol. 74, pp. 342-352.;;Tirkel et al, ""Electronic Water Mark,"" DICTA-93, Macquarie University, Sydney, Australia, Dec., 1993, pp. 666-673.;;Kurak et al., ""A Cautionary Note On Image Downgrading,"" 1992 IEEE, pp. 153-159.;;U.S. Appl. No. 60/000,442, filed Jun. 20, 1995, Hudetz.;;U.S. Appl. No. 60/082,228, filed Apr. 16, 1998, Rhoads.;;U.S. Appl. No. 60/141,763, filed Jun. 30, 1999, Davis.;;U.S. Appl. No. 60/158,015, filed Oct. 6, 1999, Davis et al.;;U.S. Appl. No. 09/314,648, filed May 19, 1999, Rodriguez et al.;;Brassil et al., Electronic Marking and Identification Techniques to Discourage Document Copying, Proceedings of INFOCOM '94 Conference on Computer, IEEE Commun. Soc Conference, Jun. 12-16, 1994, 1278-1287.;;Bruckstein, A.M.; Richardson, T.J., A holographic transform domain image watermarking method, Circuits, Systems, and Signal Processing vol. 17, No. 3 pp. 361-389, 1998. This paper includes an appendix containing an internal memo of Bell Labs, which according to the authors of the paper, was dated Sep. 1994.;;""High Water FBI Limited Presentation Image Copyright Protection Software,"" FBI Ltd brochure; Jul., 1995, 17 pages.;;Koch et al., ""Copyright Protection for Multimedia Data,"" Fraunhofer Institute for Computer Graphics, Dec. 16, 1994, 15 pages.;;Koch et al., ""Towards Robust and Hidden Image Copyright Labeling,"" Proc. of 1995 IEEE Workshop on Nonlinear Signal and Image Processing, Jun. 20-22, 1995, 4 pages.;;Kurak et al., ""A Cautionary Note On Image Downgrading,"" 1992 IEEE, pp. 153-159.;;Mintzer et al., ""Safeguarding Digital library Contents and Users"" Digital Watermarking, D-Lib Magazine, Dec. 1997: ISSN 1082-9873.;;Rindfrey, ""Towards an Equitable System for Access Control and Copyright Protection in Broadcast Image Services: The Equicrypt Approach,"" Intellectual Property Rights and New Technolgies; Proc. of the Conference, R. Oldenbourgh Verlag Wien Munchen 1995, 12 pages.;;Schreiber et al., ""A Compatible High-Definition Television System Using the Noise-Margin Method of Hiding Enhancement Information,"" SMPTE Journal, Dec. 1989, pp. 873-879.;;SDMI Example Use Scenarios (Non-Exhaustive), Version 1.2, Jun. 16, 1999.;;Szepanski, ""A Signal Theoretic Method for Creating Forgery-Proof Documents of Automatic Verification,"" Proceedings 1979 Carnahan Conference on Crime Countermeasures, May 16, 1979, pp. 101-109.;;Szepanski, ""Additive Binary Data Transmission for Video Signals,"" Papers Presented at Conf. Of Comm. Engineering Soc. Sep. 30-Oct. 3, 1980, Technical Reports vol. 74, pp. 342-352.;;Tanaka et al., ""A Visual Retrieval System with Private Information for Image Database,"" Proceeding International Conference on DSP Applications and Technology, Oct. 1991, pp. 415-421.;;Tanaka et al., ""New Integrated Coding Schemes for Computer-Aided Facsimile,"" Proc. IEEE Int'l Conf. on Sys. Integration, Apr. 1990, pp. 275-281.;;Tirkel et al, ""Electronic Water Mark,"" DICTA-93, Macquarie University, Sydney, Australia, Dec., 1993, pp. 666-673.;;Weber et al., ""Correlative Image Registration,"" Seminars in Nuclear Medicine, vol. XXIV, No. 4, Oct., 1994, pp. 311-323.;;Szepanski, ""A Signal Theoretic Method for Creating Forgery-Proof Documents for Automatic Verification,"" Proceedings 1979 Carnahan Conference on Crime Countermeasures, May 16, 1979, pp. 101-109.;;Dautzenberg, ""Watermarking Images,"" Department of Microelectronics and Electrical Engineering, Trinity College Dublin, 47, pages, Oct. 1994.;;Szepanski, ""Additive Binary Data Transmission for Video Signals,"" Conference of the Communications Engineering Society, 1980, NTG Technical Reports, vol. 74, pp. 343-351. (German text and English translation enclosed).;;Cookson, Chris, General Principles of Music Uses on Portable Devices, presented to SDMI, Mar. 5, 1999.;;Winograd, J.M., ""Audio Watermarking Architecture for Secure Digital Music Distribution,"" a Proposal to the SDMI Portable Devices Working Group, by Aris Technologies, Inc., Mar. 26, 1999.;;Mintzer et al., ""Safeguarding Digital Library Contents and Users: Digital Watermarking,"" D-Lib Magazine, Dec. 1997, 12 pages.;;U.S. Appl. No. 60/071,983, filed Jan. 20, 1998, Levy.;;U.S. Appl. No. 09/404,291, filed Sep. 23, 1999, Levy.;;U.S. Appl. No. 60/114,725, filed Dec. 31, 1998, Levy.;;U.S. Appl. No. 09/234,780, filed Jan. 20, 1999, Rhoads/Gustafson.;;U.S. Appl. No. 60/116,641, filed Jan. 21, 1999, Cookson.;;U.S. Appl. No. 09/478,713, filed Jan. 6, 2000, Cookson.;;U.S. Appl. No. 09/765,102, filed Jan. 17, 2001, Shaw.;;U.S. Appl. No. 09/761,349, filed Jan. 16, 2001, Rhoads.;;U.S. Appl. No. 09/761,280, filed Jan. 16, 2001, Rhoads.;;U.S. Appl. No. 09/645,779, filed Aug. 24, 2000, Tian et al.;;U.S. Appl. No. 09/689,226, filed Oct. 11, 2000, Brunk.;;U.S. Appl. No. 09/689,250, filed Oct. 11, 2000, Ahmed.;;U.S. Appl. No. 09/689,293, filed Oct. 11, 2000, Tian et al.;;U.S. Appl. No. 09/625,577, filed Jul. 25, 2000, Carr et al.;;U.S. Appl. No. 09/574,726, filed May 18, 2000, Rhoads et al.;;U.S. Appl. No. 09/562,524, filed May 1, 2000, Carr et al.;;U.S. Appl. No. 09/498,223, filed Feb. 3, 2000, Rhoads et al.;;U.S. Appl. No. 09/465,418, filed Dec. 16, 1999, Rhoads et al.;;U.S. Appl. No. 09/431,990, filed Nov. 3, 1999, Rhoads.;;U.S. Appl. No. 09/428,359, filed Oct. 28, 2000, Davis et al.;;U.S. Appl. No. 09/342,972, filed Jun. 29, 1999, Rhoads.;;U.S. Appl. No. 09/293,602, filed Apr. 15, 1999, Rhoads.;;U.S. Appl. No. 09/293,601, filed Apr. 15, 1999, Rhoads.;;U.S. Appl. No. 09/287,940, filed Apr. 7, 1999, Rhoads.;;U.S. Appl. No. 09/185,380, filed Nov. 3, 1998, Davis et al.;;U.S. Appl. No. 09/074,034, filed May 6, 1998, Rhoads.;;U.S. Appl. No. 09/127,502, filed Jul. 31, 1998, Rhoads.;;U.S. Appl. No. 60/082,228, filed Apr. 16, 1998, Rhoads.;;U.S. Appl. No. 60/198,138, filed Apr. 17, 2000, Alattar.;;Audio Watermarking Architectures for Secure Digital Music Distribution, A Proposal to the SDMI Portable Devices Working Group by ARIS Technolgies, Inc, Mar. 26, 1999, pp. 1-11.;;Audio Watermarking Architecutres for Persistent Protection, Presentation to SDMI PDWG, Mar. 29, 1999, J. Winograd, Aris Technolgies, pp. 1-16.;;Audio Watermarking System to Screen Digital Audio Content for LCM Acceptance, A Proposal Submitted in Response to PDWG99050504-Transition CfP by ARIS Technolgies, Inc., May 23, 1999, Document Version 1.0, 15 pages.;;Boland et al., ""Watermarking Digital Images for Copyright Protection"", Fifth Int'l Conference on Image Processing and it's Application, Jul. 1995, pp. 326-330.;;Levy, ""AIPL's Proposal for SDMI: An Underlying Security System"" (slide presentation), Mar. 29, 1999, 23 slides..;;Microsoft Response to CfP for Technology Solutions to Screen Digital Audio Content for LCM Acceptance, SDMI, PDWG Tokyo, May 23, 1999, 9 pages.;;Response to CfP for Technology Solutions to Screen Digital Audio Content for LCM Acceptance, NTT Waveless Radio Consotium, May 23, 1999, 9 pages.;;Sandford II et al., ""The Data Embedding Method"", Proceedings of the SPIE vol. 2615, pp. 226-259, 1996.;;Thomas, Keith, Screening Technology for Content from Compact Discs, May 24, 1999, 11 pages.;;Tirkel et al., ""Electronic Water Mark,"" Dicta-93, Marquarie University, Sydney, Australia, Dec., 1993, pp. 666-672.;;Vidal et al., ""Non-Noticeable Information Embedding in Color Images: Marking and Detection"", IEEE 1999, pp. 293-297.;;Wolfgang et al., ""A Watermark for Digital Images,"" Computer Vision and Image Processing Laboratory, Purdue University, Sep. 1996, pp. 219-222.;;""Access Control and COpyright Protection for Images, WorkPackage 8: Watermarking,"" Jun. 30, 1995, 46 pages.;;""Access Control and COpyright Protection for Images, WorkPackage 3: Evaluation of Existing Systems,"" Apr. 19, 1995, 68 pages.;;""Access Control and COpyright Protection for Images, WorkPackage 1: Access Control and Copyright Protection for Images Need Evaluation,"" Jun., 1995, 21 pages.;;""Access Control and COpyright Protection for Images, Conditional Access and Copyright Protection Based on the Use of Trusted Third Parties,"" 1995, 43 pages.;;Arachelian, ""White Noise Storm,"" Apr. 11, 1994, Internet reference, 13 pages.;;Arazi, et al., ""Intuition, Perception, and Secure Communication,"" IEEE Transactionson Systems, Man, and Cybernetics, vol. 19, No. 5, Sep./Oct. 1989, pp. 1016-1020.;;Arthur, ""Digital Fingerprints Protect Artwork,"" New Scientist, Nov. 12, 1994, p. 24.;;Aura, ""Invisible Communication,"" Helskinki University of Technology, Digital Systems Laboratory, Nov. 5, 1995, 13 pages.;;Bender et al, ""Techniques for Data Hiding,"" Draft Preprint, Private Correspondence, dated Oct. 30, 1995.;;Bender et al., ""Techniques for Data Hiding,"" Massachusetts Institute of Technology, Media Laboratory, Jan. 1995, 10 pages.;;Boneh, ""Collusion-Secure Fingerprinting for Digital Data,"" Department of Computer Science, Princeton University, 1995, 31 pages.",EXPIRED
475,US,B2,US 11789635 B2,071-915-980-250-460,2023-10-17,2023,US 202117160465 A,2021-01-28,US 202117160465 A,2021-01-28,Copying data between storage systems,"Copying data from a source storage system to a target storage system includes resetting a write tracker on the source storage system to track writes to the source storage system by one or more host computing systems, copying data from the source storage system to the target storage system after resetting the write tracker, suspending writes to the source storage system after copying the data, and copying data portions of the source storage system to the target storage system that are indicated as being written by the write tracker after suspending writes to the source storage system. Applications that write data to the source storage system may be quiesced in connection with suspending writes to the source storage system. Data portions may be repeatedly copied from the source storage system to the target storage system until an end condition is reached.",EMC IP HOLDING CO LLC,LECRONE DOUGLAS E;;BURT DENIS J;;QUINN BRETT A;;LINSTEAD PAUL A,EMC IP HOLDING COMPANY LLC (2021-01-27),https://lens.org/071-915-980-250-460,Granted Patent,yes,8,0,2,2,0,G06F3/0617;;G06F3/065;;G06F3/067;;G06F3/0659;;G06F3/0634;;G06F3/065;;G06F3/067;;G06F3/0604,G06F3/06,,0,0,,,,ACTIVE
476,US,A1,US 2002/0181736 A1,049-824-154-820-360,2002-12-05,2002,US 11884602 A,2002-04-08,US 11884602 A;;US 62940100 A;;US 34310499 A;;US 57142200 A,1999-06-29,Methods for determining contents of media,"
   By printing documents and other objects with machine readable indicia, such as steganographic digital watermarks or barcodes, a great variety of document management functions can be enabled. The indicia can be added as part of the printing process (after document data has been output by an originating application program), such as by printer driver software, by a Postscript engine in a printer, etc. The indicia can encode data about the document, or can encode an identifier that references a database record containing such data. By showing the printed document to a computer device with a suitable optical input device (e.g., a webcam), an electronic version of the document can be recalled for editing, or other responsive action can be taken. 
",SEDER PHILLIP ANDREW;;CARR J. SCOTT;;PERRY BURT W.;;RHOADS GEOFFREY B.,SEDER PHILLIP ANDREW;;CARR J SCOTT;;PERRY BURT W;;RHOADS GEOFFREY B,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC LLC (2008-08-01);;DMRC CORPORATION (2008-08-01),https://lens.org/049-824-154-820-360,Patent Application,yes,0,25,9,1547,0,G06Q10/10;;G06Q30/02;;G07F17/26;;G06Q30/02;;G06Q10/10;;G07F17/26,G06Q10/00;;G06Q30/00;;G07F17/26,3821,0,0,,,,EXPIRED
477,BR,A,BR PI0602507 A,084-649-029-018-612,2007-11-06,2007,BR PI0602507 A,2006-07-04,US 35786206 A,2006-02-21,eletrodo de bastão,"ELETRODO DE BASTãO. A presente invenção refere-se a um eletrodo de bastão para depositar um friso de metal de alta resistência em uma peça de trabalho onde a intensidade de resistência do metal de solda é de cerca de 13,17-19,37 kg/cm¬ 2¬ (85 ksi a 125 ksi) independente da taxa de resfriamento. O eletrodo deposita o metal de solda tendo cerca de 0,8-1,85% em peso de manganês, cerca de 0,25-0,50% em peso de molibdênio, cerca de 1,25 -2,50% em peso de níquel, e menos que cerca de 0,07% em peso de carbono, em que as proporções de carbono, manganês e molibdênio são ajustadas para fornecer um equivalente de carbono do metal de solda depositado na faixa de cerca de 0,17 a 0,30 e de preferência menos que 0,22.",LINCOLN GLOBAL INC,CHIAPPONE JON P;;DALLAM CRAIG B;;WEAVER ROBERT J;;BURT RANDALL M,,https://lens.org/084-649-029-018-612,Patent Application,no,0,1,13,13,0,B23K9/02;;B23K9/02;;B23K35/3053;;B23K35/368,B23K35/22,,0,0,,,,DISCONTINUED
478,WO,A1,WO 2013/184454 A1,188-036-195-230-685,2013-12-12,2013,US 2013/0042963 W,2013-05-29,US 201213487742 A,2012-06-04,SEAL LAND FOR STATIC STRUCTURE OF A GAS TURBINE ENGINE,"A seal land for a gas turbine engine can include a seal body that can extend between a leading edge portion, a trailing edge portion, a radially outer surface and a radially inner surface. A notch can extend at least partially through the seal body between the radially outer surface and the radially inner surface.",UNITED TECHNOLOGIES CORP,GORDON AMY M;;JAKIEL JONATHAN J;;BURT JONATHAN P;;PORTER STEVEN D,,https://lens.org/188-036-195-230-685,Patent Application,yes,7,0,6,6,0,F04D29/542;;F01D11/005;;F02C7/28;;F01D25/162;;F04D29/083;;F01D11/005;;F02C7/28;;F01D25/162;;F04D29/542;;F04D29/083,F02C7/28;;F01D11/00;;F02C3/00,,0,0,,,,PENDING
479,US,A1,US 2020/0133557 A1,194-112-437-427-624,2020-04-30,2020,US 201816176579 A,2018-10-31,US 201816176579 A,2018-10-31,DATA MIGRATION WITH WRITE BACK TO SOURCE WITH DATA PRE-COPY,Migrating data from a first storage device to a second storage device includes causing all data of the first storage device to be copied from the first storage device to the second storage device and causing the host computer to transition from performing I/O operations with the first storage device to performing I/O operations with the second storage device by modifying metadata used for I/O operations to change a mapping of logical devices to physical devices only after causing all data of the first storage device to be copied from the first storage device to the second storage device. Migrating data from the first storage device to the second storage device is independent of any I/O operations by the host. A data write operation from the host is acknowledged only after the data has been successfully written to both the first storage device and the second storage device.,EMC IP HOLDING CO LLC,LECRONE DOUGLAS E;;LINSTEAD PAUL A;;BURT DENIS J;;QUINN BRETT A,EMC IP HOLDIING COMPANY LLC (2018-10-31),https://lens.org/194-112-437-427-624,Patent Application,yes,4,0,2,2,0,G06F3/0689;;G06F3/065;;G06F3/0617;;G06F3/0647;;G06F3/0683;;G06F3/0604;;G06F3/0644,G06F3/06,,0,0,,,,ACTIVE
480,AU,B2,AU 2006/202602 B2,034-634-517-813-564,2007-11-29,2007,AU 2006/202602 A,2006-06-19,US 35786106 A,2006-02-21,Improved cellulose coated stick electrode,,LINCOLN GLOBAL INC,WEAVER ROBERT J;;BURT RANDALL M;;DALLAM CRAIG B;;CHIAPPONE JON P,,https://lens.org/034-634-517-813-564,Granted Patent,no,3,0,11,11,0,B23K35/3602;;B23K35/3602;;B23K35/0261;;B23K35/0261;;B23K35/0266;;B23K35/0266;;B23K35/3053;;B23K35/3053;;B23K35/3608;;B23K35/3608;;B23K35/3613;;B23K35/3613;;B23K35/365;;B23K35/365,B23K35/365,,0,0,,,,INACTIVE
481,US,B2,US 11237921 B2,056-570-096-808-406,2022-02-01,2022,US 201916692157 A,2019-11-22,US 201916692157 A,2019-11-22,Protecting storage backup configuration,"Changing operational backup parameters on a storage system includes a first actor generating a request to change operational backup parameters, providing the request from the first actor to a second actor, the second actor authorizing the request, and modifying the operational backup parameters in response to the second actor authorizing the request. The first actor may be assigned a role that allows the first actor to generate the request to change operational backup parameters of the storage system and the second actor may be assigned a role that allows the second actor to authorize the request to change operational backup parameters of the storage system. The request may include a time window provided by the first actor. Authorizing a request to change operational backup parameters of the storage system may create a token and an authorization key. The token may be indicative of the request provided by the first actor.",EMC IP HOLDING CO LLC,LECRONE DOUGLAS E;;LINSTEAD PAUL A;;QUINN BRETT A;;BURT DENIS J,EMC IP HOLDING COMPANY LLC (2019-11-21),https://lens.org/056-570-096-808-406,Granted Patent,yes,13,0,2,2,0,G06F21/6218;;G06F21/602;;G06F21/335;;G06F2201/84;;G06F11/1469;;G06F11/1451;;G06F11/1471;;G06F11/1469;;G06F11/1464;;G06F11/1461;;G06F21/6218;;G06F21/602;;G06F11/1448;;G06F21/107;;G06F21/1014,G06F11/14;;G06F21/60;;G06F21/62,,2,2,068-360-313-233-144;;043-004-375-083-737,10.1109/glocomw.2015.7414154;;10.5120/13078-0253,Paul Crocker; Two Factor Encryption in cloud storage providers using Hardware Tokens; 2015; IEEE; p. 1-6 (Year: 2015).;;Gitanjali et al; Policy Specification in Role based Access Control on Clouds; Aug. 2013; International Journal of Computer Applications (0975-8887); vol. 75—No. 1; p. 39-43 (Year: 2013).,ACTIVE
482,US,B1,US 8898444 B1,079-001-313-653-063,2014-11-25,2014,US 201113334884 A,2011-12-22,US 201113334884 A,2011-12-22,Techniques for providing a first computer system access to storage devices indirectly through a second computer system,"Described are techniques for providing access to storage devices. An I/O request directed to a storage device is sent over a network connection from a first computer system to a second computer system. The second computer system includes a simulated computing environment simulating aspects of the first computer system. The I/O request is received at the second computer system. The data storage system is connected to the second computer system over a first connection operating in accordance with a first protocol thereby providing the second computer system access to the storage device of the data storage system. The simulated computing environment of the second computer system may, for example, include emulation capabilities in accordance with the first protocol thereby allowing the second computer system to issue the first I/O request to the first storage device on behalf of the first computer system.",LECRONE DOUGLAS E;;LINSTEAD PAUL A;;OUELLETE ROGER A;;BURT DENIS J;;EMC CORP,LECRONE DOUGLAS E;;LINSTEAD PAUL A;;OUELLETE ROGER A;;BURT DENIS J,EMC CORPORATION (2011-12-22);;EMC IP HOLDING COMPANY LLC (2016-09-06),https://lens.org/079-001-313-653-063,Granted Patent,yes,22,6,1,1,0,G06F9/45558;;G06F9/45558;;G06F2009/45579;;G06F2009/45579,G06F9/24;;G06F3/00;;G06F9/455,713/1;;713/2;;710/1;;710/11;;710/28;;718/1;;718/100;;718/102;;718/103;;718/104;;718/105;;718/106,1,0,,,"U.S. Appl. No. 12/215,984, filed Jun. 30, 2008, ""I/O Fault Injection Using Simulated Computing Environments"".",ACTIVE
483,US,A1,US 2008/0222167 A1,106-729-196-663-439,2008-09-11,2008,US 85509707 A,2007-09-13,US 85509707 A;;US 82556806 P;;US 82556606 P,2006-09-13,SUBMISSION SYSTEM AND METHOD,"A submission data system is used by various organizations each to receive, process, and use information originating outside of the organization. The submission system includes a submission center and various stations communicatively linked thereto. The stations are used by administrators, submitters, and post-submission users to communicate with the submission center. The submission center further includes a submission data structure generator that generates submission data structures tailored to the particular information and presentation requirements of the various organizations.",SPONSORWISE,HINDS RUSSELL S;;MUNSON MICHAEL J;;CUMMINGS BURT;;BROWN MARK;;WELCH PIA,SPONSORWISE INC (2007-10-18),https://lens.org/106-729-196-663-439,Patent Application,yes,3,3,1,1,0,G06F16/958;;G06F16/958,G06F17/30,707/100;;X707E17001,0,0,,,,DISCONTINUED
484,CA,C,CA 2550558 C,155-956-762-961-893,2012-07-31,2012,CA 2550558 A,2006-06-14,US 35786206 A,2006-02-21,STICK ELECTRODE,"A stick electrode for depositing an high strength weld metal bead on a workpiece where the yield strength of the weld metal is between 85 ksi and 125 ksi irrespective of the cooling rate. The electrode deposits weld metal having 0.80 - 1.85% by weight manganese, 0.25 - 0.50% by weight molybdenum, 1.25 - 2.50% by weight nickel, and less than 0.07% by weight carbon, wherein the ratios of the carbon, manganese and molybdenum are adjusted to provide a carbon equivalent in deposited weld metal in the range of 0.17 to 0.30 and preferably less than 0.22.",LINCOLN GLOBAL INC,BURT RANDALL M;;CHIAPPONE JON P;;DALLAM CRAIG B;;WEAVER ROBERT J,,https://lens.org/155-956-762-961-893,Granted Patent,no,0,0,13,13,0,B23K9/02;;B23K9/02;;B23K35/3053;;B23K35/368,B23K35/30,,0,0,,,,INACTIVE
485,US,B1,US 6425618 B1,167-147-077-970-033,2002-07-30,2002,US 68209901 A,2001-07-19,US 68209901 A,2001-07-19,Articulating cargo bed extender,"
    An extendable support mechanism for a cargo bed of a pickup truck or the like. One or more support members are attached to opposite sides of the cargo bed and adapted to be positioned vertically upwardly from the cargo bed in order to support a tent-like structure or an object which is also positioned in part on the cab of the vehicle. Preferably, three tubular support members are provided in the support mechanism. Each of the tubular members are comprised of two telescopic members and are extendable in order to vary the height of the support member in the vertical direction in order to be used to hold members on the top of the vehicle. The support mechanism can be attached to an articulating bracket member which allows the support member also to be used as a cargo bed extender when desired, and also to be rotated to a stored position inside the cargo bed. In an alternate embodiment, the support members are held in vertical position on the sides of the cargo bed by fixed bracket members. 
",FORD GLOBAL TECH INC,GARLAND TRAVIS STEVEN;;NALLY WARREN L;;BRZUCH RONALD J;;SLOAN BURT E,FORD GLOBAL TECHNOLOGIES INC (2001-06-29),https://lens.org/167-147-077-970-033,Granted Patent,yes,3,78,1,1,0,B60P3/40;;B60P3/40,B60P3/40,296/3;;296/26.11;;224/405;;224/484,0,0,,,,EXPIRED
486,US,B2,US 10852983 B2,006-113-891-746-796,2020-12-01,2020,US 201816176579 A,2018-10-31,US 201816176579 A,2018-10-31,Data migration with write back to source with data pre-copy,Migrating data from a first storage device to a second storage device includes causing all data of the first storage device to be copied from the first storage device to the second storage device and causing the host computer to transition from performing I/O operations with the first storage device to performing I/O operations with the second storage device by modifying metadata used for I/O operations to change a mapping of logical devices to physical devices only after causing all data of the first storage device to be copied from the first storage device to the second storage device. Migrating data from the first storage device to the second storage device is independent of any I/O operations by the host. A data write operation from the host is acknowledged only after the data has been successfully written to both the first storage device and the second storage device.,EMC IP HOLDING CO LLC,LECRONE DOUGLAS E;;LINSTEAD PAUL A;;BURT DENIS J;;QUINN BRETT A,EMC IP HOLDIING COMPANY LLC (2018-10-31),https://lens.org/006-113-891-746-796,Granted Patent,yes,4,0,2,2,0,G06F3/0689;;G06F3/065;;G06F3/0617;;G06F3/0647;;G06F3/0683;;G06F3/0604;;G06F3/0644,G06F3/06,,0,0,,,,ACTIVE
487,US,B2,US 7868625 B2,025-718-693-562-84X,2011-01-11,2011,US 12176508 A,2008-05-15,US 12176508 A,2008-05-15,Slot interposer probe,"The slot interposer probe consists of a board with a male edge connector and a female edge connector connected to its opposed edges and circuitry electrically connecting the male edge connector to the female edge connector. The female edge connector may be a straddle-mount connector. The board may have an inner layer sandwiched between two outer layers. There may be a probe having a high-speed buffer connected to a plurality of capacitors, isolation resistors, and vias that intercepts signals carried by transmission lines on the inner layer. The vias may have a length equal to the inner layer's width. The high-speed buffer receives intercepted signals from the vias, copies and amplifies the signals, and drives them through coaxial cables to an acquisition module. The invention also includes a method of intercepting signals between a first electrical device and a second electrical device.",TEKTRONIX INC,BURT DEVIN G;;O'BRIEN JOSHUA J;;KOCH DAVID W;;JONES ROXANN R,,https://lens.org/025-718-693-562-84X,Granted Patent,yes,1,1,2,2,0,G01R31/2808;;G06F11/2733;;G01R31/2808;;G06F11/2733,G01R31/08,324/555;;324/538,0,0,,,,INACTIVE
488,CA,A1,CA 2550558 A1,112-031-874-750-009,2007-08-21,2007,CA 2550558 A,2006-06-14,US 35786206 A,2006-02-21,STICK ELECTRODE,"A stick electrode for depositing an high strength weld metal bead on a workpiece where the yield strength of the weld metal is between 85 ksi and 125 ksi irrespective of the cooling rate. The electrode deposits weld metal having 0.80 - 1.85% by weight manganese, 0.25 - 0.50% by weight molybdenum, 1.25 - 2.50% by weight nickel, and less than 0.07% by weight carbon, wherein the ratios of the carbon, manganes e and molybdenum are adjusted to provide a carbon equivalent in deposited weld met al in the range of 0.17 to 0.30 and preferably less than 0.22.",LINCOLN GLOBAL INC,BURT RANDALL M;;DALLAM CRAIG B;;WEAVER ROBERT J;;CHIAPPONE JON P,,https://lens.org/112-031-874-750-009,Patent Application,no,0,2,13,13,0,B23K9/02;;B23K9/02;;B23K35/3053;;B23K35/368,B23K35/30,,0,0,,,,INACTIVE
489,US,A1,US 2007/0193994 A1,156-817-702-729-845,2007-08-23,2007,US 35786106 A,2006-02-21,US 35786106 A,2006-02-21,Cellulose coated stick electrode,"In a stick electrode for electric arc welding having a center alloy wire and an outer cellulose coating which coating includes powdered fluxing agents, alloy powder, cellulose powder and a binder. The improvement involves forming the binder as a solution of sodium silicate and 61-78 percent by weight of the binder. The binder comprises 25-35% of the coating to produce at least about 4% by weight of water in the electrode. Furthermore, the fluxing agent is titanium dioxide with a percentage greater than 12 percent of the coating.",LINCOLN GLOBAL INC,BURT RANDALL M;;CHIAPPONE JON P;;DALLAM CRAIG B;;WEAVER ROBERT J,LINCOLN GLOBAL INC (2006-02-14),https://lens.org/156-817-702-729-845,Patent Application,yes,22,7,11,11,0,B23K35/3602;;B23K35/3602;;B23K35/0261;;B23K35/0261;;B23K35/0266;;B23K35/0266;;B23K35/3053;;B23K35/3053;;B23K35/3608;;B23K35/3608;;B23K35/3613;;B23K35/3613;;B23K35/365;;B23K35/365,B23K35/02,219/145.23,0,0,,,,ACTIVE
490,AU,C1,AU 2006/202605 C1,053-106-684-668-026,2009-07-30,2009,AU 2006/202605 A,2006-06-19,US 35786206 A,2006-02-21,Stick electrode,,LINCOLN GLOBAL INC,DALLAM CRAIG B;;BURT RANDALL M;;WEAVER ROBERT J;;CHIAPPONE JON P,,https://lens.org/053-106-684-668-026,Amended Patent,no,0,0,13,13,0,B23K9/02;;B23K9/02;;B23K35/3053;;B23K35/368,B23K35/22,,1,0,,,"Stick Electrode Product Catalogue,",INACTIVE
491,US,B2,US 6694042 B2,135-847-541-488-993,2004-02-17,2004,US 11884602 A,2002-04-08,US 11884602 A;;US 62940100 A;;US 34310499 A;;US 57142200 A,1999-06-29,Methods for determining contents of media,"
    By printing documents and other objects with machine readable indicia, such as steganographic digital watermarks or barcodes, a great variety of document management functions can be enabled. The indicia can be added as part of the printing process (after document data has been output by an originating application program), such as by printer driver software, by a Postscript engine in a printer, etc. The indicia can encode data about the document, or can encode an identifier that references a database record containing such data. By showing the printed document to a computer device with a suitable optical input device (e.g., a webcam), an electronic version of the document can be recalled for editing, or other responsive action can be taken. 
",DIGIMARC CORP,SEDER PHILLIP ANDREW;;CARR J SCOTT;;PERRY BURT W;;RHOADS GEOFFREY B,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC CORPORATION (2008-08-01);;DMRC LLC (2008-08-01),https://lens.org/135-847-541-488-993,Granted Patent,yes,105,188,9,1547,0,G06Q10/10;;G06Q30/02;;G07F17/26;;G06Q30/02;;G06Q10/10;;G07F17/26,G06Q10/00;;G06Q30/00;;G07F17/26,382/100;;235/454;;382/306,99,12,054-431-441-479-71X;;155-569-330-453-350;;013-959-215-137-824;;125-269-942-420-346;;186-451-692-374-482;;067-155-203-760-737;;108-005-042-881-002;;155-569-330-453-350;;084-121-868-105-586;;052-069-041-781-619;;013-959-215-137-824;;021-805-842-161-039,10.1007/bf01202298;;10.1109/csac.1992.228224;;10.1045/december97-lotspiech;;10.1145/142750.143007;;10.1145/259963.260343;;10.1145/223904.223971;;10.1109/infcom.1994.337544;;10.1109/csac.1992.228224;;10.5594/j03939;;10.1016/s0001-2998(05)80021-2;;7817202;;10.1045/december97-lotspiech;;10.1049/cp:19950674,"U.S. patent application Ser. No. 09/074,034, Rhoads, filed May 6, 1998.;;U.S. patent application Ser. No. 09/127,502, Rhoads, filed Jul. 31, 1998.;;U.S. patent application Ser. No. 09/185,380, Davis et al., filed Nov. 3, 1998.;;U.S. patent application Ser. No. 09/314,648, Rodriguez et al., filed May 19, 1999.;;U.S. patent application Ser. No. 09/342,688, Rodriguez et al., filed Jun. 29, 1999.;;U.S. patent application Ser. No. 09/343,104, Rodriguez et al., filed Jun. 29, 1999.;;U.S. patent application Ser. No. 09/452,021, Davis et al., filed Nov. 30, 1999.;;U.S. patent application Ser. No. 09/503,881, Rhoads et al., filed Feb. 14, 2000.;;U.S. patent application Ser. No. 09/571,422, Rhoads et al., filed May 15, 2000.;;U.S. patent application Ser. No. 09/790,322, Lofgren et al., filed Feb. 21, 2001.;;U.S. patent application Ser. No. 60/000,442, Hudetz, filed Jun. 20, 1995.;;Bloomberg, ""Embedding Digital Data on Paper in Iconic Text"" SPIE vol. 3027, Document Recognition IV, pp. 67-80 (1997).;;Bruckstein, A.M.; Richardson, T.J., ""A holographic transform domain image watermarking method,"" Circuits, Systems, and Signal Processing vol. 17, No. 3 p. 361-89, 1998. This paper includes an appendix containing an internal memo of Bell Labs, which according to the authors of the paper, was dated Sep. 1994.;;""Copyright Protection for Digital Images, Digital Fingerprinting from FBI,"" Highwater FBI brochure, 1995, 4 pages.;;Dautzenberg, ""Watermarking Images,"" Department of Microelectronics and Electrical Engineering, Trinity College Dublin, 47 pages, Oct. 1994.;;""High Water FBI Limited Presentation Image Copyright Protection Software,"" FBI Ltd brochure, Jul., 1995, 17 pages.;;Johnson, et al., ""Bridging the Paper and Electronic Worlds: The Paper User Interface"", Interchi '93, pp. 507-512, Apr. 1993.;;Kurak et al., ""A Cautionary Note On Image Downgrading,"" 1992 IEEE, pp. 153-159.;;Mintzer et al., ""Safeguarding Digital library Contents and Users,"" Digital Watermarking, D-Lib Magazine, Dec. 1997: ISSN 1082-9873.;;Newman, William, et al. ""A Desk Supporting Computer-Based Interaction with paper Documents,"" ACM Conference on Human Factors in Computing Systems (CHI '92) May 3-7, 1992, pp. 587-592.;;Peairs, ""Iconic Paper,"" Proceedings of the Third International Conference on Document Analysis and Recognition (ICDAR '95), pp. 1174-1179, 1995.;;Rao, et al. ""Protofoil: Storing and Finding the Information Worker's Paper Documents in an Electronic File Cabinet,"" Human Factors in Computing Systems (CHI '94), pp. 180-186, Boston MA, Apr. 1994.;;Szepanski, ""Additive Binary Data Transmission for Video Signals,"" Papers Presented at Conf. Of Comm. Engineering Soc. Sep. 30-Oct. 3, 1980, Technical Reports vol. 74, pp. 342-352.;;Szepanski, ""A Signal Theoretic Method for Creating Forgery-Proof Documents for Automatic Verification,"" Proceedings 1979 Carnahan Conference on Crime Countermeasures, May 16, 1979, pp. 101-109.;;Tirkel et al, ""Electronic Water Mark,"" DICTA-93, Macquarie University, Sydney, Australia, Dec., 1993, pp. 666-673.;;Whittaker, et al., ""Back to the Future: Pen and Paper Technology Supports Complex Group Coordination,"" CHI '95, Conference on Human Factors in Computing Systems, Denver, Colorado (May 7-11, 1995) (text copy obtained from ACM).;;Zhao, et al. ""WWW Service to Embed and Prove Digital Copyright Watermarks,"" Fraunhofer Institute for Computer Graphics, Proc. of EU Conf. On Multimedia Applications, Services and Techniques, May 1996.;;U.S. patent application Ser. No. 60/082,228, Rhoads, filed Apr. 16, 1998.;;U.S. patent application Ser. No. 60/141,763, Davis, filed Jun. 30, 1999.;;U.S. patent application Ser. No. 60/158,015, Davis et al., filed Oct. 6, 1999.;;U.S. patent application Ser. No. 09/342,688, Rodriguez et al., filed Jun. 29, 1999.;;U.S. patent application Ser. No. 09/342,971, Rodriguez et al., filed Jun. 29, 1999.;;U.S. patent application Ser. No. 09/679,261, Davis et al., filed Oct. 4, 2000.;;U.S. patent application Ser. No. 09/562,517, Davis et al., filed May 1, 2000.;;U.S. patent application Ser. No. 09/547,664, Rhoads et al., filed Apr. 12, 2000.;;U.S. patent application Ser. No. 09/571,442, Rhoads et al., filed May 15, 2000.;;U.S. patent application Ser. No. 09/858,189, Rhoads et al., May 14, 2001.;;U.S. patent application Ser. No. 09/631,409, Brundage et al., filed Aug. 3, 2000.;;U.S. patent application Ser. No. 09/452,021, Davis et al., filed Nov. 30, 1999.;;U.S. patent application Ser. No. 09/629,401, Seder et al., filed Aug. 1, 2000.;;U.S. patent application Ser. No. 09/473,396, Evans et al., filed Dec. 28, 2000.;;U.S. patent application Ser. No. 09/563,664, Levy et al., filed May 2, 2000.;;U.S. patent application Ser. No. 09/670,115, Rhoads et al., filed Sep. 26, 2000.;;Brassil et al., Electronic Marking and Identification Techniques to Discourage Document Copying, Proceedings of INFOCOM '94 Conference on Computer, IEEE Commun. Soc Conference, Jun. 12-16, 1994, 1278-1287.;;Bruckstein, A.M.; Richardson, T.J., A holographic transform domain image watermarking method, Circuits, Systems, and Signal Processing vol. 17, No. 3 p. 361-89, 1998. This paper includes an appendix containing an internal memo of Bell Labs, which according to the authors of the paper, was dated Sep. 1994.;;""High Water FBI Limited Presentation Image Copyright Protection Software,"" FBI Ltd brochure, Jul., 1995, 17 pages.;;Koch et al., ""Copyright Protection for Multimedia Data,"" Fraunhofer Institute for Computer Graphics, Dec. 16, 1994, 15 pages.;;Koch et al., ""Towards Robust and Hidden Image Copyright Labeling,"" Proc. of 1995 IEEE Workshop on Nonlinear Signal and Image Processing, Jun. 20-22, 1995, 4 pages.;;Kurak et al., ""A Cautionary Note On Image Downgrading,"" 1992 IEEE, pp. 153-159.;;Mintzer et al., ""Safeguarding Digital library Contents and Users"" Digital Watermarking, D-Lib Magazine, Dec. 1997: ISSN 1082-9873;;Rindfrey, ""Towards an Equitable System for Access Control and Copyright Protection in Broadcast Image Services: The Equicrypt Approach,"" Intellectual Property Rights and New Technologies, Proc. of the Conference, R. Oldenbourg Verlag Wien Munchen 1995, 12 pages.;;Schreiber et al., ""A Compatible High-Definition Television System Using the Noise-Margin Method of Hiding Enhancement Information,"" SMPTE Journal, Dec. 1989, pp. 873-879.;;SDMI Example Use Scenarios (Non-Exhaustive), Version 1.2, Jun. 16, 1999.;;Szepanski, ""A Signal Theoretic Method for Creating Forgery-Proof Documents for Automatic Verification,"" Proceedings 1979 Carnahan Conference on Crime Countermeasures, May 16, 1979, pp. 101-109.;;Szepanski, ""Additive Binary Data Transmission for Video Signals,"" Papers Presented at Conf. Of Comm. Engineering Soc. Sep. 30-Oct. 3, 980, Technical Reports vol. 74, pp. 342-352.;;Tanaka et al., ""A Visual Retrieval System with Private Information for Image Database,"" Proceeding International Conference on DSP Applications and Technology, Oct. 1991, pp. 415-421.;;Tanaka et al., ""New Integrated Coding Schemes for Computer-Aided Facsimile,"" Proc. IEEE Int'l Conf. on Sys. Integration, Apr. 1990, pp. 275-281.;;Tirkel et al, ""Electronic Water Mark,"" DICTA-93, Macquarie University, Sydney, Australia, Dec., 1993, pp. 666-673.;;Weber et al., ""Correlative Image Registration,"" Seminars in Nuclear Medicine, vol. XXIV, No. 4; Oct., 1994, pp. 311-323.;;Szepanski, ""A Signal Theoretic Method for Creating Forgery-Proof Documents for Automatic Verification,"" Proceedings 1979 Carnahan Conference on Crime Countermeasures, May 16, 1979, pp. 101-109.;;Dautzenberg, ""Watermarking Images,"" Department of Microelectronics and Electrical Engineering, Trinity College Dublin, 47 pages, Oct. 1994.;;Szepanski, ""Additive Binary Data Transmission for Video Signals,"" Conference of the Communications Engineering Society, 1980, NTG Technical Reports, vol. 74, pp. 343-351. (German text and English translation enclosed).;;U.S. patent application Ser. No. 60/071,983, Levy, filed Jan. 20, 1998.;;U.S. patent application Ser. No. 09/404,291, Levy, filed Sep. 23, 1999.;;U.S. patent application Ser. No. 60/114,725, Levy, filed Dec. 31, 1998.;;U.S. patent application Ser. No. 09/234,780, Rhoads et al., filed Jan. 20, 1999.;;U.S. patent application Ser. No. 60/116,641, Cookson, filed Jan. 21, 1999.;;U.S. patent application Ser. No. 09/478,713, Cookson, filed Jan. 6, 2000.;;Cookson, Chris, General Principles of Music Uses on Portable Devices, presented to SDMI, Mar. 5, 1999.;;Winograd, J.M., ""Audio Watermarking Architecture for Secure Digital Music Distribution,"" a Proposal to the SDMI Portable Devices Working Group, by Aris Technologies, Inc., Mar. 26, 1999.;;Mintzer et al., ""Safeguarding Digital Library Contents and Users: Digital Watermarking,"" D-Lib Magazine, Dec. 1997, 12 pages.;;U.S. patent application Ser. No. 09/765,102, Shaw, filed Jan. 17, 2001.;;U.S. patent application Ser. No. 09/761,349, Rhoads, filed Jan. 16, 2001.;;U.S. patent application Ser. No. 09/761,280, Rhoads, Jan. 16, 2001.;;U.S. patent application Ser. No. 09/645,779, Tian et al., filed Aug. 24, 2000.;;U.S. patent application Ser. No. 09/689,226, Brunk, filed Oct. 11, 2000.;;U.S. patent application Ser. No. 09/689,250, Ahmed, filed Oct. 11, 2000.;;U.S. patent application Ser. No. 09/689,293, Tian et al., filed Oct. 11,2000.;;U.S. patent application Ser. No. 09/625,577, Carr et al., filed Jul. 25, 2000.;;U.S. patent application Ser. No. 09/574,726, Rhoads et al., filed May 18, 2000.;;U.S. patent application Ser. No. 09/562,524, Carr et al., filed May 1, 2000.;;U.S. patent application Ser. No. 09/498,223, Rhoads et al., filed Feb. 3, 2000.;;U.S. patent application Ser. No. 09/465,418, Rhoads et al., filed Dec. 16, 1999.;;U.S. patent application Ser. No. 09/431,990, Rhoads, filed Nov. 3, 1999.;;U.S. patent application Ser. No. 09/428,359, Davis et al., filed Oct. 28, 2000.;;U.S. patent application Ser. No. 09/342,972, Rhoads, filed Jun. 29, 1999.;;U.S. patent application Ser. No. 09/293,602, Rhoads, filed Apr. 15, 1999.;;U.S. patent application Ser. No. 09/293,601, Rhoads, filed Apr. 15, 1999.;;U.S. patent application Ser. No. 09/287,940, Rhoads, filed Apr. 7, 1999.;;U.S. patent application Ser. No. 09/185,380, Davis et al., filed Nov. 3, 1998.;;U.S. patent application Ser. No. 09/074,034, Rhoads, filed May 6, 1998.;;U.S. patent application Ser. No. 09/127,502, Rhoads, filed Jul. 31, 1998.;;U.S. patent application Ser. No. 60/082,228, Rhoads, filed Apr. 16, 1998.;;U.S. patent application Ser. No. 60/198,138, Alattar, filed Apr. 17, 2000.;;Audio Watermarking Architectures for Secure Digital Music Distribution, A Proposal to the SDMI Portable Devices Working Group by ARIS Technologies, Inc, Mar. 26, 1999, pp. 1-11.;;Audio Watermarking Architectures for Persistent Protection, Presentation to SDMI PDWG, Mar. 29, 1999, J. Winograd, Aris Techologies, pp 1-16.;;Audio Watermarking System to Screen Digital Audio Content for LCM Acceptance, A Proposal Submitted in Response to PDWG99050504-Transition CfP by ARIS Technologies, Inc., May 23, 1999, Document Version 1.0, 15 pages.;;Boland et al., ""Watermarking Digital Images for Copyright Protection"", Fifth Int'l Conference on Image Processing and it's Application, Jul. 1995, pp. 326-330.;;Levy, ""AIPL's Proposal for SDMI: An Underlying Security System"" (slide presentation), Mar. 29, 1999, 23 slides.",EXPIRED
492,US,A1,US 2009/0284268 A1,154-373-116-525-121,2009-11-19,2009,US 12176508 A,2008-05-15,US 12176508 A,2008-05-15,SLOT INTERPOSER PROBE,"The slot interposer probe consists of a board with a male edge connector and a female edge connector connected to its opposed edges and circuitry electrically connecting the male edge connector to the female edge connector. The female edge connector may be a straddle-mount connector. The board may have an inner layer sandwiched between two outer layers. There may be a probe having a high-speed buffer connected to a plurality of capacitors, isolation resistors, and vias that intercepts signals carried by transmission lines on the inner layer. The vias may have a length equal to the inner layer's width. The high-speed buffer receives intercepted signals from the vias, copies and amplifies the signals, and drives them through coaxial cables to an acquisition module. The invention also includes a method of intercepting signals between a first electrical device and a second electrical device.",TEKTRONIX INC,BURT DEVIN G;;O'BRIEN JOSHUA J;;KOCH DAVID W;;JONES ROXANN R,,https://lens.org/154-373-116-525-121,Patent Application,yes,1,4,2,2,0,G01R31/2808;;G06F11/2733;;G01R31/2808;;G06F11/2733,G01R31/28,324/555,0,0,,,,INACTIVE
493,US,A1,US 2002/0181737 A1,183-074-696-650-763,2002-12-05,2002,US 11884702 A,2002-04-08,US 11884702 A;;US 62940100 A;;US 34310499 A;;US 57142200 A,1999-06-29,Method of monitoring print data for text associated with a hyperlink,"
   By printing documents and other objects with machine readable indicia, such as steganographic digital watermarks or barcodes, a great variety of document management functions can be enabled. The indicia can be added as part of the printing process (after document data has been output by an originating application program), such as by printer driver software, by a Postscript engine in a printer, etc. The indicia can encode data about the document, or can encode an identifier that references a database record containing such data. By showing the printed document to a computer device with a suitable optical input device (e.g., a webcam), an electronic version of the document can be recalled for editing, or other responsive action can be taken. 
",SEDER PHILLIP ANDREW;;CARR J. SCOTT;;PERRY BURT W.;;RHOADS GEOFFREY B.,SEDER PHILLIP ANDREW;;CARR J SCOTT;;PERRY BURT W;;RHOADS GEOFFREY B,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC CORPORATION (2008-08-01);;DMRC LLC (2008-08-01),https://lens.org/183-074-696-650-763,Patent Application,yes,0,23,9,1547,0,G06Q10/10;;G06Q30/02;;G07F17/26;;G06Q30/02;;G06Q10/10;;G07F17/26,G06Q10/00;;G06Q30/00;;G07F17/26,3821,0,0,,,,EXPIRED
494,US,A,US 3996860 A,005-958-058-148-081,1976-12-14,1976,US 55572475 A,1975-03-06,US 55572475 A,1975-03-06,Vehicle end enclosure,"An enclosure for a vehicle end opening formed between two side walls includes two bi-fold door assemblies each comprising inner and outer panels pivotally connected to one another and with the free edge of the outer panels in turn connected to a fixed pivot point adjacent the side of the end opening wherein, each inner panel may be folded outwardly 180.degree. about its pivoted connecting means and the thus folded assembly subsequently pivoted about its fixed pivot point 270.degree. into parallel relationship with the vehicle side wall. The pivotal connecting means joining each pair of inner and outer panels includes catch means serving to secure the assembly in both the closed position enclosing the vehicle end opening as well as in the stored position parallel with the vehicle side wall.",PORTEC INC,RAVANI CHANDRAKANT D;;SCHLUCHTER RONALD G;;ROSTAFINSKI JAROSLAW J;;BURT CHARLES M,,https://lens.org/005-958-058-148-081,Granted Patent,yes,7,37,1,1,0,B60J5/108;;B61D17/06;;B60J5/108;;B61D17/06,B60J5/10;;B61D17/06,105368R,0,0,,,,EXPIRED
495,MX,A,MX PA06012357 A,025-215-381-552-840,2007-08-20,2007,MX PA06012357 A,2006-10-26,US 35786106 A,2006-02-21,CELLULOSE COATED STICK ELECTRODE.,"In a stick electrode for electric arc welding having a center alloy wire and an outer cellulose coating which coating includes powdered fluxing agents, alloy powder, cellulose powder and a binder. The improvement involves forming the binder as a solution of sodium silicate and 61-78 percent by weight of the binder. The binder comprises 25-35% of the coating to produce at least about 4% by weight of water in the electrode. Furthermore, the fluxing agent is titanium dioxide with a percentage greater than 12 percent of the coating.",LINCOLN GLOBAL INC,BURT RANDALL M;;CHIAPPONE JON P;;DALLAM CRAIG B;;WEAVER ROBERT J,,https://lens.org/025-215-381-552-840,Patent Application,no,0,0,11,11,0,B23K35/3602;;B23K35/3602;;B23K35/0261;;B23K35/0261;;B23K35/0266;;B23K35/0266;;B23K35/3053;;B23K35/3053;;B23K35/3608;;B23K35/3608;;B23K35/3613;;B23K35/3613;;B23K35/365;;B23K35/365,B23K35/00,,0,0,,,,ACTIVE
496,CN,C,CN 100591463 C,097-795-111-695-740,2010-02-24,2010,CN 200610137193 A,2006-10-23,US 35786106 A,2006-02-21,Improved cellulose coated stick electrode and its manufacture method,"In a stick electrode for electric arc welding having a center alloy wire and an outer cellulose coating which coating includes powdered fluxing agents, alloy powder, cellulose powder and a binder. Theimprovement involves forming the binder as a solution of sodium silicate and 61-78 percent by weight of the binder. The binder comprises 25-35% of the coating to produce at least about 4% by weight of water in the electrode. Furthermore, the fluxing agent is titanium dioxide with a percentage greater than 12 percent of the coating.",LINCOLN GLOBAL INC,BURT RANDALL M;;DALLAM CRAIG B;;CHIAPPONE JON P;;WEAVER ROBERT J,,https://lens.org/097-795-111-695-740,Granted Patent,no,0,0,11,11,0,B23K35/3602;;B23K35/3602;;B23K35/0261;;B23K35/0261;;B23K35/0266;;B23K35/0266;;B23K35/3053;;B23K35/3053;;B23K35/3608;;B23K35/3608;;B23K35/3613;;B23K35/3613;;B23K35/365;;B23K35/365,B23K35/365,,0,0,,,,INACTIVE
497,AU,A1,AU 2006/202605 A1,114-656-376-284-562,2007-09-06,2007,AU 2006/202605 A,2006-06-19,US 35786206 A,2006-02-21,Stick electrode,,LINCOLN GLOBAL INC,DALLAM CRAIG B;;BURT RANDALL M;;WEAVER ROBERT J;;CHIAPPONE JON P,,https://lens.org/114-656-376-284-562,Patent Application,no,0,0,13,13,0,B23K9/02;;B23K9/02;;B23K35/3053;;B23K35/368,B23K35/22,,0,0,,,,INACTIVE
498,EP,A4,EP 2855889 A4,117-747-896-867-422,2016-01-13,2016,EP 13801167 A,2013-05-29,US 201213487742 A;;US 2013/0042963 W,2012-06-04,SEAL LAND FOR STATIC STRUCTURE OF A GAS TURBINE ENGINE,,UNITED TECHNOLOGIES CORP,GORDON AMY M;;JAKIEL JONATHAN J;;BURT JONATHAN P;;PORTER STEVEN D,"RAYTHEON TECHNOLOGIES CORPORATION (N.D.GES.D.S, US (2022-09-23);;UNITED TECHNOLOGIES CORPORATION (2016-10-26)",https://lens.org/117-747-896-867-422,Search Report,no,4,0,6,6,0,F04D29/083;;F04D29/083;;F01D11/005;;F01D11/005;;F01D25/162;;F01D25/162;;F02C7/28;;F02C7/28;;F04D29/542;;F04D29/542,F02C7/28;;F01D11/00;;F01D25/16;;F02C3/00,,1,0,,,See also references of WO 2013184454A1,ACTIVE
499,MX,A,MX PA06014732 A,018-522-398-740-369,2008-10-09,2008,MX PA06014732 A,2006-12-15,US 35786206 A,2006-02-21,STICK ELECTRODE .,"A stick electrode for depositing an high strength weld metal bead on a workpiece where the yield strength of the weld metal is between 85 ksi and 125 ksi irrespective of the cooling rate. The electrode deposits weld metal having 0.80-1.85% by weight manganese, 0.25-0.50% by weight molybdenum, 1.25-2.50% by weight nickel, and less than 0.07% by weight carbon, wherein the ratios of the carbon, manganese and molybdenum are adjusted to provide a carbon equivalent in deposited weld metal in the range of 0.17 to 0.30 and preferably less than 0.22.",LINCOLN GLOBAL INC,BURT RANDALL M;;CHIAPPONE JON P;;DALLAM CRAIG B;;WEAVER ROBERT J,,https://lens.org/018-522-398-740-369,Patent Application,no,0,2,13,13,0,B23K9/02;;B23K9/02;;B23K35/3053;;B23K35/368,B23K35/00,,0,0,,,,ACTIVE
500,US,A1,US 2007/0193992 A1,169-015-159-084-738,2007-08-23,2007,US 35786306 A,2006-02-21,US 35786306 A,2006-02-21,Determining quality of a stick electrode,"A method of measuring the quality of a stick electrode used in forming the root bead of a pipe joint, which electrode has a wire diameter, a length substantially greater than 12 inches and an upper exposed rod head. The method comprises: preparing a standardized workpiece including two spaced plates with a groove between the plates having a set profile including a lower gap duplicating the root gap of the pipe joint and mounting the standardized workpiece on an incline with the groove facing upwardly where the incline is at a fixed known angle. Then a stick electrode of the type to be measured is selected and the rod head of the selected electrode is connected to the power lead of a DC power source set to a given output current correlated with the type of electrode. A root bead is laid in the gap from an upper start position on said workpiece by progressively filing the gap and then discontinuing the root bead welding at a lower end position when a given length of the electrode has been consumed; and, measuring the distance between the upper start position and the lower end position with the run out distance being indicative of a quality characteristic of the electrode. This method can be used to measure the run out per time instead of run out per electrode consumed length.",LINCOLN GLOBAL INC,BURT RANDALL M;;CHIAPPONE JON P;;DALLAM CRAIG B;;WEAVER ROBERT J,LINCOLN GLOBAL INC (2006-02-14),https://lens.org/169-015-159-084-738,Patent Application,yes,2,0,2,2,0,B23K9/0286;;B23K31/12;;B23K2101/10;;B23K9/0286;;B23K31/12;;B23K2101/10,B23K9/10,2191370PS,0,0,,,,INACTIVE
501,AU,B2,AU 2006/202605 B2,135-354-406-912-602,2008-10-23,2008,AU 2006/202605 A,2006-06-19,US 35786206 A,2006-02-21,Stick electrode,,LINCOLN GLOBAL INC,DALLAM CRAIG B;;BURT RANDALL M;;WEAVER ROBERT J;;CHIAPPONE JON P,,https://lens.org/135-354-406-912-602,Granted Patent,no,0,2,13,13,0,B23K9/02;;B23K9/02;;B23K35/3053;;B23K35/368,B23K35/22,,1,0,,,"Stick Electrode Product Catalogue,",INACTIVE
502,US,B2,US 9579751 B2,116-827-909-962-642,2017-02-28,2017,US 35786106 A,2006-02-21,US 35786106 A,2006-02-21,Cellulose coated stick electrode,"In a stick electrode for electric arc welding having a center alloy wire and an outer cellulose coating which coating includes powdered fluxing agents, alloy powder, cellulose powder and a binder. The improvement involves forming the binder as a solution of sodium silicate and 61-78 percent by weight of the binder. The binder comprises 25-35% of the coating to produce at least about 4% by weight of water in the electrode. Furthermore, the fluxing agent is titanium dioxide with a percentage greater than 12 percent of the coating.",BURT RANDALL M;;CHIAPPONE JON P;;DALLAM CRAIG B;;WEAVER ROBERT J;;LINCOLN GLOBAL INC,BURT RANDALL M;;CHIAPPONE JON P;;DALLAM CRAIG B;;WEAVER ROBERT J,LINCOLN GLOBAL INC (2006-02-14),https://lens.org/116-827-909-962-642,Granted Patent,yes,37,1,11,11,0,B23K35/3602;;B23K35/3602;;B23K35/0261;;B23K35/0261;;B23K35/0266;;B23K35/0266;;B23K35/3053;;B23K35/3053;;B23K35/3608;;B23K35/3608;;B23K35/3613;;B23K35/3613;;B23K35/365;;B23K35/365,B23K35/02;;B23K35/22;;B23K35/30;;B23K35/36;;B23K35/365,,0,0,,,,ACTIVE
503,EP,A1,EP 1820598 A1,194-381-440-676-635,2007-08-22,2007,EP 06026187 A,2006-12-18,US 35786106 A,2006-02-21,Improved cellulose coated stick electrode,"In a stick electrode (10) for electric arc welding having a center alloy wire (12) and an outer cellulose coating (20) which coating includes powdered fluxing agents, alloy powder, cellulose powder and a binder. The improvement involves forming the binder as a solution of sodium silicate and 61-78 percent by weight of the binder. The binder comprises 25-35% of the coating to produce at least about 4% by weight of water in the electrode (10). Furthermore, the fluxing agent is titanium dioxide with a percentage greater than 12 percent of the coating.
",LINCOLN GLOBAL INC,BURT RANDALL M;;DALLAM CRAIG B;;CHIAPPONE JON P;;WEAVER ROBERT J,"LINCOLN GLOBAL, INC. (2017-07-19)",https://lens.org/194-381-440-676-635,Patent Application,yes,6,0,11,11,0,B23K35/0261;;B23K35/0266;;B23K35/3608;;B23K35/3613;;B23K35/3053;;B23K35/365;;B23K35/3602;;B23K35/3053;;B23K35/365;;B23K35/0261;;B23K35/0266;;B23K35/3608;;B23K35/3613;;B23K35/3602,B23K35/36;;B23K35/02,,0,0,,,,DISCONTINUED
504,CA,C,CA 2550185 C,172-052-674-135-510,2010-10-26,2010,CA 2550185 A,2006-06-14,US 35786106 A,2006-02-21,IMPROVED CELLULOSE COATED STICK ELECTRODE,"In a stick electrode for electric arc welding having a center alloy wire and an outer cellulose coating which coating includes powdered fluxing agents, alloy powder, cellulose powder and a binder. The improvement involves forming the binder as a solution of sodium silicate and 61-78 percent by weight of the binder. The binder comprises 25-35% of the coating to produce at least about 4% by weight of water in the electrode. Furthermore, the fluxing agent is titanium dioxide with a percentage greater than 12 percent of the coating.",LINCOLN GLOBAL INC,BURT RANDALL M;;CHIAPPONE JON P;;DALLAM CRAIG B;;WEAVER ROBERT J,,https://lens.org/172-052-674-135-510,Granted Patent,no,0,0,11,11,0,B23K35/3602;;B23K35/3602;;B23K35/0261;;B23K35/0261;;B23K35/0266;;B23K35/0266;;B23K35/3053;;B23K35/3053;;B23K35/3608;;B23K35/3608;;B23K35/3613;;B23K35/3613;;B23K35/365;;B23K35/365,B23K35/362,,0,0,,,,INACTIVE
505,US,A1,US 2007/0193993 A1,186-226-344-162-87X,2007-08-23,2007,US 35786206 A,2006-02-21,US 35786206 A,2006-02-21,Stick electrode,"A stick electrode for depositing an high strength weld metal bead on a workpiece where the yield strength of the weld metal is between 85 ksi and 125 ksi irrespective of the cooling rate. The electrode deposits weld metal having 0.80-1.85% by weight manganese, 0.25-0.50% by weight molybdenum, 1.25-2.50% by weight nickel, and less than 0.07% by weight carbon, wherein the ratios of the carbon, manganese and molybdenum are adjusted to provide a carbon equivalent in deposited weld metal in the range of 0.17 to 0.30 and preferably less than 0.22.",LINCOLN GLOBAL INC,BURT RANDALL M;;CHIAPPONE JON P;;DALLAM CRAIG B;;WEAVER ROBERT J,LINCOLN GLOBAL INC (2006-02-14),https://lens.org/186-226-344-162-87X,Patent Application,yes,21,4,13,13,0,B23K9/02;;B23K9/02;;B23K35/3053;;B23K35/368,B23K35/22,2191370WM;;219/146.1,0,0,,,,ACTIVE
506,US,B2,US 6694043 B2,013-948-561-794-217,2004-02-17,2004,US 11884702 A,2002-04-08,US 11884702 A;;US 62940100 A;;US 34310499 A;;US 57142200 A,1999-06-29,Method of monitoring print data for text associated with a hyperlink,"
    By printing documents and other objects with machine readable indicia, such as steganographic digital watermarks or barcodes, a great variety of document management functions can be enabled. The indicia can be added as part of the printing process (after document data has been output by an originating application program), such as by printer driver software, by a Postscript engine in a printer, etc. The indicia can encode data about the document, or can encode an identifier that references a database record containing such data. By showing the printed document to a computer device with a suitable optical input device (e.g., a webcam), an electronic version of the document can be recalled for editing, or other responsive action can be taken. 
",DIGIMARC CORP,SEDER PHILLIP ANDREW;;CARR J SCOTT;;PERRY BURT W;;RHOADS GEOFFREY B,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC LLC (2008-08-01);;DMRC CORPORATION (2008-08-01),https://lens.org/013-948-561-794-217,Granted Patent,yes,107,190,9,1547,0,G06Q10/10;;G06Q30/02;;G07F17/26;;G06Q30/02;;G06Q10/10;;G07F17/26,G06Q10/00;;G06Q30/00;;G07F17/26,382/100;;358/3.28;;382/306,42,7,108-005-042-881-002;;054-431-441-479-71X;;155-569-330-453-350;;013-959-215-137-824;;125-269-942-420-346;;186-451-692-374-482;;067-155-203-760-737,10.1109/infcom.1994.337544;;10.1007/bf01202298;;10.1109/csac.1992.228224;;10.1045/december97-lotspiech;;10.1145/142750.143007;;10.1145/259963.260343;;10.1145/223904.223971,"U.S. patent application Ser. No. 09/074,034, Rhoads, filed May 5, 1998.;;U.S. patent application Ser. No. 09/127,502, Rhoads, filed Jul. 31, 1998.;;U.S. patent application Ser. No. 09/185,380, Davis et al., filed Nov. 3, 1998.;;U.S. patent application Ser. No. 09/314,648, Rodriguez et al., filed May 19, 1999.;;U.S. patent application Ser. No. 09/342,688, Rodriguez et al., filed Jun. 29, 1999.;;U.S. patent application Ser. No. 09/343,104, Rodriguez et al., Jun. 29, 1999.;;U.S. patent application Ser. No. 09/452,021, Davis et al., filed Nov. 30, 1999.;;U.S. patent application Ser. No. 09/503,881, Rhoads et al., filed May 14, 2000.;;U.S. patent application Ser. No. 09/515,826, Rodriguez, filed Feb. 29, 2000.;;U.S. patent application Ser. No. 09/571,422, Rhoads et al., filed May 15, 2000.;;U.S. patent application Ser. No. 09/790,322, Lofgren et al., filed Feb. 21, 2001.;;U.S. patent application Ser. No. 60/000,442, Hudetz, Jun. 20, 1995.;;Bartlett, et al., ""An Overview of High Water FBI Technology,"" Posted on Internet Mar. 22, 1996, 12 pages.;;Bethoney, ""A Lasting Way For Artists To Leave Their Mark,"" PCWeek, Dec. 11, 1996.;;Bloomberg, ""Embedding Digital Data on Paper in Iconic Text"" SPIE vol. 3027, Document Recognition IV, pp. 67-81 (1997).;;Brassil et al., ""Electronic Marking and Identification Techniques to Discourage Document Copying,"" Proceedings of INFOCOM '94 Conference on Computer, IEEE Commun. Soc Conference, Jun. 12-16, 1994, pp. 1278-1287.;;Bruckstein, A.M.: Richardson, T.J., ""A holographic transform domain image watermarking method,"" Circuits, Systems, and Signal Processing vol. 17, No. 3 p. 361-89, 1998. This paper includes an appendix containing an internal memo of Bell Labs, which according to the authors of the paper, was dated Sep. 1994.;;""Copyright Protection for Digital Images, Digital Fingerprinting from FBI,"" Highwater FBI brochure, 1995, 4 pages.;;Dautzenberg, ""Watermarking Images,"" Department of Microelectronics and Electrical Engineering, Trinity College Dublin, 47 pages, Oct. 1994.;;Digimarc presentation at RSA Conference, 1/96, 4 pages.;;Digital Media Monthly, Aug., 1996 (except re Highwater FBI). Digimarc Press Release (various), 1996-1998.;;""Digital Watermarks What Are They?"" Digimarc Corporation, 1997. Seybold Report on Internet Publishing, vol. 1, No. 4, Dec. 1996.;;""Distributing Uniform Resource Locators as Bar Code Images,"" IBM Technical Disclosure Bulletin, No. 39, No. 1, pp. 167-168, 96A 60059, published Jan. 1, 1996.;;Frequently Asked Questions about Digimarc Signature Technology, Aug. 1, 1995, 9 pages.;;IBM Technical Disclosure Bulletin 96A 61092, ""Graphic Coded Icon,"" published Jan. 1, 1996.;;""High Water FBI Limited Presentation Image Copyright Protection Software,"" FBI Ltd brochure, Jul., 1995, 17 pages.;;Johnson, et al., ""Bridging the Paper and Electronic Worlds: The Paper User Interface"", Interchi '93, pp. 507-512, Apr. 1993.;;Koch et al., ""Copyright Protection for Multimedia Data,"" Proc. of the International Conference on Digital Media and Electronic Publishing, Dec. 6-8, 1994, Leeds, U.K., 15 pages.;;Kurak et al., ""A Cautionary Note On Image Downgrading,"" 1992 IEEE, pp. 153-159.;;Mintzer et al., ""Safeguarding Digital libray Contents and Users,"" Digital Watermarking, D-Lib Magazine, Dec. 1997: ISSN 1082-9873.;;Newman, William, et al. ""A Desk Supporting Computer-Based Interaction with paper Documents,"" ACM Conference on Human Factors in Computing Systems (CHI '92) May 3-7, 1992, pp. 587-592.;;Peairs, ""Iconic Paper,"" Proceedings of the Third International Conference on Document Analysis and Recognition (ICDAR '95), pp. 1174-1179, 1995.;;Rao, et al. ""Protofoil: Storing and Finding the Information Worker's Paper Documents in an Electronic File Cabinet,"" Human Factors in Computing Systems (CHI '94), pp. 180-186, Boston, MA, Apr. 1994.;;Seybold Report on Publishing Systems, vol. 25, No. 6, 1996.;;Seybold Bulletin on Computer Publishing, Oct. 18, 1995 (except re Highwater FBI).;;Simone, ""A Digital Watermark for Images,"" PC Magazine Dec. 18, 1996.;;Szepanski, ""Additive Binary Data Transmission for Video Signals,"" Papers Presented at Conf. Of Comm. Engineering Soc. Sep. 30-Oct. 3, 1980, Technical Reports vol. 74, pp. 342-352.;;Szepanski, ""A Signal Theoretic Method for Creating Forgery-Proof Documents for Automatic Verification,"" Proceedings 1979 Carnahan Conference on Crime Countermeasures, May 16, 1979, pp. 101-109.;;Tirkel et al, ""Electronic Water Mark,"" DICTA-93, Macquarie University, Sydney, Australia, Dec., 1993, pp. 666-673.;;Whittaker, et al., ""Back to the Future: Pen and Paper Technology Supports Complex Group Coordination,"" CHI '95, Conference on Human Factors in Computing Systems, Denver, Colorado (May 7-11, 1995) (text copy obtained from ACM).;;Zhao, et al., ""A WWW Service to Embed and Prove Digital Copyright Watermarks,"" Fraunhofer Institute for Computer Graphics, Proc. of EU Conf. On Multimedia Applications, Services and Techniques, May 1996.;;Zhao et al., ""Embedding Robust Labels Into Images for Copyright Protection,"" Prof. of the International Congress on Intellectual Property Rights for Specialized Information, Knowledge and New Technologies (Vienna, Austria) Aug. 21-25, 1995, 10 pages.",EXPIRED
507,US,B1,US 6522770 B1,036-390-225-674-130,2003-02-18,2003,US 62940100 A,2000-08-01,US 62940100 A;;US 57142200 A;;US 34310499 A;;US 31464899 A,1999-05-19,Management of documents and other objects using optical devices,"
    By printing documents and other objects with machine readable indicia, such as steganographic digital watermarks or barcodes, a great variety of document management functions can be enabled. The indicia can be added as part of the printing process (after document data has been output by an originating application program), such as by printer driver software, by a Postscript engine in a printer, etc. The indicia can encode data about the document, or can encode an identifier that references a database record containing such data. By showing the printed document to a computer device with a suitable optical input device (e.g., a webcam), an electronic version of the document can be recalled for editing, or other responsive action can be taken. 
",DIGIMARC CORP,SEDER PHILLIP ANDREW;;CARR J SCOTT;;PERRY BURT W;;RHOADS GEOFFREY B,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC LLC (2008-08-01);;DMRC CORPORATION (2008-08-01),https://lens.org/036-390-225-674-130,Granted Patent,yes,111,321,9,1547,0,G06Q10/10;;G06Q30/02;;G07F17/26;;G06Q30/02;;G06Q10/10;;G07F17/26,G06Q10/00;;G06Q30/00;;G07F17/26,382/100;;235/375;;380/54;;382/306,20,3,013-959-215-137-824;;054-431-441-479-71X;;155-569-330-453-350,10.1045/december97-lotspiech;;10.1007/bf01202298;;10.1109/csac.1992.228224,"U.S. application No. 09/074,034, Rhoads, filed May 6, 1998.;;U.S. application No. 09/127,502, Rhoads, filed Jul. 31, 1998.;;U.S. application No. 09/185,380, Davis et al., filed Nov. 3, 1998.;;U.S. application No. 09/314,648, Rodriguez et al., filed May 19, 1999.;;U.S. application No. 09/342,688, Rodriguez et al., filed Jun. 29, 1999.;;U.S. application No. 09/343,104, Rodriguez et al., filed Jun. 29, 1999.;;U.S. application No. 09/452,021, Davis et al., filed Nov. 30, 1999.;;U.S. application No. 09/503,881. Rhoads et al., filed Feb. 14, 2000.;;U.S. application No. 09/571,422, Rhoads et al., filed May, 15, 2000.;;U.S. application No. 09/790,332, Lofgren et al., filed Feb. 21, 2001.;;60/000,442, Jun. 20, 1995, Hudetz.;;Mintzer et al., ""Safeguarding Digital library Contents and Users"" Digital Watermarking, D-Lib Magazine, Dec. 1997: ISSN 1082-9873.;;""Copyright Protection for Digital Images, Digital Fingerprinting from FBI,"" Highwater FBI brochure, 1995, 4 pages.;;""High Water FBI Limited Presentation Image Copyright Protection Software,"" FBI Ltd brochure, Jul. 1995, 17 pages.;;Dautzenberg, ""Watermarking Images,"" Department of Microelectronics and Electrical Engineering, Trinity College Dublin, 47 pages, Oct. 1994.;;Bruckstein, A.M.; Richardson, T.J., A holographic transform domain image watermarking method, Circuits, Systems, and Signal Processing vol. 17, No. 3, pp. 361-389, 1998. This paper includes an appendix containing and internal memo of Bell Labs, which according to the authors of the paper, was dated Sep. 1994.;;Szepanski, ""A Signal Theoretic Method for Creating Forgery-Proof Documents for Automatic Verification,"" Proceedings 1979 Carnahan Conference on Crime Countermeasures, May 16, 1979, pp. 101-109.;;Szepanski, ""Addictive Binary Data Transmission for Video Signals,"" Papers Presented at Conf. Of Comm. Engineering Soc. Sep. 30-Oct. 3, 1980, Technical Reports vol. 74, pp. 342-352.;;Tirkel et al, ""Electronic Water Mark,"" DICTA-93, Macquarie University, Sydney, Australia, Dec., 1993, pp. 666-673.;;Kurak et al., ""A Cautionary Note On Image Downgrading,"" 1992 IEEE, pp. 153-159.",EXPIRED
508,EP,B1,EP 2855889 B1,047-036-191-279-171,2018-03-14,2018,EP 13801167 A,2013-05-29,US 201213487742 A;;US 2013/0042963 W,2012-06-04,SEAL LAND FOR STATIC STRUCTURE OF A GAS TURBINE ENGINE,,UNITED TECHNOLOGIES CORP,GORDON AMY M;;JAKIEL JONATHAN J;;BURT JONATHAN P;;PORTER STEVEN D,"RAYTHEON TECHNOLOGIES CORPORATION (N.D.GES.D.S, US (2022-09-23);;UNITED TECHNOLOGIES CORPORATION (2016-10-26)",https://lens.org/047-036-191-279-171,Granted Patent,yes,9,0,6,6,0,F04D29/542;;F01D11/005;;F02C7/28;;F01D25/162;;F04D29/083;;F01D11/005;;F02C7/28;;F01D25/162;;F04D29/542;;F04D29/083,F02C7/28;;F01D11/00;;F01D25/16;;F02C3/00;;F04D29/08;;F04D29/54,,0,0,,,,ACTIVE
509,US,A1,US 2021/0157680 A1,172-758-818-862-800,2021-05-27,2021,US 201916692157 A,2019-11-22,US 201916692157 A,2019-11-22,PROTECTING STORAGE BACKUP CONFIGURATION,"Changing operational backup parameters on a storage system includes a first actor generating a request to change operational backup parameters, providing the request from the first actor to a second actor, the second actor authorizing the request, and modifying the operational backup parameters in response to the second actor authorizing the request. The first actor may be assigned a role that allows the first actor to generate the request to change operational backup parameters of the storage system and the second actor may be assigned a role that allows the second actor to authorize the request to change operational backup parameters of the storage system. The request may include a time window provided by the first actor. Authorizing a request to change operational backup parameters of the storage system may create a token and an authorization key. The token may be indicative of the request provided by the first actor.",EMC IP HOLDING CO LLC,LECRONE DOUGLAS E;;LINSTEAD PAUL A;;QUINN BRETT A;;BURT DENIS J,EMC IP HOLDING COMPANY LLC (2019-11-21),https://lens.org/172-758-818-862-800,Patent Application,yes,0,0,2,2,0,G06F21/6218;;G06F21/602;;G06F21/335;;G06F2201/84;;G06F11/1469;;G06F11/1451;;G06F11/1471;;G06F11/1469;;G06F11/1464;;G06F11/1461;;G06F21/6218;;G06F21/602;;G06F11/1448;;G06F21/107;;G06F21/1014,G06F11/14;;G06F21/60;;G06F21/62,,0,0,,,,ACTIVE
510,EP,A1,EP 2855889 A1,175-867-863-837-26X,2015-04-08,2015,EP 13801167 A,2013-05-29,US 201213487742 A;;US 2013/0042963 W,2012-06-04,SEAL LAND FOR STATIC STRUCTURE OF A GAS TURBINE ENGINE,,UNITED TECHNOLOGIES CORP,GORDON AMY M;;JAKIEL JONATHAN J;;BURT JONATHAN P;;PORTER STEVEN D,"RAYTHEON TECHNOLOGIES CORPORATION (N.D.GES.D.S, US (2022-09-23);;UNITED TECHNOLOGIES CORPORATION (2016-10-26)",https://lens.org/175-867-863-837-26X,Patent Application,yes,0,0,6,6,0,F04D29/083;;F04D29/083;;F01D11/005;;F01D11/005;;F01D25/162;;F01D25/162;;F02C7/28;;F02C7/28;;F04D29/542;;F04D29/542,F02C7/28;;F01D11/00;;F01D25/16;;F02C3/00,,0,0,,,,ACTIVE
511,CN,B,CN 101024261 B,189-780-847-959-976,2013-02-13,2013,CN 200610135790 A,2006-10-19,US 35786206 A,2006-02-21,Stick electrode,,LINCOLN GLOBAL INC,CHIAPPONE JON P;;DALLAM CRAIG B;;WEAVER ROBERT J;;BURT RANDALL M,,https://lens.org/189-780-847-959-976,Granted Patent,no,0,0,13,13,0,B23K9/02;;B23K9/02;;B23K35/3053;;B23K35/368,B23K35/22;;B23K9/12;;B23K9/235;;B23K35/02,,0,0,,,,INACTIVE
512,US,B2,US 7307238 B2,020-957-432-931-009,2007-12-11,2007,US 35786306 A,2006-02-21,US 35786306 A,2006-02-21,Determining quality of a stick electrode,"A method of measuring the quality of a stick electrode used in forming the root bead of a pipe joint, which electrode has a wire diameter, a length substantially greater than 12 inches and an upper exposed rod head. The method comprises: preparing a standardized workpiece including two spaced plates with a groove between the plates having a set profile including a lower gap duplicating the root gap of the pipe joint and mounting the standardized workpiece on an incline with the groove facing upwardly where the incline is at a fixed known angle. Then a stick electrode of the type to be measured is selected and the rod head of the selected electrode is connected to the power lead of a DC power source set to a given output current correlated with the type of electrode. A root bead is laid in the gap from an upper start position on said workpiece by progressively filing the gap and then discontinuing the root bead welding at a lower end position when a given length of the electrode has been consumed; and, measuring the distance between the upper start position and the lower end position with the run out distance being indicative of a quality characteristic of the electrode. This method can be used to measure the run out per time instead of run out per electrode consumed length.",LINCOLN GLOBAL INC,BURT RANDALL M;;CHIAPPONE JON P;;DALLAM CRAIG B;;WEAVER ROBERT J,LINCOLN GLOBAL INC (2006-02-14),https://lens.org/020-957-432-931-009,Granted Patent,yes,2,1,2,2,0,B23K9/0286;;B23K31/12;;B23K2101/10;;B23K9/0286;;B23K31/12;;B23K2101/10,B23K9/095,219/130.01;;X219137 R;;228/103,0,0,,,,INACTIVE
513,CA,A,CA 988726 A,059-417-402-866-961,1976-05-11,1976,CA 175930 A,1973-07-09,US 27031572 A,1972-07-10,FROZEN EMBANKMENTS,,ATLANTIC RICHFIELD CO,BURT GLENN R;;CONDO ALBERT C;;ELIASON KAY E;;MCCORMACK JOHN J,,https://lens.org/059-417-402-866-961,Granted Patent,no,0,1,2,3,0,E02D17/18;;E02D27/32;;E02D27/32;;E02D17/18,E02D17/18;;E02D27/32,61-45.1,0,0,,,,EXPIRED
514,CA,A,CA 1003653 A,122-867-616-600-238,1977-01-18,1977,CA 238199 A,1975-10-23,CA 238199 A;;CA 175930 A;;US 27031572 A,1972-07-10,FROZEN EMBANKMENTS,,ATLANTIC RICHFIELD CO,BURT GLENN R;;CONDO ALBERT C;;ELIASON KAY E;;MCCORMACK JOHN J,,https://lens.org/122-867-616-600-238,Granted Patent,no,0,0,1,3,0,,,61-45.1,0,0,,,,EXPIRED
515,US,A1,US 2013/0323046 A1,160-005-331-049-947,2013-12-05,2013,US 201213487742 A,2012-06-04,US 201213487742 A,2012-06-04,SEAL LAND FOR STATIC STRUCTURE OF A GAS TURBINE ENGINE,"A seal land for a gas turbine engine can include a seal body that can extend between a leading edge portion, a trailing edge portion, a radially outer surface and a radially inner surface. A notch can extend at least partially through the seal body between the radially outer surface and the radially inner surface.",GORDON AMY M;;JAKIEL JONATHAN J;;BURT JONATHAN P;;PORTER STEVEN D,GORDON AMY M;;JAKIEL JONATHAN J;;BURT JONATHAN P;;PORTER STEVEN D,RAYTHEON TECHNOLOGIES CORPORATION (2012-06-04),https://lens.org/160-005-331-049-947,Patent Application,yes,14,12,6,6,0,F04D29/083;;F04D29/083;;F01D11/005;;F01D11/005;;F01D25/162;;F01D25/162;;F02C7/28;;F02C7/28;;F04D29/542;;F04D29/542,F04D29/08,415/229,0,0,,,,ACTIVE
516,US,B2,US 9394915 B2,179-069-595-842-095,2016-07-19,2016,US 201213487742 A,2012-06-04,US 201213487742 A,2012-06-04,Seal land for static structure of a gas turbine engine,"A seal land for a gas turbine engine can include a seal body that can extend between a leading edge portion, a trailing edge portion, a radially outer surface and a radially inner surface. A notch can extend at least partially through the seal body between the radially outer surface and the radially inner surface.",GORDON AMY M;;JAKIEL JONATHAN J;;BURT JONATHAN P;;PORTER STEVEN D;;UNITED TECHNOLOGIES CORP,GORDON AMY M;;JAKIEL JONATHAN J;;BURT JONATHAN P;;PORTER STEVEN D,RAYTHEON TECHNOLOGIES CORPORATION (2012-06-04),https://lens.org/179-069-595-842-095,Granted Patent,yes,32,7,6,6,0,F04D29/083;;F04D29/083;;F01D11/005;;F01D11/005;;F01D25/162;;F01D25/162;;F02C7/28;;F02C7/28;;F04D29/542;;F04D29/542,F04D29/08;;F01D11/00;;F01D25/16;;F02C7/28;;F04D29/54,,3,0,,,"International Search Report and Written Opinion for International Application No. PCT/US2013/042963 dated Sep. 13, 2013.;;International Preliminary Report on Patentability for International Application No. PCT/US2013/042963 dated Dec. 18, 2014.;;Extended European Search Report for Application No. EP 13 80 1167 dated Dec. 10, 2015.",ACTIVE
517,US,A1,US 2006/0115495 A1,093-063-163-671-557,2006-06-01,2006,US 27139205 A,2005-11-11,US 27139205 A;;US 62737204 P;;US 70873205 P,2004-11-12,Protein-noble metal nanoparticles,The present invention is a composition and method of making protein-noble metal nanoparticles and methods for using the same as anti-virals.,UNIV TEXAS,YACAMAN MIGUEL J;;ELECHIGUERRA JOSE L;;LARA HUMBERTO H;;BURT JUSTIN L,BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (2006-01-18),https://lens.org/093-063-163-671-557,Patent Application,yes,7,12,5,12,0,A61K33/38;;A61K38/02;;B82Y5/00;;A61K47/52;;A61K47/6923;;A61K47/6929;;A61P31/12;;A61K33/242;;A61K33/243;;A61K38/02;;A61K33/38;;B82Y5/00;;A61K47/52;;A61K47/6929;;A61K47/6923;;A61K33/242;;A61K33/243,A61K39/12;;A61K33/242;;A61K33/243,424/204.1;;424/186.1,0,0,,,,DISCONTINUED
518,US,A1,US 2007/0194087 A1,141-826-717-097-780,2007-08-23,2007,US 36090106 A,2006-02-23,US 36090106 A,2006-02-23,Welding electrode rating method using double cap pass test,"Methods for rating welding electrodes are presented, in which a standardized vertical-down double cap pass welding procedure is performed using a test electrode to create a test weld on a substantially flat workpiece surface, and the electrode is rated according to the amount of porosity in the test weld. A first vertical-down bead-on-plate welding operation is performed to create a substantially straight first weld bead on the workpiece surface, followed by a standardized moderate first slag removal operation to expose an upper portion of the first bead while leaving some slag along one or both longitudinal sides of the first weld bead. A standardized second vertical-down welding operation is then performed with the test electrode to cover the first weld, and another slag removal operation is used to remove any remaining slag. The test electrode is then rated according to the ratio of the number of visually discernable pores in the second weld bead divided by the test weld length.",OGBORN JONATHAN S;;WEAVER ROBERT J;;DALLAM CRAIG B;;BURT RANDALL M,OGBORN JONATHAN S;;WEAVER ROBERT J;;DALLAM CRAIG B;;BURT RANDALL M,LINCOLN GLOBAL INC (2006-02-20),https://lens.org/141-826-717-097-780,Patent Application,yes,2,4,1,1,0,B23K35/0227;;B23K35/0227,B23K31/12,228/103,0,0,,,,DISCONTINUED
519,US,A1,US 2022/0236881 A1,165-221-918-921-51X,2022-07-28,2022,US 202117160465 A,2021-01-28,US 202117160465 A,2021-01-28,COPYING DATA BETWEEN STORAGE SYSTEMS,"Copying data from a source storage system to a target storage system includes resetting a write tracker on the source storage system to track writes to the source storage system by one or more host computing systems, copying data from the source storage system to the target storage system after resetting the write tracker, suspending writes to the source storage system after copying the data, and copying data portions of the source storage system to the target storage system that are indicated as being written by the write tracker after suspending writes to the source storage system. Applications that write data to the source storage system may be quiesced in connection with suspending writes to the source storage system. Data portions may be repeatedly copied from the source storage system to the target storage system until an end condition is reached.",EMC IP HOLDING CO LLC,LECRONE DOUGLAS E;;BURT DENIS J;;QUINN BRETT A;;LINSTEAD PAUL A,EMC IP HOLDING COMPANY LLC (2021-01-27),https://lens.org/165-221-918-921-51X,Patent Application,yes,8,0,2,2,0,G06F3/0617;;G06F3/065;;G06F3/067;;G06F3/0659;;G06F3/0634;;G06F3/065;;G06F3/067;;G06F3/0604,G06F3/06,,0,0,,,,ACTIVE
520,US,A1,US 2002/0164053 A1,035-985-082-035-169,2002-11-07,2002,US 11865302 A,2002-04-08,US 11865302 A;;US 62940100 A;;US 34310499 A;;US 57142200 A,1999-06-29,Methods for opening file on computer via optical sensing,"
   By printing documents and other objects with machine readable indicia, such as steganographic digital watermarks or barcodes, a great variety of document management functions can be enabled. The indicia can be added as part of the printing process (after document data has been output by an originating application program), such as by printer driver software, by a Postscript engine in a printer, etc. The indicia can encode data about the document, or can encode an identifier that references a database record containing such data. By showing the printed document to a computer device with a suitable optical input device (e.g., a webcam), an electronic version of the document can be recalled for editing, or other responsive action can be taken. 
",SEDER PHILLIP ANDREW;;CARR J. SCOTT;;PERRY BURT W.;;RHOADS GEOFFREY B.,SEDER PHILLIP ANDREW;;CARR J SCOTT;;PERRY BURT W;;RHOADS GEOFFREY B,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC CORPORATION (2008-08-01);;DMRC LLC (2008-08-01),https://lens.org/035-985-082-035-169,Patent Application,yes,0,88,9,1547,0,G06Q10/10;;G06Q30/02;;G07F17/26;;G06Q30/02;;G06Q10/10;;G07F17/26,G06Q10/00;;G06Q30/00;;G07F17/26,3821,0,0,,,,EXPIRED
521,BR,A,BR PI0602499 A,093-177-846-657-952,2007-11-06,2007,BR PI0602499 A,2006-07-03,US 35786106 A,2006-02-21,eletrodo de bastão revestido com celulose aperfeiçoado,"ELETRODO DE BASTãO REVESTIDO COM CELULOSE APERFEIçOADO. Em um eletrodo de bastão para soldagem a arco elétrico tendo um arame de liga central e um revestimento de celulose externo, cujo revestimento inclui agentes de fluxo pulverizados, pó de liga, pó de celulose e um aglutinante. O aperfeiçoamento envolve formar o aglutinante tomo uma solução de silicato de sódio e 61-78 por cento em peso do aglutinante. O aglutinante compreende 25-35% do revestimento para produzir pelo menos cerca de 4% em peso de água no eletrodo. Além do mais, o agente de fluxo é dióxido de titânio com uma porcentagem maior do que 12 por cento do revestimento.",LINCOLN GLOBAL INC,BURT RANDALL M;;CHIAPPONE JON P;;DALLAM CRAIG B;;WEAVER ROBERT J,,https://lens.org/093-177-846-657-952,Patent Application,no,0,0,11,11,0,B23K35/3602;;B23K35/3602;;B23K35/0261;;B23K35/0261;;B23K35/0266;;B23K35/0266;;B23K35/3053;;B23K35/3053;;B23K35/3608;;B23K35/3608;;B23K35/3613;;B23K35/3613;;B23K35/365;;B23K35/365,B23K35/36,,0,0,,,,DISCONTINUED
522,CA,A1,CA 2550185 A1,115-543-616-567-760,2007-08-21,2007,CA 2550185 A,2006-06-14,US 35786106 A,2006-02-21,IMPROVED CELLULOSE COATED STICK ELECTRODE,"In a stick electrode for electric arc welding having a center alloy wire and an outer cellulose coating which coating includes powdered fluxing agents, allo y powder, cellulose powder and a binder. The improvement involves forming the binder a s a solution of sodium silicate and 61-78 percent by weight of the binder. The binder comprises 25-35% of the coating to produce at least about 4% by weight of water in the electrode. Furthermore, the fluxing agent is titanium dioxide with a percentage greater than 12 percent of the coating.",LINCOLN GLOBAL INC,BURT RANDALL M;;DALLAM CRAIG B;;WEAVER ROBERT J;;CHIAPPONE JON P,,https://lens.org/115-543-616-567-760,Patent Application,no,0,0,11,11,0,B23K35/3602;;B23K35/3602;;B23K35/0261;;B23K35/0261;;B23K35/0266;;B23K35/0266;;B23K35/3053;;B23K35/3053;;B23K35/3608;;B23K35/3608;;B23K35/3613;;B23K35/3613;;B23K35/365;;B23K35/365,B23K35/362,,0,0,,,,INACTIVE
523,CN,A,CN 103028860 A,146-262-676-714-703,2013-04-10,2013,CN 201210572744 A,2006-10-19,US 35786206 A,2006-02-21,Stick electrode,"A stick electrode for depositing an high strength weld metal bead on a workpiece 10 where the yield strength of the weld metal is between 586 to 862 N/mm 2 (85 ksi to 125 ksi) irrespective of the cooling rate. The electrode deposits weld metal having 0.80 - 1.85% by weight manganese, 0.25 - 0.50% by weight molybdenum, 1.25 - 2.50% by weight nickel, and less than 0.07% by weight carbon, wherein the ratios of the carbon, manganese and molybdenum are adjusted to provide a carbon equivalent in deposited weld metal in the range of 0.17 to 0.30 and preferably less than 0.22.",LINCOLN GLOBAL INC,BURT RANDALL M;;CHIAPPONE JON P;;DALLAM CRAIG B;;WEAVER ROBERT J,,https://lens.org/146-262-676-714-703,Patent Application,no,1,0,13,13,0,B23K9/02;;B23K9/02;;B23K35/3053;;B23K35/368,B23K35/22;;B23K9/00,,1,0,,,"LINCOLN ELECTRIC: ""JETWELD LH-110M MR, AWS: E11018-M H4R, Low Hydrogen, Low Alloy Steel Stick Electrode"", 《STICK ELECTRODE PRODUCT CATALOG FOR MILD AND LOW ALLOY STEELS》",DISCONTINUED
524,NZ,A,NZ 505979 A,083-455-480-223-109,2003-09-26,2003,NZ 50597999 A,1999-06-07,US 8844898 P;;US 9307298 P;;US 31719899 A;;US 9912776 W,1998-06-08,"Multibinding antibacterial agents comprising 2 antibiotic or aglycone ligands, connected by a linker, capable of affecting cell wall synthesis or metabolism","Multibinding compounds that are antibacterial agents. The multibinding compounds contain two ligands covalently attached to a linker, wherein one ligand is a beta lactam antibiotic and the other ligand is an optionally substituted glycopeptide antibiotic.",THERAVANCE INC,GRIFFIN JOHN H;;MORAN EDMUND J;;CHRISTENSEN BURT G;;UDICE KEVIN J;;MU YONGQI;;PACE JOHN,"THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC, US (2014-08-07)",https://lens.org/083-455-480-223-109,Patent Application,no,0,0,86,429,0,A61K31/00;;C07C233/36;;C07C233/78;;C07C237/24;;C07C271/20;;C07C321/04;;C07C323/12;;C07C335/08;;C07C335/32;;C07D207/333;;C07D211/58;;C07D215/56;;C07D233/90;;C07D235/30;;C07D401/06;;C07D401/12;;C07D401/14;;C07D405/04;;C07D413/14;;C07D471/04;;C07D471/14;;C07D473/00;;C07D473/34;;C07D475/04;;C07D475/08;;C07D487/04;;C07D487/06;;C07D493/04;;C07D493/06;;C07H19/20;;C12Q1/26;;C12Q1/44;;C12Q1/48;;C12Q1/533;;C40B30/04;;C40B40/04;;G01N33/573;;G01N33/6842;;G01N33/6845;;G01N33/92;;G01N2500/00;;G01N2500/04;;G01N2800/044;;Y10S530/807;;C07C2603/18;;A61K47/60;;A61K47/54;;A61K47/55;;A61K47/552;;A61P31/04;;A61P31/18;;A61P37/02;;A61P43/00;;A61P5/14;;A61P3/10;;Y02A50/30;;C40B30/04;;G01N33/573;;C07D405/04;;C07D207/333;;C07C321/04;;G01N33/92;;C07C323/12;;C07D211/58;;C07D235/30;;C12Q1/48;;C12Q1/26;;C07C335/08;;C07D473/34;;C07D475/08;;C07C271/20;;C07D401/12;;C07D487/04;;C12Q1/44;;C07C233/78;;C07D471/04;;G01N2800/044;;C07C237/24;;C40B40/04;;C07D473/00;;C07D487/06;;C07D493/06;;C07D413/14;;C07D401/14;;A61K31/00;;C07D493/04;;C07D471/14;;C12Q1/533;;G01N33/6842;;G01N33/6845;;C07D401/06;;C07H19/20;;C07D215/56;;C07D475/04;;G01N2500/04;;C07C233/36;;G01N2500/00;;C07C335/32;;C07D233/90;;Y10S530/807;;A61K47/552;;A61K47/54;;C07C2603/18;;A61K47/60;;A61K47/55;;Y02A50/30,A01N57/34;;A61K31/00;;C07D499/44;;A61K31/357;;A61K31/397;;A61K31/407;;A61K31/421;;A61K31/424;;A61K31/431;;A61K31/439;;A61K31/444;;A61K31/4545;;A61K31/496;;A61K31/522;;A61K31/536;;A61K31/5377;;A61K31/546;;A61K31/551;;A61K31/65;;A61K31/7028;;A61K31/7034;;A61K31/7036;;A61K31/7042;;A61K31/7048;;A61K31/7052;;A61K31/7056;;A61K31/7064;;A61K31/7068;;A61K31/7072;;A61K38/00;;A61K39/00;;A61K39/395;;A61K39/44;;A61K47/48;;A61K51/00;;A61P31/04;;A61P31/18;;A61P43/00;;C07B61/00;;C07C233/36;;C07C233/78;;C07C237/24;;C07C237/26;;C07C271/20;;C07C275/42;;C07C321/04;;C07C323/12;;C07C335/08;;C07C335/32;;C07D207/32;;C07D207/333;;C07D211/58;;C07D215/56;;C07D233/90;;C07D235/30;;C07D263/28;;C07D265/18;;C07D401/06;;C07D401/12;;C07D401/14;;C07D405/04;;C07D413/14;;C07D453/02;;C07D471/04;;C07D471/14;;C07D473/00;;C07D473/34;;C07D475/04;;C07D475/08;;C07D477/00;;C07D487/04;;C07D487/06;;C07D493/04;;C07D493/06;;C07D495/04;;C07D498/04;;C07D498/18;;C07D501/20;;C07D519/00;;C07H15/236;;C07H15/238;;C07H15/26;;C07H17/08;;C07H19/06;;C07H19/20;;C07K2/00;;C07K4/00;;C12N9/99;;C12P19/38;;C12Q1/26;;C12Q1/44;;C12Q1/48;;C12Q1/533;;C40B30/04;;C40B40/04;;G01N33/15;;G01N33/50;;G01N33/53;;G01N33/543;;G01N33/566;;G01N33/573;;G01N33/68;;G01N33/92;;G01N37/00,,0,0,,,,DISCONTINUED
525,HK,A1,HK 1028737 A1,130-684-349-758-847,2001-03-02,2001,HK 00107829 A,2000-12-06,US 8844898 P;;US 9307298 P;;US 9912776 W,1998-06-08,Novel antibacterial agents,,THERAVANCE INC,GRIFFIN JOHN H;;MORAN EDMUND J;;CHRISTENSEN BURT G;;JUDICE J KEVIN;;MU YONGQI;;PACE JOHN,,https://lens.org/130-684-349-758-847,Patent Application,no,0,0,86,429,0,A61K31/00;;C07C233/36;;C07C233/78;;C07C237/24;;C07C271/20;;C07C321/04;;C07C323/12;;C07C335/08;;C07C335/32;;C07D207/333;;C07D211/58;;C07D215/56;;C07D233/90;;C07D235/30;;C07D401/06;;C07D401/12;;C07D401/14;;C07D405/04;;C07D413/14;;C07D471/04;;C07D471/14;;C07D473/00;;C07D473/34;;C07D475/04;;C07D475/08;;C07D487/04;;C07D487/06;;C07D493/04;;C07D493/06;;C07H19/20;;C12Q1/26;;C12Q1/44;;C12Q1/48;;C12Q1/533;;C40B30/04;;C40B40/04;;G01N33/573;;G01N33/6842;;G01N33/6845;;G01N33/92;;G01N2500/00;;G01N2500/04;;G01N2800/044;;Y10S530/807;;C07C2603/18;;A61K47/60;;A61K47/54;;A61K47/55;;A61K47/552;;A61P31/04;;A61P31/18;;A61P37/02;;A61P43/00;;A61P5/14;;A61P3/10;;Y02A50/30;;C40B30/04;;G01N33/573;;C07D405/04;;C07D207/333;;C07C321/04;;G01N33/92;;C07C323/12;;C07D211/58;;C07D235/30;;C12Q1/48;;C12Q1/26;;C07C335/08;;C07D473/34;;C07D475/08;;C07C271/20;;C07D401/12;;C07D487/04;;C12Q1/44;;C07C233/78;;C07D471/04;;G01N2800/044;;C07C237/24;;C40B40/04;;C07D473/00;;C07D487/06;;C07D493/06;;C07D413/14;;C07D401/14;;A61K31/00;;C07D493/04;;C07D471/14;;C12Q1/533;;G01N33/6842;;G01N33/6845;;C07D401/06;;C07H19/20;;C07D215/56;;C07D475/04;;G01N2500/04;;C07C233/36;;G01N2500/00;;C07C335/32;;C07D233/90;;Y10S530/807;;A61K47/552;;A61K47/54;;C07C2603/18;;A61K47/60;;A61K47/55;;Y02A50/30,C07D499/44;;A01N57/34;;A61K31/00;;A61K31/357;;A61K31/397;;A61K31/407;;A61K31/421;;A61K31/424;;A61K31/431;;A61K31/439;;A61K31/444;;A61K31/4545;;A61K31/496;;A61K31/522;;A61K31/536;;A61K31/5377;;A61K31/546;;A61K31/551;;A61K31/65;;A61K31/7028;;A61K31/7034;;A61K31/7036;;A61K31/7042;;A61K31/7048;;A61K31/7052;;A61K31/7056;;A61K31/7064;;A61K31/7068;;A61K31/7072;;A61K38/00;;A61K39/00;;A61K39/395;;A61K39/44;;A61K47/48;;A61K51/00;;A61P31/04;;A61P31/18;;A61P43/00;;C07B61/00;;C07C233/36;;C07C233/78;;C07C237/24;;C07C237/26;;C07C271/20;;C07C275/42;;C07C321/04;;C07C323/12;;C07C335/08;;C07C335/32;;C07D207/32;;C07D207/333;;C07D211/58;;C07D215/56;;C07D233/90;;C07D235/30;;C07D263/28;;C07D265/18;;C07D401/06;;C07D401/12;;C07D401/14;;C07D405/04;;C07D413/14;;C07D453/02;;C07D471/04;;C07D471/14;;C07D473/00;;C07D473/34;;C07D475/04;;C07D475/08;;C07D477/00;;C07D487/04;;C07D487/06;;C07D493/04;;C07D493/06;;C07D495/04;;C07D498/04;;C07D498/18;;C07D501/20;;C07D519/00;;C07H15/236;;C07H15/238;;C07H15/26;;C07H17/08;;C07H19/06;;C07H19/20;;C07K2/00;;C07K4/00;;C12N9/99;;C12P19/38;;C12Q1/26;;C12Q1/44;;C12Q1/48;;C12Q1/533;;C40B30/04;;C40B40/04;;G01N33/15;;G01N33/50;;G01N33/53;;G01N33/543;;G01N33/566;;G01N33/573;;G01N33/68;;G01N33/92;;G01N37/00,,0,0,,,,DISCONTINUED
526,EP,A4,EP 0792494 A4,006-755-055-034-544,1998-12-02,1998,EP 95939674 A,1995-11-14,US 9514130 W;;US 33949194 A,1994-11-14,MOSAIC BASED IMAGE PROCESSING SYSTEM AND METHOD FOR PROCESSING IMAGES,,SARNOFF DAVID RES CENTER,BURT PETER J;;IRANI MICHAL;;HSU STEPHEN C;;ANANDAN PADMANABHAN;;HANSEN MICHAEL W,SARNOFF CORPORATION (1997-10-01),https://lens.org/006-755-055-034-544,Search Report,no,0,0,16,18,0,G06T3/4038;;G06T11/00;;H04N5/781;;H04N5/85;;H04N9/8047;;H04N19/503;;H04N19/30;;H04N19/63;;H04N19/61;;H04N19/20;;H04N19/23;;G06V10/16;;G06V10/24;;G06V10/20;;H04N9/8047;;G06T11/00;;H04N5/781;;H04N5/85;;G06T3/4038;;H04N19/63;;H04N19/30;;H04N19/503;;H04N19/20;;H04N19/61;;H04N19/23;;G06V10/24;;G06V10/16,G06T3/00;;H04N5/262;;G06T9/00;;G06T11/00;;G06V10/24;;H03M7/36;;H04N1/387;;H04N5/781;;H04N5/85;;H04N5/91;;H04N7/167;;H04N7/18;;H04N7/26;;H04N7/30;;H04N7/36;;H04N7/50;;H04N9/804;;H04N21/4402;;H04N21/854,,3,2,007-860-411-309-438;;081-799-446-362-099,10.1007/bf01210504;;10.1109/acv.1994.341287,"HONGJIANG ZHANG ET AL: ""AUTOMATIC PARTITIONING OF FULL-MOTION VIDEO"", MULTIMEDIA SYSTEMS, vol. 1, no. 1, 1 January 1993 (1993-01-01), pages 10 - 28, XP000572496;;R. SZELISKI: ""IMAGE MOSAICING FOR TELE-REALITY APPLICATIONS"", DEC CAMBRIDGE RESEARCH LAB - REPORT CRL 94/2, May 1994 (1994-05-01), XP002048809;;See also references of WO 9615508A1",EXPIRED
527,JP,A,JP 2002191051 A,063-931-945-573-539,2002-07-05,2002,JP 2001270749 A,2001-09-06,US 33949194 A,1994-11-14,"COMPRESSION SYSTEM, MONITOR SYSTEM, AND METHOD FOR DETECTING SCENE CHANGE","PROBLEM TO BE SOLVED: To provide a comprehensive system for detecting remote motion by combining a monitor system, a mosaic buildup system, a compression system and a display system. SOLUTION: An image processing system 100 on the basis of mosaics from a plurality of input images executes an image arrangement step, an edit step and a combining step to generate seamless mosaics for various applications from a series of the images. The mosaic based compression system 110 utilizes spatiotemporal redundancy in a series of the images to efficiently compress the image information. The mosaic based compression system 110 can be used to compress the image information for a storage device or used to compress the image information for transfer through a transfer channel limited in band. The monitor system 108 combines a mosaic buildup system 102, the compression system 110 and a display system 106 into a comprehensive system to detect remote motion.",SARNOFF CORP,BURT PETER J;;IRANI MICHAL;;HSU STEPHEN C;;ANANDAN PADMANABHAN;;HANSEN MICHAEL W,,https://lens.org/063-931-945-573-539,Patent Application,no,11,0,16,18,0,G06T3/4038;;G06T11/00;;H04N5/781;;H04N5/85;;H04N9/8047;;H04N19/503;;H04N19/30;;H04N19/63;;H04N19/61;;H04N19/20;;H04N19/23;;G06V10/16;;G06V10/24;;G06V10/20;;H04N9/8047;;G06T11/00;;H04N5/781;;H04N5/85;;G06T3/4038;;H04N19/63;;H04N19/30;;H04N19/503;;H04N19/20;;H04N19/61;;H04N19/23;;G06V10/24;;G06V10/16,G06T3/00;;G06T9/00;;G06T11/00;;G06V10/24;;H03M7/36;;H04N1/387;;H04N5/262;;H04N5/781;;H04N5/85;;H04N5/91;;H04N7/167;;H04N7/18;;H04N7/26;;H04N7/30;;H04N7/36;;H04N7/50;;H04N9/804;;H04N21/4402;;H04N21/854,,0,0,,,,DISCONTINUED
528,US,B2,US 11443065 B2,159-658-401-888-803,2022-09-13,2022,US 202016843487 A,2020-04-08,US 202016843487 A;;US 201962831129 P,2019-04-08,Systems and methods for obscuring data from a data source,"Systems and methods for obscuring data from a data source include devices and processes that may objectively measure the information loss for a dataset that is caused by applying a privacy policy, and may select and apply a policy to the dataset based on the measured information loss. The systems and methods may measure the information loss for a large dataset by taking a representative sample from the dataset and applying the policy to the sample in order to quantify the information loss. The quantified information loss can be iteratively used to change the policy in order to meet utility and/or privacy goals, and the system can subsequently apply the changed policy to the dataset.",IMMUTA INC,REGENSBURGER JOSEPH J;;BURT ANDREW D;;HAMMEN BARRY R;;ROSSI III ALFRED V,IMMUTA INC (2020-04-21),https://lens.org/159-658-401-888-803,Granted Patent,yes,10,2,4,4,0,G06F21/6254;;G06F17/18;;G06F21/6254,G06F21/62;;G06F17/18,,0,0,,,,ACTIVE
529,EP,B1,EP 0792494 B1,190-707-204-030-80X,2003-02-12,2003,EP 95939674 A,1995-11-14,US 9514130 W;;US 33949194 A,1994-11-14,MOSAIC BASED IMAGE PROCESSING SYSTEM AND METHOD FOR PROCESSING IMAGES,,SARNOFF CORP,BURT PETER J;;IRANI MICHAL;;HSU STEPHEN C;;ANANDAN PADMANABHAN;;HANSEN MICHAEL W,SARNOFF CORPORATION (1997-10-01),https://lens.org/190-707-204-030-80X,Granted Patent,yes,7,0,16,18,0,G06T3/4038;;G06T11/00;;H04N5/781;;H04N5/85;;H04N9/8047;;H04N19/503;;H04N19/30;;H04N19/63;;H04N19/61;;H04N19/20;;H04N19/23;;G06V10/16;;G06V10/24;;G06V10/20;;H04N9/8047;;G06T11/00;;H04N5/781;;H04N5/85;;G06T3/4038;;H04N19/63;;H04N19/30;;H04N19/503;;H04N19/20;;H04N19/61;;H04N19/23;;G06V10/24;;G06V10/16,G06T3/00;;G06T9/00;;H04N5/262;;G06T11/00;;G06V10/24;;H03M7/36;;H04N1/387;;H04N5/781;;H04N5/85;;H04N5/91;;H04N7/167;;H04N7/18;;H04N7/26;;H04N7/30;;H04N7/36;;H04N7/50;;H04N9/804;;H04N21/4402;;H04N21/854,,2,0,,,"HONGJIANG ZHANG ET AL: ""AUTOMATIC PARTITIONING OF FULL-MOTION VIDEO"" MULTIMEDIA SYSTEMS, vol. 1, no. 1, 1 January 1993, pages 10-28, XP000572496;;DEC CAMBRIDGE RESEARCH LAB - REPORT CRL 94/2 R. SZELISKI: 'IMAGE MOSAICING FOR TELE-REALITY APPLICATIONS' May 1994,, XP002048809",EXPIRED
530,WO,A2,WO 2008/031089 A2,024-521-981-001-750,2008-03-13,2008,US 2007/0077997 W,2007-09-10,US 84312206 P,2006-09-08,SYSTEM AND METHOD FOR HIGH PERFORMANCE IMAGE PROCESSING,"The present invention provides a method and a system for high performance image signal processing of continuous images in real time. The system comprising a focal plane array for generating continuous source image frames in real time. The focal plane array divided logically into blocks of sub-frames. The system also comprising an analog to digital converter (ADC) layer having an array of ADC elements for converting the source image frames into a digital data. The system further comprising a digital processor layer having an array of processing elements for processing the digital data and an interconnecting layer for connecting each one of the ADC elements and the digital processing elements substantially vertically to the focal plane and substantially parallel to one another. The processing comprising reducing image motion blur, increasing image dynamic range, increasing image depth of field and obtaining features of the images.",SARNOFF CORP;;BURT PETER J;;TOWER JOHN ROBERTSON;;VAN DER WAL GOOITZEN;;ACKERMAN DAVID ALAN,BURT PETER J;;TOWER JOHN ROBERTSON;;VAN DER WAL GOOITZEN;;ACKERMAN DAVID ALAN,,https://lens.org/024-521-981-001-750,Patent Application,yes,0,10,4,4,0,H04N5/33;;H04N23/959;;H04N23/676;;H04N23/951;;H04N23/68;;H04N23/6811;;H04N23/683;;H04N23/741;;H04N23/743;;H04N25/57;;H04N25/00;;H04N5/33;;H04N25/00;;H04N23/68;;H04N23/676;;H04N23/683;;H04N23/741;;H04N23/743;;H04N23/951;;H04N23/959;;H04N23/6811;;H04N25/57,G06K9/40;;G06K9/36,,0,0,,,,PENDING
531,US,A1,US 2023/0004678 A1,170-786-210-419-128,2023-01-05,2023,US 202217942417 A,2022-09-12,US 202217942417 A;;US 202016843487 A;;US 201962831129 P,2019-04-08,SYSTEMS AND METHODS FOR OBSCURING DATA FROM A DATA SOURCE,"Systems and methods for obscuring data from a data source include devices and processes that may objectively measure the information loss for the data source that is caused by applying a privacy policy, and may apply a policy to the data source based on the measured information loss. The systems and methods may measure the information loss for a large data source by taking a representative sample from the data source and applying the policy to the sample in order to quantify the information loss. The quantified information loss can be iteratively used to change the policy in order to meet utility and/or privacy goals, and the system can subsequently apply the changed policy to the data source.",IMMUTA INC,REGENSBURGER JOSEPH J;;BURT ANDREW D;;HAMMEN BARRY R;;ROSSI III ALFRED V,IMMUTA INC (2020-04-21),https://lens.org/170-786-210-419-128,Patent Application,yes,11,0,4,4,0,G06F21/6254;;G06F17/18;;G06F21/6254,G06F21/62;;G06F17/18,,0,0,,,,ACTIVE
532,WO,A1,WO 1996/015508 A1,169-724-018-942-163,1996-05-23,1996,US 9514130 W,1995-11-14,US 33949194 A,1994-11-14,MOSAIC BASED IMAGE PROCESSING SYSTEM AND METHOD FOR PROCESSING IMAGES,"A system (100) for automatically generating a mosaic from a plurality of input images. The system sequentially executes an image alignment process, an editing process, and a combining process such that, from a sequence of images (902), the system automaticallyproduces a seamless mosaic (904) for various applications. Illustrative applications for the mosaic include a mosaic based display system (104) including an image printing system, a surveillance system (108) and a mosaic based compression system (110). The mosaic based display system (104) permits a system user to display, manipulate and alter a mosaic. The mosaic based compression system(110) exploits the temporal and spatial redundancy in image sequences and efficiently compresses the image information. The compression system (110) can be used for compressing image information for storage in a storage device or can be used for compressing image information for transmission through a band-limited transmission channel. The surveillance system (108) combines the mosaic construction system, the compression system and the display system into a comprehensive system for remote motion detection.",SARNOFF DAVID RES CENTER,BURT PETER J;;IRANI MICHAL;;HSU STEPHEN C;;ANANDAN PADMANABHAN;;HANSEN MICHAEL W,,https://lens.org/169-724-018-942-163,Patent Application,yes,7,14,16,18,0,G06T3/4038;;G06T11/00;;H04N5/781;;H04N5/85;;H04N9/8047;;H04N19/503;;H04N19/30;;H04N19/63;;H04N19/61;;H04N19/20;;H04N19/23;;G06V10/16;;G06V10/24;;G06V10/20;;H04N9/8047;;G06T11/00;;H04N5/781;;H04N5/85;;G06T3/4038;;H04N19/63;;H04N19/30;;H04N19/503;;H04N19/20;;H04N19/61;;H04N19/23;;G06V10/24;;G06V10/16,G06T3/00;;G06T9/00;;H04N5/262;;G06T11/00;;G06V10/24;;H03M7/36;;H04N1/387;;H04N5/781;;H04N5/85;;H04N5/91;;H04N7/167;;H04N7/18;;H04N7/26;;H04N7/30;;H04N7/36;;H04N7/50;;H04N9/804;;H04N21/4402;;H04N21/854,,1,0,,,See also references of EP 0792494A4,PATENTED
533,US,A,US 5136075 A,068-394-446-476-487,1992-08-04,1992,US 72359491 A,1991-07-01,US 72359491 A;;US 23940988 A;;US 48778790 A,1988-09-01,Process for transhalogenating a halophosphorus compound with fluoride,"Phosphorus compounds having at least one chlorine, bromine or iodine bonded directly to phosphorus are transhalogenated with fluorine by reaction with anhydrous hydrogen fluoride in an inert solvent, e.g., xylene, methylene chloride, in a manner such that said anhydrous hydrogen fluoride is added to said phosphorus compound at a rate such that said anhydrous hydrogen fluoride reacts with said phosphorus compound without the accumulation of an amount of unreacted anhydrous hydrogen fluoride which is sufficient to cause substantial decomposition of the desired fluorophosphorus product. A catalytic amount of a pyridine-type compound may optionally included in the reaction.",ETHYL CORP,BURT EDWARD A;;BURTON LESTER P J;;AO MENG-SHENG;;STAHLY BARBARA C,ALBERMARLE CORPORATION (1994-02-28),https://lens.org/068-394-446-476-487,Granted Patent,yes,1,1,1,10,0,C07F9/146;;C07F9/146;;C07F9/65744;;C07F9/65744,C07F9/146;;C07F9/6574,558/84;;558/140,0,0,,,,EXPIRED
534,US,S,US D0691235 S,098-044-809-537-532,2013-10-08,2013,US 201229424972 F,2012-06-18,US 201229424972 F,2012-06-18,Rail cover with surface depressions,,FITZPATRICK RICHARD;;MAYBERRY MICHAEL T;;KERBS JEREMY;;BURT ERIC CHRISTOPHER;;BARANELLO MICHAEL J;;MAGPUL IND CORP,FITZPATRICK RICHARD;;MAYBERRY MICHAEL T;;KERBS JEREMY;;BURT ERIC CHRISTOPHER;;BARANELLO MICHAEL J,MAGPUL INDUSTRIES CORPORATION (2012-06-27),https://lens.org/098-044-809-537-532,Design Right,no,0,5,1,1,0,,,2201;;D22/108,0,0,,,,ACTIVE
535,CA,A1,CA 2205177 A1,193-268-650-491-46X,1996-05-23,1996,CA 2205177 A,1995-11-14,US 33949194 A;;US 9514130 W,1994-11-14,MOSAIC BASED IMAGE PROCESSING SYSTEM AND METHOD FOR PROCESSING IMAGES,"A system (100) for automatically generating a mosaic from a plurality of input images. The system sequentially executes an image alignment process, an editing process, and a combining process such that, from a sequence of images (902), the system automaticallyproduces a seamless mosaic (904) for various applications. Illustrative applications for the mosaic include a mosaic based display system (104) including an image printing system, a surveillance system (108) and a mosaic based compression system (110). The mosaic based display system (104) permits a system user to display, manipulate and alter a mosaic. The mosaic based compression system(110) exploits the temporal and spatial redundancy in image sequences and efficiently compresses the image information. The compression system (110) can be used for compressing image information for storage in a storage device or can be used for compressing image information for transmission through a band-limited transmission channel. The surveillance system (108) combines the mosaic construction system, the compression system and the display system into a comprehensive system for remote motion detection.",SARNOFF DAVID RES CENTER,HANSEN MICHAEL W;;IRANI MICHAL;;ANANDAN PADMANABHAN;;BURT PETER J;;HSU STEPHEN C,,https://lens.org/193-268-650-491-46X,Patent Application,no,0,0,16,18,0,G06T3/4038;;G06T11/00;;H04N5/781;;H04N5/85;;H04N9/8047;;H04N19/503;;H04N19/30;;H04N19/63;;H04N19/61;;H04N19/20;;H04N19/23;;G06V10/16;;G06V10/24;;G06V10/20;;H04N9/8047;;G06T11/00;;H04N5/781;;H04N5/85;;G06T3/4038;;H04N19/63;;H04N19/30;;H04N19/503;;H04N19/20;;H04N19/61;;H04N19/23;;G06V10/24;;G06V10/16,H04N5/262;;G06T3/00;;G06T9/00;;G06T11/00;;G06V10/24;;H03M7/36;;H04N1/387;;H04N5/781;;H04N5/85;;H04N5/91;;H04N7/167;;H04N7/18;;H04N7/26;;H04N7/30;;H04N7/36;;H04N7/50;;H04N9/804;;H04N21/4402;;H04N21/854,,0,0,,,,EXPIRED
536,US,A1,US 2020/0320224 A1,163-008-414-225-056,2020-10-08,2020,US 202016843487 A,2020-04-08,US 202016843487 A;;US 201962831129 P,2019-04-08,SYSTEMS AND METHODS FOR OBSCURING DATA FROM A DATA SOURCE,"Systems and methods for obscuring data from a data source include devices and processes that may objectively measure the information loss for a dataset that is caused by applying a privacy policy, and may select and apply a policy to the dataset based on the measured information loss. The systems and methods may measure the information loss for a large dataset by taking a representative sample from the dataset and applying the policy to the sample in order to quantify the information loss. The quantified information loss can be iteratively used to change the policy in order to meet utility and/or privacy goals, and the system can subsequently apply the changed policy to the dataset.",IMMUTA INC,REGENSBURGER JOSEPH J;;BURT ANDREW D;;HAMMEN BARRY R;;ROSSI III ALFRED V,IMMUTA INC (2020-04-21),https://lens.org/163-008-414-225-056,Patent Application,yes,0,9,4,4,0,G06F21/6254;;G06F17/18;;G06F21/6254,G06F21/62;;G06F17/18,,0,0,,,,ACTIVE
537,US,A,US 4908301 A,076-015-472-400-539,1990-03-13,1990,US 30871389 A,1989-02-10,US 30871389 A;;US 17161488 A,1988-03-23,"Color-self-developing, microcapsular toner particles","This, invention relates to electrostatic imaging systems, and, more particularly, color-self-developing toner particles and processes for the fabrication and use thereof. A blend of these toner particles is useful in multicolor electrostatic imaging using a single dry or liquid toner bath. Potential applications include full-color xerographic copying, full-color printing, full-color computer-generated imaging, and the like.",OLIN CORP,GROSSO PAUL V;;MORGAN MICHAEL J;;WING JR FEAGIN A;;BURT WILLIARD F,OLIN CORPORATION A CORP. OF VA (1989-02-06),https://lens.org/076-015-472-400-539,Granted Patent,yes,53,15,1,16,0,G03G9/08;;G03G13/0131;;G03G9/08;;G03G9/09;;G03G9/09;;G03G9/0928;;G03G9/0928;;G03G9/093;;G03G9/093;;G03G13/0131;;G03G13/0133;;G03G13/0133,G03G9/08;;G03G9/09;;G03G9/093;;G03G13/01,430/45;;430/42;;430/46;;430/47;;430/106;;430/114;;430/137;;430/138,2,1,038-635-128-023-200,10.1021/cen-v066n002.p023,"Chemical Week, Mead Brings Color to Business , Dec. 13, 1987, pp. 32 33.;;Chemical and Engineering News, New Color Technology Uses Microcapsules , Jan. 11, 1988, p. 23.",EXPIRED
538,US,A,US 5991444 A,091-715-368-767-622,1999-11-23,1999,US 88228097 A,1997-06-25,US 88228097 A;;US 33949194 A,1994-11-14,Method and apparatus for performing mosaic based image compression,"A system for automatically generating a mosaic from a plurality of input images. The system sequentially executes an image alignment process, an editing process, and a combining process such that, from a sequence of images, the system automatically produces a seamless mosaic for various applications. Illustrative applications for the mosaic include: (1) a mosaic based display system including an image printing system, (2) a surveillance system and (3) a mosaic based compression system. The mosaic based display system permits a system user to display, manipulate and alter a mosaic. The mosaic based compression system exploits the temporal and spatial redundancy in image sequences and efficiently compresses the image information. The compression system can be used for compressing image information for storage in a storage device or can be used for compressing image information for transmission through a band-limited transmission channel. The surveillance system combines the mosaic construction system, the compression system and the display system into a comprehensive system for remote motion detection.",SARNOFF CORP,BURT PETER J;;IRANI MICHAL;;HSU STEPHEN CHARLES;;ANANDAN PADMANABHAN;;HANSEN MICHAEL W,SARNOFF CORPORATION (1997-04-04),https://lens.org/091-715-368-767-622,Granted Patent,yes,13,214,16,18,0,G06T3/4038;;G06T11/00;;H04N5/781;;H04N5/85;;H04N9/8047;;H04N19/503;;H04N19/30;;H04N19/63;;H04N19/61;;H04N19/20;;H04N19/23;;G06V10/16;;G06V10/24;;G06V10/20;;H04N9/8047;;G06T11/00;;H04N5/781;;H04N5/85;;G06T3/4038;;H04N19/63;;H04N19/30;;H04N19/503;;H04N19/20;;H04N19/61;;H04N19/23;;G06V10/24;;G06V10/16,G06T3/00;;G06T9/00;;H04N5/262;;G06T11/00;;G06V10/24;;H03M7/36;;H04N1/387;;H04N5/781;;H04N5/85;;H04N5/91;;H04N7/167;;H04N7/18;;H04N7/26;;H04N7/30;;H04N7/36;;H04N7/50;;H04N9/804;;H04N21/4402;;H04N21/854,382/232;;382/284,10,7,098-173-496-566-324;;143-502-655-624-03X;;042-689-645-533-661;;059-009-996-238-125;;010-396-006-264-864;;068-925-363-822-866;;122-254-846-573-384,10.1109/iccv.1993.378222;;10.1117/12.966501;;10.1145/245.247;;10.1109/mmcs.1994.292488;;18291954;;10.1109/83.334983;;10.1007/3-540-57956-7_52;;10.1109/83.370675;;18289995,"Michal Irani, Isolating Multiple 2D Image Motions for Image Enhancement and for 3D Motion Analysis , Hebrew University of Jerusalem, 1993.;;Burt et al., Enhanced Image Capture Through Fusion , International Conference on Computer Vision Proceedings, 1993.;;Burt et al., Merging Images Through Pattern Decomposition , Applications of Digital Processing VIII, SPIE, vol. 575, pp. 173 181, 1985.;;Burt et al., A Multiresolution Spline With Application to Image Mosaics , ACM Transactions on Graphics, vol. 2, No. 4, pp. 217 236, Oct. 1983.;;Bove et al., Real Time Decoding and Display of Structured Video , IEEE ICMCS, May 1994.;;Lundmark et al., Image Sequence Coding at Very Low Bitrates: A Review , IEEE Transactions on Image Processing, vol. 3, No. 5, pp. 589 609, Sep. 1994.;;McLean, Structured Video Coding , Massachusetts Institute of Technology, 1991.;;Bergen et al., Hierarchical Model Based Motion Estimation , Proceedings of European Conference on Computer Vision, Mar. 23, 1992.;;Hartley, Richard I., Self Calibration from Multiple Views with a Rotating Camera , Lecture Notes in Computer Science , vol. 800, pp.471 478, 1994.;;Sun, Huifang and Kwok, Wilson, Concealment of Damaged Block Transform Coded Images Using Projections onto Convex Sets , IEEE Transactions on Image Processing , vol 4, No. 4, Apr. 1995, pp. 470 477.",EXPIRED
539,US,S,US D0676920 S,089-796-348-647-936,2013-02-26,2013,US 201129400006 F,2011-08-22,US 201129400006 F,2011-08-22,Rail cover half,,MAGPUL IND CORP;;FITZPATRICK RICHARD;;MAYBERRY MICHAEL T;;KERBS JEREMY;;BURT ERIC CHRISTOPHER;;BARANELLO MICHAEL J,FITZPATRICK RICHARD;;MAYBERRY MICHAEL T;;KERBS JEREMY;;BURT ERIC CHRISTOPHER;;BARANELLO MICHAEL J,MAGPUL INDUSTRIES CORPORATION (2011-08-30),https://lens.org/089-796-348-647-936,Design Right,no,0,5,1,1,0,,,2201;;D22/108,0,0,,,,ACTIVE
540,CA,A1,CA 2323463 A1,091-731-078-402-14X,1996-05-23,1996,CA 2323463 A,1995-11-14,CA 2205177 A;;US 33949194 A,1994-11-14,MOSAIC BASED IMAGE PROCESSING SYSTEM AND METHOD FOR PROCESSING IMAGES,"A system (100) for automatically generating a mosaic from a plurality of input images. The system sequentially executes an image alignment process, an editing process, and a combining process such that, from a sequence of images (902), the system automatically produces a seamless mosaic (904) for various applications. Illustrative applications for the mosaic include a mosaic based display system (104) including an image printing system, a surveillance system (108) and a mosaic based compression system (110). The mosaic based display system (104) permits a system user to display, manipulate and alter a mosaic. The mosaic based compression system (110) exploits the temporal and spatial redundancy in image sequences and efficiently compresses the image information. The compression system (110) can be used for compressing image information for storage in a storage device or can be used for compressing image information for transmission through a band-limited transmission channel. The surveillance system (108) combines the mosaic construction system, the compression system and the display system into a comprehensive system for remote motion detection.",SARNOFF CORP,IRANI MICHAL;;ANANDAN PADMANABHAN;;HANSEN MICHAEL W;;HSU STEPHEN C;;BURT PETER J,,https://lens.org/091-731-078-402-14X,Patent Application,no,0,2,2,18,0,G06T3/4038,G06T3/00,,0,0,,,,DISCONTINUED
541,CA,A1,CA 2323462 A1,058-155-697-301-031,1996-05-23,1996,CA 2323462 A,1995-11-14,CA 2205177 A;;US 33949194 A,1994-11-14,MOSAIC BASED IMAGE PROCESSING SYSTEM AND METHOD FOR PROCESSING IMAGES,"A system (100) for automatically generating a mosaic from a plurality of input images. The system sequentially executes an image alignment process, an editing process, and a combining process such that, from a sequence of images (902), the system automatically produces a seamless mosaic (904) for various applications. Illustrative applications for the mosaic include a mosaic based display system ( 104) including an image printing system, a surveillance system (108) and a mosaic based compression system (110). The mosaic based display system (104) permits a system user to display, manipulate and alter a mosaic. The mosaic based compression system (110) exploits the temporal and spatial redundancy in image sequences and efficiently compresses the image information. The compression system (110) can be used for compressing image information for storage in a storage device or can be used for compressing image information for transmission through a band-limited transmission channel. The surveillance system (108) combines the mosaic construction system, the compression system and the display system into a comprehensive system for remote motion detection.",SARNOFF CORP,BURT PETER J;;HSU STEPHEN C;;IRANI MICHAL;;HANSEN MICHAEL W;;ANANDAN PADMANABHAN,,https://lens.org/058-155-697-301-031,Patent Application,no,0,0,2,18,0,G06T3/4038,G06T3/00,,0,0,,,,DISCONTINUED
542,US,B2,US 11734452 B2,012-672-463-623-325,2023-08-22,2023,US 202217942417 A,2022-09-12,US 202217942417 A;;US 202016843487 A;;US 201962831129 P,2019-04-08,Systems and methods for obscuring data from a data source,"Systems and methods for obscuring data from a data source include devices and processes that may objectively measure the information loss for the data source that is caused by applying a privacy policy, and may apply a policy to the data source based on the measured information loss. The systems and methods may measure the information loss for a large data source by taking a representative sample from the data source and applying the policy to the sample in order to quantify the information loss. The quantified information loss can be iteratively used to change the policy in order to meet utility and/or privacy goals, and the system can subsequently apply the changed policy to the data source.",IMMUTA INC,REGENSBURGER JOSEPH J;;BURT ANDREW D;;HAMMEN BARRY R;;ROSSI III ALFRED V,IMMUTA INC (2020-04-21),https://lens.org/012-672-463-623-325,Granted Patent,yes,12,0,4,4,0,G06F21/6254;;G06F17/18;;G06F21/6254,G06F21/62;;G06F17/18,,1,0,,,"Notice of Allowance issued in U.S. Appl. No. 16/843,487 dated May 18, 2022, 9 pages.",ACTIVE
543,CA,C,CA 2205177 C,026-605-999-950-023,2001-10-02,2001,CA 2205177 A,1995-11-14,US 33949194 A;;US 9514130 W,1994-11-14,MOSAIC BASED IMAGE PROCESSING SYSTEM AND METHOD FOR PROCESSING IMAGES,"A system (100) for automatically generating a mosaic from a plurality of inp ut images. The system sequentially executes an image alignment process, an editing process, and a combining process such that, from a sequence of image s (902), the system automaticallyproduces a seamless mosaic (904) for various applications. Illustrative applications for the mosaic include a mosaic base d display system (104) including an image printing system, a surveillance syst em (108) and a mosaic based compression system (110). The mosaic based display system (104) permits a system user to display, manipulate and alter a mosaic . The mosaic based compression system(110) exploits the temporal and spatial redundancy in image sequences and efficiently compresses the image information. The compression system (110) can be used for compressing image information for storage in a storage device or can be used for compressing image information for transmission through a band-limited transmission channel. The surveillance system (108) combines the mosaic construction system, the compression system and the display system into a comprehensive system for remote motion detection.",DAVID SARNOFF RES CT INC,ANANDAN PADMANABHAN;;HSU STEPHEN C;;IRANI MICHAL;;BURT PETER J;;HANSEN MICHAEL W,,https://lens.org/026-605-999-950-023,Granted Patent,no,0,0,16,18,0,G06T3/4038;;G06T11/00;;H04N5/781;;H04N5/85;;H04N9/8047;;H04N19/503;;H04N19/30;;H04N19/63;;H04N19/61;;H04N19/20;;H04N19/23;;G06V10/16;;G06V10/24;;G06V10/20;;H04N9/8047;;G06T11/00;;H04N5/781;;H04N5/85;;G06T3/4038;;H04N19/63;;H04N19/30;;H04N19/503;;H04N19/20;;H04N19/61;;H04N19/23;;G06V10/24;;G06V10/16,H04N5/262;;G06T3/00;;G06T9/00;;G06T11/00;;G06V10/24;;H03M7/36;;H04N1/387;;H04N5/781;;H04N5/85;;H04N5/91;;H04N7/167;;H04N7/18;;H04N7/26;;H04N7/30;;H04N7/36;;H04N7/50;;H04N9/804;;H04N21/4402;;H04N21/854,,0,0,,,,EXPIRED
544,US,B2,US 9540052 B2,150-548-913-083-617,2017-01-10,2017,US 201414458839 A,2014-08-13,US 201414458839 A;;US 201361865983 P,2013-08-14,Side-by-side vehicle,"A utility vehicle includes a plurality of ground-engaging members, a frame assembly supported by the plurality of ground-engaging members, and a powertrain assembly. Additionally, the utility vehicle includes a body generally surrounding the frame assembly and including a hood, dashboard assembly, and a side panel.",POLARIS INC;;POLARIS INC,BURT II DANIEL L;;EATON BRENT C;;BOHNSACK MICHAEL C;;MILLER ANDREW J,POLARIS INDUSTRIES INC (2013-01-29),https://lens.org/150-548-913-083-617,Granted Patent,yes,14,12,11,11,0,B62D23/005;;B60K2005/003;;B60Y2200/86;;B60J10/80;;B60Y2200/20;;B60K5/00;;B60K13/02;;B60K2015/0474;;B62D23/005;;B60K2005/003;;B60Y2200/86;;B60Y2200/20;;B60J10/80;;B60K1/04;;B60K5/00;;B60K13/02;;B60K15/04;;B60K2001/0405;;B60K2015/0474;;B60R7/06;;B62D25/14;;B62D25/2036;;B62D33/0617,B62D33/06;;B60K1/04;;B60K5/00;;B60K13/02;;B60K15/04;;B60R7/06;;B62D23/00;;B62D25/14;;B62D25/20,,1,0,,,"International Search Report and Written Opinion of the International Searching Authority issued by the European Patent Office, dated as of the International Search Report, Oct. 21, 2014, for International Application No. PCT/US2014/050890; 15 pages.",ACTIVE
545,US,A1,US 2006/0172912 A1,053-218-544-506-099,2006-08-03,2006,US 52593603 A,2003-08-26,GB 0220250 A;;GB 0303707 W,2002-08-31,Water soluble sachet containing hard surface cleaner,"The invention relates to a water soluble container which containing concentrate composition useful for hard surface disinfecting and cleaning comprising: (a) at least one cationic surfactant having germicidal properties; (b) at least one non-ionic surfactant; (c) at least one organic solvent having a solubility in water of at least 4% wt.; (d) optionally, at least one alkanolamine; (e) optionally, at least one polyethylene glycol; and (f) optionally, up to about 10% wt. of one or more conventional additives selected from coloring agents, fragrances and fragrance solubilizers, viscosity modifying agents, other surfactants, other antimicrobial/germicidal agents, pH adjusting agents and pH buffers including organic and inorganic salts, optical brighteners, opacifying agents, hydrotropes, antifoaming agents, enzymes, anti-spotting agents, anti-oxidants, preservatives, and anti-corrosion agents; wherein said concentrate composition contains no more than 20% wt. water, and desirably contains less. The water soluble containers can be made by thermoforming or injection molding. Methods for the manufacture of such containers containing the concentrate compositions and methods for the treatment of hard surfaces using the concentrate compositions and especially aqueous dilutions of the concentrate compositions are disclosed.",BURT DIANE J;;CHRISTMAS DELFORD I;;FENG JAMES C;;FRANCH LUCIA;;GENCARELLI RALPH,BURT DIANE J;;CHRISTMAS DELFORD I;;FENG JAMES C;;FRANCH LUCIA;;GENCARELLI RALPH,RECKITT BENCKISER INC (2005-02-23);;RECKITT BENCKISER LLC (2011-01-01),https://lens.org/053-218-544-506-099,Patent Application,yes,18,44,22,22,0,C11D1/62;;C11D1/72;;C11D1/835;;C11D3/43;;C11D17/043;;C11D17/043;;C11D1/62;;C11D1/835;;C11D3/43;;C11D1/72,C11D3/48;;C11D1/62;;C11D1/72;;C11D1/835;;C11D3/43;;C11D17/04,510/383,0,0,,,,EXPIRED
546,WO,A3,WO 2008/031089 A3,151-653-773-029-07X,2008-09-25,2008,US 2007/0077997 W,2007-09-10,US 84312206 P,2006-09-08,SYSTEM AND METHOD FOR HIGH PERFORMANCE IMAGE PROCESSING,"The present invention provides a method and a system for high performance image signal processing of continuous images in real time. The system comprising a focal plane array for generating continuous source image frames in real time. The focal plane array divided logically into blocks of sub-frames. The system also comprising an analog to digital converter (ADC) layer having an array of ADC elements for converting the source image frames into a digital data. The system further comprising a digital processor layer having an array of processing elements for processing the digital data and an interconnecting layer for connecting each one of the ADC elements and the digital processing elements substantially vertically to the focal plane and substantially parallel to one another. The processing comprising reducing image motion blur, increasing image dynamic range, increasing image depth of field and obtaining features of the images.",SARNOFF CORP;;BURT PETER J;;TOWER JOHN ROBERTSON;;VAN DER WAL GOOITZEN;;ACKERMAN DAVID ALAN,BURT PETER J;;TOWER JOHN ROBERTSON;;VAN DER WAL GOOITZEN;;ACKERMAN DAVID ALAN,,https://lens.org/151-653-773-029-07X,Search Report,yes,3,0,4,4,0,H04N5/33;;H04N23/959;;H04N23/676;;H04N23/951;;H04N23/68;;H04N23/6811;;H04N23/683;;H04N23/741;;H04N23/743;;H04N25/57;;H04N25/00;;H04N5/33;;H04N25/00;;H04N23/68;;H04N23/676;;H04N23/683;;H04N23/741;;H04N23/743;;H04N23/951;;H04N23/959;;H04N23/6811;;H04N25/57,H04N9/64,,1,1,155-761-657-586-868,10.1109/4.597293,"NI Y. ET AL.: ""Histogram-equalization-based adaptive image sensor for real-time vision"", IEEE JOURNAL OF SOLID-STATE CIRCUITS, vol. 32, no. 7, July 1997 (1997-07-01), pages 1027 - 1036, XP000729362, Retrieved from the Internet <URL:http://www.imec.be/esscirc/papers-96/172.pdf>",PENDING
547,EP,A1,EP 0792494 A1,181-354-368-712-471,1997-09-03,1997,EP 95939674 A,1995-11-14,US 9514130 W;;US 33949194 A,1994-11-14,MOSAIC BASED IMAGE PROCESSING SYSTEM AND METHOD FOR PROCESSING IMAGES,,SARNOFF DAVID RES CENTER,BURT PETER J;;IRANI MICHAL;;HSU STEPHEN C;;ANANDAN PADMANABHAN;;HANSEN MICHAEL W,SARNOFF CORPORATION (1997-10-01),https://lens.org/181-354-368-712-471,Patent Application,yes,0,0,16,18,0,G06T3/4038;;G06T11/00;;H04N5/781;;H04N5/85;;H04N9/8047;;H04N19/503;;H04N19/30;;H04N19/63;;H04N19/61;;H04N19/20;;H04N19/23;;G06V10/16;;G06V10/24;;G06V10/20;;H04N9/8047;;G06T11/00;;H04N5/781;;H04N5/85;;G06T3/4038;;H04N19/63;;H04N19/30;;H04N19/503;;H04N19/20;;H04N19/61;;H04N19/23;;G06V10/24;;G06V10/16,G06T3/00;;H04N5/262;;G06T9/00;;G06T11/00;;G06V10/24;;H03M7/36;;H04N1/387;;H04N5/781;;H04N5/85;;H04N5/91;;H04N7/167;;H04N7/18;;H04N7/26;;H04N7/30;;H04N7/36;;H04N7/50;;H04N9/804;;H04N21/4402;;H04N21/854,,0,0,,,,EXPIRED
548,US,B1,US 6393163 B1,038-011-439-486-207,2002-05-21,2002,US 45374999 A,1999-12-02,US 45374999 A;;US 21542398 A;;US 88228097 A;;US 33949194 A,1994-11-14,Mosaic based image processing system,"
    A system for automatically generating a mosaic from a plurality of input images. The system sequentially executes an image alignment process, an editing process, and a combining process such that, from a sequence of images, the system automatically produces a seamless mosaic for various applications. Illustrative applications for the mosaic include: (1) a mosaic based display system including an image printing system, (2) a surveillance system and (3) a mosaic based compression system. The mosaic based display system permits a system user to display, manipulate and alter a mosaic. The mosaic based compression system exploits the temporal and spatial redundancy in image sequences and efficiently compresses the image information. The compression system can be used for compressing image information for storage in a storage device or can be used for compressing image information for transmission through a band-limited transmission channel. The surveillance system combines the mosaic construction system, the compression system and the display system into a comprehensive system for remote motion detection. 
",SARNOFF CORP,BURT PETER J;;IRANI MICHAL;;HSU STEPHEN CHARLES;;ANANDAN PADMANABHAN;;HANSEN MICHAEL W,SRI INTERNATIONAL (2011-02-04),https://lens.org/038-011-439-486-207,Granted Patent,yes,14,230,16,18,0,G06T3/4038;;G06T11/00;;H04N5/781;;H04N5/85;;H04N9/8047;;H04N19/503;;H04N19/30;;H04N19/63;;H04N19/61;;H04N19/20;;H04N19/23;;G06V10/16;;G06V10/24;;G06V10/20;;H04N9/8047;;G06T11/00;;H04N5/781;;H04N5/85;;G06T3/4038;;H04N19/63;;H04N19/30;;H04N19/503;;H04N19/20;;H04N19/61;;H04N19/23;;G06V10/24;;G06V10/16,G06T3/00;;G06T9/00;;G06T11/00;;H04N5/262;;G06V10/24;;H03M7/36;;H04N1/387;;H04N5/781;;H04N5/85;;H04N5/91;;H04N7/167;;H04N7/18;;H04N7/26;;H04N7/30;;H04N7/36;;H04N7/50;;H04N9/804;;H04N21/4402;;H04N21/854,382/294;;382/284,11,8,089-571-989-504-866;;068-925-363-822-866;;122-254-846-573-384;;098-173-496-566-324;;143-502-655-624-03X;;042-689-645-533-661;;059-009-996-238-125;;010-396-006-264-864,10.1145/146370.146374;;10.1007/3-540-57956-7_52;;10.1109/83.370675;;18289995;;10.1109/iccv.1993.378222;;10.1117/12.966501;;10.1145/245.247;;10.1109/mmcs.1994.292488;;18291954;;10.1109/83.334983,"Brown, L.G., A survey of image registration techniques, ACM computing surveys, vol. 24, No. 4, Dec. 1992.*;;Hartley, Richard I., ""Self-Calibration from Multiple Views with a Rotating Camera"", Lecture Notes in Computer Science, vol. 800 pp. 471-478, 1994.;;Sun, Huifang and Kwok, Wilson, ""Concealment of Damaged Block Transform Coded Images Using Projections onto Convex Sets"", IEEE Transactions on Image Processing, vol. 4, No. 4, Apr. 1995.;;McLean, ""Structured Video Coding"", Massachusetts Institute of Technology, 1991.;;Bergen et al., ""Hierarchical Model-Based Motion Estimation"", Proceedings of European Conference on Computer Vision, Mar. 23, 1992.;;Michal Irani, ""Isolating Multiple 2D Image Motions for Image Enhancement and for 3D Motion Analysis"", Hebrew University of Jerusalem, 1993.;;Burt et al., ""Enhanced Image Capture Through Fusion"", International Conference on Computer Vision Proceedings, 1993.;;Burt et al., ""Merging Images Through Pattern Decomposition"", Applications of Digital Processing VIII, SPIE, vol. 575, pp. 173-181, 1985.;;Burt et al., ""A Multiresolution Spline With Application to Image Mosaics"", ACM Transactions on Graphics, vol. 2, No. 4, pp. 217-236, Oct. 1983.;;Bove et al., ""Real-Time Decoding and Display of Structured Video"", IEEE ICMCS, May 1994.;;Lundmark et al., ""Image Sequence Coding at Very Low Bitrates: A Review"", IEEE Transactions on Image Processing, vol. 3, No. 5, pp. 589-609, Sep. 1994.",EXPIRED
549,US,S,US D0667917 S,123-336-929-467-021,2012-09-25,2012,US 201129400004 F,2011-08-22,US 201129400004 F,2011-08-22,Rail cover with surface partitions,,FITZPATRICK RICHARD;;MAYBERRY MICHAEL T;;KERBS JEREMY;;BURT ERIC CHRISTOPHER;;BARANELLO MICHAEL J;;MAGPUL IND CORP,FITZPATRICK RICHARD;;MAYBERRY MICHAEL T;;KERBS JEREMY;;BURT ERIC CHRISTOPHER;;BARANELLO MICHAEL J,MAGPUL INDUSTRIES CORPORATION (2011-08-20),https://lens.org/123-336-929-467-021,Design Right,no,0,7,1,1,0,,,2201;;D22/108,0,0,,,,ACTIVE
550,US,A,US 4577398 A,161-162-615-726-845,1986-03-25,1986,US 64857084 A,1984-09-07,US 64857084 A,1984-09-07,Method for mounting a semiconductor chip,"A method of attaching a semiconductor chip to a mounting surface is disclosed. A solder barrier is applied to the mounting surface, and a preform of solder is located within the solder barrier. The preform is heated and then cooled in a vacuum to preflow the solder and secure the solder to the mounting surface substantially without voids. The semiconductor chip is then placed over the preflowed solder, which is reheated and then recooled in a vacuum to secure the chip to the mounting surface.",TRILOGY COMPUTER DEV PARTNERS,SLIWA JOHN W;;BURT ROY J;;LEE CHUNE;;MACKAY JOHN;;JOHNSON CINDY A,ELXSI CORPORATION A DE CORP (1990-02-20);;INTEL CORPORATION A DE CORP (1990-02-20);;TRILOGY COMPUTER DEVELOPMENT PARTNERS LTD (1984-11-30),https://lens.org/161-162-615-726-845,Granted Patent,yes,7,34,1,1,0,H01L24/83;;H01L2224/8319;;H01L2224/83801;;H01L2924/01005;;H01L2924/01018;;H01L2924/01029;;H01L2924/01042;;H01L2924/01049;;H01L2924/01075;;H01L2924/01078;;H01L2924/01079;;H01L2924/01082;;H01L24/29;;H01L2224/2919;;H01L2924/01006;;H01L2924/01033;;H01L2924/014;;H01L2924/0665;;H01L2924/0132;;H01L2224/83138;;Y10T29/49128;;Y10T29/49128;;H01L24/83;;H01L2224/83801;;H01L2924/01042;;H01L2924/01082;;H01L2224/8319;;H01L2924/01049;;H01L2924/01075;;H01L2924/01005;;H01L2924/01078;;H01L2924/01029;;H01L2924/01079;;H01L2924/01018;;H01L24/29;;H01L2924/01033;;H01L2924/01006;;H01L2924/014;;H01L2924/0665;;H01L2224/2919;;H01L2924/0132;;H01L2224/83138,H01L21/60,H1K KRM           RM,0,0,,,,EXPIRED
551,US,A,US 5999662 A,133-220-320-769-896,1999-12-07,1999,US 21542398 A,1998-12-18,US 21542398 A;;US 88228097 A;;US 33949194 A,1994-11-14,System for automatically aligning images to form a mosaic image,"A system for automatically generating a mosaic from a plurality of input images. The system sequentially executes an image alignment process, an editing process, and a combining process such that, from a sequence of images, the system automatically produces a seamless mosaic for various applications. Illustrative applications for the mosaic include: (1) a mosaic based display system including an image printing system, (2) a surveillance system and (3) a mosaic based compression system. The mosaic based display system permits a system user to display, manipulate and alter a mosaic. The mosaic based compression system exploits the temporal and spatial redundancy in image sequences and efficiently compresses the image information. The compression system can be used for compressing image information for storage in a storage device or can be used for compressing image information for transmission through a band-limited transmission channel. The surveillance system combines the mosaic construction system, the compression system and the display system into a comprehensive system for remote motion detection.",SARNOFF CORP,BURT PETER J;;IRANI MICHAL;;HSU STEPHEN CHARLES;;ANANDAN PADMANABHAN;;HANSEN MICHAEL W,SARNOFF CORPORATION (1997-04-04),https://lens.org/133-220-320-769-896,Granted Patent,yes,12,259,16,18,0,G06T3/4038;;G06T11/00;;H04N5/781;;H04N5/85;;H04N9/8047;;H04N19/503;;H04N19/30;;H04N19/63;;H04N19/61;;H04N19/20;;H04N19/23;;G06V10/16;;G06V10/24;;G06V10/20;;H04N9/8047;;G06T11/00;;H04N5/781;;H04N5/85;;G06T3/4038;;H04N19/63;;H04N19/30;;H04N19/503;;H04N19/20;;H04N19/61;;H04N19/23;;G06V10/24;;G06V10/16,G06T3/00;;H04N5/262;;G06T9/00;;G06T11/00;;G06V10/24;;H03M7/36;;H04N1/387;;H04N5/781;;H04N5/85;;H04N5/91;;H04N7/167;;H04N7/18;;H04N7/26;;H04N7/30;;H04N7/36;;H04N7/50;;H04N9/804;;H04N21/4402;;H04N21/854,382/284;;348/588;;382/294,10,7,098-173-496-566-324;;143-502-655-624-03X;;042-689-645-533-661;;059-009-996-238-125;;010-396-006-264-864;;068-925-363-822-866;;122-254-846-573-384,10.1109/iccv.1993.378222;;10.1117/12.966501;;10.1145/245.247;;10.1109/mmcs.1994.292488;;18291954;;10.1109/83.334983;;10.1007/3-540-57956-7_52;;10.1109/83.370675;;18289995,"Michal Irani, Isolating Multiple 2D Image Motions for Image Enhancement and for 3D Motion Analysis , Hebrew University of Jerusalm, 1993.;;Burt et al., Enhanced Image Capture Through Fusion , International Conference on Computer Vision Proceedings, 1993.;;Burt et al., Merging Images Through Pattern Decomposition , Applications of Digital Processing VIII, SPIE, vol. 575, pp. 173 181, 1985.;;Burt et al., A Multiresolution Spline With Application to Image Mosaics , ACM Transactions on Graphics, vol. 2, No. 4, pp. 217 236, Oct. 1983.;;Bove et al., Real Time Decoding and Display of Structured Video , IEEE ICMCS, May 1994.;;Lundmark et al., Image Sequence Coding at Very Low Bitrates: A Review , IEEE Transactions on Image Processing, vol. 3, No. 5, pp. 589 609, Sep. 1994.;;McLean, Structured Video Coding , Massachusetts Institute of Technology, 1991.;;Bergen et al., Hierarchical Model Based Motion Estimation , Proceedings of European Conference on Computer Vision, Mar. 23, 1992.;;Hartley, Richard I., Self Calibration from Multiple Views with a Rotating Camera , Lecture Notes in Computer Science, vol. 800 pp. 471 478, 1994.;;Sun, Huifang and Kwok, Wilson, Concealment of Damaged Block Transform Coded Images Using Projections onto Convex Sets , IEEE Tranactions on Image Processing, vol. 4, No. 4, Apr. 1995.",EXPIRED
552,US,A,US 5049691 A,162-096-497-859-666,1991-09-17,1991,US 48778790 A,1990-03-05,US 48778790 A;;US 23940988 A,1988-09-01,Process for transhalogenating a halophosphorous compound with anhydrous hydrogen fluoride,"Phosphorus compounds having at least one chlorine, bromine or iodine bonded directly to phosphorus are transhalogenated with fluorine by reaction with anhydrous hydrogen fluoride in an inert solvent, e.g., xylene, methylene chloride, in a manner such that said anhydrous hydrogen fluoride is added to said phosphorus compound at a rate such that said anhydrous hydrogen fluoride reacts with said phosphorus compound without the accumulation of an amount of unreacted anhydrous hydrogen fluoride which is sufficient to cause substantial decomposition of the desired fluorophosphorus product.",ETHYL CORP,BURT EDWARD A;;BURTON LESTER P J;;AO MENG-SHENG;;STAHLY BARBARA C,ALBERMARLE CORPORATION (1994-02-28);;ETHYL CORPORATION A CORPORATION OF VA (1990-02-27),https://lens.org/162-096-497-859-666,Granted Patent,yes,1,4,1,10,0,C07F9/146;;C07F9/146;;C07F9/65744;;C07F9/65744,C07F9/146;;C07F9/6574,558/84;;558/140;;568/14;;568/16,0,0,,,,EXPIRED
553,US,A,US 5649032 A,066-458-756-079-935,1997-07-15,1997,US 33949194 A,1994-11-14,US 33949194 A,1994-11-14,System for automatically aligning images to form a mosaic image,"A system for automatically generating a mosaic from a plurality of input images. The system sequentially executes an image alignment process, an editing process, and a combining process such that, from a sequence of images, the system automatically produces a seamless mosaic for various applications. Illustrative applications for the mosaic include: (1) a mosaic based display system including an image printing system, (2) a surveillance system and (3) a mosaic based compression system. The mosaic based display system permits a system user to display, manipulate and alter a mosaic. The mosaic based compression system exploits the temporal and spatial redundancy in image sequences and efficiently compresses the image information. The compression system can be used for compressing image information for storage in a storage device or can be used for compressing image information for transmission through a band-limited transmission channel. The surveillance system combines the mosaic construction system, the compression system and the display system into a comprehensive system for remote motion detection.",SARNOFF DAVID RES CENTER,BURT PETER J;;IRANI MICHAL;;HSU STEPHEN CHARLES;;ANANDAN PADMANABHAN;;HANSEN MICHAEL W,DAVID SARNOFF RESEARCH CENTER INC (1995-01-06);;SARNOFF CORPORATION (1997-04-03),https://lens.org/066-458-756-079-935,Granted Patent,yes,8,540,16,18,0,G06T3/4038;;G06T11/00;;H04N5/781;;H04N5/85;;H04N9/8047;;H04N19/503;;H04N19/30;;H04N19/63;;H04N19/61;;H04N19/20;;H04N19/23;;G06V10/16;;G06V10/24;;G06V10/20;;H04N9/8047;;G06T11/00;;H04N5/781;;H04N5/85;;G06T3/4038;;H04N19/63;;H04N19/30;;H04N19/503;;H04N19/20;;H04N19/61;;H04N19/23;;G06V10/24;;G06V10/16,G06T3/00;;H04N5/262;;G06T9/00;;G06T11/00;;G06V10/24;;H03M7/36;;H04N1/387;;H04N5/781;;H04N5/85;;H04N5/91;;H04N7/167;;H04N7/18;;H04N7/26;;H04N7/30;;H04N7/36;;H04N7/50;;H04N9/804;;H04N21/4402;;H04N21/854,382/284;;348/588;;382/294,8,5,098-173-496-566-324;;143-502-655-624-03X;;042-689-645-533-661;;059-009-996-238-125;;010-396-006-264-864,10.1109/iccv.1993.378222;;10.1117/12.966501;;10.1145/245.247;;10.1109/mmcs.1994.292488;;18291954;;10.1109/83.334983,"Michal Irani, Isolating Multiple 2D Image Motions for Image Enhancement and for 3D Motion Analysis , Hebrew University of Jerusalem, 1993.;;Burt et al., Enhanced Image Capture Through Fusion , International Conference on Computer Vision Proceedings, 1993.;;Burt et al., Merging Images Through Pattern Decomposition , Applications of Digital Processing VIII, SPIE, vol. 575, pp. 173 181, 1985.;;Burt et al., A Multiresolution Spline With Application to Image Mosaics , ACM Transactions on Graphics, vol. 2, No. 4, pp. 217 236, Oct. 1983.;;Bove et al., Real Time Decoding and Display of Structured Video , IEEE ICMCS, May 1994.;;Lundmark et al., Image Sequence Coding at Very Low Bitrates: A Review , IEEE Transactions on Image Processing, vol. 3, No. 5, pp. 589 609, Sep. 1994.;;McLean, Structured Video Coding , Massachusetts Institute of Technology, 1991.;;Bergen et al., Hierarchical Model Based Motion Estimation , Proceedings of European Conference on Computer Vision, Mar. 23, 1992.",EXPIRED
554,WO,A2,WO 2006/130369 A2,046-024-761-656-465,2006-12-07,2006,US 2006/0019557 W,2006-05-22,US 14071605 A,2005-05-31,METHOD AND SYSTEM FOR NON-INVASIVE VENTILATORY SUPPORT,"A method and apparatus for supplying regulated air to a patient requiring a respirator. An airflow amplifier is provided with increme digital control of an air gap providing compressed primary air to the amplifier. The compressed air induces and entrains ambient air, providing for a amplified flow of non-turbulent air to the patient. The combined flows are subjected to rapid and repetitive measurements of pressure and flow conditions, which measurements serve as feedback data for maintaining operation of the system under precise controls In various modes, the method and system of the invention provide for assistance of the patient's spontaneous breathing, which can be overridden by timing means, if the patient fails to breaths naturally for an excessive period. Passive air amplification provides for extremely quiet operation, allowing assisted patients to sleep effectively. The system is not only highly effective, but exceptionally economical to install and operate.",VENTENDO PRODUCTS CORP INC,BECK BLAINE E;;CORRIS CHARLES JAMES;;LOVAS ANDRE J;;HURST JOE C;;JENNINGS BURT;;SCHEINBERG PAUL J,,https://lens.org/046-024-761-656-465,Patent Application,yes,0,8,2,2,0,A61M16/12;;A61M16/0063;;A61M16/127;;A61M16/202;;A61M2016/0027;;A61M2016/0039;;A61M2205/3553;;A61M2205/3584;;A61M2205/502;;A61M2206/11,A61M15/00;;A61M16/00;;A62B7/00,,0,0,,,,PENDING
555,WO,A3,WO 2006/130369 A3,168-710-847-513-362,2007-11-22,2007,US 2006/0019557 W,2006-05-22,US 14071605 A,2005-05-31,METHOD AND SYSTEM FOR NON-INVASIVE VENTILATORY SUPPORT,"A method and apparatus for supplying regulated air to a patient requiring a respirator. An airflow amplifier is provided with increme digital control of an air gap providing compressed primary air to the amplifier. The compressed air induces and entrains ambient air, providing for a amplified flow of non-turbulent air to the patient. The combined flows are subjected to rapid and repetitive measurements of pressure and flow conditions, which measurements serve as feedback data for maintaining operation of the system under precise controls In various modes, the method and system of the invention provide for assistance of the patient's spontaneous breathing, which can be overridden by timing means, if the patient fails to breaths naturally for an excessive period. Passive air amplification provides for extremely quiet operation, allowing assisted patients to sleep effectively. The system is not only highly effective, but exceptionally economical to install and operate.",VENTENDO PRODUCTS CORP INC,BECK BLAINE E;;CORRIS CHARLES JAMES;;LOVAS ANDRE J;;HURST JOE C;;JENNINGS BURT;;SCHEINBERG PAUL J,,https://lens.org/168-710-847-513-362,Search Report,yes,1,0,2,2,0,A61M16/12;;A61M16/0063;;A61M16/127;;A61M16/202;;A61M2016/0027;;A61M2016/0039;;A61M2205/3553;;A61M2205/3584;;A61M2205/502;;A61M2206/11,A61M15/00;;A61M16/00;;A62B7/00,,0,0,,,,PENDING
556,US,A1,US 2012/0276140 A1,116-319-902-038-309,2012-11-01,2012,US 201213457223 A,2012-04-26,US 201213457223 A;;US 97206204 A;;US 55984204 P;;US 51361403 P,2003-10-22,COMPOSITIONS AND METHODS FOR ACTIVATING INNATE AND ALLERGIC IMMUNITY,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma).",LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT;;ID BIOMEDICAL CORP QUEBEC,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,,https://lens.org/116-319-902-038-309,Patent Application,yes,3,0,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K39/35;;A61K39/02;;A61K39/095;;A61K39/104;;A61K39/108;;A61K39/112;;A61K39/116;;A61K39/118;;A61K39/36;;A61K39/39;;A61P11/00;;A61P11/06;;A61P17/00;;A61P37/08,424/203.1;;424/275.1;;424/234.1;;424/249.1;;424/263.1;;424/260.1;;424/257.1;;424/258.1;;424/250.1,3,3,001-103-753-661-611;;159-271-636-020-316;;018-299-354-320-363,9389296;;10.1016/s0091-6749(97)70170-2;;19410159;;10.1016/s1098-3597(09)62036-6;;10.1016/s0091-6749(99)70369-6;;10452747,"Schappi et al., J Allergy Clin Immunol, 1997; 100: 656-61.;;Stoloff, Clinical Cornerstone, 2008; 9(2): 6-23.;;Elliott et al., J Allergy Clin Immunol, 1999; 104: 294-300.",ACTIVE
557,WO,A1,WO 2005/042017 A1,140-607-386-718-012,2005-05-12,2005,US 2004/0035041 W,2004-10-22,US 51361403 P;;US 55984204 P,2003-10-22,COMPOSITIONS AND METHODS FOR ACTIVATING INNATE AND ALLERGIC IMMUNITY,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma).",ID BIOMEDICAL CORP QUEBEC;;LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,,https://lens.org/140-607-386-718-012,Patent Application,yes,2,2,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K39/39,,2,1,082-621-397-459-772,7768627;;pmc173317;;10.1128/iai.63.6.2382-2386.1995,"MALLETT C P ET AL: ""INTRANASAL OR INTRAGASTRIC IMMUNIZATION WITH PROTEOSOME-SHIGELLA LIPOPOLYSACCHARIDE VACCINES PROTECTS AGAINST LETHAL PNEUMONIA IN A MURINE MODEL OF SHIGELLA INFECTION"", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 63, no. 6, 1 June 1995 (1995-06-01), pages 2382 - 2386, XP000608953, ISSN: 0019-9567;;DAVID S. BURT ET AL.: ""PROTOLLIN TM - A NOVEL MUCOSAL ADJUVANT FOR THE ACTIVATION OF INNATE AND ADAPTIVE IMMUNITY"", CLINICAL AND INVESTIGATE MEDICINE, vol. 27, no. 4, XP002323596, Retrieved from the Internet <URL:www.immuno2004.org/onlineabstracts/4613.html> [retrieved on 20050407]",PENDING
558,US,B2,US 9433672 B2,173-891-403-034-674,2016-09-06,2016,US 201414263390 A,2014-04-28,US 201414263390 A;;US 201213457223 A;;US 97206204 A;;US 51361403 P;;US 55984204 P,2003-10-22,Compositions and methods for activating innate and allergic immunity,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma).",ID BIOMEDICAL CORP QUEBEC,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,,https://lens.org/173-891-403-034-674,Granted Patent,yes,5,1,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K39/38;;A61K35/74;;A61K39/00;;A61K39/02;;A61K39/095;;A61K39/145;;A61K39/155;;A61K39/165;;A61K39/275;;A61K39/385;;A61K39/39;;A61K45/00;;C07K14/005;;C07K14/22,,0,0,,,,ACTIVE
559,US,A,US 6117462 A,122-212-064-052-52X,2000-09-12,2000,US 4135598 A,1998-03-12,US 4135598 A,1998-03-12,Nutritional supplements,"A method of producing metal-rich plants for the production of nutritional supplements. Edible plants are placed in a growth environment containing metal, and are cultivated in a fashion which enhances the uptake of metal into edible portions of the plants. The plants are then harvested, and may be eaten directly or processed into capsule or tablet form, in order to obtain the metallic nutrients so incorporated.",NUCYCLE THERAPY INC;;UNIV RUTGERS,ENSLEY BURT D;;ELLESS MARK;;BLAYLOCK MICHAEL J;;HUANG JIANWEI;;RASKIN ILYA;;ONEAL JOSEPH,INB:BIOTECHNOLOGIES INC (2004-11-23);;PHYTOTECH INC (1998-06-29);;NUCYCLE THERAPY INC (2000-03-31);;RUTGERS THE STATE UNIVERSITY OF NEW JERSEY (1999-11-16);;IBIO INC (2008-07-17),https://lens.org/122-212-064-052-52X,Granted Patent,yes,5,19,3,9,0,A01G7/06;;A23V2002/00;;Y10S426/809;;A23L33/10;;A23L33/16;;A01G7/06;;A23V2002/00;;Y10S426/809;;A23L33/16;;A23L33/10,A01G7/06;;A23L1/30;;A23L1/304,426/74;;426/615;;426/809;;426/648,18,17,008-845-803-547-452;;046-703-401-561-010;;047-600-194-594-534;;112-725-112-974-993;;133-824-231-019-898;;057-883-674-197-98X;;033-623-027-870-291;;025-873-143-969-987;;006-343-854-424-230;;008-914-106-971-051;;168-659-901-522-219;;126-743-157-509-232;;169-567-664-619-604;;064-110-692-199-486;;097-577-980-393-175;;003-754-505-188-054;;010-568-317-589-031,10.1093/jn/116.9.1701;;3761026;;10.1021/jf00055a002;;10.1007/bf01054852;;7325687;;10.1001/jama.1996.03530380029025;;8601925;;10.1039/ac9963300279;;10.1080/01635589209514197;;1437646;;8233978;;10.1080/01635589309514279;;8137319;;10.1093/carcin/15.4.573;;8149465;;10.1093/carcin/15.9.1881;;7923581;;10.1093/carcin/16.11.2649;;7586181;;8824512;;10.1093/carcin/17.9.1903;;10.1021/jf00023a012;;8340027;;10.1016/0278-6915(93)90108-b;;10.1016/s0031-9422(00)85306-6;;10.1016/0304-3835(89)90034-7;;2496915;;8824523;;10.1093/carcin/17.9.1979,"Beilstein, et al., Deposition of Dietary Organic and Inorganic Selenium in Rat Erythrocyte Proteins, J. Nutr. 116:1701 1710 (1986).;;Cai, et al., Allium Chemistry: Identification of Selenoamino Acids in Ordinary and Selenium Enriched Garlic, Onion, and Broccoli Using Gas Chromatography with Atomic Emission Detection, J. Agric. Food Chem. 1995(43): 1754 1757 (1995).;;Cappon, Mercury and Selenium Content and Chemical Form in Vegetable Crops Grown on Sludge Amended Soil, Arch. Environm. Contam. Toxicol. 10:673 689 (1981).;;Clark, et al., Selenium Poisoning from a Nutritional Supplement, JAMA 275(10):1087 1088 (Apr. 10, 1996).;;Ge, et al., Identification of Selenium Species in Selenium enriched Garlic, Onion and Broccoli Using High Performance Ion Chromatography With Inductively Coupled Plasma Mass Sprectrometry Detection, Analyt. Comm. 33:279 281 (Aug., 1996).;;Ip, et al., Mammary Cancer Prevention by Regular Garlic and Selenium Enriched Garlic, Nutrition and Cancer 17(3):279 286 (1992).;;Ip, et al., Bioavailability of Selenium From Selenium Enriched Garlic, Nutrition and Cancer 20(2):129 137 (1993).;;Ip, et al., Potential of Food Modification in Cancer Prevention, Cancer Research ( Supp ) 54:1957s 1959s (Apr. 1, 1994).;;Ip, et al., Characterization of tissue selenium profiles and anticarcinogenic responses in rats fed natural sources of selenium rich products, Carcinogenesis 15(4):573 576 (1994).;;Ip, et al., Enrichment of selenium in allium vegetables for cancer prevention, Carcinogenesis 15(9):1881 1885 (1994).;;Ip, et al., Efficacy of cancer prevention by high selenium garlic is primarily dependent on the action of selenium, Carcinogenesis 16(11):2549 2652 (1995).;;Lu, et al., Effect of an aqueous extract of selenium enriched garlic on in vitro markers and in vivo efficacy in cancer prevention, Carcinogenesis 17(9):1903 1907 (1996).;;Marks, et al., S Methycysteine Sulfoxide in Brassica Vegetables and Formation of Methyl Methanethiosulfinate from Brussel Sprouts, J. Agric. Food Chem. 40(11):2098 2101 (1992).;;Marks, et al., Effect of S Methyl Cysteine Sulphoxide and its Metabolite Methyl Methane Thiosuphinate, Both Occurring Naturally in Brassica Vegetables, on Mouse Genotoxicity, Fd Chem Toxic. 31(7):491 495 (1993).;;Olson, et al., Investigations on Selenium in Wheat, Phytochemistry 9:1181 1188 (1970).;;Salt, et al., Metal Accumulation by Agquacultured Seedlings of Indian Mustard, Env. Sci. & Tech. 31(6):1636 1644 (1997).;;Stoewsand, et al., Effect of dietary brussels sprouts with increased selenium content of mammary carcinogenesis in the rat, Cancer Letters 45:43 48 (1989).;;Ip, et al., Selenium enriched garlic inhibits the early stage but not the late stage of mammary carcinogenesis, Carcinogenesis 17(9):1979 1982 (1996).",EXPIRED
560,JP,A,JP 2011157380 A,186-484-077-138-235,2011-08-18,2011,JP 2011083368 A,2011-04-05,US 51361403 P;;US 55984204 P,2003-10-22,COMPOSITION AND METHOD FOR ACTIVATING INNATE AND ALLERGIC IMMUNITY,"<P>PROBLEM TO BE SOLVED: To provide methods for making and using therapeutic formulations of proteosome-based immunoactive compositions. <P>SOLUTION: There are provided compositions, wherein immunogenic compositions including proteosomes and liposaccharides are used to induce or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen are used to induce a specific adaptive immune response. Furthermore, the compositions can alter hyperreactive responses or inflammatory immune responses, such as allergic reactions. The compositions are used as a prophylactic or in various clinical situations to treat or prevent infectious diseases (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma). <P>COPYRIGHT: (C)2011,JPO&INPIT",ID BIOMEDICAL CORP QUEBEC,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,,https://lens.org/186-484-077-138-235,Patent Application,no,0,0,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K31/715;;A61K9/72;;A61K38/43;;A61K39/00;;A61K39/002;;A61K39/02;;A61K39/108;;A61K39/118;;A61K39/12;;A61K39/145;;A61K39/39;;A61P31/04;;A61P31/10;;A61P31/12,,0,0,,,,PENDING
561,US,B1,US 6200311 B1,190-092-387-578-182,2001-03-13,2001,US 975598 A,1998-01-20,US 975598 A,1998-01-20,Minimally invasive TMR device,"The disclosure is directed to a tissue ablation device comprising an elongate probe, with a tissue ablation member located at the deflectable distal end of the probe, which is configured to access a patient's heart. The elongate probe is attached at its proximal end to a handpiece which is ergonomically designed to fit within the hand of the operator. The handpiece houses an advancement mechanism which is mechanically coupled to the tissue ablation member and can be used to axially translate the tissue ablation member in relation to the elongate probe. An activation mechanism is housed within the advancement mechanism and is coupled to the advancement mechanism in such a manner that the operator can simultaneously activate and advance the tissue removal member with one finger or thumb. The handpiece also houses a deflection actuator which applies tension to a tensile member which deflects the distal end of the probe.",ECLIPSE SURGICAL TECH,DANEK CHRISTOPHER J;;TAIMISTO MIRIAM H;;BAUGHMAN TYLER;;GERTNER KEVIN;;VALENTI JOHN;;UEBELHOER BURT,CARDIOGENESIS CORPORATION (1998-07-29);;ECLIPSE SURGICAL TECHNOLOGIES INC (1999-08-23),https://lens.org/190-092-387-578-182,Granted Patent,yes,39,641,1,1,0,A61B18/22;;A61B2017/00247;;A61B2017/00867;;A61B2017/2905;;A61B2017/2927;;A61B2017/2929;;A61B2018/00392;;A61B2018/2238;;A61B18/1815;;A61B17/320758;;A61B17/32037;;A61B17/320068;;A61B2018/00577;;A61B18/22;;A61B2017/00247;;A61B2017/00867;;A61B2017/2905;;A61B2017/2927;;A61B2017/2929;;A61B2018/00392;;A61B2018/2238,A61B17/00;;A61B17/28;;A61B18/22,606/15;;606/19;;606/42;;606/1;;607/122,1,0,,,"Eclipse Surgical Technologies, Inc. SoloGrip(TM) II, Single Use, fully disposable laser handpiece for Eclipse TMR, Copyright 1997.",EXPIRED
562,DE,D1,DE 602004027940 D1,032-468-054-666-874,2010-08-12,2010,DE 602004027940 T,2004-10-22,US 51361403 P;;US 55984204 P;;US 2004/0035041 W,2003-10-22,ZUSAMMENSETZUNGEN UND VERFAHREN ZUR AKTIVIERUNG DER EIGENEN UND ALLERGISCHEN IMMUNITÄT,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma.",ID BIOMEDICAL CORP QUEBEC,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,,https://lens.org/032-468-054-666-874,Granted Patent,no,0,0,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K39/39;;A61K39/095;;A61K39/112;;A61P11/06;;A61P37/00,,0,0,,,,ACTIVE
563,EP,A2,EP 2174665 A2,046-772-093-129-777,2010-04-14,2010,EP 10001123 A,2004-10-22,EP 04796097 A;;US 51361403 P;;US 55984204 P,2003-10-22,Compositions and methods for activating innate and allergic immunity,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma.",ID BIOMEDICAL CORP QUEBEC,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID H;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,ID BIOMEDICAL CORPORATION OF QUEBEC (2016-12-07),https://lens.org/046-772-093-129-777,Patent Application,yes,7,0,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K39/39;;A61K39/095;;A61K39/112;;A61P11/06;;A61P37/00,,34,25,086-707-718-808-930;;000-437-395-309-784;;031-746-971-121-805;;072-773-978-432-287;;067-198-252-029-430;;016-416-627-147-613;;039-804-218-014-755;;089-181-889-049-639;;000-682-460-525-539;;011-239-769-153-844;;019-043-147-421-804;;007-566-952-820-469;;083-843-865-256-061;;065-163-335-434-850;;005-277-749-572-427;;023-907-179-348-058;;053-901-990-601-316;;031-933-089-611-974;;050-513-346-896-80X;;051-252-321-227-371;;024-424-760-226-513;;082-621-397-459-772;;048-264-992-012-54X;;071-676-238-574-799;;003-945-227-502-489,10.1126/science.272.5258.50;;8600536;;10.1016/s0952-7915(97)80152-5;;9039775;;2419430;;1825981;;10.1096/fasebj.5.2.1825981;;pmc2188847;;10.1084/jem.167.2.658;;3346624;;10.1126/science.2452484;;2452484;;19431528;;pmc1435294;;10.1016/s0006-3495(84)84127-2;;15321997;;10.1128/iai.72.9.5041-5051.2004;;pmc517442;;11044679;;10.1016/s0966-842x(00)01845-x;;10334979;;10.1126/science.284.5418.1313;;15375267;;10.1126/science.1099472;;15375268;;10.1126/science.1100283;;8759723;;9510150;;pmc7130686;;2051488;;10.1016/0022-2836(91)90193-a;;pmc50453;;1438297;;10.1073/pnas.89.22.10915;;6096830;;pmc320472;;10.1093/nar/12.24.9441;;3881765;;10.1073/pnas.82.2.488;;pmc397064;;10.1016/0076-6879(87)54085-x;;3323813;;9826348;;pmc108724;;10.1128/iai.66.12.5731-5742.1998;;8890210;;pmc174416;;10.1128/iai.64.11.4580-4585.1996;;7768627;;pmc173317;;10.1128/iai.63.6.2382-2386.1995;;11567767;;10.1016/s0264-410x(01)00268-7;;pmc108433;;9673271;;10.1128/iai.66.8.3848-3855.1998;;pmc184039;;10.1186/rr199;;12783622,"FEARON; LOCKSLEY, SCIENCE, vol. 272, 1996, pages 50;;MEDZHITOV; JANEWAY, CURR. OPIN. IMMUNOL., vol. 9, 1997, pages 4;;MOSMANN ET AL., J. IMMUNOL., vol. 136, 1986, pages 2348;;STREET; MOSMANN, FASEB J., vol. 5, 1991, pages 171;;LOWELL ET AL., J. EXP. MED, vol. 167, 1988, pages 658;;LOWELL ET AL., SCIENCE, vol. 240, 1988, pages 800;;LYNCH ET AL., BIOPHYS. J, vol. 45, 1984, pages 104;;LOWELL: ""New Generation Vaccines"", 1997, MARCEL DEKKER, INC., pages: 193;;DARVEAU ET AL., INFECT. IMMUN., vol. 72, 2004, pages 5041 - 5051;;MEDZHITOV; JANEWAY, TRENDS IN MICROBIOL., vol. 8, 2000, pages 452;;HOFFMANN ET AL., SCIENCE, vol. 284, 1999, pages 1313;;LEE ET AL., SCIENCE, vol. 305, 2004, pages 1773;;HUMBLES ET AL., SCIENCE, vol. 305, 2004, pages 1776;;LACK ET AL., J. IMMUNOL., vol. 157, 1996, pages 1432;;GAVETT ET AL., J. EXP. MED., vol. 182, 1995, pages 1;;KLINE ET AL., J. IMMUNOL., vol. 160, 1998, pages 2555;;LOWELL ET AL., J. EXP. MED., vol. 167, 1988, pages 658;;LYNCH ET AL., BIOPHYS. J., vol. 45, 1984, pages 104;;ALTSCHUL, J MOL. BIOL., vol. 219, 1991, pages 555 - 565;;HENIKOFF; HENIKOFF, PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 10915 - 10919;;PERUSKI; PERUSKI: ""The Internet and the New Biology: Tools for Genomic and Molecular Research"", 1997, ASM PRESS, INC.;;""Methods in Gene Biotechnology"", 1997, CRC PRESS, INC., article ""Information Superhighway and Computer Databases of Nucleic Acids and Proteins"", pages: 123 - 151;;""Guide to Human Genome Computing"", 1998, ACADEMIC PRESS, INC.;;KRAMER ET AL., NUCLEIC ACIDS RES., vol. 12, 1984, pages 9441;;KUNKEL: ""Proc. Natl. Acad. Sci. USA"", vol. 82, 1985, ANGLIAN BIOTECHNOLOGY LTD HANDBOOK, pages: 488 - 492;;KUNKEL ET AL., METHODS IN ENZYMOL., vol. 154, 1987, pages 367 - 382;;SAMBROOK ET AL.: ""Molecular Cloning: A Laboratory Manual"", 2001, COLD SPRING HARBOR LABORATORY PRESS;;LINDLER ET AL., INFECT. IMMUN., vol. 66, 1998, pages 5731 - 5742;;ANDERSON ET AL., INFECT. IMMUN., vol. 64, 1996, pages 4580 - 4585;;""Remingtons Pharmaceutical Sciences"", 1985, MACK PUBLISHING CO.;;MALLETT ET AL., INFECT. IMMUN., vol. 63, 1995, pages 2382;;PLANTE ET AL., VACCINE, vol. 20, 2001, pages 218;;PETERSON ET AL., INFECT. IMMUN., vol. 66, 1998, pages 3848;;IRVIN ET AL., RESPIR. RES., vol. 4, 2003, pages 4",ACTIVE
564,US,A1,US 2005/0265633 A1,138-430-018-363-200,2005-12-01,2005,US 13690805 A,2005-05-25,US 13690805 A;;US 57417504 P,2004-05-25,Low latency pyramid processor for image processing systems,"A video processor that uses a low latency pyramid processing technique for fusing images from multiple sensors. The imagery from multiple sensors is enhanced, warped into alignment, and then fused with one another in a manner that provides the fusing to occur within a single frame of video, i.e., sub-frame processing. Such sub-frame processing results in a sub-frame delay between a moment of capturing the images to the display of the fused imagery.",SARNOFF CORP,PIACENTINO MICHAEL R;;VAN DER WAL GOOITZEN SIEMEN;;BURT PETER J;;BERGEN JAMES R,SARNOFF CORPORATION (2005-05-25),https://lens.org/138-430-018-363-200,Patent Application,yes,11,139,3,3,0,G06T2207/20016;;G06T5/50;;G06T2207/20221;;G06T5/50;;G06T2207/20016;;G06T2207/20221,G06K9/32;;G06K9/36;;G06K9/40;;G06K9/46;;G06T5/00;;G06T5/50,382/302;;382/265;;382/294;;382/240,0,0,,,,DISCONTINUED
565,EP,B1,EP 2174665 B1,057-747-924-372-335,2016-11-16,2016,EP 10001123 A,2004-10-22,EP 04796097 A;;US 51361403 P;;US 55984204 P,2003-10-22,Compositions and methods for activating innate and allergic immunity,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma.",ID BIOMEDICAL CORP QUEBEC,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID H;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,ID BIOMEDICAL CORPORATION OF QUEBEC (2016-12-07),https://lens.org/057-747-924-372-335,Granted Patent,yes,2,0,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K39/39;;A61K39/095;;A61K39/112;;A61P11/06;;A61P37/00,,1,1,186-670-573-319-392,12942028,"MIRLASHARI MOHAMMAD REZA ET AL: ""Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis"", MEDICAL SCIENCE MONITOR, MEDISCIENCE PUBLIKACJE NAUKOWE, WARZAW, PL, vol. 9, no. 8, 1 August 2003 (2003-08-01), pages BR316 - BR324, XP008166979, ISSN: 1234-1010, Retrieved from the Internet <URL:http://www.medscimonit.com/abstract/index/idArt/13093>",ACTIVE
566,EP,B1,EP 1689433 B1,119-569-790-996-051,2010-06-30,2010,EP 04796097 A,2004-10-22,US 2004/0035041 W;;US 51361403 P;;US 55984204 P,2003-10-22,COMPOSITIONS AND METHODS FOR ACTIVATING INNATE AND ALLERGIC IMMUNITY,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma.",ID BIOMEDICAL CORP QUEBEC,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,,https://lens.org/119-569-790-996-051,Granted Patent,yes,2,0,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K39/39;;A61K39/095;;A61K39/112;;A61P11/06;;A61P37/00,,1,1,058-600-524-958-468,pmc173248;;10.1128/iai.63.5.1947-1954.1995;;7729907,"LILLIAN L. VAN DE VERG ET AL.: ""Antibody and cytokine responses in a pulmonary model of Shigella flexneri serotype 2a infection"", INFECTION AND IMMUNITY, vol. 63, no. 5, May 1995 (1995-05-01), pages 1947 - 1954",ACTIVE
567,US,A1,US 2009/0318337 A1,021-740-160-946-467,2009-12-24,2009,US 97206204 A,2004-10-22,US 97206204 A;;US 55984204 P;;US 51361403 P,2003-10-22,Compositions and methods for activating innate and allergic immunity,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma).",ID BIOMEDICAL CORP QUEBEC,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,ID BIOMEDICAL CORPORATION OF QUEBEC (2005-01-12),https://lens.org/021-740-160-946-467,Patent Application,yes,14,9,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K39/39;;A61K38/16;;A61P37/04,514/12,0,0,,,,ACTIVE
568,US,A1,US 2009/0324639 A1,072-920-723-758-91X,2009-12-31,2009,US 11109308 A,2008-04-28,US 11109308 A;;US 97206204 A;;US 55984204 P;;US 51361403 P,2003-10-22,COMPOSITIONS AND METHODS FOR ACTIVATING INNATE AND ALLERGIC IMMUNITY,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma).",ID BIOMEDICAL CORP QUEBEC,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,,https://lens.org/072-920-723-758-91X,Patent Application,yes,20,8,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K39/145;;A61K38/16;;A61K39/00;;A61K39/02;;A61K39/07;;A61K39/108;;A61K39/118;;A61K39/12;;A61K39/39;;A61P37/04,424/206.1;;514/12;;424/184.1;;424/204.1;;424/234.1;;424/274.1;;424/265.1;;424/246.1;;424/263.1;;424/257.1,0,0,,,,DISCONTINUED
569,US,B2,US 8709447 B2,166-708-914-015-289,2014-04-29,2014,US 201213457223 A,2012-04-26,US 201213457223 A;;US 97206204 A;;US 55984204 P;;US 51361403 P,2003-10-22,Compositions and methods for activating innate and allergic immunity,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma).",LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT;;ID BIOMEDICAL CORP QUEBEC,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,,https://lens.org/166-708-914-015-289,Granted Patent,yes,36,2,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K39/35;;A61K39/00;;A61K39/116;;A61K39/36;;A61K39/38;;A61K39/39;;A61K45/00;;A61K47/00,424/275.1;;424/203.1;;424/278.1;;424/184.1,40,33,001-103-753-661-611;;159-271-636-020-316;;018-299-354-320-363;;064-706-766-480-797;;107-293-830-515-014;;107-732-274-271-558;;058-600-524-958-468;;024-424-760-226-513;;046-900-779-221-563;;021-913-821-342-314;;016-257-641-559-889;;086-707-718-808-930;;004-980-046-086-471;;025-474-060-346-778;;011-239-769-153-844;;007-566-952-820-469;;072-248-269-529-638;;029-894-243-872-70X;;065-163-335-434-850;;083-843-865-256-061;;072-863-515-004-410;;019-043-147-421-804;;051-252-321-227-371;;067-198-252-029-430;;016-416-627-147-613;;039-804-218-014-755;;082-621-397-459-772;;000-437-395-309-784;;000-682-460-525-539;;025-976-750-111-52X;;049-997-876-120-329;;121-724-358-739-397;;071-676-238-574-799,9389296;;10.1016/s0091-6749(97)70170-2;;19410159;;10.1016/s1098-3597(09)62036-6;;10.1016/s0091-6749(99)70369-6;;10452747;;15661386;;10.1016/j.vaccine.2004.09.010;;16243411;;10.1016/j.vaccine.2005.09.052;;8585293;;10.1016/0264-410x(94)00083-y;;pmc173248;;10.1128/iai.63.5.1947-1954.1995;;7729907;;8890210;;pmc174416;;10.1128/iai.64.11.4580-4585.1996;;12960260;;10.1189/jlb.0203082;;10.1517/13543784.8.2.95;;15992065;;9336663;;pmc172935;;10.1128/cmr.10.4.585;;10.1126/science.272.5258.50;;8600536;;pmc98531;;11401998;;10.1128/iai.69.7.4545-4553.2001;;7595222;;10.1084/jem.182.5.1527;;pmc2192202;;10334979;;10.1126/science.284.5418.1313;;15375268;;10.1126/science.1100283;;8717408;;10.1016/0168-1656(95)00124-7;;15315848;;10.1016/j.vaccine.2004.03.035;;9510150;;8759723;;10.1016/s1367-5931(03)00077-2;;12941417;;15375267;;10.1126/science.1099472;;9826348;;pmc108724;;10.1128/iai.66.12.5731-5742.1998;;pmc2188847;;10.1084/jem.167.2.658;;3346624;;10.1126/science.2452484;;2452484;;19431528;;pmc1435294;;10.1016/s0006-3495(84)84127-2;;7768627;;pmc173317;;10.1128/iai.63.6.2382-2386.1995;;10.1016/s0952-7915(97)80152-5;;9039775;;11044679;;10.1016/s0966-842x(00)01845-x;;17428863;;10.1128/jvi.00042-07;;pmc1900075;;10.1016/s1471-4906(02)02222-6;;12072368;;8500877;;10.1128/iai.61.6.2390-2395.1993;;pmc280860;;pmc108433;;9673271;;10.1128/iai.66.8.3848-3855.1998,"Schappi et al., J Allergy Clin Immunol, 1997; 100: 656-61.;;Stoloff, Clinical Cornerstone, 2008; 9(2): 6-23.;;Elliott et al., J Allergy Clin Immunol, 1999; 104: 294-300.;;Chabot et al., ""A novel intranasal Protollin(TM)-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice,"" Vaccine 23:1374-1383, 2005.;;Jones et al., ""Intranasal Protollin(TM)/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection,"" Vaccine 24:1625-1632, 2006.;;Levi et al., ""Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes,"" Vaccine 13(14):1353-1359, 1995.;;Van De Verg et al., ""Antibody and Cytokine Responses in a Mouse Pulmonary Model of Shigella flexneri Serotype 2a Infection,"" Infection and Immunity 63(5):1947-1954, May 1995.;;Anderson et al., ""Recombinant V Antigen Protects Mice against Pneumonic and Bubonic Plague Caused by F1-Capsule-Positive and -Negative Strains of Yersinia pestis,"" Infection and Immunity 64(11):4580-4585, Nov. 1996.;;Beutler et al., ""How we detect microbes and respond to them: the Toll-like receptors and their transducers,"" Journal of Leukocyte Biology 74:479-485, 2003.;;Boslego et al., Chapter 17, ""Gonorrhea Vaccines,"" in Vaccines, W. B. Saunders Company, 1988, pp. 211-223.;;Burt et al., ""Protollin(TM)-A Novel Mucosal Adjuvant for the Activation of Innate and Adaptive Immunity,"" Clinical and Investigative Medicine 27(4), Abstract No. 4613, Abstracts of the 12th International Congress of Immunology and 4th Annual Conference of FOCIS, Jul. 2004, URL=www.immuno2004.org/onlineabstracts/4613.html, retrieved on Apr. 7, 2005.;;Clerici et al., ""Vaccine strategies for infectious diseases,"" Expert Opinion Investigational Drugs 8(2):95-106, 1999.;;Deepe, ""Prospects for the Development of Fungal Vaccines,"" Clinical Microbiology Reviews 10(4):585-596, Oct. 1997.;;DeMets, ""Chlamydia trachomatis,"" Bacteriology at UW-Madison 330 Lecture Topic, URL=http://www.bact.wisc.edu/bact330/lecturechlamydia, 1998, accessed on Aug. 31, 2005.;;Ellis, Chapter 29, ""New Technologies for Making Vaccines,"" in Vaccines, W. B. Saunders Company, 1988, pp. 568-575.;;Fearon et al., ""The Instructive Role of Innate Immunity in the Acquired Immune Response,"" Science 272:50-54, Apr. 5, 1996.;;Fries et al., ""Safety and Immunogenicity of Proteosome-Shigella flexneri 2a Lipopolysaccharide Vaccine Administered Intranasally to Healthy Adults,"" Infection and Immunity 69(7):4545-4553, Jul. 2001.;;Gavett et al., ""Interleukin 12 Inhibits Antigen-induced Airway Hyperresponsiveness, Inflammation, and Th2 Cytokine Expression in Mice,"" J. Exp. Med. 182:1527-1536, Nov. 1995.;;Hoffman et al., ""Phylogenetic Perspectives in Innate Immunity,"" Science 284:1313-1318, May 21, 1999.;;Humbles et al., ""A Critical Role for Eosinophils in Allergic Airways Remodeling,"" Science 305:1776-1779, Sep. 17, 2004.;;Jahn-Schmid, Toward Selective Elicitation of TH1-controlled Vaccination Responses: Vaccine Applications of Bacterial Surface Layer Proteins, Journal of Biotechnology 44(1996) 225-231.;;Jones et al., ""Protollin(TM): a novel adjuvant for intranasal vaccines,"" Vaccine 22:3691-3697, 2004.;;Kline et al., ""Cutting Edge: Modulation of Airway Inflammation by CpG Oligodeoxynucleotides in a Murine Model of Asthma,"" Journal of Immunology 160:2555-2559, 1998.;;Lack et al., ""Nebulized IFN-gamma Inhibits the Development of Secondary Allergic Responses in Mice,"" Journal of Immunology 157:1432-4139, 1996.;;Lawton et al., ""Novel therapeutic strategies based on toll-like receptor signaling,"" Current Opinion in Chemical Biology 7:446-451, 2003.;;Lee et al., ""Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils,"" Science 305:1773-1776, Sep. 17, 2004.;;Lindler et al., ""Complete DNA Sequence and Detailed Analysis of the Yersinia pestis KIM5 Plasmid Encoding Murine Toxin and Capsular Antigen,"" Infection and Immunity 66(12):5731-5742, Dec. 1998.;;Lowell et al., ""Peptides Bound to Proteosomes Via Hydrophobic Feet Become Highly Immunogenic Without Adjuvants,"" Journal of Experimental Medicine 167(2):658-663, Feb. 1, 1988.;;Lowell et al., ""Proteosome-Lipopeptide Vaccines- Enhancement of Immunogenicity for Malaria CS Peptides,"" Science 240:800-802, May 6, 1988.;;Lowell, New Generation Vaccines, 2nd Edition, Marcel Dekker, Inc., New York, Chapter 15, ""Proteosomes for Improved Nasal, Oral, or Injectable Vaccines,"" pp. 193-206, 1997.;;Lynch et al., ""Spontaneously Transferred from Whole Cells and Reconstituted from Purified Proteins of Neisseria gonorrhoeae and Neisseria meningitidis,"" Biophysical Journal, 45(1):104-107, Jan. 1984.;;Mallett et al., ""Intranasal or Intragastric Immunization with Proteosome-Shigella Lipopolysaccharide Vaccines Protects against Lethal Pneumonia in a Murine Model of Shigella Infection,"" Infection and Immunity 63(6):2382-2386, Jun. 1995.;;Medzhitov et al., ""Innate immunity: impact on the adaptive immune response,"" Current Opinion In Immunology 9:4-9, 1997.;;Medzhitov et al., ""The Toll receptor family and microbial recognition,"" Trends in Microbiology 8(10):452-456, Oct. 2000.;;Milush et al., ""Mucosal Innate Immune Response Associated with a Timely Humoral Immune Response and Slower Disease Progression after Oral Transmission of Simian Immunodeficiency Virus to Rhesus macaques,"" Journal of Virology 81(12):6175-6186, Jun. 2007.;;O'Neill, ""Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal?,"" TRENDS in Immunology 23(6):296-300, 2002.;;Orr et al., ""Immunogenicity and Efficacy of Oral or Intranasal Shigella flexneri 2a and Shigella sonnei Proteosome-Lipopolysaccharide Vaccines in Animal Models,"" Infection and Immunity 61(6):2390-2395, Jun. 1993.;;Peterson et al., ""Characterization of a Neutralizing Monoclonal Antibody Directed at the Lipopolysaccharide of Chlamydia pneumoniae,"" Infection and Immunity 66(8):3848-3855, Aug. 1998.;;Stedman's Online Medical Dictionary, Definition: Immunity, accessed Aug. 31, 2005, URL=http://216.251.232.159/semdweb/internetsomdlASPI1528142.asp.;;Wetzler et al., ""Immune Stimulation by Neisserial Porins is TLR2 and MyD88 Dependent,"" Abstracts of the General Meeting of the American Society for Microbiology 102:189, 2002.",ACTIVE
570,ES,T3,ES 2346441 T3,077-678-475-892-624,2010-10-15,2010,ES 04796097 T,2004-10-22,US 51361403 P;;US 55984204 P,2003-10-22,COMPOSICIONES Y PROCEDIMIENTOS PARA ACTIVAR UNA INMUNIDAD INNATA Y ALERGICA.,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma.",ID BIOMEDICAL CORP QUEBEC,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,,https://lens.org/077-678-475-892-624,Granted Patent,no,0,0,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K39/39;;A61K39/095;;A61K39/112;;A61P11/06;;A61P37/00,,0,0,,,,ACTIVE
571,CA,C,CA 2543080 C,151-307-996-160-057,2019-01-08,2019,CA 2543080 A,2004-10-22,US 51361403 P;;US 55984204 P;;US 2004/0035041 W,2003-10-22,COMPOSITIONS AND METHODS FOR ACTIVATING INNATE AND ALLERGIC IMMUNITY,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma).",ID BIOMEDICAL CORP QUEBEC,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,,https://lens.org/151-307-996-160-057,Granted Patent,no,0,0,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K39/39;;A61K39/095;;A61K39/112;;A61P11/06;;A61P37/00,,0,0,,,,ACTIVE
572,EP,A1,EP 1689433 A1,032-503-923-464-694,2006-08-16,2006,EP 04796097 A,2004-10-22,US 2004/0035041 W;;US 51361403 P;;US 55984204 P,2003-10-22,COMPOSITIONS AND METHODS FOR ACTIVATING INNATE AND ALLERGIC IMMUNITY,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma.",ID BIOMEDICAL CORP QUEBEC,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,,https://lens.org/032-503-923-464-694,Patent Application,yes,0,0,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K39/39;;A61K39/095;;A61K39/112;;A61P11/06;;A61P37/00,,0,0,,,,ACTIVE
573,CA,A1,CA 2543080 A1,026-720-715-517-687,2005-05-12,2005,CA 2543080 A,2004-10-22,US 51361403 P;;US 55984204 P;;US 2004/0035041 W,2003-10-22,COMPOSITIONS AND METHODS FOR ACTIVATING INNATE AND ALLERGIC IMMUNITY,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma.",ID BIOMEDICAL CORP QUEBEC,JONES DAVID HUGH;;BURT DAVID S;;LOWELL GEORGE H;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,,https://lens.org/026-720-715-517-687,Patent Application,no,0,0,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K39/39;;A61K39/095;;A61K39/112;;A61P11/06;;A61P37/00,,0,0,,,,ACTIVE
574,US,B2,US 8173140 B2,181-338-508-272-990,2012-05-08,2012,US 97206204 A,2004-10-22,US 97206204 A;;US 55984204 P;;US 51361403 P,2003-10-22,Compositions and methods for activating innate and allergic immunity,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma).",LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT;;ID BIOMEDICAL CORP QUEBEC,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,ID BIOMEDICAL CORPORATION OF QUEBEC (2005-01-12),https://lens.org/181-338-508-272-990,Granted Patent,yes,28,4,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K45/00;;A61K39/00;;A61K39/095;;A61K39/385;;A61K39/39,424/278.1;;424/184.1;;424/234.1;;424/249.1;;424/250.1;;424/197.11;;424/193.1,33,27,016-257-641-559-889;;121-724-358-739-397;;004-980-046-086-471;;081-860-062-539-844;;021-913-821-342-314;;024-424-760-226-513;;086-707-718-808-930;;025-474-060-346-778;;011-239-769-153-844;;007-566-952-820-469;;065-163-335-434-850;;083-843-865-256-061;;019-043-147-421-804;;051-252-321-227-371;;067-198-252-029-430;;016-416-627-147-613;;039-804-218-014-755;;082-621-397-459-772;;000-437-395-309-784;;000-682-460-525-539;;071-676-238-574-799;;072-248-269-529-638;;025-976-750-111-52X;;029-894-243-872-70X;;046-900-779-221-563;;072-863-515-004-410;;049-997-876-120-329,9336663;;pmc172935;;10.1128/cmr.10.4.585;;8500877;;10.1128/iai.61.6.2390-2395.1993;;pmc280860;;pmc98531;;11401998;;10.1128/iai.69.7.4545-4553.2001;;10.1016/b978-1-4557-0090-5.00013-6;;10.1517/13543784.8.2.95;;15992065;;8890210;;pmc174416;;10.1128/iai.64.11.4580-4585.1996;;10.1126/science.272.5258.50;;8600536;;7595222;;10.1084/jem.182.5.1527;;pmc2192202;;10334979;;10.1126/science.284.5418.1313;;15375268;;10.1126/science.1100283;;9510150;;8759723;;15375267;;10.1126/science.1099472;;9826348;;pmc108724;;10.1128/iai.66.12.5731-5742.1998;;pmc2188847;;10.1084/jem.167.2.658;;3346624;;10.1126/science.2452484;;2452484;;19431528;;pmc1435294;;10.1016/s0006-3495(84)84127-2;;7768627;;pmc173317;;10.1128/iai.63.6.2382-2386.1995;;10.1016/s0952-7915(97)80152-5;;9039775;;11044679;;10.1016/s0966-842x(00)01845-x;;pmc108433;;9673271;;10.1128/iai.66.8.3848-3855.1998;;8717408;;10.1016/0168-1656(95)00124-7;;17428863;;10.1128/jvi.00042-07;;pmc1900075;;15315848;;10.1016/j.vaccine.2004.03.035;;12960260;;10.1189/jlb.0203082;;10.1016/s1367-5931(03)00077-2;;12941417;;10.1016/s1471-4906(02)02222-6;;12072368,"Deepe (Prospects for the development of fungal vaccines, Clinical Microbiology Reviews, 1997; 10(4): 585-96).;;Orr et al (Immunogenicity and Efficacy of Oral or Intranasal Shigella flexneri 2a and Shigella sonnei Proteosome-Lipoplysaccharide Vaccines in Animal Models, Infection and Immunity, 1993; 61(6): 2390-2395).;;Fries et al (Safety and Immunogenicity of Proteosome-Shigella flexneri 2a Lipopolysaccharide Vaccine Administered Intranasally to Healthy Adults, Infection and Immunity, 2001; 69(7): 4545-4553).;;Stedman'sOnline Medical Dictionary, Definition: Immunity, Aug. 2005.;;Boslego, J. et al (Gonorrhea Vaccines , Chapter 17, 211-223), 1988.;;Ellis, R (New Technologies for Making Vaccines, text book, 1998, 568-575).;;Clerici et al (Vaccine strategies for infectious diseases, Exp. Opin. Invest. Drugs, 1999; 8(2): 95-106).;;DeMets (Chlamydia trachomatis, Bacteriology at UW-Madison 330 Lecture Topic, http://www.bact.wisc.edu/bact330/lecturechlamydia, pp. 1-7), Aug. 2005.;;Burt, D. S. et al., ""Protollin(TM)-A Novel Mucosal Adjuvant for the Activation of Innate and Adaptive Immunity,"" Clinical and Investigate Medicine, 27(2), Abstracts of the 12th International Congress of Immunology Jul. 2004, URL:www.immuno2004.org/onlineabstracts/4613.html, retrieved on Apr. 7, 2005.;;Anderson, G.W. et al., ""Recombinant V Antigen Protects Mice against Pneumonic and Bubonic Plague Caused by F1-Capsule-Positive and -Negative Strains of Yersinia pestis,"" Infection and Immunity, 64(11):4580-4585, Nov. 1996.;;Fearon, D.T. and Locksley, R.M. ""The Instructive Role of Innate Immunity in the Acquired Immune Response,"" Science, 272:50-54, Apr. 5, 1996.;;Gavett, S.H. et al., ""Interleukin 12 Inhibits Antigen-induced Airway Hyperresponsiveness, Inflammation, and Th2 Cytokine Expression in Mice,"" J. Exp. Med., 182:1527-1536, Nov. 1995.;;Hoffman, J.A. et al., ""Pylogenetic Perspectives in Innate Immunity,"" Science, 284:1313-1318, May 21,1999.;;Humbles, A.A. et al., ""A Critical Role for Eosinophils in Allergic Airways Remodeling,"" Science, 305:1776-1779, Sep. 17, 2004.;;Kline, J.N. et al., ""Cutting Edge: Modulation of Airway Inflammation by CpG Oligodeoxynucleotides in a Murine Model of Asthma,"" Journal of Immunology., 160:2555-2559, 1998.;;Lack, G. et al., ""Nebulized IFN-gamma Inhibits the Development of Secondary Allergic Responses in Mice,"" Journal of Immunology, 157:1432-4139, 1996.;;Lee, J.J. et al., ""Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils,"" Science, 305:1773-1776, Sep. 17, 2004.;;Lindler, L.E. et al., ""Complete DNA Sequence and Detailed Analysis of the Yersinia pestis KIM5 Plasmid Encoding Murine Toxin and Capsular Antigen,"" Infection and Immunity, 66(12):5731-5742, Dec. 1998.;;Lowell, G.H. et al., ""Peptides Bound to Proteosomes Via Hydrophobic Feet Become Highly Immunogenic Without Adjuvants,"" Journal of Experimental Medicine, 167(2):658-663, Feb. 1, 1988.;;Lowell, G.H. et al., ""Proteosome-Lipopeptide Vaccines: Enhancement of Immunogenicity for Malaria CS Peptides,"" Science, 240:800-802, May 6, 1988.;;Lowell, G.H., New Generation Vaccines, 2nd Edition, Marcel Dekker, Inc., New York, Chapter 15, ""Proteosomes for Improved Nasal, Oral, or Injectable Vaccines,"" pp. 193-206, 1997.;;Lynch, E.C. et al. ""Spontaneously Transferred from Whole Cells and Reconstituted from Purified Proteins of Neisseria gonorrhoeae and Neisseria meningitidis,"" Biophysical Journal, 45(1):104-107, Jan. 1984.;;Mallett, C.P. et al., ""Intranasal or Intragastric Immunization with Proteosome-Shigella Lipopolysaccharide Vaccines Protects against Lethal Pneumonia in a Murine Model of Shigella Infection,"" Infection and Immunity, 63(6):2382-2386, Jun. 1995.;;Medzhitov, R. and Janeway, C.A., Jr., ""Innate immunity: impact on the adaptive immune response,"" Current Opinion in Immunology9:4-9, 1997.;;Medzhitov, R. and Janeway, C.A., Jr., ""The Toll receptor family and microbial recognition,"" Trends in Microbiology, 8(10):452-456, Oct. 2000.;;Peterson, E.M. et al., ""Characterization of a Neutralizing Monoclonal Antibody Directed at the Lipopolysaccharide of Chlamydia pneumoniae,"" Infection and Immunity, 66(8):3848-3855, Aug. 1998.;;Jahn-Schmid, B., Toward Selective Elicitation of TH1-controlled Vaccination Responses: Vaccine Applications of Bacterial Surface Layer Proteins, Journal of Biotechnology, 44 (1996) 225-231.;;Milush et al., ""Mucosal Innate Immune Response Associated with a Timely Humoral Immune Response and Slower Disease Progression after Oral Transmission of Simian Immunodeficiency Virus to Rhesus Macaques,"" Journal of Virology 81(12):6175-6186, Jun. 2007.;;Jones et al., ""Protollin(TM): a novel adjuvant for intranasal vaccines,"" Vaccine 22:3691-3697, 2004.;;Beutler et al., ""How we detect microbes and respond to them: the Toll-like receptors and their transducers,"" Journal of Leukocyte Biology 74:479-485, 2003.;;Lawton et al., ""Novel therapeutic strategies based on toll-like receptor signaling,"" Current Opinion in Chemical Biology 7:446-451, 2003.;;O'Neill, ""Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal?,"" TRENDS in Immunology 23(6):296-300, 2002.;;Wetzler et al., ""Immune Stimulation by Neisserial Porins is TLR2 and MyD88 Dependent,"" Abstracts of the General Meeting of the American Society for Microbiology 102:189, 2002.",ACTIVE
575,EP,A3,EP 2174665 A3,034-404-009-674-808,2010-06-23,2010,EP 10001123 A,2004-10-22,EP 04796097 A;;US 51361403 P;;US 55984204 P,2003-10-22,Compositions and methods for activating innate and allergic immunity,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma.",ID BIOMEDICAL CORP QUEBEC,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID H;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,ID BIOMEDICAL CORPORATION OF QUEBEC (2016-12-07),https://lens.org/034-404-009-674-808,Search Report,yes,2,0,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K39/39;;A61K39/095;;A61K39/112;;A61P11/06;;A61P37/00,,3,2,082-621-397-459-772;;029-894-243-872-70X,7768627;;pmc173317;;10.1128/iai.63.6.2382-2386.1995;;15315848;;10.1016/j.vaccine.2004.03.035,"MALLETT C P ET AL: ""INTRANASAL OR INTRAGASTRIC IMMUNIZATION WITH PROTEOSOME-SHIGELLA LIPOPOLYSACCHARIDE VACCINES PROTECTS AGAINST LETHAL PNEUMONIA IN A MURINE MODEL OF SHIGELLA INFECTION"", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 63, no. 6, 1 June 1995 (1995-06-01), pages 2382 - 2386, XP000608953, ISSN: 0019-9567;;JONES T ET AL: ""Protollin(TM): a novel adjuvant for intranasal vaccines"", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 22, no. 27-28, 9 September 2004 (2004-09-09), pages 3691 - 3697, XP004526949, ISSN: 0264-410X;;DAVID S. BURT ET AL.: ""PROTOLLIN TM - A NOVEL MUCOSAL ADJUVANT FOR THE ACTIVATION OF INNATE AND ADAPTIVE IMMUNITY"", CLINICAL AND INVESTIGATE MEDICINE, vol. 27, no. 4, XP002323596, Retrieved from the Internet <URL:www.immuno2004.org/onlineabstracts/4613.html> [retrieved on 20050407]",ACTIVE
576,ES,T3,ES 2615169 T3,046-968-274-888-793,2017-06-05,2017,ES 10001123 T,2004-10-22,US 51361403 P;;US 55984204 P,2003-10-22,Composiciones y procedimientos de activación de la inmunidad innata y alérgica,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma.",ID BIOMEDICAL CORP QUEBEC,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID H;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,,https://lens.org/046-968-274-888-793,Granted Patent,no,0,0,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K39/39;;A61K39/095;;A61K39/112;;A61P11/06;;A61P37/00,,0,0,,,,ACTIVE
577,US,A1,US 2014/0234374 A1,046-831-802-043-210,2014-08-21,2014,US 201414263390 A,2014-04-28,US 201414263390 A;;US 201213457223 A;;US 97206204 A;;US 51361403 P;;US 55984204 P,2003-10-22,COMPOSITIONS AND METHODS FOR ACTIVATING INNATE AND ALLERGIC IMMUNITY,"Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma).",LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT;;ID BIOMEDICAL CORP QUEBEC,LOWELL GEORGE H;;BURT DAVID S;;JONES DAVID HUGH;;ZIMMERMANN JOSEPH J;;RIOUX CLEMENT,,https://lens.org/046-831-802-043-210,Patent Application,yes,5,0,22,22,0,A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;A61P11/00;;A61P11/06;;A61P17/00;;A61P31/04;;A61P31/10;;A61P31/12;;A61P31/16;;A61P37/00;;A61P37/04;;A61P37/06;;A61P37/08;;C07K14/22;;A61K2039/6037;;C12N2710/24143;;A61K39/165;;C07K14/005;;A61K39/145;;A61K39/00;;A61K35/74;;A61K39/39;;A61K2039/55544;;A61K2039/55572;;A61K2039/57;;Y02A50/30;;A61K39/095,A61K39/39;;A61K39/095,424/249.1,0,0,,,,ACTIVE
578,US,A1,US 2002/0178790 A1,178-034-579-861-142,2002-12-05,2002,US 80087201 A,2001-03-07,US 80087201 A;;US 18793100 P,2000-03-08,Differential permeometer,"
   Permeability of a porous, sheet-like sample is determined using a device that is designed to measure the pressure differential between a first stream of fluid applied across an entire thickness of a test sample and a second stream of fluid applied across an entire thickness of a reference sample. The flow rate for both the test fluid flow system and the reference fluid flow system is determined independently, by measuring a pressure drop throughout the flow system. Data obtained from pressure and flow rate for test and reference fluids are used to calculate percent change in permeability and/or actual permeability using Darcy's Law. 
",SWERSEY BURT;;HARVEY MARCIE J.;;KAPLAN ELIAS;;LAMANA JENNIFER;;HOWARD STEPHEN J.;;MELONEY DEAN;;WEED JOHN;;NOVAK TIMOTHY,SWERSEY BURT;;HARVEY MARCIE J;;KAPLAN ELIAS;;LAMANA JENNIFER;;HOWARD STEPHEN J;;MELONEY DEAN;;WEED JOHN;;NOVAK TIMOTHY,RENSSELAER POLYTECHNIC INSTITUTE (2001-04-28),https://lens.org/178-034-579-861-142,Patent Application,yes,11,20,2,2,0,G01N15/0826;;G01N15/0826,G01N15/08,73/38,0,0,,,,EXPIRED
579,US,B1,US 9170904 B1,138-602-656-335-149,2015-10-27,2015,US 21598408 A,2008-06-30,US 21598408 A,2008-06-30,I/O fault injection using simulated computing environments,"A system for injecting I/O faults into a closed system, for example, the injection of link level I/O faults, involves the use of a simulated computing environment. In an embodiment, the system provides for fault injection using an emulated IBM System z environment and including the use of FICON and/or other suitable communication channel protocols. The emulated System z environment may include a simulated z/OS and/or emulated System z hardware and software components.",LECRONE DOUGLAS E;;JONES JEFFREY L;;LINSTEAD PAUL A;;BURT DENIS J;;POCOCK BRUCE A;;EMC CORP,LECRONE DOUGLAS E;;JONES JEFFREY L;;LINSTEAD PAUL A;;BURT DENIS J;;POCOCK BRUCE A,EMC CORPORATION (2008-08-19);;EMC IP HOLDING COMPANY LLC (2016-09-06),https://lens.org/138-602-656-335-149,Granted Patent,yes,13,22,1,2,0,G06F11/261;;G06F11/261;;G06F11/3664;;G06F11/3664,G06F11/00;;G06F11/26;;G06F11/36,,8,4,024-868-913-295-403;;036-584-735-967-924;;021-987-748-850-583;;029-878-661-869-909,10.1147/sj.411.0055;;10.1147/rd.464.0367;;10.1147/rd.435.0807;;10.1147/rd.483.0489,"Loveland, et al., ""Testing z/OS: The premier operating system for IBM's zSeries server,"" IBM Systems Journal, vol. 41, No. 1, 2002, pp. 55-73.;;Plambeck, et al., ""Development and attributes of z/Architecture,"" IBM J. Res. & Dev., vol. 46, No. 4/5, Jul./Sep. 2002, pp. 367-379.;;""z/Architecture: Principles of Operation,"" IBM, SA22-7832-04, 2005, pp. 1-58.;;""Hercules-General Information,"" Hercules System/370, ESA/390, z/Architecture Emulator, Version 3, Release 05, Modification 0, Publication No. HEGI030500-00, Sep. 1, 2007, pp. 1-140.;;DeCusatis, et al., ""Fiber optic interconnects for the IBM S/390 Parallel Enterprise Server G5,"" IBM J. Res. Develop., vol. 43, No. 5/6, Sep./Nov. 1999, pp. 807-828.;;Wyman, et al., ""Multiple-logical-channel subsystems: Increasing zSeries I/O scalability and connectivity,"" IBM J. Res. & Dev., vol. 48, No. 3/4, May/Jul. 2004, pp. 489-505.;;""IBM system z10 Enterprise Class (z10 EC) Reference Guide,"" IBM, Feb. 2008, 49 pp.;;""Introducing PSI System64(TM) The 64-Bit Open Mainframe for Today's z/Os Datacenter,"" Platform Solutions, Inc., Aug. 13, 2007, SHARE Session 9800, http://www.platform-solutions.com/literature.php, 36 pp.",ACTIVE
580,US,A,US 5895510 A,169-472-178-743-405,1999-04-20,1999,US 95576797 A,1997-10-22,US 95576797 A,1997-10-22,Air filter assembly,"In an air filter assembly a non-metallic air filter media is clamped between a pair of opposed metal end flanges, one of which is mounted by a threaded mounting rod in alignment with an opening through a horizontal panel. A metal sleeve integral with one of the end flanges stiffens the assembly and prevents the filter media from collapsing. The air filter assembly is used with numerous similar air filter assemblies to filter inlet combustion air for large gas turbine engines.",DANA CORP,BUTLER PATRICK G;;BROWNING BURT O;;GARNER WESLEY B;;ROGERS PAUL A;;WINKELER TIMOTHY J,DANA CORPORATION (1998-01-28);;WIX FILTRATION CORP (2004-11-30),https://lens.org/169-472-178-743-405,Granted Patent,yes,12,84,1,1,0,B01D46/2411;;B01D46/58;;B01D46/2411;;B01D46/58,B01D46/00;;B01D46/24,55/490;;55/495;;55/497;;55/502;;55/508;;55/510,0,0,,,,EXPIRED
581,US,B1,US 6253077 B1,181-814-089-983-660,2001-06-26,2001,US 8007298 A,1998-05-15,US 8007298 A;;US 4662897 P,1997-05-16,Downstream power control in point-to-multipoint systems,The invention provides methods and systems for power control in point-to-multipoint communications systems. Methods are described for downstream using an off-the-air monitor 31 and pick-up antenna 33. The monitor detects the power level of the pick-up signal and a control signal sets the transmittal output from the base station in proportion to the detected composite power level.,TEXAS INSTRUMENTS INC,BURT DONALD G;;MYERS WILLIAM K;;LANGSTON J LELAND;;MARIN JAMES SCOTT;;DARBE KEVIN B,TEXAS INSTRUMENTS INCORPORATED (1997-05-23),https://lens.org/181-814-089-983-660,Granted Patent,yes,14,61,1,1,0,H04W52/343;;H04W52/343;;H04W52/346;;H04W52/346,H04B7/005,455/424;;455/522;;455/67.1,0,0,,,,EXPIRED
582,EP,A1,EP 3325516 A1,183-937-186-677-748,2018-05-30,2018,EP 16745341 A,2016-07-21,US 201562194957 P;;US 201562273657 P;;US 201662316310 P;;US 2016/0043265 W,2015-07-21,A MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA,,DYAX CORP,MASON SHAUNA;;KENNISTON JON A;;NIXON ANDREW;;SEXTON DANIEL J;;COMEAU STEPHEN R;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-09-08);;DYAX CORP. (2018-06-13),https://lens.org/183-937-186-677-748,Patent Application,yes,0,0,29,29,0,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36,,0,0,,,,ACTIVE
583,WO,A3,WO 2014/031205 A3,032-441-252-942-526,2014-05-08,2014,US 2013/0042966 W,2013-05-29,US 201213487721 A,2012-06-04,SEAL LAND FOR STATIC STRUCTURE OF A GAS TURBINE ENGINE,A seal land for a gas turbine engine can include a seal body circumferentially extending about a longitudinal centerline axis. The seal body includes at least one sealing surface that extends in a plane that is transverse to the longitudinal centerline axis.,UNITED TECHNOLOGIES CORP,PORTER STEVEN D;;BURT JONATHAN P;;JAKIEL JONATHAN J;;GORDON AMY M;;DUELM SHELTON O,,https://lens.org/032-441-252-942-526,Search Report,yes,5,0,7,7,0,F16J15/0887;;F16J15/0887;;F01D9/02;;F01D9/02;;F01D11/005;;F01D11/005;;F01D11/08;;F01D11/08;;F02C7/28;;F02C7/28,F02C7/28;;F01D11/00;;F01D25/24,,1,0,,,See also references of EP 2855892A4,PENDING
584,CA,A1,CA 2249353 A1,049-827-622-567-76X,1997-09-25,1997,CA 2249353 A,1997-03-19,US 62113896 A;;US 2712796 P;;US 9704956 W,1996-03-21,METHOD FOR HYPERACCUMULATION OF METALS IN PLANT SHOOTS,"The present invention provides methods by which hyperaccumulation of metals in plant shoots is induced by exposure to inducing agents. In preferred embodiments, manipulations that increase availability of metals to the plant are employed prior to application of the inducing agent. Effective inducing agents include conditions of low pH, chelators, herbicides, and high levels of heavy metals. Other phytotoxic agents are also useful. Application of multiple inducing agents results in synergistic effects.",PHYTOTECH INC,BLAYLOCK MICHAEL J;;KUMAR NANDA P B A;;KAPULNIK YORAM;;DUSHENKOV SLAVIK;;ENSLEY BURT D,,https://lens.org/049-827-622-567-76X,Patent Application,no,0,2,1,7,0,,A01N61/00;;B09C1/00;;C02F3/32,,0,0,,,,DISCONTINUED
585,CN,A,CN 108137705 A,142-090-717-834-899,2018-06-08,2018,CN 201680046558 A,2016-07-21,US 201562194957 P;;US 201562273657 P;;US 201662316310 P;;US 2016/0043265 W,2015-07-21,A MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA,"Disclosed herein are anti-Factor Xlla antibodies and methods of using such for treating diseases associated with Factor XII, including diseases associated with contact system activation, plasma prekallikrein signaling (e.g., hereditary angioedema), and ocular diseases.",DYAX CORP,MASON SHAUNA;;KENNISTON JON A;;NIXON ANDREW;;SEXTON DANIEL J;;COMEAU STEPHEN R;;ADELMAN BURT,,https://lens.org/142-090-717-834-899,Patent Application,no,6,3,29,29,0,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36,,4,0,,,"张子彦主编: ""《遗传性血液病学》"", 30 June 2012;;LARSSON, MAGNUS等: ""A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk"", 《SCIENCE TRANSLATIONAL MEDICINE》;;ESNOUF, MP等: ""A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C(1)over-bar esterase inhibitor"", 《THROMBOSIS AND HAEMOSTASIS》;;贺石林等: ""内在凝血途径的接触激活--抗血栓形成研究的新靶点"", 《血栓与止血学》",ACTIVE
586,EP,A1,EP 2817496 A1,042-920-864-969-43X,2014-12-31,2014,EP 13751563 A,2013-02-21,US 201213403407 A;;US 2013/0026969 W,2012-02-23,TURBINE FRAME FAIRING FOR A GAS TURBINE ENGINE,,UNITED TECHNOLOGIES CORP,FARAH JORGE I;;KAPUSTKA THEODORE W;;BURT JONATHAN P;;JAKIEL JONATHAN J;;STEWART DANA P,"RAYTHEON TECHNOLOGIES CORPORATION (N.D.GES.D.S, US (2022-09-23);;UNITED TECHNOLOGIES CORPORATION (2016-10-26)",https://lens.org/042-920-864-969-43X,Patent Application,yes,0,0,6,6,0,B23K1/0018;;B23K1/0018;;B23K2101/001;;B23K2101/001;;F01D25/162;;F01D25/162;;F01D9/04;;F01D9/044;;F01D9/044;;F01D9/065;;F01D9/065;;F01D25/246;;F05D2230/237;;F05D2230/237,F02C7/00;;B23K1/00;;B23K101/00;;F01D9/02;;F01D9/04;;F01D9/06;;F01D25/16;;F01D25/24,,0,0,,,,ACTIVE
587,US,A1,US 2003/0202677 A1,097-786-503-813-721,2003-10-30,2003,US 42835999 A,1999-10-28,US 42835999 A;;US 18538098 A,1998-11-03,METHOD AND SYSTEM FOR RECOGNIZING SECURITY DOCUMENTS,"
   A document is analyzed to determine whether it is a banknote or the like, by reference to image data corresponding to the document. Two analysis techniques may be used, one based on detection of a visible pattern characteristic of a security document, the other based on detection of a steganographic digital watermark characteristic of a security document. If either characteristic is found, the image is flagged, and appropriate anti-counterfeiting steps may be taken. Detection of the visible pattern can be performed using a series of successively more rigorous tests. If the image fails a test, successive testing steps can be skipped, speeding the process. Hough transform-based pattern recognition techniques are used in some embodiments. Provision of both a visible pattern detector and a watermark detector in a single apparatus enhances detection reliability, while permitting various implementation efficiencies. 
",DAVIS BRUCE. L.;;PERRY BURT W.;;CARR J. SCOTT;;SHAW GILBERT B.;;RHOADS GEOFFREY B.,DAVIS BRUCE L;;PERRY BURT W;;CARR J SCOTT;;SHAW GILBERT B;;RHOADS GEOFFREY B,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC CORPORATION (2008-08-01);;DMRC LLC (2008-08-01),https://lens.org/097-786-503-813-721,Patent Application,yes,0,0,10,1547,0,G06F21/10;;G06F2221/2101;;G07D7/20;;H04N1/00843;;H04N1/00877;;G07D7/0034;;G06V10/40;;G06F12/16;;H04N1/00843;;G06F2221/2101;;G07D7/20;;H04N1/00877;;G06F21/10;;G07D7/0034;;G06V10/40,G06F3/12;;G06F1/00;;G06F21/00;;G06V10/40;;G07D7/12;;G07D7/20;;H04N1/00;;H04N1/387;;H04N1/40,3821,0,0,,,,EXPIRED
588,US,A1,US 2021/0230299 A1,139-478-032-830-951,2021-07-29,2021,US 202017136483 A,2020-12-29,US 202017136483 A;;US 201815746048 A;;US 2016/0043265 W;;US 201662316310 P;;US 201562273657 P;;US 201562194957 P,2015-07-21,MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA,"Disclosed herein are anti-Factor XIIa antibodies and methods of using such for treating diseases associated with Factor XII, including diseases associated with contact system activation, plasma prekallikrein signaling (e.g., hereditary angioedema), and ocular diseases.",DYAX CORP,MASON SHAUNA;;KENNISTON JON A;;NIXON ANDREW;;SEXTON DANIEL J;;COMEAU STEPHEN R;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2016-09-01),https://lens.org/139-478-032-830-951,Patent Application,yes,0,1,29,29,128,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36,,0,0,,,,PENDING
589,EP,B1,EP 2817496 B1,131-002-409-829-236,2017-07-05,2017,EP 13751563 A,2013-02-21,US 201213403407 A;;US 2013/0026969 W,2012-02-23,TURBINE FRAME FAIRING FOR A GAS TURBINE ENGINE,,UNITED TECHNOLOGIES CORP,FARAH JORGE I;;KAPUSTKA THEODORE W;;BURT JONATHAN P;;JAKIEL JONATHAN J;;STEWART DANA P,"RAYTHEON TECHNOLOGIES CORPORATION (N.D.GES.D.S, US (2022-09-23);;UNITED TECHNOLOGIES CORPORATION (2016-10-26)",https://lens.org/131-002-409-829-236,Granted Patent,yes,9,0,6,6,0,F01D25/162;;F05D2230/237;;B23K1/0018;;F01D9/044;;F01D9/065;;B23K2101/001;;F01D9/04;;F01D25/246;;B23K2101/001;;B23K1/0018;;F01D25/162;;F05D2230/237;;F01D9/065;;F01D9/044,F02C7/00;;B23K1/00;;B23K101/00;;F01D9/02;;F01D9/04;;F01D9/06;;F01D25/16;;F01D25/24,,0,0,,,,ACTIVE
590,WO,A1,WO 2002/011056 A1,162-098-201-286-563,2002-02-07,2002,US 0121268 W,2001-07-05,US 62940100 A,2000-08-01,MANAGEMENT OF DOCUMENTS AND OTHER OBJECTS USING OPTICAL DEVICES,"By printing documents and other objects with machine readable indicia, such as steganographic digital watermarks or barcodes, a great variety of document management functions can be enabled. The indicia can be added as part of the printing process (after document data has been output by an originating application program (12)), such as by printer driver (14) software, by a Postscript engine in a printer, etc. The indicia can encode data about the document, or can encode an identifier that references a database (18) record containing such data. By showing the printed document to a computer device (20) with a suitable optical input device (e.g., a webcam), an electronic version of the document can be recalled for editing, or other responsive action can be taken.",DIGIMARC CORP;;SEDER PHILLIP ANDREW;;CARR J SCOTT;;PERRY BURT W;;GRAHAM STANLEY E;;RHOADS GEOFFREY B,SEDER PHILLIP ANDREW;;CARR J SCOTT;;PERRY BURT W;;GRAHAM STANLEY E;;RHOADS GEOFFREY B,,https://lens.org/162-098-201-286-563,Patent Application,yes,8,0,9,1547,0,G06Q10/10;;G06Q30/02;;G07F17/26;;G06Q30/02;;G06Q10/10;;G07F17/26,G06Q10/00;;G06Q30/00;;G07F17/26,,0,0,,,,PENDING
591,MX,A,MX 2018000714 A,103-467-621-694-521,2019-11-18,2019,MX 2018000714 A,2016-07-21,US 201562194957 P;;US 201562273657 P;;US 201662316310 P;;US 2016/0043265 W,2015-07-21,A MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA.,"Disclosed herein are anti-Factor Xlla antibodies and methods of using such for treating diseases associated with Factor XII, including diseases associated with contact system activation, plasma prekallikrein signaling (e.g., hereditary angioedema), and ocular diseases.",DYAX CORP,BURT ADELMAN;;JON A KENNISTON;;STEPHEN R COMEAU;;ANDREW NIXON;;SHAUNA MASON;;DANIEL J SEXTON,,https://lens.org/103-467-621-694-521,Patent Application,no,0,0,29,29,0,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36,,0,0,,,,PENDING
592,WO,A2,WO 2007/024760 A2,199-800-528-630-581,2007-03-01,2007,US 2006/0032541 W,2006-08-21,US 71018805 P;;US 33134306 A,2005-08-23,MACHINE VISION COUNTING SYSTEM APPARATUS AND METHOD,"A machine-vision-based counter includes an image acquisition component (imager), wherein light provides discrimination between a background field and imageable units located away from the imager. The imager outputs data representing the field and units; an image processor receiving imager data finds countable units therein. An operator interface accepts command inputs and presents count output. A controller manages image acquisition, processor, and operator interface functions. A counting method includes configuring an imager to detect light, directing light from a source to units positioned to be detected by the imager, and directing the light to the imager. The method includes discriminating between a background field and imageable units; providing, as an imager output, data representing the field and units; configuring the processor to interpret the data as counted units on a background field; and configuring an operator interface to present a count result.",SPX CORP;;LIMER DANIEL J;;LANG DAVID A;;BURT CHRISTOPHER S;;GOUIN PHILIP R;;TARR NELSON D,LIMER DANIEL J;;LANG DAVID A;;BURT CHRISTOPHER S;;GOUIN PHILIP R;;TARR NELSON D,,https://lens.org/199-800-528-630-581,Patent Application,yes,0,2,6,6,0,A61J7/02;;G01N2015/1472;;G01N2015/1486;;G06M1/101;;G06M11/00;;G06V20/66;;G01N15/1433;;A61J7/02;;G01N2015/1486;;G01N2015/1472;;G06M1/101;;G06M11/00;;G01N15/1433,G03G15/00,,0,0,,,,PENDING
593,WO,A1,WO 2013/126471 A1,194-789-259-035-453,2013-08-29,2013,US 2013/0026969 W,2013-02-21,US 201213403407 A,2012-02-23,TURBINE FRAME FAIRING FOR A GAS TURBINE ENGINE,A static structure of a gas turbine engine includes a multiple of airfoil segments and at least one structural reinforcement ring mounted to the multiple of airfoil segments.,UNITED TECHNOLOGIES CORP,FARAH JORGE I;;KAPUSTKA THEODORE W;;BURT JONATHAN P;;JAKIEL JONATHAN J;;STEWART DANA P,,https://lens.org/194-789-259-035-453,Patent Application,yes,6,1,6,6,0,F01D25/162;;F05D2230/237;;B23K1/0018;;F01D9/044;;F01D9/065;;B23K2101/001;;F01D9/04;;F01D25/246;;B23K2101/001;;B23K1/0018;;F01D25/162;;F05D2230/237;;F01D9/065;;F01D9/044,F02C7/00;;F01D9/02;;F01D25/24,,0,0,,,,PENDING
594,JP,A,JP 2023145564 A,160-266-633-037-891,2023-10-11,2023,JP 2023117873 A,2023-07-19,JP 2021084554 A;;US 201562194957 P;;US 201562273657 P;;US 201662316310 P;;JP 2018501883 A,2015-07-21,MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIa,"To provide an anti-factor XIIa antibody, and use thereof for treating a disease related to contact system activation, plasma prekallikrein signaling (e.g., hereditary angioedema) and a disease related to factor XII such as an eye disease.SOLUTION: Provided is an antibody that specifically binds to factor XIIa (FXIIa) but does not specifically bind to factor XII (FXII). One aspect of the disclosure is a monoclonal antibody that binds to factor XIIa (FXIIa) but does not bind to factor XII (FXII). In some embodiments, this antibody is a full-length antibody or an antigen-binding fragment such as Fab. In some embodiments, this antibody is a human antibody or a humanized antibody.SELECTED DRAWING: Figure 4",TAKEDA PHARMACEUTICAL,SHAUNA MASON;;JON A KENNISTON;;NIXON ANDREW;;DANIEL J SEXTON;;STEPHEN R COMEAU;;BURT ADELMAN,,https://lens.org/160-266-633-037-891,Patent Application,no,0,0,29,29,0,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C12N15/13;;A61K39/395;;A61P7/02;;A61P9/00;;A61P11/00;;A61P27/02;;C07K16/36;;C12N1/19;;C12N1/21;;C12N5/10;;C12N15/63;;C12P21/08,,0,0,,,,PENDING
595,US,B2,US 10913802 B2,168-403-583-897-074,2021-02-09,2021,US 201615746048 A,2016-07-21,US 201615746048 A;;US 201562194957 P;;US 201562273657 P;;US 201662316310 P;;US 2016/0043265 W,2015-07-21,Monoclonal antibody inhibitor of factor XIIA,"Disclosed herein are anti-Factor XIIa antibodies and methods of using such for treating diseases associated with Factor XII, including diseases associated with contact system activation, plasma prekallikrein signaling (e.g., hereditary angioedema), and ocular diseases.",DYAX CORP,MASON SHAUNA;;KENNISTON JON A;;NIXON ANDREW;;SEXTON DANIEL J;;COMEAU STEPHEN R;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2016-09-01),https://lens.org/168-403-583-897-074,Granted Patent,yes,33,1,29,29,128,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36;;A61K39/00;;A61P7/02;;A61P9/00;;A61P11/00,,15,13,045-942-104-775-903;;095-334-545-560-259;;027-477-313-726-928;;070-371-651-435-940;;006-137-353-823-826;;002-302-629-930-421;;086-519-631-966-495;;139-464-677-939-869;;031-719-370-148-435;;077-532-829-551-519;;028-497-872-239-135;;023-111-518-916-846;;106-927-117-509-706,12850000;;10.1016/s0006-291x(03)01131-8;;10.1006/jmbi.1996.0548;;8876650;;10.1073/pnas.79.6.1979;;pmc346105;;6804947;;10896241;;10.1055/s-0037-1613936;;24970892;;10.1074/jbc.m114.569061;;pmc4156074;;pmc3361654;;10.4161/mabs.4.2.19000;;22453100;;24500405;;10.1126/scitranslmed.3006804;;10.1182/blood.v126.23.2268.2268;;10.1038/nbt0297-159;;9035142;;10.1038/nbt1142;;16151406;;10.4161/mabs.3.5.16983;;pmc3225846;;22048693;;pmc2841541;;10.1093/protein/gzp077;;20019028;;23023498;;10.1038/nm.2942,"Bendig, M.M. Humanization of rodent monoclonal antibodies by CDR grafting. Methods: A Comparision to Methods in Enzymology, 1995, 8:83-93.;;Casset, F.,et al. A peptide mimetic of an anti-CD4 monoclonal antibody by rational design. Biochem. Biophys. Res. Comm., 2003, 307:198-205.;;MacCallum, R.M., et al. Antibody-antigen interactions: Contact analysis and binding site topography. J. Mol. Biol., 1996, 262:732-745.;;Paul, W.E., Fundamental Immunology, 3rd Edition, 1993, pp. 292-295.;;Rudikoff, S., et al. Single amino acid substitution altering antigen-binding specificity. Immunology, 1982, 79:1979-1983.;;Esnouf et al., A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor. Thromb Haemost. Jun. 2000;83(6):874-81.;;Kenniston et al., Inhibition of plasma kallikrein by a highly specific active site blocking antibody. J Biol Chem. Aug. 22, 2014;289(34):23596-608. doi: 10.1074/jbc.M114.569061. Epub Jun. 26, 2014.;;Kontermann, Dual targeting strategies with bispecific antibodies. MAbs. Mar.-Apr. 2012;4(2):182-97. doi: 10.4161/mabs.4.2.19000. Epub Mar. 1, 2012.;;Larsson et al., A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk. Sci Transl Med. Feb. 5, 2014;6(222):222ra17. doi: 10.1126/scitranslmed.3006804.;;Mason et al., Discovery and Characterization of a Highly Specific Antibody Inhibitor of Factor XIIa, and the Subsequent Generation of a Factor XIIa/Plasma Kallikrein Bispecific Antibody. Blood. Dec. 2015;126(23):2268.;;Coloma et al. Design and production of novel tetravalent bispecific antibodies. Nat Biotechnol. Feb. 1997;15(2):159-63. doi: 10.1038/nbt0297-159.;;Holliger et al., Engineered antibody fragments and the rise of single domains. Nat Biotechnol. Sep. 2005;23(9):1126-36. doi: 10.1038/nbt1142.;;Kuo et al., Neonatal Fc receptor and IgG-based therapeutics. MAbs. Sep.-Oct. 2011;3(5):422-30. doi: 10.4161/mabs.3.5.16983. Epub Sep. 1, 2011.;;Orcutt et al., A modular IgG-scFv bispecific antibody topology. Protein Eng Des Sel. Apr. 2010;23(4):221-8. doi: 10.1093/protein/gzp077. Epub Dec. 17, 2009.;;Takehisa et al., A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model. Nat Med. Oct. 2012;18(10):1570-4. doi: 10.1038/nm.2942. Epub Sep. 30, 2012.",ACTIVE
596,CA,A1,CA 2993026 A1,199-270-110-618-491,2017-01-26,2017,CA 2993026 A,2016-07-21,US 201562194957 P;;US 201562273657 P;;US 201662316310 P;;US 2016/0043265 W,2015-07-21,A MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA,"Disclosed herein are anti-Factor Xlla antibodies and methods of using such for treating diseases associated with Factor XII, including diseases associated with contact system activation, plasma prekallikrein signaling (e.g., hereditary angioedema), and ocular diseases.",DYAX CORP,MASON SHAUNA;;KENNISTON JON A;;NIXON ANDREW;;SEXTON DANIEL J;;COMEAU STEPHEN R;;ADELMAN BURT,,https://lens.org/199-270-110-618-491,Patent Application,no,0,0,29,29,128,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36,,0,0,,,,PENDING
597,EP,A1,EP 1137975 A1,050-719-259-912-182,2001-10-04,2001,EP 99961538 A,1999-10-28,US 9925375 W;;US 18538098 A,1998-11-03,METHOD AND SOFTWARE FOR EVIDENCING ILLICIT USE OF A COMPUTER SYSTEM,,DIGIMARC CORP,DAVIS BRUCE L;;PERRY BURT W;;CARR J SCOTT;;SHAW GILBERT B;;RHOADS GEOFFREY B,,https://lens.org/050-719-259-912-182,Patent Application,yes,0,0,10,1547,0,G06F21/10;;G06F2221/2101;;G07D7/20;;H04N1/00843;;H04N1/00877;;G07D7/0034;;G06V10/40;;G06F12/16;;H04N1/00843;;G06F2221/2101;;G07D7/20;;H04N1/00877;;G06F21/10;;G07D7/0034;;G06V10/40,G06F3/12;;G06F1/00;;G06F21/00;;G06V10/40;;G07D7/12;;G07D7/20;;H04N1/00;;H04N1/387;;H04N1/40,,0,0,,,,DISCONTINUED
598,AU,A,AU 2000/018093 A,021-974-823-438-845,2000-05-22,2000,AU 2000/018093 A,1999-10-28,US 18538098 A;;US 9925375 W,1998-11-03,Method and software for evidencing illicit use of a computer system,,DIGIMARC CORP,DAVIS BRUCE L;;PERRY BURT W;;CARR J SCOTT;;SHAW GILBERT B;;RHOADS GEOFFREY B,,https://lens.org/021-974-823-438-845,Patent Application,no,0,0,10,1547,0,G06F21/10;;G06F2221/2101;;G07D7/20;;H04N1/00843;;H04N1/00877;;G07D7/0034;;G06V10/40;;G06F12/16;;H04N1/00843;;G06F2221/2101;;G07D7/20;;H04N1/00877;;G06F21/10;;G07D7/0034;;G06V10/40,G06F3/12;;G06F1/00;;G06F21/00;;G06V10/40;;G07D7/12;;G07D7/20;;H04N1/00;;H04N1/387;;H04N1/40,,0,0,,,,DISCONTINUED
599,WO,A1,WO 2017/015431 A1,047-985-456-197-839,2017-01-26,2017,US 2016/0043265 W,2016-07-21,US 201562194957 P;;US 201562273657 P;;US 201662316310 P,2015-07-21,A MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA,"Disclosed herein are anti-Factor Xlla antibodies and methods of using such for treating diseases associated with Factor XII, including diseases associated with contact system activation, plasma prekallikrein signaling (e.g., hereditary angioedema), and ocular diseases.",DYAX CORP,MASON SHAUNA;;KENNISTON JON A;;NIXON ANDREW;;SEXTON DANIEL J;;COMEAU STEPHEN R;;ADELMAN BURT,,https://lens.org/047-985-456-197-839,Patent Application,yes,48,7,29,29,128,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36,,71,34,070-371-651-435-940;;086-519-631-966-495;;002-007-578-507-698;;078-432-639-041-575;;008-083-146-934-082;;041-909-244-299-232;;013-181-635-285-001;;019-779-601-634-917;;056-201-471-905-934;;028-862-168-091-90X;;106-753-778-592-300;;069-831-019-492-211;;022-133-574-143-973;;030-630-100-818-462;;030-607-398-087-475;;030-607-398-087-475;;016-599-925-793-124;;030-323-674-660-051;;029-167-201-221-537;;077-658-154-371-483;;048-533-680-093-283;;029-167-201-221-537;;077-658-154-371-483;;077-658-154-371-483;;039-753-140-984-833;;089-633-612-001-004;;117-296-629-798-047;;074-543-290-342-119;;120-037-439-200-704;;057-519-325-148-652;;062-825-278-526-054;;045-766-584-546-295;;034-731-998-344-029;;033-629-260-535-243,10896241;;10.1055/s-0037-1613936;;24500405;;10.1126/scitranslmed.3006804;;10458776;;10.1002/(sici)1521-4141(199908)29:08<2613::aid-immu2613>3.0.co;2-j;;10.1074/jbc.m604292200;;16793771;;10.1128/aac.01285-13;;pmc3837853;;24080653;;12391234;;10.4049/jimmunol.169.9.5171;;10.1073/pnas.87.6.2264;;2315319;;pmc53667;;pmc46825;;8390686;;10.1073/pnas.90.12.5873;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;1172191;;10.1038/256495a0;;6811415;;10.1007/bf02796338;;10.1146/annurev.iy.12.040194.002245;;10.1146/annurev.immunol.12.1.433;;8011287;;10.1038/348552a0;;2247164;;pmc392030;;10.1073/pnas.81.21.6851;;6436822;;pmc392030;;10.1073/pnas.81.21.6851;;6436822;;10.1038/312604a0;;6095112;;pmc298637;;2513570;;10.1073/pnas.86.24.10029;;10.1016/0092-8674(87)90536-8;;3034429;;pmc49329;;10.1073/pnas.89.12.5547;;1319065;;9741432;;10.1089/hum.1998.9.13-1939;;10.1016/0092-8674(87)90536-8;;3034429;;pmc49329;;10.1073/pnas.89.12.5547;;1319065;;pmc49329;;10.1073/pnas.89.12.5547;;1319065;;pmc41550;;10.1073/pnas.92.14.6522;;7604026;;6933450;;pmc349762;;10.1073/pnas.77.7.4030;;7763812;;10.1016/0167-7799(93)90115-p;;pmc53961;;2339110;;10.1073/pnas.87.10.3655;;7621239;;7981309;;10.1089/hum.1994.5.7-845;;7842013;;10.1038/ng1094-148;;1391034;;10.1089/hum.1992.3.2-147;;2793840;;10.1016/s0021-9258(18)71447-6;;8139545;;pmc358608;;10.1128/mcb.14.4.2411;;10.1128/mcb.14.4.2411-2418.1994,"ESNOUF M PETER ET AL: ""A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor"", THROMBOSIS AND HAEMOSTASIS, SCHATTAUER GMBH, DE, vol. 83, no. 6, 1 June 2000 (2000-06-01), pages 874 - 881, XP009154609, ISSN: 0340-6245;;LARSSON MAGNUS ET AL: ""A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk"", SCIENCE TRANSLATIONAL MEDICINE, vol. 6, no. 222, February 2014 (2014-02-01), XP002762081;;EUR. J. IMMUNOL., vol. 29, 1999, pages 2613 - 2624;;KABAT ET AL.: ""Sequences of Proteins of Immunological Interest"", 1991, U.S. PUBLIC HEALTH SERVICE, NATIONAL INSTITUTES OF HEALTH;;DALL'ACQUA ET AL., J.B.C., vol. 281, 2006, pages 23514 - 23524;;ROBBIE ET AL., ANTIMICROB. AGENTS CHEMOTHER, vol. 57, no. 12, 2013, pages 6147;;DALL' ACQUA ET AL., J. IMMUNOL., vol. 169, 2002, pages 5171 - 5180;;DALL'ACQUA ET AL., J. IMMUNOL., vol. 169, 2002, pages 5171 - 5180;;J. SAMBROOK, ET AL.: ""Molecular Cloning: A Laboratory Manual, 2nd ed."", 1989, COLD SPRING HARBOR LABORATORY PRESS;;F.M. AUSUBEL, ET AL.: ""Current Protocols in Molecular Biology"", JOHN WILEY & SONS, INC.;;KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 2264 - 68;;KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 5873 - 77;;ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 10;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, no. 17, 1997, pages 3389 - 3402;;HARLOW; LANE: ""Antibodies: A Laboratory Manual"", 1998, COLD SPRING HARBOR LABORATORY;;KOHLER, B.; MILSTEIN, C., NATURE, vol. 256, 1975, pages 495 - 497;;BUCK, D. W. ET AL., IN VITRO, vol. 18, 1982, pages 377 - 381;;WINTER ET AL., ANNU. REV. IMMUNOL., vol. 12, 1994, pages 433 - 455;;MCCAFFERTY ET AL., NATURE, vol. 348, 1990, pages 552 - 553;;MORRISON ET AL., PROC. NAT. ACAD. SCI., vol. 81, 1984, pages 6851;;MORRISON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 81, 1984, pages 6851;;NEUBERGER ET AL., NATURE, vol. 312, 1984, pages 604;;AND TAKEDA ET AL., NATURE, vol. 314, 1984, pages 452;;QUEEN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 10029 - 10033;;HARLOW; LANE: ""Using Antibodies, a Laboratory Manual"", 1999, COLD SPRING HARBOR LABORATORY PRESS, article ""Chapter 11"";;BROWN, M. ET AL., CELL, vol. 49, 1987, pages 603 - 612;;GOSSEN, M.; BUJARD, H., PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 5547 - 5551;;YAO, F. ET AL., HUMAN GENE THERAPY, vol. 9, 1998, pages 1939 - 1950;;SHOCKELT, P. ET AL., PROC. NATL. ACAD. SCI. USA, vol. 92, 1995, pages 6522 - 6526;;M. BROWN ET AL., CELL, vol. 49, 1987, pages 603 - 612;;M. GOSSEN ET AL., NATL. ACAD. SCI. USA, vol. 89, 1992, pages 5547 - 5551;;YAO ET AL., HUMAN GENE THERAPY;;GOSSEN ET AL., NATL. ACAD. SCI. USA, vol. 89, 1992, pages 5547 - 5551;;SHOCKETT ET AL., PROC. NATL. ACAD. SCI. USA, vol. 92, 1995, pages 6522 - 6526;;K. E. HOOVER: ""Remington: The Science and Practice of Pharmacy, 20th ed."", 2000, LIPPINCOTT WILLIAMS AND WILKINS;;EPSTEIN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 82, 1985, pages 3688;;HWANG ET AL., PROC. NATL. ACAD. SCI. USA, vol. 77, 1980, pages 4030;;MCMILLAN, C.V. ET AL., PATIENT, vol. 5, no. 2, 2012, pages 113 - 26;;FINDEIS ET AL., TRENDS BIOTECHNOL., vol. 11, 1993, pages 202;;CHIOU ET AL.: ""Gene Therapeutics: Methods And Applications Of Direct Gene Transfer"", 1994;;WU ET AL., J. BIOL. CHEM., vol. 263, 1988, pages 621;;WU ET AL., J. BIOL. CHEM., vol. 269, 1994, pages 542;;ZENKE ET AL., PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 3655;;WU ET AL., J. BIOL. CHEM., vol. 266, 1991, pages 338;;JOLLY, CANCER GENE THERAPY, vol. 1, 1994, pages 51;;KIMURA, HUMAN GENE THERAPY, vol. 5, 1994, pages 845;;CONNELLY, HUMAN GENE THERAPY, vol. 1, 1995, pages 185;;KAPLITT, NATURE GENETICS, vol. 6, 1994, pages 148;;CURIEL, HUM. GENE THER., vol. 3, 1992, pages 147;;WU, J. BIOL. CHEM., vol. 264, 1989, pages 16985;;PHILIP, MOL. CELL. BIOL., vol. 14, 1994, pages 2411;;WOFFENDIN, PROC. NATL. ACAD. SCI., vol. 91, 1994, pages 1581;;M. J. GAIT: ""Oligonucleotide Synthesis"", 1984;;""Methods in Molecular Biology"", HUMANA PRESS;;J. E. CELLIS: ""Cell Biology: A Laboratory Notebook"", 1998, ACADEMIC PRESS;;R. I. FRESHNEY: ""Animal Cell Culture"", 1987;;J. P. MATHER; P. E. ROBERTS: ""Introduction to Cell and Tissue Culture"", 1998, PLENUM PRESS;;A. DOYLE, J. B. GRIFFITHS, AND D. G. NEWELL: ""Cell and Tissue Culture: Laboratory Procedures"", August 1993, J. WILEY AND SONS;;""Methods in Enzymology"", ACADEMIC PRESS, INC.;;D. M. WEIR AND C. C. BLACKWELL: ""Handbook of Experimental Immunology"", .;;J. M. MILLER AND M. P. CALOS: ""Gene Transfer Vectors for Mammalian Cells"", 1987;;F. M. AUSUBEL, ET AL.: ""Current Protocols in Molecular Biology"", 1987;;MULLIS, ET AL.: ""PCR: The Polymerase Chain Reaction"", 1994;;J. E. COLIGAN ET AL.: ""Current Protocols in Immunology"", 1991;;""Short Protocols in Molecular Biology"", 1999, WILEY AND SONS;;C. A. JANEWAY; P. TRAVERS, IMMUNOBIOLOGY, 1997;;P. FINCH, ANTIBODIES, 1997;;D. CATTY: ""Antibodies: a practical approach"", 1988, IRL PRESS;;P. SHEPHERD AND C. DEAN: ""Monoclonal antibodies: a practical approach"", 2000, OXFORD UNIVERSITY PRESS;;E. HARLOW; D. LANE: ""Using antibodies: a laboratory manual"", 1999, COLD SPRING HARBOR LABORATORY PRESS;;M. ZANETTI AND J. D. CAPRA: ""The Antibodies"", 1995, HARWOOD ACADEMIC PUBLISHERS",PENDING
600,US,B2,US 7385626 B2,109-579-433-460-888,2008-06-10,2008,US 63898403 A,2003-08-12,US 63898403 A;;US 41989302 P,2002-10-21,Method and system for performing surveillance,"A method and system for detecting moving objects and controlling a surveillance system includes a processing module adapted to receive image information from at least one imaging sensor. The system performs motion detection analysis upon captured images and controls the camera in a specific manner upon detection of a moving object. The image processing uses the camera's physical orientation to a surveillance area to facilitate mapping images captured by the camera to a reference map of the surveillance area. Using the camera orientation, a moving object's position (e.g., latitude, longitude and altitude) within a scene can be derived.",SARNOFF CORP,AGGARWAL MANOJ;;SAWHNEY HARPREET;;SAMARASAKERA SUPUN;;KUMAR RAKESH;;BURT PETER;;ELEDATH JAYAN;;HANNA KEITH J,SRI INTERNATIONAL (2011-02-04);;SARNOFF CORPORATION (2003-08-08),https://lens.org/109-579-433-460-888,Granted Patent,yes,9,129,7,10,0,G08B13/19608;;G08B13/19641;;G08B13/1968;;G08B13/19682;;G08B13/19689;;H04N7/181;;G06T7/269;;G06V20/52;;H04N7/181;;G08B13/19641;;G08B13/19689;;G08B13/19682;;G08B13/1968;;G08B13/19608;;G06T7/269;;G06V20/52,H04N7/18,348/143,1,0,,,"International Search Report dated Apr. 20, 2004 for corresponding PCT application, PCT/US03/33383.",ACTIVE
601,AU,B9,AU 2016/297018 B9,120-839-892-403-483,2022-12-01,2022,AU 2016/297018 A,2016-07-21,US 201562273657 P;;US 201562194957 P;;US 201662316310 P;;US 2016/0043265 W,2015-07-21,A monoclonal antibody inhibitor of factor XIIa,"Disclosed herein are anti-Factor Xlla antibodies and methods of using such for treating diseases associated with Factor XII, including diseases associated with contact system activation, plasma prekallikrein signaling (e.g., hereditary angioedema), and ocular diseases.",TAKEDA PHARMACEUTICALS CO,MASON SHAUNA;;KENNISTON JON A;;NIXON ANDREW;;SEXTON DANIEL J;;COMEAU STEPHEN R;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/120-839-892-403-483,Amended Patent,no,1,0,29,29,0,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36,,0,0,,,,ACTIVE
602,AU,A,AU 2001/073184 A,156-527-143-112-631,2002-02-13,2002,AU 2001/073184 A,2001-07-05,US 62940100 A;;US 0121268 W,2000-08-01,Management of documents and other objects using optical devices,,DIGIMARC CORP,SEDER PHILLIP ANDREW;;CARR J SCOTT;;PERRY BURT W;;GRAHAM STANLEY E;;RHOADS GEOFFREY B,,https://lens.org/156-527-143-112-631,Patent Application,no,0,0,9,1547,0,G06Q10/10;;G06Q30/02;;G07F17/26;;G06Q30/02;;G06Q10/10;;G07F17/26,G06Q10/00;;G06Q30/00;;G07F17/26,,0,0,,,,PENDING
603,US,A1,US 2019/0002584 A1,164-586-658-236-73X,2019-01-03,2019,US 201615746048 A,2016-07-21,US 201615746048 A;;US 201562194957 P;;US 201562273657 P;;US 201662316310 P;;US 2016/0043265 W,2015-07-21,A MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA,"Disclosed herein are anti-Factor Xlla antibodies and methods of using such for treating diseases associated with Factor XII, including diseases associated with contact system activation, plasma prekallikrein signaling (e.g., hereditary angioedema), and ocular diseases.",DYAX CORP,MASON SHAUNA;;KENNISTON JON A;;NIXON ANDREW;;SEXTON DANIEL J;;COMEAU STEPHEN R;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2016-09-01),https://lens.org/164-586-658-236-73X,Patent Application,yes,0,1,29,29,128,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36,,0,0,,,,ACTIVE
604,AU,A1,AU 2022/268373 A1,104-919-500-720-026,2022-12-15,2022,AU 2022/268373 A,2022-11-10,AU 2022/268373 A;;AU 2016/297018 A;;US 201562273657 P;;US 201562194957 P;;US 201662316310 P;;US 2016/0043265 W,2015-07-21,A monoclonal antibody inhibitor of Factor XIIa,"A MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA Disclosed herein are anti-Factor XIIa antibodies and methods of using such for treating diseases associated with Factor XII, including diseases associated with contact system activation, plasma prekallikrein signaling (e.g., hereditary angioedema), and ocular diseases.",TAKEDA PHARMACEUTICALS CO,MASON SHAUNA;;KENNISTON JON A;;NIXON ANDREW;;SEXTON DANIEL J;;COMEAU STEPHEN R;;ADELMAN BURT,,https://lens.org/104-919-500-720-026,Patent Application,no,0,0,29,29,0,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36,,0,0,,,,PENDING
605,WO,A2,WO 2014/031205 A2,199-127-572-671-527,2014-02-27,2014,US 2013/0042966 W,2013-05-29,US 201213487721 A,2012-06-04,SEAL LAND FOR STATIC STRUCTURE OF A GAS TURBINE ENGINE,A seal land for a gas turbine engine can include a seal body circumferentially extending about a longitudinal centerline axis. The seal body includes at least one sealing surface that extends in a plane that is transverse to the longitudinal centerline axis.,UNITED TECHNOLOGIES CORP,PORTER STEVEN D;;BURT JONATHAN P;;JAKIEL JONATHAN J;;GORDON AMY M;;DUELM SHELTON O,,https://lens.org/199-127-572-671-527,Patent Application,yes,2,0,7,7,0,F16J15/0887;;F16J15/0887;;F01D9/02;;F01D9/02;;F01D11/005;;F01D11/005;;F01D11/08;;F01D11/08;;F02C7/28;;F02C7/28,F02C7/28;;F01D11/00;;F01D25/24,,1,0,,,See also references of EP 2855892A4,PENDING
606,AU,B2,AU 2016/297018 B2,195-183-531-263-173,2022-08-11,2022,AU 2016/297018 A,2016-07-21,US 201562273657 P;;US 201562194957 P;;US 201662316310 P;;US 2016/0043265 W,2015-07-21,A monoclonal antibody inhibitor of factor XIIa,"Disclosed herein are anti-Factor Xlla antibodies and methods of using such for treating diseases associated with Factor XII, including diseases associated with contact system activation, plasma prekallikrein signaling (e.g., hereditary angioedema), and ocular diseases.",TAKEDA PHARMACEUTICALS CO,MASON SHAUNA;;KENNISTON JON A;;NIXON ANDREW;;SEXTON DANIEL J;;COMEAU STEPHEN R;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/195-183-531-263-173,Granted Patent,no,1,0,29,29,0,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36,,0,0,,,,ACTIVE
607,CN,A,CN 116333144 A,070-182-741-400-933,2023-06-27,2023,CN 202211273734 A,2016-07-21,US 201562194957 P;;US 201562273657 P;;US 201662316310 P;;CN 201680046558 A;;US 2016/0043265 W,2015-07-21,Monoclonal antibody inhibitor of factor XIIA,"The name of the invention is a monoclonal antibody inhibitor of factor XIIA. Disclosed herein are anti-Factor XIIa antibodies and methods of using anti-Factor XIIa antibodies to treat diseases associated with Factor XII, including diseases associated with contact system activation, plasma prekallikrein signaling (e.g., hereditary angioedema), and ocular diseases.",TAKEDA PHARMACEUTICALS CO,MASON SCOTT;;KENNISTON JON A;;NIXON ANDREW;;SEXTON DANIEL J;;COMEAU STEPHEN R;;ADELMAN BURT,,https://lens.org/070-182-741-400-933,Patent Application,no,0,0,29,29,0,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36;;A61P7/02;;A61P7/10;;A61P27/02;;C12N15/13;;C12P21/08,,0,0,,,,PENDING
608,EP,A1,EP 4011916 A1,072-535-830-318-505,2022-06-15,2022,EP 21204197 A,2016-07-21,US 201562194957 P;;US 201562273657 P;;US 201662316310 P;;EP 16745341 A;;US 2016/0043265 W,2015-07-21,A MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA,"Disclosed herein are anti-Factor XIIa antibodies and methods of using such for treating diseases associated with Factor XII, including diseases associated with contact system activation, plasma prekallikrein signaling ( e.g. , hereditary angioedema), and ocular diseases.
",TAKEDA PHARMACEUTICALS CO,MASON SHAUNA;;KENNISTON JON A;;NIXON ANDREW;;SEXTON DANIEL J;;COMEAU STEPHEN R;;ADELMAN BURT,,https://lens.org/072-535-830-318-505,Patent Application,yes,49,0,29,29,128,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36;;A61K39/395,,54,28,070-371-651-435-940;;086-519-631-966-495;;002-007-578-507-698;;078-432-639-041-575;;008-083-146-934-082;;041-909-244-299-232;;030-323-674-660-051;;019-779-601-634-917;;056-201-471-905-934;;028-862-168-091-90X;;048-533-680-093-283;;106-753-778-592-300;;069-831-019-492-211;;022-133-574-143-973;;030-630-100-818-462;;030-607-398-087-475;;030-607-398-087-475;;029-167-201-221-537;;077-658-154-371-483;;077-658-154-371-483;;089-633-612-001-004;;117-296-629-798-047;;120-037-439-200-704;;057-519-325-148-652;;062-825-278-526-054;;045-766-584-546-295;;034-731-998-344-029;;033-629-260-535-243,10896241;;10.1055/s-0037-1613936;;24500405;;10.1126/scitranslmed.3006804;;10458776;;10.1002/(sici)1521-4141(199908)29:08<2613::aid-immu2613>3.0.co;2-j;;10.1074/jbc.m604292200;;16793771;;10.1128/aac.01285-13;;pmc3837853;;24080653;;12391234;;10.4049/jimmunol.169.9.5171;;pmc298637;;2513570;;10.1073/pnas.86.24.10029;;pmc46825;;8390686;;10.1073/pnas.90.12.5873;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;9741432;;10.1089/hum.1998.9.13-1939;;1172191;;10.1038/256495a0;;6811415;;10.1007/bf02796338;;10.1146/annurev.iy.12.040194.002245;;10.1146/annurev.immunol.12.1.433;;8011287;;10.1038/348552a0;;2247164;;pmc392030;;10.1073/pnas.81.21.6851;;6436822;;pmc392030;;10.1073/pnas.81.21.6851;;6436822;;10.1016/0092-8674(87)90536-8;;3034429;;pmc49329;;10.1073/pnas.89.12.5547;;1319065;;pmc49329;;10.1073/pnas.89.12.5547;;1319065;;6933450;;pmc349762;;10.1073/pnas.77.7.4030;;7763812;;10.1016/0167-7799(93)90115-p;;7621239;;7981309;;10.1089/hum.1994.5.7-845;;7842013;;10.1038/ng1094-148;;1391034;;10.1089/hum.1992.3.2-147;;2793840;;10.1016/s0021-9258(18)71447-6;;8139545;;pmc358608;;10.1128/mcb.14.4.2411;;10.1128/mcb.14.4.2411-2418.1994,"ESNOUF M PETER ET AL: ""A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor"", THROMBOSIS AND HAEMOSTASIS, SCHATTAUER GMBH, DE, vol. 83, no. 6, 1 June 2000 (2000-06-01), pages 874 - 881, XP009154609, ISSN: 0340-6245;;LARSSON MAGNUS ET AL: ""A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk"", SCIENCE TRANSLATIONAL MEDICINE, vol. 6, no. 222, February 2014 (2014-02-01), XP002762081;;""GenBank"", Database accession no. NP_000496.2;;EUR. J. IMMUNOL., vol. 29, 1999, pages 2613 - 2624;;WU ET AL., J. BIOL. CHEM., vol. 266, 1991, pages 338;;DALL'ACQUA ET AL., J.B.C., vol. 281, 2006, pages 23514 - 23524;;ROBBIE ET AL., ANTIMICROB. AGENTS CHEMOTHER, vol. 57, no. 12, 2013, pages 6147;;DALL'ACQUA ET AL., J. IMMUNOL., vol. 169, 2002, pages 5171 - 5180;;QUEEN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 10029 - 10033;;KARLINALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 3655 - 68;;KARLINALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 5873 - 77;;ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 10;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, no. 17, 1997, pages 3389 - 3402;;YAO, F. ET AL., HUMAN GENE THERAPY, vol. 9, 1998, pages 1939 - 1950;;KOHLER, B.MILSTEIN, C., NATURE, vol. 256, 1975, pages 495 - 497;;BUCK, D. W. ET AL., VITRO, vol. 18, 1982, pages 377 - 381;;WINTER ET AL., ANNU. REV. IMMUNOL., vol. 12, 1994, pages 433 - 455;;MCCAFFERTY ET AL., NATURE, vol. 348, 1990, pages 552 - 553;;MORRISON ET AL., PROC. NAT. ACAD. SCI., vol. 81, 1984, pages 6851;;MORRISON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 81, 1984, pages 6851;;TAKEDA ET AL., NATURE, vol. 314, 1984, pages 452;;HARLOWLANE: ""Using antibodies: a laboratory manual"", 1999, COLD SPRING HARBOR LABORATORY PRESS;;BROWN, M. ET AL., CELL, vol. 49, 1987, pages 603 - 612;;GOSSEN, M.BUJARD, H., PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 5547 - 5551;;SHOCKELT, P. ET AL., PROC. NATL. ACAD. SCI. USA, vol. 92, 1995, pages 6522 - 6526;;M. GOSSEN ET AL., NATL. ACAD. SCI. USA, vol. 89, 1992, pages 5547 - 5551;;YAO ET AL.: ""Remington: The Science and Practice of Pharmacy 20th Ed."", 2000, LIPPINCOTT WILLIAMS AND WILKINS;;EPSTEIN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 82, 1985, pages 3688;;HWANG ET AL., PROC. NATL. ACAD. SCI. USA, vol. 77, 1980, pages 4030;;MCMILLAN, C.V. ET AL., PATIENT, vol. 5, no. 2, 2012, pages 113 - 26;;FINDEIS ET AL., TRENDS BIOTECHNOL, vol. 11, 1993, pages 202;;CHIOU ET AL., GENE THERAPEUTICS: METHODS AND APPLICATIONS OF DIRECT GENE TRANSFER, 1994;;WU ET AL., J. BIOL. CHEM., vol. 263, 1988, pages 621;;WU ET AL., J. BIOL. CHEM., vol. 269, 1994, pages 542;;JOLLY, CANCER GENE THERAPY, vol. 1, 1994, pages 51;;KIMURA, HUMAN GENE THERAPY, vol. 5, 1994, pages 845;;CONNELLY, HUMAN GENE THERAPY, vol. 1, 1995, pages 185;;KAPLITT, NATURE GENETICS, vol. 6, 1994, pages 148;;CURIEL, HUM. GENE THER., vol. 3, 1992, pages 147;;CURIEL, HUM. GENE THER, vol. 3, 1992, pages 147;;WU, J. BIOL. CHEM., vol. 264, 1989, pages 16985;;PHILIP, MOL. CELL. BIOL., vol. 14, 1994, pages 2411;;WOFFENDIN, PROC. NATL. ACAD. SCI., vol. 91, 1994, pages 1581;;SAMBROOK ET AL.: ""Molecular Cloning: A Laboratory Manual"", 1989, COLD SPRING HARBOR PRESS;;""Oligonucleotide Synthesis"", 1984;;J. P. MATHERP. E. ROBERTS: ""Introduction to Cell and Tissue Culture"", 1998, ACADEMIC PRESS;;""Gene Transfer Vectors for Mammalian Cells"", 1987;;""Cell and Tissue Culture: Laboratory Procedures"", 1993, J. WILEY AND SONS;;""Current Protocols in Molecular Biology"", 1994, ACADEMIC PRESS;;""Current Protocols in Immunology"", 1991;;C. A. JANEWAYP. TRAVERS, IMMUNOBIOLOGY, 1997;;P. FINCH, ANTIBODIES, 1997;;""Antibodies: a practical approach"", 1988, IRL PRESS;;""The Antibodies"", 1995, HARWOOD ACADEMIC PUBLISHERS",PENDING
609,US,A,US 5917117 A,080-856-257-755-960,1999-06-29,1999,US 62113896 A,1996-03-21,US 62113896 A,1996-03-21,Inducing hyperaccumulation of metals in plant shoots,"The present invention provides methods by which hyperaccumulation of metals in plant shoots is induced by exposure to inducing agents. Hyperaccumulation occurs as part of a two-step process in which metals are first accumulated into plant roots; subsequent transport to plant shoots is induced by exposure to the agent. In preferred embodiments, manipulations that increase availability of metals to the plant are employed prior to application of the inducing agent. Effective inducing agents include conditions of low pH, chelators, herbicides, and high levels of heavy metals. Other phytotoxic agents are also useful. Application of multiple inducing agents results in synergistic effects.",PHYTOTECH INC,ENSLEY BURT D;;BLAYLOCK MICHAEL J;;DUSHENKOV SLAVIK;;KUMAR NANDA P B A;;KAPULNIK YORAM,PHYTOTECH INC (1996-03-25);;RUTGERS THE STATE UNIVERSITY OF NEW JERSEY (1999-11-16),https://lens.org/080-856-257-755-960,Granted Patent,yes,45,54,1,7,0,B09C1/105;;C02F3/327;;Y02W10/10;;C02F3/327;;B09C1/105;;Y02W10/10,B09C1/10;;C02F3/32;;C22B3/24,75/711;;75/712;;210/602,53,25,090-887-020-789-083;;019-382-667-234-97X;;001-952-227-530-538;;008-731-639-909-064;;112-947-294-650-730;;066-105-147-091-513;;069-569-249-253-629;;021-140-042-090-902;;067-154-719-687-054;;111-830-706-222-965;;053-173-400-552-620;;056-582-577-643-268;;017-331-718-091-647;;146-276-024-839-401;;027-587-169-036-945;;055-192-752-327-415;;043-698-455-491-713;;041-428-178-266-370;;071-765-299-909-681;;012-748-637-847-387;;074-576-821-261-07X;;028-767-443-295-718;;004-403-666-639-620;;081-696-076-917-680;;033-929-219-453-515,10.1016/b978-0-7506-9301-1.50049-4;;10.2134/jeq1992.00472425002100040040x;;pmc425995;;16662008;;10.1104/pp.68.4.835;;10.1007/bf02370879;;10.1016/0143-1471(82)90060-5;;10.1007/bf00011873;;10.1021/es00005a015;;22192017;;10.1094/phyto-77-190;;10.1007/bf00028889;;1463837;;10.1007/bf00212092;;10.1007/bf00212568;;10.1016/0925-8574(93)90032-b;;10.1016/0166-445x(84)90003-1;;22192016;;10.1021/es00005a014;;10.1007/978-94-011-2008-1_145;;10.1007/bf00288793;;24227139;;10.1007/bf01610117;;10.1016/0269-7483(89)90099-2;;10.1016/0038-0717(87)90058-7;;10.1007/978-1-4615-3912-4_3;;9634787;;10.1038/nbt0595-468;;8010696;;10.1111/j.1749-6632.1994.tb47418.x;;10.4319/lo.1992.37.1.0025;;10.1080/01904169309364612;;10.1104/pp.109.4.1141;;8539285;;pmc157644,"Baker et al., The potential for heavy metal decontamination , Min. Env. Man., pp. 12 14, Sep. 1995.;;Baker et al., The potential for the use of metal accumulating plants for the in situ decontamination of metal polluted soils , Proc. EUROSOL Conf., Eur. Conf. on Integrated Res. Soil Sed. Protect. Remed., MECC Maastricht, the Netherlands, Sep. 1992.;;Baker et al., In situ decontamination of heavy metal polluted soils using crops of metal accumulating plants a feasibility study , In situ Bioreclamation, Butterworth Heinemann, Stonham, MA, pp. 600 605, 1991. Month unavailable and not in issue .;;Baker et al, Terrestrial higher plants which hyperaccumulate metallic elements a review of their distribution, ecology, and phytochemistry , Biorecovery, 1:81 126, 1989. Month unavailable and not in issue .;;Bender et al., Lead removal from contaminated water by a mixed microbial ecosystem , Wat. Sci. Tech. 21:1661 1664, 1989. Month unavailable and not in issue .;;Berti et al., Remediating soil Pb with green plants , presented at the Intl. Conf. of the Soc. for Env. Geochem. and Health, New Orleans, LA, Jul. 25 27, 1993 (pub d Sep. 1993.;;Bishop, Pollution fighters hope a humble weed will help reclaim contaminated soil , Wall St. J., Feb. 29, 1996.;;Boon et al., Lead, cadmium, and zinc contamination of aspen garden soils and vegetation , Fert. Soils Plants Nutr., 116:775, 1992. Month unavailable and not in issue .;;Cataldo et al., Cadmium distribution and chemical fate in soybean plants , Plant Physiol. 68:835 839, 1981. Month unavailable and not in issue .;;Chaney et al., Potential use of metal hyperaccumulators , Mining Env. Management, pp. 9 11, Sep. 1995.;;Chatterjee, Oilseed brassicas in Indian agriculture, Vikas Publishing House, Chapter 6 ( Agronomy ), pp. 139 159, 1991. Month unavailable and not in issue .;;Checkai et al., Effects of ionic and complexed metal concentrations on plant uptake of cadmium and micronutrient metals from solution , Plant and Soil, 99:335 345, 1987. Month unavailable and not in issue .;;Chigbo et al., Uptake of arsenic, cadmium, lead and mercury from polluted waters by the water hyacinth eichhornia crassipes , Environ. Poll. A 27:31 36, 1982. Month unavailable and not in issue .;;Conley et al., An assessment of the root zone method of wastewater treatment , J. Water. Poll. Control. Fed. 63:239 247, May, 1991.;;Crowley, Mechanisms of iron acquisition from siderophores by microorganisms and plants , Plant and Soil, 130:179 198, 1991. Month unavailable and not in issue .;;Dierberg et al., Removal of copper and lead using a thin film technique , Aquatic Plants for Water Treatment and Resource Recovery, Magnolia Publishing (eds. Reddy and Smith), pp. 407 504, 1987. Month unavailable and not in issue .;;Doushenkov, Phytoremediation potential of crop plants , Supp. to Plant. Physiol. 105:43, May, 1994 (Abstracts of papers from Ann. Mtg. of Am. Soc. Plant Physiol., Portland, OR, Jul. 30 Aug. 3, 1994).;;Doushenkov, Rhizofiltration: the use of plants to remove heavy metals from aqueous streams , Environ. Sci. Technol., 29(5):1239 1245, May, 1995.;;Elad et al., Possible role of competition for nutrients in biocontrol of pythium damping off by bacteria , Ecol. and Epidemiol., 77(2):190 195, 1987. Month unavailable and not in issue .;;Evans et al., Expression of the pea metallothionein like gene PsMT A in Escherichia coli and Arabidopsis thaliana and analysis of trace metal ion accumulation: implications for PsMT A function , Plant. Mol. Biol., 20:1019 1028, 1992. Month unavailable and not in issue .;;Haider et al., Pollution control by water hyacinth , Proc. of the Int l Conf. on Water Hyacinth, Hyderabad, India, Feb. 7 11, 1983 (pub. 1984), pp. 627 634.;;Halvorson et al., The critical Zn 2 concentration for corn and nonabsorption of chelated zinc , Soil Soc. A.M. J., 41:531 534, 1977. Month unavailable and not in issue .;;Heaton et al., Lead uptake by the water hyacinth , Aquatic plants for water treatment and resource recovery, Magnolia Publishing (eds. Reddy and Smith), pp. 471 485, 1987. Month unavailable and not in issue .;;Heaton et al., Lead uptake by Eichhornia crassipes , Toxicol. Env. Chem. 11:125 135, 1986. Month unavailable and not in issue .;;Heubert et al., The effect of EDTA on cadmium and zinc uptake and toxicity in Lemna trisulca L , Arch. Environ. Contam. Toxicol., 22:313 318, 1992. Month unavailable and not in issue .;;Jamil et al., Biotransfer of metals to the insect Neochetina eichhornae via aquatic plants , Arch. Evir. Contam. Toxicol. 22:459 463, 1992. Month unavailable and not in issue .;;Jewell, Resource recovery wastewater treatment , Am. Scientist. 82:366 375, Jul. 1994.;;Jorgensen, Removal of heavy metals from compost and soil by ecotechnological methods , Ecological Engineering, 2:89 100, 1993. Month unavailable and not in issue .;;Kay et al., Effects of heavy metals on water hyacinths ( Eichhornia crassipes (Mart.) Solms) , Aquatic Toxicol., 5:117 128, 1984. Month unavailable and not in issue .;;Keefer et al., Chemical composition of vegetables grown on an agricultural soil amended with sewage sludges , Biol. Abstr., 82:9330, 1986. Month unavailable and not in issue .;;Kumar et al., Phytoextraction: the use of plants to remove heavy metals from soils , Environ. Sci. Technol., 29(5):1232 1238, May 1995.;;Lee et al., Copper untake by the water hyacinth , J. Environ. Sci. Health, A22(2):141 160, 1987. Month unavailable and not in issue .;;Dupont takes team approach to using plants for remediation , The Bioremediation report, p. 4, Jan., 1995.;;McGrath et al., The potential for the use of metal accumulating plants for the in situ decontamination of metal polluted soils , Soil Environ., pp. 673 676, 1993. Month unavailable and not in issue .;;Misra et al., Heavy metal tolerant transgenic Brassica napus and Nicotiana tabacum L. plants , Theor. Appl. Genet., 78:161 168, 1989. Month unavailable and not in issue .;;Muramoto et al., Removal of some heavy metals from polluted water by the water hyacinth ( Eichhornia crassipes ) , Bull Envir. Contam. Toxicol. 30:170 177, 1983. Month unavailable and not in issue .;;Okieimen et al., Removal of heavy ions from aqueous solution with melon ( Citrullus vulgaris ) seed husks , Biological Wastes, 29:11 16, 1989. Month unavailable and not in issue .;;Ordentich et al., Rhizosphere Colonization by Serratia morcescers for the control of Sclerotium rolfsii , Soil Biol. Biochem., 19(6):747 751, 1987. Month unavailable and not in issue .;;Raskin et al., Bioconcentration of heavy metals by plants , Curr. Op. Biotech. 5:285 290, 1994. Month unavailable and not in issue .;;Raymer et al., Canola and Rapeseed, Chapter 3, Agronomy of canola in the United States , (Shahidi, ed.), Van Nostrand Rheinhold, pp. 25 25, 1990. Month unavailable and not in issue .;;Reeves et al., Abnormal accumulation of trace metals by plants , Mining Env. Management, pp. 4 7, Sep. 1995.;;Salt et al., Phytoremediation: a new technology for the environmental cleanup of toxic metals , presented at the 33rd Ann. Conf. of Metallurgists: Advances in Material Production, Performance, and Stewardship, Toronto, Ont., Aug. 20 25, 1994.;;Salt et al., Phytoremediation: a novel strategy for the removal of toxic metals from the environment using plants , Bio/Technology, 13:468, May, 1995.;;Stomp et al., Genetic strategies for enhancing phytoremediation , presented at Recomb. DNA Tech. II. Conf., Palm Coast FL, Jan. 31 Feb. 3, 1993, pub Ann. NY Acad. Sci., 721:481 492 (Bajpaj, et al., eds.), 1994.;;Sunda et al., Feedback interactions between zinc and phytoplankton in seawater , Limnol. Oceanog., 37(1):25 40, 1992. Month unavailable and not in issue .;;Sunda et al., The relationship between cupric ion activity and the toxicity of copper to phytoplankton , J. Marine Res., 34(4):511 529, 1976. Month unavailable and not in issue .;;Taiz et al., Plant Physiology, Essential Elements , pp. 107 108, 1991. Month unavailable and not in issue .;;Thomas et al., Canola growers manual, Chapters 6 9, Published by the Canola Council of Canada, 1984. Month unavailable and not in issue .;;Turnquist, Nickel uptake by the water hyacinth , J. Environ. Sci. Health, A25:897 912, 1990. Month unavailable and not in issue .;;Wills et al., Absorption of 59 Fe by water hyacinths , Aquatic Plants for Water Treatment and Resource Recovery, Magnolia Publishing (eds. Reddy and Smith), pp. 471 485, 1987. Month unavailable and not in issue .;;Wolverton, Aquatic plants for wastewater treatment: an overview , Aqu. Plants Treat. Res. Recov., Magnolia Publishing (eds. Reddy and Smith), pp. 3 15, 1987. Month unavailable and not in issue .;;Yusuf et al., Effects of several production factors on two varieties of rapeseed in the central United States , J. Plant Nutr., 16(7):1279 1288, 1993. Month unavailable and not in issue .;;Rauser, Phytochelatins and related peptides , Plant Physiol., 109:1141 1149, Dec. 1995.",EXPIRED
610,US,A1,US 2013/0224010 A1,125-506-985-997-862,2013-08-29,2013,US 201213403407 A,2012-02-23,US 201213403407 A,2012-02-23,TURBINE FRAME FAIRING FOR A GAS TURBINE ENGINE,A static structure of a gas turbine engine includes a multiple of airfoil segments and at least one structural reinforcement ring mounted to the multiple of airfoil segments.,FARAH JORGE I;;KAPUSTKA THEODORE W;;BURT JONATHAN P;;JAKIEL JONATHAN J;;STEWART DANA P,FARAH JORGE I;;KAPUSTKA THEODORE W;;BURT JONATHAN P;;JAKIEL JONATHAN J;;STEWART DANA P,RTX CORPORATION (2012-02-16),https://lens.org/125-506-985-997-862,Patent Application,yes,4,10,6,6,0,B23K1/0018;;B23K1/0018;;B23K2101/001;;B23K2101/001;;F01D25/162;;F01D25/162;;F01D9/04;;F01D9/044;;F01D9/044;;F01D9/065;;F01D9/065;;F01D25/246;;F05D2230/237;;F05D2230/237,F01D25/24;;B23K31/02;;F01D1/04,415/209.2;;228/178,0,0,,,,ACTIVE
611,KR,A,KR 20180096567 A,126-320-862-062-283,2018-08-29,2018,KR 20187005024 A,2016-07-21,US 201562194957 P;;US 201562273657 P;;US 201662316310 P;;US 2016/0043265 W,2015-07-21,XIIA 인자의 단일클론 항체 저해제,"항-XIIa 인자 항체 및 XII 인자와 연관된 질환, 예컨대 접촉 시스템 활성화, 혈장 프리칼리크레인 신호전달과 연관된 질환(예를 들어, 유전성 혈관부종) 및 눈 질환을 치료하는 데 이를 사용하는 방법이 본 명세서에 개시되어 있다.",DYAX CORP,MASON SHAUNA;;KENNISTON JON A;;NIXON ANDREW;;SEXTON DANIEL J;;COMEAU STEPHEN R;;ADELMAN BURT,,https://lens.org/126-320-862-062-283,Patent Application,no,0,0,29,29,256,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36;;A61P27/02,,0,0,,,,DISCONTINUED
612,CA,A1,CA 2347179 A1,189-639-484-937-088,2000-05-11,2000,CA 2347179 A,1999-10-28,US 18538098 A;;US 9925375 W,1998-11-03,METHOD AND SOFTWARE FOR EVIDENCING ILLICIT USE OF A COMPUTERSYSTEM,"A computer (10) is provided with software that looks for certain activities that may be illicit (e.g. processing of a graphic file corresponding to a banknote). If such an activity is detected, tracer data detailing the activi ty is generated and secretly stored in the computer (10). If the computer (10) is later searched or seized, the tracer data can be recovered and employed as evidence of the computer's use, e.g. in counterfeiting. To detect whether graphic image data corresponds to a banknote, two analysis techniques may be used. One is based on detection of a visible pattern characteristic of a security document. The other is based on detection of a steganographic digit al watermark characteristic of a security document. If either characteristic is found, the image is flagged, and appropriate anti-counterfeiting steps may b e taken. Detection of the visible pattern can be performed using a series of successively more rigorous tests. If the image fails the first test, successive tests can be skipped, speeding the process. Hough transform-based pattern recognition techniques are used in some embodiments. Provision of bo th a visible pattern detector and a watermark detector in a single apparatus enhances reliability, while permetting various implementation efficiencies.< /SDOAB>",DIGIMARC CORP,SHAW GILBERT B;;DAVIS BRUCE L;;CARR J SCOTT;;PERRY BURT W;;RHOADS GEOFFREY B,,https://lens.org/189-639-484-937-088,Patent Application,no,0,0,10,1547,0,G06F21/10;;G06F2221/2101;;G07D7/20;;H04N1/00843;;H04N1/00877;;G07D7/0034;;G06V10/40;;G06F12/16;;H04N1/00843;;G06F2221/2101;;G07D7/20;;H04N1/00877;;G06F21/10;;G07D7/0034;;G06V10/40,G06F3/12;;G06F1/00;;G06F21/00;;G06V10/40;;G07D7/12;;G07D7/20;;H04N1/00;;H04N1/387;;H04N1/40,,0,0,,,,DISCONTINUED
613,WO,A8,WO 2017/015431 A8,040-892-195-554-81X,2017-03-23,2017,US 2016/0043265 W,2016-07-21,US 201562194957 P;;US 201562273657 P;;US 201662316310 P,2015-07-21,A MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA,"Disclosed herein are anti-Factor Xlla antibodies and methods of using such for treating diseases associated with Factor XII, including diseases associated with contact system activation, plasma prekallikrein signaling (e.g., hereditary angioedema), and ocular diseases.",DYAX CORP,MASON SHAUNA;;KENNISTON JON A;;NIXON ANDREW;;SEXTON DANIEL J;;COMEAU STEPHEN R;;ADELMAN BURT,,https://lens.org/040-892-195-554-81X,Amended Application,yes,0,0,29,29,0,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36,,0,0,,,,PENDING
614,EP,B1,EP 3325516 B1,075-592-876-224-408,2021-12-15,2021,EP 16745341 A,2016-07-21,US 201562194957 P;;US 201562273657 P;;US 201662316310 P;;US 2016/0043265 W,2015-07-21,A MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA,,TAKEDA PHARMACEUTICALS CO,MASON SHAUNA;;KENNISTON JON A;;NIXON ANDREW;;SEXTON DANIEL J;;COMEAU STEPHEN R;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-09-08);;DYAX CORP. (2018-06-13),https://lens.org/075-592-876-224-408,Granted Patent,yes,3,0,29,29,0,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36,,2,0,,,"ESNOUF M PETER ET AL: ""A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor"", THROMBOSIS AND HAEMOSTASIS, SCHATTAUER GMBH, DE, vol. 83, no. 6, 1 June 2000 (2000-06-01), pages 874-881, XP009154609, ISSN: 0340-6245;;LARSSON MAGNUS ET AL: ""A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk"", SCIENCE TRANSLATIONAL MEDICINE, vol. 6, no. 222, February 2014 (2014-02), XP002762081,",ACTIVE
615,EP,A2,EP 2855892 A2,103-663-205-547-387,2015-04-08,2015,EP 13830737 A,2013-05-29,US 201213487721 A;;US 2013/0042966 W,2012-06-04,SEAL LAND FOR STATIC STRUCTURE OF A GAS TURBINE ENGINE,,UNITED TECHNOLOGIES CORP,PORTER STEVEN D;;BURT JONATHAN P;;JAKIEL JONATHAN J;;GORDON AMY M;;DUELM SHELTON O,RAYTHEON TECHNOLOGIES CORPORATION (2021-03-24);;UNITED TECHNOLOGIES CORPORATION (2016-10-26),https://lens.org/103-663-205-547-387,Patent Application,yes,0,0,7,7,0,F16J15/0887;;F16J15/0887;;F01D9/02;;F01D9/02;;F01D11/005;;F01D11/005;;F01D11/08;;F01D11/08;;F02C7/28;;F02C7/28,F02C7/28;;F01D9/02;;F01D11/00;;F01D11/08;;F01D25/24;;F16J15/08,,0,0,,,,ACTIVE
616,JP,A,JP 2021121615 A,176-786-890-688-37X,2021-08-26,2021,JP 2021084554 A,2021-05-19,JP 2018501883 A;;US 201562194957 P;;US 201562273657 P;;US 201662316310 P,2015-07-21,MONOCLONAL ANTIBODY INHIBITORS OF FACTOR XIIa,"To provide anti-Factor XIIa antibodies for treating diseases associated with Factor XII including diseases associated with contact system activation, plasma prekallikrein signaling (e.g., hereditary angioedema) and ocular diseases.SOLUTION: Disclosed is a monoclonal antibody that binds to Factor XIIa (FXIIa) but not to Factor XII (FXII). The antibody may be a full-length antibody or an antigen binding fragment thereof such as Fab, and may be a human antibody or humanized antibody. The antibody may interact with one or more amino acid residues in the chain C of FXIIa.SELECTED DRAWING: Figure 4",DYAX CORP,SHAUNA MASON;;JON A KENNISTON;;NIXON ANDREW;;DANIEL J SEXTON;;STEPHEN R COMEAU;;BURT ADELMAN,,https://lens.org/176-786-890-688-37X,Patent Application,no,3,0,29,29,0,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36,,0,0,,,,ACTIVE
617,US,B2,US 9851008 B2,183-210-339-386-718,2017-12-26,2017,US 201213487721 A,2012-06-04,US 201213487721 A,2012-06-04,Seal land for static structure of a gas turbine engine,A seal land for a gas turbine engine can include a seal body circumferentially extending about a longitudinal centerline axis. The seal body includes at least one sealing surface that extends in a plane that is transverse to the longitudinal centerline axis.,PORTER STEVEN D;;BURT JONATHAN P;;JAKIEL JONATHAN J;;GORDON AMY M;;DUELM SHELTON O;;UNITED TECHNOLOGIES CORP,PORTER STEVEN D;;BURT JONATHAN P;;JAKIEL JONATHAN J;;GORDON AMY M;;DUELM SHELTON O,RTX CORPORATION (2012-06-01),https://lens.org/183-210-339-386-718,Granted Patent,yes,22,0,7,7,0,F16J15/0887;;F16J15/0887;;F01D9/02;;F01D9/02;;F01D11/005;;F01D11/005;;F01D11/08;;F01D11/08;;F02C7/28;;F02C7/28,F01D11/00;;F01D9/02;;F01D11/08;;F02C7/28;;F16J15/08,,3,0,,,"International Search Report and Written Opinion for PCT Application No. PCT/US2013/042966 dated Mar. 20, 2014.;;International Preliminary Report on Patentability for PCT Application No. PCT/US2013/042966 dated Dec. 18, 2014.;;Extended European Search Report for Application No. EP 13 83 0737 dated Feb. 9, 2016.",ACTIVE
618,US,B2,US 9194252 B2,185-594-778-763-894,2015-11-24,2015,US 201213403407 A,2012-02-23,US 201213403407 A,2012-02-23,Turbine frame fairing for a gas turbine engine,A static structure of a gas turbine engine includes a multiple of airfoil segments and at least one structural reinforcement ring mounted to the multiple of airfoil segments.,FARAH JORGE I;;KAPUSTKA THEODORE W;;BURT JONATHAN P;;JAKIEL JONATHAN J;;STEWART DANA P;;UNITED TECHNOLOGIES CORP,FARAH JORGE I;;KAPUSTKA THEODORE W;;BURT JONATHAN P;;JAKIEL JONATHAN J;;STEWART DANA P,RTX CORPORATION (2012-02-16),https://lens.org/185-594-778-763-894,Granted Patent,yes,17,15,6,6,0,B23K1/0018;;B23K1/0018;;B23K2101/001;;B23K2101/001;;F01D25/162;;F01D25/162;;F01D9/04;;F01D9/044;;F01D9/044;;F01D9/065;;F01D9/065;;F01D25/246;;F05D2230/237;;F05D2230/237,F01D25/24;;B23K1/00;;F01D9/04;;F01D25/16,,2,0,,,"International Search Report and Written Opinion for International Application No. PCT/US2013/026969 completed on Jun. 20, 2013.;;International Preliminary Search Report on Patentability for PCT Application No. PCT/US2013/026969 mailed Sep. 4, 2014.",ACTIVE
619,US,B2,US 6716956 B2,029-944-670-412-639,2004-04-06,2004,US 4085002 A,2002-01-09,US 4085002 A,2002-01-09,Process for preparing polyarylene ethers,"
    Disclosed is a process for preparing a polymer of the formula 

    wherein x is an integer of 0 or 1, A is one of several specific groups, such as 

    B is one of several specified groups, such as 

    or mixtures thereof, and n is an integer representing the number of repeating monomer units, said process comprising (A) providing a reaction mixture which comprises (i) a solvent, (ii) a compound of the formula 

    (iii) a compound of the formula 

    (iv) a compound of the formula 

    wherein a is an integer of from 1 to 5, R is a hydrogen atom, an alkyl group, an aryl group, an arylalkyl group, an alkylaryl group, an alkoxy group, an aryloxy group, an arylalkyloxy group, an alkylaryloxy group, a polyalkyleneoxy group, or a mixture thereof, and (v) a carbonate base; and (B) heating the reaction mixture and removing generated water from the reaction mixture, thereby effecting a polymerization reaction. 
",XEROX CORP,BENDER TIMOTHY P;;DEVISSER CHRISTINE J;;BURT RICHARD A;;SMITH PAUL F;;SABAN MARKO D,XEROX CORPORATION (2001-12-18),https://lens.org/029-944-670-412-639,Granted Patent,yes,72,7,2,2,0,C08G65/4012;;C08G65/4012,C08G8/02;;C08G14/00,528/125;;528/126;;528/220;;528/488;;528/492;;528/501;;528/503;;525/310;;525/471;;525/534,3,0,,,"Bender et al, The synthesis of Poly(arylene ether)s in solution at Pilot Plant Scale with control over Molecular weight and End-group composition, Sep. 2002, Chem Abstract 137: 233008.*;;Copending application Ser. No. 09/268,794 entitled ""High Performance Curable Polymers And Processes For The Preparation Thereof,"" filed on Mar. 16, 1999 by Narang et al.;;Copending application Ser. No. 09/844,371 entitled ""Bonding Process,"" filed on Apr. 27, 2001 by Delouise et al.",EXPIRED
620,EP,A4,EP 2855892 A4,159-764-300-760-578,2016-03-09,2016,EP 13830737 A,2013-05-29,US 201213487721 A;;US 2013/0042966 W,2012-06-04,SEAL LAND FOR STATIC STRUCTURE OF A GAS TURBINE ENGINE,,UNITED TECHNOLOGIES CORP,PORTER STEVEN D;;BURT JONATHAN P;;JAKIEL JONATHAN J;;GORDON AMY M;;DUELM SHELTON O,RAYTHEON TECHNOLOGIES CORPORATION (2021-03-24);;UNITED TECHNOLOGIES CORPORATION (2016-10-26),https://lens.org/159-764-300-760-578,Search Report,no,3,0,7,7,0,F16J15/0887;;F16J15/0887;;F01D9/02;;F01D9/02;;F01D11/005;;F01D11/005;;F01D11/08;;F01D11/08;;F02C7/28;;F02C7/28,F02C7/28;;F01D9/02;;F01D11/00;;F01D11/08;;F01D25/24;;F16J15/08,,1,0,,,See also references of WO 2014031205A2,ACTIVE
621,DE,D1,DE 602007007686 D1,066-110-135-909-863,2010-08-26,2010,DE 602007007686 T,2007-04-13,GB 0608159 A;;US 71788707 A,2006-04-26,Halterung zur Montage eines Wärmetauschers,"The invention relates to a heat exchanger mounting bracket which has a first member with a retaining channel and a second member with a retaining lug. The retaining channel of the first member retains the retaining lug of the second member at an initial mounting position, with a predetermined retaining force, by way of at least a formation on the first member. The retaining channel and lug are releaseable from one another when a force greater than or equal to the predetermined retaining force is applied between the first and second members. A heat exchanger mounting bracket is also provided where a body member is provided with a longitudinal slot toward one end for locating a portion (P) of a heat exchanger, and a pivotal arrangement toward the other end. The pivotal arrangement and longitudinal slot allow displacement of the portion (P) of the heat exchanger from a fore to an aft position upon application of an impact force.",DELPHI TECH INC,JAMIL BEN HAMIDA;;SLAWOMIR KEDZIORA;;COYLE BRIAN J;;GMEREK ROBERT CHARLES BURT;;LEITCH FRANK JOSEPH,,https://lens.org/066-110-135-909-863,Granted Patent,no,0,0,5,8,0,B60K11/04;;F28F9/002;;F28F2275/143;;F28F2280/105;;F28F2265/00;;F28F9/002;;B60K11/04;;F28F2275/143;;F28F2280/105;;F28F2265/00,B60K11/04;;F28F9/00,,0,0,,,,ACTIVE
622,US,B2,US 6843106 B2,056-542-090-623-488,2005-01-18,2005,US 80087201 A,2001-03-07,US 80087201 A;;US 18793100 P,2000-03-08,Differential permeometer,"Permeability of a porous, sheet-like sample is determined using a device that is designed to measure the pressure differential between a first stream of fluid applied across an entire thickness of a test sample and a second stream of fluid applied across an entire thickness of a reference sample. The flow rate for both the test fluid flow system and the reference fluid flow system is determined independently, by measuring a pressure drop throughout the flow system. Data obtained from pressure and flow rate for test and reference fluids are used to calculate percent change in permeability and/or actual permeability using Darcy's Law.",RENSSELAER POLYTECH INST,SWERSEY BURT;;HARVEY MARCIE J;;KAPLAN ELIAS;;LAMANA JENNIFER;;HOWARD STEPHEN J;;MELONEY DEAN;;WEED JOHN P;;NOVAK TIMOTHY,RENSSELAER POLYTECHNIC INSTITUTE (2001-04-28),https://lens.org/056-542-090-623-488,Granted Patent,yes,14,18,2,2,0,G01N15/0826;;G01N15/0826,G01N15/08,73/38,0,0,,,,EXPIRED
623,US,A1,US 2003/0176621 A1,082-072-731-130-560,2003-09-18,2003,US 4085002 A,2002-01-09,US 4085002 A,2002-01-09,Process for preparing polyarylene ethers,"
    Disclosed is a process for preparing a polymer of the formula 

    wherein x is an integer of 0 or 1, A is one of several specific groups, such as 

    B is one of several specified groups, such as 

    or mixtures thereof, and n is an integer representing the number of repeating monomer units, said process comprising (A) providing a reaction mixture which comprises (i) a solvent, (ii) a compound of the formula 

    (iii) a compound of the formula 

    (iv) a compound of the formula 

   wherein a is an integer of from 1 to 5, R is a hydrogen atom, an alkyl group, an aryl group, an arylalkyl group, an alkylaryl group, an alkoxy group, an aryloxy group, an arylalkyloxy group, an alkylaryloxy group, a polyalkyleneoxy group, or a mixture thereof, and (v) a carbonate base; and (B) heating the reaction mixture and removing generated water from the reaction mixture, thereby effecting a polymerization reaction. 
",XEROX CORP,BENDER TIMOTHY P;;DEVISSER CHRISTINE J;;BURT RICHARD A;;SMITH PAUL F;;SABAN MARKO D,XEROX CORPORATION (2001-12-18),https://lens.org/082-072-731-130-560,Patent Application,yes,0,3,2,2,0,C08G65/4012;;C08G65/4012,C08G8/02;;C08G14/00,528/125,0,0,,,,EXPIRED
624,US,B2,US 6674886 B2,116-730-273-912-007,2004-01-06,2004,US 42835999 A,1999-10-28,US 42835999 A;;US 18538098 A,1998-11-03,Method and system for recognizing security documents,"
    A document is analyzed to determine whether it is a banknote or the like, by reference to image data corresponding to the document. Two analysis techniques may be used, one based on detection of a visible pattern characteristic of a security document, the other based on detection of a steganographic digital watermark characteristic of a security document. If either characteristic is found, the image is flagged, and appropriate anti-counterfeiting steps may be taken. Detection of the visible pattern can be performed using a series of successively more rigorous tests. If the image fails a test, successive testing steps can be skipped, speeding the process. Hough transform-based pattern recognition techniques are used in some embodiments. Provision of both a visible pattern detector and a watermark detector in a single apparatus enhances detection reliability, while permitting various implementation efficiencies. 
",DIGIMARC CORP,DAVIS BRUCE L;;PERRY BURT W;;CARR J SCOTT;;SHAW GILBERT B;;RHOADS GEOFFREY B,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC CORPORATION (2008-08-01);;DMRC LLC (2008-08-01),https://lens.org/116-730-273-912-007,Granted Patent,yes,37,57,10,1547,0,G06F21/10;;G06F2221/2101;;G07D7/20;;H04N1/00843;;H04N1/00877;;G07D7/0034;;G06V10/40;;G06F12/16;;H04N1/00843;;G06F2221/2101;;G07D7/20;;H04N1/00877;;G06F21/10;;G07D7/0034;;G06V10/40,G06F3/12;;G06F1/00;;G06F21/00;;G06V10/40;;G07D7/12;;G07D7/20;;H04N1/00;;H04N1/387;;H04N1/40,382/135;;340/5.86,16,2,054-041-970-960-409;;123-478-746-608-833,10.1016/0031-3203(81)90009-1;;10.1007/3-540-49380-8_1,"Ballard, ""Generalizing the Hough Transform to Detect Arbitrary Shapes,"" Pattern Recognition, vol. 13, No. 2, pp. 111-122, 1981.;;Szepanski, ""A Signal Theoretic Method for Creating Forgery-Proof Documents for Automatic Verification,"" Proceedings 1979 Carnahan Conference on Crime Countermeasures, May 16, 1979, pp. 101-109.;;U.S. patent application Ser. No. 09/074,034, Rhoads, filed May 5, 1998.;;U.S. patent application Ser. No. 09/127,502, Rhoads, filed Jul. 31, 1998.;;U.S. patent application Ser. No. 09/185,380, Davis et al., filed Nov. 3, 1998.;;U.S. patent application Ser. No. 09/287,940, Rhoads, filed Apr. 7, 1999.;;U.S. patent application Ser. No. 09/293,601, Rhoads, filed Apr. 15, 1999.;;U.S. patent application Ser. No. 09/293,602, Rhoads, filed Apr. 15, 1999.;;U.S. patent application Ser. No. 09/342,972, Rhoads, filed Jun. 29, 1999.;;U.S. patent application Ser. No. 09/431,990, Rhoads, filed Nov. 3, 1999.;;U.S. patent application Ser. No. 09/465,418, Rhoads et al., filed Dec. 16, 1999.;;U.S. patent application Ser. No. 09/562,524, Carr et al., filed May 1, 2000.;;U.S. patent application Ser. No. 09/761,280, Rhoads, filed Jan. 16, 2001.;;U.S. patent application Ser. No. 09/761,349, Rhoads, filed Jan. 16, 2001.;;U.S. patent application Ser. No. 09/765,102, Shaw, filed Jan. 17, 2001.;;Gruhl et al., ""Information Hiding to Foil the Casual Counterfeiter,"" Data Hiding Workshop, Apr. 15, 1998, 15 pages.",EXPIRED
625,WO,A1,WO 2000/026749 A1,155-064-496-632-312,2000-05-11,2000,US 9925375 W,1999-10-28,US 18538098 A,1998-11-03,METHOD AND SOFTWARE FOR EVIDENCING ILLICIT USE OF A COMPUTER SYSTEM,"A computer (10) is provided with software that looks for certain activities that may be illicit (e.g. processing of a graphic file corresponding to a banknote). If such an activity is detected, tracer data detailing the activity is generated and secretly stored in the computer (10). If the computer (10) is later searched or seized, the tracer data can be recovered and employed as evidence of the computer's use, e.g. in counterfeiting. To detect whether graphic image data corresponds to a banknote, two analysis techniques may be used. One is based on detection of a visible pattern characteristic of a security document. The other is based on detection of a steganographic digital watermark characteristic of a security document. If either characteristic is found, the image is flagged, and appropriate anti-counterfeiting steps may be taken. Detection of the visible pattern can be performed using a series of successively more rigorous tests. If the image fails the first test, successive tests can be skipped, speeding the process. Hough transform-based pattern recognition techniques are used in some embodiments. Provision of both a visible pattern detector and a watermark detector in a single apparatus enhances reliability, while permetting various implementation efficiencies.",DIGIMARC CORP;;DAVIS BRUCE L;;PERRY BURT W;;CARR J SCOTT;;SHAW GILBERT B;;RHOADS GEOFFREY B,DAVIS BRUCE L;;PERRY BURT W;;CARR J SCOTT;;SHAW GILBERT B;;RHOADS GEOFFREY B,,https://lens.org/155-064-496-632-312,Patent Application,yes,8,16,10,1547,0,G06F21/10;;G06F2221/2101;;G07D7/20;;H04N1/00843;;H04N1/00877;;G07D7/0034;;G06V10/40;;G06F12/16;;H04N1/00843;;G06F2221/2101;;G07D7/20;;H04N1/00877;;G06F21/10;;G07D7/0034;;G06V10/40,G06F3/12;;G06F1/00;;G06F21/00;;G06V10/40;;G07D7/12;;G07D7/20;;H04N1/00;;H04N1/387;;H04N1/40,,0,0,,,,PENDING
626,CO,A2,CO 2018001599 A2,171-518-145-577-757,2018-05-10,2018,CO 2018001599 A,2018-02-19,US 2016/0043265 W;;US 201562194957 P;;US 201562273657 P;;US 201662316310 P,2015-07-21,Un inhibidor de anticuerpo monoclonal de factor xiia,"Acá se divulgan anticuerpos anti-Factor XIIa y método para usar los mismos para el tratamiento de enfermedades asociadas con Factor XII, incluyendo enfermedades asociadas con activación de sistema de contacto, señalización de precalicreína de plasma (por ejemplo, angioedema hereditario), y enfermedades oculares.",DYAX CORP,ADELMAN BURT;;NIXON ANDREW;;MASON SHAUNA;;KENNISTON JON A;;SEXTON DANIEL J;;COMEAU STEPHEN R,,https://lens.org/171-518-145-577-757,Patent Application,no,0,0,29,29,0,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36,,0,0,,,,PENDING
627,US,A1,US 2006/0115536 A1,037-916-106-652-588,2006-06-01,2006,US 27108305 A,2005-11-11,US 27108305 A;;US 62737204 P;;US 62798704 P,2004-11-12,Glycerin based synthesis of silver nanoparticles and nanowires,"The present invention includes compositions and methods for the production of noble metal nanoparticles and nanowires conjugated to polyols or polymers. The present invention allows the incorporation of noble metal nanoparticles to a wide range of products such as body care products to exploit the biocidal properties of silver nanoparticles against bacteria, viruses and fungi.",UNIV TEXAS,YACAMAN MIGUEL J;;ELECHIGUERRA JOSE L;;BURT JUSTIN L;;MORONES JOSE R;;LOPEZ LETICIA L,BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (2006-01-18),https://lens.org/037-916-106-652-588,Patent Application,yes,7,54,1,12,0,A61K33/24;;A61K33/26;;A61K33/34;;A61K33/38;;B22F2998/00;;B82Y30/00;;A61K33/242;;A61K33/243;;B22F1/0547;;B22F1/102;;B22F2998/00;;A61K33/24;;A61K33/26;;B82Y30/00;;A61K33/38;;A61K33/34;;A61K33/242;;A61K33/243;;B22F1/0547;;B22F1/102,A61K33/38;;A61K9/14;;A61K33/24;;A61K33/242;;A61K33/243;;B22F1/102,424/489;;424/618;;977/915,0,0,,,,DISCONTINUED
628,EP,A4,EP 2817496 A4,016-987-205-715-966,2015-12-23,2015,EP 13751563 A,2013-02-21,US 201213403407 A;;US 2013/0026969 W,2012-02-23,TURBINE FRAME FAIRING FOR A GAS TURBINE ENGINE,,UNITED TECHNOLOGIES CORP,FARAH JORGE I;;KAPUSTKA THEODORE W;;BURT JONATHAN P;;JAKIEL JONATHAN J;;STEWART DANA P,"RAYTHEON TECHNOLOGIES CORPORATION (N.D.GES.D.S, US (2022-09-23);;UNITED TECHNOLOGIES CORPORATION (2016-10-26)",https://lens.org/016-987-205-715-966,Search Report,no,4,0,6,6,0,B23K1/0018;;B23K1/0018;;B23K2101/001;;B23K2101/001;;F01D25/162;;F01D25/162;;F01D9/04;;F01D9/044;;F01D9/044;;F01D9/065;;F01D9/065;;F01D25/246;;F05D2230/237;;F05D2230/237,F02C7/00;;B23K1/00;;B23K101/00;;F01D9/02;;F01D9/04;;F01D9/06;;F01D25/16;;F01D25/24,,1,0,,,See also references of WO 2013126471A1,ACTIVE
629,US,A1,US 2007/0047980 A1,085-901-822-146-431,2007-03-01,2007,US 33134306 A,2006-01-13,US 33134306 A;;US 71018805 P,2005-08-23,Machine vision counting system apparatus and method,"A machine-vision-based counter includes an image acquisition component (imager), wherein light provides discrimination between a background field and imageable units located away from the imager The imager outputs data representing the field and units; an image processor receiving imager data finds countable units therein. An operator interface accepts command inputs and presents count output. A controller manages image acquisition, processor, and operator interface functions. A counting method includes configuring an imager to detect light, directing light from a source to units positioned to be detected by the imager, and directing the light to the imager. The method includes discriminating between a background field and imageable units; providing, as an imager output, data representing the field and units; configuring an image-processor to receive imager data; configuring the processor to interpret the data as counted units on a background field; and configuring an operator interface to present a count result.",LIMER DANIEL J;;LANG DAVID A;;BURT CHRISTOPHER S;;GOUIN PHILIP R;;TARR NELSON D,LIMER DANIEL J;;LANG DAVID A;;BURT CHRISTOPHER S;;GOUIN PHILIP R;;TARR NELSON D,SPX CORPORATION (2008-02-21);;ILLINOIS TOOL WORKS INC (2008-12-31);;SPX CORPORATION (A DELAWARE CORPORATION) (2006-05-12),https://lens.org/085-901-822-146-431,Patent Application,yes,13,25,6,6,0,A61J7/02;;G01N2015/1472;;G01N2015/1486;;G06M1/101;;G06M11/00;;G06V20/66;;G01N15/1433;;A61J7/02;;G01N2015/1486;;G01N2015/1472;;G06M1/101;;G06M11/00;;G01N15/1433,G03G15/00,399/25,0,0,,,,ACTIVE
630,AU,A1,AU 2016/297018 A1,134-809-755-715-262,2018-02-08,2018,AU 2016/297018 A,2016-07-21,US 201562273657 P;;US 201562194957 P;;US 201662316310 P;;US 2016/0043265 W,2015-07-21,A monoclonal antibody inhibitor of factor XIIa,"Disclosed herein are anti-Factor Xlla antibodies and methods of using such for treating diseases associated with Factor XII, including diseases associated with contact system activation, plasma prekallikrein signaling (e.g., hereditary angioedema), and ocular diseases.",TAKEDA PHARMACEUTICALS CO,MASON SHAUNA;;KENNISTON JON A;;NIXON ANDREW;;SEXTON DANIEL J;;COMEAU STEPHEN R;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/134-809-755-715-262,Patent Application,no,0,0,29,29,0,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36,,0,0,,,,ACTIVE
631,EP,B1,EP 2855892 B1,160-777-825-386-417,2021-06-30,2021,EP 13830737 A,2013-05-29,US 201213487721 A;;US 2013/0042966 W,2012-06-04,MID-TURBINE FRAME FOR A GAS TURBINE ENGINE COMPRISING A SEAL LAND,,RAYTHEON TECH CORP,PORTER STEVEN D;;BURT JONATHAN P;;JAKIEL JONATHAN J;;GORDON AMY M;;DUELM SHELTON O,RAYTHEON TECHNOLOGIES CORPORATION (2021-03-24);;UNITED TECHNOLOGIES CORPORATION (2016-10-26),https://lens.org/160-777-825-386-417,Granted Patent,yes,2,0,7,7,0,F16J15/0887;;F16J15/0887;;F01D9/02;;F01D9/02;;F01D11/005;;F01D11/005;;F01D11/08;;F01D11/08;;F02C7/28;;F02C7/28,F02C7/28;;F01D9/02;;F01D11/00;;F01D11/08;;F01D25/24;;F16J15/08,,0,0,,,,ACTIVE
632,US,B1,US 6308080 B1,183-876-670-342-134,2001-10-23,2001,US 7947298 A,1998-05-15,US 7947298 A;;US 4675097 P,1997-05-16,Power control in point-to-multipoint systems,The invention provides methods and systems for power control in point-to-multipoint communications systems. Methods are described for both downstream and upstream control. Subscriber signals received at the base station 11 are level detected at receiver 77 and power adjust processing 79 and a control signal is sent to control output from the subscriber transmitter 65. The invention maximizes the signal-to-noise ratio and signal-to-interference ratio for subscribers (CPE) while minimizing transmitted power. The invention is ideal for use in local multipoint distribution service (LMDS) systems.,TEXAS INSTRUMENTS INC,BURT DONALD G;;MYERS WILLIAM K;;LANGSTON J LELAND;;MARIN JAMES SCOTT;;DARBE KEVIN B,TEXAS INSTRUMENTS INCORPORATED (1997-05-23),https://lens.org/183-876-670-342-134,Granted Patent,yes,16,217,1,1,0,H04W52/08;;H04W52/343;;H04W52/346;;H04W84/14;;H04W88/08;;H04W52/343;;H04W52/346;;H04W88/08;;H04W84/14;;H04W52/08,H04B7/005;;H04W52/00;;H04W52/08;;H04W52/34;;H04W84/14;;H04W88/08,455/522;;455/69;;455/127;;455/561,0,0,,,,EXPIRED
633,HK,A1,HK 1255423 A1,039-321-063-356-614,2019-08-16,2019,HK 18114586 A,2018-11-15,US 201562194957 P;;US 201562273657 P;;US 201662316310 P;;US 2016/0043265 W,2015-07-21,A MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA,,DYAX CORP,MASON SHAUNA;;KENNISTON JON A;;NIXON ANDREW;;SEXTON DANIEL J;;COMEAU STEPHEN R;;ADELMAN BURT,,https://lens.org/039-321-063-356-614,Patent Application,no,0,0,29,29,0,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K/,,0,0,,,,PENDING
634,BR,A2,BR 112018001202 A2,117-966-292-240-450,2018-09-25,2018,BR 112018001202 A,2016-07-21,US 2016/0043265 W;;US 201562194957 P;;US 201562273657 P;;US 201662316310 P,2015-07-21,"anticorpo monoclonal, ácido nucleico, vetor, célula hospedeira, composição farmacêutica e método","são divulgados neste documento anticorpos anti-fator xiia e métodos de uso desses para tratar doenças associadas ao fator xii, incluindo doenças associadas a ativação do sistema contato, sinalização de precalicreína plasmática (e.g., angioedema hereditário), e doenças oculares.",DYAX CORP,ANDREW NIXON;;BURT ADELMAN;;DANIEL J SEXTON;;JON A KENNISTON;;SHAUNA MASON;;STEPHEN R COMEAU,TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) (2021-10-05);;DYAX CORP. (US) (2018-10-16),https://lens.org/117-966-292-240-450,Patent Application,no,0,1,29,29,0,C07K16/36;;A61P7/02;;A61P27/02;;A61P7/10;;C07K2317/24;;C07K2317/94;;C07K2317/92;;C07K2317/34;;C07K2317/76;;C07K2317/565;;A61K2039/505;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/76;;C07K2317/90;;C07K2317/92;;C07K16/36;;A61P11/00;;A61P27/02;;A61P43/00;;A61P7/02;;A61P9/00;;A61P27/02;;C07K16/36;;A61K2039/505;;C07K2317/34;;C07K2317/55;;C07K2317/21;;C07K2317/92;;C07K2317/90;;C07K2317/76;;A61K2039/505;;C07K2317/21;;C07K2317/34;;C07K2317/55;;C07K2317/90;;C07K2317/76;;C07K2317/92;;C07K16/36;;C07K2317/24;;C07K2317/94,C07K16/36,,0,0,,,,PENDING
635,US,A1,US 2013/0323045 A1,156-049-467-853-854,2013-12-05,2013,US 201213487721 A,2012-06-04,US 201213487721 A,2012-06-04,SEAL LAND FOR STATIC STRUCTURE OF A GAS TURBINE ENGINE,A seal land for a gas turbine engine can include a seal body circumferentially extending about a longitudinal centerline axis. The seal body includes at least one sealing surface that extends in a plane that is transverse to the longitudinal centerline axis.,PORTER STEVEN D;;BURT JONATHAN P;;JAKIEL JONATHAN J;;GORDON AMY M;;DUELM SHELTON O,PORTER STEVEN D;;BURT JONATHAN P;;JAKIEL JONATHAN J;;GORDON AMY M;;DUELM SHELTON O,RTX CORPORATION (2012-06-01),https://lens.org/156-049-467-853-854,Patent Application,yes,0,16,7,7,0,F16J15/0887;;F16J15/0887;;F01D9/02;;F01D9/02;;F01D11/005;;F01D11/005;;F01D11/08;;F01D11/08;;F02C7/28;;F02C7/28,F16J15/02;;F03B11/00,415/229;;277/650,0,0,,,,ACTIVE
636,US,A1,US 2007/0183623 A1,081-790-991-804-947,2007-08-09,2007,US 54816706 A,2006-10-10,US 54816706 A;;US 2922901 A;;US 25782200 P,2000-12-21,Watermark Systems and Methods,"A number of novel watermarking applications, and improvements to watermarking methods, are disclosed. Included are techniques for encoding printed circuit boards and street signs with watermarks, deterring credit card fraud and controlling software licensing using watermarks, registering collectibles via watermarks, encoding the margins of printed pages with watermarks, and using watermarks to convey extra information in video by which fidelity of the rendered video may be improved. One particular arrangement is a method in which a PDA, wristwatch, or other portable device with a display screen presents a pattern that includes a machine-readable identifier. This image is sensed by a separate device, such as a webcam or a camera-equipped cell phone. The sensing device can then take an action based on the identifier. In some arrangements, the action is personalized to the user.",MCKINLEY TYLER J;;SEDER PHILLIP A;;RODRIGUEZ TONY F;;PERRY BURT W;;CARR J S;;PAUL INDRANEEL;;BRUNDAGE TRENT J;;HANNIGAN BRETT T,MCKINLEY TYLER J;;SEDER PHILLIP A;;RODRIGUEZ TONY F;;PERRY BURT W;;CARR J S;;PAUL INDRANEEL;;BRUNDAGE TRENT J;;HANNIGAN BRETT T,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC CORPORATION (2008-08-01);;DMRC LLC (2008-08-01),https://lens.org/081-790-991-804-947,Patent Application,yes,98,8,16,1547,0,G06F21/125;;G06F21/36;;G06F21/6272;;G06Q10/0637;;G06Q30/0236;;G06F2221/2111;;G06F2221/2129;;G06F2221/2153;;H04N21/8358;;G06F21/1063;;G06F21/16;;G06F21/125;;G06F21/36;;G06F21/6272;;G06Q10/0637;;G06Q30/0236;;G06F2221/2111;;G06F2221/2129;;G06F2221/2153;;G06F21/16;;G06F21/1063;;H04N21/8358,G06K9/00;;G06K7/10;;G06K7/14;;G06K15/00;;G06K19/00;;H04K1/00;;H04L9/00;;H04N5/76;;H04N7/084;;H04N7/087,382/100,0,0,,,,EXPIRED
637,US,A1,US 2002/0118394 A1,084-924-169-854-19X,2002-08-29,2002,US 2922901 A,2001-12-21,US 2922901 A;;US 25782200 P,2000-12-21,Watermark systems and methods,"
   A number of novel watermarking applications, and improvements to watermarking methods, are disclosed. Included are techniques for encoding printed circuit boards and street signs with watermarks, deterring credit card fraud and controlling software licensing using watermarks, registering collectibles via watermarks, encoding the margins of printed pages with watermarks, and using watermarks to convey extra information in video by which fidelity of the rendered video may be improved. 
",MCKINLEY TYLER J.;;SEDER PHILLIP ANDREW;;RODRIGUEZ TONY F.;;PERRY BURT W.;;CARR J. SCOTT;;PAUL INDRANEEL;;BRUNDAGE TRENT J.;;HANNIGAN BRETT T.,MCKINLEY TYLER J;;SEDER PHILLIP ANDREW;;RODRIGUEZ TONY F;;PERRY BURT W;;CARR J SCOTT;;PAUL INDRANEEL;;BRUNDAGE TRENT J;;HANNIGAN BRETT T,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC CORPORATION (2008-08-01);;DMRC LLC (2008-08-01),https://lens.org/084-924-169-854-19X,Patent Application,yes,15,44,16,1547,0,G06F21/125;;G06F21/36;;G06F21/6272;;G06Q10/0637;;G06Q30/0236;;G06F2221/2111;;G06F2221/2129;;G06F2221/2153;;H04N21/8358;;G06F21/1063;;G06F21/16;;G06F21/125;;G06F21/36;;G06F21/6272;;G06Q10/0637;;G06Q30/0236;;G06F2221/2111;;G06F2221/2129;;G06F2221/2153;;G06F21/16;;G06F21/1063;;H04N21/8358,G06K7/10;;G06K7/14;;G06K15/00;;G06K19/00;;H04K1/00;;H04L9/00;;H04N5/76;;H04N7/084;;H04N7/087,358/3.28,0,0,,,,EXPIRED
638,US,S,US D0668731 S,017-649-249-249-340,2012-10-09,2012,US 201129400444 F,2011-08-29,US 201129400444 F,2011-08-29,Rail cover index attachment,,FITZPATRICK RICHARD;;MAYBERRY MICHAEL T;;KERBS JEREMY;;BURT ERIC CHRISTOPHER;;BARANELLO MICHAEL J;;BOORAS NICHOLAS JAMES;;MAGPUL IND CORP,FITZPATRICK RICHARD;;MAYBERRY MICHAEL T;;KERBS JEREMY;;BURT ERIC CHRISTOPHER;;BARANELLO MICHAEL J;;BOORAS NICHOLAS JAMES,MAGPUL INDUSTRIES CORPORATION (2011-08-30),https://lens.org/017-649-249-249-340,Design Right,no,0,8,1,1,0,,,2201;;D22/108,0,0,,,,ACTIVE
639,US,B1,US 8143398 B1,082-678-418-422-408,2012-03-27,2012,US 201113031991 A,2011-02-22,US 201113031991 A;;US 30622410 P,2010-02-19,Activity of new N-acylated ciprofloxacin derivatives against faculative intracellular bacteria,"Bartonella species are facultative intracellular pathogens responsible for a range of diseases in animals and in humans. A selection of N-acyl ciprofloxacin analogues, chemically synthesized from ciprofloxacin, have been tested in vitro for activity against Bartonella species as models for therapeutic development. Nine Bartonella strains, including five of B. henselae , two of B. quintana , and one each of B. elizabethae and B. vinsonii , have been tested for susceptibility to different N-acyl ciprofloxacin derivatives. Several techniques have been used to test the in vitro antibacterial activity of the derivatives. Seven of them, labeled RC4-125, RC4-143, RC4-147, RC5-28, RC5-29, RC5-32 and RC5-69 showed significant intracellular anti- Bartonella activity. These synthetically derived N-acyl ciprofloxacin derivatives may be useful in the therapeutic treatment of infections caused by Bartonella.",TUROS EDWARD;;ANDERSON BURT E;;CORMIER RYAN SCOTT;;THOMAS JOHN C;;KAPOLKA REBECCA J;;ROMA GLENN;;UNIV SOUTH FLORIDA,TUROS EDWARD;;ANDERSON BURT E;;CORMIER RYAN SCOTT;;THOMAS JOHN C;;KAPOLKA REBECCA J;;ROMA GLENN,UNIVERSITY OF SOUTH FLORIDA (2011-03-20),https://lens.org/082-678-418-422-408,Granted Patent,yes,1,0,1,1,0,C07D241/04;;C07D241/04,C07D241/04,544/357,6,6,004-926-271-999-94X;;014-362-937-941-341;;032-259-589-587-119;;110-610-225-385-164;;068-631-917-933-178;;002-618-172-389-372,11673033;;10.1016/s0924-8579(01)00388-0;;10.1128/aac.48.6.1921-1933.2004;;pmc415619;;15155180;;11083639;;pmc90204;;10.1128/aac.44.12.3351-3356.2000;;pmc148966;;10.1128/aac.47.1.383-386.2003;;12499219;;10.1128/mmbr.61.3.377-392.1997;;pmc232616;;10.1128/.61.3.377-392.1997;;9293187;;10.1128/cmr.10.2.203;;9105751;;pmc172916,"Ives, In vitro susceptibilities of Bartonella and Rickettsia spp. to fluoroquinolone antibiotics as determined by immunofluorescent antibody analysis of infected Vero cell monolayers, 2001, International Journal of Antimicrobial Agents, vol. 18, p. 217-222.;;Rolain et al., Recommendations for Treatment of Human Infections Caused by Bartonella Species, Antimicrobial Agents and Chemotherapy, 2004, vol. 48, No. 6, pp. 1921-1933.;;Fung-Tomc et al., Antibacterial Spectrum of a Novel Des-Fluoro(6) Quinolone, BMS-284756, Antimicrobial Agents and Chemotherapy, 2000, vol. 44, No. 12, pp. 3351-3356.;;Minnick et al., gyrA Mutations in Ciprofloxacin-Resistant Bartonella bacilliformis Strains Obtained In Vitro, Antimicrobial Agents and Chemotherapy, 2003, vol. 47, No. 1, pp. 383-386.;;Drlica et al., DNA Gyrase, Topoisomerase IV, and the 4-Quinolones, Microbiology and Molecular Biology Reviews, 1997, vol. 61, No. 3, pp. 377-392.;;Anderson et al., Bartonella spp. as Emerging Human Pathogens, Clinical Microbiology Reviews, 1997, vol. 10, No. 2, pp. 203-219.",ACTIVE
640,CN,A,CN 114644082 A,004-454-440-145-820,2022-06-21,2022,CN 202111541209 A,2021-12-16,US 202017128714 A,2020-12-21,Mechanical trigger and triggering method for self-breaking fragile structures and sealed vessels,"An apparatus includes a structure having a predetermined breakable region and a mechanical actuator disposed at or near the predetermined breakable region. The mechanical actuator includes an impact member coupled to the spring arrangement and a constraining member operably coupled to the spring arrangement. The trigger source is operably coupled to the power source. In response to receiving current from the power source, the trigger source is configured to release or break the constraining member so as to allow the spring arrangement to forcibly move the impact member into contact with and break the predetermined breakable region.",PAROALTA RES CENTER COMPANY,CHUN CHI LOK;;CHANG NANCY E;;BURT JOHN A;;LIM SAMUEL J;;NELTNER STEFAN;;COKER ERIC,,https://lens.org/004-454-440-145-820,Patent Application,no,0,0,7,7,0,B63B22/24;;B26F3/00;;B25D5/02;;B25D2250/255;;B25D2250/371;;B63B22/26;;B63B59/04;;F16K13/04;;B26F3/06,B63B22/24,,0,0,,,,PENDING
641,EP,A1,EP 0420855 A1,164-935-428-480-078,1991-04-10,1991,EP 89904990 A,1989-03-22,US 8901227 W;;US 30871389 A;;US 27454288 A;;US 17161488 A,1988-03-23,ELECTROSTATIC METHOD FOR MULTICOLOR IMAGING FROM A SINGLE TONER BATH.,"On décrit un procédé électrostatique de production d'images multicolore à partir d'un seul bain de toner. Ce bain de toner est un mélange de différents toners, chacun d'entre eux contenant un précurseur de couleur différent des autres. Cette invention concerne également des systèmes de synthèses d'images électrostatiques et plus particulièrement des particules de toner à couleur autodéveloppante, ainsi que leurs procédés de fabrication et d'utilisation. Un mélange de ces particules de toner est utile pour la synthèse d'images électrostatique multicolore qui utilise un seul bain de toner, sec ou liquide. Parmi les applications possibles, on citera notamment la photocopie xérographique, l'impression, la synthèse d'images assistée par ordinateur omnicolores.",OLIN CORP,WING FEAGIN A JR;;DAY ROGER W;;BURT WILLARD F;;GROSSO PAUL V;;MORGAN MICHAEL J,,https://lens.org/164-935-428-480-078,Patent Application,yes,0,0,10,16,0,G03G9/08;;G03G9/09;;G03G9/0928;;G03G9/093;;G03G13/0131;;G03G13/0133;;G03G13/01;;G03G13/0133;;G03G13/0131,G03G9/08;;G03G9/09;;G03G9/093;;G03G9/12;;G03G13/01;;G03G15/01,,0,0,,,,EXPIRED
642,WO,A1,WO 1989/009433 A1,059-080-134-325-155,1989-10-05,1989,US 8901227 W,1989-03-22,US 17161488 A;;US 27454288 A;;US 30871389 A,1988-03-23,ELECTROSTATIC METHOD FOR MULTICOLOR IMAGING FROM A SINGLE TONER BATH,"An electrostatic method is disclosed for providing multicolor imaging from a single toner bath. The toner bath is a blend of individual toners, each of which contains a color precursor different from the others. This invention also relates to electrostatic imaging systems, and, more particularly, color-self-developing toner particles and processes for the fabrication and use thereof. A blend of these toner particles is useful in multicolor electrostatic imaging using a single dry or liquid toner bath. Potential applications include full-color xerographic copying, full-color printing, full-color computer-generated imaging, and the like.",OLIN CORP,WING FEAGIN A JR;;DAY ROGER W;;BURT WILLARD F;;GROSSO PAUL V;;MORGAN MICHAEL J,,https://lens.org/059-080-134-325-155,Patent Application,yes,5,2,10,16,0,G03G9/08;;G03G9/09;;G03G9/0928;;G03G9/093;;G03G13/0131;;G03G13/0133;;G03G13/01;;G03G13/0133;;G03G13/0131,G03G9/08;;G03G9/09;;G03G9/093;;G03G9/12;;G03G13/01;;G03G15/01,,3,0,,,"Chemical and Engineering News, ""New Color Technology using Microcapsules, 11 January 1988, p. 23 see generally;;Chemical Week, ""Mead Brings Color to Business"" 13 December 1987, pp. 32-33. see generally;;See also references of EP 0420855A4",PATENTED
643,US,A1,US 2004/0119819 A1,139-843-718-531-369,2004-06-24,2004,US 63898403 A,2003-08-12,US 63898403 A;;US 41989302 P,2002-10-21,Method and system for performing surveillance,"
   A method and system for detecting moving objects and controlling a surveillance system includes a processing module adapted to receive image information from at least one imaging sensor. The system performs motion detection analysis upon captured images and controls the camera in a specific manner upon detection of a moving object. The image processing uses the camera's physical orientation to a surveillance area to facilitate mapping images captured by the camera to a reference map of the surveillance area. Using the camera orientation, a moving object's position (e.g., latitude, longitude and altitude) within a scene can be derived. 
",SARNOFF CORP,AGGARWAL MANOJ;;SAWHNEY HARPREET SINGH;;SAMARASAKERA SUPUN;;KUMAR RAKESH;;BURT PETER;;ELEDATH JAYAN;;HANNA KEITH J,SRI INTERNATIONAL (2011-02-04);;SARNOFF CORPORATION (2003-08-08),https://lens.org/139-843-718-531-369,Patent Application,yes,9,135,7,10,0,G08B13/19608;;G08B13/19641;;G08B13/1968;;G08B13/19682;;G08B13/19689;;H04N7/181;;G06T7/269;;G06V20/52;;H04N7/181;;G08B13/19641;;G08B13/19689;;G08B13/19682;;G08B13/1968;;G08B13/19608;;G06T7/269;;G06V20/52,H04N7/18,348 143000,0,0,,,,EXPIRED
644,EP,B1,EP 0420855 B1,044-747-185-930-898,1995-04-12,1995,EP 89904990 A,1989-03-22,US 8901227 W;;US 30871389 A;;US 27454288 A;;US 17161488 A,1988-03-23,ELECTROSTATIC METHOD FOR MULTICOLOR IMAGING FROM A SINGLE TONER BATH.,,OLIN CORP,WING FEAGIN A JR;;DAY ROGER W;;BURT WILLARD F;;GROSSO PAUL V;;MORGAN MICHAEL J,,https://lens.org/044-747-185-930-898,Granted Patent,yes,6,0,10,16,0,G03G9/08;;G03G9/09;;G03G9/0928;;G03G9/093;;G03G13/0131;;G03G13/0133;;G03G13/01;;G03G13/0133;;G03G13/0131,G03G9/08;;G03G9/09;;G03G9/093;;G03G9/12;;G03G13/01;;G03G15/01,,2,0,,,"Chemical and Engineering News, ""New Color Technology using Microcapsules, 11 January 1988, p. 23;;Chemical Week, ""Mead Brings Color to Business"", 13 December 1987, pp. 32-33",EXPIRED
645,EP,A4,EP 0420855 A4,097-513-454-483-231,1991-08-28,1991,EP 89904990 A,1989-03-22,US 8901227 W;;US 30871389 A;;US 27454288 A;;US 17161488 A,1988-03-23,ELECTROSTATIC METHOD FOR MULTICOLOR IMAGING FROM A SINGLE TONER BATH,,OLIN CORPORATION,"WING, FEAGIN, A., JR.;;DAY, ROGER, W.;;BURT, WILLARD, F.;;GROSSO, PAUL, V.;;MORGAN, MICHAEL, J.",,https://lens.org/097-513-454-483-231,Search Report,no,1,0,10,16,0,G03G9/08;;G03G9/09;;G03G9/0928;;G03G9/093;;G03G13/0131;;G03G13/0133;;G03G13/01;;G03G13/0133;;G03G13/0131,G03G9/08;;G03G9/09;;G03G9/093;;G03G9/12;;G03G13/01;;G03G15/01,,0,0,,,,EXPIRED
646,US,A,US 5329054 A,179-436-943-253-329,1994-07-12,1994,US 9316693 A,1993-07-19,US 9316693 A,1993-07-19,Decarboxylation process,Activated carboxylic acids and esters such as pentafluorobenzoic acid are rapidly decarboxylated in high yields by reacting the acid or ester with an alkanolamine reagent which catalyzes the reaction.,ALBEMARLE CORP,THERIOT KEVIN J;;KRZYSTOWCZYK NIOMI L;;CHEN YUEH-DONG;;BURT EDWARD A;;SHEPHERD JR LAWRENCE H,ALBERMARLE CORPORATION (1994-02-28);;ETHYL CORPORATION (1993-07-13),https://lens.org/179-436-943-253-329,Granted Patent,yes,8,10,6,6,0,C07C17/363;;C07C17/363,C07B37/06;;C07C17/363;;C07C25/13,570/142;;558/411;;560/103;;562/41;;562/479;;564/281;;564/391;;568/314;;568/932;;568/939;;570/190,2,1,059-531-032-392-218,10.1002/cber.19671000927,"Sartoni, et al. Chem. Ber. 100, 3016 3023 (1967).;;Burdon, et al, J. Chem. Soc. 6336 6342 (1965).",EXPIRED
647,US,A1,US 2002/0123957 A1,118-665-992-442-851,2002-09-05,2002,US 92921401 A,2001-08-14,US 92921401 A;;US 75187400 A,2000-12-29,Method and apparatus for marketing and communicating in the wine/spirits industry,"
   A method and apparatus for marketing and communicating in the wine/spirits industry. The method of the invention includes the steps of receiving an offer from at least one wine/spirit suppliers to pay for a solicitation to at least one identified consumer of a participating retail wine/spirit establishment for a selected set of products; communicating a set of possible product offerings from the at least one wine/spirit suppliers to at least one of the participating retailers of wine/spirits, where each such set includes a number of products; receiving a communication from at least one such participating retailer agreeing to offer a subset of said set of product offerings at a sale price; analyzing information related to such subset of such set of product offerings with a computer; and, communicating such information related to such sales of such subset of such set of product offerings to an interested party. 
",NOTARIUS BURT;;NAYAK DEVENDRA;;JANI ARUN;;CHAN KELLY KA YIU;;BENATI PAUL J.;;MCNICHOL A. DREW,NOTARIUS BURT;;NAYAK DEVENDRA;;JANI ARUN;;CHAN KELLY KA YIU;;BENATI PAUL J;;MCNICHOL A DREW,ORACLE INTERNATIONAL CORPORATION (2002-12-18);;WINEISIT.COM CORP (2002-11-25),https://lens.org/118-665-992-442-851,Patent Application,yes,1,213,1,1,0,G06Q30/06;;G06Q30/0601;;G06Q40/04;;G06Q30/06;;G06Q30/0601;;G06Q40/04,G06Q30/06,705/37;;705/26,0,0,,,,DISCONTINUED
648,AU,A,AU 1989/035306 A,152-033-181-714-726,1989-10-16,1989,AU 1989/035306 A,1989-03-22,US 17161488 A;;US 27454288 A;;US 30871389 A,1988-03-23,ELECTROSTATIC METHOD FOR MULTICOLOR IMAGING FROM A SINGLE TONER BATH,,OLIN CORP,WING FEAGIN A JR;;DAY ROGER W;;BURT WILLARD F;;GROSSO PAUL V;;MORGAN MICHAEL J,,https://lens.org/152-033-181-714-726,Patent Application,no,0,0,10,16,0,G03G9/08;;G03G9/09;;G03G9/0928;;G03G9/093;;G03G13/0131;;G03G13/0133;;G03G13/01;;G03G13/0133;;G03G13/0131,G03G9/08;;G03G9/09;;G03G9/093;;G03G9/12;;G03G13/01;;G03G15/01,,0,0,,,,EXPIRED
649,AU,B2,AU 627182 B2,171-667-563-349-246,1992-08-20,1992,AU 1989/035306 A,1989-03-22,US 17161488 A;;US 27454288 A;;US 30871389 A,1988-03-23,ELECTROSTATIC METHOD FOR MULTICOLOR IMAGING FROM A SINGLE TONER BATH,,OLIN CORP,WING FEAGIN A JR;;DAY ROGER W;;BURT WILLARD F;;GROSSO PAUL V;;MORGAN MICHAEL J,,https://lens.org/171-667-563-349-246,Granted Patent,no,0,0,10,16,0,G03G9/08;;G03G9/09;;G03G9/0928;;G03G9/093;;G03G13/0131;;G03G13/0133;;G03G13/01;;G03G13/0133;;G03G13/0131,G03G9/08;;G03G9/09;;G03G9/093;;G03G9/12;;G03G13/01;;G03G15/01,,0,0,,,,EXPIRED
650,JP,A,JP 2021003114 A,008-169-777-034-58X,2021-01-14,2021,JP 2020144118 A,2020-08-28,US 201461939837 P;;US 201361893505 P,2013-10-21,ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS,"To provide methods and assays for determining the activation level of a plasma kallikrein (pKal) system and the uses thereof for assessing the activity of pKal modulators on the pKal system.SOLUTION: A method for assessing plasma activation in a subject, comprises: providing a plasma sample from a subject; and measuring the level of cleaved high molecular weight kininogen (HMWK) in the plasma sample. Provided is a plasma kallikrein (pKal) inhibitor for use in the treatment of a subject having a disease associated with the pKal, where the subject has an elevated level of the cleaved HMWK as compared with a predetermined value, the subject being identified by proving a plasma sample from the subject and measuring the level of the cleaved HMWK in the plasma sample.SELECTED DRAWING: Figure 1",DYAX CORP,DANIEL J SEXTON;;RYAN FAUCETTE;;JON A KENNISTON;;GREGORY P CONLEY;;NIXON ANDREW;;CHRISTOPHER TENHOOR;;BURT ADELMAN,,https://lens.org/008-169-777-034-58X,Patent Application,no,3,0,36,36,0,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C12Q1/00;;A61K38/16;;A61K45/00;;A61P7/04;;A61P43/00;;C12N9/99;;G01N33/53,,2,0,,,"BLOOD, vol. 74, no. 2, JPN6019029414, 1989, pages 695 - 702, ISSN: 0004601525;;NATURE METHODS 8, 982(2011), JPN6018030367, ISSN: 0004601526",ACTIVE
651,US,A1,US 2014/0116002 A1,146-723-594-236-487,2014-05-01,2014,US 201313792921 A,2013-03-11,US 201313792921 A;;US 201261718820 P,2012-10-26,"PROTECTIVE BODY, HEAT SEALING SYSTEM THAT INCLUDES THE PROTECTIVE BODY, AND METHOD FOR PROVIDING THE PROTECTIVE BODY","A protective body for a heat sealing system is provided. The protective body includes a flexible supporting layer and an exposed layer. The flexible supporting layer has opposite first and second sides. The first side can be coupled to a tool of a heat sealing system. The heat sealing system heat seals a film to a container to enclose the container or to heat seal films together. The exposed layer has a lower coefficient of friction than the supporting layer and is bonded to the second side of the supporting layer. The exposed layer prevents the film that is being heat sealed from sticking to the tool, or to prevent the films being heat sealed together from sticking to the tool.",ILLINOIS TOOL WORKS,DENNY BRENDA L;;BURT TIMOTHY S;;NANS EDWARD JOEL;;PLUCINSKI KENNETH F;;NOBLE DIANE;;ASHTON DEBORAH J,ILLINOIS TOOL WORKS INC (2012-11-06),https://lens.org/146-723-594-236-487,Patent Application,yes,33,7,3,3,0,B29C65/18;;B29C66/0044;;B29C66/112;;B29C66/131;;B29C66/133;;B29C66/43;;B29C66/53461;;B29C66/8122;;B29C66/81261;;B29C66/81457;;B29C66/8167;;B29C66/8322;;B29C66/876;;B29C65/7841;;B29C66/1122;;B29C66/43121;;B29C66/836;;B29C66/24244;;B29C66/849;;Y10T428/24942;;Y10T428/31663;;Y10T428/24942;;Y10T428/31663;;B29C66/0044;;B29C66/131;;B29C66/8322;;B29C66/43;;B29C66/133;;B29C66/53461;;B29C66/876;;B29C66/8167;;B29C66/112;;B29C65/18;;B29C66/8122;;B29C66/81457;;B29C66/81261;;B29C65/7841;;B29C66/1122;;B29C66/836;;B29C66/43121;;B29C66/24244;;B29C66/849;;B32B27/08;;B32B33/00;;B65B51/10,B32B27/08;;B65B51/10;;B32B33/00,53/329.2;;428/212;;428/447;;156/245,0,0,,,,DISCONTINUED
652,AU,B2,AU 2020/217316 B2,067-972-451-595-152,2024-02-22,2024,AU 2020/217316 A,2020-08-10,AU 2020/217316 A;;AU 2014/340450 A;;US 201461939837 P;;US 201361893505 P;;US 2014/0061247 W,2013-10-21,Assays for determining plasma kallikrein system biomarkers,ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM Methods and assays for determining the activation level of the plasma kallikrein (pKal) system and the uses thereof for assessing the activity of pKal modulators on the pKal system.,TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-04-08),https://lens.org/067-972-451-595-152,Granted Patent,no,0,0,36,36,0,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C07K16/40,,0,0,,,,PENDING
653,US,A1,US 2016/0252527 A1,040-367-161-212-98X,2016-09-01,2016,US 201415030811 A,2014-10-17,US 201415030811 A;;US 201361893505 P;;US 201461939837 P;;US 2014/0061247 W,2013-10-21,ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS,Methods and assays for determining the activation level of the plasma kallikrein (pKal) system and the uses thereof for assessing the activity of pKal modulators on the pKal system.,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2017-01-16),https://lens.org/040-367-161-212-98X,Patent Application,yes,0,6,36,36,7,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,G01N33/68;;C07K16/40;;C12Q1/37,,0,0,,,,ACTIVE
654,AU,A1,AU 2020/217316 A1,094-416-945-855-446,2020-08-27,2020,AU 2020/217316 A,2020-08-10,AU 2020/217316 A;;AU 2014/340450 A;;US 201461939837 P;;US 201361893505 P;;US 2014/0061247 W,2013-10-21,Assays for determining plasma kallikrein system biomarkers,ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM Methods and assays for determining the activation level of the plasma kallikrein (pKal) system and the uses thereof for assessing the activity of pKal modulators on the pKal system.,TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-04-08),https://lens.org/094-416-945-855-446,Patent Application,no,0,0,36,36,0,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C07K16/40,,0,0,,,,PENDING
655,AU,B2,AU 2014/340450 B2,103-269-270-874-063,2020-05-21,2020,AU 2014/340450 A,2014-10-17,US 201461939837 P;;US 201361893505 P;;US 2014/0061247 W,2013-10-21,Assays for determining plasma kallikrein system biomarkers,Methods and assays for determining the activation level of the plasma kallikrein (pKal) system and the uses thereof for assessing the activity of pKal modulators on the pKal system.,TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/103-269-270-874-063,Granted Patent,no,6,0,36,36,0,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C07K16/40,,7,7,109-028-520-036-638;;012-206-824-167-831;;024-019-418-021-281;;088-462-073-629-715;;006-789-023-934-519;;026-394-309-301-759;;080-844-532-992-816,2651524;;10.1016/0022-1759(89)90376-1;;10.1182/blood.v74.2.695.695;;10.1182/blood.v74.2.695.bloodjournal742695;;2752143;;7947259;;10.1111/j.1365-2141.1994.tb04874.x;;pmc3734293;;23940538;;10.1371/journal.pone.0070140;;9129025;;10.1182/blood.v89.9.3213;;3730610;;10.1182/blood.v68.2.455.bloodjournal682455;;10.1182/blood.v68.2.455.455;;10.1016/s1081-1206(10)60493-0;;18814451,"REDDIGARI S. et al., JOURNAL OF IMMUNOLOGICAL METHODS, 1989, vol. 119, no. 1, pages 19 - 25,;;REDDIGARI S. et al., BLOOD, 1989, pages 695 - 702,;;PAGE J.D. et al., BRITISH JOURNAL OF HAEMATOLOGY, 1994, vol. 87, no. 1, pages 81 - 86;;DEFENDI F. et al., PLOS ONE, 2013, vol. 8, no. 8, page e70140;;CUGNO M. et al., BLOOD, 1997, vol. 89, no. 9, pages 3213 - 3218,;;BERRETTINI M. et al., BLOOD, 1986, vol. 68, no. 2, pages 455 - 462;;JOSEPH K et al., ""Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma"", ANNALS OF ALLERGY, ASTHMA & IMMUNOLOGY, 2008, vol. 101, no. 3, pages 279 - 286",ACTIVE
656,EP,A4,EP 3060582 A4,154-473-005-859-717,2017-07-19,2017,EP 14856778 A,2014-10-17,US 201361893505 P;;US 201461939837 P;;US 2014/0061247 W,2013-10-21,ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS,,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,"TAKEDA PHARMACEUTICAL COMPANY LIMITED, JP (2022-07-06);;TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-09-08);;DYAX CORP. (2018-06-20);;TAKEDA PHARMACEUTICAL COMPANY LIMITED; JP (2021-11-05)",https://lens.org/154-473-005-859-717,Search Report,no,6,0,36,36,0,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C12Q1/37;;C07K16/40;;C12Q1/56,,8,7,109-028-520-036-638;;012-206-824-167-831;;024-019-418-021-281;;088-462-073-629-715;;006-789-023-934-519;;026-394-309-301-759;;080-844-532-992-816,2651524;;10.1016/0022-1759(89)90376-1;;10.1182/blood.v74.2.695.695;;10.1182/blood.v74.2.695.bloodjournal742695;;2752143;;7947259;;10.1111/j.1365-2141.1994.tb04874.x;;pmc3734293;;23940538;;10.1371/journal.pone.0070140;;9129025;;10.1182/blood.v89.9.3213;;3730610;;10.1182/blood.v68.2.455.bloodjournal682455;;10.1182/blood.v68.2.455.455;;10.1016/s1081-1206(10)60493-0;;18814451,"REDDIGARI S ET AL: ""Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody"", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 119, no. 1, 21 April 1989 (1989-04-21), pages 19 - 25, XP023973489, ISSN: 0022-1759, [retrieved on 19890421], DOI: 10.1016/0022-1759(89)90376-1;;S R REDDIGARI ET AL: ""Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity"", BLOOD, 1 August 1989 (1989-08-01), UNITED STATES, pages 695 - 702, XP055346722, Retrieved from the Internet <URL:http://www.bloodjournal.org/content/bloodjournal/74/2/695.full.pdf>;;J. D. PAGE ET AL: ""An autoantibody to human plasma prekallikrein blocks activation of the contact system"", BRITISH JOURNAL OF HAEMATOLOGY, vol. 87, no. 1, 1 May 1994 (1994-05-01), GB, pages 81 - 86, XP055347009, ISSN: 0007-1048, DOI: 10.1111/j.1365-2141.1994.tb04874.x;;FEDERICA DEFENDI ET AL: ""Enzymatic Assays for the Diagnosis of Bradykinin-Dependent Angioedema"", PLOS ONE, vol. 8, no. 8, 5 August 2013 (2013-08-05), pages e70140, XP055346505, DOI: 10.1371/journal.pone.0070140;;M CUGNO ET AL: ""Activation of the coagulation cascade in C1-inhibitor deficiencies"", BLOOD, vol. 89, no. 9, 1 May 1997 (1997-05-01), UNITED STATES, pages 3213 - 3218, XP055346366, Retrieved from the Internet <URL:http://www.bloodjournal.org/content/bloodjournal/89/9/3213.full.pdf>;;M. BERRETTINI ET AL: ""Detection of In Vitro and In Vivo Cleavage of High Molecular Weight Kininogen in Human Plasma by Immunoblotting With Monoclonal Antibodies Address reprint requests to"", BLOOD, vol. 68, no. 2, 1 August 1986 (1986-08-01), pages 455 - 462, XP055335425;;JOSEPH K ET AL: ""Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma"", ANNALS OF ALLERGY, ASTHMA & IMMUNOLOGY, ARLINGTON HEIGHTS, IL, US, vol. 101, no. 3, 1 September 2008 (2008-09-01), pages 279 - 286, XP026960155, ISSN: 1081-1206, [retrieved on 20080901];;See also references of WO 2015061183A1",ACTIVE
657,AU,B2,AU 725833 B2,003-449-964-885-114,2000-10-19,2000,AU 1997/024242 A,1997-03-19,US 62113896 A;;US 2712796 P;;US 9704956 W,1996-03-21,Method for hyperaccumulation of metals in plant shoots,,EDENSPACE SYSTEMS CORP,ENSLEY BURT D;;BLAYLOCK MICHAEL J;;DUSHENKOV SLAVIK;;KUMAR NANDA P B A;;KAPULNIK YORAM;;HUANG JIANWEI,ON=EDENSPACE SYSTEMS CORPORATION; FT=THE FORMER OW (2000-09-14),https://lens.org/003-449-964-885-114,Granted Patent,no,2,0,5,7,0,B09C1/105;;C02F3/327;;Y02W10/10,B09C1/10;;C02F3/32,,0,0,,,,EXPIRED
658,BR,B1,BR 112016008970 B1,176-909-612-544-218,2023-12-26,2023,BR 112016008970 A,2014-10-17,US 2014/0061247 W;;US 201461939837 P;;US 201361893505 P,2013-10-21,"Método de ativação ex vivo, método para avaliar ativação plasmática e ensaio ex vivo",ensaios para a determinação de biomarcadores de sistema calicreína plasmática. métodos e ensaios para determinar o nível de ativação do sistema de calicreína plasmática (pkal) e usos destes para avaliar a atividade dos moduladores de pkal no sistema pkal.,DYAX CORP;;TAKEDA PHARMACEUTICALS CO,NIXON ANDREW;;ADELMAN BURT;;TENHOOR CHRISTOPHER;;DANIEL J SEXTON;;GREGORY P CONLEY;;JON A KENNINSTON;;FAUCETTE RYAN,TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) (2021-07-13);;DYAX CORP. (US) (2018-08-28),https://lens.org/176-909-612-544-218,Granted Patent,no,0,0,36,36,0,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C07K16/40,,0,0,,,,ACTIVE
659,CA,A1,CA 2927824 A1,098-111-241-798-12X,2015-04-30,2015,CA 2927824 A,2014-10-17,US 201361893505 P;;US 201461939837 P;;US 2014/0061247 W,2013-10-21,ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS,Methods and assays for determining the activation level of the plasma kallikrein (pKal) system and the uses thereof for assessing the activity of pKal modulators on the pKal system.,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,,https://lens.org/098-111-241-798-12X,Patent Application,no,0,0,36,36,7,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C07K16/40,,0,0,,,,PENDING
660,WO,A1,WO 2014/066030 A1,069-322-246-829-456,2014-05-01,2014,US 2013/0063785 W,2013-10-08,US 201261718820 P;;US 201313792921 A,2012-10-26,"PROTECTIVE BODY, HEAT SEALING SYSTEM THAT INCLUDES THE PROTECTIVE BODY, AND METHOD FOR PROVIDING THE PROTECTIVE BODY","A protective body (100) for a heat sealing system is provided. The protective body includes a flexible supporting layer (102) and an exposed layer (104). The flexible supporting layer (102) has opposite first and second sides (106, 108). The first side (106) can be coupled to a tool of a heat sealing system. The heat sealing system heat seals a film (310) to a container (300) to enclose the container (300) or heat seals films (902, 904) together. The exposed layer (104) has a lower coefficient of friction than the supporting layer (102) and is bonded to the second side (108) of the supporting layer (102). The exposed layer (104)prevents the film (310) that is being heat sealed from sticking to the tool, or to prevent the films (902, 904) being heat sealed together from sticking to the tool.",ILLINOIS TOOL WORKS,DENNY BRENDA L;;BURT TIMOTHY S;;NANS EDWARD JOEL;;PLUCINSKI KENNETH F;;NOBLE DIANE;;ASHTON DEBORAH J,,https://lens.org/069-322-246-829-456,Patent Application,yes,5,2,3,3,0,B29C65/18;;B29C66/0044;;B29C66/112;;B29C66/131;;B29C66/133;;B29C66/43;;B29C66/53461;;B29C66/8122;;B29C66/81261;;B29C66/81457;;B29C66/8167;;B29C66/8322;;B29C66/876;;B29C65/7841;;B29C66/1122;;B29C66/43121;;B29C66/836;;B29C66/24244;;B29C66/849;;Y10T428/24942;;Y10T428/31663;;Y10T428/24942;;Y10T428/31663;;B29C66/0044;;B29C66/131;;B29C66/8322;;B29C66/43;;B29C66/133;;B29C66/53461;;B29C66/876;;B29C66/8167;;B29C66/112;;B29C65/18;;B29C66/8122;;B29C66/81457;;B29C66/81261;;B29C65/7841;;B29C66/1122;;B29C66/836;;B29C66/43121;;B29C66/24244;;B29C66/849;;B32B27/08;;B32B33/00;;B65B51/10,B29C65/18,,0,0,,,,PENDING
661,EP,A1,EP 2911861 A1,140-666-660-250-118,2015-09-02,2015,EP 13783430 A,2013-10-08,US 201261718820 P;;US 201313792921 A;;US 2013/0063785 W,2012-10-26,"PROTECTIVE BODY, HEAT SEALING SYSTEM THAT INCLUDES THE PROTECTIVE BODY, AND METHOD FOR PROVIDING THE PROTECTIVE BODY",,ILLINOIS TOOL WORKS,DENNY BRENDA L;;BURT TIMOTHY S;;NANS EDWARD JOEL;;PLUCINSKI KENNETH F;;NOBLE DIANE;;ASHTON DEBORAH J,,https://lens.org/140-666-660-250-118,Patent Application,yes,0,0,3,3,0,B29C65/18;;B29C66/0044;;B29C66/112;;B29C66/131;;B29C66/133;;B29C66/43;;B29C66/53461;;B29C66/8122;;B29C66/81261;;B29C66/81457;;B29C66/8167;;B29C66/8322;;B29C66/876;;B29C65/7841;;B29C66/1122;;B29C66/43121;;B29C66/836;;B29C66/24244;;B29C66/849;;Y10T428/24942;;Y10T428/31663;;Y10T428/24942;;Y10T428/31663;;B29C66/0044;;B29C66/131;;B29C66/8322;;B29C66/43;;B29C66/133;;B29C66/53461;;B29C66/876;;B29C66/8167;;B29C66/112;;B29C65/18;;B29C66/8122;;B29C66/81457;;B29C66/81261;;B29C65/7841;;B29C66/1122;;B29C66/836;;B29C66/43121;;B29C66/24244;;B29C66/849;;B32B27/08;;B32B33/00;;B65B51/10,B29C65/18,,0,0,,,,DISCONTINUED
662,AU,A1,AU 2014/340450 A1,164-358-640-539-885,2016-06-02,2016,AU 2014/340450 A,2014-10-17,US 201461939837 P;;US 201361893505 P;;US 2014/0061247 W,2013-10-21,Assays for determining plasma kallikrein system biomarkers,Methods and assays for determining the activation level of the plasma kallikrein (pKal) system and the uses thereof for assessing the activity of pKal modulators on the pKal system.,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/164-358-640-539-885,Patent Application,no,0,0,36,36,0,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C07K16/40,,0,0,,,,ACTIVE
663,WO,A1,WO 1997/034714 A1,180-169-771-426-423,1997-09-25,1997,US 9704956 W,1997-03-19,US 62113896 A;;US 2712796 P,1996-03-21,METHOD FOR HYPERACCUMULATION OF METALS IN PLANT SHOOTS,"The present invention provides methods by which hyperaccumulation of metals in plant shoots is induced by exposure to inducing agents. In preferred embodiments, manipulations that increase availability of metals to the plant are employed prior to application of the inducing agent. Effective inducing agents include conditions of low pH, chelators, herbicides, and high levels of heavy metals. Other phytotoxic agents are also useful. Application of multiple inducing agents results in synergistic effects.",PHYTOTECH INC,ENSLEY BURT D;;BLAYLOCK MICHAEL J;;DUSHENKOV SLAVIK;;KUMAR NANDA P B A;;KAPULNIK YORAM;;HUANG JIANWEI,,https://lens.org/180-169-771-426-423,Patent Application,yes,1,33,5,7,0,B09C1/105;;C02F3/327;;Y02W10/10,B09C1/10;;C02F3/32,,5,4,074-576-821-261-07X;;146-276-024-839-401;;103-420-246-115-322;;031-962-994-925-917,9634787;;10.1038/nbt0595-468;;22192016;;10.1021/es00005a014;;10.1038/379635a0;;22276881;;10.1021/es00006a022,"D. SALT: ""Phytoremediation : a novel strategy for the removal of toxic metals from the environment using plants"", BIOTECHNOLOGY, vol. 13, May 1995 (1995-05-01), NEW YORK US, pages 468 - 474, XP000577130;;CUNNINGHAM ET AL.: ""BIOREMEDIATION OF INORGANICS"", 1995, BATELLE PRESS, COLUMBUS RICHLAND US, XP002036535, 216800;;KUMAR ET AL.: ""Phytoextraction: the use of plants to remove heavy metals from soils"", ENVIRONMENTAL SCIENCE AND TECHNOLOGY, vol. 29, no. 5, May 1995 (1995-05-01), EASTON, PA US, pages 1232 - 1238, XP000505196;;U. KRÄMER ET AL.: ""Free histidine as a metal chelator in plants that accumulate nickel"", NATURE, vol. 379, 15 February 1996 (1996-02-15), LONDON GB, pages 635 - 637, XP002024758;;S. BROWN ET AL.: ""Zinc and cadmium uptake by hyperaccumulator Thlaspi caerulescens and metal tolerant Silene vulgaris grown on sludge-amended soils"", ENVIRONMENTAL SCIENCE AND TECHNOLOGY, vol. 29, no. 6, June 1995 (1995-06-01), EASTON, PA US, pages 1581 - 1585, XP000505456",PENDING
664,CN,A,CN 105873951 A,067-530-273-932-698,2016-08-17,2016,CN 201480070281 A,2014-10-17,US 201361893505 P;;US 201461939837 P;;US 2014/0061247 W,2013-10-21,ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS,Methods and assays for determining the activation level of the plasma kallikrein (pKal) system and the uses thereof for assessing the activity of pKal modulators on the pKal system.,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,,https://lens.org/067-530-273-932-698,Patent Application,no,3,5,36,36,0,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C07K16/40,,2,2,109-028-520-036-638;;028-104-991-485-38X,2651524;;10.1016/0022-1759(89)90376-1;;8856187;;10.1016/0162-3109(96)00086-0,"SESHA REDDIGARI ET AL.: ""Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody"", 《JOURNAL OF IMMUNOLOGICAL METHODS》;;CUGNO ET AL.: ""Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies"", 《IMMUNOPHARMACOLOGY》",PENDING
665,PL,T3,PL 3060582 T3,098-103-261-770-968,2021-05-04,2021,PL 14856778 T,2014-10-17,US 201361893505 P;;US 201461939837 P;;EP 14856778 A;;US 2014/0061247 W,2013-10-21,ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS,,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,,https://lens.org/098-103-261-770-968,Patent Application,no,0,0,36,36,0,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C12Q1/37;;C07K16/40;;C12Q1/56,,0,0,,,,PENDING
666,EP,B1,EP 3060582 B1,043-676-472-911-954,2020-09-23,2020,EP 14856778 A,2014-10-17,US 201361893505 P;;US 201461939837 P;;US 2014/0061247 W,2013-10-21,ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS,,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,"TAKEDA PHARMACEUTICAL COMPANY LIMITED, JP (2022-07-06);;TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-09-08);;DYAX CORP. (2018-06-20);;TAKEDA PHARMACEUTICAL COMPANY LIMITED; JP (2021-11-05)",https://lens.org/043-676-472-911-954,Granted Patent,yes,3,0,36,36,0,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C12Q1/37;;C07K16/40;;C12Q1/56,,13,13,051-663-279-687-169;;028-104-991-485-38X;;080-844-532-992-816;;012-206-824-167-831;;024-019-418-021-281;;109-028-520-036-638;;026-394-309-301-759;;088-462-073-629-715;;116-078-088-684-888;;131-203-164-642-22X;;031-231-997-575-626;;143-067-441-552-591;;137-254-299-678-586,2451949;;10.1182/blood.v71.5.1334.bloodjournal7151334;;10.1182/blood.v71.5.1334.1334;;8856187;;10.1016/0162-3109(96)00086-0;;10.1016/s1081-1206(10)60493-0;;18814451;;10.1182/blood.v74.2.695.695;;10.1182/blood.v74.2.695.bloodjournal742695;;2752143;;7947259;;10.1111/j.1365-2141.1994.tb04874.x;;2651524;;10.1016/0022-1759(89)90376-1;;3730610;;10.1182/blood.v68.2.455.bloodjournal682455;;10.1182/blood.v68.2.455.455;;pmc3734293;;23940538;;10.1371/journal.pone.0070140;;10.1182/blood.v70.4.1053.bloodjournal7041053;;2443201;;10.1016/j.jaci.2012.12.1419;;10.1016/j.jaci.2012.12.1425;;10.1182/blood.v122.21.2347.2347;;10.1016/j.jaci.2013.12.167,"SESHA REDDIGARI AND ALLEN P. KAPLAN: ""Cleavage of Human High-Molecular Weight Kininogen by Purified Kallikreinsand Upon Contact Activation of Plasma"", BLOOD, vol. 71, no. 5, 1988, pages 1334 - 1340, XP055824534;;CUGNO M. ET AL.: ""Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies"", IMMUNOPHARMACOLOGY, vol. 33, no. 1-3, 1996, pages 361 - 364, XP002302326;;JOSEPH K; TUSCANO T B; KAPLAN A P: ""Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma"", ANNALS OF ALLERGY, ASTHMA & IMMUNOLOGY, vol. 101, September 2008 (2008-09-01), pages 279 - 286, XP026960155;;REDDIGARI S R; KAPLAN A P: ""Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity"", BLOOD, vol. 74, no. 2, 1989, pages 695 - 702, XP055346722;;PAGE J D; DELA CADENA R A; HUMPHRIES J E; COLMAN R W: ""An autoantibody to human plasma prekallikrein blocks activation of the contact system"", BRITISH JOURNAL OF HAEMOTOLOGY, vol. 87, 1994, pages 81 - 86, XP055347009;;REDDIGARI S; KAPLAN A P: ""Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody"", JOURNAL OF IMMUNOLOGICAL METHODS, vol. 119, 1989, pages 19 - 25, XP023656916;;BERRETTINI M; ET AL: ""Detection of In Vitro and In Vivo Cleavage of High Molecular Weight Kininogen in Human Plasma by Immunoblotting With Monoclonal Antibodies"", BLOOD, vol. 68, no. 2, 1986, pages 455 - 462, XP055335425;;FEDERICA DEFENDI; DELPHINE CHARIGNON; ARIJE GHANNAM; REMI BAROSO; FRANÇOISE CSOPAKI; MARION ALLEGRET-CADET; DENISE PONARD; BERTRAN: ""Enzymatic Assays for the Diagnosis of Bradykinin-Dependent Angioedema"", PLOS ONE, vol. 8, no. 8, August 2013 (2013-08-01), pages e70140, XP055346505;;VELOSO; SILVER; HAHN; COLMAN: ""A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface"", BLOOD, vol. 70, no. 4, 1987, pages 1053 - 1062, XP055036344;;JIANWEN ZHANG, DEBRA KELLOGG, RAMANDA WILSON, LEIGH HARMAN, SHANTA BANTIA, Y. S. BABU: ""750 / A Simple, Sensitive and Selective Fluorogenic Assay to Monitor Kallikrein Activity in Activated Plasma"", J ALLERGY CLIN IMMUNOL, vol. 131, no. 2, February 2013 (2013-02-01), XP055824535;;SHANTA BANTIA ET AL.: ""756/ BCX-4161, a Small Molecule and Orally Bioavailable Plasma Kallikrein Inhibitor for the Treatment of Hereditary Angioedema"", J ALLERGY CLIN IMMUNOL, vol. 131, no. 2, February 2013 (2013-02-01), XP055824536;;FAUCETTE RYAN R; CICARDI MARCO; SUFFRITTI CHIARA; KENNISTON JON A; SEXTON DANIEL J; ADELMAN BURT: ""A Biomarker Assay For The Detection Of Contact System Activation"", BLOOD, vol. 122, no. 21, 15 November 2013 (2013-11-15), pages 2347, XP055335424;;DR. Y.S. BABU MS. RAMANDA WILSON DR. JIANWEN ZHANG DR. MELANIE CORNPROPST DR. PHIL COLLIS DR. WILLIAM SHERIDAN: ""A Simple, Sensitive and Selective Fluorogenic Assay To Monitor Plasma Kallikrein Inhibitory Activity Of BCX4161 In Activated Plasma"", J ALLERGY CLIN IMMUNOL, vol. 133, no. 2, 1 February 2014 (2014-02-01), Retrieved from the Internet <URL:https://www.jacionline.org/article/S0091-6749(13)02071-X/fulltext#relatedArticles>",ACTIVE
667,DK,T3,DK 3060582 T3,076-438-924-859-071,2020-12-21,2020,DK 14856778 T,2014-10-17,US 201361893505 P;;US 201461939837 P;;US 2014/0061247 W,2013-10-21,ASSAYS TIL BESTEMMELSE AF PLASMAKALLIKREINSYSTEM-BIOMARKØRER,,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CONLEY GREGORY P,,https://lens.org/076-438-924-859-071,Granted Patent,no,0,0,36,36,0,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C12Q1/37;;C07K16/40;;C12Q1/56,,0,0,,,,ACTIVE
668,EP,A1,EP 3808857 A1,138-096-089-431-433,2021-04-21,2021,EP 20197583 A,2014-10-17,US 201361893505 P;;US 201461939837 P;;EP 14856778 A;;US 2014/0061247 W,2013-10-21,ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS,"Methods and assays for determining the activation level of the plasma kallikrein (pKal) system and the uses thereof for assessing the activity of pKal modulators on the pKal system.
",DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-08-04),https://lens.org/138-096-089-431-433,Patent Application,yes,28,1,36,36,7,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C12Q1/37;;C12Q1/56,,49,42,109-028-520-036-638;;012-206-824-167-831;;024-019-418-021-281;;088-462-073-629-715;;006-789-023-934-519;;026-394-309-301-759;;080-844-532-992-816;;004-782-005-460-503;;164-277-261-420-791;;016-326-550-218-68X;;085-610-907-501-527;;116-078-088-684-888;;026-484-171-656-715;;024-276-593-911-609;;005-248-320-665-556;;012-206-824-167-831;;092-845-354-377-772;;064-409-159-039-974;;014-581-174-616-945;;085-610-907-501-527;;109-500-732-467-583;;049-134-753-209-354;;035-188-943-391-21X;;017-150-654-990-340;;002-264-966-090-625;;127-185-373-141-041;;045-864-048-030-411;;084-421-189-184-547;;018-144-967-742-095;;037-104-736-197-766;;122-080-830-470-164;;050-507-714-041-493;;150-526-239-777-942;;069-863-076-076-464;;096-809-977-928-291;;038-056-207-283-274;;093-122-402-165-609;;038-535-940-466-805;;053-209-061-746-894;;028-862-168-091-90X;;030-451-543-728-673;;052-397-009-533-722,2651524;;10.1016/0022-1759(89)90376-1;;10.1182/blood.v74.2.695.695;;10.1182/blood.v74.2.695.bloodjournal742695;;2752143;;7947259;;10.1111/j.1365-2141.1994.tb04874.x;;pmc3734293;;23940538;;10.1371/journal.pone.0070140;;9129025;;10.1182/blood.v89.9.3213;;3730610;;10.1182/blood.v68.2.455.bloodjournal682455;;10.1182/blood.v68.2.455.455;;10.1016/s1081-1206(10)60493-0;;18814451;;10.1517/13543784.17.5.697;;18447596;;10.1160/th07-04-0250;;10.1056/nejmcp0803977;;18768946;;10.1002/elps.201200095;;22965727;;10.1182/blood.v70.4.1053.bloodjournal7041053;;2443201;;10.1182/blood.v77.12.2660.bloodjournal77122660;;1710516;;10.1182/blood.v77.12.2660.2660;;2579948;;10.1016/s0021-9258(18)89258-4;;10.1111/j.1365-2141.1984.tb03955.x;;6691922;;10.1182/blood.v74.2.695.695;;10.1182/blood.v74.2.695.bloodjournal742695;;2752143;;3501619;;10.1016/0049-3848(87)90434-8;;15306150;;10.1016/j.thromres.2004.05.005;;7654936;;10.1097/00001721-199505000-00005;;10.1002/elps.201200095;;22965727;;8605931;;10.1002/eji.1830260319;;10.1016/0022-2836(87)90412-8;;3681981;;10.1038/338518a0;;2927510;;3140379;;10.1126/science.3140379;;10.1073/pnas.85.16.5879;;3045807;;pmc281868;;10.1016/j.jaci.2010.08.012;;20889195;;10.2210/pdb7pti/pdb;;10.1093/protein/3.7.591;;1699222;;2125487;;10.1021/bi00495a002;;3263966;;10.1016/s0021-9258(19)81329-7;;2553722;;10.1016/s0021-9258(18)51542-8;;pmc43575;;10.1073/pnas.91.8.3353;;8159751;;10.1002/(sici)1097-0134(199707)28:3<405::aid-prot10>3.0.co;2-l;;9223186;;10.1016/0076-6879(90)83011-w;;2314273;;pmc305087;;10.1073/pnas.84.13.4355;;3474607;;8107089;;10.1006/jmbi.1994.1104;;pmc2142382;;10.1002/pro.5560020302;;8453370;;9600884;;pmc34487;;10.1073/pnas.95.11.5857;;0009600884;;pmc102444;;10592234;;10.1093/nar/28.1.231;;9847197;;10.1093/nar/27.1.263;;pmc148152;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;10.1016/s0097-8485(99)00011-x;;10404623;;10.1093/nar/30.1.235;;pmc99105;;11752303,"REDDIGARI S ET AL: ""Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody"", JOURNAL OF IMMUNOLOGICAL METHODS, vol. 119, no. 1, 21 April 1989 (1989-04-21), pages 19 - 25, XP023973489, DOI: 10.1016/0022-1759(89)90376-1;;S R REDDIGARI ET AL: ""Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity"", BLOOD, 1 August 1989 (1989-08-01), pages 695 - 702, XP055346722, Retrieved from the Internet <URL:http://www.bloodjournal.org/content/bloodjournal/74/2/695.full.pdf>;;J. D. PAGE ET AL: ""An autoantibody to human plasma prekallikrein blocks activation of the contact system"", BRITISH JOURNAL OF HAEMATOLOGY, vol. 87, no. 1, 1 May 1994 (1994-05-01), pages 81 - 86, XP055347009, DOI: 10.1111/j.1365-2141.1994.tb04874.x;;F DEFENDI ET AL: ""Enzymatic Assays for the Diagnosis of Bradykinin-Dependent Angioedema"", PLOS ONE, vol. 8, no. 8, 5 August 2013 (2013-08-05), pages e70140, XP055346505, DOI: 10.1371/journal.pone.0070140;;M CUGNO ET AL: ""Activation of the coagulation cascade in C1-inhibitor deficiencies"", BLOOD, vol. 89, no. 9, 1 May 1997 (1997-05-01), pages 3213 - 3218, XP055346366, Retrieved from the Internet <URL:http://www.bloodjournal.org/content/bloodjournal/89/9/3213.full.pdf>;;M. BERRETTINI ET AL: ""Detection of In Vitro and In Vivo Cleavage of High Molecular Weight Kininogen in Human Plasma by Immunoblotting With Monoclonal Antibodies Address reprint requests to"", BLOOD, vol. 68, no. 2, 1 August 1986 (1986-08-01), pages 455 - 462, XP055335425;;JOSEPH K ET AL: ""Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma"", ANNALS OF ALLERGY, vol. 101, no. 3, 1 September 2008 (2008-09-01), pages 279 - 286, XP026960155;;SEXTON D J ET AL: ""Inhibition of the plasma kallikrein-kinin system activation by DX-2930, a fully human monoclonal antibody inhibitor of plasma kallikrein"", JOURNAL OF ANGIOEDEMA, 23 May 2013 (2013-05-23), pages 45, XP055783755, Retrieved from the Internet <URL:https://www.researchgate.net/profile/Jose-Fabiani/publication/261706353_New_abdominal_crisis_trigger_on_patients_with_Hereditary_Angioedema_Jose_E_Fabiani1_Marta_Villaverde2_Fernando_Vazquez_Godoy3_1_Specialist_consultant_in_Allergy_and_Immunology/links/00b7d535191e57ecf3000000/New-abdominal-crisis-> [retrieved on 20210309];;ZURAW B L ET AL: ""New promise and hope for treating hereditary angioedema"", EXPERT OPINION ON INVESTIGATIONAL DRUGS, vol. 17, no. 5, 30 April 2008 (2008-04-30), pages 697 - 706, XP055783765, Retrieved from the Internet <URL:https://www.tandfonline.com/doi/pdf/10.1517/13543784.17.5.697?needAccess=true> DOI: 10.1517/13543784.17.5.697;;SAINZ I.M. ET AL., THROMB HAEMOST, vol. 98, 2007, pages 77 - 83;;ZURAW B.L. ET AL., N ENGL J MED, vol. 359, 2008, pages 1027 - 1036;;RUSTANDI ET AL.: ""Qualitative and quantitative evaluation of SimonTM, a new CE-based automated Western blot system as applied to vaccine development"", ELECTROPHORESIS, vol. 33, no. 17, September 2012 (2012-09-01), pages 2790 - 7, XP055688276, DOI: 10.1002/elps.201200095;;WACHTFOGEL, Y.T. ET AL., BLOOD, vol. 73, 1989, pages 6.3.1 - 6.3.6;;VELOSO, D. ET AL., BLOOD, vol. 70, no. 4, 1987, pages 1053 - 62;;KAUFMAN, N. ET AL., BLOOD, vol. 77, no. 12, 1991, pages 2660 - 2667;;HARPEL, P.C. ET AL., J BIOL CHEM, vol. 260, no. 7, 1985, pages 4257 - 63;;KERBIRIOU-NABIAS, D.M., BR J HAEMATOL, vol. 56, no. 2, 1984, pages 2734 - 86;;REDDIGARI, S.R.KAPLAN, A.P., BLOOD, vol. 74, 1999, pages 695 - 702;;SCOTT, C.F. ET AL., THROMB RES, vol. 48, no. 6, 1987, pages 685 - 700;;GALLIMORE, M.J. ET AL., THROMB RES, vol. 114, no. 2, 2004, pages 91 - 96;;BUHLER R. ET AL., BLOOD COAGUL FIBRINOLYSIS, vol. 6, no. 3, 1995, pages 223 - 232;;RUSTANDI ET AL., ELECTROPHORESIS, vol. 33, no. 17, September 2012 (2012-09-01), pages 2790 - 7;;WILDT ET AL., EUR J IMMUNOL., vol. 26, no. 3, 1996, pages 629 - 39;;KABAT, E.A. ET AL.: ""Sequences of Proteins of Immunological Interest"", 1991, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES;;CHOTHIA, C. ET AL., J. MOL. BIOL., vol. 196, 1987, pages 901 - 917, Retrieved from the Internet <URL:www.hgmp.mrc.ac.uk>;;GIRARD, T. ET AL., NATURE, vol. 338, 1989, pages 518 - 520;;BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426;;HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 5879 - 5883;;KAPLAN, A.P., J ALLERGY CLIN IMMUNOL, vol. 126, no. 5, 2010, pages 918 - 925;;MCMILLAN, C.V. ET AL., PATIENT, vol. 5, no. 2, 2012, pages 113 - 26;;EIGENBROT ET AL., PROTEIN ENGINEERING, vol. 3, no. 7, 1990, pages 591 - 598;;HYNES ET AL., BIOCHEMISTRY, vol. 29, 1990, pages 10018 - 10022;;KIDO ET AL., J. BIOL. CHEM., vol. 263, no. 34, 1988, pages 18104 - 18107;;NOVOTNY ET AL., J. BIOL. CHEM., vol. 264, no. 31, 1989, pages 18832 - 18837;;SPRECHER ET AL., PNAS USA, vol. 91, 1994, pages 3353 - 3357;;""Pfam"", Database accession no. PF00014;;SONHAMMER ET AL., PROTEINS, vol. 28, no. 3, 1997, pages 405 - 420;;GRIBSKOV ET AL., METH. ENZYMOL., vol. 183, 1990, pages 146 - 159;;GRIBSKOV ET AL., PROC. NATL. ACAD. SCI. USA, vol. 84, 1987, pages 4355 - 4358;;KROGH ET AL., J. MOL. BIOL., vol. 235, 1994, pages 1501 - 1531;;STULTZ ET AL., PROTEIN SCI., vol. 2, 1993, pages 305 - 314;;SCHULTZ ET AL., PROC. NATL. ACAD. SCI. USA, vol. 95, 1998, pages 5857;;SCHULTZ ET AL., NUCL. ACIDS RES, vol. 28, 2000, pages 231;;R. DURBIN ET AL.: ""Biological sequence analysis: probabilistic models of proteins and nucleic acids."", 1998, CAMBRIDGE UNIVERSITY PRESS;;CORPET ET AL., NUCL. ACIDS RES., vol. 27, 1999, pages 263 - 267;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402;;GOUZY ET AL., COMPUTERS AND CHEMISTRY, vol. 23, 1999, pages 333 - 340;;FALQUET ET AL., NUCLEIC ACIDS RES., vol. 30, 2002, pages 235 - 238;;KAUFMAN ET AL., BLOOD, vol. 73, pages 2660 - 2667",PENDING
669,US,B2,US 11372002 B2,110-279-950-221-982,2022-06-28,2022,US 201415030811 A,2014-10-17,US 201415030811 A;;US 201361893505 P;;US 201461939837 P;;US 2014/0061247 W,2013-10-21,Assays for determining plasma kallikrein system biomarkers,Methods and assays for determining the activation level of the plasma kallikrein (pKal) system and the uses thereof for assessing the activity of pKal modulators on the pKal system.,TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2017-01-16),https://lens.org/110-279-950-221-982,Granted Patent,yes,60,1,36,36,7,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,G01N33/68;;A61K39/00;;C07K16/36;;C07K16/40;;C12Q1/37;;C12Q1/56,,79,49,116-078-088-684-888;;026-394-309-301-759;;004-479-946-889-393;;008-499-354-702-218;;046-466-057-379-095;;006-789-023-934-519;;051-002-109-848-312;;088-462-073-629-715;;009-164-382-634-699;;143-067-441-552-591;;074-177-607-507-835;;080-844-532-992-816;;082-795-239-301-865;;088-052-241-032-685;;030-422-305-823-971;;046-363-627-958-215;;125-182-572-021-927;;024-019-418-021-281;;117-939-959-946-344;;051-663-279-687-169;;109-028-520-036-638;;092-309-561-609-370;;149-344-504-021-407;;078-352-985-001-170;;048-397-262-376-455;;001-680-842-915-740;;133-940-816-817-578;;014-581-174-616-945;;064-409-159-039-974;;028-584-999-150-491;;005-248-320-665-556;;008-684-349-046-919;;042-513-826-438-891;;012-206-824-167-831;;092-845-354-377-772;;005-127-586-276-928;;144-602-947-164-877;;019-467-602-686-96X;;006-297-863-625-283;;028-104-991-485-38X;;006-769-540-567-683;;065-684-189-547-526;;006-137-353-823-826;;126-568-744-168-22X;;007-994-211-905-538;;004-782-005-460-503;;137-254-299-678-586;;031-231-997-575-626;;131-203-164-642-22X,10.1182/blood.v70.4.1053.bloodjournal7041053;;2443201;;3730610;;10.1182/blood.v68.2.455.bloodjournal682455;;10.1182/blood.v68.2.455.455;;11150653;;10.1016/s0196-9781(00)00348-x;;24980392;;10.1016/j.anai.2014.05.028;;10.1172/jci105959;;4974623;;pmc322187;;9129025;;10.1182/blood.v89.9.3213;;8182230;;10.1016/0091-6749(94)90380-8;;pmc3734293;;23940538;;10.1371/journal.pone.0070140;;pmc3100311;;21625439;;10.1371/journal.pone.0020036;;10.1182/blood.v122.21.2347.2347;;10.1016/j.arcmed.2005.02.001;;15900628;;10.1016/s1081-1206(10)60493-0;;18814451;;10.1111/j.1476-5381.1989.tb12688.x;;pmc1854808;;2692754;;10.1161/01.atv.0000240290.70852.c0;;pmc2637648;;16902163;;10.1016/j.jaci.2006.12.591;;10.1016/s0021-9150(01)00666-9;;11888508;;10.1046/j.1365-2796.1996.418764000.x;;8568479;;7947259;;10.1111/j.1365-2141.1994.tb04874.x;;10.1016/0022-1759(94)00320-v;;7714339;;2451949;;10.1182/blood.v71.5.1334.bloodjournal7151334;;10.1182/blood.v71.5.1334.1334;;2651524;;10.1016/0022-1759(89)90376-1;;2433279;;10.1016/s0021-9258(19)75800-1;;19691495;;10.1111/j.1742-4658.2009.07218.x;;10.1155/2014/683598;;pmc4020216;;24872599;;10.1097/xce.0000000000000009;;14572818;;10.1016/s1473-0502(03)00170-8;;11099478;;10.1096/fj.99-1025com;;7654936;;10.1097/00001721-199505000-00005;;15306150;;10.1016/j.thromres.2004.05.005;;12842992;;10.1182/blood-2003-02-0661;;10.1111/j.1365-2141.1984.tb03955.x;;6691922;;10.1038/nmeth.f.353;;19124682;;10.1161/hypertensionaha.108.117663;;pmc4978181;;10.1182/blood.v74.2.695.695;;10.1182/blood.v74.2.695.bloodjournal742695;;2752143;;3501619;;10.1016/0049-3848(87)90434-8;;10.1021/bi00396a025;;2447941;;1727910;;10.1016/0014-5793(81)80174-3;;6912817;;483270;;10.1016/0049-3848(79)90058-6;;8856187;;10.1016/0162-3109(96)00086-0;;12190172;;10.1111/j.1572-0241.2002.05919.x;;10.1016/s0002-9270(02)04276-4;;10.1016/j.molmed.2008.12.001;;19162547;;24970892;;10.1074/jbc.m114.569061;;pmc4156074;;10.1016/j.jaci.2012.12.795;;22905925;;10.1111/j.1538-7836.2012.04890.x;;pmc3463646;;10.1517/13543784.17.5.697;;18447596;;10.1016/j.jaci.2013.12.167;;10.1016/j.jaci.2012.12.1425;;10.1016/j.jaci.2012.12.1419,"Veloso et al. (Blood, vol. 70, No. 4 Oct. 1987, p. 1053-1062).;;U.S. Appl. No. 15/030,790, filed Apr. 20, 2016, Pending.;;U.S. Appl. No. 14/761,690, filed Jul. 17, 2015, Published, 2015-0362493.;;PCT/US2014/061242, Feb. 3, 2015, International Search Report and Written Opinion.;;PCT/US2014/061242, May 6, 2016, International Preliminary Report on Patentability.;;PCT/US2014/012107, Apr. 14, 2014, International Search Report and Written Opinion.;;PCT/US2014/012107, Jul. 30, 2015, International Preliminary Report on Patentability.;;PCT/US2014/061247, Feb. 4, 2015, International Search Report and Written Opinion.;;PCT/US2014/061247, May 6, 2016, International Preliminary Report on Patentability.;;[No Author Listed], Image Studio Suftware Compatible with Mac ® Systems Now Available from LI-COR!. BioB Blog. May 8, 2012:1-3.;;Berrettini et al., Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies. Blood. Aug. 1986;68(2):455-62.;;Blais et al., The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins. Peptides. Dec. 2000;21(12):1903-40. Review.;;Chyung et al., A phase 1 study investigating DX-2930 in healthy subjects. Ann Allergy Asthma Immunol. Oct. 2014;113(4):460-6.e2. doi: 10.1016/j.anai.2014.05.028. Epub Jun. 26, 2014.;;Colman et al., Studies on the prekallikrein (kallikreinogen)—kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins. J Clin Invest. Jan. 1969;48(1):11-22.;;Cugno et al., Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood. May 1, 1997;89(9):3213-8.;;Cugno et al., Activation of the contact system and fibronolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamic acid. J Allergy Clin Immunol. 1994;93(5):870-876.;;Defendi et al., Enzymatic assays for the diagnosis of bradykinin-dependent angioedema. PLoS One. Aug. 5, 2013;8(8):e70140. doi: 10.1371/journal.pone.0070140. Print 2013. Erratum in: PLoS One. 2014;9(6):e100345.;;Dobóet al., Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1. PLoS One. 2011;6(5):e20036. doi: 10.1371/journal.pone.0020036. Epub May 23, 2011.;;Faucette et al., A Biomarker Assay For the Detection of Contact System Activation. Blood. 2013;122:2347. Avaible online at http://www.bloodjournal.org/conten/122/21/2347. Last accessed on Mar. 30, 2018. Abstract only.;;Isordia-Salas et al., The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation. Arch Med Res. Jan.-Feb. 2005;36(1):87-95.;;Joseph et al., Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma. Ann Allergy Asthma Immunol. Sep. 2008;101(3):279-86. doi: 10.1016/S1081-1206(10)60493-0.;;Katori et al., Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in anaesthetized rats. Br J Pharmacol. Dec. 1989;98(4):1383-91.;;Khan et al., High-molecular-weight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac-1, and gC1qR in monocytes. Arterioscler Thromb Vasc Biol. Oct. 2006;26(10):2260-6. Epub Aug. 10, 2006. Erratum in: Arterioscler Thromb Vasc Biol. Nov. 2006;26(11):e146.;;Ladner et al., Discovery of Ecallantide: A Potent and Selective Inhibitor of Plasma Kallikrein. J Allergy and Clinical Immuno. Jan. 1, 2007;119(1):S312.;;Merlo et al., Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease. Atherosclerosis. Apr. 2002;161(2):261-7.;;Nielsen et al., Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses. J Intern Med. Feb. 1996;239(2): 119-30.;;Page et al., An autoantibody to human plasma prekallikrein blocks activation of the contact system. Br J Haematol. May 1994;87(1):81-6.;;Raymond et al., Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation. J Immunol Methods. Mar. 27, 1995;180(2):247-57.;;Reddigari et al., Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma. Blood. May 1988;71(5): 1334-40.;;Reddigari et al., Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody. J Immunol Methods. Apr. 21, 1989;119(1):19-25.;;Schmaier et al., Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains. J Biol Chem. Jan. 25, 1987;262(3):1405-11.;;Schousboe et al., High molecular wieht kininogen binds to laminin—characterization and kinetic analyis. FEBS Journal. 2009;276:5228-5238.;;Torzewski et al., Animal Models of c-Reactive Protein. Hindawi Publishing Corpl, Mediators of Inflammation. 2014:1-7.;;Van Der Vekens et al., Human and equine cardiovascular endrocrinology: beware to compare. Cardivosacular Endicronology. 2013;2(4):67-76.;;Williams et al., DX-88 and HAE: a developmental perspective. Transfus Apher Sci. Dec. 2003;29(3):255-8.;;Zhang et al., Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5. FASEB J. Dec. 2000;14(15):2589-600.;;Bühler et al., Improved detection of proteolytically cleaved high molecular weight kininogen by immunoblotting using an antiserum against its reduced 47 kDa light chain. Blood Coagul Fibrinolysis. May 1995;6(3):223-32.;;Gallimore et al., Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis. Thromb Res. 2004;114(2):91-6.;;Isordia-Salas et al., The mutation Ser511Asn leads to N-glycosylation and increases the cleavage of high molecular weight kininogen in rats genetically susceptible to inflammation. Blood. Oct. 15, 2003;102(8):2835-42. Epub Jul. 3, 2003.;;Kerbiriou-Nabias et al., Radioimmunoassays of human high and low molecular weight kininogens in plasmas and platelets. Br J Haematol. Feb. 1984;56(2):273-86.;;Nguyen et al., The Simple Western™: a gel-free, blot-free, hands-free Western blotting reinvention. Nature Methods. Oct. 28, 2011;8:5-6.;;Phipps et al., Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability. Hypertension. Feb. 2009;53(2):175-81. Epub Jan. 5, 2009.;;Reddigari et al., Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity. Blood. Aug. 1, 1989;74(2):695-702.;;Scott et al., A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate. Thromb Res. Dec. 15, 1987;48(6):685-700.;;U.S. Appl. No. 15/030,790, filed Apr. 20, 2016, Published, 2016-0252533.;;EP 14855002.3, Feb. 20, 2017, Supplementary European Searh Report.;;EP 14740444.6, Jun. 17, 2016, Extended European Search Report.;;EP 14856778.7, Feb. 28, 2017, Partial Supplementary European Search Report.;;EP 14856778.7, Jun. 16, 2017, Supplementary European Search Report.;;U.S. Appl. No. 15/030,790, filed Apr. 20, 2016, Granted, U.S. Appl. No. 10,101,344.;;U.S. Appl. No. 16/131,781, filed Sep. 14, 2018, Pending.;;U.S. Appl. No. 14/761,690, filed Jul. 17, 2015, Published, 2015-03624932.;;U.S. Appl. No. 15/769,237, filed Apr. 18, 2018, Published, 2018-03068071.;;EP 18186356.4, Jan. 18, 2019, Extended European Search Report.;;PCT/US2016/057640, May 3, 2018, International Preliminary Report on Patentability.;;PCT/US2016/057640, Jan. 26, 2017, International Search Report and Written Opinion.;;[No Author Listed], Mouse High Molecular Weight Kinnogen (HMWK) ELISA Kit (Cat. No. BMS089195). MyBiosource Datasheet. Jan. 2, 1984. Revtrieved from <https://www.mybiosource.com/prods/ELIS-A-Kit/Mouse/High-Molecular-Weight-Kinogen/HMWK/datasheet.php?products_id=89195> on Dec. 13, 2018. 4 pages.;;Ishiguro et al., Mapping of functional domains of human high molecular weight and low molecular weight kininogens using murine monoclonal antibodies. Biochemistry. Nov. 3, 1987;26(22):7021-9.;;Scott et al., Sensitive antigenic determinations of high molecular weight kininogen performed by covalent coupling of capture antibody. J Lab Clin Med. Jan. 1992;119(1):77-86. Abstract only.;;Syvänen et al., A radioimmunoassay for the detection of molecular forms of human plasma kininogen. FEBS Lett. Jul. 6, 1981;129(2):241-5.;;Uchida et al., Differential assay method for high molecular weight and low molecular weight kininogens. Thromb Res. 1979;15(1-2):127-34.;;Cugno et al., Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies. Immunopharmacology. Jun. 1996;33(1-3):361-4.;;Devani et al., Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers. Am J Gastroenterol. Aug. 2002;97(8):2026-32.;;Chaudhuri et al., Glucocorticoids and rheumatoid arthritis—a reappraisal. I. J. Rheumatol. Mar. 1, 2008;3(1):21-8.;;Cugno et al., C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med. Feb. 2009;15(2):69-78. doi: 10.1016/j.molmed.2008.12.001. Epub Jan. 21, 2009.;;Huang, Alzheimer Disease. Merck Manual, Professional Version. Dec. 2019:1-7.;;Kenniston et al., Inhibition of plasma kallikrein by a highly specific active site blocking antibody. J Biol Chem. Aug. 22, 2014;289(34):23596-608. doi: 10.1074/jbc.M114.569061. Epub Jun. 26, 2014.;;Kontzias, Rheumatoid Arthritis (RA). Merck Manual, Professional Version. Dec. 2018:1-19.;;Maggio, Sepsis and Septic Shock. Merck Manual, Professional Version. Jan. 2020:1-8.;;Mehta, Diabetic Retinopathy. Merck Manual, Professional Version. Jun. 2019:1-5.;;Sexton et al., Discovery and Characterization of a Fully Human Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Treatment of Plasma Kallikrein-Mediated Edema. J. Allergy Clin. Immunol. Feb. 2013;131(2): AB32.;;Mutch et al., Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation. J Thromb Haemost. Oct. 2012;10(10):2108-15. doi: 10.1111/j.1538-7836.2012.04890.x.;;Sexton et al., Inhibition of the plasma kallikrein-kinin system activation by DX-2930, a fully human monoclonal antibody inhibitor of plasma kallikrein. Journal of Angioedema. May 2013; 1(1): 45.;;Zuraw et al., New promise and hope for treating hereditary angioedema. Expert Opin Investig Drugs. May 2008;17(5):697-706. doi: 10.1517/13543784.17.5.697.;;U.S. Appl. No. 17/141,690, filed Jan. 5, 2021, Sexton et al.;;EP 20197583.6, Mar. 19, 2021, Extended European Search Report.;;Babu et al., A Simple, Sensitive and Selective Fluorogenic Assay To Monitor Plasma Kallikrein Inhibitory Activity Of BCX4161 In Activated Plasma. J Allergy Clin Immunol. Feb. 2014; 133(2):1.;;Bantia et al., BCX-4161, a Small Molecule and Orally Bioavailable Plasma Kallikrein Inhibitor for the Treatment of Hereditary Angioedema. J Allergy Clin Immunol. Feb. 2013;131(2):1.;;Zhang et al., A Simple, Sensitive and Selective Fluorogenic Assay to Monitor Kallikrein Activity in Activated Plasma. J Allergy Clin Immunol. Feb. 2013;131(2):1-4.",ACTIVE
670,KR,A,KR 20220119171 A,139-088-186-764-279,2022-08-26,2022,KR 20227027698 A,2014-10-17,US 201361893505 P;;US 201461939837 P;;KR 20167013432 A;;US 2014/0061247 W,2013-10-21,ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS,"혈장 칼리크레인(pKal) 시스템의 활성화 수준을 결정하기 위한 방법 및 검정법, 및 pKal 시스템에서 pKal 조절제의 활성을 평가하기 위한 이의 용도.",TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,,https://lens.org/139-088-186-764-279,Patent Application,no,3,0,36,36,14,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C12Q1/37;;C07K14/755;;C07K16/36;;C12Q1/56;;G01N33/573;;G01N33/68,,1,0,,,"J. Immunol. Methods, 1989 Vol. 119(1) Abstract.",ACTIVE
671,AU,A,AU 1997/024242 A,100-198-630-202-419,1997-10-10,1997,AU 1997/024242 A,1997-03-19,US 62113896 A;;US 2712796 P;;US 9704956 W,1996-03-21,Method for hyperaccumulation of metals in plant shoots,,PHYTOTECH INC,ENSLEY BURT D;;BLAYLOCK MICHAEL J;;DUSHENKOV SLAVIK;;KUMAR NANDA P B A;;KAPULNIK YORAM;;HUANG JIANWEI,ON=EDENSPACE SYSTEMS CORPORATION; FT=THE FORMER OW (2000-09-14),https://lens.org/100-198-630-202-419,Patent Application,no,0,0,5,7,0,B09C1/105;;C02F3/327;;Y02W10/10,B09C1/10;;C02F3/32,,0,0,,,,EXPIRED
672,KR,A,KR 20160093604 A,109-286-055-006-290,2016-08-08,2016,KR 20167013432 A,2014-10-17,US 201361893505 P;;US 201461939837 P;;US 2014/0061247 W,2013-10-21,ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS,"혈장 칼리크레인(pKal) 시스템의 활성화 수준을 결정하기 위한 방법 및 검정법, 및 pKal 시스템에서 pKal 조절제의 활성을 평가하기 위한 이의 용도.",DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,,https://lens.org/109-286-055-006-290,Patent Application,no,3,0,36,36,14,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C07K14/755;;C07K16/36;;C12Q1/56;;G01N33/573;;G01N33/68,,1,0,,,"J. Immunol. Methods, 1989 Vol. 119(1) Abstract.*",ACTIVE
673,US,A1,US 2022/0291232 A1,135-106-662-733-811,2022-09-15,2022,US 202117555636 A,2021-12-20,US 202117555636 A;;US 201615030811 A;;US 2014/0061247 W;;US 201461939837 P;;US 201361893505 P,2013-10-21,ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS,Methods and assays for determining the activation level of the plasma kallikrein (pKal) system and the uses thereof for assessing the activity of pKal modulators on the pKal system.,TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,DYAX CORP (2016-07-28),https://lens.org/135-106-662-733-811,Patent Application,yes,0,0,36,36,7,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,G01N33/68;;C07K16/36;;C07K16/40;;C12Q1/37;;C12Q1/56,,12,11,076-963-805-997-135;;004-002-541-277-016;;040-883-578-380-760;;047-540-707-423-633;;050-718-006-801-471;;075-133-060-516-229;;018-524-759-000-622;;125-803-578-961-96X;;102-948-288-892-428;;000-959-013-594-769;;080-558-952-771-350,10.1517/14712598.8.8.1187;;18613770;;10.2337/db20-0427;;pmc7576572;;32826295;;32173555;;10.1016/j.nbd.2020.104833;;pmc7175647;;10.1016/j.jaip.2021.11.011;;34838707;;32066009;;10.1016/j.ejmech.2020.112137;;10.14283/jpad.2021.23;;34101796;;10.2337/dc20-0304;;pmc7305001;;32350020;;10.1073/pnas.1423764112;;pmc4386355;;25775543;;3971563;;10.1093/clinchem/31.3.423;;pmc6499653;;30780167;;10.1055/s-0039-1678737;;10.1016/j.thromres.2019.08.009;;pmc6825898;;31473403,"Andreas Lehmann (2008) Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery, Expert Opinion on Biological Therapy, 8:8, 1187-1199 (Year: 2008);;Jaffa et al., Longitudinal Plasma Kallikrein Levels and Their Association With the Risk of Cardiovascular Disease Outcomes in Type 1 Diabetes in DCCT/EDIC. Diabetes. 2020 Nov;69(11):2440-2445. Epub 2020 Aug 21. (Year: 2020);;Singh et al., Increased plasma bradykinin level is associated with cognitive impairment in Alzheimer's patients. Neurobiol Dis. 2020 Jun;139:104833. Epub 2020 Mar 12. (Year: 2020);;Busse et al. Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade. J Allergy Clin Immunol Pract. 2022 Mar;10(3):716-722. Epub 2021 Nov 25. Erratum in: J Allergy Clin Immunol Pract. 2022 Jun;10(6):1673. (Year: 2022);;Zhouling et al. Discovery and development of plasma kallikrein inhibitors for multiple diseases, European Journal of Medicinal Chemistry, Volume 190, 2020, 112137, ISSN 0223-5234 (Year: 2020);;Porsteinsson et al. Diagnosis of Early Alzheimer’s Disease: Clinical Practice in 2021. J Prev Alzheimers Dis 8, 371–386 (2021) (Year: 2021);;Potter et al., Strict Preanalytical Oral Glucose Tolerance Test Blood Sample Handling Is Essential for Diagnosing Gestational Diabetes Mellitus. Diabetes Care 1 July 2020; 43 (7): 1438–1441 (Year: 2020);;Zamolodchikov et al. Activation of the factor XII-driven contact system in Alzheimer's disease patient and mouse model plasma. Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):4068-73. Epub 2015 Mar 16. (Year: 2015);;Siles, 2017. Hereditary Angioedema. Cleveland Clinic, Disease Management, Table 1 (Year: 2017);;Adams et al. 1985. Human Kininogens of Low and High Molecular Mass: Quantification by Radioimmunoassay and Determination of Reference Values . Clinical Chemistry. 31/3, 423-426, Table 2 (Year: 1985);;Folsom et al. Plasma Concentrations of High Molecular Weight Kininogen and Prekallikrein and Venous Thromboembolism Incidence in the General Population. Thromb Haemost. 2019 May;119(5):834-843. Epub 2019 Feb 19 (Year: 2019);;Parikh et al. Prospective study of plasma high molecular weight kininogen and prekallikrein and incidence of coronary heart disease, ischemic stroke and heart failure. Thromb Res. 2019 Oct;182:89-94. Epub 2019 Aug 22. (Year: 2019)",PENDING
674,WO,A1,WO 2015/061183 A1,161-744-063-591-54X,2015-04-30,2015,US 2014/0061247 W,2014-10-17,US 201461939837 P;;US 201361893505 P,2013-10-21,ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS,Methods and assays for determining the activation level of the plasma kallikrein (pKal) system and the uses thereof for assessing the activity of pKal modulators on the pKal system.,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,,https://lens.org/161-744-063-591-54X,Patent Application,yes,24,27,36,36,7,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C07K16/40,,8,6,008-684-349-046-919;;164-277-261-420-791;;016-326-550-218-68X;;109-028-520-036-638;;024-019-418-021-281;;088-462-073-629-715,10.1038/nmeth.f.353;;10.1160/th07-04-0250;;10.1056/nejmcp0803977;;18768946;;2651524;;10.1016/0022-1759(89)90376-1;;7947259;;10.1111/j.1365-2141.1994.tb04874.x;;pmc3734293;;23940538;;10.1371/journal.pone.0070140,"NGUYEN ET AL.: ""The Simple Western?: a gel-free, blot-free, hands-free Western blotting reinvention"", NATURE METHODS, vol. 8, 1 November 2011 (2011-11-01), pages 5 - 6, XP055336385;;SAINZ I.M. ET AL., THROMB HAEMOST, vol. 98, 2007, pages 77 - 83;;ZURAW B.L. ET AL., N ENGL J MED, vol. 359, 2008, pages 1027 - 1036;;REDDIGARI ET AL., J IMMUNOL METHODS, vol. 119, pages 19 - 25;;BERRETTINI ET AL., BLOOD, vol. 68, pages 3213 - 3218;;PAGE ET AL., BR J HAEMATOL, vol. 87, pages 81 - 86;;DEFENDI ET AL., PLOS ONE, vol. 8, pages e70140;;See also references of EP 3060582A4",PENDING
675,EP,A1,EP 0888197 A1,106-590-029-556-421,1999-01-07,1999,EP 97919929 A,1997-03-19,US 9704956 W;;US 62113896 A;;US 2712796 P,1996-03-21,METHOD FOR HYPERACCUMULATION OF METALS IN PLANT SHOOTS,,PHYTOTECH INC,ENSLEY BURT D;;BLAYLOCK MICHAEL J;;DUSHENKOV SLAVIK;;KUMAR NANDA P B A;;KAPULNIK YORAM;;HUANG JIANWEI,,https://lens.org/106-590-029-556-421,Patent Application,yes,0,0,5,7,0,B09C1/105;;C02F3/327;;Y02W10/10,B09C1/10;;C02F3/32,,0,0,,,,DISCONTINUED
676,BR,A2,BR 112016008970 A2,126-499-816-105-097,2017-09-19,2017,BR 112016008970 A,2014-10-17,US 2014/0061247 W;;US 201461939837 P;;US 201361893505 P,2013-10-21,"MÉTODO DE ATIVAÇÃO EX VIVO E PARA AVALIAR ATIVAÇÃO PLASMÁTICA EM UM INDIVÍDUO, ENSAIO EX VIVO PARA DETERMINAR ATIVIDADE DE CALICREÍNA PLASMÁTICA EM UMA AMOSTRA",ENSAIOS PARA A DETERMINAÇÃO DE BIOMARCADORES DE SISTEMA CALICREÍNA PLASMÁTICA. Métodos e ensaios para determinar o nível de ativação do sistema de calicreína plasmática (pKal) e usos destes para avaliar a atividade dos moduladores de pKal no sistema pKal.,DYAX CORP;;TAKEDA PHARMACEUTICALS CO,DANIEL J SEXTON;;RYAN FAUCETTE;;JON A KENNINSTON;;GREGORY P CONLEY;;ANDREW NIXON;;CHRISTOPHER TENHOOR;;BURT ADELMAN,TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) (2021-07-13);;DYAX CORP. (US) (2018-08-28),https://lens.org/126-499-816-105-097,Patent Application,no,0,0,36,36,0,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C07K16/40,,0,0,,,,ACTIVE
677,EP,A1,EP 3060582 A1,174-624-744-469-078,2016-08-31,2016,EP 14856778 A,2014-10-17,US 201361893505 P;;US 201461939837 P;;US 2014/0061247 W,2013-10-21,ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS,,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,"TAKEDA PHARMACEUTICAL COMPANY LIMITED, JP (2022-07-06);;TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-09-08);;DYAX CORP. (2018-06-20);;TAKEDA PHARMACEUTICAL COMPANY LIMITED; JP (2021-11-05)",https://lens.org/174-624-744-469-078,Patent Application,yes,0,1,36,36,7,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C12Q1/37;;C07K16/40;;C12Q1/56,,0,0,,,,ACTIVE
678,KR,A,KR 20230054745 A,178-987-826-313-85X,2023-04-25,2023,KR 20237012295 A,2014-10-17,US 201361893505 P;;US 201461939837 P;;KR 20227027698 A;;US 2014/0061247 W,2013-10-21,ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS,"혈장 칼리크레인(pKal) 시스템의 활성화 수준을 결정하기 위한 방법 및 검정법, 및 pKal 시스템에서 pKal 조절제의 활성을 평가하기 위한 이의 용도.",TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT,,https://lens.org/178-987-826-313-85X,Patent Application,no,0,0,36,36,14,C07K16/36;;C12Q1/37;;C12Q1/56;;G01N2800/224;;G01N2800/52;;C12Y304/21034;;C12Y304/21038;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50;;A61P29/00;;A61P43/00;;A61P7/10;;C07K16/36;;C12Q1/37;;C12Q1/56;;G01N33/6893;;A61K2039/505;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2800/224;;G01N2800/52;;C07K16/40;;G01N33/573;;C07K14/755;;C12Q1/37;;C12Q1/56;;G01N33/573;;G01N33/6893;;G01N2800/52;;G01N2800/224;;G01N2333/96411;;C12Q1/37;;G01N2800/224;;G01N2800/52;;C12Q1/56;;C07K16/36;;A61K2039/505;;C07K16/40;;C07K2317/76;;C12Y304/21034;;C12Y304/21038;;G01N33/6893;;G01N2333/4713;;G01N2333/96455;;G01N2333/96458;;G01N2500/02;;G01N2500/20;;G01N2800/50,C12Q1/37;;C07K14/755;;C12Q1/56;;G01N33/573;;G01N33/68,,0,0,,,,DISCONTINUED
679,US,B2,US 11793974 B2,148-876-611-435-518,2023-10-24,2023,US 202016788192 A,2020-02-11,US 202016788192 A;;US 201962892743 P;;US 201962804032 P,2019-02-11,Fixation devices for catheters,"Fixation devices are disclosed herein that can be used to secure to a catheter. The fixation devices include a body having a central bore extending therethrough to receive a catheter and at least one end having a tapered profile tapering inwardly a distal edge thereof. The body can include an expanded intermediate portion, such as one or more bulbous portions. The fixation devices can also include suture openings or grooves to secure the devices to tissue.",ALCYONE THERAPEUTICS INC,ANAND P J;;SINGH DEEP ARJUN;;EAST ANDREW;;WASHBURN THOMAS T;;VEETEKAT RAHUL;;BETTÈ NICOLE;;FLEEGE CHRIS;;LAPINSKI MATTHEW J;;RAYMOND BURT,ALCYONE THERAPEUTICS INC (2020-11-25),https://lens.org/148-876-611-435-518,Granted Patent,yes,24,0,5,5,0,A61M2025/0286;;A61M25/02;;A61M2025/0286;;A61M25/04;;A61M2025/0246;;A61M2025/028;;A61M2025/0253;;A61M2025/0206;;A61M2025/0266;;A61M2025/024,A61M25/04;;A61M25/02,,2,0,,,"International Application No. PCT/US2020/017752, International Search Report and Written Opinion, dated Jun. 19, 2020.;;European Patent Application No. 20755022, Extended European Search Report, dated Sep. 23, 2022.",ACTIVE
680,JP,A,JP 2020002171 A,073-316-170-299-121,2020-01-09,2020,JP 2019166361 A,2019-09-12,US 201461944361 P;;US 201462021397 P;;US 201461929716 P,2014-01-21,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA,"To provide methods of treating hereditary angioedema.SOLUTION: Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein, and methods of using the proteins.SELECTED DRAWING: Figure 11",DYAX CORP,CHYUNG YUNG;;DANIEL J SEXTON;;CHRISTOPHER TENHOOR;;JON A KENNISTON;;RYAN FAUCETTE;;RYAN LARROBINO;;JOSEPH BIEDENKAPP;;BURT ADELMAN,,https://lens.org/073-316-170-299-121,Patent Application,no,1,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,A61K39/395;;A61P9/00,,2,0,,,"SEXTON D, ET AL.: ""Discovery and Characterization of a Fully Human Monoclonal Antibody Inhibitor of Plasma Kallikrein f"", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. Vol.131, No.2, Suppl., JPN6018033787, February 2013 (2013-02-01), pages 32, ISSN: 0004577294;;岡野 貞輔 編著, 新・薬剤学総論（改訂第３版）, JPN6018033788, 10 April 1987 (1987-04-10), pages 250 - 253, ISSN: 0004577295",ACTIVE
681,HR,T1,HR P20181734 T1,121-453-593-303-268,2018-12-28,2018,HR P20181734 T,2018-10-22,US 201361754607 P;;EP 14740444 A;;US 2014/0012107 W,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,,https://lens.org/121-453-593-303-268,Granted Patent,no,0,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,0,0,,,,ACTIVE
682,CA,A1,CA 2147785 A1,046-755-710-202-454,1995-10-27,1995,CA 2147785 A,1995-04-25,US 23943294 A,1994-04-26,Alkoxy-Bridged Metallophthalocyanine Dimers,,XEROX CORP,BURT RICHARD A;;LIEBERMANN GEORGE;;HAMER GORDON K;;GARDNER SANDRA J;;JENNINGS CAROL A;;DAIMON KATSUMI;;NUKADA KATSUMI,,https://lens.org/046-755-710-202-454,Patent Application,no,0,0,9,9,0,C07D519/00;;C07D519/00;;C09B47/067;;C09B47/067;;C09B47/073;;C09B47/073;;G03G5/0696;;G03G5/0696,C07D487/22;;C07D519/00;;C09B47/04;;C09B47/067;;C09B47/073;;G03G5/06,,0,0,,,,EXPIRED
683,EP,A4,EP 2948479 A4,052-175-446-808-233,2016-07-20,2016,EP 14740444 A,2014-01-17,US 201361754607 P;;US 2014/0012107 W,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,"TAKEDA PHARMACEUTICAL COMPANY LIMITED, JP (2022-07-06);;TAKEDA PHARMACEUTICAL COMPANY LIMITED, OSAKA, JP (2021-11-23);;TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-08-02);;DYAX CORP. (2018-06-20);;TAKEDA PHARMACEUTICAL COMPANY LIMITED; JP (2021-11-05)",https://lens.org/052-175-446-808-233,Search Report,no,0,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,6,5,004-479-946-889-393;;117-939-959-946-344;;082-795-239-301-865;;030-422-305-823-971;;046-466-057-379-095,11150653;;10.1016/s0196-9781(00)00348-x;;10.1016/0022-1759(94)00320-v;;7714339;;10.1111/j.1476-5381.1989.tb12688.x;;pmc1854808;;2692754;;10.1016/j.jaci.2006.12.591;;10.1172/jci105959;;4974623;;pmc322187,"CHARLES BLAIS ET AL: ""The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins"", PEPTIDES, vol. 21, no. 12, 1 December 2000 (2000-12-01), AMSTERDAM, NL, pages 1903 - 1940, XP055279044, ISSN: 0196-9781, DOI: 10.1016/S0196-9781(00)00348-X;;RAYMOND P ET AL: ""Quantification of des-Arg<9>-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation"", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 180, no. 2, 27 March 1995 (1995-03-27), pages 247 - 257, XP004021047, ISSN: 0022-1759, DOI: 10.1016/0022-1759(94)00320-V;;MAKOTO KATORI ET AL: ""Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in anaesthetized rats"", BR. J. PHARMACOL, vol. 98, 1 January 1989 (1989-01-01), pages 1383 - 1391, XP055279078;;LADNER ET AL: ""Discovery of Ecallantide: A Potent and Selective Inhibitor of Plasma Kallikrein"", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 119, no. 1, 1 January 2007 (2007-01-01), pages S312, XP005757131, ISSN: 0091-6749, DOI: 10.1016/J.JACI.2006.12.591;;ROBERT W COLMAN ET AL: ""Studies on the Prekallikrein (Kallikreinogen) -Kallikrein Enzyme System of Human Plasma I. ISOLATION AND PURIFICATION OF PLASMA KALLIKREINS INTRODUCTION"", JOURNAL OF CLINICAL INVESTIGATION, 1 January 1969 (1969-01-01), pages 11 - 22, XP055279109, Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC322187/pdf/jcinvest00207-0027.pdf> [retrieved on 20160609];;See also references of WO 2014113712A1",ACTIVE
684,MX,A,MX 2016009428 A,159-666-321-764-421,2017-04-13,2017,MX 2016009428 A,2015-01-21,US 201461929716 P;;US 201461944361 P;;US 201462021397 P;;US 2015/0012212 W,2014-01-21,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA.,Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.,DYAX CORP,YUNG CHYUNG;;DANIEL J SEXTON;;CHRISTOPHER TENHOOR;;JON A KENNISTON;;RYAN FAUCETTE;;JOSEPH BIEDENKAPP;;BURT ADELMAN;;RYAN IARROBINO,,https://lens.org/159-666-321-764-421,Patent Application,no,0,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,A61K49/00;;A61K39/395;;C07K16/00;;G01N33/53,,0,0,,,,PENDING
685,DK,T3,DK 2948479 T3,167-707-652-587-35X,2018-11-26,2018,DK 14740444 T,2014-01-17,US 201361754607 P;;US 2014/0012107 W,2013-01-20,EVALUERING OG BEHANDLING AF BRADYKININMEDIEREDE FORSTYRRELSER,,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG;;CONLEY GREG,,https://lens.org/167-707-652-587-35X,Granted Patent,no,0,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,0,0,,,,ACTIVE
686,WO,A1,WO 2015/112578 A1,160-592-216-293-409,2015-07-30,2015,US 2015/0012212 W,2015-01-21,US 201461944361 P;;US 201462021397 P;;US 201461929716 P,2014-01-21,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA,Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.,DYAX CORP,CHYUNG YUNG;;SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;LARROBINO RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT,,https://lens.org/160-592-216-293-409,Patent Application,yes,23,21,45,46,10,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,A61K49/00;;A61K39/395;;C07K16/00;;G01N33/53,,55,48,091-004-161-564-632;;008-499-354-702-218;;006-137-353-823-826;;164-277-261-420-791;;016-326-550-218-68X;;109-500-732-467-583;;049-134-753-209-354;;074-817-300-512-106;;017-150-654-990-340;;002-264-966-090-625;;048-188-266-680-461;;013-181-635-285-001;;019-779-601-634-917;;056-201-471-905-934;;028-862-168-091-90X;;097-318-320-850-899;;106-753-778-592-300;;069-831-019-492-211;;022-133-574-143-973;;030-630-100-818-462;;030-607-398-087-475;;030-607-398-087-475;;030-323-674-660-051;;029-295-665-407-969;;103-477-074-900-777;;101-039-255-543-294;;126-013-549-735-904;;042-026-882-861-725;;028-423-517-648-100;;046-750-736-499-556;;051-971-787-908-276;;012-214-936-917-65X;;085-434-580-555-434;;005-941-618-976-731;;074-203-723-868-757;;016-534-677-137-074;;104-243-866-474-715;;001-166-444-961-82X;;069-917-507-345-672;;051-940-176-386-905;;029-667-686-534-996;;011-389-300-335-273;;007-551-089-881-647;;002-237-818-610-496;;007-364-858-655-289;;056-942-841-068-650;;127-185-373-141-041;;080-454-961-811-450,10.1016/j.jaci.2007.04.028;;17559913;;24980392;;10.1016/j.anai.2014.05.028;;24970892;;10.1074/jbc.m114.569061;;pmc4156074;;10.1160/th07-04-0250;;10.1056/nejmcp0803977;;18768946;;8605931;;10.1002/eji.1830260319;;10.1016/0022-2836(87)90412-8;;3681981;;10.1038/341544a0;;2677748;;3140379;;10.1126/science.3140379;;10.1073/pnas.85.16.5879;;3045807;;pmc281868;;2315699;;10.1126/science.2315699;;10.1073/pnas.87.6.2264;;2315319;;pmc53667;;pmc46825;;8390686;;10.1073/pnas.90.12.5873;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;10.1073/pnas.85.22.8678;;pmc282523;;3054890;;1172191;;10.1038/256495a0;;6811415;;10.1007/bf02796338;;10.1146/annurev.iy.12.040194.002245;;10.1146/annurev.immunol.12.1.433;;8011287;;10.1038/348552a0;;2247164;;pmc392030;;10.1073/pnas.81.21.6851;;6436822;;pmc392030;;10.1073/pnas.81.21.6851;;6436822;;pmc298637;;2513570;;10.1073/pnas.86.24.10029;;10.1016/j.pep.2006.10.011;;17141527;;10.1016/s0022-1759(00)00290-8;;11292488;;pmc2736937;;19671134;;10.1186/1472-6750-9-70;;11499924;;10.1007/s002530000572;;11129586;;10.1271/bbb.64.2138;;1367574;;10.1016/0168-1656(91)90350-5;;10.1186/1752-0509-4-141;;20969759;;pmc2987880;;20346137;;pmc2867824;;10.1186/1471-2164-11-207;;19216534;;10.1021/pr8007623;;15943904;;10.5483/bmbrep.2005.38.3.294;;15612595;;10.1023/b:mbil.0000049871.17260.46;;2050687;;10.1016/s0021-9258(18)99043-5;;16570317;;10.1002/bit.20851;;9231415;;10.1016/s0378-1097(97)00203-6;;10.1111/j.1574-6968.1997.tb10433.x;;10.1007/bf02788058;;8756614;;10.1021/bc010003g;;11562193;;10.1073/pnas.77.7.4216;;pmc349802;;6933469;;6292436;;10.1016/0022-2836(82)90103-6;;10.1186/1479-5876-4-39;;17010186;;pmc1592514;;10.1016/s0065-2776(08)60486-1;;1502974;;9700502;;10.1111/j.1600-065x.1998.tb01188.x;;10.1002/jps.2600660104;;833720;;2674208;;10.1002/j.1552-4604.1989.tb03403.x;;10.1016/j.jaci.2010.08.012;;20889195;;19297327;;10.1074/jbc.m900508200;;pmc2679480,"SCHNEIDER ET AL.: ""Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor."", J ALLERGY CLIN IMMUNOL, vol. 120, no. 2, August 2007 (2007-08-01), pages 416 - 422, XP022199100;;CHYUNG ET AL.: ""A phase 1 study investigating DX-2930 in healthy subjects."", ANN ALLERGY ASTHMA IMMUNOL, vol. 113, no. 4, 26 June 2014 (2014-06-26), pages 460 - 466, XP029068455;;KENNISTON ET AL.: ""Inhibition of plasma kallikrein by a highly specific active site blocking antibody."", J BIOL CHEM, vol. 289, no. 34, 26 June 2014 (2014-06-26), pages 23596 - 23608, XP055215056;;SAINZ I.M. ET AL., THROMB HAEMOST, vol. 98, 2007, pages 77 - 83;;ZURAW B.L. ET AL., N ENGL J MED, vol. 359, 2008, pages 1027 - 1036;;WILDT ET AL., EUR J IMMUNOL., vol. 26, no. 3, 1996, pages 629 - 39;;KABAT, E.A. ET AL.: ""U.S. Department of Health and Human Services"", 1991, NIH PUBLICATION, article ""Sequences of Proteins of Immunological Interest"";;CHOTHIA, C. ET AL., J. MOL. BIOL., vol. 196, 1987, pages 901 - 917;;WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546;;BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426;;HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 5879 - 5883;;BOWIE ET AL., SCIENCE, vol. 247, 1990, pages 1306 - 1310;;KARLINALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 2264 - 68;;KARLINALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 5873 - 77;;ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 10;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, no. 17, 1997, pages 3389 - 3402;;HORWITZ, AH. ET AL., PROC NATL ACAD SCI U S A, vol. 85, no. 22, 1988, pages 8678 - 82;;KOHLER, B.MILSTEIN, C., NATURE, vol. 256, 1975, pages 495 - 497;;BUCK, D. W. ET AL., IN VITRO, vol. 18, 1982, pages 377 - 381;;WINTER ET AL., ANNU. REV. IMMUNOL., vol. 12, 1994, pages 433 - 455;;MCCAFFERTY ET AL., NATURE, vol. 348, 1990, pages 552 - 553;;MORRISON ET AL., PROC. NAT. ACAD. SCI., vol. 81, 1984, pages 6851;;MORRISON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 81, 1984, pages 6851;;NEUBERGER ET AL., NATURE, vol. 314, 1984, pages 452;;QUEEN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 10029 - 10033;;HARLOWLANE: ""Using Antibodies, a Laboratory Manual"", 1999, COLD SPRING HARBOR LABORATORY PRESS;;NADKARNI, A. ET AL., PROTEIN EXPR PURIF, vol. 52, no. 1, 2007, pages 219 - 29;;POWERS ET AL., J. IMMUNOL. METHODS., vol. 251, 2001, pages 123 - 35;;SCHOONOOGHE S. ET AL., BMC BIOTECHNOL., vol. 9, 2009, pages 70;;ABDEL-SALAM, HA. ET AL., APPL MICROBIOL BIOTECHNOL, vol. 56, no. 1-2, 2001, pages 157 - 64;;TAKAHASHI K. ET AL., BIOSCI BIOTECHNOL BIOCHEM, vol. 64, no. 10, 2000, pages 2138 - 44;;EDQVIST, J. ET AL., J BIOTECHNOL, vol. 20, no. 3, 1991, pages 291 - 300;;BAUMANN K. ET AL., BMC SYST. BIOL., vol. 4, 2010, pages 141;;DRAGOSITS, M. ET AL., BMC GENOMICS, vol. 11, 2010, pages 207;;DRAGOSITS, M. ET AL., J PROTEOME RES., vol. 8, no. 3, 2009, pages 1380 - 92;;NING, D. ET AL., J. BIOCHEM. AND MOL. BIOL., vol. 38, no. 3, 2005, pages 294 - 299;;KOZYR, AV ET AL., MOL BIOL (MOSK, vol. 38, no. 6, 2004, pages 1067 - 75;;BOWDISH, K. ET AL., J BIOL CHEM, vol. 266, no. 18, 1991, pages 11901 - 8;;GASSER, B. ET AL., BIOTECHOL. BIOENG., vol. 94, no. 2, 2006, pages 353 - 61;;KOBAYASHI H. ET AL., FEMS MICROBIOL LETT, vol. 152, no. 2, 1997, pages 235 - 42;;KO JH. ET AL., APPL BIOCHEM BIOTECHNOL, vol. 60, no. 1, pages 41 - 8;;SMITH, BJ. ET AL., BIOCONJUG CHEM, vol. 12, no. 5, 2001, pages 750 - 756;;URLAUBCHASIN, PROC. NATL. ACAD. SCI. USA, vol. 77, 1980, pages 4216 - 4220;;KAUFMANSHARP, MOL. BIOL., vol. 159, 1982, pages 601 621;;J. IMMUNOL. METHODS, vol. 289, no. 1-2, 2004, pages 65 - 80;;GALEFFI, P. ET AL., J TRANSL MED, vol. 4, 2006, pages 39;;BURTONWOOF, ADV. IMMUNOL., vol. 51, 1992, pages 1 - 84;;JEFFERIS ET AL., IMMUNOL. REV., vol. 163, 1998, pages 59 - 76;;BERGE, S.M. ET AL., J. PHARM. SCI., vol. 66, 1977, pages 1 - 19;;""Sustained and Controlled Release Drug Delivery Systems"", 1978, MARCEL DEKKER, INC.;;V.V. RANADE, J. CLIN. PHARMACOL., vol. 29, 1989, pages 685;;KAPLAN, A.P., J ALLERGY CLIN IMMUNOL, vol. 126, no. 5, 2010, pages 918 - 925;;MCMILLAN, C.V. ET AL., PATIENT., vol. 5, no. 2, 2012, pages 113 - 26;;LILLA ET AL., J. BIOL CHEM., vol. 284, no. 20, 2009, pages 13792 - 13803;;See also references of EP 3096798A4",PENDING
687,US,B2,US 11084884 B2,059-709-217-998-916,2021-08-10,2021,US 201515113297 A,2015-01-21,US 201515113297 A;;US 201461929716 P;;US 201461944361 P;;US 201462021397 P;;US 2015/0012212 W,2014-01-21,Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema,Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.,TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;ADELMAN BURT;;CHYUNG YUNG;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;IARROBINO RYAN;;BIEDENKAPP JOSEPH,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2020-04-24),https://lens.org/059-709-217-998-916,Granted Patent,yes,42,7,45,46,10,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,C07K16/40;;A61K39/00,,58,28,061-745-503-244-568;;052-500-805-711-529;;045-942-104-775-903;;008-499-354-702-218;;037-221-589-177-070;;107-025-092-815-187;;081-948-175-731-572;;117-771-661-619-643;;102-967-725-719-038;;002-536-676-460-583;;030-468-450-036-214;;006-137-353-823-826;;129-327-796-343-271;;020-367-308-901-689;;032-706-131-614-279;;016-655-486-455-556;;032-427-821-815-367;;042-513-826-438-891;;091-004-161-564-632;;011-414-988-517-535;;126-568-744-168-22X;;126-642-860-162-362;;053-804-015-181-307;;116-078-088-684-888;;026-831-829-605-943;;010-521-234-531-661;;095-334-545-560-259;;045-839-079-024-247,10.1172/jci107892;;pmc301700;;4140197;;10.1016/s0140-6736(00)01034-5;;10703815;;12850000;;10.1016/s0006-291x(03)01131-8;;24980392;;10.1016/j.anai.2014.05.028;;20535647;;10.1007/s11892-010-0127-1;;10.4161/19420862.2015.989047;;pmc4622072;;25530082;;17696780;;10.1515/bc.2007.104;;10.1016/j.jaci.2007.07.057;;18241690;;17259996;;10.1038/nm1534;;10648924;;10.1016/s0022-1759(99)00137-4;;10.1182/blood.v122.21.1067.1067;;24970892;;10.1074/jbc.m114.569061;;pmc4156074;;1798701;;10.1093/protein/4.7.773;;1961196;;10.1016/0161-5890(91)90003-3;;16916274;;10.1517/13543784.15.9.1077;;10.1515/hsz-2012-0316;;pmc4844060;;23362193;;18974080;;10.1093/protein/gzn058;;19124682;;10.1161/hypertensionaha.108.117663;;pmc4978181;;10.1016/j.jaci.2007.04.028;;17559913;;10.1182/blood.v122.21.1066.1066;;10.1016/j.jaci.2012.12.795;;10.1042/bj20090010;;19527222;;10.1074/jbc.m506766200;;16199530;;10.1182/blood.v70.4.1053.bloodjournal7041053;;2443201;;24621563;;pmc3951348;;10.1371/journal.pone.0091280;;10.1056/nejmoa1605767;;28225674;;10.1006/jmbi.1996.0548;;8876650;;10.1016/s1567-5769(02)00178-9;;12489798,"U.S. Appl. No. 14/773,766, filed Sep. 9, 2015, Published, 2016-0017055.;;U.S. Appl. No. 13/345,170, filed Jan. 6, 2012, Granted, U.S. Pat. No. 8,816,055.;;U.S. Appl. No. 14/310,814, filed Jun. 20, 2014, Granted, U.S. Pat. No. 9,266,964.;;U.S. Appl. No. 14/969,498, filed Dec. 15, 2015, Published, 2016-0102150.;;U.S. Appl. No. 12/985,914, filed Jan. 6, 2011, Granted, U.S. Pat. No. 8,822,653.;;U.S. Appl. No. 14/339,053, filed Jul. 23, 2014, Published, 2014-0335023.;;U.S. Appl. No. 15/706,622, filed Sep. 15, 2017, Published, 2018-0037665.;;U.S. Appl. No. 15/706,631, filed Sep. 15, 2017, Published, 2018-0037666.;;U.S. Appl. No. 15/706,613, filed Sep. 15, 2017, Published, 2018-0037664.;;U.S. Appl. No. 15/706,603, filed Sep. 15, 2017, Published, 2018-0002447.;;U.S. Appl. No. 15/706,621, filed Sep. 15, 2017, Published, 2018-0002448.;;U.S. Appl. No. 15/706,623, filed Sep. 15, 2017, Published, 2018-0002449.;;U.S. Appl. No. 14/669,607, filed Mar. 26, 2015, Published, 2015-0274841.;;U.S. Appl. No. 15/562,671, filed Sep. 28, 2017, Pending.;;U.S. Appl. No. 16/061,103, filed Jun. 11, 2018, Pending.;;EP 15740774.3, Jul. 24, 2017, Supplementary European Search Report.;;PCT/US2015/012212, Apr. 9, 2015, International Search Report and Written Opinion.;;PCT/US2015/012212, Aug. 4, 2016, International Preliminary Report on Patentability.;;[No Author Listed] Dyax's DX-2930 granted Orphan Drug designation in hereditary angioedema. Dec. 6, 2013.;;[No Author Listed] Fair Disclosure Wire, “Dyax Corp. announces positive results from phase la clinical trial of DX2930” dated Feb. 25, 2014. Last accessed from http://dialog.proquest.com/professional/printviewfile?accountid=157282 on May 20, 2016. p. 1-15.;;Bagdasarian et al., Immunochemical studies of plasma kallikrein. J Clin Invest. Dec. 1974;54(6):1444-54.;;Breedweld, Therapeutic monoclonal antibodies. Lancet. Feb. 26, 2000;355(9205):735-40. Review.;;Casset et al., A peptide mimetic of an anti-CD4 monoclonal antibody by rational design. Biochem Biophys Res Commun. Jul. 18, 2003;307(1):198-205.;;Chyung et al., A phase 1 study investigating DX-2930 in healthy subjects. Ann Allergy Asthma Immunol. Oct. 2014;113(4):460-6.e2. doi: 10.1016/j.anai.2014.05.028. Epub Jun. 26, 2014.;;Feener EP. Plasma kallikrein and diabetic macular edema. Curr Diab Rep. Aug. 2010;10(4):270-5. doi: 10.1007/s11892-010-0127-1.;;Ferrara et al., Recombinant renewable polyclonal antibodies. MAbs. 2015;7(1):32-41. doi: 10.4161/19420862.2015.989047.;;Fink et al., Cellular expression of plasma prekallikrein in human tissues. Biol Chem. Sep. 2007;388(9):957-63.;;Frank, 8. Hereditary angioedema. J Allergy Clin Immunol. Feb. 2008;121(2 Suppl):S398-401; quiz S419. doi: 10.1016/j.jaci.2007.07.057.;;Gao et al., Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat Med. Feb. 2007;13(2):181-8. Epub Jan. 28, 2007.;;Green, Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies. J Immunol Methods. Dec. 10, 1999;231(1-2):11-23.;;Kenniston et al., Discovery and Characterization of a Highly Specific Antibody Inhibitor of Plasma Kallikrein. Blood 2013;122:1067.;;Kenniston et al., Inhibition of plasma kallikrein by a highly specific active site blocking antibody. J Biol Chem. Aug. 22, 2014;289(34):23596-608. doi: 10.1074/jbc.M114.569061. Epub Jun. 26, 2014.;;Kettleborough et al., Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation. Protein Eng. Oct. 1991;4(7):773-83.;;Lederman et al., A Single Amino Acid Substitution in a Common African Allele of the CD4 Molecule Ablates Binding of the Monoclonal Antibody, OKT4. Molecular Immunology. 1991;28(11):1171-1181.;;Levy et al., The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema. Expert Opin Investig Drugs. Sep. 2006;15(9):1077-90. Review.;;Li et al., β-Endorphin omission analogs: Dissociation of immunoreactivity from other biological activities. Proc. Natl. Acad. Sci. USA. Jun. 1980;77(6):3211-3214.;;Liu et al., Plasma kallikrein-kinin system and diabetic retinopathy. Biol Chem. Mar. 2013;394(3):319-28. doi: 10.1515/hsz-2012-0316.;;Lloyd et al., Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens. Protein Eng Des Sel. Mar. 2009;22(3):159-68. doi: 10.1093/protein/gzn058. Epub Oct. 29, 2008.;;Paul. Fv Structure and Diversity in Three Dimensions. Fundamental Immunology, 3rd Edition. 1993: 292-5.;;Phipps et al., Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability. Hypertension. Feb. 2009;53(2):175-81. doi:10.1161/HYPERTENSIONAHA.108.117663. Epub Jan. 5, 2009. With 5 page Online Supplement.;;Schneider et al., Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor. J Allergy Clin Immunol. Aug. 2007;120(2):416-22. Epub Jun. 7, 2007.;;Sexton et al., Comparison of Plasma Kallikrein Inhibition by the Endogenous C1-Inhibitor Versus DX-2930, a Monoclonal Antibody Inhibitor. Blood. 2013;122:1066.;;Sexton et al., Discovery and characterization of fully human monoclonal antibody inhibitor of plasma kallikrein for the treatment of plasma kallikrein-mediated edema. J Allergy Clin Immunol. Feb. 2013;131(2):AB32. Suppl S(116). Annual meeting of the American Academy of Allergy, Asthma, and Immunology. San Antonio, TX, USA; Feb. 22-26.;;Sexton et al., Specific inhibition of tissue kallikrein 1 with a human monoclonal antibody reveals a potential role in airway diseases. Biochem J. Aug. 13, 2009;422(2):383-92. doi: 10.1042/BJ20090010.;;Tang et al., Expression, crystallization, and three-dimensional structure of the catalytic domain of human plasma kallikrein. J Biol Chem. Dec. 9, 2005;280(49):41077-89. Epub Sep. 30, 2005.;;Veloso et al., A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface. Blood. Oct. 1987;70(4):1053-62.;;Veronez et al., The involvement of proteoglycans in the human plasma prekallikrein interaction with the cell surface. PLoS One. Mar. 12, 2014;9(3):e91280. doi: 10.1371/journal.pone.0091280. eCollection 2014.;;Weaver, Animal studies paint misleading picture. Nature International Weekly Journal of Science. Published online Mar. 30, 2010. Retrieved on Aug. 1, 2017 from http://www.nature.com/news.2010.158.html.;;[No Author Listed] Shire Reports Positive Topline Phase 3 Results for Lanadelumab (SHP643) in Patients with Hereditary Angioedema. May 18, 2017. Retrieved from the Internet: http://investors.shire.com/˜/media/Files/S/Shire-IR/presentations-webcast/year-2017/shire-investor-presentation-2017-05-18.pdf on Apr. 3, 2019. 10 pages.;;Banerji et al., Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis. N Engl J Med. Feb. 23, 2017;376(8):717-728. doi: 10.1056/NEJMoa1605767.;;Bendig, Humanization of Rodent Monoclonal Antibodies by CDR Grafting. Companion to Methods in Enzymology. 1995;8:83-93.;;Boyles, Novel Kallikrein Inhibitor Promising for HAE Prophylaxis. Med Page Today. Feb. 22, 2017. Retrieved from the Internet: https://www.medpagetoday.org/pulmonology/generalpulmonary/63342?vpass=1 on Apr. 3, 2019. 4 pages.;;MacCallum et al., Antibody-antigen interactions: contact analysis and binding site topography. J Mol Biol. Oct. 11, 1996;262(5):732-45.;;Okano et al., Chapter 9.1.2 Drug Action and Blood Concentration. Shin Yakuzaiaku Soron, revised 3rd Edition, Apr. 10, 1987:205-253.;;U.S. Appl. No. 16/445,304, filed Jun. 19, 2019, Sexton et al.;;U.S. Appl. No. 16/411,242, filed May 14, 2019, Sexton et al.;;U.S. Appl. No. 16/541,743, filed Aug. 15, 2019, Conley et al.;;Shariat-Madar et al., Assembly and activation of the plasma kallikrein/kinin system: a new interpretation. Int Immunopharmacol. Dec. 2002;2(13-14):1841-9.",ACTIVE
688,CA,A1,CA 3209608 A1,057-373-510-109-461,2014-07-24,2014,CA 3209608 A,2014-01-17,US 201361754607 P;;CA 2897336 A,2013-01-20,EVALUATION AND TREATMENT OF PKAL-MEDIATED DISORDERS,"The present disclosure provides methods of evaluating a subject, e.g., a subject at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder, based on values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject. Provided methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment. Such methods can involve the use of a detection agent that preferentially binds cleaved kininogen or intact kininogen.",TAKEDA PHARMACEUTICALS CO,NIXON ANDREW;;SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,,https://lens.org/057-373-510-109-461,Patent Application,no,0,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,,,0,0,,,,PENDING
689,PL,T3,PL 3096798 T3,069-724-064-963-859,2021-07-26,2021,PL 15740774 T,2015-01-21,US 201461929716 P;;US 201461944361 P;;US 201462021397 P;;EP 15740774 A;;US 2015/0012212 W,2014-01-21,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA,,TAKEDA PHARMACEUTICALS CO,CHYUNG YUNG;;SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;IARROBINO RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT,,https://lens.org/069-724-064-963-859,Patent Application,no,0,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,A61K49/00;;A61K39/395;;C07K16/00;;G01N33/53,,0,0,,,,PENDING
690,US,B2,US 8221794 B2,085-063-527-568-56X,2012-07-17,2012,US 71685410 A,2010-03-03,US 71685410 A;;US 15139905 A;;US 38926203 A;;US 92522001 A;;US 29445899 A;;US 48026095 A;;US 41716095 A;;US 9453693 A,1993-07-19,Anti-angiogenic nanoparticle compositions,"The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.",HUNTER WILLIAM L;;MACHAN LINDSAY S;;ARSENAULT A LARRY;;BURT HELEN M;;JACKSON JOHN J;;DORDUNOO STEPHEN K;;ANGIOTECH PHARM INC,HUNTER WILLIAM L;;MACHAN LINDSAY S;;ARSENAULT A LARRY;;BURT HELEN M;;JACKSON JOHN J;;DORDUNOO STEPHEN K,SURGICAL SPECIALTIES CORPORATION LIMITED (2017-03-07),https://lens.org/085-063-527-568-56X,Granted Patent,yes,26,6,155,168,1,A61K9/0019;;A61K9/0048;;A61K9/0051;;A61K9/1635;;A61K9/1641;;A61K9/1647;;A61K9/1658;;A61K9/5031;;A61K9/5146;;A61K9/5153;;A61K9/7007;;A61K31/122;;A61K31/136;;A61K31/165;;A61K31/185;;A61K31/203;;A61K31/335;;A61K31/337;;A61K31/426;;A61K31/427;;A61K31/4745;;A61K31/519;;A61K31/525;;A61K31/555;;A61K31/565;;A61K31/57;;A61K31/702;;A61K33/00;;A61K33/06;;A61K33/24;;A61K33/30;;A61K38/57;;A61K45/06;;A61L31/10;;A61L31/145;;A61L31/16;;A61L2300/416;;A61L2300/606;;A61L2300/622;;C07C233/64;;C07K14/811;;C08L23/0853;;C08L29/04;;C08L67/04;;C08L2203/02;;C08L2312/00;;Y10S977/773;;Y10S977/915;;A61L2430/36;;A61P1/04;;A61P1/16;;A61P11/00;;A61P13/02;;A61P19/02;;A61P27/02;;A61P35/00;;A61P43/00;;A61P7/02;;A61P7/04;;A61P9/00;;A61P9/10;;A61P9/14;;A61K31/20;;C07K14/811;;A61K9/1658;;A61K33/06;;C08L2312/00;;A61K31/4745;;C08L23/0853;;A61L2300/622;;A61K33/00;;A61L31/16;;A61K9/5153;;A61K31/519;;A61L2300/416;;A61K9/7007;;A61K31/555;;A61K9/0019;;A61L31/10;;A61L2300/606;;C08L2203/02;;A61K31/565;;A61K9/1647;;A61K31/525;;A61K38/57;;A61K9/0051;;A61K31/165;;A61K9/5146;;A61K31/335;;C08L29/04;;C08L67/04;;Y10S977/915;;A61L31/145;;A61K33/30;;A61K31/337;;Y10S977/773;;A61K31/136;;A61K31/122;;A61L2430/36;;A61K31/426;;A61K45/06;;A61K31/57;;A61K31/702;;A61K9/0048;;C07C233/64;;A61K9/1635;;A61K31/203;;A61K9/5031;;A61K31/185;;A61K31/427;;A61K33/24;;A61K9/1641;;A61K9/14;;B82Y5/00,A61K9/14;;A61F2/02;;C07D305/14;;A61F2/06;;A61F2/84;;A61K9/00;;A61K9/16;;A61K9/50;;A61K9/51;;A61K9/70;;A61K31/122;;A61K31/136;;A61K31/175;;A61K31/185;;A61K31/19;;A61K31/203;;A61K31/335;;A61K31/337;;A61K31/519;;A61K31/57;;A61K33/24;;A61K38/00;;A61K38/55;;A61K38/57;;A61K45/00;;A61K45/06;;A61K47/30;;A61K47/32;;A61K47/34;;A61K47/36;;A61K47/42;;A61K47/48;;A61L27/34;;A61L27/54;;A61L31/00;;A61L31/08;;A61L31/10;;A61L31/14;;A61L31/16;;A61P1/04;;A61P1/16;;A61P7/04;;A61P9/00;;A61P11/00;;A61P13/02;;A61P27/02;;A61P35/00;;C07K14/81;;C08L23/08;;C08L29/04;;C08L67/04,424/501;;424/489;;424/499;;977/773;;977/915,4,0,,,"U.S. Appl. No. 12/817,682, filed Jun. 17, 2010, Hunter.;;U.S. Appl. No. 12/820,572, filed Jun. 22, 2010, Hunter, et al.;;U.S. Appl. No. 12/820,523, filed Jun. 22, 2010, Hunter.;;U.S. Appl. No. 12/820,614, filed Jun. 22, 2010, Hunter.",EXPIRED
691,ES,T3,ES 2856076 T3,123-051-056-883-800,2021-09-27,2021,ES 15740774 T,2015-01-21,US 201461929716 P;;US 201461944361 P;;US 201462021397 P;;US 2015/0012212 W,2014-01-21,Proteínas de unión a calicreína plasmática y usos de las mismas en el tratamiento de angioedema hereditario,"Un anticuerpo que se une a calicreína plasmática activa para su uso en un método de tratamiento de angioedema hereditario (HAE), comprendiendo el método administrar a un sujeto que lo necesita el anticuerpo en una cantidad eficaz de aproximadamente 300 mg cada dos semanas o cada cuatro semanas; en el que el anticuerpo comprende una región variable de la cadena pesada de SEQ ID NO: 3 y una región variable de la cadena ligera de SEQ ID NO: 4, en el que el anticuerpo es un anticuerpo de longitud completa.",TAKEDA PHARMACEUTICALS CO,CHYUNG YUNG;;SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;IARROBINO RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT,,https://lens.org/123-051-056-883-800,Granted Patent,no,0,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,A61K49/00;;A61K39/395;;C07K16/00;;G01N33/53,,0,0,,,,ACTIVE
692,EP,A1,EP 3456744 A1,024-298-080-994-741,2019-03-20,2019,EP 18186356 A,2014-01-17,US 201361754607 P;;EP 14740444 A;;US 2014/0012107 W,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,"The present disclosure provides methods of evaluating a subject, e.g., a subject at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder, based on values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject. Provided methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment. Such methods can involve the use of a detection agent that preferentially binds cleaved kininogen or intact kininogen.",DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-09-08),https://lens.org/024-298-080-994-741,Patent Application,yes,22,0,50,50,9,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40;;G01N33/50,,46,40,005-127-586-276-928;;144-602-947-164-877;;005-248-320-665-556;;019-467-602-686-96X;;006-297-863-625-283;;082-795-239-301-865;;164-277-261-420-791;;016-326-550-218-68X;;109-500-732-467-583;;049-134-753-209-354;;074-817-300-512-106;;017-150-654-990-340;;002-264-966-090-625;;005-248-320-665-556;;012-206-824-167-831;;092-845-354-377-772;;064-409-159-039-974;;014-581-174-616-945;;028-750-850-934-248;;093-508-528-510-043;;040-796-358-211-273;;045-864-048-030-411;;084-421-189-184-547;;050-668-089-586-400;;035-188-943-391-21X;;037-104-736-197-766;;018-144-967-742-095;;122-080-830-470-164;;050-507-714-041-493;;150-526-239-777-942;;069-863-076-076-464;;096-809-977-928-291;;038-056-207-283-274;;093-122-402-165-609;;038-535-940-466-805;;053-209-061-746-894;;028-862-168-091-90X;;030-451-543-728-673;;052-397-009-533-722;;035-188-943-391-21X,10.1021/bi00396a025;;2447941;;1727910;;10.1111/j.1365-2141.1984.tb03955.x;;6691922;;10.1016/0014-5793(81)80174-3;;6912817;;483270;;10.1016/0049-3848(79)90058-6;;10.1111/j.1476-5381.1989.tb12688.x;;pmc1854808;;2692754;;10.1160/th07-04-0250;;10.1056/nejmcp0803977;;18768946;;8605931;;10.1002/eji.1830260319;;10.1016/0022-2836(87)90412-8;;3681981;;10.1038/341544a0;;2677748;;3140379;;10.1126/science.3140379;;10.1073/pnas.85.16.5879;;3045807;;pmc281868;;10.1111/j.1365-2141.1984.tb03955.x;;6691922;;10.1182/blood.v74.2.695.695;;10.1182/blood.v74.2.695.bloodjournal742695;;2752143;;3501619;;10.1016/0049-3848(87)90434-8;;15306150;;10.1016/j.thromres.2004.05.005;;7654936;;10.1097/00001721-199505000-00005;;10.1093/rheumatology/41.1.38;;11792878;;10335742;;6639693;;10.1002/art.1780261107;;10.2210/pdb7pti/pdb;;10.1093/protein/3.7.591;;1699222;;2125487;;10.1021/bi00495a002;;10.1016/s0021-9258(18)68737-x;;2452157;;10.1038/338518a0;;2927510;;2553722;;10.1016/s0021-9258(18)51542-8;;3263966;;10.1016/s0021-9258(19)81329-7;;pmc43575;;10.1073/pnas.91.8.3353;;8159751;;10.1002/(sici)1097-0134(199707)28:3<405::aid-prot10>3.0.co;2-l;;9223186;;10.1016/0076-6879(90)83011-w;;2314273;;pmc305087;;10.1073/pnas.84.13.4355;;3474607;;8107089;;10.1006/jmbi.1994.1104;;pmc2142382;;10.1002/pro.5560020302;;8453370;;9600884;;pmc34487;;10.1073/pnas.95.11.5857;;0009600884;;pmc102444;;10592234;;10.1093/nar/28.1.231;;9847197;;10.1093/nar/27.1.263;;pmc148152;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;10.1016/s0097-8485(99)00011-x;;10404623;;10.1093/nar/30.1.235;;pmc99105;;11752303;;10.1038/338518a0;;2927510,"HIROSHI ISHIGURO ET AL: ""Mapping of functional domains of human high molecular weight and low molecular weight kininogens using murine monoclonal antibodies"", BIOCHEMISTRY, vol. 26, no. 22, 1 November 1987 (1987-11-01), US, pages 7021 - 7029, XP055534087, ISSN: 0006-2960, DOI: 10.1021/bi00396a025;;DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1992, SCOTT C F ET AL: ""SENSITIVE ANTIGENIC DETERMINATIONS OF HIGH MOLECULAR WEIGHT KININOGEN PERFORMED BY COVALENT COUPLING OF CAPTURE ANTIBODY"", XP002787402, Database accession no. PREV199293073204;;E M KERBIRIOU-NABIAS: ""British 1oumal o/ Hmmratolog!~ Radioimmunoassays of human high and low molecular weight kininogens in plasmas and platelets"", 2 January 1984 (1984-01-02), XP055534084, Retrieved from the Internet <URL:https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2141.1984.tb03955.x> [retrieved on 19840102];;SYVA@?NEN A C ET AL: ""A radioimmunoassay for the detection of molecular forms of human plasma kininogen"", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 129, no. 2, 6 July 1981 (1981-07-06), pages 241 - 245, XP025417051, ISSN: 0014-5793, [retrieved on 19810706], DOI: 10.1016/0014-5793(81)80174-3;;UCHIDA Y ET AL: ""Differential assay method for high molecular weight and low molecular weight kininogens"", THROMBOSIS RESEARCH, TARRYTOWN, NY, US, vol. 15, no. 1-2, 1 January 1979 (1979-01-01), pages 127 - 134, XP022876086, ISSN: 0049-3848, [retrieved on 19790101], DOI: 10.1016/0049-3848(79)90058-6;;MAKOTO KATORI ET AL: ""Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in anaesthetized rats"", BR. J. PHARMACOL, vol. 98, 1 January 1989 (1989-01-01), pages 1383 - 1391, XP055279078;;MYBIOSOURCE DATASHEET: ""Mouse High Molecular Weight Kininogen (HMWK) ELISA Kit (Cat.No: MBS089195)"", 2 January 1984 (1984-01-02) - 13 December 2018 (2018-12-13), XP002787403, Retrieved from the Internet <URL:https://www.mybiosource.com/prods/ELISA-Kit/Mouse/High-Molecular-Weight-Kininogen/HMWK/datasheet.php?products_id=89195> [retrieved on 20181213];;SAINZ I.M. ET AL., THROMB HAEMOST, vol. 98, 2007, pages 77 - 83;;ZURAW B.L. ET AL., N ENGL J MED, vol. 359, 2008, pages 1027 - 1036;;""Current Protocols in Molecular Biology"", 1989, JOHN WILEY & SONS, pages: 6.3.1 - 6.3.6;;DE WILDT ET AL., EUR J IMMUNOL., vol. 26, no. 3, 1996, pages 629 - 39;;KABAT, E.A. ET AL.: ""Sequences of Proteins of Immunological Interest"", 1991, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES;;CHOTHIA, C. ET AL., J. MOL. BIOL., vol. 196, 1987, pages 901 - 917;;WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546;;BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426;;HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 5879 - 5883;;KERBIRIOU-NABIAS, D.M., BR J HAEMATOL, vol. 56, no. 2, 1984, pages 2734 - 86;;REDDIGARI, S.R.; KAPLAN, A.P., BLOOD, vol. 74, 1999, pages 695 - 702;;SCOTT, C.F. ET AL., THROMB RES, vol. 48, no. 6, 1987, pages 685 - 700;;GALLIMORE, M.J. ET AL., THROMB RES, vol. 114, no. 2, 2004, pages 91 - 96;;BUHLER R. ET AL., BLOOD COAGUL FIBRINOLYSIS, vol. 6, no. 3, 1995, pages 223 - 232;;MCMILLAN, C.V. ET AL., PATIENT, vol. 5, no. 2, 2012, pages 113 - 26;;BARDWELL ET AL., RHEUMATOLOGY, vol. 41, no. 1, 2002, pages 38 - 45;;WARE ET AL., MED. CARE., vol. 37, 1999, pages 40 - 50;;MEENAN ET AL., ARTHRITIS RHEUM., vol. 35, no. 1, 1992, pages 1 - 10;;PINCUS ET AL., ARTHRITIS RHEUM, vol. 26, no. 11, 1983, pages 1346 - 53;;EIGENBROT ET AL., PROTEIN ENGINEERING, vol. 3, no. 7, 1990, pages 591 - 598;;HYNES ET AL., BIOCHEMISTRY, vol. 29, 1990, pages 10018 - 10022;;WUN ET AL., J. BIOL. CHEM., vol. 263, no. 13, 1988, pages 6001 - 6004;;GIRARD ET AL., NATURE, vol. 338, 1989, pages 518 - 20;;NOVOTNY ET AL., J. BIOL. CHEM., vol. 264, no. 31, 1989, pages 18832 - 18837;;KIDO ET AL., J. BIOL. CHEM., vol. 263, no. 34, 1988, pages 18104 - 18107;;SPRECHER ET AL., PNAS USA, vol. 91, 1994, pages 3353 - 3357;;SONHAMMER ET AL., PROTEINS, vol. 28, no. 3, 1997, pages 405 - 420;;GRIBSKOV ET AL., METH. ENZYMOL., vol. 183, 1990, pages 146 - 159;;GRIBSKOV ET AL., PROC. NATL. ACAD. SCI. USA, vol. 84, 1987, pages 4355 - 4358;;KROGH ET AL., J. MOL. BIOL., vol. 235, 1994, pages 1501 - 1531;;STULTZ ET AL., PROTEIN SCI., vol. 2, 1993, pages 305 - 314;;SCHULTZ ET AL., PROC. NATL. ACAD. SCI. USA, vol. 95, 1998, pages 5857;;SCHULTZ ET AL., NUCL. ACIDS RES, vol. 28, 2000, pages 231;;R. DURBIN ET AL.: ""Biological sequence analysis: probabilistic models of proteins and nucleic acids"", 1998, CAMBRIDGE UNIVERSITY PRESS;;CORPET ET AL., NUCL. ACIDS RES., vol. 27, 1999, pages 263 - 267;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402;;GOUZY ET AL., COMPUTERS AND CHEMISTRY, vol. 23, 1999, pages 333 - 340;;FALQUET ET AL., NUCLEIC ACIDS RES., vol. 30, 2002, pages 235 - 238;;GIRARD, T. ET AL., NATURE, vol. 338, 1989, pages 518 - 520",ACTIVE
693,BR,B1,BR 112016016916 B1,061-068-197-290-121,2023-12-19,2023,BR 112016016916 A,2015-01-21,US 2015/0012212 W;;US 201461929716 P;;US 201461944361 P;;US 201462021397 P,2014-01-21,Uso de um anticorpo que se liga à calicreína plasmática ativa para tratamento de angiodema hereditário (hae),"uso de um anticorpo que se liga à calicreína plasmática ativa para tratamento de angiodema hereditário (hae). proteínas de ligação de calicreína plasmática, tais como anticorpos de ligação para ativar calicreína plasmática e métodos de utilização dessas proteínas no tratamento do angioedema hereditário são providos neste documento.",DYAX CORP;;TAKEDA PHARMACEUTICALS CO,ADELMAN BURT;;TENHOOR CHRISTOPHER;;DANIEL J SEXTON;;JON A KENNISTON;;BIEDENKAPP JOSEPH;;FAUCETTE RYAN;;IARROBINO RYAN;;CHYUNG YUNG,TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) (2021-10-05);;DYAX CORP. (US) (2018-08-28),https://lens.org/061-068-197-290-121,Granted Patent,no,0,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,A61K39/395;;A61K49/00;;C07K16/00;;G01N33/53,,0,0,,,,ACTIVE
694,AU,B2,AU 2015/209481 B2,174-127-044-103-692,2020-07-30,2020,AU 2015/209481 A,2015-01-21,US 201461944361 P;;US 201462021397 P;;US 201461929716 P;;US 2015/0012212 W,2014-01-21,Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema,Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.,DYAX CORP,CHYUNG YUNG;;SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;IARROBINO RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/174-127-044-103-692,Granted Patent,no,1,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,C07K16/00;;A61K39/395;;A61K49/00;;G01N33/53,,2,0,,,"SEXTON DANIEL ET AL, JOURNAL OF ALLERGY AND CLINICAL IMMUNO, ELSEVIER, AMSTERDAM, NL, (2013-02-26), vol. 131, no. 2, Suppl. S, doi:10.1016/J.JACI.2012.12.795, ISSN 0091-6749, page AB32;;Ubc, ""Dyax's DX-2930 granted Orphan Drug designation in hereditary angioedema"", (2013-12-06), URL: http://www.ubc.com/dyaxs-dx-2930-granted-orphan-drug-designation-hereditary-angioedema, (2017-07-06)",ACTIVE
695,JP,A,JP 2019055975 A,034-016-365-140-824,2019-04-11,2019,JP 2018221155 A,2018-11-27,US 201361754607 P,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,"To provide: methods of evaluating a subject, e.g., a subject at risk for or suffering from a plasma kallikrein (pKal)-mediated or bradykinin-mediated disorder, on the basis of values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject, where the methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA) or other diseases mediated by pKal useful in evaluation and treatment, where the methods can involve the use of a detection agent that preferentially binds cleaved kininogen or intact kininogen; and pharmaceutical compositions relating to the methods.SOLUTION: There is provided a pharmaceutical composition for use in treating a pKal-mediated disease of a subject, the composition comprising a pKal inhibitor and a pharmaceutically acceptable carrier, the subject having values of cleaved kininogen and/or intact kininogen deviated from reference values.SELECTED DRAWING: None",DYAX CORP,DANIEL J SEXTON;;RYAN FAUCETTE;;JON A KENNISTON;;GREG CONLEY;;NIXON ANDREW;;CHRISTOPHER TENHOOR;;BURT ADELMAN;;CHYUNG YUNG,,https://lens.org/034-016-365-140-824,Patent Application,no,1,0,50,50,9,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,A61K45/00;;A61P1/04;;A61P7/10;;A61P9/00;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00,,2,1,004-479-946-889-393,11150653;;10.1016/s0196-9781(00)00348-x,"BLAIS, C. ET AL.: ""The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins"", PEPTIDES, vol. 21, no. 12, JPN6017046579, December 2000 (2000-12-01), pages 1903 - 1940, XP055279044, ISSN: 0004156576, DOI: 10.1016/S0196-9781(00)00348-X;;SEXTON D, ET AL.: ""Discovery and Characterization of a Fully Human Monoclonal Antibody Inhibitor of Plasma Kallikrein f"", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. Vol.131, No.2, Suppl., JPN6018033787, February 2013 (2013-02-01), pages 32, ISSN: 0004156577",ACTIVE
696,CN,A,CN 106132442 A,102-116-364-882-060,2016-11-16,2016,CN 201580010172 A,2015-01-21,US 201461929716 P;;US 201461944361 P;;US 201462021397 P;;US 2015/0012212 W,2014-01-21,Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema,Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.,DYAX CORP,CHYUNG YUNG;;SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;LARROBINO RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT,,https://lens.org/102-116-364-882-060,Patent Application,no,5,6,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,A61K49/00;;A61K39/395;;C07K16/00;;G01N33/53,,2,0,,,"汤蕊;张宏誉;: ""遗传性血管性水肿的治疗"", 中华临床免疫和变态反应杂志;;江建雄;郑敏;: ""遗传性血管性水肿的研究进展"", 国际皮肤性病学杂志",ACTIVE
697,EP,A3,EP 0679693 A3,135-226-916-994-314,1997-12-10,1997,EP 95302666 A,1995-04-21,US 23319594 A,1994-04-26,Processes for the preparation of alkoxy-bridged metallophthalocyanine dimers.,"A process for the preparation of alkoxy-bridged metallophthalocyanine dimers by the reaction of a trivalent metal compound with ortho-phthalodinitrile or 1,3-diiminoisoindoline in the presence of a diol.",XEROX CORP,BURT RICHARD A;;LIEBERMANN GEORGE;;HAMER GORDON K;;GARDNER SANDRA J;;JENNINGS CAROL A;;DAIMON KATSUMI;;NUKADA KATSUMI,,https://lens.org/135-226-916-994-314,Search Report,yes,6,0,8,8,0,C07D519/00;;C07D519/00;;C09B47/067;;C09B47/067;;C09B47/073;;C09B47/073,G03G5/06;;C07D487/22;;C07D519/00;;C09B47/04;;C09B47/067;;C09B47/073,,2,0,,,"DATABASE WPI Section Ch Week 9415, Derwent World Patents Index; Class E23, AN 94-124213, XP002043402;;DATABASE WPI Section Ch Week 9347, Derwent World Patents Index; Class A89, AN 93-371652, XP002043303",EXPIRED
698,JP,A,JP 2021008483 A,125-180-821-341-317,2021-01-28,2021,JP 2020164435 A,2020-09-30,US 201361754607 P,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,"To provide pharmaceutical compositions for use in treating a plasma kallikrein (pKal)-mediated disorder in a subject identified as being at risk for or having the plasma kallikrein (pKal)-mediated disorder.SOLUTION: A pharmaceutical composition comprises a plasma kallikrein (pKal) inhibitor, which is DX-2930 or DX-88, and a pharmaceutically acceptable carrier.SELECTED DRAWING: Figure 1",DYAX CORP,DANIEL J SEXTON;;RYAN FAUCETTE;;JON A KENNISTON;;GREG CONLEY;;NIXON ANDREW;;CHRISTOPHER TENHOOR;;BURT ADELMAN;;CHYUNG YUNG,,https://lens.org/125-180-821-341-317,Patent Application,no,1,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,A61K45/00;;A61K39/395;;A61P9/00;;A61P19/02;;A61P43/00;;G01N33/53,,1,1,004-479-946-889-393,11150653;;10.1016/s0196-9781(00)00348-x,"BLAIS, C. ET AL.: ""The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins"", PEPTIDES, vol. 21, no. 12, JPN6017046579, December 2000 (2000-12-01), pages 1903 - 1940, XP055279044, ISSN: 0004583056, DOI: 10.1016/S0196-9781(00)00348-X",PENDING
699,DE,T2,DE 69522847 T2,013-119-405-413-517,2002-03-28,2002,DE 69522847 T,1995-04-21,US 23943294 A,1994-04-26,Alkoxyüberbrückte Dimere von Metallphthalocyaninen,,XEROX CORP,BURT RICHARD A;;LEIBERMANN GEORGE;;HAMER GORDON K;;GARDNER SANDRA J;;JENNINGS CAROL A;;DAIMON KATSUMI;;NUKADA KATSUMI,,https://lens.org/013-119-405-413-517,Granted Patent,no,0,0,9,9,0,C07D519/00;;C07D519/00;;C09B47/067;;C09B47/067;;C09B47/073;;C09B47/073;;G03G5/0696;;G03G5/0696,C07D487/22;;C07D519/00;;C09B47/04;;C09B47/067;;C09B47/073;;G03G5/06,,0,0,,,,EXPIRED
700,EP,A3,EP 4234583 A3,093-402-020-037-990,2024-01-24,2024,EP 23164279 A,2014-01-17,US 201361754607 P;;EP 18186356 A;;EP 14740444 A;;US 2014/0012107 W,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,"The present disclosure provides methods of evaluating a subject, e.g., a subject at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder, based on values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject. Provided methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment. Such methods can involve the use of a detection agent that preferentially binds cleaved kininogen or intact kininogen.",TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,,https://lens.org/093-402-020-037-990,Search Report,yes,2,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40;;C07K16/00;;C12Q1/56;;G01N33/50,,5,5,073-525-752-096-501;;082-795-239-301-865;;005-601-797-966-73X;;109-028-520-036-638;;010-233-793-836-422,10.1111/j.1651-2227.2011.02266.x;;21401717;;10.1111/j.1476-5381.1989.tb12688.x;;pmc1854808;;2692754;;10.1023/a:1018891323205;;9398817;;2651524;;10.1016/0022-1759(89)90376-1;;pmc3477304;;10.1002/art.34607;;22739815,"ROBIN KAHN ET AL: ""Kinin system activation in vasculitis*"", ACTA PAEDIATRICA, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 100, no. 7, 8 April 2011 (2011-04-08), pages 950 - 957, XP071699386, ISSN: 0803-5253, DOI: 10.1111/J.1651-2227.2011.02266.X;;MAKOTO KATORI ET AL: ""Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in anaesthetized rats"", BR. J. PHARMACOL, vol. 98, 1 January 1989 (1989-01-01), pages 1383 - 1391, XP055279078;;STADNICKI A ET AL: ""Activation of plasma contact and coagulation systems and neutrophils in the active phase of ulcerative colitis"", DIGESTIVE DISEASES AND SCIENCES., vol. 42, no. 11, 1 November 1997 (1997-11-01), US, pages 2356 - 2366, XP093081661, ISSN: 0163-2116, DOI: 10.1023/A:1018891323205;;REDDIGARI S ET AL: ""Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody"", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 119, no. 1, 21 April 1989 (1989-04-21), pages 19 - 25, XP023656916, ISSN: 0022-1759, [retrieved on 19890421], DOI: 10.1016/0022-1759(89)90376-1;;JIHONG DAI ET AL: ""Role of plasma kallikrein-kinin system activation in synovial recruitment of endothelial progenitor cells in experimental arthritis"", ARTHRITIS & RHEUMATISM, vol. 64, no. 11, 1 November 2012 (2012-11-01), pages 3574 - 3582, XP055061608, ISSN: 0004-3591, DOI: 10.1002/art.34607",PENDING
701,CA,C,CA 2147785 C,103-459-414-391-683,1999-04-06,1999,CA 2147785 A,1995-04-25,US 23943294 A,1994-04-26,ALKOXY-BRIDGED METALLOPHTHALOCYANINE DIMERS,"Alkoxy-bridged metallophthalocyanine dimers of the formula C32H16N8MOROMN8H16C32, or of the formula <IMG> wherein M is a metal, and R is an alkyl or an alkyl ether.",XEROX CORP,BURT RICHARD A;;LIEBERMANN GEORGE;;HAMER GORDON K;;GARDNER SANDRA J;;JENNINGS CAROL A;;DAIMON KATSUMI;;NUKADA KATSUMI,,https://lens.org/103-459-414-391-683,Granted Patent,no,0,0,9,9,0,C07D519/00;;C07D519/00;;C09B47/067;;C09B47/067;;C09B47/073;;C09B47/073;;G03G5/0696;;G03G5/0696,C07D487/22;;C07D519/00;;C09B47/04;;C09B47/067;;C09B47/073;;G03G5/06,,0,0,,,,EXPIRED
702,BR,A8,BR 112015016231 A8,141-981-092-607-399,2019-10-29,2019,BR 112015016231 A,2014-01-17,US 2014/0012107 W;;US 201361754607 P,2013-01-20,"método para identificar um sujeito em risco de ou tendo um distúrbio mediado por pkal, método para avaliar um tratamento de um distúrbio mediado por pkal em um sujeito, método para tratar uma doença mediada por pkal, composição farmacêutica para uso no tratamento de uma doença mediada por pkal de um sujeito e método para determinar um valor de cininogênio clivado, cininogênio intacto ou ambos, em uma amostra","método para identificar um sujeito em risco de ou tendo um distúrbio mediado por pkal, método para determinar se um distúrbio é suscetível ao tratamento com um inibidor de pkal, método para avaliar um tratamento de um distúrbio mediado por pkal em um sujeito, método para tratar uma doença mediada por pkal, composição farmacêutica para uso no tratamento de uma doença mediada por pkal de um sujeito e método para determinar um valor de cininogênio clivado, cininogênio intacto ou ambos, em uma amostra a presente divulgação provê métodos para avaliar um sujeito, por exemplo, um sujeito em risco de ou sofrendo de um distúrbio mediado por pkal ou mediado por bradicinina, com base nos valores (por exemplo, porcentagens) de cininogênio intacto e/ou clivado em uma amostra do sujeito. métodos providos admitem análise de pacientes com angioedema mediada por calicreína plasmática (kma) ou outras doenças mediadas por pkal úteis na avaliação e tratamento. tais métodos podem envolver o uso de um agente de detecção que liga preferencialmente cininogênio clivado ou cininogênio intacto.",DYAX CORP,ANDREW NIXON;;BURT ADELMAN;;CHRISTOPHER TENHOOR;;DANIEL J SEXTON;;GREG CONLEY;;JON A KENNISTON;;RYAN FAUCETTE;;YUNG CHYUNG,TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) (2021-10-05);;DYAX CORP. (US) (2018-08-28),https://lens.org/141-981-092-607-399,Patent Application,no,0,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,0,0,,,,PENDING
703,EP,A4,EP 3096798 A4,170-544-985-220-921,2017-08-23,2017,EP 15740774 A,2015-01-21,US 201461929716 P;;US 201461944361 P;;US 201462021397 P;;US 2015/0012212 W,2014-01-21,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA,,DYAX CORP,CHYUNG YUNG;;SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;IARROBINO RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT,"TAKEDA PHARMACEUTICAL COMPANY LIMITED, JP (2022-07-06);;TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-09-08);;DYAX CORP. (2018-06-20);;TAKEDA PHARMACEUTICAL COMPANY LIMITED; JP (2021-11-05)",https://lens.org/170-544-985-220-921,Search Report,no,1,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,A61K49/00;;A61K39/395;;C07K16/00;;G01N33/53,,6,2,126-568-744-168-22X;;117-771-661-619-643,10.1016/j.jaci.2012.12.795;;10.1016/j.jaci.2007.07.057;;18241690,"UBC: ""Dyax's DX-2930 granted Orphan Drug designation in hereditary angioedema"", 6 December 2013 (2013-12-06), XP055388561, Retrieved from the Internet <URL:http://www.ubc.com/dyaxs-dx-2930-granted-orphan-drug-designation-hereditary-angioedema> [retrieved on 20170706];;DANIEL J SEXTON ET AL: ""Comparison Of Plasma Kallikrein Inhibition By The Endogenous C1-Inhibitor Versus DX-2930, a Monoclonal Antibody Inhibitor"", BLOOD, 5 December 2013 (2013-12-05), XP055388434, Retrieved from the Internet <URL:http://www.bloodjournal.org/content/122/21/1066> [retrieved on 20170706];;SEXTON DANIEL ET AL: ""Discovery and Characterization of a Fully Human Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Treatment of Plasma Kallikrein-Mediated Edema"", JOURNAL OF ALLERGY AND CLINICAL IMMUNO, ELSEVIER, AMSTERDAM, NL, vol. 131, no. 2, Suppl. S, 26 February 2013 (2013-02-26), pages AB32, XP009169342, ISSN: 0091-6749, DOI: 10.1016/J.JACI.2012.12.795;;JON A KENNISTON ET AL: ""Discovery and Characterization Of a Highly Specific Antibody Inhibitor Of Plasma Kallikrein"", 5 December 2013 (2013-12-05), XP055388440, Retrieved from the Internet <URL:http://www.bloodjournal.org/content/122/21/1067> [retrieved on 20170706];;FRANK ET AL: ""8. Hereditary angioedema"", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 121, no. 2, 29 January 2008 (2008-01-29), pages S398 - S401, XP022431817, ISSN: 0091-6749, DOI: 10.1016/J.JACI.2007.07.057;;See also references of WO 2015112578A1",ACTIVE
704,CN,A,CN 105073778 A,186-483-038-342-968,2015-11-18,2015,CN 201480005158 A,2014-01-17,US 2014/0012107 W;;US 201361754607 P,2013-01-20,Evaluation and treatment of bradykinin-mediated disorders,"The present disclosure provides methods of evaluating a subject, e.g., a subject at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder, based on values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject. Provided methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment. Such methods can involve the use of a detection agent that preferentially binds cleaved kininogen or intact kininogen.",DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,,https://lens.org/186-483-038-342-968,Patent Application,no,0,4,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,3,3,042-513-826-438-891;;117-939-959-946-344;;004-479-946-889-393,19124682;;10.1161/hypertensionaha.108.117663;;pmc4978181;;10.1016/0022-1759(94)00320-v;;7714339;;11150653;;10.1016/s0196-9781(00)00348-x,"JOANNA A. PHIPPS ET AL.,: ""Plasma Kallikrein Mediates Angiotensin II Type 1 Receptor–Stimulated Retinal Vascular Permeability"", 《HYPERTENSION》;;RAYMOND P ET AL.,: ""Quantification of des-Arg 9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation"", 《JOURNAL OF IMMUNOLOGICAL METHODS》;;CHARLES BLAIS ET AL.,: ""The kallikrein-kininogen-kinin system: lessons from the quantification fo endogenous kinins"", 《PEPTIDES》",ACTIVE
705,CA,A1,CA 2620159 A1,189-163-901-821-983,2007-03-01,2007,CA 2620159 A,2006-08-21,US 71018805 P;;US 33134306 A;;US 2006/0032541 W,2005-08-23,MACHINE VISION COUNTING SYSTEM APPARATUS AND METHOD,"A machine-vision-based counter includes an image acquisition component (imager), wherein light provides discrimination between a background field a nd imageable units located away from the imager. The imager outputs data representing the field and units; an image processor receiving imager data finds countable units therein. An operator interface accepts command inputs and presents count output. A controller manages image acquisition, processor , and operator interface functions. A counting method includes configuring an imager to detect light, directing light from a source to units positioned to be detected by the imager, and directing the light to the imager. The method includes discriminating between a background field and imageable units; providing, as an imager output, data representing the field and units; configuring the processor to interpret the data as counted units on a background field; and configuring an operator interface to present a count result.",SPX CORP,TARR NELSON D;;LIMER DANIEL J;;LANG DAVID A;;GOUIN PHILIP R;;BURT CHRISTOPHER S;;DISCHINGER RANDALL D,,https://lens.org/189-163-901-821-983,Patent Application,no,0,0,6,6,0,A61J7/02;;G01N2015/1472;;G01N2015/1486;;G06M1/101;;G06M11/00;;G06V20/66;;G01N15/1433;;A61J7/02;;G01N2015/1486;;G01N2015/1472;;G06M1/101;;G06M11/00;;G01N15/1433,G03G15/00,,0,0,,,,ACTIVE
706,BR,A8,BR 112016016916 A8,192-525-017-140-021,2018-05-02,2018,BR 112016016916 A,2015-01-21,US 2015/0012212 W;;US 201461929716 P;;US 201461944361 P;;US 201462021397 P,2014-01-21,uso de um anticorpo que se liga à calicreína plasmática ativa para tratamento de angiodema hereditário (hae),"proteínas de ligação de calicreína plasmática, tais como anticorpos de ligação para ativar calicreína plasmática e métodos de utilização dessas proteínas no tratamento do angioedema hereditário são providos neste documento.",DYAX CORP,BURT ADELMAN;;CHRISTOPHER TENHOOR;;DANIEL J SEXTON;;JON A KENNISTON;;JOSEPH BIEDENKAPP;;RYAN FAUCETTE;;RYAN LARROBINO;;YUNG CHYUNG,TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) (2021-10-05);;DYAX CORP. (US) (2018-08-28),https://lens.org/192-525-017-140-021,Patent Application,no,0,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,A61K39/395;;A61K49/00;;C07K16/00;;G01N33/53,,0,0,,,,ACTIVE
707,WO,A3,WO 2007/024760 A3,014-418-196-838-303,2009-04-16,2009,US 2006/0032541 W,2006-08-21,US 71018805 P;;US 33134306 A,2005-08-23,MACHINE VISION COUNTING SYSTEM APPARATUS AND METHOD,"A machine-vision-based counter includes an image acquisition component (imager), wherein light provides discrimination between a background field and imageable units located away from the imager. The imager outputs data representing the field and units; an image processor receiving imager data finds countable units therein. An operator interface accepts command inputs and presents count output. A controller manages image acquisition, processor, and operator interface functions. A counting method includes configuring an imager to detect light, directing light from a source to units positioned to be detected by the imager, and directing the light to the imager. The method includes discriminating between a background field and imageable units; providing, as an imager output, data representing the field and units; configuring the processor to interpret the data as counted units on a background field; and configuring an operator interface to present a count result.",SPX CORP;;LIMER DANIEL J;;LANG DAVID A;;BURT CHRISTOPHER S;;GOUIN PHILIP R;;TARR NELSON D;;DISCHINGER RANDALL D,LIMER DANIEL J;;LANG DAVID A;;BURT CHRISTOPHER S;;GOUIN PHILIP R;;TARR NELSON D;;DISCHINGER RANDALL D,,https://lens.org/014-418-196-838-303,Search Report,yes,3,0,6,6,0,A61J7/02;;G01N2015/1472;;G01N2015/1486;;G06M1/101;;G06M11/00;;G06V20/66;;G01N15/1433;;A61J7/02;;G01N2015/1486;;G01N2015/1472;;G06M1/101;;G06M11/00;;G01N15/1433,H01L21/00,,0,0,,,,PENDING
708,HK,A1,HK 1215266 A1,010-040-677-832-749,2016-08-19,2016,HK 16103203 A,2016-03-18,US 2014/0012107 W;;US 201361754607 P,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,,https://lens.org/010-040-677-832-749,Patent Application,no,0,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K/,,0,0,,,,PENDING
709,WO,A1,WO 2014/113712 A1,071-841-727-913-698,2014-07-24,2014,US 2014/0012107 W,2014-01-17,US 201361754607 P,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,"The present disclosure provides methods of evaluating a subject, e.g., a subject at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder, based on values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject. Provided methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment. Such methods can involve the use of a detection agent that preferentially binds cleaved kininogen or intact kininogen.",DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,,https://lens.org/071-841-727-913-698,Patent Application,yes,25,40,50,50,9,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,43,37,042-513-826-438-891;;042-513-826-438-891;;133-940-816-817-578;;164-277-261-420-791;;016-326-550-218-68X;;109-500-732-467-583;;049-134-753-209-354;;074-817-300-512-106;;017-150-654-990-340;;002-264-966-090-625;;005-248-320-665-556;;012-206-824-167-831;;092-845-354-377-772;;064-409-159-039-974;;014-581-174-616-945;;028-750-850-934-248;;093-508-528-510-043;;040-796-358-211-273;;045-864-048-030-411;;084-421-189-184-547;;050-668-089-586-400;;035-188-943-391-21X;;037-104-736-197-766;;018-144-967-742-095;;122-080-830-470-164;;050-507-714-041-493;;150-526-239-777-942;;069-863-076-076-464;;096-809-977-928-291;;038-056-207-283-274;;093-122-402-165-609;;038-535-940-466-805;;053-209-061-746-894;;028-862-168-091-90X;;030-451-543-728-673;;052-397-009-533-722;;035-188-943-391-21X,19124682;;10.1161/hypertensionaha.108.117663;;pmc4978181;;19124682;;10.1161/hypertensionaha.108.117663;;pmc4978181;;11099478;;10.1096/fj.99-1025com;;10.1160/th07-04-0250;;10.1056/nejmcp0803977;;18768946;;8605931;;10.1002/eji.1830260319;;10.1016/0022-2836(87)90412-8;;3681981;;10.1038/341544a0;;2677748;;3140379;;10.1126/science.3140379;;10.1073/pnas.85.16.5879;;3045807;;pmc281868;;10.1111/j.1365-2141.1984.tb03955.x;;6691922;;10.1182/blood.v74.2.695.695;;10.1182/blood.v74.2.695.bloodjournal742695;;2752143;;3501619;;10.1016/0049-3848(87)90434-8;;15306150;;10.1016/j.thromres.2004.05.005;;7654936;;10.1097/00001721-199505000-00005;;10.1093/rheumatology/41.1.38;;11792878;;10335742;;6639693;;10.1002/art.1780261107;;10.2210/pdb7pti/pdb;;10.1093/protein/3.7.591;;1699222;;2125487;;10.1021/bi00495a002;;10.1016/s0021-9258(18)68737-x;;2452157;;10.1038/338518a0;;2927510;;2553722;;10.1016/s0021-9258(18)51542-8;;3263966;;10.1016/s0021-9258(19)81329-7;;pmc43575;;10.1073/pnas.91.8.3353;;8159751;;10.1002/(sici)1097-0134(199707)28:3<405::aid-prot10>3.0.co;2-l;;9223186;;10.1016/0076-6879(90)83011-w;;2314273;;pmc305087;;10.1073/pnas.84.13.4355;;3474607;;8107089;;10.1006/jmbi.1994.1104;;pmc2142382;;10.1002/pro.5560020302;;8453370;;9600884;;pmc34487;;10.1073/pnas.95.11.5857;;0009600884;;pmc102444;;10592234;;10.1093/nar/28.1.231;;9847197;;10.1093/nar/27.1.263;;pmc148152;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;10.1016/s0097-8485(99)00011-x;;10404623;;10.1093/nar/30.1.235;;pmc99105;;11752303;;10.1038/338518a0;;2927510,"PHIPPS ET AL.: ""Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability."", HYPERTENSION, vol. 53, no. 2, 5 January 2009 (2009-01-05), pages 175 - 181, XP055036001;;PHIPPS ET AL., HYPERTENSION, vol. 53, no. 2, February 2009 (2009-02-01), pages 175 - 81;;ZHANG ET AL., FASEB J., vol. 14, no. 15, December 2000 (2000-12-01), pages 2589 - 600;;SAINZ I.M. ET AL., THROMB HAEMOST, vol. 98, 2007, pages 77 - 83;;ZURAW B.L. ET AL., N ENGL J MED, vol. 359, 2008, pages 1027 - 1036;;""Current Protocols in Molecular Biology"", 1989, JOHN WILEY & SONS, pages: 6.3.1 - 6.3.6;;WILDT ET AL., EUR J IMMUNOL., vol. 26, no. 3, 1996, pages 629 - 39;;KABAT, E.A. ET AL.: ""Sequences of Proteins of Immunological Interest"", 1991, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, NIH PUBLICATION;;CHOTHIA, C. ET AL., J. MOL. BIOL., vol. 196, 1987, pages 901 - 917;;WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546;;BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426;;HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 5879 - 5883;;KERBIRIOU-NABIAS, D.M., BR J HAEMATOL, vol. 56, no. 2, 1984, pages 2734 - 86;;REDDIGARI, S.R.; KAPLAN, A.P., BLOOD, vol. 74, 1999, pages 695 - 702;;SCOTT, C.F. ET AL., THROMB RES, vol. 48, no. 6, 1987, pages 685 - 700;;GALLIMORE, M.J. ET AL., THROMB RES, vol. 114, no. 2, 2004, pages 91 - 96;;BUHLER R. ET AL., BLOOD COAGUL FIBRINOLYSIS, vol. 6, no. 3, 1995, pages 223 - 232;;MCMILLAN, C.V. ET AL., PATIENT., vol. 5, no. 2, 2012, pages 113 - 26;;BARDWELL ET AL., RHEUMATOLOGY, vol. 41, no. l, 2002, pages 38 - 45;;WARE ET AL., MED. CARE., vol. 37, no. 5, 1999, pages MS40 - 50;;MEENAN ET AL., ARTHRITIS RHEUM., vol. 35, no. 1, 1992, pages 1 - 10;;PINCUS ET AL., ARTHRITIS RHEUM., vol. 26, no. 11, 1983, pages 1346 - 53;;EIGENBROT ET AL., PROTEIN ENGINEERING, vol. 3, no. 7, 1990, pages 591 - 598;;HYNES ET AL., BIOCHEMISTRY, vol. 29, 1990, pages 10018 - 10022;;WUN ET AL., J. BIOL. CHEM., vol. 263, no. 13, 1988, pages 6001 - 6004;;GIRARD ET AL., NATURE, vol. 338, 1989, pages 518 - 20;;NOVOTNY ET AL., J. BIOL. CHEM., vol. 264, no. 31, 1989, pages 18832 - 18837;;KIDO ET AL., J. BIOL. CHEM., vol. 263, no. 34, 1988, pages 18104 - 18107;;SPRECHER ET AL., PNAS USA, vol. 91, 1994, pages 3353 - 3357;;SONHAMMER ET AL., PROTEINS, vol. 28, no. 3, 1997, pages 405 - 420;;GRIBSKOV ET AL., METH. ENZYMOL., vol. 183, 1990, pages 146 - 159;;GRIBSKOV ET AL., PROC. NATL. ACAD. SCI. USA, vol. 84, 1987, pages 4355 - 4358;;KROGH ET AL., J. MOL. BIOL., vol. 235, 1994, pages 1501 - 1531;;STULTZ ET AL., PROTEIN SCI., vol. 2, 1993, pages 305 - 314;;SCHULTZ ET AL., PROC. NATL. ACAD.SCI. USA, vol. 95, 1998, pages 5857;;SCHULTZ ET AL., NUCL. ACIDS RES, vol. 28, 2000, pages 231;;R. DURBIN ET AL.: ""Biological sequence analysis: probabilistic models of proteins and nucleic acids"", 1998, CAMBRIDGE UNIVERSITY PRESS;;CORPET ET AL., NUCL. ACIDS RES., vol. 27, 1999, pages 263 - 267;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402;;GOUZY ET AL., COMPUTERS AND CHEMISTRY, vol. 23, 1999, pages 333 - 340;;FALQUET ET AL., NUCLEIC ACIDS RES., vol. 30, 2002, pages 235 - 238;;GIRARD, T. ET AL., NATURE, vol. 338, 1989, pages 518 - 520;;See also references of EP 2948479A4",PENDING
710,KR,A,KR 20220045992 A,074-310-054-939-573,2022-04-13,2022,KR 20227010217 A,2014-01-17,US 201361754607 P;;KR 20217000831 A;;US 2014/0012107 W,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,"본 개시내용은 대상체의 샘플에서 온전한 키니노겐 및/또는 개열된 키니노겐의 값(예를 들어, 백분율)에 기초하여 대상체, 예를 들어 pKal 매개 또는 브래디키닌 매개 장애의 위험이 있거나 이를 앓고 있는 대상체를 평가하는 방법을 제공한다. 제공된 방법은 혈장 칼리크레인 매개 혈관 부종(KMA), 또는 평가 및 치료에서 유용한 pKal에 의해 매개되는 다른 질환을 갖는 환자의 분석을 허용한다. 이러한 방법은 개열된 키니노겐 또는 온전한 키니노겐에 우선적으로 결합하는 검출제의 사용을 포함할 수 있다.",DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,,https://lens.org/074-310-054-939-573,Patent Application,no,2,0,50,50,18,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,G01N33/68;;A61K38/00;;A61K39/00,,1,1,092-309-561-609-370,2433279;;10.1016/s0021-9258(19)75800-1,"Alvin H. Schmaier et al., 'Determination of the Bifunctional Properties of High Molecular Weight Kininogen by Studies with Monoclonal Antibodies Directed to Each of Its Chains', JBC, 1987, Vol. 262, p*",ACTIVE
711,CA,C,CA 2897336 C,073-908-885-101-835,2023-10-17,2023,CA 2897336 A,2014-01-17,US 201361754607 P;;US 2014/0012107 W,2013-01-20,EVALUATION AND TREATMENT OF PKAL-MEDIATED DISORDERS,"The present disclosure provides methods of evaluating a subject, e.g., a subject at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder, based on values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject. Provided methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment. Such methods can involve the use of a detection agent that preferentially binds cleaved kininogen or intact kininogen.",DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,,https://lens.org/073-908-885-101-835,Granted Patent,no,0,0,50,50,9,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C12Q1/37,,0,0,,,,PENDING
712,SI,T1,SI 2948479 T1,098-629-970-351-439,2019-01-31,2019,SI 201430933 T,2014-01-17,US 201361754607 P;;US 2014/0012107 W;;EP 14740444 A,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,,https://lens.org/098-629-970-351-439,Granted Patent,no,0,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/00,,0,0,,,,ACTIVE
713,BR,A2,BR 112015016231 A2,128-665-130-620-514,2017-07-11,2017,BR 112015016231 A,2014-01-17,US 2014/0012107 W;;US 201361754607 P,2013-01-20,"método para identificar um sujeito em risco de ou tendo um distúrbio mediado por pkal , método para determinar se um distúrbio é suscetível ao tratamento com um inibidor de pkal , método para avaliar um tratamento de um distúrbio mediado por pkal em um sujeito , método para tratar uma doença mediada por pkal , composição farmacêutica para uso no tratamento de uma doença mediada por pkal de um sujeito e método para determinar um valor de cininogênio clivado , cininogênio intacto ou ambos , em ma amostra",,DYAX CORP,ANDREW NIXON;;BURT ADELMAN;;CHRISTOPHER TENHOOR;;DANIEL J SEXTON;;GREG CONLEY;;JON A KENNISTON;;RYAN FAUCETTE;;YUNG CHYUNG,TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) (2021-10-05);;DYAX CORP. (US) (2018-08-28),https://lens.org/128-665-130-620-514,Patent Application,no,0,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,0,0,,,,PENDING
714,EP,B1,EP 3096798 B1,048-170-835-945-955,2020-11-25,2020,EP 15740774 A,2015-01-21,US 201461929716 P;;US 201461944361 P;;US 201462021397 P;;US 2015/0012212 W,2014-01-21,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA,,DYAX CORP,SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;IARROBINO RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT;;CHYUNG YUNG,"TAKEDA PHARMACEUTICAL COMPANY LIMITED, JP (2022-07-06);;TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-09-08);;DYAX CORP. (2018-06-20);;TAKEDA PHARMACEUTICAL COMPANY LIMITED; JP (2021-11-05)",https://lens.org/048-170-835-945-955,Granted Patent,yes,3,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,A61K49/00;;A61K39/395;;C07K16/00;;G01N33/53,,8,0,,,"Ubc: ""Dyax's DX-2930 granted Orphan Drug designation in hereditary angioedema"", , 6 December 2013 (2013-12-06), XP055388561, Retrieved from the Internet: URL:http://www.ubc.com/dyaxs-dx-2930-grant ed-orphan-drug-designation-hereditary-angi oedema [retrieved on 2017-07-06];;Daniel J Sexton ET AL: ""Comparison Of Plasma Kallikrein Inhibition By The Endogenous C1-Inhibitor Versus DX-2930, a Monoclonal Antibody Inhibitor"", Blood, 5 December 2013 (2013-12-05), XP055388434, Retrieved from the Internet: URL:http://www.bloodjournal.org/content/12 2/21/1066 [retrieved on 2017-07-06];;SEXTON DANIEL ET AL: ""Discovery and Characterization of a Fully Human Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Treatment of Plasma Kallikrein-Mediated Edema"", JOURNAL OF ALLERGY AND CLINICAL IMMUNO, ELSEVIER, AMSTERDAM, NL, vol. 131, no. 2, Suppl. S, 26 February 2013 (2013-02-26), page AB32, XP009169342, ISSN: 0091-6749, DOI: 10.1016/J.JACI.2012.12.795;;Jon A Kenniston ET AL: ""Discovery and Characterization Of a Highly Specific Antibody Inhibitor Of Plasma Kallikrein"", , 5 December 2013 (2013-12-05), XP055388440, Retrieved from the Internet: URL:http://www.bloodjournal.org/content/12 2/21/1067 [retrieved on 2017-07-06];;FRANK ET AL: ""8. Hereditary angioedema"", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 121, no. 2, 29 January 2008 (2008-01-29), pages S398-S401, XP022431817, ISSN: 0091-6749, DOI: 10.1016/J.JACI.2007.07.057;;SCHNEIDER ET AL.: 'Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor.' J ALLERGY CLIN IMMUNOL vol. 120, no. 2, August 2007, pages 416 - 422, XP022199100;;CHYUNG ET AL.: 'A phase 1 study investigating DX-2930 in healthy subjects.' ANN ALLERGY ASTHMA IMMUNOL vol. 113, no. 4, 26 June 2014, pages 460 - 466, XP029068455;;KENNISTON ET AL.: 'Inhibition of plasma kallikrein by a highly specific active site blocking antibody.' J BIOL CHEM vol. 289, no. 34, 26 June 2014, ISSN 0021-9258 pages 23596 - 23608, XP055215056",ACTIVE
715,CA,A1,CA 2937329 A1,135-290-460-849-966,2015-07-30,2015,CA 2937329 A,2015-01-21,US 201461929716 P;;US 201461944361 P;;US 201462021397 P;;US 2015/0012212 W,2014-01-21,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA,Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.,DYAX CORP,CHYUNG YUNG;;SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;LARROBINO RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT,,https://lens.org/135-290-460-849-966,Patent Application,no,0,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,A61K49/00;;A61K39/395;;C07K16/00;;G01N33/53,,0,0,,,,PENDING
716,KR,A,KR 20210007044 A,179-624-056-139-675,2021-01-19,2021,KR 20217000831 A,2014-01-17,US 201361754607 P;;KR 20157022389 A;;US 2014/0012107 W,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,"본 개시내용은 대상체의 샘플에서 온전한 키니노겐 및/또는 개열된 키니노겐의 값(예를 들어, 백분율)에 기초하여 대상체, 예를 들어 pKal 매개 또는 브래디키닌 매개 장애의 위험이 있거나 이를 앓고 있는 대상체를 평가하는 방법을 제공한다. 제공된 방법은 혈장 칼리크레인 매개 혈관 부종(KMA), 또는 평가 및 치료에서 유용한 pKal에 의해 매개되는 다른 질환을 갖는 환자의 분석을 허용한다. 이러한 방법은 개열된 키니노겐 또는 온전한 키니노겐에 우선적으로 결합하는 검출제의 사용을 포함할 수 있다.",DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,,https://lens.org/179-624-056-139-675,Patent Application,no,2,0,50,50,18,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,G01N33/68;;A61K38/16;;A61K38/17;;A61K39/395;;C07K16/36;;G01N33/53,,1,1,092-309-561-609-370,2433279;;10.1016/s0021-9258(19)75800-1,"Alvin H. Schmaier et al., 'Determination of the Bifunctional Properties of High Molecular Weight Kininogen by Studies with Monoclonal Antibodies Directed to Each of Its Chains', JBC, 1987, Vol. 262, p*",ACTIVE
717,EP,A1,EP 3848057 A1,029-304-025-270-96X,2021-07-14,2021,EP 20209536 A,2015-01-21,US 201461929716 P;;US 201461944361 P;;US 201462021397 P;;EP 15740774 A;;US 2015/0012212 W,2014-01-21,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA,Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.,DYAX CORP,CHYUNG YUNG;;SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;IARROBINO RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-08-04),https://lens.org/029-304-025-270-96X,Patent Application,yes,21,0,45,46,10,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,A61K49/00;;A61K39/395;;C07K16/00;;G01N33/53,,54,46,126-568-744-168-22X;;117-771-661-619-643;;164-277-261-420-791;;016-326-550-218-68X;;109-500-732-467-583;;028-423-517-648-100;;049-134-753-209-354;;074-817-300-512-106;;017-150-654-990-340;;002-264-966-090-625;;048-188-266-680-461;;013-181-635-285-001;;019-779-601-634-917;;056-201-471-905-934;;028-862-168-091-90X;;097-318-320-850-899;;106-753-778-592-300;;069-831-019-492-211;;022-133-574-143-973;;030-630-100-818-462;;030-607-398-087-475;;030-607-398-087-475;;030-323-674-660-051;;029-295-665-407-969;;103-477-074-900-777;;101-039-255-543-294;;126-013-549-735-904;;042-026-882-861-725;;046-750-736-499-556;;051-971-787-908-276;;012-214-936-917-65X;;085-434-580-555-434;;005-941-618-976-731;;074-203-723-868-757;;016-534-677-137-074;;104-243-866-474-715;;001-166-444-961-82X;;069-917-507-345-672;;051-940-176-386-905;;011-389-300-335-273;;007-551-089-881-647;;002-237-818-610-496;;007-364-858-655-289;;056-942-841-068-650;;127-185-373-141-041;;080-454-961-811-450,10.1016/j.jaci.2012.12.795;;10.1016/j.jaci.2007.07.057;;18241690;;10.1160/th07-04-0250;;10.1056/nejmcp0803977;;18768946;;8605931;;10.1002/eji.1830260319;;1367574;;10.1016/0168-1656(91)90350-5;;10.1016/0022-2836(87)90412-8;;3681981;;10.1038/341544a0;;2677748;;3140379;;10.1126/science.3140379;;10.1073/pnas.85.16.5879;;3045807;;pmc281868;;2315699;;10.1126/science.2315699;;10.1073/pnas.87.6.2264;;2315319;;pmc53667;;pmc46825;;8390686;;10.1073/pnas.90.12.5873;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;10.1073/pnas.85.22.8678;;pmc282523;;3054890;;1172191;;10.1038/256495a0;;6811415;;10.1007/bf02796338;;10.1146/annurev.iy.12.040194.002245;;10.1146/annurev.immunol.12.1.433;;8011287;;10.1038/348552a0;;2247164;;pmc392030;;10.1073/pnas.81.21.6851;;6436822;;pmc392030;;10.1073/pnas.81.21.6851;;6436822;;pmc298637;;2513570;;10.1073/pnas.86.24.10029;;10.1016/j.pep.2006.10.011;;17141527;;10.1016/s0022-1759(00)00290-8;;11292488;;pmc2736937;;19671134;;10.1186/1472-6750-9-70;;11499924;;10.1007/s002530000572;;11129586;;10.1271/bbb.64.2138;;10.1186/1752-0509-4-141;;20969759;;pmc2987880;;20346137;;pmc2867824;;10.1186/1471-2164-11-207;;19216534;;10.1021/pr8007623;;15943904;;10.5483/bmbrep.2005.38.3.294;;15612595;;10.1023/b:mbil.0000049871.17260.46;;2050687;;10.1016/s0021-9258(18)99043-5;;16570317;;10.1002/bit.20851;;9231415;;10.1016/s0378-1097(97)00203-6;;10.1111/j.1574-6968.1997.tb10433.x;;10.1007/bf02788058;;8756614;;10.1021/bc010003g;;11562193;;10.1073/pnas.77.7.4216;;pmc349802;;6933469;;10.1186/1479-5876-4-39;;17010186;;pmc1592514;;10.1016/s0065-2776(08)60486-1;;1502974;;9700502;;10.1111/j.1600-065x.1998.tb01188.x;;10.1002/jps.2600660104;;833720;;2674208;;10.1002/j.1552-4604.1989.tb03403.x;;10.1016/j.jaci.2010.08.012;;20889195;;19297327;;10.1074/jbc.m900508200;;pmc2679480,"UBC: ""Dyax's DX-2930 granted Orphan Drug designation in hereditary angioedema"", 6 December 2013 (2013-12-06), XP055388561, Retrieved from the Internet <URL:http://www.ubc.com/dyaxs-dx-2930-granted-orphan-drug-designation-hereditary-angioedema> [retrieved on 20170706];;DANIEL J SEXTON ET AL: ""Comparison Of Plasma Kallikrein Inhibition By The Endogenous C1-Inhibitor Versus DX-2930, a Monoclonal Antibody Inhibitor"", BLOOD, 5 December 2013 (2013-12-05), XP055388434, Retrieved from the Internet <URL:http://www.bloodjournal.org/content/122/21/1066> [retrieved on 20170706];;SEXTON DANIEL ET AL: ""Discovery and Characterization of a Fully Human Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Treatment of Plasma Kallikrein-Mediated Edema"", JOURNAL OF ALLERGY AND CLINICAL IMMUNO, ELSEVIER, AMSTERDAM, NL, vol. 131, no. 2, Suppl. S, 26 February 2013 (2013-02-26), pages AB32, XP009169342, ISSN: 0091-6749, DOI: 10.1016/J.JACI.2012.12.795;;JON A KENNISTON ET AL: ""Discovery and Characterization Of a Highly Specific Antibody Inhibitor Of Plasma Kallikrein"", 5 December 2013 (2013-12-05), XP055388440, Retrieved from the Internet <URL:http://www.bloodjournal.org/content/122/21/1067> [retrieved on 20170706];;FRANK ET AL: ""8. Hereditary angioedema"", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 121, no. 2, 29 January 2008 (2008-01-29), pages S398 - S401, XP022431817, ISSN: 0091-6749, DOI: 10.1016/J.JACI.2007.07.057;;SAINZ I.M. ET AL., THROMB HAEMOST, vol. 98, 2007, pages 77 - 83;;ZURAW B.L. ET AL., N ENGL J MED, vol. 359, 2008, pages 1027 - 1036;;DE WILDT ET AL., EUR J IMMUNOL., vol. 26, no. 3, 1996, pages 629 - 39;;EDQVIST, J. ET AL., J BIOTECHNOL, vol. 20, no. 3, 1991, pages 291 - 300;;CHOTHIA, C. ET AL., J. MOL. BIOL., vol. 196, 1987, pages 901 - 917;;WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546;;BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426;;HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 5879 - 5883;;BOWIE ET AL., SCIENCE, vol. 247, 1990, pages 1306 - 1310;;KARLINALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 2264 - 68;;KARLINALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 5873 - 77;;ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 10;;ALTSCHUL ET AL., NUCLEIC ACIDS RES, vol. 25, no. 17, 1997, pages 3389 - 3402;;HORWITZ, AH. ET AL., PROC NATL ACAD SCI U S A, vol. 85, no. 22, 1988, pages 8678 - 82;;KOHLER, B.MILSTEIN, C., NATURE, vol. 256, 1975, pages 495 - 497;;BUCK, D. W. ET AL., IN VITRO, vol. 18, 1982, pages 377 - 381;;WINTER ET AL., ANNU. REV. IMMUNOL., vol. 12, 1994, pages 433 - 455;;MCCAFFERTY ET AL., NATURE, vol. 348, 1990, pages 552 - 553;;MORRISON ET AL., PROC. NAT. ACAD. SCI., vol. 81, 1984, pages 6851;;MORRISON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 81, 1984, pages 6851;;NEUBERGER ET AL., NATURE, vol. 314, 1984, pages 452;;QUEEN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 10029 - 10033;;HARLOWLANE: ""Using Antibodies, a Laboratory Manual"", 1999, COLD SPRING HARBOR LABORATORY PRESS;;NADKARNI, A. ET AL., PROTEIN EXPR PURIF, vol. 52, no. 1, 2007, pages 219 - 29;;POWERS ET AL., J. IMMUNOL. METHODS., vol. 251, 2001, pages 123 - 35;;SCHOONOOGHE S. ET AL., BMC BIOTECHNOL., vol. 9, 2009, pages 70;;ABDEL-SALAM, HA. ET AL., APPL MICROBIOL BIOTECHNOL, vol. 56, no. 1-2, 2001, pages 157 - 64;;TAKAHASHI K. ET AL., BIOSCI BIOTECHNOL BIOCHEM, vol. 64, no. 10, 2000, pages 2138 - 44;;BAUMANN K. ET AL., BMC SYST. BIOL., vol. 4, 2010, pages 141;;DRAGOSITS, M. ET AL., BMC GENOMICS, vol. 11, 2010, pages 207;;DRAGOSITS, M. ET AL., J PROTEOME RES, vol. 8, no. 3, 2009, pages 1380 - 92;;NING, D. ET AL., J. BIOCHEM. AND MOL. BIOL., vol. 38, no. 3, 2005, pages 294 - 299;;KOZYR, AV ET AL., MOL BIOL (MOSK, vol. 38, no. 6, 2004, pages 1067 - 75;;BOWDISH, K. ET AL., J BIOL CHEM, vol. 266, no. 18, 1991, pages 11901 - 8;;GASSER, B. ET AL., BIOTECHOL. BIOENG., vol. 94, no. 2, 2006, pages 353 - 61;;KOBAYASHI H. ET AL., FEMS MICROBIOL LETT, vol. 152, no. 2, 1997, pages 235 - 42;;KO JH. ET AL., 2996 APPL BIOCHEM BIOTECHNOL, vol. 60, no. 1, pages 41 - 8;;SMITH, BJ. ET AL., BIOCONJUG CHEM, vol. 12, no. 5, 2001, pages 750 - 756;;URLAUBCHASIN, PROC. NATL. ACAD. SCI. USA, vol. 77, 1980, pages 4216 - 4220;;J. IMMUNOL. METHODS, vol. 289, no. 1-2, 2004, pages 65 - 80;;GALEFFI, P. ET AL., J TRANSL MED, vol. 4, 2006, pages 39;;BURTONWOOF, ADV. IMMUNOL., vol. 51, 1992, pages 1 - 84;;JEFFERIS ET AL., IMMUNOL. REV., vol. 163, 1998, pages 59 - 76;;BERGE, S.M. ET AL., J. PHARM. SCI., vol. 66, 1977, pages 1 - 19;;""Sustained and Controlled Release Drug Delivery Systems"", 1978, MARCEL DEKKER, INC.;;V.V. RANADE, J. CLIN. PHARMACOL., vol. 29, 1989, pages 685;;KAPLAN, A.P., J ALLERGY CLIN IMMUNOL, vol. 126, no. 5, 2010, pages 918 - 925;;MCMILLAN, C.V. ET AL., PATIENT, vol. 5, no. 2, 2012, pages 113 - 26;;LILLA ET AL., J. BIOL CHEM., vol. 284, no. 20, 2009, pages 13792 - 13803",PENDING
718,EP,A3,EP 0679692 A3,073-244-468-925-64X,1997-12-17,1997,EP 95302664 A,1995-04-21,US 23943294 A,1994-04-26,Alkoxy-bridged metallophthalocyanine dimers.,"Alkoxy-bridged metallophthalocyanine dimers of the formula C 32 H 16 N 8 MOROMN 8 H 16 C 32 , or of the formula  wherein M is a metal, and R is an alkyl or an alkyl ether.",XEROX CORP,BURT RICHARD A;;LEIBERMANN GEORGE;;HAMER GORDON K;;GARDNER SANDRA J;;JENNINGS CAROL A;;DAIMON KATSUMI;;NUKADA KATSUMI,,https://lens.org/073-244-468-925-64X,Search Report,yes,6,0,9,9,0,C07D519/00;;C07D519/00;;C09B47/067;;C09B47/067;;C09B47/073;;C09B47/073;;G03G5/0696;;G03G5/0696,C07D487/22;;C07D519/00;;C09B47/04;;C09B47/067;;C09B47/073;;G03G5/06,,2,0,,,"DATABASE WPI Section Ch Week 9415, Derwent World Patents Index; Class E23, AN 94-124213, XP002043402;;DATABASE WPI Section Ch Week 9347, Derwent World Patents Index; Class A89, AN 93-371652, XP002043303",EXPIRED
719,US,A,US 3148689 A,075-421-657-481-862,1964-09-15,1964,US 7109760 A,1960-11-22,US 7109760 A,1960-11-22,Method and system for gas transmission,,COLORADO INTERSTATE GAS COMPAN,BEAN DAVID W;;NORMAN EAGLETON HAROLD;;OLSON ROBERT R;;PRAEGER JR OTTO;;SCHABERG BURT P;;VINSON DONALD J,,https://lens.org/075-421-657-481-862,Granted Patent,no,7,11,1,1,0,B08B9/0328;;B08B9/0551;;B08B9/057;;Y10T137/4891;;Y10T137/0318;;Y10T137/4891;;Y10T137/0318;;B08B9/0328;;B08B9/057;;B08B9/0551,B08B9/04;;B63B9/04,,0,0,,,,EXPIRED
720,EP,A2,EP 0679692 A2,181-303-075-478-538,1995-11-02,1995,EP 95302664 A,1995-04-21,US 23943294 A,1994-04-26,Alkoxy-bridged metallophthalocyanine dimers.,"Alkoxy-bridged metallophthalocyanine dimers of the formula C 32 H 16 N 8 MOROMN 8 H 16 C 32 , or of the formula
  wherein M is a metal, and R is an alkyl or an alkyl ether.",XEROX CORP,BURT RICHARD A;;LEIBERMANN GEORGE;;HAMER GORDON K;;GARDNER SANDRA J;;JENNINGS CAROL A;;DAIMON KATSUMI;;NUKADA KATSUMI,,https://lens.org/181-303-075-478-538,Patent Application,yes,0,1,9,9,0,C07D519/00;;C07D519/00;;C09B47/067;;C09B47/067;;C09B47/073;;C09B47/073;;G03G5/0696;;G03G5/0696,C07D487/22;;C07D519/00;;C09B47/04;;C09B47/067;;C09B47/073;;G03G5/06,,0,0,,,,EXPIRED
721,US,A1,US 2017/0002094 A1,066-473-108-804-76X,2017-01-05,2017,US 201515113297 A,2015-01-21,US 201515113297 A;;US 201461929716 P;;US 201461944361 P;;US 201462021397 P;;US 2015/0012212 W,2014-01-21,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA,Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.,DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;CHYUNG YUNG;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;LARROBINO RAYAN;;BIEDENKAPP JOE,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2020-04-24),https://lens.org/066-473-108-804-76X,Patent Application,yes,1,14,45,46,10,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,C07K16/40,,0,0,,,,ACTIVE
722,EP,B1,EP 2948479 B1,125-993-213-369-867,2018-08-01,2018,EP 14740444 A,2014-01-17,US 201361754607 P;;US 2014/0012107 W,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,"TAKEDA PHARMACEUTICAL COMPANY LIMITED, JP (2022-07-06);;TAKEDA PHARMACEUTICAL COMPANY LIMITED, OSAKA, JP (2021-11-23);;TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-08-02);;DYAX CORP. (2018-06-20);;TAKEDA PHARMACEUTICAL COMPANY LIMITED; JP (2021-11-05)",https://lens.org/125-993-213-369-867,Granted Patent,yes,4,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,6,0,,,"CHARLES BLAIS ET AL: ""The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins"", PEPTIDES, vol. 21, no. 12, 1 December 2000 (2000-12-01), pages 1903-1940, XP055279044, AMSTERDAM, NL ISSN: 0196-9781, DOI: 10.1016/S0196-9781(00)00348-X;;RAYMOND P ET AL: ""Quantification of des-Arg<9>-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation"", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 180, no. 2, 27 March 1995 (1995-03-27), pages 247-257, XP004021047, ISSN: 0022-1759, DOI: 10.1016/0022-1759(94)00320-V;;MAKOTO KATORI ET AL: ""Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in anaesthetized rats"", BR. J. PHARMACOL, vol. 98, 1 January 1989 (1989-01-01), pages 1383-1391, XP055279078,;;LADNER ET AL: ""Discovery of Ecallantide: A Potent and Selective Inhibitor of Plasma Kallikrein"", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 119, no. 1, 1 January 2007 (2007-01-01), page S312, XP005757131, ISSN: 0091-6749, DOI: 10.1016/J.JACI.2006.12.591;;Robert W Colman ET AL: ""Studies on the Prekallikrein (Kallikreinogen) -Kallikrein Enzyme System of Human Plasma I. ISOLATION AND PURIFICATION OF PLASMA KALLIKREINS INTRODUCTION"", Journal of clinical investigation, 1 January 1969 (1969-01-01), pages 11-22, XP055279109, Retrieved from the Internet: URL:http://www.ncbi.nlm.nih.gov/pmc/articl es/PMC322187/pdf/jcinvest00207-0027.pdf [retrieved on 2016-06-09];;PHIPPS ET AL.: 'Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability.' HYPERTENSION vol. 53, no. 2, 05 January 2009, pages 175 - 181, XP055036001",ACTIVE
723,AU,A1,AU 2020/277178 A1,139-120-044-857-67X,2020-12-24,2020,AU 2020/277178 A,2020-11-25,AU 2020/277178 A;;AU 2018/260845 A;;AU 2014/207420 A;;US 201361754607 P;;US 2014/0012107 W,2013-01-20,Evaluation and treatment of bradykinin-mediated disorders,"EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED The present disclosure provides methods of evaluating a subject, e.g., a subject at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder, based on values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject. Provided methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment. Such methods can involve the use of a detection agent that preferentially binds cleaved kininogen or intact kininogen.",TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-04-08),https://lens.org/139-120-044-857-67X,Patent Application,no,0,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,0,0,,,,PENDING
724,US,A1,US 2021/0087293 A1,161-211-286-927-782,2021-03-25,2021,US 202017010354 A,2020-09-02,US 202017010354 A;;US 201615113297 A;;US 2015/0012212 W;;US 201462021397 P;;US 201461944361 P;;US 201461929716 P,2014-01-21,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA,Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.,DYAX CORP,SEXTON DANIEL J;;ADELMAN BURT;;CHYUNG YUNG;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;IARROBINO RYAN;;BIEDENKAPP JOSEPH,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2020-04-24),https://lens.org/161-211-286-927-782,Patent Application,yes,1,3,45,46,10,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,C07K16/40,,1,1,117-771-661-619-643,10.1016/j.jaci.2007.07.057;;18241690,"Frank (J Allergy Clin Immunol Volume 121, Issue 2, Supplement 2, S398-S401, Feb 2008)",PENDING
725,KR,A,KR 20160122169 A,008-022-146-834-357,2016-10-21,2016,KR 20167022785 A,2015-01-21,US 201461929716 P;;US 201461944361 P;;US 201462021397 P;;US 2015/0012212 W,2014-01-21,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA,"혈장 칼리크레인 결합 단백질, 예컨대 활성 혈장 칼리크레인에 결합하는 항체 및 유전성 혈관부종을 치료하는 데 있어서 이러한 단백질을 사용하는 방법이 본 명세서에 제공된다.",DYAX CORP,CHYUNG YUNG;;SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT;;LARROBINO RYAN,,https://lens.org/008-022-146-834-357,Patent Application,no,4,0,45,46,20,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,C07K16/40;;A61K39/00;;A61K39/395,,0,0,,,,ACTIVE
726,BR,A2,BR 112016016916 A2,054-932-448-999-879,2018-01-23,2018,BR 112016016916 A,2015-01-21,US 2015/0012212 W;;US 201461929716 P;;US 201461944361 P;;US 201462021397 P,2014-01-21,método de tratamento de angiodema hereditário (hae),"proteínas de ligação de calicreína plasmática, tais como anticorpos de ligação para ativar calicreína plasmática e métodos de utilização dessas proteínas no tratamento do angioedema hereditário são providos neste documento.",DYAX CORP,BURT ADELMAN;;CHRISTOPHER TENHOOR;;DANIEL J SEXTON;;JON A KENNISTON;;JOSEPH BIEDENKAPP;;RYAN FAUCETTE;;RYAN LARROBINO;;YUNG CHYUNG,TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) (2021-10-05);;DYAX CORP. (US) (2018-08-28),https://lens.org/054-932-448-999-879,Patent Application,no,0,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,A61K39/395;;A61K49/00;;C07K16/00;;G01N33/53,,0,0,,,,ACTIVE
727,AU,A1,AU 2014/207420 A1,095-604-732-324-603,2015-07-02,2015,AU 2014/207420 A,2014-01-17,US 201361754607 P;;US 2014/0012107 W,2013-01-20,Evaluation and treatment of bradykinin-mediated disorders,"The present disclosure provides methods of evaluating a subject, e.g., a subject at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder, based on values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject. Provided methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment. Such methods can involve the use of a detection agent that preferentially binds cleaved kininogen or intact kininogen.",DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/095-604-732-324-603,Patent Application,no,0,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,0,0,,,,ACTIVE
728,AU,A1,AU 2020/244370 A1,081-168-435-444-338,2020-10-29,2020,AU 2020/244370 A,2020-09-28,AU 2020/244370 A;;AU 2015/209481 A;;US 201461944361 P;;US 201462021397 P;;US 201461929716 P;;US 2015/0012212 W,2014-01-21,Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.,TAKEDA PHARMACEUTICALS CO,CHYUNG YUNG;;SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;IARROBINO RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-04-08),https://lens.org/081-168-435-444-338,Patent Application,no,0,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,C07K16/00;;A61K39/395;;A61K49/00;;G01N33/53,,0,0,,,,PENDING
729,CA,A1,CA 2897336 A1,085-748-732-507-178,2014-07-24,2014,CA 2897336 A,2014-01-17,US 201361754607 P;;US 2014/0012107 W,2013-01-20,EVALUATION AND TREATMENT OF PKAL-MEDIATED DISORDERS,"The present disclosure provides methods of evaluating a subject, e.g., a subject at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder, based on values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject. Provided methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment. Such methods can involve the use of a detection agent that preferentially binds cleaved kininogen or intact kininogen.",DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,,https://lens.org/085-748-732-507-178,Patent Application,no,0,0,50,50,9,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40;;C12Q1/37,,0,0,,,,PENDING
730,CN,A,CN 111044725 A,181-648-031-449-94X,2020-04-21,2020,CN 201911415224 A,2014-01-17,US 201361754607 P;;CN 201480005158 A,2013-01-20,Evaluation and treatment of bradykinin-mediated disorders,"The invention relates to evaluation and treatment of bradykinin-mediated disorders. The present disclosure provides methods of evaluating a subject, e.g., a subject at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder, based on values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject. Provided methods permit analysis of patients with plasmakallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment. Such methods can involve the use of a detection agent that preferentially binds cleavedkininogen or intact kininogen.",DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,,https://lens.org/181-648-031-449-94X,Patent Application,no,2,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,G01N33/573,,2,1,042-513-826-438-891,19124682;;10.1161/hypertensionaha.108.117663;;pmc4978181,"唐法娣等: ""大鼠后肢热诱导的缓激肽和P物质的释放"";;JOANNA A. PHIPPS ET AL.: ""Plasma Kallikrein Mediates Angiotensin II Type 1 Receptor–Stimulated Retinal Vascular Permeability""",PENDING
731,AU,B2,AU 2018/260845 B2,009-875-171-787-16X,2020-09-03,2020,AU 2018/260845 A,2018-11-07,AU 2018/260845 A;;AU 2014/207420 A;;US 201361754607 P;;US 2014/0012107 W,2013-01-20,Evaluation and treatment of bradykinin-mediated disorders,"EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS The present disclosure provides methods for determining a value of cleaved kininogen, intact kininogen, or both, in a sample, the method comprising contacting a sample containing intact and cleaved kininogen with a detection reagent under conditions allowing for interaction between the detection agent and the intact and cleaved kininogen, wherein the detection agent specifically binds cleaved kininogen as compared to intact kininogen, or specifically binds intact kininogen as compared to cleaved kininogen; measuring the level of cleaved kininogen and the level of intact kininogen in the sample based on their interaction with the detection reagent; and determining a value of the cleaved kininogen, the value of the intact kininogen, or both, in the sample based on the amounts of the cleaved kininogen and intact kininogen. The present disclosure also provides methods of evaluating a subject, e.g., a subject at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder, based on values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject. Provided methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment. Such methods can involve the use of a detection agent that preferentially binds cleaved kininogen or intact kininogen.",TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/009-875-171-787-16X,Granted Patent,no,2,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,1,1,026-394-309-301-759,3730610;;10.1182/blood.v68.2.455.bloodjournal682455;;10.1182/blood.v68.2.455.455,"Berrettini, M., et al. (1986) ""Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies."" Blood, vol. 68, no. 2, pp: 455-462.",ACTIVE
732,DK,T3,DK 3096798 T3,031-319-671-265-384,2021-03-01,2021,DK 15740774 T,2015-01-21,US 201461929716 P;;US 201461944361 P;;US 201462021397 P;;US 2015/0012212 W,2014-01-21,PLASMAKALLIKREINBINDENDE PROTEINER OG ANVENDELSER DERAF TIL BEHANDLING AF HEREDITÆRT ANGIOØDEM,,DYAX CORP,CHYUNG YUNG;;SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;BIEDENKAPP JOSEPH;;ADELMAN BURT;;IARROBINO RYAN;;FAUCETTE RYAN,,https://lens.org/031-319-671-265-384,Granted Patent,no,0,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,A61K49/00;;A61K39/395;;C07K16/00;;G01N33/53,,0,0,,,,ACTIVE
733,AU,B2,AU 2014/207420 B2,049-492-538-473-259,2018-08-09,2018,AU 2014/207420 A,2014-01-17,US 201361754607 P;;US 2014/0012107 W,2013-01-20,Evaluation and treatment of bradykinin-mediated disorders,"The present disclosure provides methods of evaluating a subject, e.g., a subject at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder, based on values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject. Provided methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment. Such methods can involve the use of a detection agent that preferentially binds cleaved kininogen or intact kininogen.",TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/049-492-538-473-259,Granted Patent,no,0,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,0,0,,,,ACTIVE
734,RS,B1,RS 57890 B1,072-069-287-140-438,2019-01-31,2019,RS P20181235 A,2014-01-17,US 201361754607 P;;US 2014/0012107 W;;EP 14740444 A,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,,https://lens.org/072-069-287-140-438,Granted Patent,no,0,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,0,0,,,,ACTIVE
735,EA,B1,EA 038532 B1,082-706-717-145-637,2021-09-10,2021,EA 201691470 A,2015-01-21,US 201461929716 P;;US 201461944361 P;;US 201462021397 P;;US 2015/0012212 W,2014-01-21,METHOD OF TREATING HEREDITARY ANGIOEDEMA (HAE),"The invention relates to a method of treating hereditary angioedema (HAE), the method comprising administering to a subject in need thereof an antibody at a dose of about 300 mg every 2 weeks or every 4 weeks, wherein the antibody comprises a heavy chain (HC) CDR1 comprising the sequence of SEQ ID NO: 5; HC CDR2 comprising the sequence of SEQ ID NO: 6; HC CDR3 HC comprising the sequence of SEQ ID NO: 7; and a light chain (LC) CDR1 comprising the sequence of SEQ ID NO: 8; LC CDR2 comprising the sequence of SEQ ID NO: 9; and LC CDR3 comprising the sequence of SEQ ID NO: 10; and wherein the antibody inhibits plasma kallikrein and is a full length antibody.",TAKEDA PHARMACEUTICALS CO,CHYUNG YUNG;;SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;IARROBINO RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT,,https://lens.org/082-706-717-145-637,Granted Patent,no,2,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,,,3,3,091-004-161-564-632;;008-499-354-702-218;;006-137-353-823-826,10.1016/j.jaci.2007.04.028;;17559913;;24980392;;10.1016/j.anai.2014.05.028;;24970892;;10.1074/jbc.m114.569061;;pmc4156074,"SCHNEIDER et al. Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor. J. Allergy Clin. Immunol., August 2007, Vol 120, № 2, Pages 416-422, Especially abstract.;;CHYUNG et al. A phase 1 study investigating DX-2930 in healthy subjects. Ann. Allergy Asthma Immunol., ePub 26 June 2014, Vol 113, № 4, Pages 460-466, Especially abstract, entire document.;;KENNISTON et al. Inhibition of plasma kallikrein by a highly specific active site blocking antibody, J. Biol. Chem., ePub 26 June 2014, Vol 289, № 34, Pages 23596-23608, pg 23604, fig 5A, Table 3, pg 23605, fig 6.",ACTIVE
736,EP,A1,EP 2948479 A1,109-624-324-191-551,2015-12-02,2015,EP 14740444 A,2014-01-17,US 201361754607 P;;US 2014/0012107 W,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,"TAKEDA PHARMACEUTICAL COMPANY LIMITED, JP (2022-07-06);;TAKEDA PHARMACEUTICAL COMPANY LIMITED, OSAKA, JP (2021-11-23);;TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-08-02);;DYAX CORP. (2018-06-20);;TAKEDA PHARMACEUTICAL COMPANY LIMITED; JP (2021-11-05)",https://lens.org/109-624-324-191-551,Patent Application,yes,0,1,50,50,9,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,0,0,,,,ACTIVE
737,PT,T,PT 2948479 T,112-877-943-591-478,2018-11-14,2018,PT 14740444 T,2014-01-17,US 201361754607 P,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,,DYAX CORP,BURT ADELMAN;;DANIEL J SEXTON;;RYAN FAUCETTE;;JON A KENNISTON;;GREG CONLEY;;ANDREW NIXON;;CHRISTOPHER TENHOOR;;YUNG CHYUNG,,https://lens.org/112-877-943-591-478,Patent Application,no,0,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,0,0,,,,PENDING
738,CA,C,CA 2620159 C,042-739-460-776-993,2014-12-16,2014,CA 2620159 A,2006-08-21,US 71018805 P;;US 33134306 A;;US 2006/0032541 W,2005-08-23,MACHINE VISION COUNTING SYSTEM APPARATUS AND METHOD,"A machine-vision-based counter includes an image acquisition component (imager), wherein light provides discrimination between a background field and imageable units located away from the imager. The imager outputs data representing the field and units; an image processor receiving imager data finds countable units therein. An operator interface accepts command inputs and presents count output. A controller manages image acquisition, processor, and operator interface functions. A counting method includes configuring an imager to detect light, directing light from a source to units positioned to be detected by the imager, and directing the light to the imager. The method includes discriminating between a background field and imageable units; providing, as an imager output, data representing the field and units; configuring the processor to interpret the data as counted units on a background field; and configuring an operator interface to present a count result.",SPX CORP,LIMER DANIEL J;;LANG DAVID A;;BURT CHRISTOPHER S;;GOUIN PHILIP R;;TARR NELSON D;;DISCHINGER RANDALL D,,https://lens.org/042-739-460-776-993,Granted Patent,no,0,0,6,6,0,A61J7/02;;G01N2015/1472;;G01N2015/1486;;G06M1/101;;G06M11/00;;G06V20/66;;G01N15/1433;;A61J7/02;;G01N2015/1486;;G01N2015/1472;;G06M1/101;;G06M11/00;;G01N15/1433,G06M11/00;;A61J7/02;;G06T7/00,,0,0,,,,ACTIVE
739,US,A1,US 2003/0130954 A1,067-502-776-454-562,2003-07-10,2003,US 30152802 A,2002-11-20,US 30152802 A;;US 24414302 A;;US 34310499 A;;US 31464899 A;;US 56740500 A;;US 62964900 A;;US 68928900 A;;US 93929801 A;;US 12750298 A;;US 33251201 P;;US 32314801 P,1998-07-31,Postal applications including digital watermarks,"
   The present invention relates to postal metering devices and mail systems that variously employ digital watermarking techniques. In one implementation we provide on an envelope a marketing image in addition to postage indicia. The marketing image includes a digital watermark embedded therein. The watermark includes a link to access information that is associated with the envelope's sender. In some cases the digital watermark is fragile, allowing us to determine whether the marking image or postal indicia is authentic. 
",CARR J. SCOTT;;RHOADS GEOFFREY B.;;PERRY BURT W.;;SEDER PHILLIP ANDREW;;CLEMENTS LORIE R.;;LOFGREN NEIL E.,CARR J SCOTT;;RHOADS GEOFFREY B;;PERRY BURT W;;SEDER PHILLIP ANDREW;;CLEMENTS LORIE R;;LOFGREN NEIL E,DIGIMARC CORPORATION (2003-02-19),https://lens.org/067-502-776-454-562,Patent Application,yes,98,73,1,1547,0,B41M3/10;;B41M3/14;;B42D15/0093;;D21H21/40;;G06Q30/02;;G06T1/0021;;G07D7/004;;G07F17/26;;H04N1/32144;;H04N1/32352;;H04N2201/3205;;H04N2201/3207;;H04N2201/3226;;H04N2201/3233;;H04N2201/3249;;H04N2201/327;;H04N2201/3271;;B42D25/29;;G07D7/0034;;B42D25/29;;G06T1/0021;;G06Q30/02;;G07D7/004;;H04N2201/3233;;B41M3/14;;H04N1/32144;;D21H21/40;;H04N2201/3271;;H04N2201/3226;;H04N2201/3205;;G07F17/26;;H04N2201/3207;;H04N1/32352;;B42D15/0093;;B41M3/10;;H04N2201/3249;;H04N2201/327;;G07D7/0034,B41M3/10;;B41M3/14;;B42D15/00;;D21H21/40;;G06Q30/02;;G06T1/00;;G07D7/00;;G07D7/12;;G07F17/26;;H04N1/32,705 6,0,0,,,,DISCONTINUED
740,KR,A,KR 20220107077 A,092-488-017-268-767,2022-08-01,2022,KR 20227025028 A,2015-01-21,US 201461929716 P;;US 201461944361 P;;US 201462021397 P;;KR 20167022785 A;;US 2015/0012212 W,2014-01-21,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA,"혈장 칼리크레인 결합 단백질, 예컨대 활성 혈장 칼리크레인에 결합하는 항체 및 유전성 혈관부종을 치료하는 데 있어서 이러한 단백질을 사용하는 방법이 본 명세서에 제공된다.",TAKEDA PHARMACEUTICALS CO,CHYUNG YUNG;;SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;IARROBINO RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT,,https://lens.org/092-488-017-268-767,Patent Application,no,0,0,45,46,24,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,C07K16/40;;A61K39/00;;A61P7/10;;A61P9/00,,0,0,,,,DISCONTINUED
741,EP,A2,EP 0679693 A2,112-596-643-654-173,1995-11-02,1995,EP 95302666 A,1995-04-21,US 23319594 A,1994-04-26,Processes for the preparation of alkoxy-bridged metallophthalocyanine dimers.,"A process for the preparation of alkoxy-bridged metallophthalocyanine dimers by the reaction of a trivalent metal compound with ortho-phthalodinitrile or 1,3-diiminoisoindoline in the presence of a diol.",XEROX CORP,BURT RICHARD A;;LIEBERMANN GEORGE;;HAMER GORDON K;;GARDNER SANDRA J;;JENNINGS CAROL A;;DAIMON KATSUMI;;NUKADA KATSUMI,,https://lens.org/112-596-643-654-173,Patent Application,yes,0,3,8,8,0,C07D519/00;;C07D519/00;;C09B47/067;;C09B47/067;;C09B47/073;;C09B47/073,G03G5/06;;C07D487/22;;C07D519/00;;C09B47/04;;C09B47/067;;C09B47/073,,0,0,,,,EXPIRED
742,US,A,US 5493016 A,158-502-319-319-305,1996-02-20,1996,US 23319594 A,1994-04-26,US 23319594 A,1994-04-26,Processes for the preparation of alkoxy-bridged metallophthalocyanine dimers,"A process for the preparation of alkoxy-bridged metallophthalocyanine dimers by the reaction of a trivalent metal compound with ortho-phthalodinitrile or 1,3-diiminoisoindoline in the presence of a diol.",XEROX CORP,BURT RICHARD A;;LIEBERMANN GEORGE;;HAMER GORDON K;;GARDNER SANDRA J;;JENNINGS CAROL A;;DAIMON KATSUMI;;NUKADA KATSUMI,XEROX CORPORATION (1995-03-31),https://lens.org/158-502-319-319-305,Granted Patent,yes,8,32,8,8,0,C07D519/00;;C07D519/00;;C09B47/067;;C09B47/067;;C09B47/073;;C09B47/073,G03G5/06;;C07D487/22;;C07D519/00;;C09B47/04;;C09B47/067;;C09B47/073,540/139;;540/140;;540/142;;540/143,5,2,037-530-097-486-319;;028-777-494-013-142,10.1021/ic00242a029;;10.1021/ic50122a047,"Organic Chemistry, By Morrison and Boyd Allyn and Bacon; Fifth Editon., 1987 p. 178.;;Bull. Soc. Chim. Fr., 23 (1962), D. Colaitis.;;J. Chem. Soc., 1717, 1936, P. A. Barrett et al.;;Inorg. Chem., 25, 3972, 1986, C. Ercolani et al.;;Inorg. Chem. 12, 930, 1973, W. R. Bennett et al.",EXPIRED
743,AU,A1,AU 2018/260845 A1,157-994-244-224-543,2018-11-22,2018,AU 2018/260845 A,2018-11-07,AU 2018/260845 A;;AU 2014/207420 A;;US 201361754607 P;;US 2014/0012107 W,2013-01-20,Evaluation and treatment of bradykinin-mediated disorders,"EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS The present disclosure provides methods for determining a value of cleaved kininogen, intact kininogen, or both, in a sample, the method comprising contacting a sample containing intact and cleaved kininogen with a detection reagent under conditions allowing for interaction between the detection agent and the intact and cleaved kininogen, wherein the detection agent specifically binds cleaved kininogen as compared to intact kininogen, or specifically binds intact kininogen as compared to cleaved kininogen; measuring the level of cleaved kininogen and the level of intact kininogen in the sample based on their interaction with the detection reagent; and determining a value of the cleaved kininogen, the value of the intact kininogen, or both, in the sample based on the amounts of the cleaved kininogen and intact kininogen. The present disclosure also provides methods of evaluating a subject, e.g., a subject at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder, based on values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject. Provided methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment. Such methods can involve the use of a detection agent that preferentially binds cleaved kininogen or intact kininogen.",DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/157-994-244-224-543,Patent Application,no,0,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,0,0,,,,ACTIVE
744,EP,B1,EP 0679692 B1,021-864-759-348-046,2001-09-26,2001,EP 95302664 A,1995-04-21,US 23943294 A,1994-04-26,Alkoxy-bridged metallophthalocyanine dimers,,XEROX CORP,BURT RICHARD A;;LEIBERMANN GEORGE;;HAMER GORDON K;;GARDNER SANDRA J;;JENNINGS CAROL A;;DAIMON KATSUMI;;NUKADA KATSUMI,,https://lens.org/021-864-759-348-046,Granted Patent,yes,6,3,9,9,0,C07D519/00;;C07D519/00;;C09B47/067;;C09B47/067;;C09B47/073;;C09B47/073;;G03G5/0696;;G03G5/0696,C07D487/22;;C07D519/00;;C09B47/04;;C09B47/067;;C09B47/073;;G03G5/06,,2,0,,,"DATABASE WPI Section Ch, Week 9415 Derwent Publications Ltd., London, GB; Class E23, AN 94-124213 XP002043402 & JP 06 073 299 A (FUJI XEROX CO LTD) , 15 March 1994;;DATABASE WPI Section Ch, Week 9347 Derwent Publications Ltd., London, GB; Class A89, AN 93-371652 XP002043303 & JP 05 273 775 A (KONICA CORP) , 22 October 1993",EXPIRED
745,KR,A,KR 20150106006 A,098-739-671-039-178,2015-09-18,2015,KR 20157022389 A,2014-01-17,US 201361754607 P;;US 2014/0012107 W,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,,https://lens.org/098-739-671-039-178,Patent Application,no,4,0,50,50,18,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,A61K38/16;;A61K38/17;;A61K39/395;;G01N33/53,,1,0,,,"Charles Blais, Jr. et al., 'The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins', Peptides, 2000, Vol. 21, pp 1903-1940. 1부.*",ACTIVE
746,DE,T2,DE 69525872 T2,113-346-809-756-36X,2002-07-18,2002,DE 69525872 T,1995-04-21,US 23319594 A,1994-04-26,Verfahren zur Herstellung von Alkoxyüberbrückten Metallphthalocyaninendimeren,,XEROX CORP,BURT RICHARD A;;LIEBERMANN GEORGE;;HAMER GORDON K;;GARDNER SANDRA J;;JENNINGS CAROL A;;DAIMON KATSUMI;;NUKADA KATSUMI,,https://lens.org/113-346-809-756-36X,Granted Patent,no,0,0,8,8,0,C07D519/00;;C07D519/00;;C09B47/067;;C09B47/067;;C09B47/073;;C09B47/073,G03G5/06;;C07D487/22;;C07D519/00;;C09B47/04;;C09B47/067;;C09B47/073,,0,0,,,,EXPIRED
747,ZA,B,ZA 202004653 B,153-734-341-380-402,2022-01-26,2022,ZA 202004653 A,2020-07-28,US 201461929716 P;;US 201461944361 P;;US 201462021397 P,2014-01-21,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA,,DYAX CORP,YUNG CHYUNG;;DANIEL J SEXTON;;CHRISTOPHER TENHOOR;;JON A KENNISTON;;RYAN FAUCETTE;;JOSEPH BIEDENKAPP;;BURT ADELMAN;;IARROBINO RYAN,,https://lens.org/153-734-341-380-402,Granted Patent,no,0,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,,,0,0,,,,ACTIVE
748,EP,B1,EP 0679693 B1,189-206-122-908-040,2002-03-20,2002,EP 95302666 A,1995-04-21,US 23319594 A,1994-04-26,Processes for the preparation of alkoxy-bridged metallophthalocyanine dimers,,XEROX CORP,BURT RICHARD A;;LIEBERMANN GEORGE;;HAMER GORDON K;;GARDNER SANDRA J;;JENNINGS CAROL A;;DAIMON KATSUMI;;NUKADA KATSUMI,,https://lens.org/189-206-122-908-040,Granted Patent,yes,6,0,8,8,0,C07D519/00;;C07D519/00;;C09B47/067;;C09B47/067;;C09B47/073;;C09B47/073,G03G5/06;;C07D487/22;;C07D519/00;;C09B47/04;;C09B47/067;;C09B47/073,,2,0,,,"DATABASE WPI Section Ch, Week 9415 Derwent Publications Ltd., London, GB; Class E23, AN 94-124213 XP002043402 & JP 06 073 299 A (FUJI XEROX CO LTD) , 15 March 1994;;DATABASE WPI Section Ch, Week 9347 Derwent Publications Ltd., London, GB; Class A89, AN 93-371652 XP002043303 & JP 05 273 775 A (KONICA CORP) , 22 October 1993",EXPIRED
749,US,A,US 5466796 A,005-617-014-107-389,1995-11-14,1995,US 23943294 A,1994-04-26,US 23943294 A,1994-04-26,Alkoxy-bridged metallophthalocyanine dimers,"Alkoxy-bridged metallophthalocyanine dimers of the formula C.sub.32 H.sub.16 N.sub.8 MOROMN.sub.8 H.sub.16 C.sub.32, or of the formula ##STR1## wherein M is a metal, and R is an alkyl or an alkyl ether.",XEROX CORP,BURT RICHARD A;;LIEBERMANN GEORGE;;HAMER GORDON K;;GARDNER SANDRA J;;JENNINGS CAROL A;;DAIMON KATSUMI;;NUKADA KATSUMI,XEROX CORPORATION (1995-03-31),https://lens.org/005-617-014-107-389,Granted Patent,yes,3,11,9,9,0,C07D519/00;;C07D519/00;;C09B47/067;;C09B47/067;;C09B47/073;;C09B47/073;;G03G5/0696;;G03G5/0696,C07D487/22;;C07D519/00;;C09B47/04;;C09B47/067;;C09B47/073;;G03G5/06,540/139;;540/122;;540/140,5,2,037-530-097-486-319;;028-777-494-013-142,10.1021/ic00242a029;;10.1021/ic50122a047,"Ercolani et al. Inorg. Chem, 25, 3972 6 1986.;;Bull. Soc. Chim. Fr., 23 (1962), D. Colaitis.;;J. Chem. Soc., 1717, 1936, P. A. Barrett et al.;;Russ. J. Phys. Chem. (Engl. Transl.), 41, 251, 1967, I. S. Kirin et al.;;Inorg. Chem. 12, 930, 1973, W. R. Bennett et al.",EXPIRED
750,PL,T3,PL 2948479 T3,042-567-803-381-961,2019-02-28,2019,PL 14740444 T,2014-01-17,US 201361754607 P;;EP 14740444 A;;US 2014/0012107 W,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,,DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,,https://lens.org/042-567-803-381-961,Patent Application,no,0,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,0,0,,,,PENDING
751,DE,D1,DE 69522847 D1,056-849-248-613-041,2001-10-31,2001,DE 69522847 T,1995-04-21,US 23943294 A,1994-04-26,Alkoxyüberbrückte Dimere von Metallphthalocyaninen,,XEROX CORP,BURT RICHARD A;;LEIBERMANN GEORGE;;HAMER GORDON K;;GARDNER SANDRA J;;JENNINGS CAROL A;;DAIMON KATSUMI;;NUKADA KATSUMI,,https://lens.org/056-849-248-613-041,Granted Patent,no,0,0,9,9,0,C07D519/00;;C07D519/00;;C09B47/067;;C09B47/067;;C09B47/073;;C09B47/073;;G03G5/0696;;G03G5/0696,C07D487/22;;C07D519/00;;C09B47/04;;C09B47/067;;C09B47/073;;G03G5/06,,0,0,,,,EXPIRED
752,DE,D1,DE 69525872 D1,077-796-552-822-513,2002-04-25,2002,DE 69525872 T,1995-04-21,US 23319594 A,1994-04-26,Verfahren zur Herstellung von Alkoxyüberbrückten Metallphthalocyaninendimeren,,XEROX CORP,BURT RICHARD A;;LIEBERMANN GEORGE;;HAMER GORDON K;;GARDNER SANDRA J;;JENNINGS CAROL A;;DAIMON KATSUMI;;NUKADA KATSUMI,,https://lens.org/077-796-552-822-513,Granted Patent,no,0,0,8,8,0,C07D519/00;;C07D519/00;;C09B47/067;;C09B47/067;;C09B47/073;;C09B47/073,G03G5/06;;C07D487/22;;C07D519/00;;C09B47/04;;C09B47/067;;C09B47/073,,0,0,,,,EXPIRED
753,CA,C,CA 2937329 C,112-351-279-933-962,2022-05-31,2022,CA 2937329 A,2015-01-21,US 201461929716 P;;US 201461944361 P;;US 201462021397 P;;US 2015/0012212 W,2014-01-21,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA,Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.,DYAX CORP,CHYUNG YUNG;;SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;IARROBINO RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT,,https://lens.org/112-351-279-933-962,Granted Patent,no,0,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,A61K39/395;;C07K16/40;;C12Q1/50,,0,0,,,,PENDING
754,EP,A2,EP 4234583 A2,176-376-202-035-438,2023-08-30,2023,EP 23164279 A,2014-01-17,US 201361754607 P;;EP 18186356 A;;EP 14740444 A;;US 2014/0012107 W,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,"The present disclosure provides methods of evaluating a subject, e.g., a subject at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder, based on values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject. Provided methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment. Such methods can involve the use of a detection agent that preferentially binds cleaved kininogen or intact kininogen.",TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,,https://lens.org/176-376-202-035-438,Patent Application,yes,21,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40;;G01N33/50,,36,29,164-277-261-420-791;;016-326-550-218-68X;;035-188-943-391-21X;;109-500-732-467-583;;049-134-753-209-354;;017-150-654-990-340;;002-264-966-090-625;;005-248-320-665-556;;012-206-824-167-831;;092-845-354-377-772;;064-409-159-039-974;;014-581-174-616-945;;028-750-850-934-248;;040-796-358-211-273;;045-864-048-030-411;;084-421-189-184-547;;018-144-967-742-095;;037-104-736-197-766;;122-080-830-470-164;;050-507-714-041-493;;150-526-239-777-942;;069-863-076-076-464;;096-809-977-928-291;;038-056-207-283-274;;038-535-940-466-805;;053-209-061-746-894;;028-862-168-091-90X;;030-451-543-728-673;;052-397-009-533-722,10.1160/th07-04-0250;;10.1056/nejmcp0803977;;18768946;;10.1038/338518a0;;2927510;;8605931;;10.1002/eji.1830260319;;10.1016/0022-2836(87)90412-8;;3681981;;3140379;;10.1126/science.3140379;;10.1073/pnas.85.16.5879;;3045807;;pmc281868;;10.1111/j.1365-2141.1984.tb03955.x;;6691922;;10.1182/blood.v74.2.695.695;;10.1182/blood.v74.2.695.bloodjournal742695;;2752143;;3501619;;10.1016/0049-3848(87)90434-8;;15306150;;10.1016/j.thromres.2004.05.005;;7654936;;10.1097/00001721-199505000-00005;;10.1093/rheumatology/41.1.38;;11792878;;6639693;;10.1002/art.1780261107;;10.2210/pdb7pti/pdb;;10.1093/protein/3.7.591;;1699222;;2125487;;10.1021/bi00495a002;;3263966;;10.1016/s0021-9258(19)81329-7;;2553722;;10.1016/s0021-9258(18)51542-8;;pmc43575;;10.1073/pnas.91.8.3353;;8159751;;10.1002/(sici)1097-0134(199707)28:3<405::aid-prot10>3.0.co;2-l;;9223186;;10.1016/0076-6879(90)83011-w;;2314273;;pmc305087;;10.1073/pnas.84.13.4355;;3474607;;8107089;;10.1006/jmbi.1994.1104;;pmc2142382;;10.1002/pro.5560020302;;8453370;;pmc102444;;10592234;;10.1093/nar/28.1.231;;9847197;;10.1093/nar/27.1.263;;pmc148152;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;10.1016/s0097-8485(99)00011-x;;10404623;;10.1093/nar/30.1.235;;pmc99105;;11752303,"SAINZ I.M. ET AL., THROMB HAEMOST, vol. 98, 2007, pages 77 - 83;;ZURAW B.L. ET AL., N ENGL J MED, vol. 359, 2008, pages 1027 - 1036;;GIRARD, T. ET AL., NATURE, vol. 338, 1989, pages 518 - 520;;WILDT ET AL., EUR J IMMUNOL., vol. 26, no. 3, 1996, pages 629 - 39;;KABAT, E.A. ET AL.: ""Sequences of Proteins of Immunological Interest"", 1991, NIH PUBLICATION, pages: 91 - 3242;;CHOTHIA, C. ET AL., J. MOL. BIOL., vol. 196, 1987, pages 901 - 917;;BIRD, SCIENCE, vol. 242, 1988, pages 423 - 426;;HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 5879 - 5883;;KERBIRIOU-NABIAS, D.M., BR J HAEMATOL, vol. 56, no. 2, 1984, pages 2734 - 86;;REDDIGARI, S.R.KAPLAN, A.P., BLOOD, vol. 74, 1999, pages 695 - 702;;SCOTT, C.F. ET AL., THROMB RES, vol. 48, no. 6, 1987, pages 685 - 700;;GALLIMORE, M.J. ET AL., THROMB RES, vol. 114, no. 2, 2004, pages 91 - 96;;BUHLER R. ET AL., BLOOD COAGUL FIBRINOLYSIS, vol. 6, no. 3, 1995, pages 223 - 232;;MCMILLAN, C.V. ET AL., PATIENT, vol. 5, no. 2, 2012, pages 113 - 26;;BARDWELL ET AL., RHEUMATOLOGY, vol. 41, no. 1, 2002, pages 38 - 45;;WARE ET AL., MED. CARE., vol. 37, no. 5, 1999, pages 40 - 50;;MEENAN ET AL., ARTHRITIS RHEUM., vol. 35, no. 1, 1992, pages 1 - 10;;PINCUS ET AL., ARTHRITIS RHEUM., vol. 26, no. 11, 1983, pages 1346 - 53;;EIGENBROT ET AL., PROTEIN ENGINEERING, vol. 3, no. 7, 1990, pages 591 - 598;;HYNES ET AL., BIOCHEMISTRY, vol. 29, 1990, pages 10018 - 10022;;KIDO ET AL., J. BIOL. CHEM., vol. 263, no. 13, 1988, pages 18104 - 18107;;NOVOTNY ET AL., J. BIOL. CHEM., vol. 264, no. 31, 1989, pages 18832 - 18837;;SPRECHER ET AL., PNAS USA, vol. 91, 1994, pages 3353 - 3357;;""SWISS-PROT"", Database accession no. A4 HUMAN (P05067), A4 MACFA (P53601), A4 MACMU (P29216);;SONHAMMER ET AL., PROTEINS, vol. 28, no. 3, 1997, pages 405 - 420;;GRIBSKOV ET AL., METH. ENZYMOL., vol. 183, 1990, pages 146 - 159;;GRIBSKOV ET AL., PROC. NATL. ACAD. SCI. USA, vol. 84, 1987, pages 4355 - 4358;;KROGH, J. MOL. BIOL., vol. 235, 1994, pages 1501 - 1531;;STULTZ, PROTEIN SCI., vol. 2, 1993, pages 305 - 314;;SCHULTZ ET AL., PROC. NATL. ACAD., vol. 95, 1998, pages 5857;;SCHULTZ ET AL., NUCL. ACIDS RES, vol. 28, 2000, pages 231;;R. DURBIN ET AL.: ""Biological sequence analysis: probabilistic models of proteins and nucleic acids"", 1998, CAMBRIDGE UNIVERSITY PRESS;;CORPET ET AL., NUCL. ACIDS RES., vol. 27, 1999, pages 263 - 267;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402;;GOUZY ET AL., COMPUTERS AND CHEMISTRY, vol. 23, 1999, pages 333 - 340;;FALQUET ET AL., NUCLEIC ACIDS RES., vol. 30, 2002, pages 235 - 238",PENDING
755,TR,T4,TR 201815856 T4,194-479-280-033-168,2018-11-21,2018,TR 201815856 T,2014-01-17,US 201361754607 P,2013-01-20,Bradikinin-aracılı rahatsızlıkların değerlendirilmesi ve tedavisi.,"Mevcut açıklama, bir süjenin, örneğin, bir pKal-aracılı veya bradikinin-aracılı rahatsızlık riskinde olan veya bundan muzdarip bir süjenin, süjenin bir numunesindeki bozulmamış ve/veya klevaj edilmiş kininojenin değerlerine (örneğin, yüzdelerine) dayalı olarak değerlendirilmesinin yöntemlerini sağlamaktadır. Sağlanan yöntemler, plazma kallikrein-aracılı anjiyoödemi (KMA) veya pKal'in aracılık ettiği diğer hastalıkları olan hastaların, değerlendirmede ve tedavide faydalı analizine izin verir. Bu tip yöntemler, klevaj edilmiş kininojeni veya bozulmamış kininojeni tercihli olarak bağlayan bir saptama ajanının kullanımını içerebilir.",DYAX CORP,J DANIEL SEXTON;;RYAN FAUCETTE;;A JON KENNISTON;;GREG CONLEY;;ANDREW NIXON;;CHRISTOPHER TENHOOR;;BURT ADELMAN;;YUNG CHYUNG,,https://lens.org/194-479-280-033-168,Granted Patent,no,0,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40,,0,0,,,,ACTIVE
756,AU,C1,AU 2015/209481 C1,015-592-463-398-980,2020-10-29,2020,AU 2015/209481 A,2015-01-21,US 201461944361 P;;US 201462021397 P;;US 201461929716 P;;US 2015/0012212 W,2014-01-21,Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema,Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.,TAKEDA PHARMACEUTICALS CO,CHYUNG YUNG;;SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;IARROBINO RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/015-592-463-398-980,Amended Patent,no,1,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,C07K16/00;;A61K39/395;;A61K49/00;;G01N33/53,,2,0,,,"SEXTON DANIEL ET AL, JOURNAL OF ALLERGY AND CLINICAL IMMUNO, ELSEVIER, AMSTERDAM, NL, (2013-02-26), vol. 131, no. 2, Suppl. S, doi:10.1016/J.JACI.2012.12.795, ISSN 0091-6749, page AB32;;Ubc, ""Dyax's DX-2930 granted Orphan Drug designation in hereditary angioedema"", (2013-12-06), URL: http://www.ubc.com/dyaxs-dx-2930-granted-orphan-drug-designation-hereditary-angioedema, (2017-07-06)",ACTIVE
757,US,B2,US 7599516 B2,009-596-647-024-837,2009-10-06,2009,US 33134306 A,2006-01-13,US 33134306 A;;US 71018805 P,2005-08-23,Machine vision counting system apparatus and method,"A machine-vision-based counter includes an image acquisition component (imager), wherein light provides discrimination between a background field and imageable units located away from the imager. The imager outputs data representing the field and units; an image processor receiving imager data finds countable units therein. An operator interface accepts command inputs and presents count output. A controller manages image acquisition, processor, and operator interface functions. A counting method includes configuring an imager to detect light, directing light from a source to units positioned to be detected by the imager, and directing the light to the imager. The method includes discriminating between a background field and imageable units; providing, as an imager output, data representing the field and units; configuring an image-processor to receive imager data; configuring the processor to interpret the data as counted units on a background field; and configuring an operator interface to present a count result.",ILLINOIS TOOL WORKS,LIMER DANIEL J;;LANG DAVID A;;BURT CHRISTOPHER S;;GOUIN PHILIP R;;TARR NELSON D;;DISCHINGER RANDALL D,SPX CORPORATION (2008-02-21);;ILLINOIS TOOL WORKS INC (2008-12-31);;SPX CORPORATION (A DELAWARE CORPORATION) (2006-05-12),https://lens.org/009-596-647-024-837,Granted Patent,yes,39,44,6,6,0,A61J7/02;;G01N2015/1472;;G01N2015/1486;;G06M1/101;;G06M11/00;;G06V20/66;;G01N15/1433;;A61J7/02;;G01N2015/1486;;G01N2015/1472;;G06M1/101;;G06M11/00;;G01N15/1433,G06K9/00,382/100;;211/88.01;;453/4;;453/7,1,0,,,"International Search Report mailed Mar. 25, 2008; 2 pages.",ACTIVE
758,ZA,B,ZA 201605342 B,074-633-886-917-445,2020-11-25,2020,ZA 201605342 A,2016-08-02,US 201461929716 P;;US 201461944361 P;;US 201462021397 P;;US 2015/0012212 W,2014-01-21,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA,,DYAX CORP,YUNG CHYUNG;;DANIEL J SEXTON;;CHRISTOPHER TENHOOR;;JON A KENNISTON;;RYAN FAUCETTE;;JOSEPH BIEDENKAPP;;LARROBINO RYAN;;BURT ADELMAN,,https://lens.org/074-633-886-917-445,Granted Patent,no,0,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,,,0,0,,,,ACTIVE
759,AU,A1,AU 2015/209481 A1,089-410-997-915-713,2016-08-25,2016,AU 2015/209481 A,2015-01-21,US 201461944361 P;;US 201462021397 P;;US 201461929716 P;;US 2015/0012212 W,2014-01-21,Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema,Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.,DYAX CORP,CHYUNG YUNG;;SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;LARROBINO RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-20),https://lens.org/089-410-997-915-713,Patent Application,no,0,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,C07K16/00;;A61K39/395;;A61K49/00;;G01N33/53,,0,0,,,,ACTIVE
760,MX,A,MX 2021013665 A,147-729-961-145-020,2021-12-10,2021,MX 2021013665 A,2016-07-20,US 201461929716 P;;US 201461944361 P;;US 201462021397 P,2014-01-21,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA.,Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.,TAKEDA PHARMACEUTICALS CO,CHYUNG YUNG;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT;;SEXTON DANIEL J;;LARROBINO RYAN,,https://lens.org/147-729-961-145-020,Patent Application,no,0,0,45,46,0,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,C07K16/40;;A61K39/395;;A61P7/10;;A61P9/00;;G01N33/53,,0,0,,,,PENDING
761,EP,B1,EP 3456744 B1,168-989-794-443-858,2023-03-29,2023,EP 18186356 A,2014-01-17,US 201361754607 P;;EP 14740444 A;;US 2014/0012107 W,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,,TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREG;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-09-08),https://lens.org/168-989-794-443-858,Granted Patent,yes,0,0,50,50,0,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,C07K16/40;;G01N33/50,,1,1,109-028-520-036-638,2651524;;10.1016/0022-1759(89)90376-1,"REDDIGARI S ET AL: ""Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody"", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 119, no. 1, 21 April 1989 (1989-04-21), pages 19 - 25, XP023656916, ISSN: 0022-1759, [retrieved on 19890421], DOI: 10.1016/0022-1759(89)90376-1",ACTIVE
762,EP,A1,EP 3096798 A1,191-086-494-145-249,2016-11-30,2016,EP 15740774 A,2015-01-21,US 201461929716 P;;US 201461944361 P;;US 201462021397 P;;US 2015/0012212 W,2014-01-21,PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA,,DYAX CORP,CHYUNG YUNG;;SEXTON DANIEL J;;TENHOOR CHRISTOPHER;;KENNISTON JON A;;FAUCETTE RYAN;;IARROBINO RYAN;;BIEDENKAPP JOSEPH;;ADELMAN BURT,"TAKEDA PHARMACEUTICAL COMPANY LIMITED, JP (2022-07-06);;TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-09-08);;DYAX CORP. (2018-06-20);;TAKEDA PHARMACEUTICAL COMPANY LIMITED; JP (2021-11-05)",https://lens.org/191-086-494-145-249,Patent Application,yes,0,0,45,46,10,A61K2039/505;;A61K2039/545;;C07K2317/76;;C07K16/40;;A61P7/10;;A61P9/00;;C07K16/40;;A61K2039/505;;A61K2039/545;;A61K39/395;;A61P7/10;;A61P9/00;;C07K2317/565;;C07K2317/76;;C07K2317/92;;C12Y207/03002;;C12Y304/21034;;C07K16/40;;A61K2039/545;;A61K2039/505;;C07K2317/76;;A61P7/10;;A61P9/00;;A61K2039/505;;C07K2317/76;;A61K2039/545;;C07K16/40;;C07K2317/565;;C07K2317/92,A61K49/00;;A61K39/395;;C07K16/00;;G01N33/53,,0,0,,,,ACTIVE
763,JP,A,JP 2000153394 A,179-608-298-079-310,2000-06-06,2000,JP 30208399 A,1999-10-25,US 19336498 A,1998-11-17,MANUFACTURE OF BRAZING SHEET,"PROBLEM TO BE SOLVED: To improve a degree of freedom of a production by arranging a core material and a sheet having a joining clad and mechanically adhering flux to a sheet to conduct CAB brazing an aluminum brazing assembly with using a single process and with eliminating use of the flux. SOLUTION: In coating flux 19 on a sheet 13, the flux supplied in a flux hopper 22 is applied at a dry state by a general static electricity device or is applied at a wet state by using a carrier. When the flux 19 is rolled/applied on the sheet 13 between a pair of rollers 24 and heated/dried by the hot air from a heat source 26, the carrier of the flux 19 is evaporated, the flux 19 is left on the surface of the sheet 13, the sheet is coiled to a coiling wheel 32. By this method, a brazing sheet adhering the flux 19 can conduct stronger brazing by directly assembling, the flux is not required to apply on an assembly preassembled.",FORD GLOBAL TECH INC;;ALCOA INC,EVANS TIMOTHY VAN;;ZALUZEC MATTHEW J;;GRAB GERALD A;;MEHRABAN HENRY;;BURT RONALD P;;EYE JOHN B;;UYEDA STACY,,https://lens.org/179-608-298-079-310,Patent Application,no,0,5,4,4,0,B23K1/203;;B23K35/0238;;B23K35/286;;B23K35/3605;;F28D1/0391;;F28F3/025;;B23K35/36;;B23K35/0222;;B23K35/0227;;B23K35/0233;;B23K2101/14;;B23K2103/10;;B23K3/08;;B23K35/0238;;B23K1/203;;F28D1/0391;;F28F3/025;;B23K35/286;;B23K35/3605;;B23K35/0233;;B23K35/0222;;B23K35/0227;;B23K35/36;;B23K2101/14;;B23K2103/10,B23K1/20;;B23K3/08;;B23K35/40;;B23K35/02;;B23K35/22;;B23K35/28;;B23K35/36,,0,0,,,,PENDING
764,AU,A,AU 1997/026097 A,141-703-056-722-71X,1997-11-07,1997,AU 1997/026097 A,1997-04-07,US 63407296 A;;US 9705798 W,1996-04-17,"Bis(isobutyraldimine) of 1,4-diaminobutane in hdi trimer and biuret-based coatings",,ARCO CHEM TECH,TUCKER BENJAMIN W;;BARNOWSKI HENRY J;;BARSA EDWARD A;;WHITMAN PETER J;;CHEN AUGUSTIN T;;BURT WILLARD F;;GOLDSTEIN STEPHEN L;;O'CONNOR JAMES M,,https://lens.org/141-703-056-722-71X,Patent Application,no,0,0,3,3,0,C08G18/3256;;C08G18/7831;;C08G18/792;;C08G18/792;;C08G18/3256;;C08G18/7831,C08G18/32;;C08G18/78;;C08G18/79,,0,0,,,,PENDING
765,US,A1,US 2022/0170936 A1,098-579-980-435-158,2022-06-02,2022,US 202117491813 A,2021-10-01,US 202117491813 A;;US 201514761690 A;;US 2014/0012107 W;;US 201361754607 P,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,"The present disclosure provides methods of evaluating a subject, e.g., a subject at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder, based on values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject. Provided methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment. Such methods can involve the use of a detection agent that preferentially binds cleaved kininogen or intact kininogen.",TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2015-08-10),https://lens.org/098-579-980-435-158,Patent Application,yes,0,0,50,50,9,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,G01N33/573;;A61K39/395;;C07K7/06;;C07K16/36;;C07K16/40,,0,0,,,,PENDING
766,US,A,US 5185226 A,032-657-797-492-564,1993-02-09,1993,US 72335191 A,1991-06-28,US 72335191 A;;US 17161488 A;;US 27454288 A;;US 45355189 A,1988-03-23,Electrostatic method for multicolor imaging from a single toner bath comprising double-encapsulated toner particles,"An electrostatic method is disclosed for providing multicolor imaging from a single toner bath. The toner bath is a blend of individual toners, each of which contains a color precursor different from the others. Also disclosed is a method for the double encapsulation of toner particles to produce toner particles characterized by multiple encapsulation.",OLIN CORP,GROSSO PAUL V;;WING JR FEAGIN A;;MORGAN MICHAEL J;;STEGMEIER RENATE C;;DAY ROGER W;;BURT WILLARD F,OLIN CORPORATION A CORP. OF VA (1991-06-21),https://lens.org/032-657-797-492-564,Granted Patent,yes,12,41,1,16,0,G03G9/08;;G03G9/09;;G03G9/0928;;G03G9/093;;G03G13/0131;;G03G13/0133;;G03G9/0928;;G03G9/09;;G03G9/093;;G03G9/08;;G03G13/0131;;G03G13/0133,G03G9/08;;G03G9/09;;G03G9/093;;G03G13/01,430/47;;430/42;;430/45;;430/138,3,1,038-635-128-023-200,10.1021/cen-v066n002.p023,"Chemical Week, Mead Brings Color to Business , Dec. 13, 1987, pp. 32 33.;;Chemical & Engineering News, New Color Technology Uses Microcapsules , Jan. 11, 1988, p. 23.;;Olin Hunt Publication entitled Non Impact Printing .",EXPIRED
767,US,B2,US 11156612 B2,115-283-215-414-888,2021-10-26,2021,US 201414761690 A,2014-01-17,US 201414761690 A;;US 201361754607 P;;US 2014/0012107 W,2013-01-20,Methods of determining levels of cleaved and/or intact kininogen,"The present disclosure provides methods of evaluating a subject, e.g., a subject at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder, based on values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject. Provided methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment. Such methods can involve the use of a detection agent that preferentially binds cleaved kininogen or intact kininogen.",TAKEDA PHARMACEUTICALS CO,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2015-08-10),https://lens.org/115-283-215-414-888,Granted Patent,yes,55,2,50,50,9,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,G01N33/573;;A61K39/395;;C07K7/06;;C07K16/36;;C07K16/40,,70,50,012-206-824-167-831;;014-581-174-616-945;;092-309-561-609-370;;014-581-174-616-945;;143-067-441-552-591;;008-499-354-702-218;;046-363-627-958-215;;026-394-309-301-759;;001-680-842-915-740;;008-499-354-702-218;;029-371-596-652-443;;004-479-946-889-393;;014-581-174-616-945;;046-466-057-379-095;;064-409-159-039-974;;028-584-999-150-491;;082-795-239-301-865;;005-248-320-665-556;;030-422-305-823-971;;008-684-349-046-919;;042-513-826-438-891;;117-939-959-946-344;;012-206-824-167-831;;092-845-354-377-772;;006-789-023-934-519;;051-002-109-848-312;;088-462-073-629-715;;074-177-607-507-835;;080-844-532-992-816;;088-052-241-032-685;;109-028-520-036-638;;149-344-504-021-407;;078-352-985-001-170;;048-397-262-376-455;;133-940-816-817-578;;005-127-586-276-928;;125-182-572-021-927;;051-663-279-687-169;;144-602-947-164-877;;019-467-602-686-96X;;006-297-863-625-283;;028-104-991-485-38X;;006-769-540-567-683;;116-078-088-684-888;;065-684-189-547-526;;006-137-353-823-826;;126-568-744-168-22X;;007-994-211-905-538;;024-019-418-021-281;;004-782-005-460-503,10.1182/blood.v74.2.695.695;;10.1182/blood.v74.2.695.bloodjournal742695;;2752143;;7654936;;10.1097/00001721-199505000-00005;;2433279;;10.1016/s0021-9258(19)75800-1;;7654936;;10.1097/00001721-199505000-00005;;10.1182/blood.v122.21.2347.2347;;24980392;;10.1016/j.anai.2014.05.028;;10.1016/s0021-9150(01)00666-9;;11888508;;3730610;;10.1182/blood.v68.2.455.bloodjournal682455;;10.1182/blood.v68.2.455.455;;14572818;;10.1016/s1473-0502(03)00170-8;;24980392;;10.1016/j.anai.2014.05.028;;10.1016/s0973-3698(10)60075-1;;11150653;;10.1016/s0196-9781(00)00348-x;;7654936;;10.1097/00001721-199505000-00005;;10.1172/jci105959;;4974623;;pmc322187;;15306150;;10.1016/j.thromres.2004.05.005;;12842992;;10.1182/blood-2003-02-0661;;10.1111/j.1476-5381.1989.tb12688.x;;pmc1854808;;2692754;;10.1111/j.1365-2141.1984.tb03955.x;;6691922;;10.1016/j.jaci.2006.12.591;;10.1038/nmeth.f.353;;19124682;;10.1161/hypertensionaha.108.117663;;pmc4978181;;10.1016/0022-1759(94)00320-v;;7714339;;10.1182/blood.v74.2.695.695;;10.1182/blood.v74.2.695.bloodjournal742695;;2752143;;3501619;;10.1016/0049-3848(87)90434-8;;9129025;;10.1182/blood.v89.9.3213;;8182230;;10.1016/0091-6749(94)90380-8;;pmc3734293;;23940538;;10.1371/journal.pone.0070140;;10.1016/j.arcmed.2005.02.001;;15900628;;10.1016/s1081-1206(10)60493-0;;18814451;;10.1161/01.atv.0000240290.70852.c0;;pmc2637648;;16902163;;2651524;;10.1016/0022-1759(89)90376-1;;19691495;;10.1111/j.1742-4658.2009.07218.x;;10.1155/2014/683598;;pmc4020216;;24872599;;10.1097/xce.0000000000000009;;11099478;;10.1096/fj.99-1025com;;10.1021/bi00396a025;;2447941;;10.1046/j.1365-2796.1996.418764000.x;;8568479;;2451949;;10.1182/blood.v71.5.1334.bloodjournal7151334;;10.1182/blood.v71.5.1334.1334;;1727910;;10.1016/0014-5793(81)80174-3;;6912817;;483270;;10.1016/0049-3848(79)90058-6;;8856187;;10.1016/0162-3109(96)00086-0;;12190172;;10.1111/j.1572-0241.2002.05919.x;;10.1016/s0002-9270(02)04276-4;;10.1182/blood.v70.4.1053.bloodjournal7041053;;2443201;;10.1016/j.molmed.2008.12.001;;19162547;;24970892;;10.1074/jbc.m114.569061;;pmc4156074;;10.1016/j.jaci.2012.12.795;;22905925;;10.1111/j.1538-7836.2012.04890.x;;pmc3463646;;7947259;;10.1111/j.1365-2141.1994.tb04874.x;;10.1517/13543784.17.5.697;;18447596,"Dobo et al, PLoS ONE, 2011; vol. 6, No. 5, 1-8.;;Reddigari, S. R. & Kaplan, A. P., Blood, 1989, 74:695-702.;;Buhler R. et al. Blood Coagulation & Fibrinolysis, 1995, 6(3):223-232.;;Schmaier et al, (The Journal of Biological Chemistry, 1987; vol. 262, No. 25 pp. 1405-1411.;;Buhler R. et al. Blood Coagulation & Fibrinolysis, 1995, vol. 6. No. 3, pp. 223-232.;;Faucette et al, Blood, Oct. 2013, vol. 122, 2347.;;Chyung et al, Ann Allergy Asthma Immunology, 2014, vol. 113, pp. 460-466.;;Merlo et al, Atherosclerosis, 2002, vol. 161, pp. 261-261.;;Berrettini et al, Blood, 1987; vol. 68, No. 2, pp. 455-462.;;Williams et al, Transfusion and Apheresis Science, 2003, vol. 29, pp. 255-258.;;Chyung et al, Ann Allergy Asthma Immunology 113; 2014, pp. 460-466.;;Chaudhuri et al, Indian Journal of Rheumatology 2008, vol. 3, No. 1; pp. 21-28.;;Rheumatoid Arthritis, Merck Manual Professional Version, Dec. 2018.;;Alzheimer disease, Merck Manual Professional Version, Dec. 2019.;;Septic shock, Merck Manual Professional Version, Jan. 2020.;;Diabetic retinopathy, Merck Manual Professional Version, Jan. 2019.;;Blais et al., The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins. Peptides. Dec. 2000;21(12):1903-40. Review.;;Bühler et al., Improved detection of proteolytically cleaved high molecular weight kininogen by immunoblotting using an antiserum against its reduced 47 kDa light chain. Blood Coagul Fibrinolysis. May 1995;6(3):223-32.;;Colman et al., Studies on the prekallikrein (kallikreinogen)—kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins. J Clin Invest. Jan. 1969;48(1):11-22.;;Gallimore et al., Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis. Thromb Res. 2004;114(2):91-6.;;Isordia-Salas et al., The mutation Ser511Asn leads to N-glycosylation and increases the cleavage of high molecular weight kininogen in rats genetically susceptible to inflammation. Blood. Oct. 15, 2003;102(8):2835-42.;;Katori et al., Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in anaesthetized rats. Br J Pharmacol. Dec. 1989;98(4):1383-91.;;Kerbiriou-Nabias et al., Radioimmunoassays of human high and low molecular weight kininogens in plasmas and platelets. Br J Haematol. Feb. 1984;56(2):273-86.;;Ladner et al., Discovery of Ecallantide: A Potent and Selective Inhibitor of Plasma Kallikrein. J Allergy and Clinical Immuno. Jan. 1, 2007;119(1):S312.;;Nguyen et al., The Simple Western™: a gel-free, blot-free, hands-free Western blotting reinvention. Nature Methods. Oct. 28, 2011;8:5-6.;;Phipps et al., Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability. Hypertension. Feb. 2009;53(2):175-81. doi: 10.1161/HYPERTENSIONAHA.108.117663.;;Raymond et al., Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation. J Immunol Methods. Mar. 27, 1995;180(2):247-57.;;Reddigari et al., Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity. Blood. Aug. 1, 1989;74(2):695-702.;;Scott et al., A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate. Thromb Res. Dec. 15, 1987;48(6):685-700.;;U.S. Appl. No. 15/030,790, filed Apr. 20, 2016, Published, 2016-0252533.;;U.S. Appl. No. 15/030,811, filed Apr. 20, 2016, Published, 2016-0252527.;;PCT/US2014/061242, Feb. 3, 2015, International Search Report and Written Opinion.;;PCT/US2014/061242, May 6, 2016, International Preliminary Report on Patentability.;;EP 14740444.6, Jun. 17, 2016, Extended European Search Report.;;PCT/US2014/012107, Apr. 14, 2014, International Search Report and Written Opinion.;;PCT/US2014/012107, Jun. 30, 2015, International Preliminary Report on Patentability.;;PCT/US2014/061247, Feb. 4, 2015, International Search Report and Written Opinion.;;PCT/US2014/06124, May 6, 2016, International Preliminary Report on Patentability.;;[No Author Listed], Image Studio Suftware Compatible with Mac® Systems Now Available from LI-COR!. BioB Blog. May 8, 2012:1-3.;;Cugno et al., Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood. May 1, 1997;89(9):3213-8.;;Cugno et al., Activation of the contact system and fibronolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamic acid. J Allergy Clin Immunol. 1994;93(5):870-876.;;Defendi et al., Enzymatic assays for the diagnosis of bradykinin-dependent angioedema. PLoS One. Aug. 5, 2013;8(8):e70140. doi:10.1371/journal.pone.0070140. Print 2013. Erratum in: PLoS One. 2014;9(6):e100345.;;Isordia-Salas et al., The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation. Arch Med Res. Jan.-Feb. 2005;36(1):87-95.;;Joseph et al., Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma. Ann Allergy Asthma Immunol. Sep. 2008;101(3):279-86. doi: 10.1016/S1081-1206(10)60493-0.;;Khan et al., High-molecular-weight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac-1, and gC1qR in monocytes. Arterioscler Thromb Vasc Biol. Oct. 2006;26(10):2260-6. Epub Aug. 10, 2006. Erratum in: Arterioscler Thromb Vasc Biol. Nov. 2006;26(11):e146.;;Reddigari et al., Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody. J Immunol Methods. Apr. 21, 1982;119(1):19-25.;;Schousboe et al., High molecular wieht kininogen binds to laminin—characterization and kinetic analyis. FEBS Journal. 2009;276:5228-5238.;;Torzewski et al., Animal Models of c-Reactive Protein. Hindawi Publishing Corpl, Mediators of Inflammation. 2014:1-7.;;Van Der Vekens et al., Human and equine cardiovascular endrocrinology: beware to compare. Cardivosacular Endicronology. 2013;2(4):67-76.;;Zhang et al., Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5. FASEB J. Dec. 2000;14(15):2589-600.;;[No Author Listed], Mouse High Molecular Weight Kinnogen (HMWK) ELISA Kit (Cat. No. BMS089195). MyBiosource Datasheet. Jan. 2, 1984. Revtrieved from <https://www.mybiosource.com/prods/ELIS-A-Kit/Mouse/High-Molecular-Weight-Kinogen/HMWK/datasheet.php?products_id=89195> on Dec. 13, 2018. 4 pages.;;Ishiguro et al., Mapping of functional domains of human high molecular weight and low molecular weight kininogens using murine monoclonal antibodies. Biochemistry. Nov. 3, 1987;26(22):7021-9.;;Nielsen et al., Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses. J Intern Med. Feb. 1996;239(2):119-30.;;Reddigari et al., Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma. Blood. May 1988;71(5):1334-40.;;Scott et al., Sensitive antigenic determinations of high molecular weight kininogen performed by covalent coupling of capture antibody. J Lab Clin Med. Jan. 1992;119(1):77-86. Abstract only.;;Syvänen et al., A radioimmunoassay for the detection of molecular forms of human plasma kininogen. FEBS Lett. Jul. 6, 1981;129(2):241-5.;;Uchida et al., Differential assay method for high molecular weight and low molecular weight kininogens. Thromb Res. 1979;15(1-2):127-34.;;Cugno et al., Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies. Immunopharmacology. Jun. 1996;33(1-3):361-4.;;Devani et al., Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers. Am J Gastroenterol. Aug. 2002;97(8):2026-32.;;Veloso et al., A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface. Blood. Oct. 1987;70(4):1053-62.;;Cugno et al., C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med. Feb. 2009;15(2):69-78. doi: 10.1016/j.molmed.2008.12.001. Epub Jan. 21, 2009.;;Kenniston et al., Inhibition of plasma kallikrein by a highly specific active site blocking antibody. J Biol Chem. Aug. 22, 2014;289(34):23596-608. doi: 10.1074/jbc.M114.569061. Epub Jun. 26, 2014.;;Sexton et al., Discovery and Characterization of a Fully Human Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Treatment of Plasma Kallikrein-Mediated Edema. J. Allergy Clin. Immunol. Feb. 2013;131(2):AB32.;;U.S. Appl. No. 16/849,492, filed Apr. 14, 2020, Sexton et al.;;U.S. Appl. No. 17/141,690, filed Jan. 5, 2021, Sexton et al.;;Bennett R., BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX4161 for the Treatment of Hereditary Angioedema. BioCryst Pharmaceuticals, Inc. Mar. 25, 2013. 2 pages.;;Mutch et al., Immobilized transition metals stimulate contact activation and drive factor XII-mediated coagulation. J Thromb Haemost. Oct. 2012;10(10):2108-15. doi: 10.1111/j.1538-7836.2012.04890.x.;;Page et al., An autoantibody to human plasma prekallikrein blocks activation of the contact system. Br J Haematol. May 1994;87(1):81-6.;;Sexton et al., Inhibition of the plasma kallikrein-kinin system activation by DX-2930, a fully human monoclonal antibody inhibitor of plasma kallikrein. Journal of Angioedema. May 2013;1(1): 45.;;Zuraw et al., New promise and hope for treating hereditary angioedema. Expert Opin Investig Drugs. May 2008;17(5):697-706. doi: 10.1517/13543784.17.5.697.",ACTIVE
768,US,A1,US 2015/0362493 A1,174-342-523-517-069,2015-12-17,2015,US 201414761690 A,2014-01-17,US 201414761690 A;;US 201361754607 P;;US 2014/0012107 W,2013-01-20,EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS,"The present disclosure provides methods of evaluating a subject, e.g., a subject at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder, based on values (e.g., percentages) of intact and/or cleaved kininogen in a sample of the subject. Provided methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment. Such methods can involve the use of a detection agent that preferentially binds cleaved kininogen or intact kininogen.",DYAX CORP,SEXTON DANIEL J;;FAUCETTE RYAN;;KENNISTON JON A;;CONLEY GREGORY P;;NIXON ANDREW;;TENHOOR CHRISTOPHER;;ADELMAN BURT;;CHYUNG YUNG,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-02-26);;DYAX CORP (2015-08-10),https://lens.org/174-342-523-517-069,Patent Application,yes,5,6,50,50,9,C07K16/36;;A61P1/04;;A61P17/00;;A61P19/02;;A61P29/00;;A61P35/00;;A61P43/00;;A61P7/10;;A61P9/00;;G01N2333/96455;;C12Q1/56;;G01N33/5735;;G01N2800/065;;G01N2800/102;;C07K16/36;;A61P29/00;;A61P35/00;;C07K7/06;;C07K16/40;;G01N2800/70;;A61P19/02;;G01N2333/745;;A61P9/00;;A61P7/10;;G01N2800/52;;A61P17/00;;C07K2317/76;;A61P1/04;;A61P43/00;;C07K2317/21;;G01N33/6893;;G01N2800/065;;G01N2800/102;;A61K38/00;;G01N2333/96455;;G01N2800/085;;A61K2039/505;;C07K16/36;;A61K39/3955;;C07K7/06;;C07K16/40;;C07K2317/21;;C07K2317/76;;G01N33/5735;;G01N2333/745;;G01N2800/065;;G01N2800/102;;G01N2800/52;;G01N2800/70,G01N33/573;;C07K7/06;;C07K16/40,,5,4,012-206-824-167-831;;014-581-174-616-945;;092-309-561-609-370;;014-581-174-616-945,10.1182/blood.v74.2.695.695;;10.1182/blood.v74.2.695.bloodjournal742695;;2752143;;7654936;;10.1097/00001721-199505000-00005;;2433279;;10.1016/s0021-9258(19)75800-1;;7654936;;10.1097/00001721-199505000-00005,"Dobo et al, PLoS ONE, 2011; Vol. 6, No. 5, 1-8.;;Reddigari, S. R. & Kaplan, A. P., Blood, 1989, 74:695-702.;;Buhler R. et al. Blood Coagulation & Fibrinolysis, 1995, 6(3):223-232.;;Schmaier et al, (The Journal of Biological Chemistry, 1987; Vol. 262, No. 25 pages 1405-1411.;;Buhler R. et al. Blood Coagulation & Fibrinolysis, 1995, Vol: 6. No: 3, pages 223-232.",ACTIVE
769,US,A,US 5064736 A,161-179-817-078-867,1991-11-12,1991,US 45355189 A,1989-12-20,US 45355189 A;;US 17161488 A;;US 27454288 A,1988-03-23,Electrostatic method for multicolor imaging from a single toner bath,"An electrostatic method is disclosed for providing multicolor imaging from a single toner bath. The toner bath is a blend of individual toners, each of which contains a color precursor different from the others. Also disclosed is a method for the double encapsulation of toner particles to produce toner particles characterized by multiple encapsulation.",OLIN CORP,GROSSO PAUL V;;WING JR FEAGIN A;;MORGAN MICHAEL J;;STEGMEIER RENATE C;;DAY ROGER W;;BURT WILLARD F,OLIN CORPORATION A CORP. OF VA (1989-01-29),https://lens.org/161-179-817-078-867,Granted Patent,yes,16,4,1,16,0,G03G9/08;;G03G13/0131;;G03G9/08;;G03G9/09;;G03G9/09;;G03G9/0928;;G03G9/0928;;G03G9/093;;G03G9/093;;G03G13/0131;;G03G13/0133;;G03G13/0133,G03G9/08;;G03G9/09;;G03G9/093;;G03G13/01,430/42;;430/45;;430/47;;430/106;;430/138,3,1,038-635-128-023-200,10.1021/cen-v066n002.p023,"Chemical Week, Mead Brings Color to Business , Dec. 13, 1987, pp. 32 33.;;Chemical & Engineering News, New Color Technology Uses Microcapsules , Jan. 11, 1988, p. 23.;;Olin Hunt Publication entitled Non Impact Printing .",EXPIRED
770,WO,A1,WO 1997/039063 A1,131-403-087-012-30X,1997-10-23,1997,US 9705798 W,1997-04-07,US 63407296 A,1996-04-17,"BIS(ISOBUTYRALDIMINE) OF 1,4-DIAMINOBUTANE IN HDI TRIMER AND BIURET-BASED COATINGS","Disclosed are new coatings compositions based on an HDI isocyanurate or biuret polyisocyanate and a bis(imine) reaction product of a diaminoalkane containing between two and five carbon atoms with an alkyl aldehyde containing between four and seven carbon atoms (advantageously a bis(imine) product of the reaction of 1,4-diaminobutane and isobutyraldehyde). The latter bis(imine) is completely miscible in HDI isocyanurate and biuret polyisocyanates, and, as a reactive diluent, allows the preparation of high performance coatings formulations that require only small amounts of solvents to achieve a conveniently sprayable viscosity.",ARCO CHEM TECH,TUCKER BENJAMIN W;;BARNOWSKI HENRY J JR;;BARSA EDWARD A;;WHITMAN PETER J;;CHEN AUGUSTIN T;;BURT WILLARD F;;GOLDSTEIN STEPHEN L;;O'CONNOR JAMES M,,https://lens.org/131-403-087-012-30X,Patent Application,yes,5,4,3,3,0,C08G18/3256;;C08G18/7831;;C08G18/792;;C08G18/792;;C08G18/3256;;C08G18/7831,C08G18/32;;C08G18/78;;C08G18/79,,0,0,,,,PENDING
771,KR,A,KR 20100039459 A,176-482-859-362-379,2010-04-15,2010,KR 20107007176 A,2000-05-15,US 31464899 A;;US 34268899 A;;US 34268999 A;;US 34297199 A;;US 34310199 A;;US 34310499 A;;US 53107600 A;;US 54312500 A;;US 54766400 A;;US 55299800 A;;US 14146899 P;;US 15158699 P;;US 15801599 P;;US 16333299 P;;US 16461999 P,1999-05-19,METHODS AND SYSTEMS FOR CONTROLLING COMPUTERS OR LINKING TO INTERNET RESOURCES FROM PHYSICAL AND ELECTRONIC OBJECTS,"Physical or electronic objects are encoded with identifiers, which serve to trigger object-appropriate responses from computer systems that encounter such objects. The encoding may be steganographic (e.g., by digital watermarks), so the presence of such identifiers is not evident to persons encountering the objects. An exemplary application is a computer system that looks at a printed magazine advertisement (20) and initiates a link to a corresponding internet page. In one such implementation, the computer system senses an identifer encoded in the advertisement, forwards the identifier to a remote database, receives from the database (17) a corresponding internet address (18a, 18b, 18c), and directs a browser to that address (18a, 18b, 18c). The same arrangement can be used for on-line ordering from printed merchandise catalogs. Another application is a computer system that looks at a printed spreadsheet (20), and retrieves from disk storage an electonic version of the same document for editing.",DIGIMARC CORP,RHOADS GEOFFREY B;;RODRIGUEZ TONY F;;DAVIS BRUCE L;;CARR J SCOTT;;GROSSI BRIAN J;;MCKINLEY TYLER J;;SEDER PHILLIP A;;PERRY BURT W;;HEIN WILLIAM C;;MACINTOSH BRIAN T,,https://lens.org/176-482-859-362-379,Patent Application,no,0,0,6,1547,0,G06F16/9554;;G06Q30/02;;G06F16/9554;;G06Q30/02;;G07F17/26;;G07F17/26,G06F17/00;;G06F3/12;;G06F12/00;;G06F13/00;;G06F17/30;;G06K7/00;;G06K9/00;;G06K9/36;;G06K19/06;;G06Q30/02;;G06Q30/06;;G06Q50/00;;G07F17/26;;G09C5/00;;H04L9/00;;H04W4/02,,0,0,,,,EXPIRED
772,EP,A1,EP 1004390 A1,054-201-747-222-139,2000-05-31,2000,EP 99308895 A,1999-11-08,US 19336498 A,1998-11-17,Method of making a braze sheet,A method is disclosed of making a braze sheet for a brazed assembly. The method includes the steps of providing a sheet (13) of a core material (14) and a composition cladding (15) and mechanically embedding a flux (19) into the sheet (13).,FORD GLOBAL TECH INC,EVANS TIMOTHY VAN;;ZALUZEC MATTHEW J;;GRAB GERALD ADAM;;MEHRABAN HENRY;;BURT RONALD P;;UYEDA STACY Y;;EYE JOHN B,,https://lens.org/054-201-747-222-139,Patent Application,yes,2,11,4,4,0,B23K1/203;;B23K35/0238;;B23K35/286;;B23K35/3605;;F28D1/0391;;F28F3/025;;B23K35/36;;B23K35/0222;;B23K35/0227;;B23K35/0233;;B23K2101/14;;B23K2103/10;;B23K3/08;;B23K35/0238;;B23K1/203;;F28D1/0391;;F28F3/025;;B23K35/286;;B23K35/3605;;B23K35/0233;;B23K35/0222;;B23K35/0227;;B23K35/36;;B23K2101/14;;B23K2103/10,B23K1/20;;B23K3/08;;B23K35/02;;B23K35/40;;B23K35/22;;B23K35/28;;B23K35/36,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1996, no. 03 29 March 1996 (1996-03-29)",DISCONTINUED
773,US,A,US 6120848 A,019-756-735-518-784,2000-09-19,2000,US 19336498 A,1998-11-17,US 19336498 A,1998-11-17,Method of making a braze sheet,A method is disclosed of making a braze sheet for a brazed assembly. The method includes the steps of providing a sheet of a core material and a composition cladding and mechanically embedding a flux into the sheet.,FORD MOTOR CO;;ALCOA INC,VAN EVANS TIMOTHY;;ZALUZEC MATTHEW J;;GRAB GERRY A;;MEHRABAN HENRY;;BURT RONALD P;;UYEDA STACY Y;;EYE JOHN B,ALCOA INC (1999-11-19);;FORD MOTOR COMPANY (1998-11-06),https://lens.org/019-756-735-518-784,Granted Patent,yes,13,11,4,4,0,B23K1/203;;B23K35/0238;;B23K35/286;;B23K35/3605;;F28D1/0391;;F28F3/025;;B23K35/36;;B23K35/0222;;B23K35/0227;;B23K35/0233;;B23K2101/14;;B23K2103/10;;B23K3/08;;B23K35/0238;;B23K1/203;;F28D1/0391;;F28F3/025;;B23K35/286;;B23K35/3605;;B23K35/0233;;B23K35/0222;;B23K35/0227;;B23K35/36;;B23K2101/14;;B23K2103/10,B23K1/20;;B23K3/08;;B23K35/02;;B23K35/40;;B23K35/22;;B23K35/28;;B23K35/36,427/359;;427/475;;427/310;;427/376.1;;427/419.1;;427/428;;148/23;;148/26;;228/223;;228/224,0,0,,,,EXPIRED
774,JP,A,JP 2000197964 A,186-071-155-516-284,2000-07-18,2000,JP 31965399 A,1999-11-10,US 19140698 A,1998-11-12,BRAZED ASSEMBLY AND MANUFACTURE THEREOF,"PROBLEM TO BE SOLVED: To execute flux-brazing without applying a flux agent before assembling by joining at least one 1st component and at least one 2nd component during brazing process to each other. SOLUTION: A brazing sheet is manufactured, after applying a flux 19 to a thin sheet 13, by rolling and coating with a pair of rollers 24. The brazing sheet to which the flux 19 is mechanically stuck like this is used for manufacturing a beat exchanger assembly or the like. The thin sheet 13 possesses the flux 19 on either or both of the internal surface and external surface. In forming the component of the assembly, the brazing sheet is pressed, rolled and cut and is made into a tube, header, side support, fin, or the like. At this time, because the parts have the flux 19 on its internal surface, fluxing work in an assembly shop is unneccessitated.",FORD GLOBAL TECH INC;;ALCOA INC,SCHROEDER GREGORY T;;ZALUZEC MATTHEW J;;GRAB GERALD A;;EVANS TIMOTHY VAN;;EYE JOHN B;;BURT RONALD P;;UYEDA STACY,,https://lens.org/186-071-155-516-284,Patent Application,no,0,1,3,3,0,B23K1/19;;B23K3/08;;B23K1/0012;;B23K1/203;;B23K2101/14;;B23K2103/10,B23K3/08;;B23K1/00;;B23K1/19;;B23K1/20;;B23K3/00;;F28F1/00,,0,0,,,,PENDING
775,KR,A,KR 20090038942 A,022-888-478-067-515,2009-04-21,2009,KR 20097007254 A,2000-05-15,US 31464899 A;;US 34268899 A;;US 34268999 A;;US 34297199 A;;US 34310199 A;;US 34310499 A;;US 53107600 A;;US 54312500 A;;US 54766400 A;;US 55299800 A;;US 14146899 P;;US 15158699 P;;US 15801599 P;;US 16333299 P;;US 16461999 P,1999-05-19,METHODS AND SYSTEMS FOR CONTROLLING COMPUTERS OR LINKING TO INTERNET RESOURCES FROM PHYSICAL AND ELECTRONIC OBJECTS,"Physical or electronic objects are encoded with identifiers, which serve to trigger object-appropriate responses from computer systems that encounter such objects. The encoding may be steganographic (e.g., by digital watermarks), so the presence of such identifiers is not evident to persons encountering the objects. An exemplary application is a computer system that looks at a printed magazine advertisement (20) and initiates a link to a corresponding internet page. In one such implementation, the computer system senses an identifer encoded in the advertisement, forwards the identifier to a remote database, receives from the database (17) a corresponding internet address (18a, 18b, 18c), and directs a browser to that address (18a, 18b, 18c). The same arrangement can be used for on-line ordering from printed merchandise catalogs. Another application is a computer system that looks at a printed spreadsheet (20), and retrieves from disk storage an electonic version of the same document for editing.",DIGIMARC CORP,RHOADS GEOFFREY B;;RODRIGUEZ TONY F;;DAVIS BRUCE L;;CARR J SCOTT;;GROSSI BRIAN J;;MCKINLEY TYLER J;;SEDER PHILLIP A;;PERRY BURT W;;HEIN WILLIAM C;;MACINTOSH BRIAN T,,https://lens.org/022-888-478-067-515,Patent Application,no,0,3,6,1547,0,G06F16/9554;;G06Q30/02;;G06F16/9554;;G06Q30/02;;G07F17/26;;G07F17/26,G06F17/00;;G06F3/12;;G06F12/00;;G06F13/00;;G06F17/30;;G06K7/00;;G06K9/00;;G06K9/36;;G06K19/06;;G06Q30/02;;G06Q30/06;;G06Q50/00;;G07F17/26;;G09C5/00;;H04L9/00,,0,0,,,,EXPIRED
776,CA,A1,CA 2397055 A1,101-851-404-934-780,2001-07-19,2001,CA 2397055 A,2001-01-03,US 48382500 A;;US 0100133 W,2000-01-15,SYSTEM AND METHOD FOR WRITING FIBER GRATINGS,"A system (30) for writing fiber gratings has a plurality of writing stations (44, 46), each writing station (44, 46) including a fiber mounting fixture (52, 62) for receiving an optical fiber to be exposed to a beam (36) from a laser (34). The system includes a data capture module (54) for capturing dat a generated from the exposure of optical fibers in each writing stations (44, 46) and a steering assembly (48, 56, 58) for directing the laser beam (36) t o each of the plurality of writing stations (44, 46) in turn.",CORNING INC,MORGAN WALTER L;;MCGINNIS JAMES E;;D ALBERTO TIFFANIE G;;SCHMIDLIN EDWARD M;;SHULTZ MICHAEL G;;BURT RONALD L;;DAHLMAN JOSHUA J;;O'LOUGHLIN ROBERT J JR,,https://lens.org/101-851-404-934-780,Patent Application,no,0,0,7,7,0,G02B6/02138;;G02B6/02138,G02B6/02;;G03F7/20,,0,0,,,,DISCONTINUED
777,EP,A1,EP 1259842 A1,122-793-590-698-257,2002-11-27,2002,EP 01942419 A,2001-01-03,US 0100133 W;;US 48382500 A,2000-01-15,SYSTEM AND METHOD FOR WRITING FIBER GRATINGS,,CORNING INC,BURT RONALD L;;DAHLMAN JOSHUA J;;D ALBERTO TIFFANIE G;;MCGINNIS JAMES E;;MORGAN WALTER L;;O'LOUGHLIN ROBERT J JR;;SCHMIDLIN EDWARD M;;SHULTZ MICHAEL G,,https://lens.org/122-793-590-698-257,Patent Application,yes,0,0,7,7,0,G02B6/02138;;G02B6/02138,G02B6/02;;G03F7/20,,0,0,,,,DISCONTINUED
778,EP,A4,EP 1259842 A4,040-363-924-500-456,2005-05-04,2005,EP 01942419 A,2001-01-03,US 0100133 W;;US 48382500 A,2000-01-15,SYSTEM AND METHOD FOR WRITING FIBER GRATINGS,,CORNING INC,BURT RONALD L;;DAHLMAN JOSHUA J;;D ALBERTO TIFFANIE G;;MCGINNIS JAMES E;;MORGAN WALTER L;;O'LOUGHLIN ROBERT J JR;;SCHMIDLIN EDWARD M;;SHULTZ MICHAEL G,,https://lens.org/040-363-924-500-456,Search Report,no,10,0,7,7,0,G02B6/02138;;G02B6/02138,G02B6/02;;G03F7/20,,9,0,,,"PATENT ABSTRACTS OF JAPAN vol. 2000, no. 03 30 March 2000 (2000-03-30);;PATENT ABSTRACTS OF JAPAN vol. 006, no. 132 (E - 119) 17 July 1982 (1982-07-17);;PATENT ABSTRACTS OF JAPAN vol. 007, no. 116 (M - 216) 20 May 1983 (1983-05-20);;PATENT ABSTRACTS OF JAPAN vol. 001, no. 083 (M - 029) 30 July 1977 (1977-07-30);;PATENT ABSTRACTS OF JAPAN vol. 014, no. 271 (M - 0983) 12 June 1990 (1990-06-12);;PATENT ABSTRACTS OF JAPAN vol. 013, no. 560 (M - 906) 13 December 1989 (1989-12-13);;PATENT ABSTRACTS OF JAPAN vol. 009, no. 323 (P - 414) 18 December 1985 (1985-12-18);;PATENT ABSTRACTS OF JAPAN vol. 005, no. 111 (C - 063) 18 July 1981 (1981-07-18);;See also references of WO 0151971A1",DISCONTINUED
779,AU,A,AU 2001/029263 A,100-479-855-122-517,2001-07-24,2001,AU 2001/029263 A,2001-01-03,US 48382500 A;;US 0100133 W,2000-01-15,System and method for writing fiber gratings,,CORNING INC,BURT RONALD L;;DAHLMAN JOSHUA J;;ALBERTO TIFFANIE G D;;MCGINNIS JAMES E;;MORGAN WALTER L;;O'LOUGHLIN ROBERT J JR;;SCHMIDLIN EDWARD M;;SHULTZ MICHAEL G,,https://lens.org/100-479-855-122-517,Patent Application,no,0,0,7,7,0,G02B6/02138;;G02B6/02138,G02B6/02;;G03F7/20,,0,0,,,,DISCONTINUED
780,WO,A1,WO 2001/051971 A1,131-213-699-533-010,2001-07-19,2001,US 0100133 W,2001-01-03,US 48382500 A,2000-01-15,SYSTEM AND METHOD FOR WRITING FIBER GRATINGS,"A system (30) for writing fiber gratings has a plurality of writing stations (44, 46), each writing station (44, 46) including a fiber mounting fixture (52, 62) for receiving an optical fiber to be exposed to a beam (36) from a laser (34). The system includes a data capture module (54) for capturing data generated from the exposure of optical fibers in each writing stations (44, 46) and a steering assembly (48, 56, 58) for directing the laser beam (36) to each of the plurality of writing stations (44, 46) in turn.",CORNING INC,BURT RONALD L;;DAHLMAN JOSHUA J;;D ALBERTO TIFFANIE G;;MCGINNIS JAMES E;;MORGAN WALTER L;;O'LOUGHLIN ROBERT J JR;;SCHMIDLIN EDWARD M;;SHULTZ MICHAEL G,,https://lens.org/131-213-699-533-010,Patent Application,yes,2,1,7,7,0,G02B6/02138;;G02B6/02138,G02B6/02;;G03F7/20,,1,0,,,See also references of EP 1259842A4,PENDING
781,WO,A1,WO 2000/070585 A1,195-606-666-294-163,2000-11-23,2000,US 0013333 W,2000-05-15,US 31464899 A;;US 34268899 A;;US 34268999 A;;US 34297199 A;;US 34310199 A;;US 34310499 A;;US 14146899 P;;US 15158699 P;;US 15801599 P;;US 16333299 P;;US 16461999 P;;US 53107600 A;;US 54312500 A;;US 54766400 A;;US 55299800 A,1999-05-19,METHODS AND SYSTEMS FOR CONTROLLING COMPUTERS OR LINKING TO INTERNET RESOURCES FROM PHYSICAL AND ELECTRONIC OBJECTS,"Physical or electronic objects are encoded with identifiers, which serve to trigger object-appropriate responses from computer systems that encounter such objects. The encoding may be steganographic (e.g., by digital watermarks), so the presence of such identifiers is not evident to persons encountering the objects. An exemplary application is a computer system that looks at a printed magazine advertisement (20) and initiates a link to a corresponding internet page. In one such implementation, the computer system senses an identifer encoded in the advertisement, forwards the identifier to a remote database, receives from the database (17) a corresponding internet address (18a, 18b, 18c), and directs a browser to that address (18a, 18b, 18c). The same arrangement can be used for on-line ordering from printed merchandise catalogs. Another application is a computer system that looks at a printed spreadsheet (20), and retrieves from disk storage an electonic version of the same document for editing.",DIGIMARC CORP;;RHOADS GEOFFREY B;;RODRIGUEZ TONY F;;DAVIS BRUCE L;;CARR J SCOTT;;GROSSI BRIAN J;;MCKINLEY TYLER J;;SEDER PHILLIP A;;PERRY BURT W;;HEIN WILLIAM C III;;MACINTOSH BRIAN T,RHOADS GEOFFREY B;;RODRIGUEZ TONY F;;DAVIS BRUCE L;;CARR J SCOTT;;GROSSI BRIAN J;;MCKINLEY TYLER J;;SEDER PHILLIP A;;PERRY BURT W;;HEIN WILLIAM C III;;MACINTOSH BRIAN T,,https://lens.org/195-606-666-294-163,Patent Application,yes,9,60,14,1547,0,G06Q30/02;;G07F17/26;;G06F16/9554;;G06F17/00,G06F12/00;;G06F13/00;;G06F17/00;;G06F17/30;;G06K7/00;;G06K19/06;;G06Q30/02;;G06V30/224;;G07F17/26;;G09C5/00;;H04L9/00,,0,0,,,,PENDING
782,EP,A3,EP 1054335 A3,143-709-153-866-643,2003-12-17,2003,EP 00110633 A,2000-05-18,US 31464899 A;;US 34268899 A;;US 34268999 A;;US 34297199 A;;US 34310199 A;;US 34310499 A;;US 14146899 P;;US 15158699 P;;US 15801599 P;;US 16333299 P;;US 16461999 P;;US 53107600 A;;US 54312500 A;;US 54766400 A;;US 55299800 A,1999-05-19,Methods and systems for controlling computers or linking to internet resources from physical and electronic objects,"Physical or electronic objects are encoded with identifiers, which serve to trigger object-appropriate responses from computer systems that encounter such objects. The encoding may be steganographic (e.g., by digital watermarks), so the presence of such identifiers is not evident to persons encountering the objects. An exemplary application is a computer system that looks at a printed magazine advertisement and initiates a link to a corresponding internet page. In one such implementation, the computer system senses an identifier encoded in the advertisement, forwards the identifier to a remote database, receives from the database a corresponding internet address, and directs a browser to that address. The same arrangement can be used for on-line ordering from printed merchandise catalogs. Another application is a computer system that looks at a printed spreadsheet, and retrieves from disk storage an electronic version of the same document for editing. In one such implementation, the computer system senses an identifier encoded in the printed spreadsheet, checks the identifier against a local index of documents stored on the computer, and recalls the corresponding document for editing. A variety of other applications, and associated methods and apparatuses, are also disclosed.",DIGIMARC CORP,GROSSI BRIAN J;;SEDER PHILLIP A;;MCKINLEY TYLER J;;PERRY BURT W;;RHOADS GEOFFREY B;;DAVIS BRUCE L;;RODRIQUEZ TONY F;;CARR J SCOTT;;HEIN WILLIAM C III;;MACINTOSH BRIAN T,,https://lens.org/143-709-153-866-643,Search Report,yes,5,0,14,1547,0,G06Q30/02;;G07F17/26;;G06F16/9554;;G06F17/00,G06F12/00;;G06F13/00;;G06F17/00;;G06F17/30;;G06K7/00;;G06K19/06;;G06Q30/02;;G06V30/224;;G07F17/26;;G09C5/00;;H04L9/00,,2,0,,,"GAROFALAKIS J ET AL: ""Digital robbery;authors are not unprotected"", COMPUTER GRAPHICS INTERNATIONAL, 1998. PROCEEDINGS HANNOVER, GERMANY 22-26 JUNE 1998, LOS ALAMITOS, CA, USA,IEEE COMPUT. SOC, US, 22 June 1998 (1998-06-22), pages 558 - 563, XP010291474, ISBN: 0-8186-8445-3;;PATENT ABSTRACTS OF JAPAN vol. 1999, no. 05 31 May 1999 (1999-05-31)",DISCONTINUED
783,CA,A1,CA 2373511 A1,176-508-817-064-915,2000-11-23,2000,CA 2373511 A,2000-05-15,US 31464899 A;;US 34268899 A;;US 34268999 A;;US 34297199 A;;US 34310199 A;;US 34310499 A;;US 14146899 P;;US 15158699 P;;US 15801599 P;;US 16333299 P;;US 16461999 P;;US 53107600 A;;US 54312500 A;;US 54766400 A;;US 55299800 A;;US 0013333 W,1999-05-19,METHODS AND SYSTEMS FOR CONTROLLING COMPUTERS OR LINKING TO INTERNET RESOURCES FROM PHYSICAL AND ELECTRONIC OBJECTS,"Physical or electronic objects are encoded with identifiers, which serve to trigger object-appropriate responses from computer systems that encounter su ch objects. The encoding may be steganographic (e.g., by digital watermarks), s o the presence of such identifiers is not evident to persons encountering the objects. An exemplary application is a computer system that looks at a print ed magazine advertisement (20) and initiates a link to a corresponding internet page. In one such implementation, the computer system senses an identifer encoded in the advertisement, forwards the identifier to a remote database, receives from the database (17) a corresponding internet address (18a, 18b, 18c), and directs a browser to that address (18a, 18b, 18c). The same arrangement can be used for on-line ordering from printed merchandise catalogs. Another application is a computer system that looks at a printed spreadsheet (20), and retrieves from disk storage an electonic version of th e same document for editing.",DIGIMARC CORP,DAVIS BRUCE L;;MCKINLEY TYLER J;;SEDER PHILLIP A;;CARR J SCOTT;;GROSSI BRIAN J;;RHOADS GEOFFREY B;;MACINTOSH BRIAN T;;HEIN WILLIAM C III;;RODRIGUEZ TONY F;;PERRY BURT W,,https://lens.org/176-508-817-064-915,Patent Application,no,0,0,14,1547,0,G06Q30/02;;G07F17/26;;G06F16/9554;;G06F17/00,G06F12/00;;G06F13/00;;G06F17/00;;G06F17/30;;G06K7/00;;G06K19/06;;G06Q30/02;;G06V30/224;;G07F17/26;;G09C5/00;;H04L9/00,,0,0,,,,EXPIRED
784,AU,A1,AU 2005/205804 A1,098-020-389-168-702,2005-09-29,2005,AU 2005/205804 A,2005-09-02,AU 2000/048513 A;;US 31464899 A;;US 34268899 A;;US 34268999 A;;US 34297199 A;;US 34310199 A;;US 34310499 A;;US 14146899 P;;US 15158699 P;;US 15801599 P;;US 16333299 P;;US 16461999 P;;US 53107600 A;;US 54312500 A;;US 54766400 A;;US 55299800 A,1999-05-19,Methods and systems for controlling computers or linking to internet resources from physical and electronic objects,,DIGIMARC CORP,MACINTOSH BRIAN T;;HEIN WILLIAM C III;;SEDER PHILLIP A;;GROSSI BRIAN J;;DAVIS BRUCE L;;PERRY BURT W;;MCKINLEY TYLER J;;RHOADS GEOFFREY B;;RODRIGUEZ TONY F;;CARR J SCOTT,DIGIMARC CORPORATION (2009-02-12),https://lens.org/098-020-389-168-702,Patent Application,no,0,0,14,1547,0,G06Q30/02;;G07F17/26;;G06F16/9554;;G06F17/00,G06F12/00;;G06F13/00;;G06F17/00;;G06F17/30;;G06K7/00;;G06K19/06;;G06Q30/02;;G06V30/224;;G07F17/26;;G09C5/00;;H04L9/00,,0,0,,,,DISCONTINUED
785,AU,A,AU 2000/048513 A,081-376-142-663-269,2000-12-05,2000,AU 2000/048513 A,2000-05-12,US 16461999 P;;US 34268899 A;;US 34268999 A;;US 34297199 A;;US 34310199 A;;US 34310499 A;;US 0013333 W;;US 31464899 A;;US 14146899 P;;US 15158699 P;;US 15801599 P;;US 16333299 P;;US 53107600 A;;US 54312500 A;;US 54766400 A;;US 55299800 A,1999-05-19,Methods and systems for controlling computers or linking to internet resources from physical and electronic objects,,DIGIMARC CORP,GEOFFREY B RHOADS;;TONY F RODRIGUEZ;;BRUCE L DAVIS;;J SCOTT CARR;;BRIAN J GROSSI;;TYLER J MCKINLEY;;PHILLIP A SEDER;;BURT W PERRY;;WILLIAM C HEIN III;;BRIAN T MACINTOSH,,https://lens.org/081-376-142-663-269,Patent Application,no,0,0,14,1547,0,G06Q30/02;;G07F17/26;;G06F16/9554;;G06F17/00,G06F12/00;;G06F13/00;;G06F17/00;;G06F17/30;;G06K7/00;;G06K19/06;;G06Q30/02;;G06V30/224;;G07F17/26;;G09C5/00;;H04L9/00,,0,0,,,,PENDING
786,EP,A2,EP 1054335 A2,172-724-166-687-713,2000-11-22,2000,EP 00110633 A,2000-05-18,US 31464899 A;;US 34268899 A;;US 34268999 A;;US 34297199 A;;US 34310199 A;;US 34310499 A;;US 14146899 P;;US 15158699 P;;US 15801599 P;;US 16333299 P;;US 16461999 P;;US 53107600 A;;US 54312500 A;;US 54766400 A;;US 55299800 A,1999-05-19,Methods and systems for controlling computers or linking to internet resources from physical and electronic objects,"Physical or electronic objects are encoded with identifiers, which serve to trigger object-appropriate responses from computer systems that encounter such objects. The encoding may be steganographic (e.g., by digital watermarks), so the presence of such identifiers is not evident to persons encountering the objects. An exemplary application is a computer system that looks at a printed magazine advertisement and initiates a link to a corresponding internet page. In one such implementation, the computer system senses an identifier encoded in the advertisement, forwards the identifier to a remote database, receives from the database a corresponding internet address, and directs a browser to that address. The same arrangement can be used for on-line ordering from printed merchandise catalogs. Another application is a computer system that looks at a printed spreadsheet, and retrieves from disk storage an electronic version of the same document for editing. In one such implementation, the computer system senses an identifier encoded in the printed spreadsheet, checks the identifier against a local index of documents stored on the computer, and recalls the corresponding document for editing. A variety of other applications, and associated methods and apparatuses, are also disclosed.",DIGIMARC CORP,GROSSI BRIAN J;;SEDER PHILLIP A;;MCKINLEY TYLER J;;PERRY BURT W;;RHOADS GEOFFREY B;;DAVIS BRUCE L;;RODRIQUEZ TONY F;;CARR J SCOTT;;HEIN WILLIAM C III;;MACINTOSH BRIAN T,,https://lens.org/172-724-166-687-713,Patent Application,yes,0,111,14,1547,0,G06Q30/02;;G07F17/26;;G06F16/9554;;G06F17/00,G06F12/00;;G06F13/00;;G06F17/00;;G06F17/30;;G06K7/00;;G06K19/06;;G06Q30/02;;G06V30/224;;G07F17/26;;G09C5/00;;H04L9/00,,0,0,,,,DISCONTINUED
787,EP,A4,EP 1185967 A4,002-118-224-100-120,2004-11-03,2004,EP 00930749 A,2000-05-15,US 0013333 W;;US 31464899 A;;US 34268899 A;;US 34268999 A;;US 34297199 A;;US 34310199 A;;US 34310499 A;;US 14146899 P;;US 15158699 P;;US 15801599 P;;US 16333299 P;;US 16461999 P;;US 53107600 A;;US 54312500 A;;US 54766400 A;;US 55299800 A,1999-05-19,METHODS AND SYSTEMS FOR CONTROLLING COMPUTERS OR LINKING TO INTERNET RESOURCES FROM PHYSICAL AND ELECTRONIC OBJECTS,,DIGIMARC CORP,RHOADS GEOFFREY B;;RODRIGUEZ TONY F;;DAVIS BRUCE L;;CARR J SCOTT;;GROSSI BRIAN J;;MCKINLEY TYLER J;;SEDER PHILLIP A;;PERRY BURT W;;HEIN WILLIAM C III;;MACINTOSH BRIAN T,DIGIMARC CORPORATION (2005-05-11),https://lens.org/002-118-224-100-120,Search Report,no,4,0,14,1547,0,G06Q30/02;;G07F17/26;;G06F16/9554;;G06F17/00,G06F12/00;;G06F13/00;;G06F17/00;;G06F17/30;;G06K7/00;;G06K19/06;;G06Q30/02;;G06V30/224;;G07F17/26;;G09C5/00;;H04L9/00,,3,1,047-460-524-314-469,10.1147/sj.353.0313,"GAROFALAKIS J ET AL: ""Digital robbery;authors are not unprotected"", COMPUTER GRAPHICS INTERNATIONAL, 1998. PROCEEDINGS HANNOVER, GERMANY 22-26 JUNE 1998, LOS ALAMITOS, CA, USA,IEEE COMPUT. SOC, US, 22 June 1998 (1998-06-22), pages 558 - 563, XP010291474, ISBN: 0-8186-8445-3;;ZHAO J: ""a www service to embed and prove digital copyright watermarks"", PROCEEDINGS OF EUROPEAN CONFERENCE ON MULTIMEDIA APPLICATIONS, SERVICES AND TECHNIQUES, vol. 2, 28 May 1996 (1996-05-28) - 30 May 1996 (1996-05-30), LOUVAIN, BELGIUM, pages 695 - 709, XP000199921;;BENDER W ET AL: ""TECHNIQUES FOR DATA HIDING"", IBM SYSTEMS JOURNAL, IBM CORP. ARMONK, NEW YORK, US, vol. 35, no. 3/4, 1996, pages 313 - 335, XP000635079, ISSN: 0018-8670",DISCONTINUED
788,EP,A1,EP 1185967 A1,003-236-603-146-245,2002-03-13,2002,EP 00930749 A,2000-05-15,US 0013333 W;;US 31464899 A;;US 34268899 A;;US 34268999 A;;US 34297199 A;;US 34310199 A;;US 34310499 A;;US 14146899 P;;US 15158699 P;;US 15801599 P;;US 16333299 P;;US 16461999 P;;US 53107600 A;;US 54312500 A;;US 54766400 A;;US 55299800 A,1999-05-19,METHODS AND SYSTEMS FOR CONTROLLING COMPUTERS OR LINKING TO INTERNET RESOURCES FROM PHYSICAL AND ELECTRONIC OBJECTS,,DIGIMARC CORP,RHOADS GEOFFREY B;;RODRIGUEZ TONY F;;DAVIS BRUCE L;;CARR J SCOTT;;GROSSI BRIAN J;;MCKINLEY TYLER J;;SEDER PHILLIP A;;PERRY BURT W;;HEIN WILLIAM C III;;MACINTOSH BRIAN T,DIGIMARC CORPORATION (2005-05-11),https://lens.org/003-236-603-146-245,Patent Application,yes,0,2,14,1547,0,G06Q30/02;;G07F17/26;;G06F16/9554;;G06F17/00,G06F12/00;;G06F13/00;;G06F17/00;;G06F17/30;;G06K7/00;;G06K19/06;;G06Q30/02;;G06V30/224;;G07F17/26;;G09C5/00;;H04L9/00,,0,0,,,,DISCONTINUED
789,CA,C,CA 2373511 C,124-005-710-861-825,2014-07-08,2014,CA 2373511 A,2000-05-15,US 31464899 A;;US 34268899 A;;US 34268999 A;;US 34297199 A;;US 34310199 A;;US 34310499 A;;US 14146899 P;;US 15158699 P;;US 15801599 P;;US 16333299 P;;US 16461999 P;;US 53107600 A;;US 54312500 A;;US 54766400 A;;US 55299800 A;;US 0013333 W,1999-05-19,METHODS AND SYSTEMS FOR CONTROLLING COMPUTERS OR LINKING TO INTERNET RESOURCES FROM PHYSICAL AND ELECTRONIC OBJECTS,"Physical or electronic objects are encoded with identifiers, which serve to trigger object-appropriate responses from computer systems that encounter such objects. The encoding may be steganographic (e.g., by digital watermarks), so the presence of such identifiers is not evident to persons encountering the objects. An exemplary application is a computer system that looks at a printed magazine advertisement (20) and initiates a link to a corresponding internet page. In one such implementation, the computer system senses an identifer encoded in the advertisement, forwards the identifier to a remote database, receives from the database (17) a corresponding internet address (18a, 18b, 18c), and directs a browser to that address (18a, 18b, 18c). The same arrangement can be used for on-line ordering from printed merchandise catalogs. Another application is a computer system that looks at a printed spreadsheet (20), and retrieves from disk storage an electonic version of the same document for editing.",DIGIMARC CORP,RHOADS GEOFFREY B;;RODRIGUEZ TONY F;;DAVIS BRUCE L;;CARR J SCOTT;;GROSSI BRIAN J;;MCKINLEY TYLER J;;SEDER PHILLIP A;;PERRY BURT W;;HEIN WILLIAM C III;;MACINTOSH BRIAN T,,https://lens.org/124-005-710-861-825,Granted Patent,no,0,0,14,1547,0,G06Q30/02;;G07F17/26;;G06F16/9554;;G06F17/00,G06K7/00;;G06F12/00;;G06F13/00;;G06F17/00;;G06F17/30;;G06K19/06;;G06Q20/16;;G06Q30/02;;G06Q30/06;;G06V30/224;;G07F17/26;;G09C5/00;;H04L9/00,,0,0,,,,EXPIRED
790,US,A1,US 2018/0295732 A1,070-277-360-216-86X,2018-10-11,2018,US 201715482022 A,2017-04-07,US 201715482022 A,2017-04-07,HOUSING AND COMPLEMENTARY SNAP-FIT BRACKET,"A housing for an industrial sensor comprises integral U-shaped pockets configured to engage with attachment features of a complementary mounting bracket. The bracket comprises an overhang feature on a second end and a snap feature on an opposing first end. The housing can be mounted to the bracket by inserting a mounting boss formed within one of the U-shaped pockets underneath the overhang feature of the bracket, and pressing the housing against the bracket to cause the snap feature to engage with another mounting boss formed in the other U-shaped pocket. These mounting features allow the housing to be mounted easily and quickly without the use for additional tools. The housing can also be quickly removed from the bracket by pressing an extended tab near the snap feature to facilitate disengagement of the housing from the bracket.",ROCKWELL AUTOMATION TECH INC,SANTOS ROBERTO S;;TAMBEAU STEVEN R;;TAYLOR BRIAN J;;SACHERSKI BURT;;FOOKS ELIK I;;NAIR SURESH R;;FLANNERY MICHAEL;;WAKEFIELD SCOTT,ROCKWELL AUTOMATION TECHNOLOGIES INC (2017-03-24),https://lens.org/070-277-360-216-86X,Patent Application,yes,0,0,2,2,0,G01D11/245;;F16B2/10;;F16B5/121;;F16B5/126;;F16M11/041;;H05K5/0204;;F16M13/02;;F16B2/22;;H05K5/0204;;F16M13/02;;F16B2/22;;G01D11/245;;F16B5/126;;F16B2/10;;F16M11/041;;F16B5/121;;H05K5/0217,H05K5/02;;F16B2/22;;F16M13/02,,0,0,,,,ACTIVE
791,US,S,US D0817891 S,020-330-299-688-628,2018-05-15,2018,US 201729599883 F,2017-04-07,US 201729599883 F,2017-04-07,Smart tap housing,,ROCKWELL AUTOMATION TECH INC,SANTOS ROBERTO S;;TAMBEAU STEVEN R;;TAYLOR BRIAN J;;SACHERSKI BURT;;FOOKS ELIK I;;NAIR SURESH R;;FLANNERY MICHAEL;;WAKEFIELD SCOTT,ROCKWELL AUTOMATION TECHNOLOGIES INC (2017-04-04),https://lens.org/020-330-299-688-628,Design Right,no,0,3,1,1,0,,,1303;;D13/152,0,0,,,,ACTIVE
792,US,B2,US 10143097 B2,034-405-811-052-226,2018-11-27,2018,US 201715482022 A,2017-04-07,US 201715482022 A,2017-04-07,Housing and complementary snap-fit bracket,"A housing for an industrial sensor comprises integral U-shaped pockets configured to engage with attachment features of a complementary mounting bracket. The bracket comprises an overhang feature on a second end and a snap feature on an opposing first end. The housing can be mounted to the bracket by inserting a mounting boss formed within one of the U-shaped pockets underneath the overhang feature of the bracket, and pressing the housing against the bracket to cause the snap feature to engage with another mounting boss formed in the other U-shaped pocket. These mounting features allow the housing to be mounted easily and quickly without the use for additional tools. The housing can also be quickly removed from the bracket by pressing an extended tab near the snap feature to facilitate disengagement of the housing from the bracket.",ROCKWELL AUTOMATION TECH INC,SANTOS ROBERTO S;;TAMBEAU STEVEN R;;TAYLOR BRIAN J;;SACHERSKI BURT;;FOOKS ELIK I;;NAIR SURESH R;;FLANNERY MICHAEL;;WAKEFIELD SCOTT,ROCKWELL AUTOMATION TECHNOLOGIES INC (2017-03-24),https://lens.org/034-405-811-052-226,Granted Patent,yes,14,2,2,2,0,G01D11/245;;F16B2/10;;F16B5/121;;F16B5/126;;F16M11/041;;H05K5/0204;;F16M13/02;;F16B2/22;;H05K5/0204;;F16M13/02;;F16B2/22;;G01D11/245;;F16B5/126;;F16B2/10;;F16M11/041;;F16B5/121;;H05K5/0217,H05K5/02;;F16B2/22;;F16M13/02,,8,0,,,"Eaton, Product Range Catalog. Connect Switchgear intelligently with SmartWire-DT® Operate Machines and Systems efficiently. 2012, 85 pages, Publication No. CA0506001Z-EN-INT Doku/DHW/ip 05/15, Article No. 153577, Printed in Germany, Eaton Corporation, www.eaton.eu/swd.;;Efector, IFM, AC2316 Dual Sensor T5 2SI 1DO T M12, May 12, 2011, 2 pages, IFM Ecefotr, Inc, Malvern PA.;;Pilz, Passive junction—PDP67 F 4 code, Dec. 2009, 2 pages, Pilz GmbH & Co. KG, Germany, www.pilz.com.;;Sick, Sensor Intelligence Flexi Classic Efficient Control to the End of the Line, May 8, 2015, 32 pages, 8011770, Sick AG, Germany, www.sick.com.;;Eaton, SmartWire-DT Modules IP67 Manual, May 2015, 112 pages, MN012006ZEN, Eaton Industries GmbH, www.eaton.com.;;Eaton, Connect Intelligently Increase Availability Cost Optimization, 2014, 24 pages, Article No. 118731, Eaton corporation, Printed in Germany.;;Sick, Sensor Intelligence Flexi Loop Safe sensor cascade hardware Operating Manual, May 24, 2016, 104 pages, Sick AG, Germany, www.sick.com.;;Office Action for U.S. Appl. No. 29/599,883 dated Dec. 29, 2017, 16 pages.",ACTIVE
793,EP,A4,EP 3908353 A4,193-259-769-824-052,2022-10-26,2022,EP 20755022 A,2020-02-11,US 201962804032 P;;US 201962892743 P;;US 2020/0017752 W,2019-02-11,FIXATION DEVICES FOR CATHETERS,,ALCYONE THERAPEUTICS INC,ANAND PJ;;SINGH DEEP ARJUN;;EAST ANDREW;;WASHBURN THOMAS T;;VEETEKAT RAHUL;;BETTE NICOLE;;FLEEGE CHRIS;;LAPINSKI MATTHEW J;;RAYMOND BURT,"ALCYONE THERAPEUTICS, INC. (2022-04-27)",https://lens.org/193-259-769-824-052,Search Report,no,5,0,5,5,0,A61M2025/0286;;A61M25/02;;A61M2025/0286;;A61M25/04;;A61M2025/0246;;A61M2025/028;;A61M2025/0253;;A61M2025/0206;;A61M2025/0266;;A61M2025/024,A61M25/02;;A61M25/00;;A61M25/01;;A61M39/10,,0,0,,,,PENDING
794,US,A1,US 2020/0254222 A1,154-396-419-926-012,2020-08-13,2020,US 202016788192 A,2020-02-11,US 202016788192 A;;US 201962892743 P;;US 201962804032 P,2019-02-11,FIXATION DEVICES FOR CATHETERS,"Fixation devices are disclosed herein that can be used to secure to a catheter. The fixation devices include a body having a central bore extending therethrough to receive a catheter and at least one end having a tapered profile tapering inwardly a distal edge thereof. The body can include an expanded intermediate portion, such as one or more bulbous portions. The fixation devices can also include suture openings or grooves to secure the devices to tissue.",ALCYONE LIFESCIENCES INC,ANAND PJ;;SINGH DEEP ARJUN;;EAST ANDREW;;WASHBURN THOMAS T;;VEETEKAT RAHUL;;BETTÈ NICOLE;;FLEEGE CHRIS;;LAPINSKI MATTHEW J;;RAYMOND BURT,ALCYONE THERAPEUTICS INC (2020-11-25),https://lens.org/154-396-419-926-012,Patent Application,yes,10,2,5,5,0,A61M2025/0286;;A61M25/02;;A61M2025/0286;;A61M25/04;;A61M2025/0246;;A61M2025/028;;A61M2025/0253;;A61M2025/0206;;A61M2025/0266;;A61M2025/024,A61M25/04,,0,0,,,,ACTIVE
795,EP,A1,EP 3908353 A1,067-330-184-583-856,2021-11-17,2021,EP 20755022 A,2020-02-11,US 201962804032 P;;US 201962892743 P;;US 2020/0017752 W,2019-02-11,FIXATION DEVICES FOR CATHETERS,,ALCYONE LIFESCIENCES INC,ANAND PJ;;SINGH DEEP ARJUN;;EAST ANDREW;;WASHBURN THOMAS T;;VEETEKAT RAHUL;;BETTE NICOLE;;FLEEGE CHRIS;;LAPINSKI MATTHEW J;;RAYMOND BURT,"ALCYONE THERAPEUTICS, INC. (2022-04-27)",https://lens.org/067-330-184-583-856,Patent Application,yes,0,0,5,5,0,A61M2025/0286;;A61M25/02;;A61M2025/0286;;A61M25/04;;A61M2025/0246;;A61M2025/028;;A61M2025/0253;;A61M2025/0206;;A61M2025/0266;;A61M2025/024,A61M25/02;;A61M25/00;;A61M25/01;;A61M39/10,,0,0,,,,PENDING
796,WO,A2,WO 2014/159501 A2,192-283-228-497-937,2014-10-02,2014,US 2014/0023938 W,2014-03-12,US 201361782359 P,2013-03-14,PROCESSES FOR PREPARING TETRAHYDROISOQUINOLINES,"Disclosed are processes for preparing tetrahydroisoquinolines, intermediates useful in the preparation of tetrahydroisoquinolines, processes for preparing such intermediates, and compositions comprising the tetrahydroisoquinolines and other compounds, e.g, intermediates and by-products of the processes described herein. Pharmaceutical compositions comprising tetrahydroisoquinolines, methods of using tetrahydroisoquinolines in the treatment of depression are also disclosed.",BRISTOL MYERS SQUIBB CO,GONZALEZ-BOBES FRANCISCO;;CONLON DAVID ALAN;;LOBBEN PAUL C;;BURT JUSTIN LOCKHEART;;ENGSTROM JOSHUA;;WEI CAROLYN S;;ZHU JASON J;;FAN YU,,https://lens.org/192-283-228-497-937,Patent Application,yes,0,0,3,3,0,C07D217/04;;C07D401/04;;A61K9/2018;;A61K9/2054;;A61K9/2059;;A61K9/284;;A61K9/2853;;A61K31/501;;A61P25/00;;C07D217/04;;C07D401/04;;A61K9/2059;;A61K9/2054;;A61K9/284;;A61K9/2853;;A61K9/2018;;A61K31/501;;A61K9/20;;A61K9/48,C07D217/04,,0,0,,,,PENDING
797,WO,A3,WO 2014/159501 A3,093-605-310-156-736,2014-11-20,2014,US 2014/0023938 W,2014-03-12,US 201361782359 P,2013-03-14,PROCESSES FOR PREPARING TETRAHYDROISOQUINOLINES,"Disclosed are processes for preparing tetrahydroisoquinolines, intermediates useful in the preparation of tetrahydroisoquinolines, processes for preparing such intermediates, and compositions comprising the tetrahydroisoquinolines and other compounds, e.g, intermediates and by-products of the processes described herein. Pharmaceutical compositions comprising tetrahydroisoquinolines, methods of using tetrahydroisoquinolines in the treatment of depression are also disclosed.",BRISTOL MYERS SQUIBB CO,GONZALEZ-BOBES FRANCISCO;;CONLON DAVID ALAN;;LOBBEN PAUL C;;BURT JUSTIN LOCKHEART;;ENGSTROM JOSHUA;;WEI CAROLYN S;;ZHU JASON J;;FAN YU,,https://lens.org/093-605-310-156-736,Search Report,yes,3,0,3,3,0,C07D217/04;;C07D401/04;;A61K9/2018;;A61K9/2054;;A61K9/2059;;A61K9/284;;A61K9/2853;;A61K31/501;;A61P25/00;;C07D217/04;;C07D401/04;;A61K9/2059;;A61K9/2054;;A61K9/284;;A61K9/2853;;A61K9/2018;;A61K31/501;;A61K9/20;;A61K9/48,A61K31/501;;C07D217/04;;A61P25/00;;C07D401/04,,0,0,,,,PENDING
798,EP,A1,EP 0679954 A1,117-736-780-058-590,1995-11-02,1995,EP 95302665 A,1995-04-21,US 23383294 A,1994-04-26,Photoconductive imaging members containing metallophthalocyanine dimers.,"Photoconductive imaging members comprised of an alkoxy-bridged metallophthalocyanine dimer as a charge generator material, wherein said dimer is of the formula C₃₂H₁₆N₈MOROMN₈H₁₆C₃₂ wherein M is a trivalent metal, and R is an alkyl group or an alkyl ether group.
 ",XEROX CORP,BURT RICHARD A;;KEOSHKERIAN BARKEV;;LIEBERMANN GEORGE;;HSIAO CHENG-KUO;;GARDNER SANDRA J;;MURTI DASARAO K;;DAIMON KATSUMI;;SAKAGUCHI YASUO;;IGARASHI RYOSAKU,,https://lens.org/117-736-780-058-590,Patent Application,yes,2,1,10,10,0,C09B47/045;;G03G5/0696;;C09B47/045;;G03G5/0696,C09B47/04;;G03G5/06,,1,0,,,"DATABASE WPI Week 9415, Derwent World Patents Index; AN 94-124213",EXPIRED
799,US,A,US 5456998 A,022-851-539-357-104,1995-10-10,1995,US 23383294 A,1994-04-26,US 23383294 A,1994-04-26,Photoconductive imaging members containing alkoxy-bridged metallophthalocyanine dimers,"Photoconductive imaging members comprised of an alkoxy-bridged metallophthalocyanine dimer as a charge generator material, wherein said dimer is of the formula C.sub.32 H.sub.16 N.sub.8 MOROMN.sub.8 H.sub.16 C.sub.32 wherein M is a trivalent metal, and R is an alkyl group or an alkyl ether group ##STR1##",XEROX CORP,BURT RICHARD A;;KEOSHKERIAN BARKEV;;LIEBERMANN GEORGE;;HSIAO CHENG-KUO;;GARDNER SANDRA J;;MURTI DASARAO K;;DAIMON KATSUMI;;SAKAGUCHI YASUO;;IGARASHI RYOSAKU,FUJI XEROX COMPANY LTD (1995-03-31);;XEROX CORPORATION (1995-03-31),https://lens.org/022-851-539-357-104,Granted Patent,yes,9,26,10,10,0,C09B47/045;;G03G5/0696;;C09B47/045;;G03G5/0696,C09B47/04;;G03G5/06,430/58;;430/59;;430/78,5,3,111-036-676-518-109;;028-777-494-013-142;;037-530-097-486-319,10.1021/ic50212a061;;10.1021/ic50122a047;;10.1021/ic00242a029,"Inorganic Chemistry, 19, Studies of A Series of Haloaluminum, gallium, and indium Phthalocyanines , Linsky et al., pp. 3131 3135 (1980).;;Bull. Soc. Chim. Fr., 23 (1962), D. Colaitis.;;Russ. J. Phys. Chem. (Engl. Transl.), 41, 251, 1967, I. S. Kirin et al.;;Inorg. Chem. 12, 930, 1973, W. R. Bennett et al.;;Inorg. Chem., 25, 3972, 1986, C. Ercolani et al.",EXPIRED
800,BR,A,BR 9501785 A,041-389-436-306-912,1996-02-27,1996,BR 9501785 A,1995-04-25,US 23383294 A,1994-04-26,Membros formadores de imagens fotocondutores,,XEROX CORP,BURT RICHARD A;;KEOSHKERIAN BARKEV;;LIEBERMANN GEORGE;;HSIAQ CHENG-KUO;;GARDNER SANDRA J;;MURTI DASARAO K;;DAIMON KATSUMI;;SAKAGUCHI YASUO;;IGARASHI RYOSAKU,,https://lens.org/041-389-436-306-912,Patent Application,no,0,0,10,10,0,C09B47/045;;G03G5/0696;;C09B47/045;;G03G5/0696,C09B47/04;;G03G5/06,,0,0,,,,EXPIRED
801,US,A1,US 2016/0022675 A1,154-595-430-988-478,2016-01-28,2016,US 201414774522 A,2014-03-12,US 201414774522 A;;US 201361782359 P;;US 2014/0023938 W,2013-03-14,PROCESSES FOR PREPARING TETRAHYDROISOQUINOLINES,"Disclosed are processes for preparing tetrahydroisoquinolines, intermediates useful in the preparation of tetrahydroisoquinolines, processes for preparing such intermediates, and compositions comprising the tetrahydroisoquinolines and other compounds, e.g, intermediates and by-products of the processes described herein. Pharmaceutical compositions comprising tetrahydroisoquinolines, methods of using tetrahydroisoquinolines in the treatment of depression are also disclosed.",BRISTOL MYERS SQUIBB CO,GONZALEZ-BOBES FRANCISCO;;CONLON DAVID ALAN;;LOBBEN PAUL C;;BURT JUSTIN LOCKHEART;;ENGSTROM JOSHUA;;WEI CAROLYN S;;ZHU JASON J;;FAN YU,BRISTOL-MYERS SQUIBB COMPANY (2014-05-07);;ALBANY MOLECULAR RESEARCH INC (2016-05-06),https://lens.org/154-595-430-988-478,Patent Application,yes,1,1,3,3,0,C07D217/04;;C07D401/04;;A61K9/2018;;A61K9/2054;;A61K9/2059;;A61K9/284;;A61K9/2853;;A61K31/501;;A61P25/00;;C07D217/04;;C07D401/04;;A61K9/2059;;A61K9/2054;;A61K9/284;;A61K9/2853;;A61K9/2018;;A61K31/501;;A61K9/20;;A61K9/48,A61K31/501;;A61K9/20;;A61K9/48;;C07D217/04,,0,0,,,,DISCONTINUED
802,EP,B1,EP 0679954 B1,165-422-898-658-654,1999-07-14,1999,EP 95302665 A,1995-04-21,US 23383294 A,1994-04-26,Photoconductive imaging members containing metallophthalocyanine dimers,,XEROX CORP,BURT RICHARD A;;KEOSHKERIAN BARKEV;;LIEBERMANN GEORGE;;HSIAO CHENG-KUO;;GARDNER SANDRA J;;MURTI DASARAO K;;DAIMON KATSUMI;;SAKAGUCHI YASUO;;IGARASHI RYOSAKU,,https://lens.org/165-422-898-658-654,Granted Patent,yes,2,0,10,10,0,C09B47/045;;G03G5/0696;;C09B47/045;;G03G5/0696,C09B47/04;;G03G5/06,,1,0,,,"DATABASE WPI Week 9415 Derwent Publications Ltd., London, GB; AN 94-124213 & JP-A-06 073 299 (FUJI XEROX) , 15 March 1994",EXPIRED
803,DE,T2,DE 69510721 T2,116-729-157-605-503,1999-12-02,1999,DE 69510721 T,1995-04-21,US 23383294 A,1994-04-26,Metallophthalocyanine-Dimere enthaltende photoleitflähige Bildherstellungselemente,,XEROX CORP,BURT RICHARD A;;KEOSHKERIAN BARKEV;;LIEBERMANN GEORGE;;HSIAO CHENG-KUO;;GARDNER SANDRA J;;MURTI DASARAO K;;DAIMON KATSUMI;;SAKAGUCHI YASUO;;IGARASHI RYOSAKU,,https://lens.org/116-729-157-605-503,Granted Patent,no,0,0,10,10,0,C09B47/045;;G03G5/0696;;C09B47/045;;G03G5/0696,C09B47/04;;G03G5/06,,0,0,,,,EXPIRED
804,DE,D1,DE 69510721 D1,117-377-210-363-970,1999-08-19,1999,DE 69510721 T,1995-04-21,US 23383294 A,1994-04-26,Metallophthalocyanine-Dimere enthaltende photoleitflähige Bildherstellungselemente,,XEROX CORP,BURT RICHARD A;;KEOSHKERIAN BARKEV;;LIEBERMANN GEORGE;;HSIAO CHENG-KUO;;GARDNER SANDRA J;;MURTI DASARAO K;;DAIMON KATSUMI;;SAKAGUCHI YASUO;;IGARASHI RYOSAKU,,https://lens.org/117-377-210-363-970,Granted Patent,no,0,0,10,10,0,C09B47/045;;G03G5/0696;;C09B47/045;;G03G5/0696,C09B47/04;;G03G5/06,,0,0,,,,EXPIRED
805,CA,A1,CA 2147784 A1,154-615-381-432-937,1995-10-27,1995,CA 2147784 A,1995-04-25,US 23383294 A,1994-04-26,PHOTOCONDUCTIVE IMAGING MEMBERS CONTAINING ALKOXY-BRIDGED METALLOPHTHALOCYANINE DIMERS,"Photoconductive imaging members comprised of an alkoxybridged metallophthalocyanine dimer as a charge generator material, wherein said dimer is of the formula C32H16N8MOROMN8H16C32wherein M is a trivalent metal, and R is an alkyl group or an alkyl ether group <IMG>",XEROX CORP,BURT RICHARD A;;KEOSHKERIAN BARKEV;;LIEBERMANN GEORGE;;HSIAO CHENG-KUO;;GARDNER SANDRA J;;MURTI DASARAO K;;DAIMON KATSUMI;;SAKAGUCHI YASUO;;IGARASHI RYOSAKU,,https://lens.org/154-615-381-432-937,Patent Application,no,0,0,10,10,0,C09B47/045;;G03G5/0696;;C09B47/045;;G03G5/0696,C09B47/04;;G03G5/06,,0,0,,,,EXPIRED
806,CA,C,CA 2147784 C,136-524-135-143-455,2001-04-10,2001,CA 2147784 A,1995-04-25,US 23383294 A,1994-04-26,PHOTOCONDUCTIVE IMAGING MEMBERS CONTAINING ALKOXY-BRIDGED METALLOPHTHALOCYANINE DIMERS,"Photoconductive imaging members comprised of an alkoxy- bridged metallophthalocyanine dimer as a charge generator material, wherein said dimer is of the formula C32H16N8MOROMN8H16C32wherein M is a trivalent metal, and R is an alkyl group or an alkyl ether group",,BURT RICHARD A;;KEOSHKERIAN BARKEV;;LIEBERMANN GEORGE;;HSIAO CHENG-KUO;;GARDNER SANDRA J;;MURTI DASARAO K;;DAIMON KATSUMI;;SAKAGUSHI YASUO;;IGARASHI RYOSAKU,,https://lens.org/136-524-135-143-455,Granted Patent,no,0,0,10,10,0,C09B47/045;;G03G5/0696;;C09B47/045;;G03G5/0696,C09B47/04;;G03G5/06,,0,0,,,,EXPIRED
807,CA,A1,CA 2502232 A1,150-507-429-995-947,2004-04-29,2004,CA 2502232 A,2003-10-14,US 41876202 P;;US 42125402 P;;US 49470903 P;;US 49523603 P;;US 49537303 P;;US 0332886 W,2002-10-15,IDENTIFICATION DOCUMENT AND RELATED METHODS,"The present invention provides methods and systems for authenticating identification documents (100). We also teach an identification document (10 0) including two or more digital watermarks (27, 60). The watermarks correspond with each other or with indicia carried by the identification document (100) . The correspondence can be verified to determine authenticity. We also provid e digital watermark detection methods and systems to identify the different watermarks (100) through embedded orientation components. We then focus watermark message-decoding efforts on areas identified as likely including watermark orientation components (27, 60). In one implementation we provide a watermark detection trigger to identify so-called legacy documents. The trigger may indicate the presence or expected absence of a digital watermark . In other implementations we provide a versatile document authenticator to toggle between watermarking and non-watermarking authentication processes depending on a detection trigger (100).",DIGIMARC CORP,HANNIGAN BRETT T;;BRADLEY BRETT ALAN;;STACH JOHN;;PERRY BURT W;;DURST ROBERT T;;WEAVER MATTHEW M;;BRUNDAGE TRENT J;;SHER-JAN MAHMOOD,,https://lens.org/150-507-429-995-947,Patent Application,no,0,0,11,31,0,B42D2035/34;;G06T1/0071;;G06T2201/0051;;G07F7/08;;G07F7/086;;G07F7/12;;H04N1/32144;;H04N1/32288;;H04N1/32352;;H04N2201/3233;;H04N2201/3235;;H04N2201/327;;G06Q20/347;;G06Q20/401;;G06T1/0028;;G09C5/00;;H04K1/00;;H04L9/3231;;H04N1/32304;;H04N2201/3205;;H04L2209/56;;H04L2209/608;;H04L2209/805;;B42D25/00;;B42D25/309;;G07D7/0034;;B42D25/47;;B42D25/23;;B42D25/333;;B42D25/20;;G06T2201/0051;;H04N2201/327;;G06T1/0071;;H04N2201/3233;;H04N1/32352;;H04N1/32144;;G07F7/12;;G07F7/086;;H04N2201/3235;;H04N1/32288;;G07F7/08;;G09C5/00;;G06T1/0028;;H04K1/00;;G06Q20/401;;H04N1/32304;;G06Q20/347;;H04L2209/56;;H04L9/3231;;H04L2209/805;;H04L2209/608;;H04N2201/3205;;B42D25/00;;B42D25/309;;G07D7/0034,B42D15/10;;G06T1/00;;G07D7/12;;G07F7/08;;G07F7/12;;H04N1/32,,0,0,,,,EXPIRED
808,EP,A4,EP 1551644 A4,020-846-531-264-641,2008-01-02,2008,EP 03779118 A,2003-10-14,US 0332886 W;;US 41876202 P;;US 42125402 P;;US 49470903 P;;US 49523603 P;;US 49537303 P,2002-10-15,IDENTIFICATION DOCUMENT AND RELATED METHODS,,DIGIMARC CORP,BRUNDAGE TRENT J;;SHER-JAN MAHMOOD;;WEAVER MATTHEW M;;HANNIGAN BRETT T;;BRADLEY BRETT ALAN;;STACH JOHN;;PERRY BURT W;;DURST ROBERT T,,https://lens.org/020-846-531-264-641,Search Report,no,7,0,11,31,0,B42D2035/34;;G06T1/0071;;G06T2201/0051;;G07F7/08;;G07F7/086;;G07F7/12;;H04N1/32144;;H04N1/32288;;H04N1/32352;;H04N2201/3233;;H04N2201/3235;;H04N2201/327;;G06Q20/347;;G06Q20/401;;G06T1/0028;;G09C5/00;;H04K1/00;;H04L9/3231;;H04N1/32304;;H04N2201/3205;;H04L2209/56;;H04L2209/608;;H04L2209/805;;B42D25/00;;B42D25/309;;G07D7/0034;;B42D25/47;;B42D25/23;;B42D25/333;;B42D25/20;;G06T2201/0051;;H04N2201/327;;G06T1/0071;;H04N2201/3233;;H04N1/32352;;H04N1/32144;;G07F7/12;;G07F7/086;;H04N2201/3235;;H04N1/32288;;G07F7/08;;G09C5/00;;G06T1/0028;;H04K1/00;;G06Q20/401;;H04N1/32304;;G06Q20/347;;H04L2209/56;;H04L9/3231;;H04L2209/805;;H04L2209/608;;H04N2201/3205;;B42D25/00;;B42D25/309;;G07D7/0034,B42D15/10;;G06T1/00;;G07D7/12;;G07F7/08;;G07F7/12;;H04N1/32,,1,0,,,See also references of WO 2004035321A1,DISCONTINUED
809,EP,A1,EP 1551644 A1,049-165-510-173-926,2005-07-13,2005,EP 03779118 A,2003-10-14,US 0332886 W;;US 41876202 P;;US 42125402 P;;US 49470903 P;;US 49523603 P;;US 49537303 P,2002-10-15,IDENTIFICATION DOCUMENT AND RELATED METHODS,,DIGIMARC CORP,BRUNDAGE TRENT J;;SHER-JAN MAHMOOD;;WEAVER MATTHEW M;;HANNIGAN BRETT T;;BRADLEY BRETT ALAN;;STACH JOHN;;PERRY BURT W;;DURST ROBERT T,,https://lens.org/049-165-510-173-926,Patent Application,yes,0,1,11,31,0,B42D2035/34;;G06T1/0071;;G06T2201/0051;;G07F7/08;;G07F7/086;;G07F7/12;;H04N1/32144;;H04N1/32288;;H04N1/32352;;H04N2201/3233;;H04N2201/3235;;H04N2201/327;;G06Q20/347;;G06Q20/401;;G06T1/0028;;G09C5/00;;H04K1/00;;H04L9/3231;;H04N1/32304;;H04N2201/3205;;H04L2209/56;;H04L2209/608;;H04L2209/805;;B42D25/00;;B42D25/309;;G07D7/0034;;B42D25/47;;B42D25/23;;B42D25/333;;B42D25/20;;G06T2201/0051;;H04N2201/327;;G06T1/0071;;H04N2201/3233;;H04N1/32352;;H04N1/32144;;G07F7/12;;G07F7/086;;H04N2201/3235;;H04N1/32288;;G07F7/08;;G09C5/00;;G06T1/0028;;H04K1/00;;G06Q20/401;;H04N1/32304;;G06Q20/347;;H04L2209/56;;H04L9/3231;;H04L2209/805;;H04L2209/608;;H04N2201/3205;;B42D25/00;;B42D25/309;;G07D7/0034,B42D15/10;;G06T1/00;;G07D7/12;;B42D15/00;;G07D7/20;;G07F7/08;;G07F7/12;;G09C1/00;;H04L9/00;;H04N1/32,,0,0,,,,DISCONTINUED
810,EP,A1,EP 2927854 A1,008-048-193-320-290,2015-10-07,2015,EP 15162164 A,2015-04-01,US 201414245762 A,2014-04-04,INDUSTRIAL-ENABLED MOBILE DEVICE,"An industrial-enabled mobile electronic device, such as a personal mobile phone or tablet computer, allows a user to wirelessly interact with industrial devices for a variety of purposes. The mobile electronic device can communicate with an industrial device to read and write configuration settings, read and view log data, send commands to the industrial device, and other such functions. The mobile electronic device can perform various types of analysis on images and video of the industrial device captured by the mobile electronic device, including identifying and translating a model or device number printed on the device, or translating error codes displayed by the industrial device. The mobile electronic device can also retrieve additional information about the industrial device or the device's stored data via interaction with a remote technical support service, and can be used to facilitate dialog with a remote technical support person.
",ROCKWELL AUTOMATION TECH INC,NAIR SURESH R;;SACHERSKI BURT;;BURKE CHRISTOPHER J;;JONES DEREK W;;BOUTAUD FREDERIC;;HARDEGGER MARTIN;;PAPENBREER RUDOLF LAURENZ;;O'BRIEN DAVID M;;SUGIMOTO KENTARO,,https://lens.org/008-048-193-320-290,Patent Application,yes,2,44,5,5,0,G05B19/042;;G06Q10/10;;G05B19/418;;G08C17/02;;Y02P90/02;;G05B19/0423;;G06Q10/10;;G05B19/418;;Y02P90/02;;G08C17/02;;G08C2201/20;;G08C2201/30;;G08C2201/61;;G08C2201/70;;G08C2201/93,G06Q10/10,,0,0,,,,DISCONTINUED
811,EP,A4,EP 0865637 A4,113-838-087-863-382,1999-08-18,1999,EP 96942113 A,1996-12-04,US 9619132 W;;US 790695 P;;US 2303796 P;;US 2765396 P,1995-12-04,WIDE FIELD OF VIEW/NARROW FIELD OF VIEW RECOGNITION SYSTEM AND METHOD,,SARNOFF DAVID RES CENTER,HANNA KEITH JAMES;;BURT PETER J;;PELEG SHMUEL;;HERMAN JOSHUA R;;DIXON DOUGLAS F;;MISHRA DEPAN;;WIXSON LAMBERT E;;MANDELBAUM ROBERT;;COYLE PETER,,https://lens.org/113-838-087-863-382,Search Report,no,0,0,4,25,0,G06V40/166;;G06V40/171;;G06V40/19,G06K9/00,,3,2,042-868-510-882-577;;158-307-208-850-474,10.1109/icpr.1994.577210;;10.1109/ccst.1991.202194,"HASEGAWA O ET AL: ""REAL-TIME PARALLEL AND COOPERATIVE RECOGNITION OF FACIAL IMAGES FORAN INTERACTIVE VISUAL HUMAN INTERFACE"", PROCEEDINGS OF THE IAPR INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION, JERUSALEM, OCT. 9 - 13, 1994 CONFERENCE C: SIGNAL PROCESSING / CONFERENCE D: PARALLEL COMPUTING, vol. 3, no. CONF. 12, 9 October 1994 (1994-10-09), INSTITUTE OF ELECTRICAL AND ELECTRONICS ENGINEERS, pages 384 - 387, XP000509979;;SEITZ P ET AL: """"THE DIGITAL DOORKEEPER"" - AUTOMATIC FACE RECOGNITION WITH THE COMPUTER"", PROCEEDINGS OF THE ANNUAL INTERNATIONAL CARNAHAN CONFERENCE ON SECURITY TECHNOLOGY, TAIPEI, OCT. 1 - 3, 1991, no. CONF. 25, 1 October 1991 (1991-10-01), INSTITUTE OF ELECTRICAL AND ELECTRONICS ENGINEERS, pages 77 - 83, XP000300411;;See also references of WO 9721188A1",DISCONTINUED
812,US,B1,US 6714665 B1,152-230-202-021-930,2004-03-30,2004,US 75934696 A,1996-12-03,US 75934696 A;;US 72736696 A;;US 30067894 A;;US 2765396 P;;US 2303796 P;;US 790695 P,1994-09-02,Fully automated iris recognition system utilizing wide and narrow fields of view,"
    A recognition system which obtains and analyzes images of at least one object in a scene comprising a wide field of view (WFOV) imager which is used to capture an image of the scene and to locate the object and a narrow field of view (NFOV) imager which is responsive to the location information provided by the WFOV imager and which is used to capture an image of the object, the image of the object having a higher resolution than the image captured by the WFOV imager is disclosed. In one embodiment, a system that obtains and analyzes images of the irises of eyes of a human or animal in an image with little or no active involvement by the human or animal is disclosed. A method for obtaining and analyzing images of at least one object in a scene comprising capturing a wide field of view image of the object to locate the object in the scene; and then using a narrow field of view imager responsive to the location information provided in the capturing step to obtain higher resolution image of the object is also disclosed. 
",SARNOFF CORP,HANNA KEITH JAMES;;BURT PETER J;;PELEG SHMUEL;;DIXON DOUGLAS F;;MISHRA DEEPAM;;WIXSON LAMBERT E;;MANDLEBAUM ROBERT;;COYLE PETER;;HERMAN JOSHUA R,SRI INTERNATIONAL (2011-02-04);;DAVID SARNOFF RESEARCH CENTER INC (1997-02-12);;SARNOFF CORPORATION (1997-04-04),https://lens.org/152-230-202-021-930,Granted Patent,yes,15,798,1,25,0,G07C9/37;;G06V40/161;;G06V40/19;;G06V40/18;;G06V10/245;;G06F18/00;;G07C9/37;;G06V40/18;;G06V40/19;;G06V40/161;;G06V10/245;;G06F18/00,G06V40/18;;G06V40/19;;G07C9/00,382/117;;382/106;;382/190;;382/209,3,1,047-797-420-619-042,10.3758/bf03201340,"Copy of International Search Report dated Mar. 7, 1997 from corresponding. international application.;;A System for Non-intrusive Human Iris Acquisition and Identification, K. Hanna, et al. Presented at Machine Vision Applications, Tokyo, Nov. 96.;;Methods & Designs, High-Speed Data Processing and Unobtrusive Monitoring of Eye Movements, Robert H. Lambert, Richard A. Monty and Robert J. Hall, Behavior Research Methods & Instrumentation, 1974, vol. 6 (6) 525-530.",EXPIRED
813,EP,A1,EP 0865637 A1,186-731-004-301-711,1998-09-23,1998,EP 96942113 A,1996-12-04,US 9619132 W;;US 790695 P;;US 2303796 P;;US 2765396 P,1995-12-04,WIDE FIELD OF VIEW/NARROW FIELD OF VIEW RECOGNITION SYSTEM AND METHOD,,SARNOFF DAVID RES CENTER,HANNA KEITH JAMES;;BURT PETER J;;PELEG SHMUEL;;HERMAN JOSHUA R;;DIXON DOUGLAS F;;MISHRA DEPAN;;WIXSON LAMBERT E;;MANDELBAUM ROBERT;;COYLE PETER,,https://lens.org/186-731-004-301-711,Patent Application,yes,0,6,4,25,0,G06V40/166;;G06V40/171;;G06V40/19,G06K9/00,,0,0,,,,DISCONTINUED
814,US,B2,US 9489832 B2,015-164-586-783-239,2016-11-08,2016,US 201414245762 A,2014-04-04,US 201414245762 A,2014-04-04,Industrial-enabled mobile device,"An industrial-enabled mobile electronic device, such as a personal mobile phone or tablet computer, allows a user to wirelessly interact with industrial devices for a variety of purposes. The mobile electronic device can communicate with an industrial device to read and write configuration settings, read and view log data, send commands to the industrial device, and other such functions. The mobile electronic device can perform various types of analysis on images and video of the industrial device captured by the mobile electronic device, including identifying and translating a model or device number printed on the device, or translating error codes displayed by the industrial device. The mobile electronic device can also retrieve additional information about the industrial device or the device's stored data via interaction with a remote technical support service, and can be used to facilitate dialog with a remote technical support person.",ROCKWELL AUTOMATION TECH INC,NAIR SURESH R;;SACHERSKI BURT;;BURKE CHRISTOPHER J;;JONES DEREK W;;BOUTAUD FREDERIC;;HARDEGGER MARTIN;;PAPENBREER RUDOLF LAURENZ;;O'BRIEN DAVID M;;SUGIMOTO KENTARO,ROCKWELL AUTOMATION TECHNOLOGIES INC (2014-03-13),https://lens.org/015-164-586-783-239,Granted Patent,yes,7,45,5,5,0,G05B19/042;;G08C17/02;;G08C17/02;;G05B19/0423;;G05B19/418;;G05B19/418;;G06Q10/10;;G06Q10/10;;G08C2201/20;;G08C2201/30;;G08C2201/61;;G08C2201/70;;G08C2201/93;;Y02P90/02;;Y02P90/02,G05B19/00;;G06Q10/10;;G08C17/02,,1,0,,,"Extended European Search Report for EP Application Serial No. 15162164.6, dated Aug. 14, 2015, 6 pages.",ACTIVE
815,WO,A1,WO 2004/035321 A1,158-474-325-897-990,2004-04-29,2004,US 0332886 W,2003-10-14,US 41876202 P;;US 42125402 P;;US 49470903 P;;US 49523603 P;;US 49537303 P,2002-10-15,IDENTIFICATION DOCUMENT AND RELATED METHODS,"The present invention provides methods and systems for authenticating identification documents (100). We also teach an identification document (100) including two or more digital watermarks (27, 60). The watermarks correspond with each other or with indicia carried by the identification document (100). The correspondence can be verified to determine authenticity. We also provide digital watermark detection methods and systems to identify the different watermarks (100) through embedded orientation components. We then focus watermark message-decoding efforts on areas identified as likely including watermark orientation components (27, 60). In one implementation we provide a watermark detection trigger to identify so-called legacy documents. The trigger may indicate the presence or expected absence of a digital watermark. In other implementations we provide a versatile document authenticator to toggle between watermarking and non-watermarking authentication processes depending on a detection trigger (100).",DIGIMARC CORP;;BRUNDAGE TRENT J;;SHER-JAN MAHMOOD;;WEAVER MATTHEW M;;HANNIGAN BRETT T;;BRADLEY BRETT ALAN;;STACH JOHN;;PERRY BURT W;;DURST ROBERT T,BRUNDAGE TRENT J;;SHER-JAN MAHMOOD;;WEAVER MATTHEW M;;HANNIGAN BRETT T;;BRADLEY BRETT ALAN;;STACH JOHN;;PERRY BURT W;;DURST ROBERT T,,https://lens.org/158-474-325-897-990,Patent Application,yes,10,11,11,31,0,B42D2035/34;;G06T1/0071;;G06T2201/0051;;G07F7/08;;G07F7/086;;G07F7/12;;H04N1/32144;;H04N1/32288;;H04N1/32352;;H04N2201/3233;;H04N2201/3235;;H04N2201/327;;G06Q20/347;;G06Q20/401;;G06T1/0028;;G09C5/00;;H04K1/00;;H04L9/3231;;H04N1/32304;;H04N2201/3205;;H04L2209/56;;H04L2209/608;;H04L2209/805;;B42D25/00;;B42D25/309;;G07D7/0034;;B42D25/47;;B42D25/23;;B42D25/333;;B42D25/20;;G06T2201/0051;;H04N2201/327;;G06T1/0071;;H04N2201/3233;;H04N1/32352;;H04N1/32144;;G07F7/12;;G07F7/086;;H04N2201/3235;;H04N1/32288;;G07F7/08;;G09C5/00;;G06T1/0028;;H04K1/00;;G06Q20/401;;H04N1/32304;;G06Q20/347;;H04L2209/56;;H04L9/3231;;H04L2209/805;;H04L2209/608;;H04N2201/3205;;B42D25/00;;B42D25/309;;G07D7/0034,B42D15/10;;G06T1/00;;G07D7/12;;G07F7/08;;G07F7/12;;H04N1/32,,1,0,,,See also references of EP 1551644A4,PENDING
816,US,A1,US 2015/0287318 A1,051-019-484-175-181,2015-10-08,2015,US 201414245762 A,2014-04-04,US 201414245762 A,2014-04-04,INDUSTRIAL-ENABLED MOBILE DEVICE,"An industrial-enabled mobile electronic device, such as a personal mobile phone or tablet computer, allows a user to wirelessly interact with industrial devices for a variety of purposes. The mobile electronic device can communicate with an industrial device to read and write configuration settings, read and view log data, send commands to the industrial device, and other such functions. The mobile electronic device can perform various types of analysis on images and video of the industrial device captured by the mobile electronic device, including identifying and translating a model or device number printed on the device, or translating error codes displayed by the industrial device. The mobile electronic device can also retrieve additional information about the industrial device or the device's stored data via interaction with a remote technical support service, and can be used to facilitate dialog with a remote technical support person.",ROCKWELL AUTOMATION TECH INC,NAIR SURESH R;;SACHERSKI BURT;;BURKE CHRISTOPHER J;;JONES DEREK W;;BOUTAUD FREDERIC;;HARDEGGER MARTIN;;PAPENBREER RUDOLF LAURENZ;;O'BRIEN DAVID M;;SUGIMOTO KENTARO,ROCKWELL AUTOMATION TECHNOLOGIES INC (2014-03-13),https://lens.org/051-019-484-175-181,Patent Application,yes,5,140,5,5,0,G05B19/042;;G08C17/02;;G08C17/02;;G05B19/0423;;G05B19/418;;G05B19/418;;G06Q10/10;;G06Q10/10;;G08C2201/20;;G08C2201/30;;G08C2201/61;;G08C2201/70;;G08C2201/93;;Y02P90/02;;Y02P90/02,G08C17/02,,0,0,,,,ACTIVE
817,CN,A,CN 104977874 A,198-484-221-864-545,2015-10-14,2015,CN 201510158340 A,2015-04-03,US 201414245762 A,2014-04-04,Industrial-enabled Mobile Device,"An industrial-enabled mobile electronic device, such as a personal mobile phone or tablet computer, allows a user to wirelessly interact with industrial devices for a variety of purposes. The mobile electronic device can communicate with an industrial device to read and write configuration settings, read and view log data, send commands to the industrial device, and other such functions. The mobile electronic device can perform various types of analysis on images and video of the industrial device captured by the mobile electronic device, including identifying and translating a model or device number printed on the device, or translating error codes displayed by the industrial device. The mobile electronic device can also retrieve additional information about the industrial device or the device's stored data via interaction with a remote technical support service, and can be used to facilitate dialog with a remote technical support person.",ROCKWELL AUTOMATION TECH INC,NAIR SURESH R;;SACHERSKI BURT;;BURKE CHRISTOPHER J;;JONES DEREK W;;BOUTAUD FREDERIC;;HARDEGGER MARTIN;;PAPENBREER RUDOLF LAURENZ;;O'BRIEN DAVID M;;SUGIMOTO KENTAR,,https://lens.org/198-484-221-864-545,Patent Application,no,5,26,5,5,0,G05B19/042;;G08C17/02;;G08C17/02;;G05B19/0423;;G05B19/418;;G05B19/418;;G06Q10/10;;G06Q10/10;;G08C2201/20;;G08C2201/30;;G08C2201/61;;G08C2201/70;;G08C2201/93;;Y02P90/02;;Y02P90/02,G05B19/042,,0,0,,,,ACTIVE
818,AU,A1,AU 2003/285891 A1,191-139-561-874-676,2004-05-04,2004,AU 2003/285891 A,2003-10-14,US 42125402 P;;US 49470903 P;;US 49523603 P;;US 49537303 P;;US 41876202 P;;US 0332886 W,2002-10-15,IDENTIFICATION DOCUMENT AND RELATED METHODS,,DIGIMARC CORP,BRUNDAGE TRENT J;;SHER-JAN MAHMOOD;;WEAVER MATTHEW M;;HANNIGAN BRETT T;;BRADLEY BRETT ALAN;;STACH JOHN;;PERRY BURT W;;DURST ROBERT T,,https://lens.org/191-139-561-874-676,Patent Application,no,0,0,11,31,0,B42D2035/34;;G06T1/0071;;G06T2201/0051;;G07F7/08;;G07F7/086;;G07F7/12;;H04N1/32144;;H04N1/32288;;H04N1/32352;;H04N2201/3233;;H04N2201/3235;;H04N2201/327;;G06Q20/347;;G06Q20/401;;G06T1/0028;;G09C5/00;;H04K1/00;;H04L9/3231;;H04N1/32304;;H04N2201/3205;;H04L2209/56;;H04L2209/608;;H04L2209/805;;B42D25/00;;B42D25/309;;G07D7/0034;;B42D25/47;;B42D25/23;;B42D25/333;;B42D25/20;;G06T2201/0051;;H04N2201/327;;G06T1/0071;;H04N2201/3233;;H04N1/32352;;H04N1/32144;;G07F7/12;;G07F7/086;;H04N2201/3235;;H04N1/32288;;G07F7/08;;G09C5/00;;G06T1/0028;;H04K1/00;;G06Q20/401;;H04N1/32304;;G06Q20/347;;H04L2209/56;;H04L9/3231;;H04L2209/805;;H04L2209/608;;H04N2201/3205;;B42D25/00;;B42D25/309;;G07D7/0034,B42D15/10;;G06T1/00;;G07D7/12;;G07F7/08;;G07F7/12;;H04N1/32,,0,0,,,,DISCONTINUED
819,WO,A1,WO 1997/021188 A1,187-362-301-268-503,1997-06-12,1997,US 9619132 W,1996-12-04,US 790695 P;;US 2303796 P;;US 2765396 P,1995-12-04,WIDE FIELD OF VIEW/NARROW FIELD OF VIEW RECOGNITION SYSTEM AND METHOD,"A recognition system which obtains and analyzes images of at least one object in a scene comprising a wide field of view (WFOV) imager (10, 12) which is used to capture an image of a scene and to locate the object and a narrow field of view (NFOV) imager (14) which is responsive to the location information provided by the WFOV imager and which is used to capture an image of the object (56), the image of the object having a higher resolution than the image captured by the WFOV imager is disclosed. In one embodiment, a system that obtains and analyzes images of the irises of eyes of a human or animal in an image with little or no active involvement by the human or animal is disclosed. A method of obtaining and analyzing the images of at least one object in a scene comprising capturing a wide field of view image of the object to locate the object in the scene; and then using a narrow field of view imager responsive to the location information (54) provided in the capturing step to obtain a higher resolution image of the object is also disclosed.",SARNOFF DAVID RES CENTER,HANNA KEITH JAMES;;BURT PETER J;;PELEG SHMUEL;;HERMAN JOSHUA R;;DIXON DOUGLAS F;;MISHRA DEPAN;;WIXSON LAMBERT E;;MANDELBAUM ROBERT;;COYLE PETER,,https://lens.org/187-362-301-268-503,Patent Application,yes,6,88,4,25,0,G06V40/166;;G06V40/171;;G06V40/19,G06K9/00,,1,0,,,See also references of EP 0865637A4,PENDING
820,AU,A,AU 1997/011271 A,124-619-436-724-129,1997-06-27,1997,AU 1997/011271 A,1996-12-04,US 790695 P;;US 2303796 P;;US 2765396 P;;US 9619132 W,1995-12-04,Wide field of view/narrow field of view recognition system and method,,SARNOFF DAVID RES CENTER,HANNA KEITH JAMES;;BURT PETER J;;PELEG SHMUEL;;HERMAN JOSHUA R;;DIXON DOUGLAS F;;MISHRA DEPAN;;WIXSON LAMBERT E;;MANDELBAUM ROBERT;;COYLE PETER,,https://lens.org/124-619-436-724-129,Patent Application,no,0,0,4,25,0,G06V40/166;;G06V40/171;;G06V40/19,G06K9/00,,0,0,,,,PENDING
821,AU,A1,AU 2011/323473 A1,107-930-113-703-206,2013-05-02,2013,AU 2011/323473 A,2011-11-01,US 40892610 P;;US 2011/0058810 W,2010-11-01,Vehicle and transmission for a vehicle,"A vehicle is described having a transmission (22) driven through a propulsion unit (20) such as an engine, and through a CVT (24). The transmission is comprised of an input shaft (60) and an output shaft (100) which are coaxially disposed. An idler shaft (62) is driven by the input shaft, and the idler shaft drives the output shaft, through selected gear sets (64, 66, 68), to provide different gear ratios or drive directions. The CVT also has a fan (132) on the driven side which feeds air through the CVT for cooling. The CVT comprises a drive side clutch (52) and a driven side clutch (50) with the output shaft of the (100) extending through the CVT driven clutch (50).",POLARIS INC,DIETER BENJAMIN J;;OLSON ALAN S;;WEBER DANIEL SCOTT;;RODRIGUEZ WILLIAM BURT;;SCHREIER JOHN D;;NELSON STEPHEN L;;DANIELSON RON R;;SUNSDAHL ROY A,,https://lens.org/107-930-113-703-206,Patent Application,no,0,0,14,14,0,B60K17/00;;B60K17/00;;F16H37/021;;F16H37/021;;F16H37/027;;F16H37/027;;F16H57/035;;F16H57/035;;F16H2057/02065;;F16H2057/02065;;Y10T74/19;;Y10T74/19;;Y10T74/19074;;Y10T74/19074;;Y10T74/19084;;Y10T74/19084;;Y10T74/19102;;Y10T74/19102;;Y10T74/19219;;Y10T74/19219;;Y10T74/19555;;Y10T74/19555;;Y10T74/19651;;Y10T74/19651,B60K17/00;;F16H37/08,,0,0,,,,INACTIVE
822,US,A1,US 2007/0189597 A1,100-776-947-222-751,2007-08-16,2007,US 50980506 A,2006-08-25,US 50980506 A;;US 33134306 A;;US 71018805 P,2005-08-23,Machine vision counting system apparatus and method,"A machine-vision-based counter includes an image acquisition component (imager), wherein light provides discrimination between a background field and imageable units located away from the imager. The imager outputs data representing the field and units; an image processor receiving imager data finds countable units therein. An operator interface accepts command inputs and presents count output. A controller manages image acquisition, processor, and operator interface functions. A counting method includes configuring an imager to detect light, directing light from a source to units positioned to be detected by the imager, and directing the light to the imager. The method includes discriminating between a background field and imageable units; providing, as an imager output, data representing the field and units; configuring an image processor to receive imager data; configuring the processor to interpret the data as counted units on a background field; and configuring an operator interface to present a count result.",LIMER DANIEL J;;LANG DAVID A;;BURT CHRISTOPHER S;;GOUIN PHILIP R;;TARR NELSON D;;BULLOCK RYAN W;;YANEZ DAVID A;;THOPPAE VIJAI M,LIMER DANIEL J;;LANG DAVID A;;BURT CHRISTOPHER S;;GOUIN PHILIP R;;TARR NELSON D;;BULLOCK RYAN W;;YANEZ DAVID A;;THOPPAE VIJAI M,ILLINOIS TOOL WORKS INC (2008-12-31);;SPX CORPORATION (A DELAWARE CORPORATION) (2007-04-05),https://lens.org/100-776-947-222-751,Patent Application,yes,29,78,4,4,0,A61J7/02;;G01N2015/1472;;G01N2015/1486;;G06V10/145;;G06V10/141;;G06V2201/06;;G06V20/66;;G06F18/00;;G01N15/1433;;A61J7/02;;G01N2015/1472;;G01N2015/1486;;G06V10/141;;G06V10/145;;G06V2201/06;;G06F18/00;;G06V20/66;;G01N15/1433,G06V10/141;;G06V10/145;;G06V20/66,382/153;;382/128,0,0,,,,DISCONTINUED
823,US,B2,US 8127833 B2,170-171-723-951-936,2012-03-06,2012,US 61066406 A,2006-12-14,US 61066406 A,2006-12-14,Methods and apparatus for harvesting potential energy downhole,"Methods and apparatus for harvesting energy while moving a tool through a well are shown and described. The harvested energy can be used by the tool to perform work once it reaches an intended location in the well, or along the way. A considerable amount of potential energy is typically lost by oilfield tools as they move down through a borehole. Methods and apparatus described herein recover and/or store some of the energy during the downward movement of the tool.",PABON JAHIR ALFONSO;;O'CONNELL JAMES GARLAND;;TILLEY BURT S;;BROUILLARD MATTHEW E J;;SCHWARTZ TAL;;ROWAN BRANDON CHRISTOPHER;;PENNER MARK MEFIKA;;FREEMAN JEREMY JAMES;;SCHLUMBERGER TECHNOLOGY CORP,PABON JAHIR ALFONSO;;O'CONNELL JAMES GARLAND;;TILLEY BURT S;;BROUILLARD MATTHEW E J;;SCHWARTZ TAL;;ROWAN BRANDON CHRISTOPHER;;PENNER MARK MEFIKA;;FREEMAN JEREMY JAMES,SCHLUMBERGER TECHNOLOGY CORPORATION (2006-12-15),https://lens.org/170-171-723-951-936,Granted Patent,yes,10,8,7,7,0,E21B41/0085;;E21B41/0085;;E21B41/0085,E21B47/00,166/65.1;;166/254.2,1,0,,,"Patent Cooperation Treaty, International Search Report, dated May 14, 2008, 4 pages.",ACTIVE
824,EP,A2,EP 2635453 A2,116-166-954-260-898,2013-09-11,2013,EP 11782510 A,2011-11-01,US 40892610 P;;US 2011/0058810 W,2010-11-01,VEHICLE AND TRANSMISSION FOR A VEHICLE,,POLARIS INC,DIETER BENJAMIN J;;OLSON ALAN S;;WEBER DANIEL SCOTT;;RODRIGUEZ WILLIAM BURT;;SCHREIER JOHN D;;NELSON STEPHEN L;;DANIELSON RON R;;SUNSDAHL ROY A,,https://lens.org/116-166-954-260-898,Patent Application,yes,0,0,14,14,0,B60K17/00;;B60K17/00;;F16H37/021;;F16H37/021;;F16H37/027;;F16H37/027;;F16H57/035;;F16H57/035;;F16H2057/02065;;F16H2057/02065;;Y10T74/19;;Y10T74/19;;Y10T74/19074;;Y10T74/19074;;Y10T74/19084;;Y10T74/19084;;Y10T74/19102;;Y10T74/19102;;Y10T74/19219;;Y10T74/19219;;Y10T74/19555;;Y10T74/19555;;Y10T74/19651;;Y10T74/19651,B60K17/00;;F16H37/08,,1,0,,,See references of WO 2012061407A2,DISCONTINUED
825,AU,A8,AU 2003/217642 A8,126-054-778-502-70X,2003-09-09,2003,AU 2003/217642 A,2003-02-19,US 35832102 P;;US 0305337 W,2002-02-19,Security methods employing drivers licenses and other documents,,DIGMARC CORP,HEIN WILLIAM C III;;DECKER STEPHEN K;;HAWES JONATHAN L;;MUNDAY JOHN;;LEVY KENNETH L;;DAVIS BRUCE L;;CARR J SCOTT;;PERRY BURT W,,https://lens.org/126-054-778-502-70X,Patent Application,no,0,0,9,31,0,G06Q10/02;;G06Q50/265;;G07C2209/41;;G07C9/22;;G07C9/20;;G07C9/27;;G06Q10/02;;G07C2209/41;;G06Q50/265;;G07C9/20;;G07C9/22,G06Q10/02;;G06Q50/26;;G07C9/00,,0,0,,,,DISCONTINUED
826,CN,A,CN 103476621 A,195-217-738-441-304,2013-12-25,2013,CN 201180052627 A,2011-11-01,US 2011/0058810 W;;US 40892610 P,2010-11-01,Vehicle and transmission for a vehicle,"A vehicle is described having a transmission (22) driven through a propulsion unit (20) such as an engine, and through a CVT (24). The transmission is comprised of an input shaft (60) and an output shaft (100) which are coaxially disposed. An idler shaft (62) is driven by the input shaft, and the idler shaft drives the output shaft, through selected gear sets (64, 66, 68), to provide different gear ratios or drive directions. The CVT also has a fan (132) on the driven side which feeds air through the CVT for cooling. The CVT comprises a drive side clutch (52) and a driven side clutch (50) with the output shaft of the (100) extending through the CVT driven clutch (50).",POLARIS INC,DIETER BENJAMIN J;;OLSON ALAN S;;WEBER DANIEL SCOTT;;RODRIGUEZ WILLIAM BURT;;SCHREIER JOHN D;;NELSON STEPHEN L;;DANIELSON RON R;;SUNSDAHL ROY A,,https://lens.org/195-217-738-441-304,Patent Application,no,8,7,14,14,0,B60K17/00;;B60K17/00;;F16H37/021;;F16H37/021;;F16H37/027;;F16H37/027;;F16H57/035;;F16H57/035;;F16H2057/02065;;F16H2057/02065;;Y10T74/19;;Y10T74/19;;Y10T74/19074;;Y10T74/19074;;Y10T74/19084;;Y10T74/19084;;Y10T74/19102;;Y10T74/19102;;Y10T74/19219;;Y10T74/19219;;Y10T74/19555;;Y10T74/19555;;Y10T74/19651;;Y10T74/19651,B60K17/00;;F16H37/08,,0,0,,,,ACTIVE
827,MX,A,MX 2013004544 A,141-506-478-028-442,2013-07-15,2013,MX 2013004544 A,2011-11-01,US 40892610 P;;US 2011/0058810 W,2010-11-01,VEHICLE AND TRANSMISSION FOR A VEHICLE.,"A vehicle is described having a transmission (22) driven through a propulsion unit (20) such as an engine, and through a CVT (24). The transmission is comprised of an input shaft (60) and an output shaft (100) which are coaxially disposed. An idler shaft (62) is driven by the input shaft, and the idler shaft drives the output shaft, through selected gear sets (64, 66, 68), to provide different gear ratios or drive directions. The CVT also has a fan (132) on the driven side which feeds air through the CVT for cooling. The CVT comprises a drive side clutch (52) and a driven side clutch (50) with the output shaft of the (100) extending through the CVT driven clutch (50).",POLARIS INC,DIETER BENJAMIN J;;OLSON ALAN S;;SCHREIER JOHN D;;SUNSDAHL ROY A;;NELSON STEPHEN L;;WEBER DANIEL SCOTT;;RODRIGUEZ WILLIAM BURT;;DANIELSON RON R,,https://lens.org/141-506-478-028-442,Patent Application,no,0,0,14,14,0,B60K17/00;;B60K17/00;;F16H37/021;;F16H37/021;;F16H37/027;;F16H37/027;;F16H57/035;;F16H57/035;;F16H2057/02065;;F16H2057/02065;;Y10T74/19;;Y10T74/19;;Y10T74/19074;;Y10T74/19074;;Y10T74/19084;;Y10T74/19084;;Y10T74/19102;;Y10T74/19102;;Y10T74/19219;;Y10T74/19219;;Y10T74/19555;;Y10T74/19555;;Y10T74/19651;;Y10T74/19651,B60K17/00;;F16H37/08,,0,0,,,,ACTIVE
828,EP,A4,EP 1481347 A4,091-435-968-317-418,2009-08-26,2009,EP 03713599 A,2003-02-19,US 0305337 W;;US 35832102 P,2002-02-19,SECURITY METHODS EMPLOYING DRIVERS LICENSES AND OTHER DOCUMENTS,,DIGIMARC CORP,CARR J SCOTT;;DAVIS BRUCE L;;DECKER STEPHEN K;;HAWES JONATHAN L;;HEIN WILLIAM C III;;LEVY KENNETH L;;MUNDAY JOHN;;PERRY BURT W,DIGIMARC CORPORATION (2009-07-08),https://lens.org/091-435-968-317-418,Search Report,no,4,0,9,31,0,G06Q10/02;;G06Q50/265;;G07C2209/41;;G07C9/22;;G07C9/20;;G07C9/27;;G06Q10/02;;G07C2209/41;;G06Q50/265;;G07C9/20;;G07C9/22,G06Q10/02;;G06Q50/26;;G07C9/00,,0,0,,,,DISCONTINUED
829,WO,A2,WO 2003/071396 A2,168-506-068-540-03X,2003-08-28,2003,US 0305337 W,2003-02-19,US 35832102 P,2002-02-19,SECURITY METHODS EMPLOYING DRIVERS LICENSES AND OTHER DOCUMENTS,"Driver&apos;s licenses and other security documents include one or more machine-readable features, each conveying plural bits of information. These features are used in a variety of ways to increase security, and/or to enhance functionality. In one embodiment, data encoded on a driver&apos;s license is used at airport check-in, to link to a state DMV database and obtain information by which the document, and its custodian, can be authenticated. In like fashion, a license can be used to authenticate a bearer and/or his/her age prior to the sale of alcohol or tobacco products. In other embodiments, different elements of a driver&apos;s license (e.g., the substrate, photo, text data, and machine-readable data) are logically bound together (e.g., interlinked through payloads conveyed by different machine-readable features) as a deterrent against counterfeiting. Driver&apos;s licenses can be similarly logically bound to personal checks and other documents. Many other arrangements are also disclosed.",DIGMARC CORP;;CARR J SCOTT;;DAVIS BRUCE L;;DECKER STEPHEN K;;HAWES JONATHAN L;;HEIN WILLIAM C III;;LEVY KENNETH L;;MUNDAY JOHN;;PERRY BURT W,CARR J SCOTT;;DAVIS BRUCE L;;DECKER STEPHEN K;;HAWES JONATHAN L;;HEIN WILLIAM C III;;LEVY KENNETH L;;MUNDAY JOHN;;PERRY BURT W,,https://lens.org/168-506-068-540-03X,Patent Application,yes,0,0,9,31,0,G06Q10/02;;G06Q50/265;;G07C2209/41;;G07C9/22;;G07C9/20;;G07C9/27;;G06Q10/02;;G07C2209/41;;G06Q50/265;;G07C9/20;;G07C9/22,G06Q10/02;;G06Q50/26;;G07C9/00,,0,0,,,,PENDING
830,CA,A1,CA 2661305 A1,081-644-580-027-797,2008-03-06,2008,CA 2661305 A,2007-08-24,US 50980506 A;;US 2007/0018681 W,2006-08-25,MACHINE VISION COUNTING SYSTEM APPARATUS AND METHOD,"A machine-vision-based counter includes an image acquisition component (i mager), wherein light provides discrimination between a background field and imageable units located away from the imager. The imager outputs data repre senting the field and units; an image processor receiving imager data finds countable units therein. An operator interface accepts command inputs and pr esents count output. A controller manages image acquisition, processor and o perator interface functions. A counting method includes configuring an image r to detect light directing from a source to units positioned to be detected by the imager, and directing the light to the imager. The method includes d iscriminating between a background field and imageable units; providing, as an imager output, data representing the field and units; configuring an imag e processor to receive imager data; configuring the processor to interpret t he data as counted units on a background field; and configuring an operator interface to present a count result.",ILLINOIS TOOL WORKS,BURT CHRISTOPHER S;;LANG DAVID A;;GOUIN PHILIP R;;BULLOCK RYAN W;;TARR NELSON D;;YANEZ DAVID A;;THOPPAE VIJAI M;;LIMER DANIEL J,,https://lens.org/081-644-580-027-797,Patent Application,no,0,0,4,4,0,A61J7/02;;G01N2015/1472;;G01N2015/1486;;G06V10/145;;G06V10/141;;G06V2201/06;;G06V20/66;;G06F18/00;;G01N15/1433;;A61J7/02;;G01N2015/1472;;G01N2015/1486;;G06V10/141;;G06V10/145;;G06V2201/06;;G06F18/00;;G06V20/66;;G01N15/1433,B43L25/04;;G01D1/00;;G06V10/141;;G06V10/145;;G06V20/66,,0,0,,,,DISCONTINUED
831,US,B2,US 8950290 B2,016-181-730-453-834,2015-02-10,2015,US 201113286882 A,2011-11-01,US 201113286882 A;;US 40892610 P,2010-11-01,Vehicle and transmission for a vehicle,"A vehicle is described having a transmission driven through a propulsion unit such as an engine, and through a CVT. The transmission is comprised of an input shaft and an output shaft which are coaxially disposed. An idler shaft is driven by the input shaft, and the idler shaft drives the output shaft, through selected gear sets, to provide different gear ratios or drive directions. The CVT also has a fan on the driven side which feeds air through the CVT for cooling. The CVT comprises a drive side clutch and a driven side clutch with the output shaft of the extending through the CVT driven clutch.",DIETER BENJAMIN J;;OLSON ALAN S;;WEBER DANIEL SCOTT;;RODRIGUEZ WILLIAM BURT;;SCHREIER JOHN D;;NELSON STEPHEN L;;DANIELSON RON R;;SUNSDAHL ROY A;;POLARIS INC,DIETER BENJAMIN J;;OLSON ALAN S;;WEBER DANIEL SCOTT;;RODRIGUEZ WILLIAM BURT;;SCHREIER JOHN D;;NELSON STEPHEN L;;DANIELSON RON R;;SUNSDAHL ROY A,POLARIS INDUSTRIES INC (2012-01-23),https://lens.org/016-181-730-453-834,Granted Patent,yes,16,12,14,14,0,B60K17/00;;B60K17/00;;F16H37/021;;F16H37/021;;F16H37/027;;F16H37/027;;F16H57/035;;F16H57/035;;F16H2057/02065;;F16H2057/02065;;Y10T74/19;;Y10T74/19;;Y10T74/19074;;Y10T74/19074;;Y10T74/19084;;Y10T74/19084;;Y10T74/19102;;Y10T74/19102;;Y10T74/19219;;Y10T74/19219;;Y10T74/19555;;Y10T74/19555;;Y10T74/19651;;Y10T74/19651,F16H37/06;;B60K17/00;;F16H37/02;;F16H57/02;;F16H57/035,74665GE;;X 74665 GA,2,0,,,"International Search Report and Written Opinion issued by the European Patent Office, dated May 16, 2013, for International Application No. PCT/US2011/058810; 13 pages.;;International Preliminary Report on Patentability issued by the International Bureau of WIPO, Geneva, Switzerland, dated Jun. 12, 2013, for International Application No. PCT/US2011/058810; 8 pages.",ACTIVE
832,WO,A3,WO 2008/027290 A3,041-457-718-715-847,2009-04-09,2009,US 2007/0018681 W,2007-08-24,US 50980506 A,2006-08-25,MACHINE VISION COUNTING SYSTEM APPARATUS AND METHOD,"A machine-vision-based counter includes an image acquisition component (imager), wherein light provides discrimination between a background field and imageable units located away from the imager. The imager outputs data representing the field and units; an image processor receiving imager data finds countable units therein. An operator interface accepts command inputs and presents count output. A controller manages image acquisition, processor and operator interface functions. A counting method includes configuring an imager to detect light directing from a source to units positioned to be detected by the imager, and directing the light to the imager. The method includes discriminating between a background field and imageable units; providing, as an imager output, data representing the field and units; configuring an image processor to receive imager data; configuring the processor to interpret the data as counted units on a background field; and configuring an operator interface to present a count result.",SPX CORP;;LIMER DANIEL J;;LANG DAVID A;;BURT CHRISTOPHER S;;GOUIN PHILIP R;;TARR NELSON D;;BULLOCK RYAN W;;YANEZ DAVID A;;THOPPAE VIJAI M,LIMER DANIEL J;;LANG DAVID A;;BURT CHRISTOPHER S;;GOUIN PHILIP R;;TARR NELSON D;;BULLOCK RYAN W;;YANEZ DAVID A;;THOPPAE VIJAI M,,https://lens.org/041-457-718-715-847,Search Report,yes,2,0,4,4,0,A61J7/02;;G01N2015/1472;;G01N2015/1486;;G06V10/145;;G06V10/141;;G06V2201/06;;G06V20/66;;G06F18/00;;G01N15/1433;;A61J7/02;;G01N2015/1472;;G01N2015/1486;;G06V10/141;;G06V10/145;;G06V2201/06;;G06F18/00;;G06V20/66;;G01N15/1433,B43L25/04;;G01D1/00;;G06V10/141;;G06V10/145;;G06V20/66,,0,0,,,,PENDING
833,MX,B,MX 335983 B,051-383-019-029-921,2016-01-07,2016,MX 2013004544 A,2011-11-01,US 40892610 P;;US 2011/0058810 W,2010-11-01,VEHICLE AND TRANSMISSION FOR A VEHICLE.,"A vehicle is described having a transmission (22) driven through a propulsion unit (20) such as an engine, and through a CVT (24). The transmission is comprised of an input shaft (60) and an output shaft (100) which are coaxially disposed. An idler shaft (62) is driven by the input shaft, and the idler shaft drives the output shaft, through selected gear sets (64, 66, 68), to provide different gear ratios or drive directions. The CVT also has a fan (132) on the driven side which feeds air through the CVT for cooling. The CVT comprises a drive side clutch (52) and a driven side clutch (50) with the output shaft of the (100) extending through the CVT driven clutch (50).",POLARIS INC,DIETER BENJAMIN J;;OLSON ALAN S;;SCHREIER JOHN D;;SUNSDAHL ROY A;;NELSON STEPHEN L;;WEBER DANIEL SCOTT;;RODRIGUEZ WILLIAM BURT;;DANIELSON RON R,,https://lens.org/051-383-019-029-921,Granted Patent,no,0,0,14,14,0,B60K17/00;;B60K17/00;;F16H37/021;;F16H37/021;;F16H37/027;;F16H37/027;;F16H57/035;;F16H57/035;;F16H2057/02065;;F16H2057/02065;;Y10T74/19;;Y10T74/19;;Y10T74/19074;;Y10T74/19074;;Y10T74/19084;;Y10T74/19084;;Y10T74/19102;;Y10T74/19102;;Y10T74/19219;;Y10T74/19219;;Y10T74/19555;;Y10T74/19555;;Y10T74/19651;;Y10T74/19651,F16H37/06;;B60K17/00;;F16H37/02;;F16H57/02;;F16H57/035,,0,0,,,,ACTIVE
834,AU,B2,AU 2011/323473 B2,156-512-504-857-136,2016-04-07,2016,AU 2011/323473 A,2011-11-01,US 40892610 P;;US 2011/0058810 W,2010-11-01,Vehicle and transmission for a vehicle,"A vehicle is described having a transmission (22) driven through a propulsion unit (20) such as an engine, and through a CVT (24). The transmission is comprised of an input shaft (60) and an output shaft (100) which are coaxially disposed. An idler shaft (62) is driven by the input shaft, and the idler shaft drives the output shaft, through selected gear sets (64, 66, 68), to provide different gear ratios or drive directions. The CVT also has a fan (132) on the driven side which feeds air through the CVT for cooling. The CVT comprises a drive side clutch (52) and a driven side clutch (50) with the output shaft of the (100) extending through the CVT driven clutch (50).",POLARIS INDUSTRIES INC,DIETER BENJAMIN J;;OLSON ALAN S;;WEBER DANIEL SCOTT;;RODRIGUEZ WILLIAM BURT;;SCHREIER JOHN D;;NELSON STEPHEN L;;DANIELSON RON R;;SUNSDAHL ROY A,,https://lens.org/156-512-504-857-136,Granted Patent,no,0,0,14,14,0,F16H37/021;;F16H37/027;;F16H57/035;;F16H2057/02065;;Y10T74/19219;;Y10T74/19651;;Y10T74/19555;;Y10T74/19;;Y10T74/19074;;Y10T74/19084;;Y10T74/19102;;B60K17/00;;Y10T74/19219;;Y10T74/19651;;Y10T74/19555;;Y10T74/19;;Y10T74/19074;;Y10T74/19084;;Y10T74/19102;;F16H37/021;;F16H37/027;;F16H57/035;;F16H2057/02065;;B60K17/00,B60K17/00;;F16H37/08,,0,0,,,,INACTIVE
835,WO,A3,WO 2003/071396 A3,007-977-431-966-880,2004-05-13,2004,US 0305337 W,2003-02-19,US 35832102 P,2002-02-19,SECURITY METHODS EMPLOYING DRIVERS LICENSES AND OTHER DOCUMENTS,"Driver&apos;s licenses and other security documents include one or more machine-readable features, each conveying plural bits of information. These features are used in a variety of ways to increase security, and/or to enhance functionality. In one embodiment, data encoded on a driver&apos;s license is used at airport check-in, to link to a state DMV database and obtain information by which the document, and its custodian, can be authenticated. In like fashion, a license can be used to authenticate a bearer and/or his/her age prior to the sale of alcohol or tobacco products. In other embodiments, different elements of a driver&apos;s license (e.g., the substrate, photo, text data, and machine-readable data) are logically bound together (e.g., interlinked through payloads conveyed by different machine-readable features) as a deterrent against counterfeiting. Driver&apos;s licenses can be similarly logically bound to personal checks and other documents. Many other arrangements are also disclosed.",DIGMARC CORP;;CARR J SCOTT;;DAVIS BRUCE L;;DECKER STEPHEN K;;HAWES JONATHAN L;;HEIN WILLIAM C III;;LEVY KENNETH L;;MUNDAY JOHN;;PERRY BURT W,CARR J SCOTT;;DAVIS BRUCE L;;DECKER STEPHEN K;;HAWES JONATHAN L;;HEIN WILLIAM C III;;LEVY KENNETH L;;MUNDAY JOHN;;PERRY BURT W,,https://lens.org/007-977-431-966-880,Search Report,yes,2,0,9,31,0,G06Q10/02;;G06Q50/265;;G07C2209/41;;G07C9/22;;G07C9/20;;G07C9/27;;G06Q10/02;;G07C2209/41;;G06Q50/265;;G07C9/20;;G07C9/22,G06Q10/02;;G06Q50/26;;G07C9/00,,0,0,,,,PENDING
836,WO,A2,WO 2008/027290 A2,102-057-930-326-839,2008-03-06,2008,US 2007/0018681 W,2007-08-24,US 50980506 A,2006-08-25,MACHINE VISION COUNTING SYSTEM APPARATUS AND METHOD,"A machine-vision-based counter includes an image acquisition component (imager), wherein light provides discrimination between a background field and imageable units located away from the imager. The imager outputs data representing the field and units; an image processor receiving imager data finds countable units therein. An operator interface accepts command inputs and presents count output. A controller manages image acquisition, processor and operator interface functions. A counting method includes configuring an imager to detect light directing from a source to units positioned to be detected by the imager, and directing the light to the imager. The method includes discriminating between a background field and imageable units; providing, as an imager output, data representing the field and units; configuring an image processor to receive imager data; configuring the processor to interpret the data as counted units on a background field; and configuring an operator interface to present a count result.",SPX CORP;;LIMER DANIEL J;;LANG DAVID A;;BURT CHRISTOPHER S;;GOUIN PHILIP R;;TARR NELSON D;;BULLOCK RYAN W;;YANEZ DAVID A;;THOPPAE VIJAI M,LIMER DANIEL J;;LANG DAVID A;;BURT CHRISTOPHER S;;GOUIN PHILIP R;;TARR NELSON D;;BULLOCK RYAN W;;YANEZ DAVID A;;THOPPAE VIJAI M,,https://lens.org/102-057-930-326-839,Patent Application,yes,0,0,4,4,0,A61J7/02;;G01N2015/1472;;G01N2015/1486;;G06V10/145;;G06V10/141;;G06V2201/06;;G06V20/66;;G06F18/00;;G01N15/1433;;A61J7/02;;G01N2015/1472;;G01N2015/1486;;G06V10/141;;G06V10/145;;G06V2201/06;;G06F18/00;;G06V20/66;;G01N15/1433,G06V10/141;;G06V10/145;;G06V20/66,,0,0,,,,PENDING
837,CA,C,CA 2816579 C,159-521-488-185-520,2018-11-27,2018,CA 2816579 A,2011-11-01,US 40892610 P;;US 2011/0058810 W,2010-11-01,VEHICLE AND TRANSMISSION FOR A VEHICLE,"A vehicle is described having a transmission (22) driven through a propulsion unit (20) such as an engine, and through a CVT (24). The transmission is comprised of an input shaft (60) and an output shaft (100) which are coaxially disposed. An idler shaft (62) is driven by the input shaft, and the idler shaft drives the output shaft, through selected gear sets (64, 66, 68), to provide different gear ratios or drive directions. The CVT also has a fan (132) on the driven side which feeds air through the CVT for cooling. The CVT comprises a drive side clutch (52) and a driven side clutch (50) with the output shaft of the (100) extending through the CVT driven clutch (50).",POLARIS INC,DIETER BENJAMIN J;;OLSON ALAN S;;WEBER DANIEL SCOTT;;RODRIGUEZ WILLIAM BURT;;SCHREIER JOHN D;;NELSON STEPHEN L;;DANIELSON RON R;;SUNSDAHL ROY A,,https://lens.org/159-521-488-185-520,Granted Patent,no,0,0,14,14,0,F16H37/021;;F16H37/027;;F16H57/035;;F16H2057/02065;;Y10T74/19219;;Y10T74/19651;;Y10T74/19555;;Y10T74/19;;Y10T74/19074;;Y10T74/19084;;Y10T74/19102;;B60K17/00;;Y10T74/19219;;Y10T74/19651;;Y10T74/19555;;Y10T74/19;;Y10T74/19074;;Y10T74/19084;;Y10T74/19102;;F16H37/021;;F16H37/027;;F16H57/035;;F16H2057/02065;;B60K17/00,B60K17/00;;F16H37/08,,0,0,,,,ACTIVE
838,US,A1,US 2012/0137828 A1,175-387-355-394-48X,2012-06-07,2012,US 201113286882 A,2011-11-01,US 201113286882 A;;US 40892610 P,2010-11-01,VEHICLE AND TRANSMISSION FOR A VEHICLE,"A vehicle is described having a transmission driven through a propulsion unit such as an engine, and through a CVT. The transmission is comprised of an input shaft and an output shaft which are coaxially disposed. An idler shaft is driven by the input shaft, and the idler shaft drives the output shaft, through selected gear sets, to provide different gear ratios or drive directions. The CVT also has a fan on the driven side which feeds air through the CVT for cooling. The CVT comprises a drive side clutch and a driven side clutch with the output shaft of the extending through the CVT driven clutch.",DIETER BENJAMIN J;;OLSON ALAN S;;WEBER DANIEL SCOTT;;RODRIGUEZ WILLIAM BURT;;SCHREIER JOHN D;;NELSON STEPHEN L;;DANIELSON RON R;;SUNSDAHL ROY A;;POLARIS INC,DIETER BENJAMIN J;;OLSON ALAN S;;WEBER DANIEL SCOTT;;RODRIGUEZ WILLIAM BURT;;SCHREIER JOHN D;;NELSON STEPHEN L;;DANIELSON RON R;;SUNSDAHL ROY A,POLARIS INDUSTRIES INC (2012-01-23),https://lens.org/175-387-355-394-48X,Patent Application,yes,4,11,14,14,0,B60K17/00;;B60K17/00;;F16H37/021;;F16H37/021;;F16H37/027;;F16H37/027;;F16H57/035;;F16H57/035;;F16H2057/02065;;F16H2057/02065;;Y10T74/19;;Y10T74/19;;Y10T74/19074;;Y10T74/19074;;Y10T74/19084;;Y10T74/19084;;Y10T74/19102;;Y10T74/19102;;Y10T74/19219;;Y10T74/19219;;Y10T74/19555;;Y10T74/19555;;Y10T74/19651;;Y10T74/19651,F16H35/02;;F16H1/22;;F16H35/00;;F16H37/06,74665 F;;74/640;;74/393;;74/414;;74/325,0,0,,,,ACTIVE
839,BR,A2,BR 112013010118 A2,046-974-846-458-846,2017-04-04,2017,BR 112013010118 A,2011-11-01,US 2011/0058810 W;;US 40892610 P,2010-11-01,"veículo, e, transmissão",,POLARIS INC,ALAN S OLSON;;BENJAMIN J DIETER;;DANIEL SCOTT WEBER;;JOHN D SCHREIER;;RON R DANIELSON;;ROY A SUNSDAHL;;STEPHEN L NELSON;;WILLIAM BURT RODRIGUEZ,,https://lens.org/046-974-846-458-846,Patent Application,no,0,0,14,14,0,B60K17/00;;B60K17/00;;F16H37/021;;F16H37/021;;F16H37/027;;F16H37/027;;F16H57/035;;F16H57/035;;F16H2057/02065;;F16H2057/02065;;Y10T74/19;;Y10T74/19;;Y10T74/19074;;Y10T74/19074;;Y10T74/19084;;Y10T74/19084;;Y10T74/19102;;Y10T74/19102;;Y10T74/19219;;Y10T74/19219;;Y10T74/19555;;Y10T74/19555;;Y10T74/19651;;Y10T74/19651,B60K17/00;;F16H37/08,,0,0,,,,DISCONTINUED
840,AU,A1,AU 2003/217642 A1,031-455-385-498-941,2003-09-09,2003,AU 2003/217642 A,2003-02-19,US 35832102 P;;US 0305337 W,2002-02-19,SECURITY METHODS EMPLOYING DRIVERS LICENSES AND OTHER DOCUMENTS,,DIGMARC CORP,CARR J SCOTT;;DAVIS BRUCE L;;DECKER STEPHEN K;;HAWES JONATHAN L;;HEIN WILLIAM C III;;LEVY KENNETH L;;MUNDAY JOHN;;PERRY BURT W,,https://lens.org/031-455-385-498-941,Patent Application,no,0,0,9,31,0,G06Q10/02;;G06Q50/265;;G07C2209/41;;G07C9/22;;G07C9/20;;G07C9/27;;G06Q10/02;;G07C2209/41;;G06Q50/265;;G07C9/20;;G07C9/22,G06Q10/02;;G06Q50/26;;G07C9/00,,0,0,,,,DISCONTINUED
841,WO,A3,WO 2012/061407 A3,057-903-836-892-05X,2013-07-18,2013,US 2011/0058810 W,2011-11-01,US 40892610 P,2010-11-01,VEHICLE AND TRANSMISSION FOR A VEHICLE,"A vehicle is described having a transmission (22) driven through a propulsion unit (20) such as an engine, and through a CVT (24). The transmission is comprised of an input shaft (60) and an output shaft (100) which are coaxially disposed. An idler shaft (62) is driven by the input shaft, and the idler shaft drives the output shaft, through selected gear sets (64, 66, 68), to provide different gear ratios or drive directions. The CVT also has a fan (132) on the driven side which feeds air through the CVT for cooling. The CVT comprises a drive side clutch (52) and a driven side clutch (50) with the output shaft of the (100) extending through the CVT driven clutch (50).",POLARIS INC;;DIETER BENJAMIN J;;OLSON ALAN S;;WEBER DANIEL SCOTT;;RODRIGUEZ WILLIAM BURT;;SCHREIER JOHN D;;NELSON STEPHEN L;;DANIELSON RON R;;SUNSDAHL ROY A,DIETER BENJAMIN J;;OLSON ALAN S;;WEBER DANIEL SCOTT;;RODRIGUEZ WILLIAM BURT;;SCHREIER JOHN D;;NELSON STEPHEN L;;DANIELSON RON R;;SUNSDAHL ROY A,,https://lens.org/057-903-836-892-05X,Search Report,yes,11,0,14,14,0,B60K17/00;;B60K17/00;;F16H37/021;;F16H37/021;;F16H37/027;;F16H37/027;;F16H57/035;;F16H57/035;;F16H2057/02065;;F16H2057/02065;;Y10T74/19;;Y10T74/19;;Y10T74/19074;;Y10T74/19074;;Y10T74/19084;;Y10T74/19084;;Y10T74/19102;;Y10T74/19102;;Y10T74/19219;;Y10T74/19219;;Y10T74/19555;;Y10T74/19555;;Y10T74/19651;;Y10T74/19651,B60K17/00;;F16H37/08,,0,0,,,,PENDING
842,CA,A1,CA 2816579 A1,096-736-000-428-213,2012-05-10,2012,CA 2816579 A,2011-11-01,US 40892610 P;;US 2011/0058810 W,2010-11-01,VEHICLE AND TRANSMISSION FOR A VEHICLE,"A vehicle is described having a transmission (22) driven through a propulsion unit (20) such as an engine, and through a CVT (24). The transmission is comprised of an input shaft (60) and an output shaft (100) which are coaxially disposed. An idler shaft (62) is driven by the input shaft, and the idler shaft drives the output shaft, through selected gear sets (64, 66, 68), to provide different gear ratios or drive directions. The CVT also has a fan (132) on the driven side which feeds air through the CVT for cooling. The CVT comprises a drive side clutch (52) and a driven side clutch (50) with the output shaft of the (100) extending through the CVT driven clutch (50).",POLARIS INC,DIETER BENJAMIN J;;OLSON ALAN S;;WEBER DANIEL SCOTT;;RODRIGUEZ WILLIAM BURT;;SCHREIER JOHN D;;NELSON STEPHEN L;;DANIELSON RON R;;SUNSDAHL ROY A,,https://lens.org/096-736-000-428-213,Patent Application,no,0,0,14,14,0,B60K17/00;;B60K17/00;;F16H37/021;;F16H37/021;;F16H37/027;;F16H37/027;;F16H57/035;;F16H57/035;;F16H2057/02065;;F16H2057/02065;;Y10T74/19;;Y10T74/19;;Y10T74/19074;;Y10T74/19074;;Y10T74/19084;;Y10T74/19084;;Y10T74/19102;;Y10T74/19102;;Y10T74/19219;;Y10T74/19219;;Y10T74/19555;;Y10T74/19555;;Y10T74/19651;;Y10T74/19651,B60K17/00;;F16H37/08,,0,0,,,,ACTIVE
843,EP,A2,EP 1481347 A2,113-954-487-422-066,2004-12-01,2004,EP 03713599 A,2003-02-19,US 0305337 W;;US 35832102 P,2002-02-19,SECURITY METHODS EMPLOYING DRIVERS LICENSES AND OTHER DOCUMENTS,,DIGMARC CORP,CARR J SCOTT;;DAVIS BRUCE L;;DECKER STEPHEN K;;HAWES JONATHAN L;;HEIN WILLIAM C III;;LEVY KENNETH L;;MUNDAY JOHN;;PERRY BURT W,DIGIMARC CORPORATION (2009-07-08),https://lens.org/113-954-487-422-066,Patent Application,yes,0,0,9,31,0,G06Q10/02;;G06Q50/265;;G07C2209/41;;G07C9/22;;G07C9/20;;G07C9/27;;G06Q10/02;;G07C2209/41;;G06Q50/265;;G07C9/20;;G07C9/22,G06Q10/02;;G06Q50/26;;G07C9/00,,0,0,,,,DISCONTINUED
844,WO,A2,WO 2012/061407 A2,031-837-375-173-928,2012-05-10,2012,US 2011/0058810 W,2011-11-01,US 40892610 P,2010-11-01,VEHICLE AND TRANSMISSION FOR A VEHICLE,"A vehicle is described having a transmission (22) driven through a propulsion unit (20) such as an engine, and through a CVT (24). The transmission is comprised of an input shaft (60) and an output shaft (100) which are coaxially disposed. An idler shaft (62) is driven by the input shaft, and the idler shaft drives the output shaft, through selected gear sets (64, 66, 68), to provide different gear ratios or drive directions. The CVT also has a fan (132) on the driven side which feeds air through the CVT for cooling. The CVT comprises a drive side clutch (52) and a driven side clutch (50) with the output shaft of the (100) extending through the CVT driven clutch (50).",POLARIS INC;;DIETER BENJAMIN J;;OLSON ALAN S;;WEBER DANIEL SCOTT;;RODRIGUEZ WILLIAM BURT;;SCHREIER JOHN D;;NELSON STEPHEN L;;DANIELSON RON R;;SUNSDAHL ROY A,DIETER BENJAMIN J;;OLSON ALAN S;;WEBER DANIEL SCOTT;;RODRIGUEZ WILLIAM BURT;;SCHREIER JOHN D;;NELSON STEPHEN L;;DANIELSON RON R;;SUNSDAHL ROY A,,https://lens.org/031-837-375-173-928,Patent Application,yes,1,0,14,14,0,B60K17/00;;B60K17/00;;F16H37/021;;F16H37/021;;F16H37/027;;F16H37/027;;F16H57/035;;F16H57/035;;F16H2057/02065;;F16H2057/02065;;Y10T74/19;;Y10T74/19;;Y10T74/19074;;Y10T74/19074;;Y10T74/19084;;Y10T74/19084;;Y10T74/19102;;Y10T74/19102;;Y10T74/19219;;Y10T74/19219;;Y10T74/19555;;Y10T74/19555;;Y10T74/19651;;Y10T74/19651,B60K17/00;;F16H37/08,,0,0,,,,PENDING
845,WO,A1,WO 2015/023749 A1,057-462-355-575-909,2015-02-19,2015,US 2014/0050890 W,2014-08-13,US 201361865983 P,2013-08-14,SIDE-BY-SIDE VEHICLE,"A utility vehicle includes a plurality of ground-engaging members, a frame assembly supported by the plurality of ground-engaging members, and a powertrain assembly. Additionally, the utility vehicle includes a body generally surrounding the frame assembly and including a hood, dashboard assembly, and a side panel.",POLARIS INC,BURT II DANIEL L;;EATON BRENT C;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;HANTEN MICHAEL J;;KINSMAN ANTHONY J;;HANSON BRENT J;;MELVIN TIMOTHY F;;ROGALA JAMES E;;BLACK-MACKEN RYAN;;STENBERG KURT E;;BRACY GARTH H;;GOULET JEFF M;;JOHNSTUN JEREMIAH T,,https://lens.org/057-462-355-575-909,Patent Application,yes,3,0,11,11,0,B62D23/005;;B60K2005/003;;B60Y2200/86;;B60J10/80;;B60Y2200/20;;B60K5/00;;B60K13/02;;B60K2015/0474;;B62D23/005;;B60K2005/003;;B60Y2200/86;;B60Y2200/20;;B60J10/80;;B60K1/04;;B60K5/00;;B60K13/02;;B60K15/04;;B60K2001/0405;;B60K2015/0474;;B60R7/06;;B62D25/14;;B62D25/2036;;B62D33/0617,B62D23/00;;B60K13/02,,0,0,,,,PENDING
846,US,A1,US 2015/0047917 A1,112-280-798-214-358,2015-02-19,2015,US 201414458839 A,2014-08-13,US 201414458839 A;;US 201361865983 P,2013-08-14,SIDE-BY-SIDE VEHICLE,"A utility vehicle includes a plurality of ground-engaging members, a frame assembly supported by the plurality of ground-engaging members, and a powertrain assembly. Additionally, the utility vehicle includes a body generally surrounding the frame assembly and including a hood, dashboard assembly, and a side panel.",POLARIS INC,BURT II DANIEL L;;EATON BRENT C;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;HANTEN MICHAEL J;;KINSMAN ANTHONY J;;HANSON BRENT J;;MELVIN TIMOTHY F;;ROGALA JAMES E;;BLACK-MACKEN RYAN;;STENBERG KURT E;;BRACY GARTH H;;GOULET JEFF M;;JOHNSTUN JEREMIAH T,POLARIS INDUSTRIES INC (2013-01-29),https://lens.org/112-280-798-214-358,Patent Application,yes,2,42,11,11,0,B62D23/005;;B60K2005/003;;B60Y2200/86;;B60J10/80;;B60Y2200/20;;B60K5/00;;B60K13/02;;B60K2015/0474;;B62D23/005;;B60K2005/003;;B60Y2200/86;;B60Y2200/20;;B60J10/80;;B60K1/04;;B60K5/00;;B60K13/02;;B60K15/04;;B60K2001/0405;;B60K2015/0474;;B60R7/06;;B62D25/14;;B62D25/2036;;B62D33/0617,B62D33/06;;B60J10/08;;B60K1/04;;B60K5/00;;B60K13/02;;B60K15/04;;B60R7/06;;B62D25/14;;B62D25/20,180/292;;180/89.1;;180/90.6;;180/69.4;;180/68.5;;180/90;;180/68.3,0,0,,,,ACTIVE
847,EP,A1,EP 3033264 A1,182-092-417-770-934,2016-06-22,2016,EP 14756189 A,2014-08-13,US 201361865983 P;;US 2014/0050890 W,2013-08-14,SIDE-BY-SIDE VEHICLE,,POLARIS INC,BURT II DANIEL L;;EATON BRENT C;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;HANTEN MICHAEL J;;KINSMAN ANTHONY J;;HANSON BRENT J;;MELVIN TIMOTHY F;;ROGALA JAMES E;;BLACK-MACKEN RYAN;;STENBERG KURT E;;BRACY GARTH H;;GOULET JEFF M;;JOHNSTUN JEREMIAH T,,https://lens.org/182-092-417-770-934,Patent Application,yes,0,0,11,11,0,B62D23/005;;B60K2005/003;;B60Y2200/86;;B60J10/80;;B60Y2200/20;;B60K5/00;;B60K13/02;;B60K2015/0474;;B62D23/005;;B60K2005/003;;B60Y2200/86;;B60Y2200/20;;B60J10/80;;B60K1/04;;B60K5/00;;B60K13/02;;B60K15/04;;B60K2001/0405;;B60K2015/0474;;B60R7/06;;B62D25/14;;B62D25/2036;;B62D33/0617,B62D23/00;;B60K13/02,,0,0,,,,DISCONTINUED
848,AU,B2,AU 2014/306646 B2,187-426-780-202-826,2018-02-01,2018,AU 2014/306646 A,2014-08-13,US 201361865983 P;;US 2014/0050890 W,2013-08-14,Side-by-side vehicle,"A utility vehicle includes a plurality of ground-engaging members, a frame assembly supported by the plurality of ground-engaging members, and a powertrain assembly. Additionally, the utility vehicle includes a body generally surrounding the frame assembly and including a hood, dashboard assembly, and a side panel.",POLARIS INC,BURT II DANIEL L;;EATON BRENT C;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;HANTEN MICHAEL J;;KINSMAN ANTHONY J;;HANSON BRENT J;;MELVIN TIMOTHY F;;ROGALA JAMES E;;BLACK-MACKEN RYAN;;STENBERG KURT E;;BRACY GARTH H;;GOULET JEFF M;;JOHNSTUN JEREMIAH T,,https://lens.org/187-426-780-202-826,Granted Patent,no,2,0,11,11,0,B62D23/005;;B60K2005/003;;B60Y2200/86;;B60J10/80;;B60Y2200/20;;B60K5/00;;B60K13/02;;B60K2015/0474;;B62D23/005;;B60K2005/003;;B60Y2200/86;;B60Y2200/20;;B60J10/80;;B60K1/04;;B60K5/00;;B60K13/02;;B60K15/04;;B60K2001/0405;;B60K2015/0474;;B60R7/06;;B62D25/14;;B62D25/2036;;B62D33/0617,B62D23/00;;B60K13/02,,0,0,,,,INACTIVE
849,MX,A,MX 2016001941 A,104-329-708-973-647,2016-06-02,2016,MX 2016001941 A,2014-08-13,US 201361865983 P;;US 2014/0050890 W,2013-08-14,SIDE-BY-SIDE VEHICLE.,"A utility vehicle includes a plurality of ground-engaging members, a frame assembly supported by the plurality of ground-engaging members, and a powertrain assembly. Additionally, the utility vehicle includes a body generally surrounding the frame assembly and including a hood, dashboard assembly, and a side panel.",POLARIS INC,KINSMAN ANTHONY J;;EATON BRENT C;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;HANTEN MICHAEL J;;HANSON BRENT J;;MELVIN TIMOTHY F;;ROGALA JAMES E;;BLACK-MACKEN RYAN;;STENBERG KURT E;;BRACY GARTH H;;JOHNSTUN JEREMIAH T;;BURT DANIEL L II;;GOULET JEFF M,,https://lens.org/104-329-708-973-647,Patent Application,no,0,0,11,11,0,B62D23/005;;B60K2005/003;;B60Y2200/86;;B60J10/80;;B60Y2200/20;;B60K5/00;;B60K13/02;;B60K2015/0474;;B62D23/005;;B60K2005/003;;B60Y2200/86;;B60Y2200/20;;B60J10/80;;B60K1/04;;B60K5/00;;B60K13/02;;B60K15/04;;B60K2001/0405;;B60K2015/0474;;B60R7/06;;B62D25/14;;B62D25/2036;;B62D33/0617,B60K13/02;;B62D23/00,,0,0,,,,ACTIVE
850,CA,C,CA 2921360 C,136-486-579-837-162,2020-10-27,2020,CA 2921360 A,2014-08-13,US 201361865983 P;;US 2014/0050890 W,2013-08-14,SIDE-BY-SIDE VEHICLE,"A utility vehicle includes a plurality of ground-engaging members, a frame assembly supported by the plurality of ground-engaging members, and a powertrain assembly. Additionally, the utility vehicle includes a body generally surrounding the frame assembly and including a hood, dashboard assembly, and a side panel.",POLARIS INC,BURT DANIEL L;;EATON BRENT C;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;HANTEN MICHAEL J;;KINSMAN ANTHONY J;;HANSON BRENT J;;MELVIN TIMOTHY F;;ROGALA JAMES E;;BLACK-MACKEN RYAN;;STENBERG KURT E;;BRACY GARTH H;;GOULET JEFF M;;JOHNSTUN JEREMIAH T,,https://lens.org/136-486-579-837-162,Granted Patent,no,0,0,11,11,0,B62D23/005;;B60K2005/003;;B60Y2200/86;;B60J10/80;;B60Y2200/20;;B60K5/00;;B60K13/02;;B60K2015/0474;;B62D23/005;;B60K2005/003;;B60Y2200/86;;B60Y2200/20;;B60J10/80;;B60K1/04;;B60K5/00;;B60K13/02;;B60K15/04;;B60K2001/0405;;B60K2015/0474;;B60R7/06;;B62D25/14;;B62D25/2036;;B62D33/0617,B62D23/00;;B60K13/02,,0,0,,,,ACTIVE
851,CN,A,CN 105793143 A,017-357-704-517-18X,2016-07-20,2016,CN 201480051129 A,2014-08-13,US 201361865983 P;;US 2014/0050890 W,2013-08-14,SIDE-BY-SIDE VEHICLE,"A utility vehicle includes a plurality of ground-engaging members, a frame assembly supported by the plurality of ground-engaging members, and a powertrain assembly. Additionally, the utility vehicle includes a body generally surrounding the frame assembly and including a hood, dashboard assembly, and a side panel.",POLARIS INC,BURT II DANIEL L;;EATON BRENT C;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;HANTEN MICHAEL J;;KINSMAN ANTHONY J;;HANSON BRENT J;;MELVIN TIMOTHY F;;ROGALA JAMES E;;BLACK-MACKEN RYAN;;STENBERG KURT E;;BRACY GARTH H;;GOULET JEFF M;;JOHNSTUN JEREMIAH T,,https://lens.org/017-357-704-517-18X,Patent Application,no,6,5,11,11,0,B62D23/005;;B60K2005/003;;B60Y2200/86;;B60J10/80;;B60Y2200/20;;B60K5/00;;B60K13/02;;B60K2015/0474;;B62D23/005;;B60K2005/003;;B60Y2200/86;;B60Y2200/20;;B60J10/80;;B60K1/04;;B60K5/00;;B60K13/02;;B60K15/04;;B60K2001/0405;;B60K2015/0474;;B60R7/06;;B62D25/14;;B62D25/2036;;B62D33/0617,B62D23/00;;B60K13/02,,0,0,,,,ACTIVE
852,CA,A1,CA 2921360 A1,064-400-972-496-739,2015-02-19,2015,CA 2921360 A,2014-08-13,US 201361865983 P;;US 2014/0050890 W,2013-08-14,SIDE-BY-SIDE VEHICLE,"A utility vehicle includes a plurality of ground-engaging members, a frame assembly supported by the plurality of ground-engaging members, and a powertrain assembly. Additionally, the utility vehicle includes a body generally surrounding the frame assembly and including a hood, dashboard assembly, and a side panel.",POLARIS INC,BURT DANIEL L II;;EATON BRENT C;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;HANTEN MICHAEL J;;KINSMAN ANTHONY J;;HANSON BRENT J;;MELVIN TIMOTHY F;;ROGALA JAMES E;;BLACK-MACKEN RYAN;;STENBERG KURT E;;BRACY GARTH H;;GOULET JEFF M;;JOHNSTUN JEREMIAH T,,https://lens.org/064-400-972-496-739,Patent Application,no,0,1,11,11,0,B62D23/005;;B60K2005/003;;B60Y2200/86;;B60J10/80;;B60Y2200/20;;B60K5/00;;B60K13/02;;B60K2015/0474;;B62D23/005;;B60K2005/003;;B60Y2200/86;;B60Y2200/20;;B60J10/80;;B60K1/04;;B60K5/00;;B60K13/02;;B60K15/04;;B60K2001/0405;;B60K2015/0474;;B60R7/06;;B62D25/14;;B62D25/2036;;B62D33/0617,B62D23/00;;B60K13/02,,0,0,,,,ACTIVE
853,AU,A1,AU 2014/306646 A1,006-399-861-336-231,2016-03-10,2016,AU 2014/306646 A,2014-08-13,US 201361865983 P;;US 2014/0050890 W,2013-08-14,Side-by-side vehicle,"A utility vehicle includes a plurality of ground-engaging members, a frame assembly supported by the plurality of ground-engaging members, and a powertrain assembly. Additionally, the utility vehicle includes a body generally surrounding the frame assembly and including a hood, dashboard assembly, and a side panel.",POLARIS INC,BURT II DANIEL L;;EATON BRENT C;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;HANTEN MICHAEL J;;KINSMAN ANTHONY J;;HANSON BRENT J;;MELVIN TIMOTHY F;;ROGALA JAMES E;;BLACK-MACKEN RYAN;;STENBERG KURT E;;BRACY GARTH H;;GOULET JEFF M;;JOHNSTUN JEREMIAH T,,https://lens.org/006-399-861-336-231,Patent Application,no,0,0,11,11,0,B62D23/005;;B60K2005/003;;B60Y2200/86;;B60J10/80;;B60Y2200/20;;B60K5/00;;B60K13/02;;B60K2015/0474;;B62D23/005;;B60K2005/003;;B60Y2200/86;;B60Y2200/20;;B60J10/80;;B60K1/04;;B60K5/00;;B60K13/02;;B60K15/04;;B60K2001/0405;;B60K2015/0474;;B60R7/06;;B62D25/14;;B62D25/2036;;B62D33/0617,B62D23/00;;B60K13/02,,0,0,,,,INACTIVE
854,EP,A1,EP 4281161 A1,031-854-662-877-156,2023-11-29,2023,EP 22746760 A,2022-01-28,US 202163143377 P;;US 2022/0014437 W,2021-01-29,FIXATION DEVICES FOR CATHETERS,,ALCYONE THERAPEUTICS INC,EAST ANDREW;;RAYMOND BURT;;WOOD ANDRE CARLINE;;SINGH DEEP ARJUN;;FREUND JONATHAN;;MCGUIRE JOHN L;;SUBRAMANIAN KRISHNA;;LAPINSKI MATTHEW J;;HOLMES MEGAN;;WASHBURN THOMAS T,,https://lens.org/031-854-662-877-156,Patent Application,yes,0,0,8,8,0,A61M25/02;;A61M2025/024;;A61M2025/0286;;A61M2025/028;;A61M25/02;;A61M2025/0286;;A61M2025/024,A61M25/02;;A61M25/01;;A61M25/04,,0,0,,,,PENDING
855,US,B2,US 11607529 B2,177-168-856-662-422,2023-03-21,2023,US 202217588087 A,2022-01-28,US 202217588087 A;;US 202163143377 P,2021-01-29,Fixation devices for catheters,Fixation devices are disclosed herein that can be used to secure to a catheter and to tissue. The fixation devices include a body having a bore extending therethrough to receive a catheter. The fixation devices can also include suture openings or grooves to secure the devices to tissue.,ALCYONE THERAPEUTICS INC,EAST ANDREW;;RAYMOND BURT;;WOOD ANDRE CARLINE;;SINGH DEEP ARJUN;;FREUND JONATHAN;;MCGUIRE JOHN L;;SUBRAMANIAN KRISHNA;;LAPINSKI MATTHEW J;;HOLMES MEGAN;;WASHBURN THOMAS T,ALCYONE THERAPEUTICS INC (2019-07-11),https://lens.org/177-168-856-662-422,Granted Patent,yes,36,0,8,8,0,A61M25/02;;A61M2025/024;;A61M2025/0286;;A61M2025/028;;A61M25/02;;A61M2025/0286;;A61M2025/024,A61M25/02,,1,0,,,"International Application No. PCT/US2022/014437, International Search Report and Written Opinion, dated Jun. 6, 2022.",ACTIVE
856,WO,A1,WO 2022/165268 A1,040-815-546-744-211,2022-08-04,2022,US 2022/0014437 W,2022-01-28,US 202163143377 P,2021-01-29,FIXATION DEVICES FOR CATHETERS,Fixation devices are disclosed herein that can be used to secure to a catheter and to tissue. The fixation devices include a body having a bore extending therethrough to receive a catheter. The fixation devices can also include suture openings or grooves to secure the devices to tissue.,ALCYONE THERAPEUTICS INC,EAST ANDREW;;RAYMOND BURT;;WOOD ANDRE CARLINE;;SINGH DEEP ARJUN;;FREUND JONATHAN;;MCGUIRE JOHN L;;SUBRAMANIAN KRISHNA;;LAPINSKI MATTHEW J;;HOLMES MEGAN;;WASHBURN THOMAS T,,https://lens.org/040-815-546-744-211,Patent Application,yes,4,0,8,8,0,A61M25/02;;A61M2025/024;;A61M2025/0286;;A61M2025/028;;A61M25/02;;A61M2025/0286;;A61M2025/024,A61M25/02;;A61M25/01;;A61M25/04,,0,0,,,,PENDING
857,AU,A1,AU 2022/214941 A1,066-909-721-219-651,2023-09-07,2023,AU 2022/214941 A,2022-01-28,US 202163143377 P;;US 2022/0014437 W,2021-01-29,FIXATION DEVICES FOR CATHETERS,Fixation devices are disclosed herein that can be used to secure to a catheter and to tissue. The fixation devices include a body having a bore extending therethrough to receive a catheter. The fixation devices can also include suture openings or grooves to secure the devices to tissue.,ALCYONE THERAPEUTICS INC,EAST ANDREW;;RAYMOND BURT;;WOOD ANDRE CARLINE;;SINGH DEEP ARJUN;;FREUND JONATHAN;;MCGUIRE JOHN L;;SUBRAMANIAN KRISHNA;;LAPINSKI MATTHEW J;;HOLMES MEGAN;;WASHBURN THOMAS T,,https://lens.org/066-909-721-219-651,Patent Application,no,0,0,8,8,0,A61M25/02;;A61M2025/024;;A61M2025/0286;;A61M2025/028;;A61M25/02;;A61M2025/0286;;A61M2025/024,A61M25/01;;A61M25/02;;A61M25/04,,0,0,,,,PENDING
858,US,B1,US 6522808 B1,114-998-640-639-431,2003-02-18,2003,US 48382500 A,2000-01-15,US 48382500 A,2000-01-15,System and method for writing fiber gratings and other components,"
    A system for writing fiber gratings has a plurality of writing stations, each writing station including a fiber mounting fixture for receiving an optical fiber to be exposed to a beam from a laser. The system includes a data capture module for capturing data generated from the exposure of optical fibers in each of the writing stations, and a steering assembly for directing the laser beam to each of the plurality of writing stations in turn. 
",CORNING INC,BURT RONALD L;;DAHLMAN JOSHUA J;;D ALBERTO TIFFANIE G;;MCGINNIS JAMES E;;MORGAN WALTER L;;O'LOUGHLIN JR ROBERT;;SCHMIDLIN EDWARD M;;SHULTZ MICHAEL G,CORNING INCORPORATED (2000-04-18);;MOTOROLA INC (2000-01-27),https://lens.org/114-998-640-639-431,Granted Patent,yes,3,13,7,7,0,G02B6/02138;;G02B6/02138,G02B6/02;;G03F7/20,385/37;;430/290,0,0,,,,EXPIRED
859,CA,A1,CA 3206683 A1,007-491-932-012-444,2022-08-04,2022,CA 3206683 A,2022-01-28,US 202163143377 P;;US 2022/0014437 W,2021-01-29,FIXATION DEVICES FOR CATHETERS,Fixation devices are disclosed herein that can be used to secure to a catheter and to tissue. The fixation devices include a body having a bore extending therethrough to receive a catheter. The fixation devices can also include suture openings or grooves to secure the devices to tissue.,ALCYONE THERAPEUTICS INC,EAST ANDREW;;RAYMOND BURT;;WOOD ANDRE CARLINE;;SINGH DEEP ARJUN;;FREUND JONATHAN;;MCGUIRE JOHN L;;SUBRAMANIAN KRISHNA;;LAPINSKI MATTHEW J;;HOLMES MEGAN;;WASHBURN THOMAS T,,https://lens.org/007-491-932-012-444,Patent Application,no,0,0,8,8,0,A61M25/02;;A61M2025/024;;A61M2025/0286;;A61M2025/028;;A61M25/02;;A61M2025/0286;;A61M2025/024,A61M25/04,,0,0,,,,PENDING
860,US,A,US 5856420 A,121-283-089-767-793,1999-01-05,1999,US 63407296 A,1996-04-17,US 63407296 A,1996-04-17,"Bis(isobutyraldimine) of 1,4-diaminobutane in HDI trimer and biuret-based coatings","Disclosed are new coatings compositions based on an HDI isocyanurate or biuret polyisocyanate and a bis(imine) reaction product of a diaminoalkane containing between two and five carbon atoms with an alkyl aldehyde containing between four and seven carbon atoms (advantageously a bis(imine) product of the reaction of 1,4-diaminobutane and isobutyraldehyde). The latter bis(imine) is completely miscible in HDI isocyanurate and biuret polyisocyanates, and, as a reactive diluent, allows the preparation of high performance coatings formulations that require only small amounts of solvents to achieve a conveniently sprayable viscosity.",ARCO CHEM TECH,TUCKER BENJAMIN W;;BARNOWSKI JR HENRY G;;BARSA EDWARD A;;WHITMAN PETER J;;CHEN AUGUSTIN T;;BURT WILLARD F;;GOLDSTEIN STEPHEN L;;O'CONNOR JAMES M,BAYER CORPORATION (2002-01-01);;OLIN CORPORATION (1996-04-15);;COVESTRO LLC (2014-12-31);;ARCO CHEMICAL TECHNOLOGY L.P (1996-12-04),https://lens.org/121-283-089-767-793,Granted Patent,yes,5,10,3,3,0,C08G18/3256;;C08G18/7831;;C08G18/792;;C08G18/792;;C08G18/3256;;C08G18/7831,C08G18/32;;C08G18/78;;C08G18/79,528/53;;524/236;;524/590;;528/44;;528/52;;528/55;;528/85,0,0,,,,EXPIRED
861,US,A1,US 2022/0241559 A1,133-451-459-800-307,2022-08-04,2022,US 202217588087 A,2022-01-28,US 202217588087 A;;US 202163143377 P,2021-01-29,Fixation Devices for Catheters,Fixation devices are disclosed herein that can be used to secure to a catheter and to tissue. The fixation devices include a body having a bore extending therethrough to receive a catheter. The fixation devices can also include suture openings or grooves to secure the devices to tissue.,ALCYONE THERAPEUTICS INC,EAST ANDREW;;RAYMOND BURT;;WOOD ANDRE CARLINE;;SINGH DEEP ARJUN;;FREUND JONATHAN;;MCGUIRE JOHN L;;SUBRAMANIAN KRISHNA;;LAPINSKI MATTHEW J;;HOLMES MEGAN;;WASHBURN THOMAS T,ALCYONE THERAPEUTICS INC (2019-07-11),https://lens.org/133-451-459-800-307,Patent Application,yes,20,0,8,8,0,A61M25/02;;A61M2025/024;;A61M2025/0286;;A61M2025/028;;A61M25/02;;A61M2025/0286;;A61M2025/024,A61M25/02,,0,0,,,,ACTIVE
862,CN,A,CN 102791697 A,054-861-007-628-815,2012-11-21,2012,CN 201080056450 A,2010-10-12,US 2010/0052385 W;;US 25084209 P;;US 32524510 P,2009-10-12,Amino-pyrimidine compounds as inhibitors of TBKL and/or IKK epsilon,"The invention relates to certain amino-pyrimidine compounds which inhibit TBK1 and/or IKK epsilon and which may therefore find application in treating inflammation, cancer, septic shock and/or Primary open Angle Glaucoma (POAG).",MYREXIS INC,RYAN HOLCOMB;;KAZUYUKI SUZUKI;;HALTER ROBERT J;;SEBAHAR PAUL R;;MCLEOD DONALD A;;SHENDEROVICH MARK D;;YAGER KRAIG M;;GREGORY BURSAVICH MATTHEW;;YUNGAI ASHANTAI J;;BURT RICHARDS;;BARTEL PAUL L;;WETTSTEIN DANIEL A,,https://lens.org/054-861-007-628-815,Patent Application,no,2,9,12,12,0,C07D239/42;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;A61P1/00;;A61P11/00;;A61P17/06;;A61P19/04;;A61P21/00;;A61P25/00;;A61P29/00;;A61P29/02;;A61P3/00;;A61P3/04;;A61P35/00;;A61P43/00;;A61P5/48;;A61P3/10;;C07D413/12;;C07D405/12;;A61K31/5377;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;C07D487/08;;C07D405/12;;C07D401/12;;C07D403/12;;C07D413/14;;C07D417/12;;C07D239/42;;C07D405/14;;C07D417/14;;C07D403/14,C07D239/42;;A61K31/505;;A61K31/506;;A61P29/02;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08,,0,0,,,,DISCONTINUED
863,AU,A1,AU 2010/306927 A1,004-757-672-272-544,2012-05-31,2012,AU 2010/306927 A,2010-10-12,US 25084209 P;;US 32524510 P;;US 2010/0052385 W,2009-10-12,Amino - pyrimidine compounds as inhibitors of TBKL and/or IKK epsilon,"The invention relates to certain amino-pyrimidine compounds which inhibit TBK1 and/or IKK epsilon and which may therefore find application in treating inflammation, cancer, septic shock and/or Primary open Angle Glaucoma (POAG).",MYREXIS INC,HOLCOMB RYAN;;SUZUKI KAZUYUKI;;HALTER ROBERT J;;SEBAHAR PAUL R;;MCLEOD DONALD A;;SHENDEROVICH MARK D;;YAGER KRAIG M;;BURSAVICH MATTHEW GREGORY;;YUNGAI ASHANTAI J;;RICHARDS BURT;;BARTEL PAUL L;;WETTSTEIN DANIEL A,,https://lens.org/004-757-672-272-544,Patent Application,no,0,0,12,12,0,C07D239/42;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;A61P1/00;;A61P11/00;;A61P17/06;;A61P19/04;;A61P21/00;;A61P25/00;;A61P29/00;;A61P29/02;;A61P3/00;;A61P3/04;;A61P35/00;;A61P43/00;;A61P5/48;;A61P3/10;;C07D413/12;;C07D405/12;;A61K31/5377;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;C07D487/08;;C07D405/12;;C07D401/12;;C07D403/12;;C07D413/14;;C07D417/12;;C07D239/42;;C07D405/14;;C07D417/14;;C07D403/14,C07D239/42;;A61K31/505;;A61K31/506;;A61P29/02;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08,,0,0,,,,DISCONTINUED
864,EP,A1,EP 2488503 A1,167-845-113-316-345,2012-08-22,2012,EP 10768665 A,2010-10-12,US 25084209 P;;US 32524510 P;;US 2010/0052385 W,2009-10-12,AMINO - PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBKL AND/OR IKK EPSILON,,MYREXIS INC,HOLCOMB RYAN;;SUZUKI KAZUYUKI;;HALTER ROBERT J;;SEBAHAR PAUL R;;MCLEOD DONALD A;;SHENDEROVICH MARK D;;YAGER KRAIG M;;BURSAVICH MATTHEW GREGORY;;YUNGAI ASHANTAI J;;RICHARDS BURT;;BARTEL PAUL L;;WETTSTEIN DANIEL A,,https://lens.org/167-845-113-316-345,Patent Application,yes,0,0,12,12,0,C07D239/42;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;A61P1/00;;A61P11/00;;A61P17/06;;A61P19/04;;A61P21/00;;A61P25/00;;A61P29/00;;A61P29/02;;A61P3/00;;A61P3/04;;A61P35/00;;A61P43/00;;A61P5/48;;A61P3/10;;C07D413/12;;C07D405/12;;A61K31/5377;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;C07D487/08;;C07D405/12;;C07D401/12;;C07D403/12;;C07D413/14;;C07D417/12;;C07D239/42;;C07D405/14;;C07D417/14;;C07D403/14,C07D239/42;;A61K31/505;;A61K31/506;;A61P29/02;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08,,0,0,,,,DISCONTINUED
865,CA,A1,CA 2777762 A1,151-874-427-677-655,2011-04-21,2011,CA 2777762 A,2010-10-12,US 25084209 P;;US 32524510 P;;US 2010/0052385 W,2009-10-12,AMINO - PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBK1 AND/OR IKK EPSILON,"The invention relates to certain amino-pyrimidine compounds which inhibit TBK1 and/or IKK epsilon and which may therefore find application in treating inflammation, cancer, septic shock and/or Primary open Angle Glaucoma (POAG).",MYREXIS INC,HOLCOMB RYAN;;SUZUKI KAZUYUKI;;HALTER ROBERT J;;SEBAHAR PAUL R;;MCLEOD DONALD A;;SHENDEROVICH MARK D;;YAGER KRAIG M;;BURSAVICH MATTHEW GREGORY;;YUNGAI ASHANTAI J;;RICHARDS BURT;;BARTEL PAUL L;;WETTSTEIN DANIEL A,,https://lens.org/151-874-427-677-655,Patent Application,no,0,0,12,12,0,C07D239/42;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;A61P1/00;;A61P11/00;;A61P17/06;;A61P19/04;;A61P21/00;;A61P25/00;;A61P29/00;;A61P29/02;;A61P3/00;;A61P3/04;;A61P35/00;;A61P43/00;;A61P5/48;;A61P3/10;;C07D413/12;;C07D405/12;;A61K31/5377;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;C07D487/08;;C07D405/12;;C07D401/12;;C07D403/12;;C07D413/14;;C07D417/12;;C07D239/42;;C07D405/14;;C07D417/14;;C07D403/14,C07D239/42;;A61K31/505;;A61K31/506;;A61P29/02;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08,,0,0,,,,DISCONTINUED
866,EP,A1,EP 3210213 A1,098-712-528-865-266,2017-08-30,2017,EP 15852308 A,2015-10-23,US 201462067570 P;;US 2015/0057059 W,2014-10-23,METHOD FOR APPROXIMATING REMAINING LIFETIME OF ACTIVE DEVICES,,SAMTEC INC,CORNELIUS JOSHUA R;;ZBINDEN ERIC JEAN;;VERDIELL JEAN-MARC ANDRE;;KOZLOVSKY WILLIAM J;;BURT KEVIN;;TROXELL THOMAS BENJAMIN;;LEROY LESLY;;LANGSAM DAVID A;;BAXTER ANDREW JOHN,,https://lens.org/098-712-528-865-266,Patent Application,yes,0,0,6,10,0,G01M99/002;;G01K1/022;;G01K3/04;;G01M99/002;;G06F1/28;;G06F11/00;;G06F2212/7203;;G06F2212/7211;;G01M11/30;;G11C16/02,H01B11/00;;H01B7/00,,0,0,,,,PENDING
867,TW,B,TW I621839 B,166-936-859-237-288,2018-04-21,2018,TW 104134827 A,2015-10-23,US 201462067570 P,2014-10-23,Active optical cable and method of calculating ah effective age of the same,,SAMTEC INC,CORNELIUS JOSHUA R;;ZBINDEN ERIC JEAN;;VERDIELL JEAN-MARC ANDRE;;KOZLOVSKY WILLIAM J;;BURT KEVIN;;TROXELL THOMAS BENJAMIN;;LEROY LESLY;;LANGSAM DAVID A;;BAXTER ANDY JOHN,,https://lens.org/166-936-859-237-288,Granted Patent,no,2,0,6,10,0,G01M99/002;;G01K1/022;;G01K3/04;;G01M99/002;;G06F1/28;;G06F11/00;;G06F2212/7203;;G06F2212/7211;;G01M11/30;;G11C16/02,,,0,0,,,,INACTIVE
868,US,B1,US 6202266 B1,076-013-410-560-44X,2001-03-20,2001,US 34893499 A,1999-07-07,US 34893499 A,1999-07-07,Clamp for mounting storage accessories,"A versatile user-adjustable clamp for clamping accessories to the panels of ready-to-assemble furniture articles, and other surfaces such as countertops, has a main body member, a jaw member, and a knob. The main body member has a substantially spool-shaped section with accessory interface means at opposing ends thereof, and a rectangular section that projects tangentially from the spool-shaped section. The spool-shaped section of the main body member telescopingly receives the jaw member, and has a knob-receiving aperture. The knob is rotatably secured within the knob aperture and provides a means for actuating the telescopic movement of the jaw member relative to the main clamp body. The jaw member includes a flat surface interface that is oriented parallel to the rectangular section of the main clamp body, and has a separate accessory interface means therein. This separate accessory interface means can include a snap-lock feature, allowing users to confirm that the clamp is securely fastened to an associated accessory. The clamp can be used as a hinge when rotatably mounted to a pair of hinge-halves that comprise a further accessory interface means, using the first two accessory interface means.",KENLIN GROUP INC,VAN DEN BRANDEN DAVID J;;EVANS PAUL C;;MCCOY MICHAEL D;;FAHNSTROM DALE E;;MENDELSON BURT F;;POMERLEAU LAWRENCE J;;DRESNER CHARLES;;WHITTIER KELLY;;CONLEY CHRISTOPHER V;;TERNOVITS SCOTT A;;O'CONNOR MAUREEN A,KENLIN GROUP INC (2000-05-31);;KENLIN ENTERPRISES INC. AN ILLINOIS CORPORATION (1999-03-17);;HANDY BUTTON MACHINE CO (2005-01-26),https://lens.org/076-013-410-560-44X,Granted Patent,yes,16,20,11,11,0,A47B96/06;;A47B97/00;;B25B5/10;;B25B5/163;;F16B2/10;;F16M13/022;;F16M2200/022;;Y10T24/44974;;Y10T24/2175;;Y10T24/44444;;Y10T24/44504;;Y10T24/44974;;Y10T24/2175;;Y10T24/44444;;Y10T24/44504;;F16B2/10;;B25B5/10;;A47B97/00;;B25B5/163;;A47B96/06;;F16M13/022;;F16M2200/022,A47B96/06;;A47B97/00;;A47G29/00;;A44B99/00;;B25B5/10;;B25B5/16;;F16B2/10;;F16M13/02,24/569;;X 24 68 CD;;24/514;;24/507,0,0,,,,EXPIRED
869,WO,A1,WO 2011/046970 A1,182-260-682-733-405,2011-04-21,2011,US 2010/0052385 W,2010-10-12,US 25084209 P;;US 32524510 P,2009-10-12,AMINO - PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBKL AND/OR IKK EPSILON,"The invention relates to certain amino-pyrimidine compounds which inhibit TBK1 and/or IKK epsilon and which may therefore find application in treating inflammation, cancer, septic shock and/or Primary open Angle Glaucoma (POAG).",MYREXIS INC;;HOLCOMB RYAN;;SUZUKI KAZUYUKI;;HALTER ROBERT J;;SEBAHAR PAUL R;;MCLEOD DONALD A;;SHENDEROVICH MARK D;;YAGER KRAIG M;;BURSAVICH MATTHEW GREGORY;;YUNGAI ASHANTAI J;;RICHARDS BURT;;BARTEL PAUL L;;WETTSTEIN DANIEL A,HOLCOMB RYAN;;SUZUKI KAZUYUKI;;HALTER ROBERT J;;SEBAHAR PAUL R;;MCLEOD DONALD A;;SHENDEROVICH MARK D;;YAGER KRAIG M;;BURSAVICH MATTHEW GREGORY;;YUNGAI ASHANTAI J;;RICHARDS BURT;;BARTEL PAUL L;;WETTSTEIN DANIEL A,,https://lens.org/182-260-682-733-405,Patent Application,yes,8,84,12,12,0,C07D239/42;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;A61P1/00;;A61P11/00;;A61P17/06;;A61P19/04;;A61P21/00;;A61P25/00;;A61P29/00;;A61P29/02;;A61P3/00;;A61P3/04;;A61P35/00;;A61P43/00;;A61P5/48;;A61P3/10;;C07D413/12;;C07D405/12;;A61K31/5377;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;C07D487/08;;C07D405/12;;C07D401/12;;C07D403/12;;C07D413/14;;C07D417/12;;C07D239/42;;C07D405/14;;C07D417/14;;C07D403/14,A61K31/505;;C07D239/42;;A61K31/506;;A61P29/02;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08,,60,56,053-370-843-905-520;;065-787-595-730-408;;053-370-843-905-520;;042-647-448-079-273;;004-179-032-290-291;;147-038-003-111-676;;063-158-407-544-305;;008-467-553-582-080;;022-968-452-249-417;;007-998-226-508-808;;028-755-545-791-36X;;088-974-709-655-88X;;000-050-520-674-208;;064-604-435-403-001;;089-695-493-068-268;;016-468-626-065-637;;014-012-117-093-025;;044-998-717-936-489;;054-293-891-849-72X;;059-908-749-992-584;;019-622-009-573-46X;;113-710-090-403-544;;023-965-218-118-34X;;106-176-515-797-622;;029-228-819-767-693;;076-008-122-899-880;;033-439-262-125-291;;033-439-262-125-291;;035-576-955-687-557;;109-675-454-073-238;;001-212-879-835-747;;025-334-029-297-694;;084-507-421-496-746;;009-621-640-082-286;;084-147-620-747-601;;055-106-338-233-719;;040-081-313-970-111;;048-126-638-268-424;;036-144-452-553-36X;;052-294-832-465-701;;002-469-289-337-350;;042-647-448-079-273;;022-968-452-249-417;;089-695-493-068-268;;045-791-058-371-469;;063-308-764-338-017;;121-750-490-021-226;;020-427-213-543-091;;027-344-849-476-315;;000-602-511-059-53X;;029-228-819-767-693;;035-576-955-687-557;;109-675-454-073-238;;001-212-879-835-747;;025-334-029-297-694;;084-147-620-747-601,10.1093/intimm/11.8.1357;;10421793;;10.1038/sj.onc.1206406;;12761501;;10.1093/intimm/11.8.1357;;10421793;;12736252;;10.1074/jbc.m303001200;;12702806;;10.1126/science.1081315;;17236232;;10.1002/eji.200636090;;10.1038/cr.2008.273;;19160540;;10.1016/j.tibs.2008.01.002;;18353649;;10.4049/jimmunol.174.10.6424;;15879144;;pmc2713581;;18653628;;10.1136/ard.2008.095356;;10.1002/art.22421;;17328045;;pmc151388;;10.1073/pnas.0337679100;;12604793;;10.1038/nm1590;;17479100;;19808788;;10.1093/hmg/ddp293;;pmc2758706;;18583934;;pmc2825026;;10.4161/cc.7.12.6162;;pmc2626626;;18724932;;10.1016/j.cell.2008.06.032;;10.1038/ni.1932;;pmc3142795;;20890285;;pmc2443782;;17968926;;10.1002/art.22928;;20392289;;pmc2991775;;10.1186/ar2883;;20298124;;10.3109/08916930903510872;;10.1093/intimm/dxh318;;16214811;;10.1038/sj.jid.5701087;;17928888;;10.1016/j.addr.2007.12.002;;18280611;;19890046;;10.4049/jimmunol.0901386;;pmc2920602;;20803699;;10.1002/ibd.21282;;pmc2958454;;11713901;;10.1007/pl00000223;;10.1016/j.cell.2009.06.046;;pmc2756060;;19737522;;10.1016/j.cell.2009.06.046;;pmc2756060;;19737522;;10.1677/joe-08-0276;;19251743;;17574021;;10.1016/j.cell.2007.03.052;;pmc2746958;;19481526;;10.1016/j.molcel.2009.04.031;;10.2353/ajpath.2009.080767;;pmc2708818;;19497997;;20188669;;10.1016/j.molcel.2010.01.018;;10.1073/pnas.0511319103;;pmc1449677;;16537515;;17018283;;10.3410/f.1047456.496620;;10.1016/j.cell.2006.08.034;;pmc2783335;;10.1038/nature08460;;19847166;;10.1139/cjpp-77-2-79;;10535697;;10.1139/y99-005;;10.1146/annurev.med.39.1.221;;10.1146/annurev.me.39.020188.001253;;3130771;;6202678;;10.1002/jps.2600731214;;6527242;;10.1093/ajhp/51.2.210;;8160672;;12736252;;10.1074/jbc.m303001200;;10.4049/jimmunol.174.10.6424;;15879144;;18583934;;pmc2825026;;10.4161/cc.7.12.6162;;10.1038/nri2690;;20098460;;10.1002/art.27224;;pmc2879587;;20112391;;pmc3086558;;10.1038/jid.2010.200;;20613770;;10.1038/nrrheum.2010.2;;20125096;;pmc1869622;;10.2119/2006-00085.baechler;;17515957;;18223159;;10.1152/ajplung.00390.2007;;20803699;;10.1002/ibd.21282;;pmc2958454;;10.1677/joe-08-0276;;19251743;;17574021;;10.1016/j.cell.2007.03.052;;pmc2746958;;19481526;;10.1016/j.molcel.2009.04.031;;10.2353/ajpath.2009.080767;;pmc2708818;;19497997;;17018283;;10.3410/f.1047456.496620;;10.1016/j.cell.2006.08.034,"SHIMADA ET AL.: ""IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IKB kinases"", INT. IMMUNOL., vol. 11, 1999, pages 1357 - 1362, XP000909004, DOI: doi:10.1093/intimm/11.8.1357;;MATSUDA ET AL.: ""Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways"", ONCOGENE, vol. 22, 2003, pages 3307 - 3318, XP002297871, DOI: doi:10.1038/sj.onc.1206406;;SHIMADA ET AL., INT. IMMUNOL., vol. 11, 1999, pages 1357 - 1362;;KRAVCHENKO ET AL.: ""IKKi/IKKepsilon plays a key role in integrating signals induced by pro-inflammatory stimuli"", J. BIOL. CHEM., vol. 278, 2003, pages 26612 - 26619, XP002297127, DOI: doi:10.1074/jbc.M303001200;;SHARMA ET AL.: ""Triggering the interferon antiviral response through an IKK-related pathway"", SCIENCE, vol. 300, 2003, pages 1148 - 1151, XP002459128, DOI: doi:10.1126/science.1081315;;SOLIS ET AL.: ""Involvement of TBK1 and IKKepsilon in lipopolysaccharide-induced activation of the interferon response in primary human macrophages"", EUR. J IMMUNOL., vol. 37, 2007, pages 529 - 539;;CLEMENT ET AL.: ""The IKK-related kinases: from innate immunity to oncogenesis"", CELL RES., vol. 18, 2008, pages 889 - 899, XP002618661, DOI: doi:10.1038/cr.2008.273;;CHAU ET AL.: ""Are the IKKs and IKK-related kinases TBK1 and IKKepsilon similarly activated"", TRENDS BIOCHEM SCI., vol. 33, 2008, pages 171 - 180, XP022588326, DOI: doi:10.1016/j.tibs.2008.01.002;;SWEENEY ET AL.: ""Regulation of c-Jun phosphorylation by the I?B kinase-? complex in fibroblast-like synoviocytes"", J. IMMUNOL., vol. 174, 2005, pages 6424 - 6430;;CORR ET AL.: ""Synergistic benefit in inflammatory arthritis by targeting I?B kinase ? and interferon ?"", ANN. RHEUM. DIS., vol. 68, 2009, pages 257 - 263;;SWEENEY ET AL.: ""Antiviral gene expression in rheumatoid arthritis"", ARTHRITIS RHEUM., vol. 56, 2007, pages 743 - 752;;CRISPIN ET AL.: ""Pathogenesis of human systemic lupus erythematosus: recent advances"", TRENDS MOL. MED., vol. 16, 2010, pages 47 - 57, XP026904282, DOI: doi:10.1016/j.molmed.2009.12.005;;BAECHLER ET AL.: ""Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus"", PROC. NATL. ACAD. SCI. U.S.A., vol. 100, 2003, pages 2610 - 2615;;BACCALA ET AL.: ""TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity"", NAT. MED., vol. 13, 2007, pages 543551;;CROW; REHWINKEL: ""Aicardi-Goutières syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity"", HUM. MOL. GENET., vol. 18, 2009, pages 130 - 136;;KAVANAGH ET AL.: ""New roles for the major human 3'-5' exonuclease TREX1 in human disease"", CELL CYCLE, vol. 7, 2008, pages 1718 - 1725, XP009109892;;STETSON ET AL.: ""Trexl prevents cell-intrinsic initiation of autoimmunity"", CELL, vol. 134, 2008, pages 587 - 598;;UNTERHOLZNER ET AL.: ""IFI16 is an innate immune sensor for intracellular DNA"", NAT. IMMUNOL., 3 October 2010 (2010-10-03);;WALSH ET AL.: ""Type I Interferon-Inducible Gene Expression in Blood Is Present and Reflects Disease Activity in Dermatomyositis and Polymyositis"", ARTHRITIS RHEUM., vol. 56, 2007, pages 3784 - 3792, XP008127186, DOI: doi:10.1002/art.22928;;DELGADO-VEGA ET AL.: ""Genetic associations in type I interferon related pathways with autoimmunity"", ARTHRITIS RES. THER., vol. 12, no. 1, 14 April 2010 (2010-04-14), pages 52;;SOZZANI ET AL.: ""Type I interferons in systemic autoimmunity"", AUTOIMM., vol. 43, 2010, pages 196 - 203;;HONDA ET AL.: ""Regulation of the type I IFN induction: a current view"", INTERN. IMMUNOL, vol. 17, 2005, pages 1367 - 1378;;PRENS ET AL.: ""IFN-alpha enhances poly-IC responses in human keratinocytes by inducing expression of cytosolic innate RNA receptors: relevance for psoriasis"", J. INVEST. DERMATOL., vol. 128, 2008, pages 932 - 938;;TAKAOKA; TANIGUCHI: ""Cytosolic DNA recognition for triggering innate immune response"", ADV. DRUG DELIVERY REV., vol. 60, 2008, pages 847 - 857, XP022586002, DOI: doi:10.1016/j.addr.2007.12.002;;WANG ET AL.: ""Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses"", J. IMMUNOL., vol. 183, 2009, pages 6989 - 6997;;CARIO: ""Toll-like receptors in inflammatory bowel diseases: a decade later"", INFLAMM. BOWEL DIS., vol. 16, 2010, pages 1583 - 1597, XP055165864, DOI: doi:10.1002/ibd.21282;;MCCORMACK ET AL.: ""Tissue cytokine and chemokine expression in inflammatory bowel disease"", INFLAMM. RES., vol. 50, 2001, pages 491 - 495;;CHIANG ET AL.: ""The protein kinase IKKF, regulates energy balance in obese mice"", CELL, vol. 138, 2009, pages 961 - 975;;CHIANG ET AL., CELL, vol. 138, 2009, pages 961 - 975;;MUNOZ ET AL.: ""TANK-binding kinase 1 mediates phosphorylation of insulin receptor at serine residue 994: a potential link between inflammation and insulin resistance"", J. ENDOCRINOL., vol. 201, 2009, pages 185 - 197;;BOEHM ET AL.: ""Integrative genomic approaches identify IKBKE as a breast cancer oncogene"", CELL, vol. 129, 2007, pages 1065 - 1079, XP002498282, DOI: doi:10.1016/j.cell.2007.03.052;;HUTTI ET AL.: ""Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation"", MOL. CELL, vol. 34, 2009, pages 461 - 472;;GUO ET AL.: ""Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer"", AM. J. PATHOL., vol. 175, 2009, pages 324 - 333, XP002618660, DOI: doi:10.2353/ajpath.2009.080767;;RENNER ET AL.: ""SUMOylation-dependent localization of IKKE in PML nuclear bodies is essential for protection against DNA-damage-triggered cell death"", MOL. CELL., vol. 37, 2010, pages 503 - 515;;KORHERR ET AL.: ""Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway"", PROC. NATL. ACAD. SCI. USA, vol. 103, 2006, pages 4240 - 4245;;CHIEN ET AL.: ""RalB GTPase-mediated activation of the I?B family kinase TBK1 couples innate immune signaling to tumor cell survival"", CELL, vol. 127, 2006, pages 157 - 170;;BARBIE ET AL.: ""Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1"", NATURE, vol. 462, 2009, pages 108 - 112;;KUSHNER ET AL., CAN. J. PHYSIOL. PHARMACOL., vol. 77, 1999, pages 79 - 88;;BROWN ET AL., ANNUAL REVIEW OF MEDICINE, vol. 39, 1988, pages 221 - 229;;WILSON ET AL., J. CLIN. PSYCH., vol. 45, 1984, pages 242 - 247;;PHILLIPS ET AL., J. PHARMACEUT. SCI., vol. 73, 1984, pages 1718 - 1720;;BURNHAM, AM. J. HOSP. PHARM., vol. 15, 1994, pages 210 - 218;;""Methods in Cell Biology"", vol. XIV, 1976, ACADEMIC PRESS;;KRAVCHENKO ET AL., J. BIOL. CHEM., vol. 278, 2003, pages 26612 - 26619;;SOLIS ET AL., EUR. J. IMMUNOL., vol. 37, 2007, pages 529 - 539;;SWEENEY ET AL., J. IMMUNOL., vol. 174, 2005, pages 6424 - 6430;;KAVANAGH ET AL.: ""New roles for the major human 3'-5' exonuclease TREXI in human disease"", CELL CYCLE, vol. 7, 2008, pages 1718 - 1725, XP009109892;;HORNUNG; LATZ, INTRACELLULAR DNA RECOGNITION; NAT. REV. IMMUNOL., vol. 10, 2010, pages 123 - 130;;ASSASSI ET AL.: ""Systemic sclerosis and lupus: points in an interferon-mediated continuum"", ARTHRITIS RHEUM., vol. 62, 2010, pages 589 - 598, XP055020817, DOI: doi:10.1002/art.27224;;FARINA ET AL.: ""Poly(I:C) Drives Type I IFN- and TGFbeta-Mediated Inflammation and Dermal Fibrosis Simulating Altered Gene Expression in Systemic Sclerosis"", J INVEST. DERMATO., 8 July 2010 (2010-07-08);;DALAKAS: ""Immunotherapy of Myositis: Issues, Concerns and Future Prospects"", NAT. REV. RHEUM., vol. 6, 2010, pages 129 - 137;;BAECHLER ET AL.: ""An Interferon Signature in the Peripheral Blood of Dermatomyositis Patients is Associated with Disease Activity"", MOL. MED., vol. 13, 2007, pages 59 - 68, XP008127184, DOI: doi:10.2119/2006-00085.Baechler;;CHURG ET AL.: ""Mechanisms of cigarette smoke-induced COPD: Insights from animal models"", AM. J. PHYSIOL. LUNG CELL. MOL. PHYSIOL., vol. 294, 2008, pages 612 - 631;;CARIO: ""Toll-like Receptors in Inflammatory Bowel Diseases: A Decade Later"", INFLAMM. BOWEL DIS., vol. 16, 2010, pages 1583 - 1597, XP055165864, DOI: doi:10.1002/ibd.21282;;MUNOZ ET AL., J. ENDOCRINOL., vol. 201, 2009, pages 185 - 197;;BOEHM ET AL., CELL, vol. 129, 2007, pages 1065 - 1079;;HUTTI ET AL., MOL. CELL, vol. 34, 2009, pages 461 - 472;;GUO ET AL., AM. J. PATHOL., vol. 175, 2009, pages 324 - 333;;CHIEN ET AL., CELL, vol. 127, 2006, pages 157 - 170;;CHIANG ET AL.: ""The protein kinase IKKF. regulates energy balance in obese mice"", CELL, vol. 138, 2009, pages 961 - 975",PENDING
870,MX,A,MX 2012004313 A,043-567-979-003-653,2012-07-20,2012,MX 2012004313 A,2010-10-12,US 25084209 P;;US 32524510 P;;US 2010/0052385 W,2009-10-12,AMINO - PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBKL AND/OR IKK EPSILON.,"The invention relates to certain amino-pyrimidine compounds which inhibit TBK1 and/or IKK epsilon and which may therefore find application in treating inflammation, cancer, septic shock and/or Primary open Angle Glaucoma (POAG).",MYREXIS INC,MCLEOD DONALD A;;HOLCOMB RYAN;;BURSAVICH MATTHEW GREGORY;;SUZUKI KAZUYUKI;;HALTER ROBERT J;;SEBAHAR PAUL R;;SHENDEROVICH MARK D;;YAGER KRAIG M;;YUNGAI ASHANTAI J;;RICHARDS BURT;;BARTEL PAUL L;;WETTSTEIN DANIEL A,,https://lens.org/043-567-979-003-653,Patent Application,no,0,0,12,12,0,C07D239/42;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;A61P1/00;;A61P11/00;;A61P17/06;;A61P19/04;;A61P21/00;;A61P25/00;;A61P29/00;;A61P29/02;;A61P3/00;;A61P3/04;;A61P35/00;;A61P43/00;;A61P5/48;;A61P3/10;;C07D413/12;;C07D405/12;;A61K31/5377;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;C07D487/08;;C07D405/12;;C07D401/12;;C07D403/12;;C07D413/14;;C07D417/12;;C07D239/42;;C07D405/14;;C07D417/14;;C07D403/14,A61K31/505;;C07D239/42;;A61K31/506;;A61P29/02;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08,,0,0,,,,DISCONTINUED
871,US,A1,US 2016/0116368 A1,177-739-640-290-064,2016-04-28,2016,US 201514921061 A,2015-10-23,US 201514921061 A;;US 201462067570 P,2014-10-23,METHOD FOR APPROXIMATING REMAINING LIFETIME OF ACTIVE DEVICES,"A method of calculating an effective age of an active optical cable including a fiber optic cable, at least one optical transducer, a first memory, and a second memory includes, during regular intervals that are divided into regular subintervals and after each of the regular subintervals, sensing an operational parameter of the active optical cable and recording in the second memory a value corresponding to a sensed operational parameter; after each of the regular intervals, storing in the first memory the values recorded in the second memory; and calculating the effective age of the active optical cable based on the values stored in the first memory.",SAMTEC INC,CORNELIUS JOSHUA R;;ZBINDEN ERIC JEAN;;VERDIELL JEAN-MARC ANDRE;;KOZLOVSKY WILLIAM J;;BURT KEVIN;;TROXELL THOMAS BENJAMIN;;LEROY LESLY;;LANGSAM DAVID A;;BAXTER ANDREW JOHN,SAMTEC INC (2015-10-21),https://lens.org/177-739-640-290-064,Patent Application,yes,2,7,4,10,0,G01M99/002;;G06F1/28;;G01K1/022;;G01M11/30;;G11C16/02;;G01K11/32;;G01M99/002;;G06F11/00;;G06F1/28;;G01M11/30;;G11C16/02,G01M11/00;;G11C16/02,,0,0,,,,DISCONTINUED
872,BR,A2,BR 112012008677 A2,098-470-881-798-667,2018-03-20,2018,BR 112012008677 A,2010-10-12,US 2010/0052385 W;;US 25084209 P;;US 32524510 P,2009-10-12,compostos amino-pirimidina como inibidores de tbkl e/ou ikk epsilon,"compostos amino-pirimidina com inibidores de tbkl e/ou ikk epsilon. a invenção diz respeito a certos compostos amino-pirimidina, que inibem tbkl e/ou ikk épsilon e os quais podem, portanto, ser aplicados no tratamento de inflamações, choque séptico e/ou glaucoma primário de ângulo aberto (poag).",MYREXIS INC,ASHANTAI J YUNGAI;;BURT RICHARDS;;DANIEL A WETTSTEIN;;DONALD A MCLEOD;;KAZUYUKI SUZUKI;;KRAIG M YAGER;;MARK D SHENDEROVICH;;MATTHEW GREGORY BURSAVICH;;PAUL L BARTEL;;PAUL R SEBAHAR;;ROBERT J HALTER;;RYAN HOLCOMB,,https://lens.org/098-470-881-798-667,Patent Application,no,0,0,12,12,0,C07D239/42;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;A61P1/00;;A61P11/00;;A61P17/06;;A61P19/04;;A61P21/00;;A61P25/00;;A61P29/00;;A61P29/02;;A61P3/00;;A61P3/04;;A61P35/00;;A61P43/00;;A61P5/48;;A61P3/10;;C07D413/12;;C07D405/12;;A61K31/5377;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;C07D487/08;;C07D405/12;;C07D401/12;;C07D403/12;;C07D413/14;;C07D417/12;;C07D239/42;;C07D405/14;;C07D417/14;;C07D403/14,A61K31/505;;A61K31/506;;A61P29/02;;C07D239/42;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08,,0,0,,,,DISCONTINUED
873,CA,C,CA 2502232 C,052-743-741-017-824,2013-10-01,2013,CA 2502232 A,2003-10-14,US 41876202 P;;US 42125402 P;;US 49470903 P;;US 49523603 P;;US 49537303 P;;US 0332886 W,2002-10-15,IDENTIFICATION DOCUMENT AND RELATED METHODS,"The present invention provides methods and systems for authenticating identification documents (100). We also teach an identification document (100) including two or more digital watermarks (27, 60). The watermarks correspond with each other or with indicia carried by the identification document (100). The correspondence can be verified to determine authenticity. We also provide digital watermark detection methods and systems to identify the different watermarks (100) through embedded orientation components. We then focus watermark message-decoding efforts on areas identified as likely including watermark orientation components (27, 60). In one implementation we provide a watermark detection trigger to identify so-called legacy documents. The trigger may indicate the presence or expected absence of a digital watermark. In other implementations we provide a versatile document authenticator to toggle between watermarking and non-watermarking authentication processes depending on a detection trigger (100).",DIGIMARC CORP,BRUNDAGE TRENT J;;SHER-JAN MAHMOOD;;WEAVER MATTHEW M;;HANNIGAN BRETT T;;BRADLEY BRETT ALAN;;STACH JOHN;;PERRY BURT W;;DURST ROBERT T;;RHOADS GEOFFREY B,,https://lens.org/052-743-741-017-824,Granted Patent,no,0,0,11,31,0,B42D2035/34;;G06T1/0071;;G06T2201/0051;;G07F7/08;;G07F7/086;;G07F7/12;;H04N1/32144;;H04N1/32288;;H04N1/32352;;H04N2201/3233;;H04N2201/3235;;H04N2201/327;;G06Q20/347;;G06Q20/401;;G06T1/0028;;G09C5/00;;H04K1/00;;H04L9/3231;;H04N1/32304;;H04N2201/3205;;H04L2209/56;;H04L2209/608;;H04L2209/805;;B42D25/00;;B42D25/309;;G07D7/0034;;B42D25/47;;B42D25/23;;B42D25/333;;B42D25/20;;G06T2201/0051;;H04N2201/327;;G06T1/0071;;H04N2201/3233;;H04N1/32352;;H04N1/32144;;G07F7/12;;G07F7/086;;H04N2201/3235;;H04N1/32288;;G07F7/08;;G09C5/00;;G06T1/0028;;H04K1/00;;G06Q20/401;;H04N1/32304;;G06Q20/347;;H04L2209/56;;H04L9/3231;;H04L2209/805;;H04L2209/608;;H04N2201/3205;;B42D25/00;;B42D25/309;;G07D7/0034,B42D15/00;;B42D15/10;;G06T1/00;;G07D7/12;;G07F7/08;;G07F7/12;;G09C1/00;;H04L9/00;;H04N1/32,,0,0,,,,EXPIRED
874,US,A1,US 2004/0181671 A1,102-394-476-503-811,2004-09-16,2004,US 68649503 A,2003-10-14,US 68649503 A;;US 41876202 P;;US 42125402 P;;US 49470903 P;;US 49523603 P;;US 49537303 P;;US 1112901 A;;US 44278099 A;;US 10925998 P,1998-11-19,Identification document and related methods,"
   The present invention provides methods and systems for authenticating identification documents. We also teach an identification document including two or more digital watermarks. The watermarks correspond with each other or with indicia carried by the identification document. The correspondence can be verified to determine authenticity. We also provide digital watermark detection methods and systems to identify the different watermarks through embedded orientation components. We then focus watermark message-decoding efforts on areas identified as likely including watermark orientation components. In one implementation we provide a watermark detection trigger to identify so-called legacy documents. The trigger may indicate the presence or expected absence of a digital watermark. In other implementations we provide a versatile document authenticator to toggle between watermarking and non-watermarking authentication processes depending on a detection trigger. 
",BRUNDAGE TRENT J.;;SHER-JAN MAHMOOD;;WEAVER MATTHEW M.;;HANNIGAN BRETT T.;;BRADLEY BRETT A.;;STACH JOHN;;PERRY BURT W.;;DURST ROBERT T.;;RHOADS GEOFFREY B.,BRUNDAGE TRENT J;;SHER-JAN MAHMOOD;;WEAVER MATTHEW M;;HANNIGAN BRETT T;;BRADLEY BRETT A;;STACH JOHN;;PERRY BURT W;;DURST ROBERT T;;RHOADS GEOFFREY B,,https://lens.org/102-394-476-503-811,Patent Application,yes,99,180,11,31,0,B42D2035/34;;G06T1/0071;;G06T2201/0051;;G07F7/08;;G07F7/086;;G07F7/12;;H04N1/32144;;H04N1/32288;;H04N1/32352;;H04N2201/3233;;H04N2201/3235;;H04N2201/327;;G06Q20/347;;G06Q20/401;;G06T1/0028;;G09C5/00;;H04K1/00;;H04L9/3231;;H04N1/32304;;H04N2201/3205;;H04L2209/56;;H04L2209/608;;H04L2209/805;;B42D25/00;;B42D25/309;;G07D7/0034;;B42D25/47;;B42D25/23;;B42D25/333;;B42D25/20;;G06T2201/0051;;H04N2201/327;;G06T1/0071;;H04N2201/3233;;H04N1/32352;;H04N1/32144;;G07F7/12;;G07F7/086;;H04N2201/3235;;H04N1/32288;;G07F7/08;;G09C5/00;;G06T1/0028;;H04K1/00;;G06Q20/401;;H04N1/32304;;G06Q20/347;;H04L2209/56;;H04L9/3231;;H04L2209/805;;H04L2209/608;;H04N2201/3205;;B42D25/00;;B42D25/309;;G07D7/0034,B42D15/10;;G06T1/00;;G07D7/12;;G07F7/08;;G07F7/12;;H04N1/32,713/176,0,0,,,,DISCONTINUED
875,NZ,A,NZ 599826 A,151-700-779-185-70X,2014-08-29,2014,NZ 59982610 A,2010-10-12,US 2010/0052385 W;;US 32524510 P;;US 25084209 P,2009-10-12,Amino-pyrimidine compounds as inhibitors of ikk epsilon and/or tbk1,"The disclosure relates to amino-pyrimidine compounds of formula (I) which selectively inhibit the kinase activities of TBK1 and/or IKK epsilon, wherein the variables shown if formula (I) are as defined in the specification. These compounds may be used in the treatment of inflammation, septic shock, Primary open Angle Glaucoma (POAG), RA, SLE, diseases associated with aberrant accumulation of cytosolic nucleic acids (including Sjogrens syndrome, Aicardi-Goutieres syndrome, subtypes of SLE, chilblain lupus, and RVCL), systemic sclerosis, myositis (including dermatomyositis and polymyositis), psoriasis, COPD, lBD, obesity, insulin resistance, NlDDM, metabolic syndrome and cancer, and complications associated with these diseases and disorders.",MYREXIS INC,HALTER ROBERT J;;HOLCOMB RYAN;;WETTSTEIN DANIEL A;;SHENDEROVICH MARK D;;YUNGAI ASHANTAI J;;YAGER KRAIG M;;RICHARDS BURT;;BARTEL PAUL L;;MCLEOD DONALD A;;SUZUKI KAZUYUKI;;SEBAHAR PAUL R;;BURSAVICH MATTHEW GREGORY,,https://lens.org/151-700-779-185-70X,Patent Application,no,0,0,12,12,0,C07D239/42;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;A61P1/00;;A61P11/00;;A61P17/06;;A61P19/04;;A61P21/00;;A61P25/00;;A61P29/00;;A61P29/02;;A61P3/00;;A61P3/04;;A61P35/00;;A61P43/00;;A61P5/48;;A61P3/10;;C07D413/12;;C07D405/12;;A61K31/5377;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;C07D487/08;;C07D405/12;;C07D401/12;;C07D403/12;;C07D413/14;;C07D417/12;;C07D239/42;;C07D405/14;;C07D417/14;;C07D403/14,C07D239/42;;A61K31/505;;A61K31/506;;A61P29/02;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08,,0,0,,,,DISCONTINUED
876,CN,A,CN 107148564 A,044-949-361-188-06X,2017-09-08,2017,CN 201580057472 A,2015-10-23,US 201462067570 P;;US 2015/0057059 W,2014-10-23,Method for approximating remaining lifetime of active devices,"A method of calculating an effective age of an active optical cable including a fiber optic cable, at least one optical transducer, a first memory, and a second memory includes, during regular intervals that are divided into regular subintervals and after each of the regular subintervals, sensing an operational parameter of the active optical cable and recording in the second memory a value corresponding to a sensed operational parameter; after each of the regular intervals, storing in the first memory the values recorded in the second memory; and calculating the effective age of the active optical cable based on the values stored in the first memory.",SAMTEC INC,CORNELIUS JOSHUA R;;ZBINDEN ERIC JEAN;;VERDIELL JEAN-MARC ANDRE;;KOZLOVSKY WILLIAM J;;BURT KEVIN;;TROXELL THOMAS BENJAMIN;;LEROY LESLY;;LANGSAM DAVID A;;BAXTER ANDREW JOHN,,https://lens.org/044-949-361-188-06X,Patent Application,no,5,0,6,10,0,G01M99/002;;G01K1/022;;G01K3/04;;G01M99/002;;G06F1/28;;G06F11/00;;G06F2212/7203;;G06F2212/7211;;G01M11/30;;G11C16/02,G01M99/00,,0,0,,,,DISCONTINUED
877,TW,A,TW 201632858 A,073-815-527-698-368,2016-09-16,2016,TW 104134827 A,2015-10-23,US 201462067570 P,2014-10-23,Method for approximating remaining lifetime of active devices,"A method of calculating an effective age of an active optical cable including a fiber optic cable, at least one optical transducer, a first memory, and a second memory includes, during regular intervals that are divided into regular subintervals and after each of the regular subintervals, sensing an operational parameter of the active optical cable and recording in the second memory a value corresponding to a sensed operational parameter; after each of the regular intervals, storing in the first memory the values recorded in the second memory; and calculating the effective age of the active optical cable based on the values stored in the first memory.",SAMTEC INC,CORNELIUS JOSHUA R;;ZBINDEN ERIC JEAN;;VERDIELL JEAN-MARC ANDRE;;KOZLOVSKY WILLIAM J;;BURT KEVIN;;TROXELL THOMAS BENJAMIN;;LEROY LESLY;;LANGSAM DAVID A;;BAXTER ANDY JOHN,,https://lens.org/073-815-527-698-368,Patent of Addition,no,0,0,6,10,0,G01M99/002;;G01K1/022;;G01K3/04;;G01M99/002;;G06F1/28;;G06F11/00;;G06F2212/7203;;G06F2212/7211;;G01M11/30;;G11C16/02,G01M11/00;;G11C16/02,,0,0,,,,INACTIVE
878,US,A,US 6075905 A,025-476-546-685-322,2000-06-13,2000,US 89688797 A,1997-07-16,US 89688797 A;;US 2192596 P,1996-07-17,Method and apparatus for mosaic image construction,"A method of constructing an image mosaic comprising the steps of selecting source images, aligning the source images, selecting source segments, enhancing the images, and merging the images to form the image mosaic is disclosed. An apparatus for constructing an image mosaic comprising means for selecting source images, means for aligning the source images, means for selecting source image segments, means for enhancing the images, and means for merging the images to form the image mosaic is also disclosed. The process may be performed automatically by the system or may be guided interactively by a human operator. Applications include the construction of photographic quality prints form video and digital camera images.",SARNOFF CORP,HERMAN JOSHUA RANDY;;BERGEN JAMES RUSSELL;;PELEG SHMUEL;;PARAGANO VINCENT;;DIXON DOUGLAS F;;BURT PETER J;;SAWHNEY HARPREET;;GENDEL GARY A;;KUMAR RAKESH;;BRILL MICHAEL H,SARNOFF CORPORATION (1998-01-15),https://lens.org/025-476-546-685-322,Granted Patent,yes,15,888,11,11,0,G06T3/4038;;H04N19/597;;H04N19/23;;G06V10/16;;G06V10/24;;G06T11/00;;G06T3/4038;;H04N19/597;;H04N19/23;;G06V10/24;;G06V10/16,G06T3/40;;G06T11/00;;G06T3/00;;G06V10/24;;H04N1/387;;H04N5/265;;H04N7/26,382/284;;382/294;;348/588,26,13,042-689-645-533-661;;059-029-655-790-358;;095-264-022-660-794;;052-665-822-647-544;;037-660-978-000-513;;081-799-446-362-099;;008-560-511-091-933;;031-367-424-937-477;;059-009-996-238-125;;010-396-006-264-864;;076-294-565-526-821;;098-173-496-566-324;;130-334-462-081-436,10.1145/245.247;;10.1109/wvrs.1995.476849;;10.1145/218380.218398;;10.1109/wvm.1991.212812;;10.1109/mnrao.1994.346248;;10.1109/acv.1994.341287;;10.1049/cp:19940827;;10.1006/ciun.1994.1060;;10.1109/mmcs.1994.292488;;18291954;;10.1109/83.334983;;10.1006/jvci.1993.1030;;10.1109/iccv.1993.378222;;10.1109/cvpr.1988.196228,"Burt, et al, Merging Images Through Pattern Decomposition David Sarnoff Research Center, SPIE vol. 575 Applications of Digital Image Processing VIII(1985), pp. 173 180.;;Bergen, et al, Hierarchial Model Based Estimation David Sarnoff Research Center, Mar. 23, 1992, pp. 1 21 To Appear in Proc. Of European Conference on Computer Vision 92 .;;Burt, et al, A Multiresolution Spline With Application to Image Mosaics, David Sarnoff Research Center, ACM Transactions on Graphics, vol. 2, No. 4, Oct. 1983, pp. 217 236.;;Hanna, et al, Combining Stereo and Motion Analysis for Direct Estimation of Scene Structure , David Sarnoff Research Center, To Appear In Proc. Fourth Int. Co., on Computer Vision (ICCV 93), Berlin, Germany. May 1993.;;Direct Methods for Visual Scene Reconstruction , Richard Szeliski and Sing Bing Kang, Cambridge Research Lab. 1995 IEEE.;;Sensitivity of the Pose Refinement Problem to Accurate Estimation of Camera Parameters , Rakesh Kumar and Allen R. Hanson, University of Massachusetts at Amherst, Dec. 1990.;;Plenoptic Modeling: An Image Based Rendering System Leonard McMillan and Gary Bishop Department Computer Science University of North Carolina at Chapel Hill, Computer Graphics Proceedings, Annual Conference Series, 1995. pp39 45.;;Robust Structure from Motion using Motion Parallax , Robert Cipolla University of Cambridge Yasukasu Okamoto and Yoshinori Kuno, Toshiba Corporation. 1933 IEE.;;Direct multi resolution estimation of ego motion and structure from motion , K.J. Hanna, David Sarnoff Research Center, 1991 IEEE, pp 156 162.;;Simplifying Multiple Motion and Structure Analysis Using Planar Parallax and Image Warping , Harpreet S. Sawhney, IBM Almaden Research Center. 1994 IEEE. pp 104 1.;;Image Mosaicing for Tele Reality Applications , Richard Szeliski, Cambridge Research Lab. 1994 IEEE pp 44 53.;;Real Time Compositing System of a Real Camera Image and a Computer Graphic Image , K. Haseba, A. Suzuki, K. Publication No. 397. IEEE, 1994.;;McLean, Structured Video Coding Submitted to the Media Arts and Sciences Section, School of Architecture and Planning in partial fulfillment of the requirements for the degree of Master of Science at the Massachusetts Instute of Technology, Jun. 1991.;;Robust Methods for Estimating Pose and a Sensitivity Analysis , Rakesh Kumar, David Hanson, Computer Science Department, University of Massachusetts at Amherst, Massachusetts 01003. Accepted Mar. 9, 1994.;;CVGIP: Image Understanding, vol. 60, No. 3, Nov., pp. 313 342, 1994.;;Isolating Multiple 2D Image Motions for Image Enhancement and for 3D Motion Analysis. Thesis for the degree of Doctor of Philosophy by Michal Irani. Submitted to the Scientific Council of the Hebrew University of Jerusalem 91904 Jerusalem, Israel, No date provided.;;Real Time Decoding and Display of Structured Video , V. Michael Bove, Jr., Brett D. Granger, and John A. Watlington, Media Laboratory, Massachusetts Institute of Technology, 20 Ames Street, Cambridge MA 02139 USA, Proc. IEEE ICMCS 94, Boston MA, to be published May 1994.;;Image Sequence Coding at Very Low Bitrates: A Review , Haibo Li, Astrid Lundmark, and Robert Forcheimer, IEEE Transactions On Image Processing, vol. 3 No. 5. Sep. 1994.;;Video mosaic displays , Peter Burt, Michael Hansen and P. Anandan, David Sarnoff Research Center CN 5300, Princeton, NJ 08543 5300. SPIE vol. 2736, p 119 12. 1996.;;Pyramid Based Texture Analysis/Synthesis , David J. Heeger, Stanford University, Stanford, CA 94305, James R. Bergen, SRI David Sarnoff Research Center, Princeton, NJ 08544, No date provided.;;Motion Analysis for Image Enhancement: Resolution, Occlusion, and Transparency, Michal Irani and Shmuel Peleg, Institute of Computer Science, The Hebrew University of Jerusalem, 91904 Jerusalem, Israel. Received Nov. 30, 1992; accepted Aug. 23, 1993, Journal of Visual Communication and Image Representation vol. 4, Dec., pp. 324 335, 1993.;;Copy of International Search Report dated Nov. 12, 1997, from corresponding international application.;;Burt, Peter J. et al., Enhanced Image Capture through Fusion Issued Feb. 1993, IEEE. See pp. 173 182.;;Burt, Peter J. Moment Images, Polynomial Fit Filters, and the Problem of Surface Interpolation issued Apr. 1988, IEEE. See pp.144 152.;;Irani, Michal et al. Mosaid Based Representations of Video Sequences and Their Applications issued Aug. 1995, IEEE. See pp. 605 611.;;Hansen, M. et al. Real Time Scene Stabilization and Mosaic Construction issued 1994, IEEE. See pp. 54 62.",EXPIRED
879,KR,A,KR 20170048584 A,082-104-929-828-028,2017-05-08,2017,KR 20177009524 A,2015-10-23,US 201462067570 P;;US 201514921061 A;;US 2015/0057059 W,2014-10-23,METHOD FOR APPROXIMATING REMAINING LIFETIME OF ACTIVE DEVICES,"광섬유 케이블, 적어도 하나의 광학 변환 소자, 제 1 메모리 및 제 2 메모리를 포함하는 액티브 광케이블의 유효 수명을 산출하는 방법으로서, 일정 부분 간격으로 분할되는 일정 간격 동안 및 각각의 상기 일정 부분 간격 후에, 상기 액티브 광케이블의 동작 파라미터를 감지하고 상기 감지된 동작 파라미터에 상응하는 값을 상기 제 2 메모리에 기록하는 단계; 각각의 상기 일정 간격 후에, 상기 제 2 메모리에 기록된 값을 상기 제 1 메모리에 저장하는 단계; 및 상기 제 1 메모리에 저장된 값에 근거하여 상기 액티브 광케이블의 유효 수명을 산출하는 단계를 포함하는 방법.",SAMTEC INC,CORNELIUS JOSHUA R;;ZBINDEN ERIC JEAN;;VERDIELL JEAN MARC ANDRE;;KOZLOVSKY WILLIAM J;;BURT KEVIN;;TROXELL THOMAS BENJAMIN;;LEROY LESLY;;LANGSAM DAVID A;;BAXTER ANDREW JOHN,,https://lens.org/082-104-929-828-028,Patent Application,no,0,0,4,10,0,G01M99/002;;G06F1/28;;G01K1/022;;G01M11/30;;G11C16/02;;G01K11/32;;G01M99/002;;G06F11/00;;G06F1/28;;G01M11/30;;G11C16/02,G01M11/00;;G11C16/02,,0,0,,,,DISCONTINUED
880,EP,A4,EP 3210213 A4,063-912-188-496-025,2018-05-02,2018,EP 15852308 A,2015-10-23,US 201462067570 P;;US 2015/0057059 W,2014-10-23,METHOD FOR APPROXIMATING REMAINING LIFETIME OF ACTIVE DEVICES,,SAMTEC INC,CORNELIUS JOSHUA R;;ZBINDEN ERIC JEAN;;VERDIELL JEAN-MARC ANDRE;;KOZLOVSKY WILLIAM J;;BURT KEVIN;;TROXELL THOMAS BENJAMIN;;LEROY LESLY;;LANGSAM DAVID A;;BAXTER ANDREW JOHN,,https://lens.org/063-912-188-496-025,Search Report,no,2,0,6,10,0,G01M99/002;;G01K1/022;;G01K3/04;;G01M99/002;;G06F1/28;;G06F11/00;;G06F2212/7203;;G06F2212/7211;;G01M11/30;;G11C16/02,H01B11/00;;G01K1/02;;G01K3/04;;H01B7/00,,1,0,,,See also references of WO 2016065228A1,PENDING
881,WO,A1,WO 2016/065228 A1,188-204-533-129-134,2016-04-28,2016,US 2015/0057059 W,2015-10-23,US 201462067570 P;;US 201514921061 A,2014-10-23,METHOD FOR APPROXIMATING REMAINING LIFETIME OF ACTIVE DEVICES,"A method of calculating an effective age of an active optical cable including a fiber optic cable, at least one optical transducer, a first memory, and a second memory includes, during regular intervals that are divided into regular subintervals and after each of the regular subintervals, sensing an operational parameter of the active optical cable and recording in the second memory a value corresponding to a sensed operational parameter; after each of the regular intervals, storing in the first memory the values recorded in the second memory; and calculating the effective age of the active optical cable based on the values stored in the first memory.",SAMTEC INC,CORNELIUS JOSHUA R;;ZBINDEN ERIC JEAN;;VERDIELL JEAN-MARC ANDRE;;KOZLOVSKY WILLIAM J;;BURT KEVIN;;TROXELL THOMAS BENJAMIN;;LEROY LESLY;;LANGSAM DAVID A;;BAXTER ANDREW JOHN,,https://lens.org/188-204-533-129-134,Patent Application,yes,5,0,4,10,0,G01M99/002;;G06F1/28;;G01K1/022;;G01M11/30;;G11C16/02;;G01K11/32;;G01M99/002;;G06F11/00;;G06F1/28;;G01M11/30;;G11C16/02,H01B11/00;;H01B7/00,,0,0,,,,PENDING
882,IT,A1,IT MI20010813 A1,006-911-686-706-652,2002-10-13,2002,IT MI20010813 A,2001-04-13,EP 00109063 A,2000-04-28,VALUTAZIONE DI FIBROSI DEL FEGATO CON ALGORITMI BASATI SU MARCATORI DEL SIERO,,BAYER AG,VOLKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT GUIDO;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF,,https://lens.org/006-911-686-706-652,Patent Application,no,0,0,8,19,0,G01N33/6887;;G01N33/6893;;G01N2333/47;;G01N2333/78;;G01N2333/8146;;G01N2333/96486;;G01N2800/085,G01N33/53;;G01N33/573;;G01N33/68,,0,0,,,,PENDING
883,KR,A,KR 20120114224 A,156-466-083-672-656,2012-10-16,2012,KR 20127012283 A,2010-10-12,US 25084209 P;;US 32524510 P,2009-10-12,AMINO-PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBKL AND/OR IKK EPSILON,,MYREXIS INC,HOLCOMB RYAN;;SUZUKI KAZUYUKI;;HALTER ROBERT J;;SEBAHAR PAUL R;;MCLEOD DONALD A;;SHENDEROVICH MARK D;;YAGER KRAIG M;;BURSAVICH MATTHEW GREGORY;;YUNGAI ASHANTAI J;;RICHARDS BURT;;BARTEL PAUL L;;WETTSTEIN DANIEL A,,https://lens.org/156-466-083-672-656,Patent Application,no,0,1,12,12,0,C07D239/42;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;A61P1/00;;A61P11/00;;A61P17/06;;A61P19/04;;A61P21/00;;A61P25/00;;A61P29/00;;A61P29/02;;A61P3/00;;A61P3/04;;A61P35/00;;A61P43/00;;A61P5/48;;A61P3/10;;C07D413/12;;C07D405/12;;A61K31/5377;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;C07D487/08;;C07D405/12;;C07D401/12;;C07D403/12;;C07D413/14;;C07D417/12;;C07D239/42;;C07D405/14;;C07D417/14;;C07D403/14,A61K31/5377;;A61P29/00;;C07D405/12,,0,0,,,,DISCONTINUED
884,IT,A0,IT MI20010813 A0,006-843-841-150-657,2001-04-13,2001,IT MI20010813 A,2001-04-13,EP 00109063 A,2000-04-28,VALUTAZIONE DI FIBROSI DEL FEGATO CON ALGORITMI BASATI SU MARCATORI DEL SIERO,,BAYER AG,VOLKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT GUIDO;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF,,https://lens.org/006-843-841-150-657,Patent Application,no,0,0,8,19,0,G01N33/6887;;G01N33/6893;;G01N2333/47;;G01N2333/78;;G01N2333/8146;;G01N2333/96486;;G01N2800/085,G01N33/53;;G01N33/573;;G01N33/68,,0,0,,,,PENDING
885,TW,U,TW M531600 U,121-420-990-067-835,2016-11-01,2016,TW 104217002 U,2015-10-23,US 201462067570 P,2014-10-23,Active optical cable,"A method of calculating an effective age of an active optical cable including a fiber optic cable, at least one optical transducer, a first memory, and a second memory includes, during regular intervals that are divided into regular subintervals and after each of the regular subintervals, sensing an operational parameter of the active optical cable and recording in the second memory a value corresponding to a sensed operational parameter; after each of the regular intervals, storing in the first memory the values recorded in the second memory; and calculating the effective age of the active optical cable based on the values stored in the first memory.",SAMTEC INC,CORNELIUS JOSHUA R;;ZBINDEN ERIC JEAN;;VERDIELL JEAN-MARC ANDRE;;KOZLOVSKY WILLIAM J;;BURT KEVIN;;TROXELL THOMAS BENJAMIN;;LEROY LESLY;;LANGSAM DAVID A;;BAXTER ANDY JOHN,,https://lens.org/121-420-990-067-835,Limited Patent,no,0,0,6,10,0,G01M99/002;;G01K1/022;;G01K3/04;;G01M99/002;;G06F1/28;;G06F11/00;;G06F2212/7203;;G06F2212/7211;;G01M11/30;;G11C16/02,G02B6/00,,0,0,,,,ACTIVE
886,US,A1,US 2015/0352108 A1,082-941-248-674-551,2015-12-10,2015,US 201414581065 A,2014-12-23,US 201414581065 A;;US 201414273387 A;;US 201314027041 A;;US 201213445627 A;;US 2010/0052385 W;;US 25084209 P;;US 32524510 P,2009-10-12,AMINO-PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBK1 AND/OR IKK EPSILON,"The invention relates to certain amino-pyrimidine compounds which inhibit TBK1 and/or IKK epsilon and which may therefore find application in treating inflammation, cancer, septic shock and/or Primary open Angle Glaucoma (POAG).",ALZHEIMER S INST OF AMERICA,HOLCOMB RYAN C;;SUZUKI KAZUYUKI;;HALTER ROBERT J;;SEBAHAR PAUL R;;MCLEOD DONALD A;;SHENDEROVICH MARK D;;YAGER KRAIG M;;BURSAVICH MATTHEW GREGORY;;YUNGAI ASHANTAI J;;RICHARDS BURT;;BARTEL PAUL L;;WETTSTEIN DANIEL A,,https://lens.org/082-941-248-674-551,Patent Application,yes,0,8,12,12,0,C07D239/42;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;A61P1/00;;A61P11/00;;A61P17/06;;A61P19/04;;A61P21/00;;A61P25/00;;A61P29/00;;A61P29/02;;A61P3/00;;A61P3/04;;A61P35/00;;A61P43/00;;A61P5/48;;A61P3/10;;C07D413/12;;C07D405/12;;A61K31/5377;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;C07D487/08;;C07D405/12;;C07D401/12;;C07D403/12;;C07D413/14;;C07D417/12;;C07D239/42;;C07D405/14;;C07D417/14;;C07D403/14,A61K31/505;;A61K31/506;;A61K31/52;;A61K31/5377;;A61K31/541;;A61K31/551;;A61K31/635,,0,0,,,,DISCONTINUED
887,US,A1,US 2012/0238540 A1,133-344-808-842-721,2012-09-20,2012,US 201213445627 A,2012-04-12,US 201213445627 A;;US 2010/0052385 W;;US 25084209 P;;US 32524510 P,2009-10-12,AMINO-PYRIMIDINE COMPOUNDS AS INHIBITORS OF IKK EPSILON AND/OR TBK1,"The invention relates to certain amino-pyrimidine compounds that inhibit IKK epsilon and/or TBK1, methods of making such compounds, pharmaceutical compositions comprising such compounds, and the use of these compounds in treating a variety of diseases and disorders.",HOLCOMB RYAN C;;SUZUKI KAZUYUKI;;HALTER ROBERT J;;SEBAHAR PAUL R;;MCLEOD DONALD A;;SHENDEROVICH MARK D;;YAGER KRAIG M;;BURSAVICH MATTHEW GREGORY;;YUNGAI ASHANTAI J;;RICHARDS BURT;;BARTEL PAUL L;;WETTSTEIN DANIEL A;;MYREXIS INC,HOLCOMB RYAN C;;SUZUKI KAZUYUKI;;HALTER ROBERT J;;SEBAHAR PAUL R;;MCLEOD DONALD A;;SHENDEROVICH MARK D;;YAGER KRAIG M;;BURSAVICH MATTHEW GREGORY;;YUNGAI ASHANTAI J;;RICHARDS BURT;;BARTEL PAUL L;;WETTSTEIN DANIEL A,MYREXIS INC (2012-05-09),https://lens.org/133-344-808-842-721,Patent Application,yes,0,26,12,12,0,C07D239/42;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D417/14;;C07D487/08;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;A61P1/00;;A61P11/00;;A61P17/06;;A61P19/04;;A61P21/00;;A61P25/00;;A61P29/00;;A61P29/02;;A61P3/00;;A61P3/04;;A61P35/00;;A61P43/00;;A61P5/48;;A61P3/10;;C07D413/12;;C07D405/12;;A61K31/5377;;A61K31/505;;A61K31/5377;;A61K31/506;;A61K31/635;;A61K31/551;;A61K31/541;;A61K31/52;;C07D487/08;;C07D405/12;;C07D401/12;;C07D403/12;;C07D413/14;;C07D417/12;;C07D239/42;;C07D405/14;;C07D417/14;;C07D403/14,A61K31/506;;A61K31/5377;;A61K31/551;;A61P1/00;;A61P3/00;;A61P3/04;;A61P5/48;;A61P11/00;;A61P17/06;;A61P19/04;;A61P29/00;;A61P35/00;;C07D403/12;;C07D405/12;;C07D413/12;;C07D413/14;;C12N5/071,514/210.18;;544/122;;514/235.8;;544/332;;514/275;;514/210.2;;544/82;;514/232.2;;540/492;;514/218;;435/366,0,0,,,,DISCONTINUED
888,CN,A,CN 103732067 A,169-002-562-208-013,2014-04-16,2014,CN 201280028694 A,2012-04-12,US 2012/0033384 W;;US 201161474366 P,2011-04-12,"Compounds,compositions and therapeutic uses thereof","The invention relates to compounds, pharmaceutical compositions and medicaments comprising such compounds, and the use of these compounds, compositions, and medicaments in methods of treating diseases and disorders.",MYREXIS INC,HOLCOMB RYAN C;;BARTEL PAUL L;;SUZUKI KAZUYUKI;;MCLEOD DONALD A;;DASTRUP DAVID M;;HOARAU CHRISTOPHE;;HALTER ROBERT J;;BURSAVICH MATTHEW GREGORY;;SHENDEROVICH MARK D;;RICHARDS BURT,,https://lens.org/169-002-562-208-013,Patent Application,no,6,5,11,11,0,A61K31/506;;A61P3/00;;A61P3/04;;A61P3/10;;A61P11/00;;A61P17/00;;A61P17/06;;A61P19/02;;A61P21/00;;A61P29/00;;A61P35/00;;A61P37/02;;A61P43/00;;C07D239/42;;C07D401/12;;C07D401/12;;C07D239/32;;C07D401/14;;C07D401/14;;C07D403/14;;C07D403/14;;C07D405/14;;C07D405/14;;C07D409/14;;C07D409/14;;C07D413/14;;C07D413/14;;C07D417/14;;C07D417/14,A01N43/54;;C07D239/42;;C07D251/18;;C07D401/04,,0,0,,,,DISCONTINUED
889,AU,A,AU 2001/067380 A,111-272-052-802-237,2001-11-20,2001,AU 2001/067380 A,2001-04-26,EP 00109063 A;;EP 0104696 W;;IT MI20010813 A,2000-04-28,Assessment of liver fibrosis scoring with serum marker algorithms,,BAYER AG,VOLKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF,,https://lens.org/111-272-052-802-237,Patent Application,no,0,0,11,19,0,G01N33/6887;;G01N33/6893;;G01N2333/47;;G01N2333/78;;G01N2333/8146;;G01N2333/96486;;G01N2800/085;;G01N33/6893;;G01N2333/78;;G01N33/6887;;G01N2333/96486;;G01N2333/47;;G01N2333/8146;;G01N2800/085,G01N33/53;;G01N33/573;;G01N33/68,,0,0,,,,DISCONTINUED
890,WO,A2,WO 2001/086304 A2,090-621-526-335-267,2001-11-15,2001,EP 0104696 W,2001-04-26,EP 00109063 A;;IT MI20010813 A,2000-04-28,ASSESSMENT OF LIVER FIBROSIS SCORING WITH SERUM MARKER ALGORITHMS,"The present invention concerns a method for diagnosing liver fibrosis wherein two or more diagnostic markers are measured and the measurements are correlated by a mathematic algorithm characterized in that the diagnostic markers are selected from the group N-terminal procollagen III propeptide (PIIINP), Collagen IV, Collagen VI, Tenascin, Laminin, Hyaluronan, MMP-2, TIMP-1 and MMP-9/TIMP-1 complex. The algorithm can be used to predict the histological score of a liver biopsy.",BAYER AG;;BAYER AG;;VOELKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF,VOELKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF,,https://lens.org/090-621-526-335-267,Patent Application,yes,0,18,11,19,0,G01N33/6887;;G01N33/6893;;G01N2333/47;;G01N2333/78;;G01N2333/8146;;G01N2333/96486;;G01N2800/085;;G01N33/6893;;G01N2333/78;;G01N33/6887;;G01N2333/96486;;G01N2333/47;;G01N2333/8146;;G01N2800/085,G01N33/53;;G01N33/573;;G01N33/68,,0,0,,,,PATENTED
891,WO,A3,WO 2001/086304 A3,132-463-625-978-47X,2002-04-04,2002,EP 0104696 W,2001-04-26,EP 00109063 A;;IT MI20010813 A,2000-04-28,DIAGNOSTIC OF LIVER FIBROSIS WITH SERUM MARKER ALGORITHMS,"The present invention concerns a method for diagnosing liver fibrosis wherein two or more diagnostic markers are measured and the measurements are correlated by a mathematic algorithm characterized in that the diagnostic markers are selected from the group N-terminal procollagen III propeptide (PIIINP), Collagen IV, Collagen VI, Tenascin, Laminin, Hyaluronan, MMP-2, TIMP-1 and MMP-9/TIMP-1 complex. The algorithm can be used to predict the histological score of a liver biopsy.",BAYER AG;;BAYER AG;;VOELKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF,VOELKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF,,https://lens.org/132-463-625-978-47X,Search Report,yes,1,0,11,19,0,G01N33/6887;;G01N33/6893;;G01N2333/47;;G01N2333/78;;G01N2333/8146;;G01N2333/96486;;G01N2800/085;;G01N33/6893;;G01N2333/78;;G01N33/6887;;G01N2333/96486;;G01N2333/47;;G01N2333/8146;;G01N2800/085,G01N33/53;;G01N33/573;;G01N33/68,,9,8,002-531-710-699-983;;062-365-641-881-671;;105-598-766-725-563;;083-992-979-382-575;;029-598-669-042-109;;012-720-667-615-881;;084-187-406-751-374;;056-519-399-917-315,10.1016/s0168-8278(98)80318-8;;9551682;;10.1016/0140-6736(93)91946-j;;8105167;;3168214;;10.1093/clinchem/34.10.2026;;10.1093/clinchem/42.4.558;;8605673;;9594340;;10371419;;10.1111/j.1530-0277.1999.tb04208.x;;10.1097/00000374-199905000-00027;;10572522;;10.1055/s-2007-1024516;;pmc1866318;;10.1016/s0002-9440(10)65703-3;;9846979,"C. PILETTE ET AL.: ""Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores."", JOURNAL OF HEPATOLOGY., vol. 28, no. 3, March 1998 (1998-03-01), XX, XX, pages 439 - 446, XP001019675;;J. P. TEARE ET AL.: ""Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis"", LANCET THE., vol. 342, no. 8876, 9 October 1993 (1993-10-09), LANCET LIMITED. LONDON., GB, pages 895 - 898, XP002149457, ISSN: 0140-6736;;J. KROPF ET AL.: ""Efficacy of serum laminin measurement for diagnosis of fibrotic liver diseases"", CLINICAL CHEMISTRY, vol. 34, no. 10, October 1988 (1988-10-01), WINSTON US, pages 2026 - 2030, XP002149458;;J. GUÉCHOT ET AL.: ""Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis."", CLINICAL CHEMISTRY, vol. 42, no. 4, April 1996 (1996-04-01), WINSTON US, pages 558 - 563, XP002149459;;CHEMICAL ABSTRACTS, vol. 131, no. 24, 13 December 1999, Columbus, Ohio, US; abstract no. 321003, R. ENDO ET AL.: ""Serial changes in the serum levels of type IV collagen, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in patients with acute and fulminant hepatitis"" page 496; column 2; XP002149461;;X. JI ET AL.: ""Clinical significance of serum 7S collagen and type VI collagen levels for the diagnosis of hepatic fibrosis."", CHINESE MEDICAL JOURNAL / ZHONGHUA YIXUE ZAZHI YINGWEN BAN., vol. 110, no. 3, 1997, CHINESE MEDICAL ASSOCIATION, BEIJING., CN, pages 198 - 201, XP001019695, ISSN: 0366-6999;;M. J. P. ARTHUR ET AL.: ""Tissue inhibitors of metalloproteinases: role in liver fibrosis and alcoholic liver disease."", ALCOHOLISM: CLINICAL AND EXPERIMENTAL RESEARCH., vol. 23, no. 5, May 1999 (1999-05-01), WILLIAMS AND WILKINGS, BALTIMORE, MD., US, pages 940 - 943, XP001019678, ISSN: 0145-6008;;D. SCHUPPAN ET AL.: ""Serummarker der Leberfibrose."", DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, vol. 124, no. 41, 15 October 1999 (1999-10-15), GEORG THIEME, STUTTGART,, DE, pages 1213 - 1218, XP001019674, ISSN: 0012-0472;;A. E. KOSSAKOWSKA ET AL.: ""Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis."", AMERICAN JOURNAL OF PATHOLOGY., vol. 153, no. 6, December 1998 (1998-12-01), PHILADELPHIA, PA., US, pages 1895 - 1902, XP001019668, ISSN: 0002-9440",PATENTED
892,US,A9,US 2005/0160271 A9,172-757-985-755-303,2005-07-21,2005,US 68649503 A,2003-10-14,US 68649503 A;;US 41876202 P;;US 42125402 P;;US 49470903 P;;US 49523603 P;;US 49537303 P;;US 1112901 A;;US 44278099 A;;US 10925998 P,1998-11-19,Identification document and related methods,The present invention provides methods and systems for authenticating identification documents. We also teach an identification document including two or more digital watermarks. The watermarks correspond with each other or with indicia carried by the identification document. The correspondence can be verified to determine authenticity. We also provide digital watermark detection methods and systems to identify the different watermarks through embedded orientation components. We then focus watermark message-decoding efforts on areas identified as likely including watermark orientation components. In one implementation we provide a watermark detection trigger to identify so-called legacy documents. The trigger may indicate the presence or expected absence of a digital watermark. In other implementations we provide a versatile document authenticator to toggle between watermarking and non-watermarking authentication processes depending on a detection trigger.,BRUNDAGE TRENT J.;;SHER-JAN MAHMOOD;;WEAVER MATTHEW M.;;HANNIGAN BRETT T.;;BRADLEY BRETT A.;;STACH JOHN;;PERRY BURT W.;;DURST ROBERT T.JR.;;RHOADS GEOFFREY B.,BRUNDAGE TRENT J;;SHER-JAN MAHMOOD;;WEAVER MATTHEW M;;HANNIGAN BRETT T;;BRADLEY BRETT A;;STACH JOHN;;PERRY BURT W;;DURST ROBERT T JR;;RHOADS GEOFFREY B,DIGIMARC CORPORATION (2004-04-09),https://lens.org/172-757-985-755-303,Amended Application,yes,99,116,11,31,0,B42D2035/34;;G06T1/0071;;G06T2201/0051;;G07F7/08;;G07F7/086;;G07F7/12;;H04N1/32144;;H04N1/32288;;H04N1/32352;;H04N2201/3233;;H04N2201/3235;;H04N2201/327;;G06Q20/347;;G06Q20/401;;G06T1/0028;;G09C5/00;;H04K1/00;;H04L9/3231;;H04N1/32304;;H04N2201/3205;;H04L2209/56;;H04L2209/608;;H04L2209/805;;B42D25/00;;B42D25/309;;G07D7/0034;;B42D25/47;;B42D25/23;;B42D25/333;;B42D25/20;;G06T2201/0051;;H04N2201/327;;G06T1/0071;;H04N2201/3233;;H04N1/32352;;H04N1/32144;;G07F7/12;;G07F7/086;;H04N2201/3235;;H04N1/32288;;G07F7/08;;G09C5/00;;G06T1/0028;;H04K1/00;;G06Q20/401;;H04N1/32304;;G06Q20/347;;H04L2209/56;;H04L9/3231;;H04L2209/805;;H04L2209/608;;H04N2201/3205;;B42D25/00;;B42D25/309;;G07D7/0034,B42D15/10;;G06T1/00;;G07D7/12;;G07F7/08;;G07F7/12;;H04N1/32,713/176,0,0,,,,DISCONTINUED
893,US,A1,US 2004/0053242 A1,106-770-967-638-042,2004-03-18,2004,US 25868903 A,2003-10-07,EP 0104696 W;;EP 00109063 A;;IT MI20010813 A,2000-04-28,Assessment of liver fibrosis scoring with serum marker algorithms,"
   The present invention concerns a method for diagnosing liver fibrosis wherein two or more diagnostic markers are measured and the measurements are correlated by a mathematic algorithm characterized in that the diagnostic markers are selected from the group N-terminal procollagen III propeptide (PIIINP), Collagen IV/, Collagen VI, Tenascin, Laminin, Hyaluronan, MMP-2, TIMP-1 and MMP-9/TIMP complex. The algorithm can be used to predict the histological score of a liver biopsy. 
",VOLKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;GEHRMANN MATHIAS;;HENNIG GUIDO;;UNGER SYLVIA;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J.;;BURT ALASTAIR D.;;PINZANI MASSIMO;;SCHUPPAN DETLEF,VOLKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;GEHRMANN MATHIAS;;HENNIG GUIDO;;UNGER SYLVIA;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF,SIEMENS HEALTHCARE DIAGNOSTICS INC (2010-01-18);;BAYER HEALTCHCARE LLC (2005-06-06),https://lens.org/106-770-967-638-042,Patent Application,yes,0,14,11,19,0,G01N33/6887;;G01N33/6893;;G01N2333/47;;G01N2333/78;;G01N2333/8146;;G01N2333/96486;;G01N2800/085;;G01N33/6893;;G01N2333/78;;G01N33/6887;;G01N2333/96486;;G01N2333/47;;G01N2333/8146;;G01N2800/085,G01N33/53;;G01N33/573;;G01N33/68,435/6;;435/7.2;;702/19,0,0,,,,EXPIRED
894,EP,A2,EP 1283989 A2,055-379-062-337-333,2003-02-19,2003,EP 01945050 A,2001-04-26,EP 01945050 A;;EP 0104696 W;;EP 00109063 A;;IT MI20010813 A,2000-04-28,DIAGNOSIS OF LIVER FIBROSIS WITH SERUM MARKER ALGORITHMS,,BAYER AG;;BAYER AG,VOELKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF,"SIEMENS HEALTHCARE DIAGNOSTICS INC., TARRYTOWN, US (2012-02-07)",https://lens.org/055-379-062-337-333,Patent Application,yes,0,2,11,19,0,G01N33/6887;;G01N33/6893;;G01N2333/47;;G01N2333/78;;G01N2333/8146;;G01N2333/96486;;G01N2800/085;;G01N33/6893;;G01N2333/78;;G01N33/6887;;G01N2333/96486;;G01N2333/47;;G01N2333/8146;;G01N2800/085,G01N33/53;;G01N33/573;;G01N33/68,,0,0,,,,EXPIRED
895,US,A1,US 2019/0143871 A1,046-441-619-633-091,2019-05-16,2019,US 201816229881 A,2018-12-21,US 201816229881 A;;US 201615154131 A;;US 201562162354 P,2015-05-15,UTILITY VEHICLE,"A utility vehicle includes a plurality of ground-engaging members, a frame, a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors to enclose the operator area.",POLARIS INC,WEBER DANIEL S;;FLICK BRIAN N;;CARRUTH CURTIS C;;PETERSON SHAWN D;;BURT DANIEL L;;ERSPAMER BRENT A;;JOHNSON CLINTON A;;SEIDEL BRIAN J;;BOHNSACK MICHAEL C,POLARIS INDUSTRIES INC (2016-04-01),https://lens.org/046-441-619-633-091,Patent Application,yes,0,19,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60P1/04;;B60G3/02;;B60G3/20;;B60G11/48;;B60G15/06;;B60J5/04;;B60K5/04;;B60K11/06;;B60K13/02;;B60K13/04;;B60K17/06;;B60K37/02;;B60N2/01;;B62D21/18;;B62D33/02;;E05D5/02;;E05D11/06,,0,0,,,,DISCONTINUED
896,EP,B1,EP 1283989 B1,126-375-068-674-686,2007-07-11,2007,EP 01945050 A,2001-04-26,EP 01945050 A;;EP 0104696 W;;EP 00109063 A;;IT MI20010813 A,2000-04-28,DIAGNOSIS OF LIVER FIBROSIS WITH SERUM MARKER ALGORITHMS,,BAYER AG;;BAYER CORP,VOELKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF,"SIEMENS HEALTHCARE DIAGNOSTICS INC., TARRYTOWN, US (2012-02-07)",https://lens.org/126-375-068-674-686,Granted Patent,yes,0,0,11,19,0,G01N33/6887;;G01N33/6893;;G01N2333/47;;G01N2333/78;;G01N2333/8146;;G01N2333/96486;;G01N2800/085;;G01N33/6893;;G01N2333/78;;G01N33/6887;;G01N2333/96486;;G01N2333/47;;G01N2333/8146;;G01N2800/085,G01N33/68;;G01N33/53;;G01N33/573,,3,2,034-755-153-034-877;;040-959-043-882-615,8697587;;10.1093/clinchem/42.8.1263;;7525168;;10.1007/bf02087661,"CLINICAL CHEMISTRY, vol. 42, no. 8, 1996, pages 1263 - 1269;;DIGESTIVE DISEASES AND SCIENCES, vol. 39, no. 11, 1994, pages 2426 - 2432;;Web-page: http://www.hepcnet.net/scoring_grading.html. Date: Jan 27, 2001",EXPIRED
897,DE,D1,DE 60129314 D1,085-001-322-474-021,2007-08-23,2007,DE 60129314 T,2001-04-26,EP 00109063 A;;IT MI20010813 A;;EP 0104696 W,2000-04-28,DIAGNOSE VON LEBERFIBROSE MIT HILFE VON SERUMMARKERALGORITHMEN,,BAYER AG;;BAYER CORP,VOELKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF,,https://lens.org/085-001-322-474-021,Granted Patent,no,0,0,11,19,0,G01N33/6887;;G01N33/6893;;G01N2333/47;;G01N2333/78;;G01N2333/8146;;G01N2333/96486;;G01N2800/085;;G01N33/6893;;G01N2333/78;;G01N33/6887;;G01N2333/96486;;G01N2333/47;;G01N2333/8146;;G01N2800/085,G01N33/68;;G01N33/53;;G01N33/573,,0,0,,,,EXPIRED
898,DE,T2,DE 60129314 T2,012-030-009-853-329,2008-07-17,2008,DE 60129314 T,2001-04-26,EP 00109063 A;;IT MI20010813 A;;EP 0104696 W,2000-04-28,DIAGNOSE VON LEBERFIBROSE MIT HILFE VON SERUMMARKERALGORITHMEN,,BAYER AG;;BAYER CORP,VOELKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF,,https://lens.org/012-030-009-853-329,Granted Patent,no,0,0,11,19,0,G01N33/6887;;G01N33/6893;;G01N2333/47;;G01N2333/78;;G01N2333/8146;;G01N2333/96486;;G01N2800/085;;G01N33/6893;;G01N2333/78;;G01N33/6887;;G01N2333/96486;;G01N2333/47;;G01N2333/8146;;G01N2800/085,G01N33/68;;G01N33/53;;G01N33/573,,0,0,,,,EXPIRED
899,US,B2,US 7141380 B2,159-998-532-851-067,2006-11-28,2006,US 25868903 A,2003-10-07,EP 0104696 W;;EP 00109063 A;;IT MI20010813 A,2000-04-28,Assessment of liver fibrosis scoring with serum marker algorithms,"The present invention concerns a method for diagnosing liver fibrosis wherein two or more diagnostic markers are measured and the measurements are correlated by a mathematic algorithm characterized in that the diagnostic markers are selected from the group N-terminal procollagen III propeptide (PIIINP), Collagen IV, Collagen VI, Tenascin, Laminin, Hyaluronan, MMP-2, TIMP-1 and MMP-9/TIMP-1 complex. The algorithm can be used to predict the histological score of a liver biopsy.",VOLKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;GEHRMANN MATHIAS;;HENNIG GUIDO;;UNGER SYLVIA;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF,VOLKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;GEHRMANN MATHIAS;;HENNIG GUIDO;;UNGER SYLVIA;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF,SIEMENS HEALTHCARE DIAGNOSTICS INC (2010-01-18);;BAYER HEALTCHCARE LLC (2005-06-06),https://lens.org/159-998-532-851-067,Granted Patent,yes,0,9,11,19,0,G01N33/6887;;G01N33/6893;;G01N2333/47;;G01N2333/78;;G01N2333/8146;;G01N2333/96486;;G01N2800/085;;G01N33/6893;;G01N2333/78;;G01N33/6887;;G01N2333/96486;;G01N2333/47;;G01N2333/8146;;G01N2800/085,G01N33/573;;G01N33/53;;G01N33/68,435/7.1,1,1,002-531-710-699-983,10.1016/s0168-8278(98)80318-8;;9551682,"Pilette et al (Journal of Hepatology vol. 28, pp. 439-446, 1998).",EXPIRED
900,TW,B,TW 357268 B,139-106-380-764-72X,1999-05-01,1999,TW 85112914 A,1996-10-22,US 56454395 A,1995-11-30,Vector electricity meters and associated vector electricity metering methods,"An electricity metering method of electric wires having at least 2 conductive routes, including the following steps being conducted by the electric meter; sensing on the electric wire a wiring voltage signal and a wiring current signal; determination of a crossing period of the sensed wire voltage and wire current; conversion of the sensed wire voltage and wire current into digital signals; and calculation of the digital signal for the measurement of the vector electric meter on the electric wire at the determined crossing period.",GEN ELECTRIC,PROVOST ROLAND J;;LAVOIE GREGORY PAUL;;ELMORE DAVID D;;GERMER WARREN RALPH;;BURT ARTHUR CHARLES;;CRITTENDEN CURTIS WHITMORE;;HOFFMAN MARK E;;BULLOCK DONALD FRANK;;STAVER DANIEL ARTHUR,,https://lens.org/139-106-380-764-72X,Granted Patent,no,0,1,16,16,0,G01R21/1331;;G01R21/1331,G01R21/133,,0,0,,,,EXPIRED
901,US,A1,US 2007/0016790 A1,169-114-585-353-834,2007-01-18,2007,US 52736106 A,2006-09-25,US 52736106 A;;US 68649503 A;;US 1112901 A;;US 44278099 A;;US 41876202 P;;US 42125402 P;;US 49470903 P;;US 49523603 P;;US 49537303 P;;US 10925998 P,1998-11-19,Identification document and related methods,The present invention provides methods and systems for authenticating identification documents. We also teach an identification document including two or more digital watermarks. The watermarks correspond with each other or with indicia carried by the identification document. The correspondence can be verified to determine authenticity. We also provide digital watermark detection methods and systems to identify the different watermarks through embedded orientation components. We then focus watermark message-decoding efforts on areas identified as likely including watermark orientation components. In another implementation we provide a watermark detection trigger to identify so-called legacy documents. The trigger may indicate the presence or expected absence of a digital watermark. In other implementations we provide a versatile document authenticator to toggle between watermarking and non-watermarking authentication processes depending on a detection trigger. Other implementations are provided as well.,BRUNDAGE TRENT J;;SHER-JAN MAHMOOD;;WEAVER MATTHEW M;;HANNIGAN BRETT T;;BRADLEY BRETT A;;STACH JOHN;;PERRY BURT W;;DURST ROBERT T JR;;RHOADS GEOFFREY B,BRUNDAGE TRENT J;;SHER-JAN MAHMOOD;;WEAVER MATTHEW M;;HANNIGAN BRETT T;;BRADLEY BRETT A;;STACH JOHN;;PERRY BURT W;;DURST ROBERT T JR;;RHOADS GEOFFREY B,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC CORPORATION (2008-08-01);;DMRC LLC (2008-08-01),https://lens.org/169-114-585-353-834,Patent Application,yes,99,175,11,31,0,B42D2035/34;;G06T1/0071;;G06T2201/0051;;G07F7/08;;G07F7/086;;G07F7/12;;H04N1/32144;;H04N1/32288;;H04N1/32352;;H04N2201/3233;;H04N2201/3235;;H04N2201/327;;G06Q20/347;;G06Q20/401;;G06T1/0028;;G09C5/00;;H04K1/00;;H04L9/3231;;H04N1/32304;;H04N2201/3205;;H04L2209/56;;H04L2209/608;;H04L2209/805;;B42D25/00;;B42D25/309;;G07D7/0034;;B42D25/47;;B42D25/23;;B42D25/333;;B42D25/20;;G06T2201/0051;;H04N2201/327;;G06T1/0071;;H04N2201/3233;;H04N1/32352;;H04N1/32144;;G07F7/12;;G07F7/086;;H04N2201/3235;;H04N1/32288;;G07F7/08;;G09C5/00;;G06T1/0028;;H04K1/00;;G06Q20/401;;H04N1/32304;;G06Q20/347;;H04L2209/56;;H04L9/3231;;H04L2209/805;;H04L2209/608;;H04N2201/3205;;B42D25/00;;B42D25/309;;G07D7/0034,B42D15/10;;H04L9/00;;G06T1/00;;G07D7/12;;G07F7/08;;G07F7/12;;H04N1/32,713/176,0,0,,,,EXPIRED
902,US,A1,US 2016/0332536 A1,056-378-994-026-772,2016-11-17,2016,US 201615154131 A,2016-05-13,US 201615154131 A;;US 201562162354 P,2015-05-15,UTILITY VEHICLE,"A utility vehicle includes a plurality of ground-engaging members, a frame, a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors to enclose the operator area.",POLARIS INC,WEBER DANIEL S;;FLICK BRIAN N;;CARRUTH CURTIS C;;PETERSON SHAWN D;;BURT II DANIEL L;;ERSPAMER BRENT A;;JOHNSON CLINTON A;;SEIDEL BRIAN J;;BOHNSACK MICHAEL C,POLARIS INDUSTRIES INC (2016-04-01),https://lens.org/056-378-994-026-772,Patent Application,yes,0,11,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60N2/01;;B60J5/04;;B62D21/18;;B62D33/02,,0,0,,,,ACTIVE
903,US,B2,US 10183605 B2,088-458-848-429-283,2019-01-22,2019,US 201615154131 A,2016-05-13,US 201615154131 A;;US 201562162354 P,2015-05-15,Utility vehicle,"A utility vehicle includes a plurality of ground-engaging members, a frame, a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors to enclose the operator area.",POLARIS INC,WEBER DANIEL S;;FLICK BRIAN N;;CARRUTH CURTIS C;;PETERSON SHAWN D;;BURT II DANIEL L;;ERSPAMER BRENT A;;JOHNSON CLINTON A;;SEIDEL BRIAN J;;BOHNSACK MICHAEL C,POLARIS INDUSTRIES INC (2016-04-01),https://lens.org/088-458-848-429-283,Granted Patent,yes,115,14,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60P1/04;;B60G3/02;;B60G3/20;;B60G11/48;;B60G15/06;;B60J5/04;;B60K5/00;;B60K5/04;;B60K11/06;;B60K13/02;;B60K13/04;;B60K17/06;;B60K17/08;;B60K37/02;;B60N2/01;;B62D1/18;;B62D21/18;;B62D33/02;;E05D3/02;;E05D5/02;;E05D11/06,,27,0,,,"International Search Report and Written Opinion issued by the International Searching Authority, dated Sep. 19, 2016 for corresponding International Application No. PCT/US2016/031992; 22 pages.;;Ray Sedorchuk, New for 2004, Yamaha Rhino 660 4×4, ATV Connection Magazine, © 2006; 3 pages.;;Yamaha, Company Website, 2006 Rhino 450 Auto 4×4, © 2005; 3 pages.;;Yamaha, Company Website, 2006 Rhino 660 Auto 4×4 Special Edition, © 2006; 4 pages.;;Yamaha, Company Website, 2006 Rhino 660 Auto 4×4, © 2006; 4 pages.;;Yamaha, Company Website, Rhino 660 Auto 4×4 Exploring Edition Specifications, © 2006; 3 pages.;;Artic Cat, Company Website, Prowler XT650 H1, undated; 9 pages.;;Club Car, Company Website, product pages for XRT 1500 SE, undated; 2 pages.;;Honda Hippo 1800 New Competition for Yamaha's Rhino, Dirt Wheels Magazine, Apr. 2006, pp. 91-92.;;Buyer's Guide Supplement, 2006 Kart Guide, Powersports Business Magazine; 6 pages.;;BRP Can-Am Commander photo, undated; 1 page.;;Polaris Ranger Welcome to Ranger Country Brochure 2006, © 2005; 24 pages.;;Polaris Ranger Brochure ATVs and Side x Sides Brochure 2010, © 2009; 26 pages.;;Polaris Ranger RZR Brochure 2011, © 2010; 16 pages.;;Polaris Ranger Brochure 2011, © 2010; 22 pages.;;Kawasaki Mule Utility Vehicle Brochure 2009, © 2008; 10 pages.;;Kawasaki Mule The Off-Road Capable 610 4×4 XC Brochure 2011, © 2010; 6 pages.;;Kawasaki Teryx Recreation Utility Vehicle Brochure 2009, © 2008; 8 pages.;;Kawasaki Teryx 750 FI 4×4 Sport Brochure 2011, © 2010; 6 pages.;;Polaris Ranger Off-Road Utility Vehicles Brochure 2004, © 2003; 20 pages.;;Polaris Ranger Work/Play Only Brochure 2008, © 2007; 28 pages.;;Polaris Ranger Brochure 2009, © 2008; 32 pages.;;International Search Report and Written Opinion issued by the European Patent Office, dated Jun. 28, 2012, for International PCT Application No. PCT/US2012/024664; 19 pages.;;International Preliminary Report on Patentability issued by the European Patent Office, dated Mar. 8, 2013, for International PCT Application No. PCT/US2012/024664; 24 pages.;;International Search Report and Written Opinion issued by the European Patent Office, dated Jul. 23, 2013, for International PCT Application No. PCT/US2013/039304; 11 pages.;;International Search Report and Written Opinion issued by the European Patent Office, dated Sep. 9, 2014, for related International Application No. PCT/US2014/039824; 9 pages.;;International Search Report and Written Opinion issued by the European Patent Office, dated Jul. 25, 2014, for related International Application No. PCT/US2014/028152; 20 pages.",ACTIVE
904,US,S,US D0609732 S,118-006-448-297-76X,2010-02-09,2010,US 32701108 F,2008-10-29,US 32701108 F,2008-10-29,Camera,,FLIR SYSTEMS,FRANK JEFFREY D;;PAS GUY;;RICHARDSON PATRICK B;;ROTA JR LOUIS J;;BURT WARN;;TREMBLAY MARCEL;;HINDS TREASURE;;XUE MENG;;SCHEIBLHUBER ANKE;;LI JONATHAN;;WILLIAMS DAVID;;LI YAOHUA,FLIR SYSTEMS INC (2008-10-29),https://lens.org/118-006-448-297-76X,Design Right,no,0,37,1,1,0,,,1601;;D16/203,0,0,,,,EXPIRED
905,US,A1,US 2020/0070709 A1,093-838-128-676-257,2020-03-05,2020,US 201916677110 A,2019-11-07,US 201916677110 A;;US 201816229881 A;;US 201615154131 A;;US 201562162354 P,2015-05-15,UTILITY VEHICLE,"A utility vehicle includes a plurality of ground-engaging members, a frame, a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors to enclose the operator area.",POLARIS INC,WEBER DANIEL S;;FLICK BRIAN N;;CARRUTH CURTIS C;;PETERSON SHAWN D;;BURT DANIEL L;;ERSPAMER BRENT A;;JOHNSON CLINTON A;;SEIDEL BRIAN J;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;FIELDS JASON R;;KUHL AMERY D,POLARIS INDUSTRIES INC (2020-09-11),https://lens.org/093-838-128-676-257,Patent Application,yes,0,4,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60P1/04;;B60G3/02;;B60G3/20;;B60G11/48;;B60G15/06;;B60J5/04;;B60K5/04;;B60K11/06;;B60K13/02;;B60K13/04;;B60K17/06;;B60K37/02;;B60N2/01;;B62D21/18;;B62D33/02;;E05D5/02;;E05D11/06,,0,0,,,,ACTIVE
906,US,A1,US 2023/0331081 A1,041-878-747-396-369,2023-10-19,2023,US 202318212400 A,2023-06-21,US 202318212400 A;;US 201916677110 A;;US 201816229881 A;;US 201615154131 A;;US 201562162354 P,2015-05-15,UTILITY VEHICLE,"A utility vehicle includes a plurality of ground-engaging members, a frame, a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors to enclose the operator area.",POLARIS INC,WEBER DANIEL S;;FLICK BRIAN N;;CARRUTH CURTIS C;;PETERSON SHAWN D;;BURT DANIEL L;;ERSPAMER BRENT A;;JOHNSON CLINTON A;;SEIDEL BRIAN J;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;FIELDS JASON R;;KUHL AMERY D,,https://lens.org/041-878-747-396-369,Patent Application,yes,0,0,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60K17/04;;B60G3/20;;B60G15/06;;B60K11/06;;B60K13/02;;F16H57/04,,0,0,,,,PENDING
907,AU,A1,AU 2020/378350 A1,146-201-325-718-21X,2022-06-09,2022,AU 2020/378350 A,2020-11-05,US 201962932947 P;;US 2020/0059235 W,2019-11-08,Hydrophilic medical products and hydration mediums for hydrating the same,"Hydration mediums, assemblies containing hydration mediums and methods of making the same.",HOLLISTER INC,FARRELL DAVID J;;PANESAR SATWINDER S;;HORKAN CARLOS;;MURNAGHAN KEVIN;;SILEIKA TADAS S;;MURRAY MICHAEL G;;NAUGHTON VINCENT;;O'DONNELL PAUL M;;O'MAHONY JOHN P;;CLARKE JOHN T;;DEAN NICOLE L;;BURT RAJAN A;;PETTIGREW JACQUELINE M J,,https://lens.org/146-201-325-718-21X,Patent Application,no,0,0,5,5,0,A61L29/14;;A61L29/146;;A61L2400/10;;A61M25/002;;A61M2025/0046;;A61M25/0111;;A61M2210/1096;;A61L29/16;;A61L29/143;;A61L29/141;;A61L2300/11;;A61L29/02;;A61L29/06;;A61L29/14;;A61L29/143;;A61L29/146;;A61L2300/802;;A61L2400/10;;A61M25/002,A61L27/50;;A61B50/30;;A61L29/14;;A61M25/00,,0,0,,,,PENDING
908,BR,A2,BR 112013026202 A2,116-717-307-601-623,2017-07-25,2017,BR 112013026202 A,2012-04-12,US 2012/0033384 W;;US 201161474366 P,2011-04-12,composições e usos terapêuticos de inibidores quinase epsilon relacionado a ikk e quinase i de ligação a tank,"resumo da patente de invenção para: “composições e usos terapêuticos de inibidores quinase epsilon relacionado a ikk e quinase i de ligação a tank”. a invenção se refere a compostos, composições farmacêuticas e medicamentos compreendendo tais compostos, e o uso destes compostos, composições e medicamentos em métodos de tratamento de doenças e distúrbios",MYREXIS INC,BURT RICHARDS;;CHRISTOPHE HOARAU;;DAVID M DASTRUP;;DONALD A MCLEOD;;KAZUYUKI SUZUKI;;MARK D SHENDEROVICH;;MATTHEW GREGORY BURSAVICH;;PAUL L BARTEL;;PAUL R SEBAHAR;;ROBERT J HALTER;;RYAN HOLCOMB,,https://lens.org/116-717-307-601-623,Patent Application,no,0,0,11,11,0,A61K31/506;;A61P3/00;;A61P3/04;;A61P3/10;;A61P11/00;;A61P17/00;;A61P17/06;;A61P19/02;;A61P21/00;;A61P29/00;;A61P35/00;;A61P37/02;;A61P43/00;;C07D239/42;;C07D401/12;;C07D401/12;;C07D239/32;;C07D401/14;;C07D401/14;;C07D403/14;;C07D403/14;;C07D405/14;;C07D405/14;;C07D409/14;;C07D409/14;;C07D413/14;;C07D413/14;;C07D417/14;;C07D417/14,C07D239/42;;A01N43/54;;C07D251/18;;C07D401/04,,0,0,,,,DISCONTINUED
909,US,A1,US 2014/0288044 A1,016-688-191-302-561,2014-09-25,2014,US 201214112847 A,2012-04-12,US 201214112847 A;;US 201161474366 P;;US 2012/0033384 W,2011-04-12,COMPOSITIONS AND THERAPEUTIC USES OF IKK-RELATED KINASE EPSILON AND TANKBINDING KINASE 1 INHIBITORS,"The invention relates to compounds, pharmaceutical compositions and medicaments comprising such compounds, and the use of these compounds, compositions, and medicaments in methods of treating diseases and disorders.",HOLCOMB RYAN;;SEBAHAR PAUL R;;SUZUKI KAZUYUKI;;MCLEOD DONALD A;;DASTRUP DAVID M;;HOARAU CHRISTOPHE;;HALTER ROBERT J;;BURSAVICH MATTHEW GREGORY;;SHENDEROVICH MARK D;;RICHARDS BURT;;BARTEL PAUL L;;ALZHEIMER S INST OF AMERICA INC,HOLCOMB RYAN;;SEBAHAR PAUL R;;SUZUKI KAZUYUKI;;MCLEOD DONALD A;;DASTRUP DAVID M;;HOARAU CHRISTOPHE;;HALTER ROBERT J;;BURSAVICH MATTHEW GREGORY;;SHENDEROVICH MARK D;;RICHARDS BURT;;BARTEL PAUL L,ALZHEIMER'S INSTITUTE OF AMERICA INC (2013-10-29),https://lens.org/016-688-191-302-561,Patent Application,yes,5,3,11,11,0,A61K31/506;;A61P3/00;;A61P3/04;;A61P3/10;;A61P11/00;;A61P17/00;;A61P17/06;;A61P19/02;;A61P21/00;;A61P29/00;;A61P35/00;;A61P37/02;;A61P43/00;;C07D239/42;;C07D401/12;;C07D401/12;;C07D239/32;;C07D401/14;;C07D401/14;;C07D403/14;;C07D403/14;;C07D405/14;;C07D405/14;;C07D409/14;;C07D409/14;;C07D413/14;;C07D413/14;;C07D417/14;;C07D417/14,C07D401/12;;C07D401/14;;C07D405/14;;C07D409/14;;C07D413/14;;C07D417/14,514/210.18;;544/331;;514/275;;544/122;;514/235.8;;544/296;;544/295;;514/252.18;;514/210.2;;514/236.5;;544/238;;514/252.02;;544/120;;435/375,2,0,,,"KINASE INHIBITORS, METHODS IN MOLECULAR BIOLOGY 795 (B. Kuster ed., 2012) (""Kuster"");;B.A. Chabner et al., Chemotherapy of Neoplastic Diseases, Neoplastic Agents in, GOODMAN & GILMAN'S: THE PHARMACOLOGICAL BASIS OF THERAPEUTICS 1315-1403, 1315 (L.L. Brunton et al., eds., 11th ed., 2006)",DISCONTINUED
910,CA,A1,CA 2832919 A1,157-840-355-736-793,2012-10-18,2012,CA 2832919 A,2012-04-12,US 201161474366 P;;US 2012/0033384 W,2011-04-12,"COMPOUNDS, COMPOSITIONS, AND THERAPEUTIC USES THEREOF","The invention relates to compounds, pharmaceutical compositions and medicaments comprising such compounds, and the use of these compounds, compositions, and medicaments in methods of treating diseases and disorders.",ALZHELMER S INST OF AMERICA INC,HOLCOMB RYAN C;;SEBAHAR PAUL R;;SUZUKI KAZUYUKI;;MCLEOD DONALD A;;DASTRUP DAVID M;;HOARAU CHRISTOPHE;;HALTER ROBERT J;;BURSAVICH MATTHEW GREGORY;;SHENDEROVICH MARK D;;RICHARDS BURT;;BARTEL PAUL L,,https://lens.org/157-840-355-736-793,Patent Application,no,0,0,11,11,0,A61K31/506;;A61P3/00;;A61P3/04;;A61P3/10;;A61P11/00;;A61P17/00;;A61P17/06;;A61P19/02;;A61P21/00;;A61P29/00;;A61P35/00;;A61P37/02;;A61P43/00;;C07D239/42;;C07D401/12;;C07D401/12;;C07D239/32;;C07D401/14;;C07D401/14;;C07D403/14;;C07D403/14;;C07D405/14;;C07D405/14;;C07D409/14;;C07D409/14;;C07D413/14;;C07D413/14;;C07D417/14;;C07D417/14,A01N43/54;;C07D239/42;;C07D251/18;;C07D401/04,,0,0,,,,DISCONTINUED
911,AU,A1,AU 2012/242777 A1,114-595-610-825-368,2013-10-31,2013,AU 2012/242777 A,2012-04-12,US 201161474366 P;;US 2012/0033384 W,2011-04-12,Compositions and therapeutic uses of IKK-related kinase epsilon and TANKbinding kinase 1 inhibitors,"The invention relates to compounds, pharmaceutical compositions and medicaments comprising such compounds, and the use of these compounds, compositions, and medicaments in methods of treating diseases and disorders.",ALZHEIMERS INSTITUTE OF AMERICA INC,HOLCOMB RYAN C;;SEBAHAR PAUL R;;SUZUKI KAZUYUKI;;MCLEOD DONALD A;;DASTRUP DAVID M;;HOARAU CHRISTOPHE;;HALTER ROBERT J;;BURSAVICH MATTHEW GREGORY;;SHENDEROVICH MARK D;;RICHARDS BURT;;BARTEL PAUL L,"ALZHEIMER'S INSTITUTE OF AMERICA, INC. (2014-01-09)",https://lens.org/114-595-610-825-368,Patent Application,no,0,0,11,11,0,A61K31/506;;A61P3/00;;A61P3/04;;A61P3/10;;A61P11/00;;A61P17/00;;A61P17/06;;A61P19/02;;A61P21/00;;A61P29/00;;A61P35/00;;A61P37/02;;A61P43/00;;C07D239/42;;C07D401/12;;C07D401/12;;C07D239/32;;C07D401/14;;C07D401/14;;C07D403/14;;C07D403/14;;C07D405/14;;C07D405/14;;C07D409/14;;C07D409/14;;C07D413/14;;C07D413/14;;C07D417/14;;C07D417/14,A01N43/54;;C07D239/42;;C07D251/18;;C07D401/04,,0,0,,,,DISCONTINUED
912,US,A1,US 2004/0049401 A1,197-827-607-823-098,2004-03-11,2004,US 37042103 A,2003-02-19,US 37042103 A;;US 35832102 P,2002-02-19,Security methods employing drivers licenses and other documents,"
   Driver's licenses and other security documents include one or more machine-readable features, each conveying plural bits of information. These features are used in a variety of ways to increase security, and/or to enhance functionality. In one embodiment, data encoded on a driver's license is used at airport check-in, to link to a state DMV database and obtain information by which the document, and its custodian, can be authenticated. In like fashion, a license can be used to authenticate a bearer and/or his/her age prior to the sale of alcohol or tobacco products. In other embodiments, different elements of a driver's license (e.g., the substrate, photo, text data, and machine-readable data) are logically bound together (e.g., interlinked through payloads conveyed by different machine-readable features) as a deterrent against counterfeiting. Driver's licenses can be similarly logically bound to personal checks and other documents. Many other arrangements are also disclosed. 
",CARR J. SCOTT;;DAVIS BRUCE L.;;DECKER STEPHEN K.;;HAWES JONATHAN L.;;HEIN WILLIAM C.;;LEVY KENNETH L.;;MUNDAY JOHN;;PERRY BURT W.;;SEDER PHILLIP ANDREW;;MEYER JOEL R.;;MCKINLEY TYLER J.;;BRUNK HUGH L.;;STEWART STEVEN W.,CARR J SCOTT;;DAVIS BRUCE L;;DECKER STEPHEN K;;HAWES JONATHAN L;;HEIN WILLIAM C;;LEVY KENNETH L;;MUNDAY JOHN;;PERRY BURT W;;SEDER PHILLIP ANDREW;;MEYER JOEL R;;MCKINLEY TYLER J;;BRUNK HUGH L;;STEWART STEVEN W,DIGIMARC CORPORATION (2003-10-04);;L-1 SECURE CREDENTIALING INC (2008-08-13),https://lens.org/197-827-607-823-098,Patent Application,yes,39,146,9,31,0,G06Q10/02;;G06Q50/265;;G07C2209/41;;G07C9/22;;G07C9/20;;G07C9/27;;G06Q10/02;;G07C2209/41;;G06Q50/265;;G07C9/20;;G07C9/22,G06Q10/02;;G06Q50/26;;G07C9/00,705/1,0,0,,,,DISCONTINUED
913,NZ,A,NZ 334560 A,188-003-185-110-881,2000-07-28,2000,NZ 33456099 A,1999-03-09,GB 9807650 A,1998-04-14,"aqueous disinfecting concentrate containing a quaternary ammonium compound and a binary surfactant system containing a nonionic surfactant and urea, a benzoate or ethoxylated lanolin and a further nonionic surfactant","The aqueous disinfecting and cleaning composition in the form of a concentrate that exhibits reduced irritancy comprises: a) a disinfecting effective amount of a quaternary ammonium compound having a germicidal properties; b) 0.01-10 wt% of a nonionic surfactant compound which is based on a polymeric alkylene oxide block copolymer; c) a mitigating effective amount of urea, benzoates, or ethoxylated surfactants; d) 0.1-10 wt% of a further non-ionic surfactant ; e) 0-3 wt% of a polymeric cationic surfactant based on a polyquaternary ammonium salt; f) 0-3 wt% of a builder; g) optionally 0-5 wt% of one or more additives and h) water to form 100 wt% of the concentrate form of the aqueous disinfecting and cleaning composition.",RECKITT & COLMAN INC,LU R Z;;SMIALOWICZ D T;;RYPKEMA R E;;MCCUE K A;;KLOEPPEL A A;;BURT D J;;LOVE M D;;BOGART R W;;NANAVATI N V;;TARASCHI F A,,https://lens.org/188-003-185-110-881,Patent Application,no,0,0,8,8,0,C11D1/008;;C11D1/44;;C11D1/62;;C11D1/8355;;C11D3/3707;;C11D3/48;;C11D2111/14;;C11D3/48;;C11D1/008;;C11D1/62;;C11D3/3707;;C11D1/44;;C11D1/8355;;C11D2111/14,C11D1/42;;C11D1/62;;C11D1/835;;C11D3/37;;C11D3/48;;C11D11/00,,0,0,,,,PENDING
914,MX,A,MX 2013011908 A,013-875-861-526-05X,2014-03-27,2014,MX 2013011908 A,2012-04-12,US 201161474366 P;;US 2012/0033384 W,2011-04-12,COMPOSITIONS AND THERAPEUTIC USES OF IKK-RELATED KINASE EPSILON AND TANKBINDING KINASE 1 INHIBITORS.,"The invention relates to compounds, pharmaceutical compositions and medicaments comprising such compounds, and the use of these compounds, compositions, and medicaments in methods of treating diseases and disorders.",ALZHEIMER S INST OF AMERICA INC,HOLCOMB RYAN C;;SEBAHAR PAUL R;;SUZUKI KAZUYUKI;;MCLEOD DONALD A;;DASTRUP DAVID M;;HOARAU CHRISTOPHE;;HALTER ROBERT J;;BURSAVICH MATTHEW GREGORY;;SHENDEROVICH MARK D;;RICHARDS BURT;;BARTEL PAUL L,,https://lens.org/013-875-861-526-05X,Patent Application,no,0,0,11,11,0,A61K31/506;;A61P3/00;;A61P3/04;;A61P3/10;;A61P11/00;;A61P17/00;;A61P17/06;;A61P19/02;;A61P21/00;;A61P29/00;;A61P35/00;;A61P37/02;;A61P43/00;;C07D239/42;;C07D401/12;;C07D401/12;;C07D239/32;;C07D401/14;;C07D401/14;;C07D403/14;;C07D403/14;;C07D405/14;;C07D405/14;;C07D409/14;;C07D409/14;;C07D413/14;;C07D413/14;;C07D417/14;;C07D417/14,A01N43/54;;C07D239/42;;C07D251/18;;C07D401/04,,0,0,,,,DISCONTINUED
915,EP,A1,EP 2696683 A1,019-394-062-272-904,2014-02-19,2014,EP 12771276 A,2012-04-12,US 201161474366 P;;US 2012/0033384 W,2011-04-12,COMPOSITIONS AND THERAPEUTIC USES OF IKK-RELATED KINASE EPSILON AND TANKBINDING KINASE 1 INHIBITORS,,ALZHEIMER S INST OF AMERICA INC,HOLCOMB RYAN C;;SEBAHAR PAUL R;;SUZUKI KAZUYUKI;;MCLEOD DONALD A;;DASTRUP DAVID M;;HOARAU CHRISTOPHE;;HALTER ROBERT J;;BURSAVICH MATTHEW GREGORY;;SHENDEROVICH MARK D;;RICHARDS BURT;;BARTEL PAUL L,,https://lens.org/019-394-062-272-904,Patent Application,yes,0,0,11,11,0,A61K31/506;;A61P3/00;;A61P3/04;;A61P3/10;;A61P11/00;;A61P17/00;;A61P17/06;;A61P19/02;;A61P21/00;;A61P29/00;;A61P35/00;;A61P37/02;;A61P43/00;;C07D239/42;;C07D401/12;;C07D401/12;;C07D239/32;;C07D401/14;;C07D401/14;;C07D403/14;;C07D403/14;;C07D405/14;;C07D405/14;;C07D409/14;;C07D409/14;;C07D413/14;;C07D413/14;;C07D417/14;;C07D417/14,A01N43/54;;A61K31/506;;A61P29/00;;C07D239/42;;C07D251/18;;C07D401/04,,0,0,,,,DISCONTINUED
916,NZ,A,NZ 334558 A,159-744-587-286-907,2000-03-27,2000,NZ 33455899 A,1999-03-09,GB 9807652 A,1998-04-14,aqueous disinfecting composition containing a quaternary ammonium compound and a binary surfactant system comprising a nonionic surfactant based on a polymeric alkylene oxide block copolymer and a surfactant based on an alkoxylated fatty amine and a further nonionic surfactant,"An aqueous disinfecting and cleaning composition in a concentrated form, which exhibits reduced irritancy, is claimed comprising: a) a disinfecting effective amount of a quaternary ammonium compound having germicidal properties; b) 0.01-10 %wt of a non-ionic surfactant compound based on a polymeric alkylene oxide copolymer; c) a migrating effective amount of at least one surfactant based on an alkoxylated fatty amine compound; d) 0.1-10 %wt of a further non-ionic surfactant; e) 0-3 %wt of a polymeric cationic surfactant based on a polyquaternary ammonium salt; f) optionally minor amounts of up to 5 %wt of one or more additives as defined in the specification and g) water to form up to 100 %wt of the aqueous disinfecting and cleaning composition.",RECKITT & COLMAN INC,LU R Z;;SMIALOWICZ D T;;RYPKEMA R E;;MCCUE K A;;KLOEPPEL A A;;BURT D J;;LOVE M D;;BOGART R W;;NANAVATI N V;;TARASCHI F A,,https://lens.org/159-744-587-286-907,Patent Application,no,0,0,8,8,0,C11D3/48;;C11D3/48;;C11D1/008;;C11D1/008;;C11D1/62;;C11D1/62;;C11D1/66;;C11D1/66;;C11D1/722;;C11D1/722;;C11D1/88;;C11D1/88;;C11D1/94;;C11D1/94;;C11D3/3773;;C11D3/3773,C11D1/00;;C11D1/62;;C11D1/66;;C11D1/722;;C11D1/88;;C11D1/94;;C11D3/37;;C11D3/48,,0,0,,,,PENDING
917,NZ,A,NZ 334559 A,076-944-196-210-531,2000-10-27,2000,NZ 33455999 A,1999-03-09,GB 9807649 A,1998-04-14,aqueous disinfecting concentrate containing a quaternary ammonium compound and a binary surfactant system,"The aqueous disinfecting and cleaning concentrate comprises: a) a disinfecting effective amount of quaternary ammonium compound having germicidal properties; b) 0.01-10%wt. of a polymeric alkylene oxide block copolymer nonionic surfactant; c) a mitigating effective amount of a compound selected from: A. ethoxylated cellulose; B. polyalkylene glycol having a molecular weight of at least 1000; C. alkylamidopropylbetaines and D. alkylpolyalkoxylates d) 0.1-10%wt. of a further nonionic surfactant; e) 0-3%wt. of a polyquaternary ammonium salt based polymeric cationic surfactant; f) 0-3%wt. of a builder; g) optionally up to 5%wt. of one or more additives selected from pH adjusting agents, pH buffers, non-aqueous solvents, perfumes, perfume carriers, optical brighteners, colouring agents, opacifying agents, hydrotropes, antifoaming agents, viscosity modifying agents, enzymes, anti-spotting agents, anti-oxidants and anti-corrosion agents and h) water up to 100%wt of the composition.",RECKITT & COLMAN INC,LU R Z;;SMIALOWICZ D T;;RYPKEMA R E;;MCCUE K A;;KLOEPPEL A A;;BURT D J;;LOVE M D;;BOGART R W;;NANAVATI N V;;TARASCHI F A,,https://lens.org/076-944-196-210-531,Patent Application,no,0,0,7,13,0,C11D3/48;;C11D3/48;;C11D1/62;;C11D1/62;;C11D1/72;;C11D1/72;;C11D1/722;;C11D1/722;;C11D1/835;;C11D1/835;;C11D1/90;;C11D1/90;;C11D1/94;;C11D1/94;;C11D3/225;;C11D3/225;;C11D3/3707;;C11D3/3707;;C11D3/3723;;C11D3/3723,C11D1/62;;C11D1/72;;C11D1/722;;C11D1/835;;C11D1/90;;C11D1/94;;C11D3/22;;C11D3/37;;C11D3/48,,0,0,,,,PENDING
918,KR,A,KR 20140048873 A,021-898-713-921-228,2014-04-24,2014,KR 20137029898 A,2012-04-12,US 201161474366 P;;US 2012/0033384 W,2011-04-12,COMPOSITIONS AND THERAPEUTIC USES OF IKK-RELATED KINASE EPSILON AND TANKBINDING KINASE 1 INHIBITORS,,ALZHEIMER S INST OF AMERICA INC,HOLCOMB RYAN C;;SEBAHAR PAUL R;;SUZUKI KAZUYUKI;;MCLEOD DONALD A;;DASTRUP DAVID M;;HOARAU CHRISTOPHE;;HALTER ROBERT J;;BURSAVICH MATTHEW GREGORY;;SHENDEROVICH MARK D;;RICHARDS BURT;;BARTEL PAUL L,,https://lens.org/021-898-713-921-228,Patent Application,no,0,1,11,11,0,A61K31/506;;A61P3/00;;A61P3/04;;A61P3/10;;A61P11/00;;A61P17/00;;A61P17/06;;A61P19/02;;A61P21/00;;A61P29/00;;A61P35/00;;A61P37/02;;A61P43/00;;C07D239/42;;C07D401/12;;C07D401/12;;C07D239/32;;C07D401/14;;C07D401/14;;C07D403/14;;C07D403/14;;C07D405/14;;C07D405/14;;C07D409/14;;C07D409/14;;C07D413/14;;C07D413/14;;C07D417/14;;C07D417/14,C07D239/42;;A61K31/506;;A61P29/00;;A61P35/00;;C07D239/32,,0,0,,,,DISCONTINUED
919,WO,A1,WO 2012/142329 A1,124-565-863-230-034,2012-10-18,2012,US 2012/0033384 W,2012-04-12,US 201161474366 P,2011-04-12,COMPOSITIONS AND THERAPEUTIC USES OF IKK-RELATED KINASE EPSILON AND TANKBINDING KINASE 1 INHIBITORS,"The invention relates to compounds, pharmaceutical compositions and medicaments comprising such compounds, and the use of these compounds, compositions, and medicaments in methods of treating diseases and disorders.",MYREXIS INC;;HOLCOMB RYAN C;;SEBAHAR PAUL R;;SUZUKI KAZUYUKI;;MCLEOD DONALD A;;DASTRUP DAVID M;;HOARAU CHRISTOPHE;;HALTER ROBERT J;;BURSAVICH MATTHEW GREGORY;;SHENDEROVICH MARK D;;RICHARDS BURT;;BARTEL PAUL L,HOLCOMB RYAN C;;SEBAHAR PAUL R;;SUZUKI KAZUYUKI;;MCLEOD DONALD A;;DASTRUP DAVID M;;HOARAU CHRISTOPHE;;HALTER ROBERT J;;BURSAVICH MATTHEW GREGORY;;SHENDEROVICH MARK D;;RICHARDS BURT;;BARTEL PAUL L,,https://lens.org/124-565-863-230-034,Patent Application,yes,3,46,11,11,0,A61K31/506;;A61P3/00;;A61P3/04;;A61P3/10;;A61P11/00;;A61P17/00;;A61P17/06;;A61P19/02;;A61P21/00;;A61P29/00;;A61P35/00;;A61P37/02;;A61P43/00;;C07D239/42;;C07D401/12;;C07D401/12;;C07D239/32;;C07D401/14;;C07D401/14;;C07D403/14;;C07D403/14;;C07D405/14;;C07D405/14;;C07D409/14;;C07D409/14;;C07D413/14;;C07D413/14;;C07D417/14;;C07D417/14,A01N43/54;;C07D239/42;;C07D251/18;;C07D401/04,,1,0,,,See also references of EP 2696683A4,PENDING
920,EP,A4,EP 2696683 A4,134-222-620-725-196,2014-08-13,2014,EP 12771276 A,2012-04-12,US 201161474366 P;;US 2012/0033384 W,2011-04-12,COMPOSITIONS AND THERAPEUTIC USES OF IKK-RELATED KINASE EPSILON AND TANKBINDING KINASE 1 INHIBITORS,,ALZHEIMER S INST OF AMERICA INC,HOLCOMB RYAN C;;SEBAHAR PAUL R;;SUZUKI KAZUYUKI;;MCLEOD DONALD A;;DASTRUP DAVID M;;HOARAU CHRISTOPHE;;HALTER ROBERT J;;BURSAVICH MATTHEW GREGORY;;SHENDEROVICH MARK D;;RICHARDS BURT;;BARTEL PAUL L,,https://lens.org/134-222-620-725-196,Search Report,no,3,0,11,11,0,A61K31/506;;A61P3/00;;A61P3/04;;A61P3/10;;A61P11/00;;A61P17/00;;A61P17/06;;A61P19/02;;A61P21/00;;A61P29/00;;A61P35/00;;A61P37/02;;A61P43/00;;C07D239/42;;C07D401/12;;C07D401/12;;C07D239/32;;C07D401/14;;C07D401/14;;C07D403/14;;C07D403/14;;C07D405/14;;C07D405/14;;C07D409/14;;C07D409/14;;C07D413/14;;C07D413/14;;C07D417/14;;C07D417/14,A01N43/54;;A61K31/506;;A61P29/00;;C07D239/42;;C07D251/18;;C07D401/04,,1,0,,,See also references of WO 2012142329A1,DISCONTINUED
921,CA,A1,CA 2476895 A1,167-008-500-043-422,2003-08-28,2003,CA 2476895 A,2003-02-19,US 35832102 P;;US 0305337 W,2002-02-19,SECURITY METHODS EMPLOYING DRIVERS LICENSES AND OTHER DOCUMENTS,"Driver's licenses and other security documents include one or more machine- readable features, each conveying plural bits of information. These features are used in a variety of ways to increase security, and/or to enhance functionality. In one embodiment, data encoded on a driver's license is used at airport check-in, to link to a state DMV database and obtain information by which the document, and its custodian, can be authenticated. In like fashion , a license can be used to authenticate a bearer and/or his/her age prior to t he sale of alcohol or tobacco products. In other embodiments, different element s of a driver's license (e.g., the substrate, photo, text data, and machine- readable data) are logically bound together (e.g., interlinked through payloads conveyed by different machine-readable features) as a deterrent against counterfeiting. Driver's licenses can be similarly logically bound t o personal checks and other documents. Many other arrangements are also disclosed.",DIGIMARC CORP,MUNDAY JOHN;;LEVY KENNETH L;;HEIN WILLIAM C III;;HAWES JONATHAN L;;DAVIS BRUCE L;;DECKER STEPHEN K;;PERRY BURT W;;CARR J SCOTT;;SEDER PHILLIP ANDREW;;MEYER JOEL R;;STEWART STEVEN W;;BRUNK HUGH L;;MCKINLEY TYLER J,,https://lens.org/167-008-500-043-422,Patent Application,no,0,0,9,31,0,G06Q10/02;;G06Q50/265;;G07C2209/41;;G07C9/22;;G07C9/20;;G07C9/27;;G06Q10/02;;G07C2209/41;;G06Q50/265;;G07C9/20;;G07C9/22,G06Q10/02;;G06Q50/26;;G07C9/00,,0,0,,,,DISCONTINUED
922,WO,A2,WO 2014/004863 A2,037-356-615-413-777,2014-01-03,2014,US 2013/0048243 W,2013-06-27,US 201261665270 P,2012-06-27,"COMPOUNDS, COMPOSITIONS, AND THERAPEUTIC USES THEREOF","The invention relates to compounds, pharmaceutical compositions and medicaments comprising such compounds, and the use of these compounds, compositions, and medicaments in methods of treating a variety of diseases and disorders.",ALZHEIMER S INST OF AMERICA INC,SEBAHAR PAUL R;;HALTER ROBERT J;;MCLEOD DONALD A;;PARKER DANIEL P;;YAGER KRAIG M;;SHENDEROVICH MARK D;;HOLCOMB RYAN C;;RICHARDS BURT;;BARTEL PAUL L;;KIM SE-HO;;SLATTUM PAUL M;;TANGALLAPALLY RAJENDRA;;TROVATO RICHARD;;YUNGAI ASHANTAI J,,https://lens.org/037-356-615-413-777,Patent Application,yes,0,63,2,2,0,C07D487/04;;C07D471/04,A61K31/5377;;C07D487/04,,0,0,,,,PENDING
923,US,A1,US 2009/0187435 A1,137-986-166-776-223,2009-07-23,2009,US 35290009 A,2009-01-13,US 35290009 A;;US 37042103 A;;US 35832102 P,2002-02-19,SECURITY METHODS EMPLOYING DRIVERS LICENSES AND OTHER DOCUMENTS,"Driver's licenses and other security documents include one or more machine-readable features, each conveying plural bits of information. These features are used in a variety of ways to increase security, and/or to enhance functionality. In one embodiment, data encoded on a driver's license is used at airport check-in, to link to a state DMV database and obtain information by which the document, and its custodian, can be authenticated. In like fashion, a license can be used to authenticate a bearer and/or his/her age prior to the sale of alcohol or tobacco products. In other embodiments, different elements of a driver's license (e.g., the substrate, photo, text data, and machine-readable data) are logically bound together (e.g., interlinked through payloads conveyed by different machine-readable features) as a deterrent against counterfeiting. Driver's licenses can be similarly logically bound to personal checks and other documents. Many other arrangements are also disclosed.",CARR J SCOTT;;DAVIS BRUCE L;;DECKER STEPHEN K;;HAWES JONATHAN L;;HEIN III WILLIAM C;;LEVY KENNETH L;;MUNDAY JOHN;;PERRY BURT W;;SEDER PHILIP ANDREW;;MEYER JOEL R;;MCKINLEY TYLER J;;BRUNK HUGH L;;STEWART STEVEN W,CARR J SCOTT;;DAVIS BRUCE L;;DECKER STEPHEN K;;HAWES JONATHAN L;;HEIN III WILLIAM C;;LEVY KENNETH L;;MUNDAY JOHN;;PERRY BURT W;;SEDER PHILIP ANDREW;;MEYER JOEL R;;MCKINLEY TYLER J;;BRUNK HUGH L;;STEWART STEVEN W,DIGIMARC CORPORATION (2003-10-04);;L-1 SECURE CREDENTIALING INC (2009-01-28),https://lens.org/137-986-166-776-223,Patent Application,yes,35,20,9,31,0,G06Q10/02;;G06Q50/265;;G07C2209/41;;G07C9/22;;G07C9/20;;G07C9/27;;G06Q10/02;;G07C2209/41;;G06Q50/265;;G07C9/20;;G07C9/22,G06F17/30;;G06K5/00;;G06Q10/02;;G06Q50/26;;G07C9/00,705/5;;235/382;;707/104.1;;X707E17044,0,0,,,,DISCONTINUED
924,WO,A3,WO 2014/004863 A3,035-227-170-390-395,2014-04-03,2014,US 2013/0048243 W,2013-06-27,US 201261665270 P,2012-06-27,"COMPOUNDS, COMPOSITIONS, AND THERAPEUTIC USES THEREOF","The invention relates to compounds, pharmaceutical compositions and medicaments comprising such compounds, and the use of these compounds, compositions, and medicaments in methods of treating a variety of diseases and disorders. The present invention provides compounds that inhibit IKK-related kinase epsilon, TANK-binding kinase 1 (TBKI), or both. These compounds may be used in the treatment of inflammation, RA, SLE, diseases associated with aberrant accumulation of cytosolic nucleic acids (including Sjogrens syndrome, Aicardi-Goutieres syndrome, subtypes of SLE, chilblain lupus, and RVCL), systemic sclerosis, myositis (including dermatomyositis and polymyositis), psoriasis, COPD, IBD, obesity, insulin resistance, NIDDM, metabolic syndrome and cancer, and complications associated with these diseases and disorders.",ALZHEIMER S INST OF AMERICA INC,SEBAHAR PAUL R;;HALTER ROBERT J;;MCLEOD DONALD A;;PARKER DANIEL P;;YAGER KRAIG M;;SHENDEROVICH MARK D;;HOLCOMB RYAN C;;RICHARDS BURT;;BARTEL PAUL L;;KIM SE-HO;;SLATTUM PAUL M;;TANGALLAPALLY RAJENDRA;;TROVATO RICHARD;;YUNGAI ASHANTAI J,,https://lens.org/035-227-170-390-395,Search Report,yes,4,0,2,2,0,C07D487/04;;C07D471/04,A61K31/437,,0,0,,,,PENDING
925,EP,A1,EP 4036613 A1,026-692-311-964-215,2022-08-03,2022,EP 22151833 A,2022-01-17,US 202117159918 A,2021-01-27,LIGHT CURTAIN ALIGNMENT USING BEAM INTENSITIES,"A component for light curtain alignment includes a light intensity receiver that receives a plurality of light intensity signals from beam receivers of a receiver unit of a light curtain. The light curtain includes a transmitter unit with beam transmitters arranged linearly on the transmitter unit. The light curtain includes the receiver unit with the plurality of beam receivers arranged linearly. Each beam receiver is configured to receive light from a corresponding beam transmitter. The component includes a light intensity transmitter configured to transmit, from the light curtain, the plurality of light intensity signals received by the light intensity receiver, where each light intensity signal is from one or more beam receivers, and a trip transmitter that transmits a trip signal in response to determining that a light intensity signal from a beam receiver of the plurality of beam receivers is below a trip threshold.
",ROCKWELL AUTOMATION TECH INC,NAIR SURESH R;;SACHERSKI BURT;;CAI YONGYAO;;LANE LEE A;;TAYLOR BRIAN J;;KILLIAN ASHLEY M;;ZOMCHEK KEVIN;;POUBLON MICHELLE;;GAO LINXI;;WOLFE TIMOTHY P;;JAEGER REBECCA R;;FOSTER WAYNE R,,https://lens.org/026-692-311-964-215,Patent Application,yes,4,0,2,2,0,G01V8/20;;G01V13/00;;H05B47/10;;F16P3/144;;G01V8/20;;G05B2219/1103,G01V8/20;;G01V13/00,,0,0,,,,PENDING
926,US,B1,US 11346498 B1,008-194-223-859-787,2022-05-31,2022,US 202117159918 A,2021-01-27,US 202117159918 A,2021-01-27,Light curtain alignment using beam intensities,"A component for light curtain alignment includes a light intensity receiver that receives a plurality of light intensity signals from beam receivers of a receiver unit of a light curtain. The light curtain includes a transmitter unit with beam transmitters arranged linearly on the transmitter unit. The light curtain includes the receiver unit with the plurality of beam receivers arranged linearly. Each beam receiver is configured to receive light from a corresponding beam transmitter. The component includes a light intensity transmitter configured to transmit, from the light curtain, the plurality of light intensity signals received by the light intensity receiver, where each light intensity signal is from one or more beam receivers, and a trip transmitter that transmits a trip signal in response to determining that a light intensity signal from a beam receiver of the plurality of beam receivers is below a trip threshold.",ROCKWELL AUTOMATION TECH INC,NAIR SURESH R;;SACHERSKI BURT;;CAI YONGYAO;;LANE LEE A;;TAYLOR BRIAN J;;KILLIAN ASHLEY M;;ZOMCHEK KEVIN;;POUBLON MICHELLE;;GAO LINXI;;WOLFE TIMOTHY P;;JAEGER REBECCA R;;FOSTER WAYNE R,ROCKWELL AUTOMATION TECHNOLOGIES INC (2021-01-20),https://lens.org/008-194-223-859-787,Granted Patent,yes,1,1,2,2,0,G01V8/20;;G01V13/00;;H05B47/10;;F16P3/144;;G01V8/20;;G05B2219/1103,F16P3/14;;G01V8/20;;H05B47/10,,2,0,,,"Manfred Stein, Most advanced Safety Light Curtain in the Market, Guardshield 450L, Jan. 2018, pp. 1-21, Rockwell Automation, Inc.;;Derek Charge, 450L Product Update, Jan. 14, 2020, pp. 1-39, Rockwell Automation, Inc.",ACTIVE
927,CA,C,CA 2190905 C,145-372-499-166-005,2005-05-03,2005,CA 2190905 A,1996-11-21,US 56454395 A,1995-11-30,VECTOR ELECTRICITY METERS AND ASSOCIATED VECTOR ELECTRICITY METERING METHODS,"Line voltage and line current signals are sensed on a power line having at least one conducting path. The sensed line voltages and line currents are converted in to a digital signal. A phase-to-neutral voltage signal and phase current signal are computed from the digital signal to thereby define a phase of the power line. An interval of orthogonality is determined from the sensed voltage and current signals, coinciding with passage of an integral number of cycles of a fundamental frequency reference signal which is computed from the computed phase-to-neutral voltage signal. A vector metering quantit y is computed for the determined interval of orthogonality from the computed phase-to- neutral voltage signal and the computed phase current signal. The vector metering quantities to be computed may be identified and computed based upon an associated detent. The vector metering quantity is also computed based on an identified circuit topology.",GEN ELECTRIC,HOFFMAN MARK E;;PROVOST ROLAND J;;MAEHL THOMAS;;LAVOIE GREGORY P;;PLIS MARK J;;ELMORE DAVID D;;GERMER WARREN R;;MAMMEN JEFFREY W;;BULLOCK DONALD F;;PUTCHA SIVARAMA SESHU;;STAVER DANIEL A;;BURT ARTHUR C;;CRITTENDEN CURTIS W;;EDGE ELLEN D,,https://lens.org/145-372-499-166-005,Granted Patent,no,0,0,16,16,0,G01R21/1331;;G01R21/1331,G01R21/133,,0,0,,,,EXPIRED
928,US,A,US 5673196 A,078-128-409-051-683,1997-09-30,1997,US 56454395 A,1995-11-30,US 56454395 A,1995-11-30,Vector electricity meters and associated vector electricity metering methods,"Line voltage and line current signals are sensed on a power line having at least one conducting path. The sensed line voltages and line currents are converted into a digital signal. A phase-to-neutral voltage signal and phase current signal are computed from the digital signal to thereby define a phase of the power line. An interval of orthogonality is determined from the sensed voltage and current signals, coinciding with passage of an integral number of cycles of a fundamental frequency reference signal which is computed from the computed phase-to-neutral voltage signal. A vector metering quantity is computed for the determined interval of orthogonality from the computed phase-to-neutral voltage signal and the computed phase current signal. The vector metering quantities to be computed may be identified and computed based upon an associated detent. The vector metering quantity is also computed based on an identified circuit topology.",GEN ELECTRIC,HOFFMAN MARK E;;PROVOST ROLAND J;;MAEHL THOMAS;;LAVOIE GREGORY P;;PLIS MARK J;;ELMORE DAVID D;;GERMER WARREN R;;MAMMEN JEFFREY W;;BULLOCK DONALD F;;PUTCHA SIVARAMA SESHU;;STAVER DANIEL A;;BURT ARTHUR C;;CRITTENDEN CURTIS W;;EDGE ELLEN D,MRH METERS LLC (F/K/A LJF METERS LLC) (2015-12-21);;ACLARA METERS LLC (2016-01-15);;GENERAL ELECTRIC COMPANY (1996-03-11),https://lens.org/078-128-409-051-683,Granted Patent,yes,8,51,16,16,0,G01R21/1331;;G01R21/1331,G01R21/133,364/483;;364/492;;324/141,7,0,,,"Curtis et al., Definitions of Power and Related Quantities , A.I.E.E. Summer Convention, Ithaca, New York, Jun. 24 28, 1935.;;Bullock et al., MinD Ur Ps & Qs: Four Powers, Computed from Voltages and Currents Under IEEE Std 100, Meet Rational Metering Requirements , EEI AEIC Meter and Service Committee Meeting, Fairmont Hotel Dallas, Texas, Mar. 27 30, 1994.;;Mack, Function Spaces and Fourier Series , Chapter 15, The General Electric A Course Engineering Analysis, pp. 366 373.;;Rosenau, Phasor, Apparent and Arithmetic Apparent AC Power, GE Meter Department Technote 03, Jun. 8, 1994.;;Bullock et al., Measurement of Polyphase Reactive Power , GE Meter Department, Aug. 1993.;;Bullock et al., An Analysis of a Sampling A. C. Watthour Meter, GE Meter Department, Technote 06, Apr. 1994.;;IEEE, IEEE Standard Dictionary of Electrical and Electronics Terms, Fourth Edition, 1988, pp. 21, 47, 281, 550 551, 690, 729, 730, 791.",EXPIRED
929,US,A1,US 2014/0304131 A1,076-908-945-611-650,2014-10-09,2014,US 201414217813 A,2014-03-18,US 201414217813 A;;US 201361789241 P,2013-03-15,SYSTEM FOR AND METHOD FOR DETERMINING OVERDRAFT PROTECTION,"A system and method in accordance with example embodiments may calculate a velocity of money associated with a particular account and a particular customer. Additionally, a system and method in accordance with example embodiments may calculate an overdraft risk score based on the velocity of money, where the overdraft risk score may be used to determine an overdraft protection limit for an account.",CAPITAL ONE FINANCIAL CORP,GANGOPADHYAY GORA;;STANMEYER THOMAS;;PEANI CAROLINE K;;ZHANG JING;;RYDZY MICHAEL F;;MU CHUN-HAO;;GOUKER CHRIS;;CHOPRA KARAN;;GRADNEY CHRISTOPHER M;;MILLER DENNIS E;;BANHOLZER THOMAS J;;SCHENKEIN SCOTT J;;WINKS PAMELA W;;BURT FRANN E;;MATTHEW GEORGE;;LI LIANG,CAPITAL ONE FINANCIAL CORPORATION (2014-03-10),https://lens.org/076-908-945-611-650,Patent Application,yes,10,7,1,1,0,G06Q40/02;;G06Q40/02,G06Q40/02,705/35,0,0,,,,DISCONTINUED
930,CA,A1,CA 2190905 A1,181-241-661-559-583,1997-05-31,1997,CA 2190905 A,1996-11-21,US 56454395 A,1995-11-30,VECTOR ELECTRICITY METERS AND ASSOCIATED VECTOR ELECTRICITY METERING METHODS,"Line voltage and line current signals are sensed on a power line having at least one conducting path. The sensed line voltages and line currents are converted into a digital signal. A phase-to-neutral voltage signal and phase current signal are computed from the digital signal to thereby define a phase of the power line. An interval of ortho gonality is determined from the sensed voltage and current signals, coinciding with passage of an integral number of cycles of a fundamental frequency reference signal which is c omputed from the computed phase-to-neutral voltage signal. A vector metering quantity is computed for the determined interval of orthogonality from the computed phase-to-neutral voltage signal and the computed phase current signal. The vector metering quantities to be computed may be identified and computed based upon an associated detent. The vector meter ing quantity is also computed based on an identified circuit topology.",GEN ELECTRIC,HOFFMAN MARK E;;PROVOST ROLAND J;;MAEHL THOMAS;;LAVOIE GREGORY P;;PLIS MARK J;;ELMORE DAVID D;;GERMER WARREN R;;MAMMEN JEFFREY W;;BULLOCK DONALD F;;PUTCHA SIVARAMA SESHU;;STAVER DANIEL A;;BURT ARTHUR C;;CRITTENDEN CURTIS W;;EDGE ELLEN D,,https://lens.org/181-241-661-559-583,Patent Application,no,0,0,16,16,0,G01R21/1331;;G01R21/1331,G01R21/133,,0,0,,,,EXPIRED
931,US,B2,US 11810412 B2,021-839-074-879-034,2023-11-07,2023,US 202217975292 A,2022-10-27,US 202217975292 A;;US 202117237920 A,2021-04-22,Radio frequency identifier apparatus for access control and user identification,"A method includes sending a first safety instruction to a machine in response to, within an entry window of time, receiving an open alert that a movable barrier is in an open state, where the movable barrier is at an entry point of an enclosure protecting personnel from the machine, receiving tag information of a person from a reader at the movable barrier, and confirming that the tag information belongs to a person authorized to enter the enclosure. The method includes sending a second safety instruction to the machine in response to, within the entry window of time, receiving the open alert, and without receiving tag information or confirming that the tag information belongs to a person authorized to enter the enclosure. The first and second safety instructions are different and the first safety instruction is less restrictive than the second safety instruction in terms of actions to prevent injury.",ROCKWELL AUTOMATION TECH INC,ZOMCHEK KEVIN;;CAI YONGYAO;;JAEGER REBECCA R;;NAIR SURESH R;;LANE LEE A;;TAYLOR BRIAN J;;SACHERSKI BURT;;KILLIAN ASHLEY M;;POUBLON MICHELLE L;;GAO LINXI;;WOLFE TIMOTHY P;;FOSTER WAYNE R,ROCKWELL AUTOMATION TECHNOLOGIES INC (2021-04-15),https://lens.org/021-839-074-879-034,Granted Patent,yes,30,0,4,4,0,G07C1/00;;G07C3/00;;G07C9/10;;G07C9/28;;G07C9/22;;G07C9/22;;G07C9/28;;G07C9/10;;G05B2219/50177;;G05B19/048;;G07C2009/00793;;G07C9/00309,G07C9/22;;G05B19/048;;G07C9/00;;G07C9/10;;G07C9/28,,3,0,,,"U.S. Appl. No. 17/237,920, Office Action Summary, dated Mar. 9, 2022, pp. 1-17.;;U.S. Appl. No. 17/237,920, Final Office Action Summary, dated Jun. 24, 2022, pp. 1-17.;;U.S. Appl. No. 17/237,920, Notice of Allowability, dated Aug. 26, 2022, pp. 1-7.",ACTIVE
932,US,A1,US 2023/0040166 A1,097-227-244-727-376,2023-02-09,2023,US 202217975292 A,2022-10-27,US 202217975292 A;;US 202117237920 A,2021-04-22,RADIO FREQUENCY IDENTIFIER APPARATUS FOR ACCESS CONTROL AND USER IDENTIFICATION,"A method includes sending a first safety instruction to a machine in response to, within an entry window of time, receiving an open alert that a movable barrier is in an open state, where the movable barrier is at an entry point of an enclosure protecting personnel from the machine, receiving tag information of a person from a reader at the movable barrier, and confirming that the tag information belongs to a person authorized to enter the enclosure. The method includes sending a second safety instruction to the machine in response to, within the entry window of time, receiving the open alert, and without receiving tag information or confirming that the tag information belongs to a person authorized to enter the enclosure. The first and second safety instructions are different and the first safety instruction is less restrictive than the second safety instruction in terms of actions to prevent injury.",ROCKWELL AUTOMATION TECH INC,ZOMCHEK KEVIN;;CAI YONGYAO;;JAEGER REBECCA R;;NAIR SURESH R;;LANE LEE A;;TAYLOR BRIAN J;;SACHERSKI BURT;;KILLIAN ASHLEY M;;POUBLON MICHELLE L;;GAO LINXI;;WOLFE TIMOTHY P;;FOSTER WAYNE R,ROCKWELL AUTOMATION TECHNOLOGIES INC (2021-04-15),https://lens.org/097-227-244-727-376,Patent Application,yes,10,2,4,4,0,G07C1/00;;G07C3/00;;G07C9/10;;G07C9/28;;G07C9/22;;G07C9/22;;G07C9/28;;G07C9/10;;G05B2219/50177;;G05B19/048;;G07C2009/00793;;G07C9/00309,G07C9/22;;G05B19/048;;G07C9/00;;G07C9/10;;G07C9/28,,0,0,,,,ACTIVE
933,US,A1,US 2022/0214680 A1,186-634-912-425-82X,2022-07-07,2022,US 202117142092 A,2021-01-05,US 202117142092 A,2021-01-05,PREDICTING END OF LIFE FOR INDUSTRIAL AUTOMATION COMPONENTS,A method for predicting end-of-life for a component includes determining a baseline lifetime model for a component connected to a machine functional safety system. The component is part of a system with physical devices. The method includes monitoring environmental conditions and usage conditions of the component and modifying the baseline lifetime model based on the monitored environmental and usage conditions to produce a modified lifetime model for the component. The method includes tracking a lifetime progress of the component with respect to the modified lifetime model and sending an alert in response to lifetime progress of the component reaching a lifetime threshold associated with the modified lifetime model.,ROCKWELL AUTOMATION TECH INC,NAIR SURESH R;;LANE LEE A;;TAYLOR BRIAN J;;CAI YONGYAO;;SACHERSKI BURT;;KILLIAN ASHLEY M;;ZOMCHEK KEVIN;;POUBLON MICHELLE L;;GAO LINXI;;WOLFE TIMOTHY P;;JAEGER ROBECCA R;;FOSTER WAYNE R,ROCKWELL AUTOMATION TECHNOLOGIES INC (2021-01-03),https://lens.org/186-634-912-425-82X,Patent Application,yes,1,2,3,3,0,G05B23/0283;;H01H2071/044;;H01H3/16;;H01H3/161;;H01H11/0062;;G06N20/00;;G05B23/0281;;G05B23/0283;;G05B23/0291,G05B23/02;;G06N20/00,,0,0,,,,ACTIVE
934,EP,A1,EP 4024151 A1,023-582-372-933-205,2022-07-06,2022,EP 21216386 A,2021-12-21,US 202117142092 A,2021-01-05,PREDICTING END OF LIFE FOR INDUSTRIAL AUTOMATION COMPONENTS,"A method for predicting end-of-life for a component includes determining a baseline lifetime model for a component connected to a machine functional safety system. The component is part of a system with physical devices. The method includes monitoring environmental conditions and usage conditions of the component and modifying the baseline lifetime model based on the monitored environmental and usage conditions to produce a modified lifetime model for the component. The method includes tracking a lifetime progress of the component with respect to the modified lifetime model and sending an alert in response to lifetime progress of the component reaching a lifetime threshold associated with the modified lifetime model.
",ROCKWELL AUTOMATION TECH INC,NAIR SURESH R;;LANE LEE A;;TAYLOR BRIAN J;;CAI YONGYAO;;SACHERSKI BURT;;KILLIAN ASHLEY M;;ZOMCHEK KEVIN;;POUBLON MICHELLE L;;GAO LINXI;;WOLFE TIMOTHY P;;JAEGER REBECCA R;;FOSTER WAYNE R,,https://lens.org/023-582-372-933-205,Patent Application,yes,4,0,3,3,0,G05B23/0283;;H01H2071/044;;H01H3/16;;H01H3/161;;H01H11/0062;;G06N20/00;;G05B23/0281;;G05B23/0283;;G05B23/0291,G05B23/02,,0,0,,,,PENDING
935,EP,A1,EP 4083733 A1,135-982-074-507-957,2022-11-02,2022,EP 22169796 A,2022-04-25,US 202117240803 A,2021-04-26,USING SENSOR DATA AND OPERATIONAL DATA OF AN INDUSTRIAL PROCESS TO IDENTIFY PROBLEMS,"A method for using sensor data and operational data of an industrial process to identify problems includes gathering sensor data from one or more sensors sensing conditions on equipment of an industrial process, receiving command information about operational commands issued to the equipment of the industrial process, and for each sensor of the one or more sensors, comparing the sensor data with signature information for the sensor. The signature information for the sensor is relevant for operational commands issued to the equipment. The method includes determining if the sensor data of a sensor of the one or more sensors exceeds the signature information corresponding to the sensor, locating a problem with a piece of equipment of the industrial process monitored by the sensor of the one or more sensors based on the sensor data exceeding the signature information for the sensor and issuing an alert reporting the problem.
",ROCKWELL AUTOMATION TECH INC,CAI YONGYAO;;NAIR SURESH R;;WOLFE TIMOTHY P;;LANE LEE A;;TAYLOR BRIAN J;;SACHERSKI BURT;;KILLIAN ASHLEY M;;ZOMCHEK KEVIN;;POUBLON MICHELLE L;;GAO LINXI;;JAEGER REBECCA R;;FOSTER WAYNE R,,https://lens.org/135-982-074-507-957,Patent Application,yes,2,0,2,2,0,G05B23/0283;;G01M13/045;;G01M13/028;;G05B23/0235;;G05B23/0248;;G01M7/00;;G05B23/0254;;G05B23/027,G05B23/02;;G01M13/028;;G01M13/045,,0,0,,,,PENDING
936,US,A1,US 2022/0343748 A1,125-587-708-954-36X,2022-10-27,2022,US 202117240806 A,2021-04-26,US 202117240806 A,2021-04-26,MONITORING MACHINE OPERATION WITH DIFFERENT SENSOR TYPES TO IDENTIFY TYPICAL OPERATION FOR DERIVATION OF A SIGNATURE,"A method for derivation of a machine signature includes receiving sensor information from a primary sensor, where the primary sensor is positioned to receive information from a portion of an industrial operation, and receiving sensor information from one or more secondary sensors. The secondary sensors are arranged to provide additional information about the industrial operation indicative of current operating conditions of the industrial operation. The method includes using the sensor information from the secondary sensors and machine learning to determine if the portion of the industrial operation is operating in a normal condition and, in response to determining that the portion of the industrial operation is operating normally, using sensor information from the primary sensor during the normal operating condition to derive a primary sensor signature for the sensor information from the primary sensor.",ROCKWELL AUTOMATION TECH INC,CAI YONGYAO;;NAIR SURESH R;;LANE LEE A;;TAYLOR BRIAN J;;SACHERSKI BURT;;KILLIAN ASHLEY M;;ZOMCHEK KEVIN;;POUBLON MICHELLE L;;GAO LINXI;;WOLFE TIMOTHY P;;JAEGER REBECCA R;;FOSTER WAYNE R,ROCKWELL AUTOMATION TECHNOLOGIES INC (2021-04-22),https://lens.org/125-587-708-954-36X,Patent Application,yes,34,0,3,3,0,G05B23/0235;;G05B23/0245;;G05B23/0221;;G05B23/021;;G06N20/00;;G05B15/02;;G08B21/182,G08B21/18;;G05B15/02;;G06N20/00,,0,0,,,,ACTIVE
937,US,A1,US 2022/0343709 A1,157-243-101-369-22X,2022-10-27,2022,US 202117237920 A,2021-04-22,US 202117237920 A,2021-04-22,RADIO FREQUENCY IDENTIFIER APPARATUS FOR ACCESS CONTROL AND USER IDENTIFICATION,"A component includes a housing mounted at an entry point of an enclosure protecting a machine. The component includes a first RFID sensor, in the housing, that reads a first RFID tag in close proximity to the first RFID sensor indicating a closed status of a movable barrier of the enclosure at the entry point. Opening of the movable barrier allows entry to the enclosure. The component includes a second RFID sensor, in the housing, that reads a second RFID tag of an authorized person. The component includes a barrier access module that sends an open alert that the movable barrier is in an open state in response to the first RFID sensor not being close enough to read the first RFID tag, and an identification module that sends tag information unique to a person from the second RFID tag.",ROCKWELL AUTOMATION TECH INC,ZOMCHEK KEVIN;;CAI YONGYAO;;JAEGER REBECCA R;;NAIR SURESH R;;LANE LEE A;;TAYLOR BRIAN J;;SACHERSKI BURT;;KILLIAN ASHLEY M;;POUBLON MICHELLE L;;GAO LINXI;;WOLFE TIMOTHY P;;FOSTER WAYNE R,ROCKWELL AUTOMATION TECHNOLOGIES INC (2021-04-15),https://lens.org/157-243-101-369-22X,Patent Application,yes,1,0,4,4,0,G07C1/00;;G07C3/00;;G07C9/10;;G07C9/28;;G07C9/22;;G07C9/22;;G07C9/28;;G07C9/10;;G05B2219/50177;;G05B19/048;;G07C2009/00793;;G07C9/00309,G07C9/22;;G05B19/048;;G07C9/00;;G07C9/10;;G07C9/28,,0,0,,,,ACTIVE
938,US,B2,US 11703849 B2,183-520-030-097-460,2023-07-18,2023,US 202117142092 A,2021-01-05,US 202117142092 A,2021-01-05,Predicting end of life for industrial automation components,A method for predicting end-of-life for a component includes determining a baseline lifetime model for a component connected to a machine functional safety system. The component is part of a system with physical devices. The method includes monitoring environmental conditions and usage conditions of the component and modifying the baseline lifetime model based on the monitored environmental and usage conditions to produce a modified lifetime model for the component. The method includes tracking a lifetime progress of the component with respect to the modified lifetime model and sending an alert in response to lifetime progress of the component reaching a lifetime threshold associated with the modified lifetime model.,ROCKWELL AUTOMATION TECH INC,NAIR SURESH R;;LANE LEE A;;TAYLOR BRIAN J;;CAI YONGYAO;;SACHERSKI BURT;;KILLIAN ASHLEY M;;ZOMCHEK KEVIN;;POUBLON MICHELLE L;;GAO LINXI;;WOLFE TIMOTHY P;;JAEGER REBECCA R;;FOSTER WAYNE R,ROCKWELL AUTOMATION TECHNOLOGIES INC (2021-01-03),https://lens.org/183-520-030-097-460,Granted Patent,yes,5,0,3,3,0,G05B23/0283;;H01H2071/044;;H01H3/16;;H01H3/161;;H01H11/0062;;G06N20/00;;G05B23/0281;;G05B23/0283;;G05B23/0291,G05B23/02;;G06N20/00,,1,0,,,"EPO, European Application No. 21216386.9, Extended European Search Report, dated May 31, 2022, pp. 1-8.",ACTIVE
939,US,B2,US 11527122 B2,176-880-521-747-427,2022-12-13,2022,US 202117237920 A,2021-04-22,US 202117237920 A,2021-04-22,Radio frequency identifier apparatus for access control and user identification,"A component includes a housing mounted at an entry point of an enclosure protecting a machine. The component includes a first RFID sensor, in the housing, that reads a first RFID tag in close proximity to the first RFID sensor indicating a closed status of a movable barrier of the enclosure at the entry point. Opening of the movable barrier allows entry to the enclosure. The component includes a second RFID sensor, in the housing, that reads a second RFID tag of an authorized person. The component includes a barrier access module that sends an open alert that the movable barrier is in an open state in response to the first RFID sensor not being close enough to read the first RFID tag, and an identification module that sends tag information unique to a person from the second RFID tag.",ROCKWELL AUTOMATION TECH INC,ZOMCHEK KEVIN;;CAI YONGYAO;;JAEGER REBECCA R;;NAIR SURESH R;;LANE LEE A;;TAYLOR BRIAN J;;SACHERSKI BURT;;KILLIAN ASHLEY M;;POUBLON MICHELLE L;;GAO LINXI;;WOLFE TIMOTHY P;;FOSTER WAYNE R,ROCKWELL AUTOMATION TECHNOLOGIES INC (2021-04-15),https://lens.org/176-880-521-747-427,Granted Patent,yes,20,2,4,4,0,G07C1/00;;G07C3/00;;G07C9/10;;G07C9/28;;G07C9/22;;G07C9/22;;G07C9/28;;G07C9/10;;G05B2219/50177;;G05B19/048;;G07C2009/00793;;G07C9/00309,G05B19/048;;G07C9/22;;G07C9/00;;G07C9/10;;G07C9/28,,0,0,,,,ACTIVE
940,US,A1,US 2022/0342408 A1,086-835-911-965-619,2022-10-27,2022,US 202117240803 A,2021-04-26,US 202117240803 A,2021-04-26,USING SENSOR DATA AND OPERATIONAL DATA OF AN INDUSTRIAL PROCESS TO IDENTIFY PROBLEMS,"A method for using sensor data and operational data of an industrial process to identify problems includes gathering sensor data from one or more sensors sensing conditions on equipment of an industrial process, receiving command information about operational commands issued to the equipment of the industrial process, and for each sensor of the one or more sensors, comparing the sensor data with signature information for the sensor. The signature information for the sensor is relevant for operational commands issued to the equipment. The method includes determining if the sensor data of a sensor of the one or more sensors exceeds the signature information corresponding to the sensor, locating a problem with a piece of equipment of the industrial process monitored by the sensor of the one or more sensors based on the sensor data exceeding the signature information for the sensor and issuing an alert reporting the problem.",ROCKWELL AUTOMATION TECH INC,CAI YONGYAO;;NAIR SURESH R;;WOLFE TIMOTHY P;;LANE LEE A;;TAYLOR BRIAN J;;SACHERSKI BURT;;KILLIAN ASHLEY M;;ZOMCHEK KEVIN;;POUBLON MICHELLE L;;GAO LINXI;;JAEGER REBECCA R;;FOSTER WAYNE R,ROCKWELL AUTOMATION TECHNOLOGIES INC (2021-04-14),https://lens.org/086-835-911-965-619,Patent Application,yes,13,0,2,2,0,G05B23/0283;;G01M13/045;;G01M13/028;;G05B23/0235;;G05B23/0248;;G01M7/00;;G05B23/0254;;G05B23/027,G05B23/02,,0,0,,,,PENDING
941,US,A1,US 2022/0214316 A1,179-358-493-362-294,2022-07-07,2022,US 202117142104 A,2021-01-05,US 202117142104 A,2021-01-05,MONITORING MACHINE OPERATION FOR VARIOUS SPEED AND LOADING CONDITIONS,"A method for monitoring machine operation for various machine speed and loads includes measuring vibration information at a sensor associated with a machine and an associated machine speed. The machine is a rotating machine. The method includes performing an operational frequency analysis of the vibration information and comparing results from the operational frequency analysis with a vibration signature for the machine. The vibration signature is for a machine speed that matches the machine speed of the measured vibration information. The vibration signature is one of several vibration signatures for the machine where each is for a different machine speed. The method includes identifying a potential failure mode based on a frequency range where the frequency analysis of the measured vibration information exceeds, by a threshold amount, the vibration signature of the plurality of vibration signatures that matches the machine speed, and transmitting an alert comprising the identified potential failure mode.",ROCKWELL AUTOMATION TECH INC,NAIR SURESH R;;LANE LEE A;;TAYLOR BRIAN J;;CAI YONGYAO;;SACHERSKI BURT;;KILLIAN ASHLEY M;;ZOMCHEK KEVIN;;POUBLON MICHELLE L;;GAO LINXI;;WOLFE TIMOTHY P;;JAEGER REBECCA R;;FOSTER WAYNE R,ROCKWELL AUTOMATION TECHNOLOGIES INC (2020-12-29),https://lens.org/179-358-493-362-294,Patent Application,yes,3,1,2,2,0,G01H1/003;;G01H3/08;;G01M13/045;;G01M13/028;;G01M13/00;;G01N29/14;;G01N29/4454;;G01N29/46;;G05B19/058;;G05B2219/14006,G01N29/44;;G01M13/00;;G01N29/14;;G01N29/46;;G05B19/05,,0,0,,,,PENDING
942,EP,A1,EP 4024148 A1,197-010-752-704-451,2022-07-06,2022,EP 21215095 A,2021-12-16,US 202117141109 A,2021-01-04,DYNAMIC RISK ASSESSMENT VIOLATION MONITORING DURING A FUNCTIONAL SAFETY PROCESS,"A method for risk assessment violation monitoring during a functional safety process includes receiving parameters from a risk assessment of a portion of a system with physical devices. The parameters of the risk assessment are applicable to a safety device of a machine safety system. The safety device is configured to prevent a hazardous condition in the system. The method includes detecting a change of a condition of the safety device. The condition is indicative of a potential safety issue affecting operation of the machine safety system. The method includes comparing parameters related to the change of the condition of the safety device with the parameters from the risk assessment and sending an alert in response to determining that the change of the condition of the safety device results in a violation of the risk assessment.
",ROCKWELL AUTOMATION TECH INC,NAIR SURESH R;;LANE LEE A;;TAYLOR BRIAN J;;CAI YONGYAO;;SACHERSKI BURT;;KILLIAN ASHLEY M;;ZOMCHEK KEVIN;;POUBLON MICHELLE L;;GAO LINXI;;WOLFE TIMOTHY P;;JAEGER REBECCA R;;FOSTER WAYNE R,,https://lens.org/197-010-752-704-451,Patent Application,yes,3,0,2,2,0,G05B9/02;;G05B19/0428;;G05B23/024;;G05B23/0254;;G05B23/0267;;G05B23/0283,G05B19/042;;G05B9/02,,0,0,,,,PENDING
943,US,B2,US 11636752 B2,153-041-141-360-245,2023-04-25,2023,US 202117240806 A,2021-04-26,US 202117240806 A,2021-04-26,Monitoring machine operation with different sensor types to identify typical operation for derivation of a signature,"A method for derivation of a machine signature includes receiving sensor information from a primary sensor, where the primary sensor is positioned to receive information from a portion of an industrial operation, and receiving sensor information from one or more secondary sensors. The secondary sensors are arranged to provide additional information about the industrial operation indicative of current operating conditions of the industrial operation. The method includes using the sensor information from the secondary sensors and machine learning to determine if the portion of the industrial operation is operating in a normal condition and, in response to determining that the portion of the industrial operation is operating normally, using sensor information from the primary sensor during the normal operating condition to derive a primary sensor signature for the sensor information from the primary sensor.",ROCKWELL AUTOMATION TECH INC,CAI YONGYAO;;NAIR SURESH R;;LANE LEE A;;TAYLOR BRIAN J;;SACHERSKI BURT;;KILLIAN ASHLEY M;;ZOMCHEK KEVIN;;POUBLON MICHELLE L;;GAO LINXI;;WOLFE TIMOTHY P;;JAEGER REBECCA R;;FOSTER WAYNE R,ROCKWELL AUTOMATION TECHNOLOGIES INC (2021-04-22),https://lens.org/153-041-141-360-245,Granted Patent,yes,34,0,3,3,0,G05B23/0235;;G05B23/0245;;G05B23/0221;;G05B23/021;;G06N20/00;;G05B15/02;;G08B21/182,G08B21/18;;G05B15/02;;G06N20/00,,1,0,,,"EPO, European Application No. 22169999.4, Extended European Search Report, dated Sep. 9, 2022, pp. 1-8.",ACTIVE
944,US,A1,US 2022/0214675 A1,082-965-494-176-60X,2022-07-07,2022,US 202117141109 A,2021-01-04,US 202117141109 A,2021-01-04,DYNAMIC RISK ASSESSMENT VIOLATION MONITORING DURING A FUNCTIONAL SAFETY PROCESS,A method for risk assessment violation monitoring during a functional safety process includes receiving parameters from a risk assessment of a portion of a system with physical devices. The parameters of the risk assessment are applicable to a safety device of a machine safety system. The safety device is configured to prevent a hazardous condition in the system. The method includes detecting a change of a condition of the safety device. The condition is indicative of a potential safety issue affecting operation of the machine safety system. The method includes comparing parameters related to the change of the condition of the safety device with the parameters from the risk assessment and sending an alert in response to determining that the change of the condition of the safety device results in a violation of the risk assessment.,ROCKWELL AUTOMATION TECH INC,NAIR SURESH R;;LANE LEE A;;TAYLOR BRIAN J;;CAI YONGYAO;;SACHERSKI BURT;;KILLIAN ASHLEY M;;ZOMCHEK KEVIN;;POUBLON MICHELLE L;;GAO LINXI;;WOLFE TIMOTHY P;;JAEGER REBECCA R;;FOSTER WAYNE R,ROCKWELL AUTOMATION TECHNOLOGIES INC (2020-12-23),https://lens.org/082-965-494-176-60X,Patent Application,yes,0,1,2,2,0,G05B9/02;;G05B19/0428;;G05B23/024;;G05B23/0254;;G05B23/0267;;G05B23/0283,G05B23/02,,0,0,,,,DISCONTINUED
945,EP,A1,EP 4024014 A1,129-765-084-755-112,2022-07-06,2022,EP 21215520 A,2021-12-17,US 202117142104 A,2021-01-05,MONITORING MACHINE OPERATION FOR VARIOUS SPEED AND LOADING CONDITIONS,"A method for monitoring machine operation for various machine speed and loads includes measuring vibration information at a sensor associated with a machine and an associated machine speed. The machine is a rotating machine. The method includes performing an operational frequency analysis of the vibration information and comparing results from the operational frequency analysis with a vibration signature for the machine. The vibration signature is for a machine speed that matches the machine speed of the measured vibration information. The vibration signature is one of several vibration signatures for the machine where each is for a different machine speed. The method includes identifying a potential failure mode based on a frequency range where the frequency analysis of the measured vibration information exceeds, by a threshold amount, the vibration signature of the plurality of vibration signatures that matches the machine speed, and transmitting an alert comprising the identified potential failure mode.
",ROCKWELL AUTOMATION TECH INC,NAIR SURESH R;;LANE LEE A;;TAYLOR BRIAN J;;CAI YONGYAO;;SACHERSKI BURT;;KILLIAN ASHLEY M;;ZOMCHEK KEVIN;;POUBLON MICHELLE L;;GAO LINXI;;WOLFE TIMOTHY P;;JAEGER REBECCA R;;FOSTER WAYNE R,,https://lens.org/129-765-084-755-112,Patent Application,yes,3,0,2,2,0,G01H1/003;;G01H3/08;;G01M13/045;;G01M13/028;;G01M13/00;;G01N29/14;;G01N29/4454;;G01N29/46;;G05B19/058;;G05B2219/14006,G01H1/00;;G01H3/08;;G01M13/028;;G01M13/045,,0,0,,,,PENDING
946,EP,A1,EP 4083734 A1,088-141-692-635-199,2022-11-02,2022,EP 22169999 A,2022-04-26,US 202117240806 A,2021-04-26,MONITORING MACHINE OPERATION WITH DIFFERENT SENSOR TYPES TO IDENTIFY TYPICAL OPERATION FOR DERIVATION OF A SIGNATURE,"A method for derivation of a machine signature includes receiving sensor information from a primary sensor, where the primary sensor is positioned to receive information from a portion of an industrial operation, and receiving sensor information from one or more secondary sensors. The secondary sensors are arranged to provide additional information about the industrial operation indicative of current operating conditions of the industrial operation. The method includes using the sensor information from the secondary sensors and machine learning to determine if the portion of the industrial operation is operating in a normal condition and, in response to determining that the portion of the industrial operation is operating normally, using sensor information from the primary sensor during the normal operating condition to derive a primary sensor signature for the sensor information from the primary sensor.
 
",ROCKWELL AUTOMATION TECH INC,CAI YONGYAO;;NAIR SURESH R;;LANE LEE A;;TAYLOR BRIAN J;;SACHERSKI BURT;;KILLIAN ASHLEY M;;ZOMCHEK KEVIN;;POUBLON MICHELLE L;;GAO LINXI;;WOLFE TIMOTHY P;;JAEGER REBECCA R;;FOSTER WAYNE R,,https://lens.org/088-141-692-635-199,Patent Application,yes,2,0,3,3,0,G05B23/0235;;G05B23/0245;;G05B23/0221;;G05B23/021;;G06N20/00;;G05B15/02;;G08B21/182,G05B23/02,,0,0,,,,PENDING
947,US,S,US D0608811 S,063-744-584-882-745,2010-01-26,2010,US 32701308 F,2008-10-29,US 32701308 F,2008-10-29,Camera,,FLIR SYSTEMS,FRANK JEFFREY D;;PAS GUY;;RICHARDSON PATRICK B;;ROTA JR LOUIS J;;DINNING DAVID F;;KENT MICHAEL;;BURT WARN;;TREMBLAY MARCEL;;HINDS TREASURE;;XUE MENG;;SCHEIBLHUBER ANKE;;LI JONATHAN;;WILLIAMS DAVID;;LI YAOHUA,FLIR SYSTEMS INC (2008-10-29),https://lens.org/063-744-584-882-745,Design Right,no,0,11,1,1,0,,,1601;;D16/203,0,0,,,,EXPIRED
948,US,A1,US 2007/0172907 A1,056-776-758-212-18X,2007-07-26,2007,US 86843704 A,2004-06-15,US 86843704 A;;EP 01945050 A;;EP 0104696 W;;US 25868903 A;;EP 00109063 A,2000-04-28,Liver disease-related methods and systems,"The invention provides diagnostic methods, kits, and systems, and related computer-readable media, which use multiple blood marker values, including serum and plasma marker values, to aid in the diagnosis of the status or progress of a liver disease in a patient. The invention also provides methods and systems, and related computer-readable media, that use blood marker values, including serum and plasma marker values: (1) to screen for active ingredients useful in the treatment of a liver disease; (2) to aid in the selection of treatment regimens for patients that are predisposed to, or suffer from, liver disease; and (3) to aid in the design of clinical programs useful in monitoring the status or progress of liver disease in one or more patients.",VOLKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF;;THIEL ROBERT P;;PETRY CHRISTOPH;;ROSENBERG WILLIAM,VOLKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF;;THIEL ROBERT P;;PETRY CHRISTOPH;;ROSENBERG WILLIAM,SIEMENS HEALTHCARE DIAGNOSTICS INC (2007-08-17);;BAYER HEALTHCARE LLC (2005-09-07),https://lens.org/056-776-758-212-18X,Patent Application,yes,5,26,11,11,3,C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20;;G16H50/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16B40/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20,C12Q1/48;;G16B40/20,435/15;;702/19,0,0,,,,EXPIRED
949,EP,A2,EP 1781097 A2,019-000-169-551-626,2007-05-09,2007,EP 05761288 A,2005-06-15,US 2005/0021002 W;;US 86843704 A,2004-06-15,LIVER DISEASE-RELATED METHODS AND SYSTEMS,,BAYER HEALTHCARE LLC,VOLKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF;;THIEL ROBERT P;;PETRY CHRISTOPH;;ROSENBERG WILLIAM,SIEMENS HEALTHCARE DIAGNOSTICS INC. (2008-07-09),https://lens.org/019-000-169-551-626,Patent Application,yes,0,0,11,11,0,C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20;;G16H50/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16B40/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20,A01N1/02;;A61K31/765;;C12M1/00;;G01N31/00;;G01N33/53;;G01N35/00;;G16B40/20,,0,0,,,,DISCONTINUED
950,AU,A1,AU 2005/264964 A1,027-933-887-103-558,2006-01-26,2006,AU 2005/264964 A,2005-06-15,US 86843704 A;;US 2005/0021002 W,2004-06-15,Liver disease-related methods and systems,,BAYER HEALTHCARE LLC,BURT ALASTAIR D;;GEHRMANN MATHIAS;;PETRY CHRISTOPH;;KROLL WERNER;;HENNIG GUIDO;;BECKA MICHAEL;;KNORR ANDREAS;;THIEL ROBERT P;;BURCHARDT ELMAR-REINHOLD;;VOLKER MICHAEL;;ARTHUR MICHAEL J;;SCHUPPAN DETLEF;;ROSENBERG WILLIAM;;UNGER SYLVIA;;PINZANI MASSIMO,,https://lens.org/027-933-887-103-558,Patent Application,no,0,0,11,11,0,C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20;;G16H50/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16B40/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20,C12Q1/68;;G16B40/20,,0,0,,,,DISCONTINUED
951,US,B2,US 7668661 B2,131-849-006-761-20X,2010-02-23,2010,US 86843704 A,2004-06-15,US 86843704 A;;EP 01945050 A;;EP 0104696 W;;US 25868903 A;;EP 00109063 A,2000-04-28,Liver disease-related methods and systems,"The invention provides diagnostic methods, kits, and systems, and related computer-readable media, which use multiple blood marker values, including serum and plasma marker values, to aid in the diagnosis of the status or progress of a liver disease in a patient. The invention also provides methods and systems, and related computer-readable media, that use blood marker values, including serum and plasma marker values: (1) to screen for active ingredients useful in the treatment of a liver disease; (2) to aid in the selection of treatment regimens for patients that are predisposed to, or suffer from, liver disease; and (3) to aid in the design of clinical programs useful in monitoring the status or progress of liver disease in one or more patients.",SIEMENS HEALTHCARE DIAGNOSTICS,VOLKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF;;THIEL ROBERT P;;PETRY CHRISTOPH;;ROSENBERG WILLIAM,SIEMENS HEALTHCARE DIAGNOSTICS INC (2007-08-17);;BAYER HEALTHCARE LLC (2005-09-07),https://lens.org/131-849-006-761-20X,Granted Patent,yes,9,3,11,11,3,C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20;;G16H50/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16B40/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20,G06F7/00;;G16B40/20,702/19;;702/20;;707/102;;703/11;;435/7.1,24,17,002-531-710-699-983;;003-775-669-742-341;;011-655-756-592-162;;081-985-988-654-60X;;049-120-950-157-226;;118-336-306-125-008;;008-222-116-182-868;;008-120-707-114-851;;108-671-083-576-084;;040-959-043-882-615;;034-755-153-034-877;;084-187-406-751-374;;029-598-669-042-109;;062-365-641-881-671;;083-992-979-382-575;;070-265-761-998-411;;002-531-710-699-983,10.1016/s0168-8278(98)80318-8;;9551682;;10.1177/172460080101600106;;11288954;;11282449;;10.1016/s0741-8329(00)00134-8;;9093523;;10.1016/s0008-6363(96)00247-7;;11099555;;10.1179/ortho.27.3.227;;10.1016/s1098-3597(01)90074-2;;11501190;;11225145;;10.1159/000055334;;11721174;;10.1093/clinchem/47.9.1696;;11514405;;7525168;;10.1007/bf02087661;;8697587;;10.1093/clinchem/42.8.1263;;10572522;;10.1055/s-2007-1024516;;9594340;;10.1016/0140-6736(93)91946-j;;8105167;;10.1093/clinchem/42.4.558;;8605673;;10.1373/49.3.450;;12600957;;10.1016/s0168-8278(98)80318-8;;9551682,"Pilette et al. Histopathological evaluation of Liver Fibrosis: quantitive image analysis vs simi-quantitative scores 1998. vol. 28, pp. 439-446.;;International Search Report PCT/US05/21002-Filed: Jun. 15, 2005.;;Alexandrakis et al., ""Use of a Variety of Biological Parameters in Distinguishing Cirrhotic From Malignant Ascites,"" Int. J. Biol. Markers, 16:45-49, 2001.;;H. Franklin Bunn & Wendell Rosse, ""Hemolytic Anemias and Acute Blood Loss,"" in Harrison's Principles of Internal Medicine, 681, 681 (Eugene Braunwald, Stephen L. Hauser, Anthony S. Fauchi, Dan L. Longo, Dennis L. Kasper & J. Larry Jameson eds., McGraw-Hill 15th ed. 2001.;;Daniluk et al., ""Serum Cytokine Levels in Alcohol-Related Liver Cirrhosis,"" Alcohol, 23:29-34, 2001.;;Henry N. Ginsberg & Ira J. Goldberg, Disorders of Lipoprotein Metabolism, in Harrison's Principles of Internal Medicine, 2245, 2246-2247 (Eugene Braunwald, Stephen L. Hauser, Anthony S. Fauchi, Dan L. Longo, Dennis L. Kasper & J. Larry Jameson eds., McGraw-Hill 15th ed 2001.;;Jensen et al., ""Collagen: Scaffold for Repair or Execution,"" Cardiovasc. Res. 33:535-539, 1997.;;Kerrigan et al., ""Matrix Turnover,"" J. Orthod., 27:227-233, 2000.;;Daniel S. Pratt & Marshall M. Kaplan, Evaluation of Liver Function, in Harrison's Principles of Internal Medicine, 1714, 1711-1714 (Eugene Braunwald, Stephen L. Hauser, Anthony S. Fauchi, Dan L. Longo, Dennis L. Kasper & J. Larry Jameson eds., McGraw-Hill 15th ed. 2001).;;Peter J. Quesenberry & Gerald A Colvin, Hematopoiesis, in Harrison's Principles of Internal Medicine, 653, 655-657 (Eugene Braunwald, Stephen L. Hauser, Anthony S. Fauchi, Dan L. Longo, Dennis L. Kasper & J. Larry Jameson eds., McGraw-Hill 15th ed 2001.;;S. Ramakrishnan et al., Textbook of Medical Biochemistry, 155-158 (Orient BlackSwan 3rd ed. 2004).;;Rochling, ""Evaluation of Abnormal Liver Tests,"" Clin. Cornerstone, 3(6):1-12, 2001.;;Shah et al., ""Apolipoprotein Deficiency and Chronic Liver Disease,"" J. Assoc. Physicians India, 49:274-278, 2001.;;Poon T C-W et al: ""Application of Classification Tree and Neural Network Algorithms to the Identification of Serological Liver Marker Profiles for the Diagnosis of Hepatocellular Carcinoma"" Oncology, S. Karger, Basel, CH, vol. 61, No. 4, 1 Nov. 001, pp. 275- 283, XP009044316 ISSN: 0030-2414 2001.;;Fortunato G et al: ""Multivariate Discriminant Function Based on Six Biochemical Markers in Blood Can Predict the Cirrhotic Evolution of Chronic Hepatitis"" Clinical Chemistry, American Association for Clinical Chemistry, Washington, DC, vol. 47, No. 9, 1. Sep. 2001, pp. 1696- 1700, XP002996105 ISSN: 0009-9147 ""abstract"" 2001.;;Duda R et al: ""Pattern Classification - Chapter 1"" 2001, John Wiley & Sons, New York, US, XP002536377, pp. 14-17 2001.;;Sylvie Naveau et al: ""Alpha -2- Macroglobulin and Hepatic Fibrosis - Diagnostic Interest"", Digestive Diseases and Sciences, vol. 39, No. 11, Nov. 1994.;;Giuseppe Castaldo: ""Differential diagnosis between heptocellular carcinoma and cirrhosis through a discriminant function based on results for serum analytes"", Clinical Chemistry, vol. 42, No. 8, 1996.;;D. Schuppan et al: ""Serummarker der Leberfibrose"", Deutsche medizinische Wochenzeitschrift, Nr. 124, 1999.;;Ji Xuhuai et al: ""Clinical significance of serum 7S collagen and type VI collagen levels for the diagnosis of hepatic fibrosis"", Chinese Medical Journal 1997, 110(3), 1997.;;J P Teare et al: ""Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis"", The Lancet, vol. 342, 1993.;;J. Guechot et al: ""Diagnostic accuracy of hyaluronan and type III procollagen amino- terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis"", Clinical Chemistry, vol. 42, No. 4, 1996.;;Enrico Rossi et al: ""Validation of the Fibro TEst Biochemical Markers Score in Assessing Liver Fibrosis in Hepatitis C Patients"" Clinical Chemistry vol. 49, No. 3, 2003.;;Christophe Pilette et al: ""Histopathological evaluation of liver fibrosis: quantitative image analysis vs smiquantitative scores - Comparison with serum markers"", Journal of Hepatology, 1998, vol. 28.",EXPIRED
952,KR,A,KR 20070026601 A,000-766-432-128-630,2007-03-08,2007,KR 20067026571 A,2006-12-15,US 86843704 A,2004-06-15,LIVER DISEASE-RELATED METHODS AND SYSTEMS,"The invention provides diagnostic methods, kits, and systems, and related computer-readable media, which use multiple blood marker values, including serum and plasma marker values, to aid in the diagnosis of the status or progress of a liver disease in a patient. The invention also provides methods and systems, and related computer-readable media, that use blood marker values, including serum and plasma marker values: (1) to screen for active ingredients useful in the treatment of a liver disease; (2) to aid in the selection of treatment regimens for patients that are predisposed to, or suffer from, liver disease; and (3) to aid in the design of clinical programs useful in monitoring the status or progress of liver disease in one or more patients. ® KIPO & WIPO 2007",BAYER HEALTHCARE LLC,VOLKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF;;THIEL ROBERT P;;PETRY CHRISTOPH;;ROSENBERG WILLIAM,,https://lens.org/000-766-432-128-630,Patent Application,no,0,2,11,11,6,C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20;;G16H50/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16B40/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20,G01N33/49;;G01N33/48;;G01N33/53;;G16B40/20,,0,0,,,,DISCONTINUED
953,EP,A4,EP 1781097 A4,038-515-901-375-136,2009-08-26,2009,EP 05761288 A,2005-06-15,US 2005/0021002 W;;US 86843704 A,2004-06-15,LIVER DISEASE-RELATED METHODS AND SYSTEMS,,SIEMENS HEALTHCARE DIAGNOSTICS,VOLKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF;;THIEL ROBERT P;;PETRY CHRISTOPH;;ROSENBERG WILLIAM,SIEMENS HEALTHCARE DIAGNOSTICS INC. (2008-07-09),https://lens.org/038-515-901-375-136,Search Report,no,0,1,11,11,0,C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20;;G16H50/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16B40/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20,A01N1/02;;A61K31/765;;C12M1/00;;G01N31/00;;G01N33/53;;G01N35/00;;G16B40/20,,3,2,008-120-707-114-851;;108-671-083-576-084,10.1159/000055334;;11721174;;10.1093/clinchem/47.9.1696;;11514405,"POON T C-W ET AL: ""APPLICATION OF CLASSIFICATION TREE AND NEURAL NETWORK ALGORITHMS TO THE IDENTIFICATION OF SEROLOGICAL LIVER MARKER PROFILES FOR THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA"", ONCOLOGY, S. KARGER, BASEL, CH, vol. 61, no. 4, 1 November 2001 (2001-11-01), pages 275 - 283, XP009044316, ISSN: 0030-2414;;FORTUNATO G ET AL: ""Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis"", CLINICAL CHEMISTRY, AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY, WASHINGTON, DC, vol. 47, no. 9, 1 September 2001 (2001-09-01), pages 1696 - 1700, XP002996105, ISSN: 0009-9147;;DUDA R O ET AL: ""Pattern Classification - Chapter 1"", 2001, JOHN WILEY & SONS, NEW YORK, US, pages: 14 - 17, XP002536377",DISCONTINUED
954,WO,A3,WO 2006/009702 A3,041-679-718-679-595,2006-12-28,2006,US 2005/0021002 W,2005-06-15,US 86843704 A,2004-06-15,LIVER DISEASE-RELATED METHODS AND SYSTEMS,"The invention provides diagnostic methods, kits, and systems, and related computer-readable media, which use multiple blood marker values, including serum and plasma marker values, to aid in the diagnosis of the status or progress of a liver disease in a patient. The invention also provides methods and systems, and related computer-readable media, that use blood marker values, including serum and plasma marker values: (1) to screen for active ingredients useful in the treatment of a liver disease; (2) to aid in the selection of treatment regimens for patients that are predisposed to, or suffer from, liver disease; and (3) to aid in the design of clinical programs useful in monitoring the status or progress of liver disease in one or more patients.",BAYER HEALTHCARE LLC;;VOLKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF;;THIEL ROBERT P;;PETRY CHRISTOPH;;ROSENBERG WILLIAM,VOLKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF;;THIEL ROBERT P;;PETRY CHRISTOPH;;ROSENBERG WILLIAM,,https://lens.org/041-679-718-679-595,Search Report,yes,3,0,11,11,0,C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20;;G16H50/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16B40/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20,A01N1/02;;A61K31/765;;C12M1/00;;G01N31/00;;G01N33/53;;G01N35/00;;G16B40/20,,1,1,002-531-710-699-983,10.1016/s0168-8278(98)80318-8;;9551682,"PILETTE ET AL.: ""Histopathological evaluation of Liver Fibrosis: quantitative image analysis vs semi-quantitative scores"", JRNL OF HEPATOLOGY, vol. 28, 1998, pages 439 - 446, XP002388410",PENDING
955,CA,A1,CA 2566914 A1,105-224-176-997-765,2006-01-26,2006,CA 2566914 A,2005-06-15,US 86843704 A;;US 2005/0021002 W,2004-06-15,LIVER DISEASE-RELATED METHODS AND SYSTEMS,,BAYER HEALTHCARE LLC,BURT ALASTAIR D;;ROSENBERG WILLIAM;;ARTHUR MICHAEL J;;PETRY CHRISTOPH;;BECKA MICHAEL;;UNGER SYLVIA;;GEHRMANN MATHIAS;;VOLKER MICHAEL;;BURCHARDT ELMAR-REINHOLD;;HENNIG GUIDO;;KNORR ANDREAS;;SCHUPPAN DETLEF;;THIEL ROBERT P;;PINZANI MASSIMO;;KROLL WERNER,,https://lens.org/105-224-176-997-765,Patent Application,no,0,0,11,11,3,C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20;;G16H50/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16B40/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20,C12Q1/68;;G16B40/20,,0,0,,,,DISCONTINUED
956,WO,A2,WO 2006/009702 A2,162-792-746-235-045,2006-01-26,2006,US 2005/0021002 W,2005-06-15,US 86843704 A,2004-06-15,LIVER DISEASE-RELATED METHODS AND SYSTEMS,"The invention provides diagnostic methods, kits, and systems, and related computer-readable media, which use multiple blood marker values, including serum and plasma marker values, to aid in the diagnosis of the status or progress of a liver disease in a patient. The invention also provides methods and systems, and related computer-readable media, that use blood marker values, including serum and plasma marker values: (1) to screen for active ingredients useful in the treatment of a liver disease; (2) to aid in the selection of treatment regimens for patients that are predisposed to, or suffer from, liver disease; and (3) to aid in the design of clinical programs useful in monitoring the status or progress of liver disease in one or more patients.",BAYER HEALTHCARE LLC;;VOLKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF;;THIEL ROBERT P;;PETRY CHRISTOPH;;ROSENBERG WILLIAM,VOLKER MICHAEL;;BECKA MICHAEL;;KROLL WERNER;;KNORR ANDREAS;;UNGER SYLVIA;;GEHRMANN MATHIAS;;HENNIG GUIDO;;BURCHARDT ELMAR-REINHOLD;;ARTHUR MICHAEL J;;BURT ALASTAIR D;;PINZANI MASSIMO;;SCHUPPAN DETLEF;;THIEL ROBERT P;;PETRY CHRISTOPH;;ROSENBERG WILLIAM,,https://lens.org/162-792-746-235-045,Patent Application,yes,0,14,11,11,0,C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20;;G16H50/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16B40/20;;C12Q1/6883;;G01N33/6893;;G01N2800/085;;G16H50/20;;G16B40/00;;Y02A90/10;;G16B40/20,C12Q1/68;;G16B40/20,,0,0,,,,PENDING
957,MX,A,MX 2022015481 A,105-564-217-969-906,2023-01-16,2023,MX 2022015481 A,2017-11-09,US 201562162354 P,2015-05-15,UTILITY VEHICLE.,"A utility vehicle (2) includes a plurality of ground-engaging members (4), a frame (10), a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat (38) and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors (200) to enclose the operator area.",POLARIS INC,RIPLEY RICHARD D;;JOHNSON CLINTON A;;FIELDS JASON R;;CARRUTH CURTIS C;;KOFSTAD TRACY S;;ERSPAMER BRENT A;;SEIDEL BRIAN J;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;BLACK-MACKEN RYAN;;BURT II DANIEL L;;FRANKER STEVEN R;;NYSSE AARON J;;FLICK BRIAN N;;KUHL AMERY D;;PETERSON SHAWN D;;WEBER DANIEL S,,https://lens.org/105-564-217-969-906,Patent Application,no,0,0,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60G15/06;;B60G7/02;;B60K5/00;;B60K11/06;;B60K13/02;;B60K13/04;;B60K17/08;;B60P1/04;;B60R7/06;;B60R11/00;;B60R11/02;;B62D1/187,,0,0,,,,PENDING
958,MX,A,MX 2022015485 A,086-954-235-496-029,2023-01-16,2023,MX 2022015485 A,2017-11-09,US 201562162354 P,2015-05-15,UTILITY VEHICLE.,"A utility vehicle (2) includes a plurality of ground-engaging members (4), a frame (10), a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat (38) and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors (200) to enclose the operator area.",POLARIS INC,RIPLEY RICHARD D;;JOHNSON CLINTON A;;FIELDS JASON R;;CARRUTH CURTIS C;;KOFSTAD TRACY S;;ERSPAMER BRENT A;;SEIDEL BRIAN J;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;BLACK-MACKEN RYAN;;BURT II DANIEL L;;FRANKER STEVEN R;;NYSSE AARON J;;FLICK BRIAN N;;KUHL AMERY D;;PETERSON SHAWN D;;WEBER DANIEL S,,https://lens.org/086-954-235-496-029,Patent Application,no,0,0,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B65G15/06;;B60G7/02;;B60K5/00;;B60K11/06;;B60K13/02;;B60K13/04;;B60K17/08;;B60P1/04;;B60R7/06;;B60R11/00;;B60R11/02;;B62D1/187,,0,0,,,,PENDING
959,MX,A,MX 2022015486 A,004-804-800-002-514,2023-01-16,2023,MX 2022015486 A,2017-11-09,US 201562162354 P,2015-05-15,UTILITY VEHICLE.,"A utility vehicle (2) includes a plurality of ground-engaging members (4), a frame (10), a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat (38) and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors (200) to enclose the operator area.",POLARIS INC,RIPLEY RICHARD D;;JOHNSON CLINTON A;;FIELDS JASON R;;CARRUTH CURTIS C;;KOFSTAD TRACY S;;ERSPAMER BRENT A;;SEIDEL BRIAN J;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;BLACK-MACKEN RYAN;;BURT II DANIEL L;;FRANKER STEVEN R;;NYSSE AARON J;;FLICK BRIAN N;;KUHL AMERY D;;PETERSON SHAWN D;;WEBER DANIEL S,,https://lens.org/004-804-800-002-514,Patent Application,no,0,0,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60G15/06;;B60G7/02;;B60K5/00;;B60K11/06;;B60K13/02;;B60K13/04;;B60K17/08;;B60P1/04;;B60R7/06;;B60R11/00;;B60R11/02;;B62D1/187,,0,0,,,,PENDING
960,MX,A,MX 2022015484 A,016-642-012-463-340,2023-01-16,2023,MX 2022015484 A,2017-11-09,US 201562162354 P,2015-05-15,UTILITY VEHICLE.,"A utility vehicle (2) includes a plurality of ground-engaging members (4), a frame (10), a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat (38) and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors (200) to enclose the operator area.",POLARIS INC,RIPLEY RICHARD D;;JOHNSON CLINTON A;;FIELDS JASON R;;CARRUTH CURTIS C;;KOFSTAD TRACY S;;ERSPAMER BRENT A;;SEIDEL BRIAN J;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;BLACK-MACKEN RYAN;;BURT II DANIEL L;;FRANKER STEVEN R;;NYSSE AARON J;;FLICK BRIAN N;;KUHL AMERY D;;PETERSON SHAWN D;;WEBER DANIEL S,,https://lens.org/016-642-012-463-340,Patent Application,no,0,0,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60G15/06;;B60G7/02;;B60K5/00;;B60K11/06;;B60K13/02;;B60K13/04;;B60K17/08;;B60P1/04;;B60R7/06;;B60R11/00;;B60R11/02;;B62D1/187,,0,0,,,,PENDING
961,MX,A,MX 2022015482 A,181-197-241-658-192,2023-01-16,2023,MX 2022015482 A,2017-11-09,US 201562162354 P,2015-05-15,UTILITY VEHICLE.,"A utility vehicle (2) includes a plurality of ground-engaging members (4), a frame (10), a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat (38) and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors (200) to enclose the operator area.",POLARIS INC,RIPLEY RICHARD D;;JOHNSON CLINTON A;;FIELDS JASON R;;CARRUTH CURTIS C;;KOFSTAD TRACY S;;ERSPAMER BRENT A;;SEIDEL BRIAN J;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;BLACK-MACKEN RYAN;;BURT II DANIEL L;;FRANKER STEVEN R;;NYSSE AARON J;;FLICK BRIAN N;;KUHL AMERY D;;PETERSON SHAWN D;;WEBER DANIEL S,,https://lens.org/181-197-241-658-192,Patent Application,no,0,0,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60G15/06;;B60G7/02;;B60K5/00;;B60K11/06;;B60K13/02;;B60K13/04;;B60K17/08;;B60P1/04;;B60R7/06;;B60R11/00;;B60R11/02;;B62D1/187,,0,0,,,,PENDING
962,MX,A,MX 2017014403 A,099-072-105-621-167,2018-04-11,2018,MX 2017014403 A,2016-05-12,US 201562162354 P;;US 2016/0031992 W,2015-05-15,UTILITY VEHICLE.,"A utility vehicle (2) includes a plurality of ground-engaging members (4), a frame (10), a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat (38) and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors (200) to enclose the operator area.",POLARIS INC,RICHARD D RIPLEY;;AARON J NYSSE;;SHAWN D PETERSON;;CLINTON A JOHNSON;;JASON R FIELDS;;CURTIS C CARRUTH;;TRACY S KOFSTAD;;BRENT A ERSPAMER;;BRIAN J SEIDEL;;MICHAEL C BOHNSACK;;ANDREW J MILLER;;RYAN BLACK-MACKEN;;DANIEL L BURT II;;STEVEN R FRANKER;;BRIAN N FLICK;;AMERY D KUHL;;DANIEL S WEBER,,https://lens.org/099-072-105-621-167,Patent Application,no,0,0,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60K13/02;;B60G7/02;;B60K5/00;;B60K11/06;;B60K13/04;;B60K17/08;;B60P1/04;;B60R7/06;;B60R11/00;;B60R11/02;;B62D1/187,,0,0,,,,PENDING
963,MX,A,MX 2022015480 A,133-003-318-664-859,2023-01-16,2023,MX 2022015480 A,2017-11-09,US 201562162354 P,2015-05-15,UTILITY VEHICLE.,"A utility vehicle (2) includes a plurality of ground-engaging members (4), a frame (10), a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat (38) and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors (200) to enclose the operator area.",POLARIS INC,RIPLEY RICHARD D;;JOHNSON CLINTON A;;FIELDS JASON R;;CARRUTH CURTIS C;;KOFSTAD TRACY S;;ERSPAMER BRENT A;;SEIDEL BRIAN J;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;BLACK-MACKEN RYAN;;BURT II DANIEL L;;FRANKER STEVEN R;;NYSSE AARON J;;FLICK BRIAN N;;KUHL AMERY D;;PETERSON SHAWN D;;WEBER DANIEL S,,https://lens.org/133-003-318-664-859,Patent Application,no,0,0,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60G15/06;;B60G7/02;;B60K5/00;;B60K11/06;;B60K13/02;;B60K13/04;;B60K17/08;;B60P1/04;;B60R7/06;;B60R11/00;;B60R11/02;;B62D1/187,,0,0,,,,PENDING
964,MX,A,MX 2022015483 A,187-137-856-608-697,2023-01-16,2023,MX 2022015483 A,2017-11-09,US 201562162354 P,2015-05-15,UTILITY VEHICLE.,"A utility vehicle (2) includes a plurality of ground-engaging members (4), a frame (10), a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat (38) and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors (200) to enclose the operator area.",POLARIS INC,RIPLEY RICHARD D;;JOHNSON CLINTON A;;FIELDS JASON R;;CARRUTH CURTIS C;;KOFSTAD TRACY S;;ERSPAMER BRENT A;;SEIDEL BRIAN J;;BOHNSACK MICHAEL C;;MILLER ANDREW J;;BLACK-MACKEN RYAN;;BURT II DANIEL L;;FRANKER STEVEN R;;NYSSE AARON J;;FLICK BRIAN N;;KUHL AMERY D;;PETERSON SHAWN D;;WEBER DANIEL S,,https://lens.org/187-137-856-608-697,Patent Application,no,0,0,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60G15/06;;B60G7/02;;B60K5/00;;B60K11/06;;B60K13/02;;B60K13/04;;B60K17/08;;B60P1/04;;B60R7/06;;B60R11/00;;B60R11/02;;B62D1/187,,0,0,,,,PENDING
965,BR,A,BR 9605750 A,043-904-685-594-608,1998-08-25,1998,BR 9605750 A,1996-11-29,US 56454395 A,1995-11-30,Medidores de eletricidade vetorial e processos associados de mediçÃo de eletrecidade vetorial,,GEN ELECTRIC,MAEHL THOMAS;;PROVOST ROLAD J;;HOFFMAN MARK E;;BURT ARTHUR CHARLES;;STAVER DANIEL ARTHUR;;PUTCHA SIVARAMA SESHU;;BULLOCK DONALD FRANK;;MAMMEN JEFFREY W;;GERMER WARREN RALPH;;ELMORE DAVID DEAN;;PLIS MARK JOSEPH;;LAVOIE GREGORY PAUL,,https://lens.org/043-904-685-594-608,Patent Application,no,0,0,16,16,0,G01R21/1331;;G01R21/1331,G01R21/133,,0,0,,,,EXPIRED
966,US,A1,US 2022/0387673 A1,068-299-930-384-722,2022-12-08,2022,US 202017773799 A,2020-11-05,US 202017773799 A;;US 201962932947 P;;US 2020/0059235 W,2019-11-08,HYDROPHILIC MEDICAL PRODUCTS AND HYDRATION MEDIUMS FOR HYDRATING THE SAME,"Hydration mediums, assemblies containing hydration mediums and methods of making the same.",HOLLISTER INC,FARRELL DAVID J;;PANESAR SATWINDER S;;HORKAN CARLOS;;MURNAGHAN KEVIN;;SILEIKA TADAS S;;MURRAY MICHAEL G;;NAUGHTON VINCENT;;O'DONNELL PAUL M;;O'MAHONY JOHN P;;CLARKE JOHN T;;DEAN NICOLE L;;BURT RAJAN A;;PETTIGREW JACQUELINE MJ,HOLLISTER INCORPORATED (2019-11-13),https://lens.org/068-299-930-384-722,Patent Application,yes,0,2,5,5,0,A61L29/14;;A61L29/146;;A61L2400/10;;A61M25/002;;A61M2025/0046;;A61M25/0111;;A61M2210/1096;;A61L29/16;;A61L29/143;;A61L29/141;;A61L2300/11;;A61L29/02;;A61L29/06;;A61L29/14;;A61L29/143;;A61L29/146;;A61L2300/802;;A61L2400/10;;A61M25/002,A61L29/14;;A61L29/02;;A61L29/06;;A61M25/00,,0,0,,,,PENDING
967,WO,A1,WO 2021/092271 A1,131-361-451-992-330,2021-05-14,2021,US 2020/0059235 W,2020-11-05,US 201962932947 P,2019-11-08,HYDROPHILIC MEDICAL PRODUCTS AND HYDRATION MEDIUMS FOR HYDRATING THE SAME,"Hydration mediums, assemblies containing hydration mediums and methods of making the same.",HOLLISTER INC,FARRELL DAVID J;;PANESAR SATWINDER S;;HORKAN CARLOS;;MURNAGHAN KEVIN;;SILEIKA TADAS S;;MURRAY MICHAEL G;;NAUGHTON VINCENT;;O'DONNELL PAUL M;;O'MAHONY JOHN P;;CLARKE JOHN T;;DEAN NICOLE L;;BURT RAJAN A;;PETTIGREW JACQUELINE MJ,,https://lens.org/131-361-451-992-330,Patent Application,yes,4,1,5,5,0,A61L29/14;;A61L29/146;;A61L2400/10;;A61M25/002;;A61M2025/0046;;A61M25/0111;;A61M2210/1096;;A61L29/16;;A61L29/143;;A61L29/141;;A61L2300/11;;A61L29/02;;A61L29/06;;A61L29/14;;A61L29/143;;A61L29/146;;A61L2300/802;;A61L2400/10;;A61M25/002,A61L27/50;;A61B50/30;;A61L29/14;;A61M25/00,,0,0,,,,PENDING
968,EP,A1,EP 4054662 A1,038-004-992-791-922,2022-09-14,2022,EP 20817127 A,2020-11-05,US 201962932947 P;;US 2020/0059235 W,2019-11-08,HYDROPHILIC MEDICAL PRODUCTS AND HYDRATION MEDIUMS FOR HYDRATING THE SAME,,HOLLISTER INC,FARRELL DAVID J;;PANESAR SATWINDER S;;HORKAN CARLOS;;MURNAGHAN KEVIN;;SILEIKA TADAS S;;MURRAY MICHAEL G;;NAUGHTON VINCENT;;O'DONNELL PAUL M;;O'MAHONY JOHN P;;CLARKE JOHN T;;DEAN NICOLE L;;BURT RAJAN A;;PETTIGREW JACQUELINE MJ,,https://lens.org/038-004-992-791-922,Patent Application,yes,0,0,5,5,0,A61L29/14;;A61L29/146;;A61L2400/10;;A61M25/002;;A61M2025/0046;;A61M25/0111;;A61M2210/1096;;A61L29/16;;A61L29/143;;A61L29/141;;A61L2300/11;;A61L29/02;;A61L29/06;;A61L29/14;;A61L29/143;;A61L29/146;;A61L2300/802;;A61L2400/10;;A61M25/002,A61B50/30;;A61L27/50;;A61L29/14;;A61M25/00,,0,0,,,,PENDING
969,CA,A1,CA 3160638 A1,190-273-471-766-365,2021-05-14,2021,CA 3160638 A,2020-11-05,US 201962932947 P;;US 2020/0059235 W,2019-11-08,HYDROPHILIC MEDICAL PRODUCTS AND HYDRATION MEDIUMS FOR HYDRATING THE SAME,"Hydration mediums, assemblies containing hydration mediums and methods of making the same.",HOLLISTER INC,FARRELL DAVID J;;PANESAR SATWINDER S;;HORKAN CARLOS;;MURNAGHAN KEVIN;;SILEIKA TADAS S;;MURRAY MICHAEL G;;NAUGHTON VINCENT;;O'DONNELL PAUL M;;O'MAHONY JOHN P;;CLARKE JOHN T;;DEAN NICOLE L;;BURT RAJAN A;;PETTIGREW JACQUELINE MJ,,https://lens.org/190-273-471-766-365,Patent Application,no,0,0,5,5,0,A61L29/14;;A61L29/146;;A61L2400/10;;A61M25/002;;A61M2025/0046;;A61M25/0111;;A61M2210/1096;;A61L29/16;;A61L29/143;;A61L29/141;;A61L2300/11;;A61L29/02;;A61L29/06;;A61L29/14;;A61L29/143;;A61L29/146;;A61L2300/802;;A61L2400/10;;A61M25/002,A61B50/30;;A61L27/50;;A61L29/14;;A61M25/00,,0,0,,,,PENDING
970,CA,A1,CA 2985632 A1,026-265-729-174-708,2016-11-24,2016,CA 2985632 A,2016-05-12,US 201562162354 P;;US 2016/0031992 W,2015-05-15,UTILITY VEHICLE,"A utility vehicle (2) includes a plurality of ground-engaging members (4), a frame (10), a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat (38) and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors (200) to enclose the operator area.",POLARIS INC,MILLER ANDREW J;;FIELDS JASON R;;WEBER DANIEL;;KUHL AMERY D;;FLICK BRIAN N;;CARRUTH CURTIS C;;PETERSON SHAWN D;;BURT DANIEL L;;ERSPAMER BRENT A;;JOHNSON CLINTON A;;SEIDEL BRIAN;;BOHNSACK MIKE;;RIPLEY RICHARD D;;KOFSTAD TRACY S;;BLACK-MACKEN RYAN;;FRANKER STEVEN R;;NYSSE AARON J,,https://lens.org/026-265-729-174-708,Patent Application,no,0,1,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60K13/02;;B60G7/02;;B60K5/00;;B60K11/06;;B60K13/04;;B60K17/08;;B60P1/04;;B60R7/06;;B60R11/00;;B60R11/02;;B62D1/187,,0,0,,,,PENDING
971,EP,A1,EP 3294582 A1,009-410-908-207-212,2018-03-21,2018,EP 16725017 A,2016-05-12,US 201562162354 P;;US 2016/0031992 W,2015-05-15,UTILITY VEHICLE,,POLARIS INC,MILLER ANDREW J;;FIELDS JASON R;;WEBER DANIEL;;KUHL AMERY D;;FLICK BRIAN N;;CARRUTH CURTIS C;;PETERSON SHAWN D;;BURT DANIEL L;;ERSPAMER BRENT A;;JOHNSON CLINTON A;;SEIDEL BRIAN;;BOHNSACK MIKE;;RIPLEY RICHARD D;;KOFSTAD TRACY S;;BLACK MACKEN RYAN;;FRANKER STEVEN R;;NYSSE AARON J,,https://lens.org/009-410-908-207-212,Patent Application,yes,0,0,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60K13/02;;B60G7/02;;B60K5/00;;B60K11/06;;B60K13/04;;B60K17/08;;B60P1/04;;B60R7/06;;B60R11/00;;B60R11/02;;B62D1/187,,0,0,,,,DISCONTINUED
972,CN,A,CN 113183701 A,091-075-537-214-699,2021-07-30,2021,CN 202110495317 A,2016-05-12,US 201562162354 P;;CN 201680028024 A,2015-05-15,Utility vehicle,"A utility vehicle (2) includes a plurality of ground-engaging members (4), a frame (10), a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat (38) and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors (200) to enclose the operator area.",POLARIS INC,MILLER ANDREW J;;FIELDS JASON R;;WEBER DANIEL;;KUHL AMERY D;;BRYAN N FLICK;;CARRUTH CURTIS C;;PETERSON SHAWN D;;BURT DANIEL L;;ERSPAMER BRENT A;;JOHNSON CLINTON A;;SEIDEL BRIAN;;BOHNSACK MIKE;;RIPLEY RICHARD D;;KOFSTAD TRACY S;;BLACK-MACKEN RYAN;;FRANKER STEVEN R;;NYSSE AARON J,,https://lens.org/091-075-537-214-699,Patent Application,no,10,0,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60G3/02;;B60G3/20;;B60G11/48;;B60G15/06;;B60J5/04;;B60K5/04;;B60K11/06;;B60K13/02;;B60K13/04;;B60K17/06;;B60K17/08;;B60K37/02;;B60N2/01;;B60P1/04;;B62D1/18;;B62D21/18;;B62D33/02;;E05D5/02;;E05D11/06,,0,0,,,,PENDING
973,AU,B2,AU 2016/265556 B2,187-786-685-591-690,2019-05-02,2019,AU 2016/265556 A,2016-05-12,US 201562162354 P;;US 2016/0031992 W,2015-05-15,Utility vehicle,"A utility vehicle (2) includes a plurality of ground-engaging members (4), a frame (10), a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat (38) and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors (200) to enclose the operator area.",POLARIS INC,MILLER ANDREW J;;FIELDS JASON R;;WEBER DANIEL;;KUHL AMERY D;;FLICK BRIAN N;;CARRUTH CURTIS C;;PETERSON SHAWN D;;BURT DANIEL L;;ERSPAMER BRENT A;;JOHNSON CLINTON A;;SEIDEL BRIAN;;BOHNSACK MIKE;;RIPLEY RICHARD D;;KOFSTAD TRACY S;;BLACK-MACKEN RYAN;;FRANKER STEVEN R;;NYSSE AARON J,,https://lens.org/187-786-685-591-690,Granted Patent,no,2,0,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60K13/02;;B60G7/02;;B60K5/00;;B60K11/06;;B60K13/04;;B60K17/08;;B60P1/04;;B60R7/06;;B60R11/00;;B60R11/02;;B62D1/187,,0,0,,,,ACTIVE
974,CN,A,CN 107635800 A,068-835-856-167-012,2018-01-26,2018,CN 201680028024 A,2016-05-12,US 201562162354 P;;US 2016/0031992 W,2015-05-15,Utility vehicle,"A utility vehicle (2) includes a plurality of ground-engaging members (4), a frame (10), a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat (38) and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors (200) to enclose the operator area.",POLARIS INC,MILLER ANDREW J;;FIELDS JASON R;;WEBER DANIEL;;KUHL AMERY D;;FLICK BRIAN N;;CARRUTH CURTIS C;;PETERSON SHAWN D;;BURT DANIEL L;;ERSPAMER BRENT A;;JOHNSON CLINTON A;;SEIDEL BRIAN;;BOHNSACK MIKE;;RIPLEY RICHARD D;;KOFSTAD TRACY S;;BLACK-MACKEN RYAN;;FRANKER STEVEN R;;NYSSE AARON J,,https://lens.org/068-835-856-167-012,Patent Application,no,11,5,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60G3/02;;B60G3/20;;B60G11/48;;B60G15/06;;B60J5/04;;B60K5/00;;B60K5/04;;B60K11/06;;B60K13/02;;B60K13/04;;B60K17/06;;B60K17/08;;B60K37/02;;B60N2/01;;B60P1/04;;B62D1/18;;B62D21/18;;B62D33/02;;E05D3/02;;E05D5/02;;E05D11/06,,0,0,,,,ACTIVE
975,WO,A1,WO 2016/186942 A1,042-500-396-109-955,2016-11-24,2016,US 2016/0031992 W,2016-05-12,US 201562162354 P,2015-05-15,UTILITY VEHICLE,"A utility vehicle (2) includes a plurality of ground-engaging members (4), a frame (10), a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat (38) and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors (200) to enclose the operator area.",POLARIS INC,MILLER ANDREW J;;FIELDS JASON R;;WEBER DANIEL;;KUHL AMERY D;;FLICK BRIAN N;;CARRUTH CURTIS C;;PETERSON SHAWN D;;BURT DANIEL L;;ERSPAMER BRENT A;;JOHNSON CLINTON A;;SEIDEL BRIAN;;BOHNSACK MIKE;;RIPLEY RICHARD D;;KOFSTAD TRACY S;;BLACK-MACKEN RYAN;;FRANKER STEVEN R;;NYSSE AARON J,,https://lens.org/042-500-396-109-955,Patent Application,yes,4,4,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60K13/02;;B60G7/02;;B60K5/00;;B60K11/06;;B60K13/04;;B60K17/08;;B60P1/04;;B60R7/06;;B60R11/00;;B60R11/02;;B62D1/187,,0,0,,,,PENDING
976,AU,A1,AU 2016/265556 A1,175-988-668-447-187,2017-12-07,2017,AU 2016/265556 A,2016-05-12,US 201562162354 P;;US 2016/0031992 W,2015-05-15,Utility vehicle,"A utility vehicle (2) includes a plurality of ground-engaging members (4), a frame (10), a powertrain assembly, a front suspension assembly, and a rear suspension assembly. A cargo bed may be supported by the frame at the rear of the vehicle. The vehicle also includes an operator seat (38) and at least one passenger seat positioned within an operator area. In one embodiment, the vehicle includes doors (200) to enclose the operator area.",POLARIS INC,MILLER ANDREW J;;FIELDS JASON R;;WEBER DANIEL;;KUHL AMERY D;;FLICK BRIAN N;;CARRUTH CURTIS C;;PETERSON SHAWN D;;BURT DANIEL L;;ERSPAMER BRENT A;;JOHNSON CLINTON A;;SEIDEL BRIAN;;BOHNSACK MIKE;;RIPLEY RICHARD D;;KOFSTAD TRACY S;;BLACK-MACKEN RYAN;;FRANKER STEVEN R;;NYSSE AARON J,,https://lens.org/175-988-668-447-187,Patent Application,no,0,0,30,30,0,B60G15/065;;B60G3/02;;B60G3/20;;B60G11/48;;B60K5/04;;B60P1/04;;B60J5/0487;;B60K17/08;;B62D21/183;;E05D11/06;;B60G15/062;;B60K17/06;;B60K11/06;;B60N2/01;;E05D5/0207;;B60K13/04;;B62D1/18;;B62D33/02;;B60K13/02;;B60G2200/14;;E05Y2900/531;;B60Y2400/72;;B60Y2200/20;;B60G2202/312;;B60G2300/124;;B60K2005/003;;E05D2003/027;;B60K35/60;;B60K35/22;;B60K35/28;;B60K2360/167;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;B60K13/04;;B60Y2200/20;;B60K13/02;;B60K2360/60;;B60K35/53;;B60K2360/685;;B60P1/04;;B60K13/04;;B62D33/02;;B60Y2200/20;;B60K11/06;;B60K17/08;;B60K2005/003;;B60Y2400/72;;E05Y2900/531;;E05D5/0207;;E05D11/06;;E05D2003/027;;B60G3/20;;B60G15/062;;B60G15/065;;B60G2200/14;;B60G2200/156;;B60G2202/312;;B60G2300/02;;B60G2300/07;;B60G2300/124;;F16H57/0416;;B60K17/04;;B60K35/53;;B60K35/60;;B60K2360/60;;B60K2360/685;;B60G11/48;;B60J5/0487;;B60N2/01;;B62D1/18;;B62D21/183;;B60G3/02;;B60K17/06;;B60K5/04;;B60K13/02,B60K13/02;;B60G7/02;;B60K5/00;;B60K11/06;;B60K13/04;;B60K17/08;;B60P1/04;;B60R7/06;;B60R11/00;;B60R11/02;;B62D1/187,,0,0,,,,ACTIVE
977,US,A1,US 2003/0032033 A1,105-980-952-764-811,2003-02-13,2003,US 12214102 A,2002-04-12,US 12214102 A;;US 28416301 P,2001-04-16,Watermark systems and methods,"
   Various improvements relating to digital watermarking and related technologies are detailed, including methods that enhance security and functionality, and new articles including watermarked puzzles and marked DNA. 
",ANGLIN HUGH W.;;BRUNK HUGH L.;;CATTONE JEREMY;;HEIN WILLIAM C.;;HUDSON ERIC C.;;JONES KEVIN C.;;LEVY KENNETH L.;;MCKINLEY TYLER J.;;PATTERSON PHILIP R.;;PERRY BURT W.;;RHOADS GEOFFREY B.;;SEDER PHILLIP ANDREW;;STEWART STEVEN W.,ANGLIN HUGH W;;BRUNK HUGH L;;CATTONE JEREMY;;HEIN WILLIAM C;;HUDSON ERIC C;;JONES KEVIN C;;LEVY KENNETH L;;MCKINLEY TYLER J;;PATTERSON PHILIP R;;PERRY BURT W;;RHOADS GEOFFREY B;;SEDER PHILLIP ANDREW;;STEWART STEVEN W,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC CORPORATION (2008-08-01);;DMRC LLC (2008-08-01),https://lens.org/105-980-952-764-811,Patent Application,yes,72,119,3,1547,0,G06T1/0021;;G06T1/0021,G06T1/00,435/6;;702/19;;X702 2;;713/201,0,0,,,,EXPIRED
978,US,A1,US 2010/0205445 A1,160-872-584-677-955,2010-08-12,2010,US 76123010 A,2010-04-15,US 76123010 A;;US 12214102 A;;US 28416301 P,2001-04-16,WATERMARK SYSTEMS AND METHODS,"Various improvements relating to digital watermarking and related technologies are detailed, including methods that enhance security and functionality, and new articles including watermarked puzzles and marked DNA.",ANGLIN HUGH W;;BRUNK HUGH L;;CATTONE JEREMY;;HEIN III WILLIAM C;;HUDSON ERIC C;;JONES KEVIN C;;LEVY KENNETH L;;MCKINLEY TYLER J;;PATTERSON PHILIP R;;PERRY BURT W;;RHOADS GEOFFREY B;;SEDER PHILLIP ANDREW;;STEWART STEVEN W,ANGLIN HUGH W;;BRUNK HUGH L;;CATTONE JEREMY;;HEIN III WILLIAM C;;HUDSON ERIC C;;JONES KEVIN C;;LEVY KENNETH L;;MCKINLEY TYLER J;;PATTERSON PHILIP R;;PERRY BURT W;;RHOADS GEOFFREY B;;SEDER PHILLIP ANDREW;;STEWART STEVEN W,DIGIMARC CORPORATION (2008-09-03);;DIGIMARC CORPORATION (AN OREGON CORPORATION) (2010-04-30);;DMRC CORPORATION (2008-08-01);;DMRC LLC (2008-08-01),https://lens.org/160-872-584-677-955,Patent Application,yes,99,5,3,1547,0,G06T1/0021;;G06T1/0021,H04L9/00;;G06T1/00,713/176,0,0,,,,DISCONTINUED
979,EP,A2,EP 0777125 A2,075-039-897-355-251,1997-06-04,1997,EP 96308666 A,1996-11-29,US 56454395 A,1995-11-30,Vector electricity meters and associated vector electricity metering methods,"Line voltage and line current signals are sensed (110,120) on a power line having at least one conducting path (220 A-C). The sensed line voltages and line currents are converted (320) into a digital signal. A phase-to-neutral voltage signal and phase current signal are computed (330) from the digital signal to thereby define a phase of the power line. An interval of orthogonality is determined from the sensed voltage and current signals, coinciding with passage of an integral number of cycles of a fundamental frequency reference signal which is computed from the computed phase-to-neutral voltage signal. A vector metering quantity is computed for the determined interval of orthogonality from the computed phase-to-neutral voltage signal and the computed phase current signal. The vector metering quantities to be computed may be identified and computed based upon an associated detent. The vector metering quantity is also computed based on an identified circuit topology.",GEN ELECTRIC,HOFFMAN MARK E;;LAVOIE GREGORY PAUL;;PROVOST ROLAND J;;PLIS MARK JOSEPH;;MAEHL THOMAS;;ELMORE DAVID DEAN;;GERMER WARREN RALPH;;PUTCHA SIVARAMA SESHU;;MAMMEN JEFFREY W;;STAVER DANIEL ARTHUR;;BULLOCK DONALD FRANK;;BURT ARTHUR CHARLES;;CRITTENDEN CURTIS WHITMORE;;EDGE ELLEN D,"ACLARA METERS LLC, US (2016-08-15);;ACLARA METERS LLC (N.D.GES.D. STAATES DELAWARE, US (2016-05-20)",https://lens.org/075-039-897-355-251,Patent Application,yes,0,6,16,16,0,G01R21/1331;;G01R21/1331,G01R21/133;;G01R22/10,,0,0,,,,EXPIRED
980,DE,D1,DE 69637822 D1,176-244-615-536-930,2009-03-12,2009,DE 69637822 T,1996-11-29,US 56454395 A,1995-11-30,Vektorelektrizitätsmeter und -verfahren,,GEN ELECTRIC,HOFFMAN MARK E;;LAVOIE GREGORY PAUL;;PROVOST ROLAND J;;PLIS MARK JOSEPH;;MAEHL THOMAS;;ELMORE DAVID DEAN;;GERMER WARREN RALPH;;PUTCHA SIVARAMA SESHU;;MAMMEN JEFFREY W;;STAVER DANIEL ARTHUR;;BULLOCK DONALD FRANK;;BURT ARTHUR CHARLES;;CRITTENDEN CURTIS WHITMORE;;EDGE ELLEN D,,https://lens.org/176-244-615-536-930,Granted Patent,no,0,0,16,16,0,G01R21/1331;;G01R21/1331,G01R21/133;;G01R22/10,,0,0,,,,EXPIRED
981,EP,A3,EP 0777125 A3,036-106-014-174-733,1998-05-20,1998,EP 96308666 A,1996-11-29,US 56454395 A,1995-11-30,Vector electricity meters and associated vector electricity metering methods,,GEN ELECTRIC,HOFFMAN MARK E;;LAVOIE GREGORY PAUL;;PROVOST ROLAND J;;PLIS MARK JOSEPH;;MAEHL THOMAS;;ELMORE DAVID BEAN;;GERMER WARREN RALPH;;PUTCHA SIVARAMA SESHU;;MAMMEN JEFFREY W;;STAVER DANIEL ARTHUR;;BULLOCK DONALD FRANK;;BURT ARTHUR CHARLES;;CRITTENDEN CURTIS WHITMORE;;EDGE ELLEN D,"ACLARA METERS LLC, US (2016-08-15);;ACLARA METERS LLC (N.D.GES.D. STAATES DELAWARE, US (2016-05-20)",https://lens.org/036-106-014-174-733,Search Report,no,1,0,16,16,0,G01R21/1331;;G01R21/1331,G01R21/133,,1,0,,,"TURNELL ET AL.: ""a microprocessor-based three phase power transducer"", IEEE INSTR. AND MEASUREMENT TECHN. CONF., 25 April 1989 (1989-04-25) - 27 April 1989 (1989-04-27), WASHINTON,D.C., US, pages 98 - 102, XP000041342",EXPIRED
982,EP,B1,EP 0777125 B1,036-234-073-410-19X,2009-01-21,2009,EP 96308666 A,1996-11-29,US 56454395 A,1995-11-30,Vector electricity meters and associated vector electricity metering methods,,GEN ELECTRIC,HOFFMAN MARK E;;LAVOIE GREGORY PAUL;;PROVOST ROLAND J;;PLIS MARK JOSEPH;;MAEHL THOMAS;;ELMORE DAVID DEAN;;GERMER WARREN RALPH;;PUTCHA SIVARAMA SESHU;;MAMMEN JEFFREY W;;STAVER DANIEL ARTHUR;;BULLOCK DONALD FRANK;;BURT ARTHUR CHARLES;;CRITTENDEN CURTIS WHITMORE;;EDGE ELLEN D,"ACLARA METERS LLC, US (2016-08-15);;ACLARA METERS LLC (N.D.GES.D. STAATES DELAWARE, US (2016-05-20)",https://lens.org/036-234-073-410-19X,Granted Patent,yes,1,0,16,16,0,G01R21/1331;;G01R21/1331,G01R21/133;;G01R22/10,,2,2,144-007-601-384-446;;030-437-848-511-255,10.1109/ee.1935.6539147;;10.1109/61.311149,"CURTIS ET AL.: ""DEFINITIONS OF POWER AND RELATED QUANTITIES"", ELECTRICAL ENGINEERING, April 1935 (1935-04-01), pages 394 - 404;;FILIPSKI ET AL.: ""Discussion of power definitions contained in the IEEE dictionary"", IEEE TRANSACTIONS ON POWER DELIVERY, vol. 9, no. 3, July 1994 (1994-07-01), pages 1237 - 1244",EXPIRED
